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Abstract 
Nuclear magnetic resonance (NMR) spectroscopy is a versatile tool in analytical chemistry, highly 
suitable for structural elucidation of organic molecules – as well as multiple other areas of research. 
The subjects covered within this thesis all concern methods which allow a shift from covalent to 
spatial structural information using NMR spectroscopy. 
Experimental distances from nuclear Overhauser effect (NOE) correlations, and dihedral angles 
from 
3
JHH-coupling constants, were used to obtain 3D structural information for several natural and 
synthetic compounds. The stereochemistry of novel natural compounds was determined, including 
that of a bicyclic non-ribosomal peptide (a novel structural motif), a steroid and several polyketides. 
Structural insights were gained for potential anti-cancer agents; the azumamides, including 
synthetic analogues. Differences in the conformational space of solution state compounds were 
identified experimentally between structural analogues, and compared to the in vitro potency of the 
compounds. The structures of two peptides that exhibited a high degree of molecular recognition 
were investigated, resulting in the elucidation of a possible mode of interaction. Also a major 
assumption in the calculation of distances from NOEs, the assumption of equal rotational 
correlation times between proton pairs, was investigated for molecules in organic solvents. 
Two spin-state selective (S
3
) HMBC experiments were developed for measurements of 
homonuclear and hetereonuclear long-range coupling constants, respectively. The new NMR 
experiments were based on two existing experiments, the multiplicity edited HMBC and the HAT 
HMBC, which were combined to obtain S
3
 editing of long-range homonuclear coupling constants. 
The output of the first S
3
 HMBC experiment was HMBC type spectra with 
n
JCH correlated cross-
peaks, from which 
n+1
JHH-coupling constants were sign-selectively determined with high accuracy. 
Very small coupling constants, including previously unreported coupling constants from strychnine, 
were extracted, with all experimental values correlating very well to theoretical coupling constants 
from DFT calculation. A pulse segment was developed to change the polarization of the CH-H pairs 
in the homonuclear S
3
 HMBC, to gain S
3
 edited 
n
JCH-coupling constants in the cross-peaks. While 
only determining coupling constants to methine carbons, the extracted experimental coupling 
constants correlated very well to theoretical coupling constants, thus extending the S
3
 HMBC 
methodology to include both 
n+1
JHH- and 
n
JCH-coupling constants.  
Residual dipolar couplings (RDCs) are a relatively late addition to the small molecular NMR 
community, where alignment media are used to obtain anisotropic samples, which allows for RDCs 
to be extracted. The number of internuclear vectors for the correlation of RDCs to 3D structures is 
often limited for small molecules. Homonuclear RDCs were extracted by use of the homonuclear S
3
 
HMBC that correlated well to alignment tensors from 
1
DCH-coupling constants, thus increasing the 
number of inter-nuclear vectors. The topic of enantiodiscrimination by RDC measurements of rigid 
organic molecules was also investigated, and new alignment media were developed to allow slight 
discrimination of enantiomers by stretched polymers. Finally a new method of back-calculation of 
RDCs from 3D structures was developed and tested, which copes better with multiple conformers 
than the commonly used SVD methodology. The approach thus resulted in good conformer 
populations for several small molecules, including multiple cinchona alkaloids. 
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Resumé 
NMR (nuclear magnetic resonance) spektroskopi er et alsidigt og vigtigt værktøj i analytisk kemi, 
der ofte er involveret i strukturopklaring af organiske molekyler såvel som i mange andre 
forskningsområder. Denne afhandling omhandler metoder til at opnå rummelig information om 
molekylære strukturer ved hjælp af NMR spektroskopi. 
3D strukturer af nye natur- og syntetiske stoffer blev således undersøgt ved hjælp af NOE (nuclear 
Overhauser effekt) korrelationer og tre-bindings J-kobling konstanter. NOE korrelationer kan 
bruges til at bestemme afstande mellem atomer i de organiske strukturer, og J-koblingskonstanter 
kan give information of den dihedrale vinkel i H-X-X-H systemer (hvor X oftest er C, N, O). For 
naturstofferne, inklusivt et stof med et hidtil ukendt to-rings-system, ledte NMR data til, at alle 
relative stereocentre blev bestemt. NOE og J-koblinger resulterede også i ny viden om en gruppe af 
potentielle anti-cancer stoffer, kaldet azumamiderne, hvor et naturstof og syntetiske analoger blev 
undersøgt. Der blev identificeret forskelle i det konformatielle rum mellem de forskellige strukturer, 
hvilket blev relateret til deres anti-cancer aktivitet. I et andet projekt blev interaktionen mellem to 
peptider undersøgt, via viden om deres respektive struktur i vand fra afstande mellem atomer. De to 
peptiderne er af særlig interesse, da de selektivt interagerer med hinanden i vandig opløsning, 
ligesom f.eks. proteiner i celler. Derudover blev det undersøgt, i hvor høj grad proton-par i 
organiske strukturer roterer og bevæger sig identisk, hvilket er en antagelse, der gøres for at kunne 
finde afstande fra NOE korrelationer. Det undersøgtes også om det var muligt a korrigere 
afstandene, fra viden om proton-pars relative rotationshastigheder i organiske solventer. 
To nye NMR eksperimenter, kaldet S
3
 (spin-state selective) HMBC, blev udviklet til at måle 
henholdsvis proton-proton og proton-kulstof J-koblingskonstanter i organiske strukturer, hvor de to 
koblende atomer er adskilt af op til flere kemiske bindinger (
n
JCH og 
n+1
JHH, n=2-4). De to NMR 
eksperimenter er baseret på to eksisterende eksperimenter, der kombineredes sådan, at det var 
muligt at måle proton-proton koblingskonstanter mellem en proton bundet til et kulstof og en 
proton, der kobler til dette kulstof. En ny pulssekvens blev tilføjet dette første S
3
 HMBC 
eksperiment, hvilket gjorde det muligt også at måle proton-kulstof koblingskonstanterne. De målte 
koblingskonstanter fra begge sekvenser korrelerede i meget høj grad med teoretisk bestemte 
koblingskonstanter, selv når disse var meget små. Dette medfører derfor muligheden for øget 
strukturel viden. 
Residuale dipolære koblinger (RDCs), en forholdsvis nyligt introduceret parameter for små 
molekyler, og er baseret på vinklen mellem en internukleær vektor og det magnetiske felt fra NMR 
spektrometret. Her er få internukleære vektorer ofte et problem for små molekyler. Det blev vist at 
det homo-nukleare S
3
 HMBC kunne benyttes til at bestemme adskillige RDCs mellem protoner, og 
derved blev flere internukleære vektorer bestemt. For at kunne aflæse RDCs bruges såkaldte 
alignment media, hvor et overskud af en bestemt orientering af molekylerne i NMR prøven skabes. 
Nye alignment media blev syntetiseret, og disse muliggjorde bestemmelsen af enantiomerer 
(spejlede molekyler) ud fra deres aflæste RDCs. Endeligt blev en ny beregningsmetode af RDCs fra 
3D strukturer testet. Metoden fungerede klart bedre end standardmetoden SVD, når fleksible 
strukturer blev undersøgt, hvilket blev vist for flere molekyler.  
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1 
1 NMR spectroscopy: Past to present 
The foundation for modern day NMR spectroscopy was laid more than 70 years ago, in 1946 by the 
work of the groups of Bloch and Purcell who first reported on NMR in bulk materials. Work that 
awarded them a shared Nobel Prize in Physics in 1952.
1,2
 One could look back even further to the 
introduction of the concept of nuclear spin, the phenomenon exploited in NMR spectroscopy, which 
was described in the 1920s.
3,4
 Since the early discoveries much has happened, from the introduction 
of superconducting magnets and development of high field instruments, to proceedings in methods 
of data acquisition, leading to today where NMR spectroscopy is one of the most widely used 
spectroscopic techniques in chemistry, structural biology and material sciences - and arguably the 
most information rich when used appropriately. It is based on an electron density dependent energy 
difference of nuclear spin orientation in an applied magnetic field, as outlined in equation (1.1), and 
the ability of interacting with these spins using radio frequency (RF) energy. 
 𝜔 = 𝛾𝐵0(1 − 𝜎) 
(1.1) 
Where ω is the resonance frequency of a given nucleus, γ is the gyromagnetic ratio of said nucleus, 
B0 is the applied magnetic field and σ is the shielding constant which is dependent on the electron 
density and configuration of electrons around the nucleus.
3
 
In the earliest days of NMR spectroscopy the technique used was continuous-wave spectroscopy, 
where the frequency of the RF pulse was varied, and the spectra recorded by scanning the spectral 
range from start to finish.
3,4
 This changed in the mid-1960s with the introduction of Fourier 
transform (FT) techniques by Ernst and Anderson; work for which Ernst was rewarded with the 
1992 Nobel Prize in Chemistry.
3,5
 FT is a method to extract frequencies from free induction decay 
(FID), and thus data for the full spectral range may be acquired from a single short RF pulse. NMR 
spectroscopy has since evolved into a versatile field, largely in part of ever evolving methods of 
using RF pulses to influence targeted nuclei and output a diverse range of spectra, each with a 
specific purpose. The large array of pulse sequences, which each hold the promise of a vast amount 
of information, means that NMR is applicable when investigating very different systems; small 
molecules, macromolecules and materials in liquid- or solid state alike. 
On the hardware side, the introduction of superconducting magnets in the mid-1960s laid the 
ground for modern day spectrometers.
3,4
 Until then 100 MHz was the maximum field strength 
obtainable, but the development of higher field instruments were available through the new 
technology, from 220 MHz in 1966, 500 MHz in 1978, 800 MHz in 1995 to modern day 
instruments pushing the 1 GHz boundaries and beyond. Due to the correlation of magnetic field 
strength, resolution and signal-to-noise (S/N), the shift to bigger magnets has vastly increased the 
scope of the technology, hand in hand with the development of better probes and other relevant 
hardware. 
This thesis will primarily focus on unique possibilities of NMR spectroscopy that sets the method 
apart from many other spectroscopic methods, namely observable interactions between nuclei. 
These magnetic dipole interactions are used extensively in this thesis and are the focus of the theory 
section.  
2.1  The nuclear Overhauser effect 
 
 
2 
2 Theory – 3D structural information from NMR, part 1 
The various projects included in this thesis share a common trait – they all rely on information 
obtained from magnetic dipolar interactions between nuclei in organic molecules.  
The main focus will be on NMR observables which are useful in elucidations and calculations of 
3D structures, namely nuclear Overhauser effect correlations (NOEs) (dipolar relaxation, through 
space), J-coupling constants (indirect dipole-dipole couplings, through bonds) and residual dipolar 
coupling constants (RDCs) (direct dipole-dipole couplings, through space). The three subjects are 
conceptually depicted in Figure 2.1 and each topic will be treated independently in this chapter and 
Chapter 5. 
 
Figure 2.1. Concepts of magnetic dipole-dipole interactions and the obtainable 3D structural information. In green are the 
direct dipole-dipole couplings, which may be used to gain information of angles and distances of internuclear vectors 
independent on their situation in the molecular structure. In blue is the dipole-dipole relaxation, which may give access to 
local internuclear distances through space. Indirect dipole-dipole couplings are highlighted in red which, among multiple 
uses, hold local information of the relative position of nuclei, mediated through the bonds in the structure. It is indicated 
whether the information may be extracted from spectra of molecules under isotropic conditions or if anisotropic conditions 
are also needed. 
Chosen theory for the different topics is presented, and focus will be on the theory which was 
applied, either directly or implicitly. This selection results in some rather broad jumps in the 
presented theory and further information may be found in more comprehensive literature sources on 
the subjects, e.g. from the cited references. 
 The nuclear Overhauser effect 2.1
The mechanism involved in nuclear Overhauser effect (NOE) spectroscopy is dipolar cross-
relaxation of nuclei in close spatial proximity. Being facilitated entirely through space in contrast to 
e.g. the bond mediated J-coupling constants, vide infra, NOEs leads to purely spatial information of 
the nuclei, as illustrated in Figure 2.2.
6,7
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Figure 2.2. Left: Illustration of the through-space dependance of NOE relaxation of protons (red), blue may be carbon or 
heteroatoms. Right: Correlation of theoretical relative NOE intensity and distance (in Å) between protons. Relative to a 
reference distance of 1.8 Å set to 1. Note the logarithmic scale of the y-axis.  
The phenomenon is named after Overhauser, who first proposed that polarization of metal nuclear 
spins would be observable upon saturation of the metal electrons in 1953.
8,9
 Solomon established 
the theoretical basis and first experimental evidence of NOEs two years later. The proposed 
Solomon equation, equation (2.1), is thus considered the basis of NOE theory.
7,10
 While the NOE 
effect is equally important in homo- and heteronuclear NMR, the latter exemplified from e.g. NOE 
enhancement of 
13
C resonances, the homonuclear variant between protons is a prime source of 
structural information and is the focus of this section. Note that the involved nuclei will be labeled 
as I and S, even though both are protons (in some publications I1 and I2 or other notation is used for 
homonuclear cases). 
2.1.1 Relaxation 
The generation of NOE correlations is a relaxation process and some points regarding general 
relaxation processes in liquid NMR spectroscopy will be made, while the literature provide a much 
more in depth description.
7
 Relaxation in NMR is the mechanism of returning to equilibrium after 
the spin population has been perturbed by RF pulses and is divided into longitudinal (T1) and 
transverse (T2) relaxation. In short T1 relaxation is the recovery of the original longitudinal 
magnetization, and T2 is the loss of transverse magnetization.
7
 For small organic molecules, which 
are the focus of this thesis, the timeframe of T2 and T1 relaxation processes are usually of equal 
orders of magnitude, while T2 may be much shorter than T1 for macromolecules or solids.
11
  
The longitudinal relaxation is the main interest for understanding NOE relaxation. The relaxation 
process is not caused by spontaneous emission, as this is slow for the energy-levels involved in 
NMR spectroscopy. Instead it is facilitated by the translations, rotation and internal motions of the 
molecules in the sample – termed “the lattice”.7 This may describe the difference between the 
relaxation properties of different sizes of molecules, as the motions, or tumbling, will be quite 
different. The energy from the relaxation is taken up by the lattice as the near infinite degrees of 
freedom of the full lattice translate to the energy levels of the lattice being a continuum. This means 
that any NMR transition will have a matched energy level in the lattice.  
The relaxation mechanism of the NOE relaxation is dominated by the contribution from the relative 
spin dipole reorientation of neighboring nuclei under rapid isotropic tumbling, as the population of 
one spin changes when the population of another nuclear spin is perturbed.
6,7
 This is the cause of 
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the dependence of NOEs on the rotational correlation time (τc). The initial population shift of a 
nuclear spin can occur by continuous saturation of a resonance, as illustrated in Figure 2.3, the basis 
of steady-state NOEs. The continuous saturation effectively leads to equal nuclear spin population 
differences across the corresponding α/β transitions. The NOE is given by the W2 and W0 cross-
relaxation where both spins switch spin state simultaneously, see the legend of Figure 2.3 for more 
information.  
 
Figure 2.3. Energy diagrams for the NOE in a homonuclear two-spin system of the protons I and S. The intensity of proton I 
is proportional to (Nαα - Nβα) + (Nαβ - Nββ). Inspired by Neuhaus and Williamson.
7
  _____________________________________ 
a) The possible spins states, given as I(α)S(β), and transition probabilities (W). The W2 transition (the double quantum) and 
the W0 (zero quantum) transition are the relevant cross-relaxation pathways. The initial populations are Nαα = x, Nββ = -x and 
Nαβ/Nβα = 0. ________________________________________________________________________________________________ 
b) Saturation of the S resonance leads to Nαα = Nαβ and Nββ = Nβα. The saturation is maintained throughout. ______________ 
c) The effect of W0 cross-relaxation leads to a transfer of the population δ/2 from Nαα to Nββ. This leads to a shift towards 
equilibrium and thus a decrease in the intensity of resonance I; a negative NOE enhancement. _________________________ 
d) The effect of W2 cross-relaxation leads to a transfer of the population δ/2 from Nββ to Nαα. This leads to a shift away from 
equilibrium and thus an increase in the intensity of resonance I; a positive NOE enhancement. 
The steady state situation in Figure 2.3 is described by the Solomon equation (2.1), which defines 
the change of Iz (a vector equal to the population difference between the spin states) over time as a 
function of the relaxation pathways and the initial population differences Iz
0
/Sz
0
. ∂Iz/dt and Sz are 
equal to 0 for steady state.
7
 
 
𝜕𝐼𝑧
𝜕𝑡
= −(𝐼𝑧 − 𝐼𝑧
0)(𝑊0𝐼𝑆 + 2𝑊1𝐼 +𝑊2𝐼𝑆) − (𝑆𝑧 − 𝑆𝑧
0)(𝑊2𝐼𝑆 −𝑊0𝐼𝑆) 
(2.1) 
This equation may be rewritten to describe the NOE enhancement, fI{S}, which describes the 
change of intensity for spin I when saturating spin S, using that Sz
0
 = (γS/γI)Iz
0
.
7
 
 𝑓𝐼{𝑆} =
(𝐼𝑧 − 𝐼𝑧
0)
𝐼𝑧
0 =
𝛾𝑆
𝛾𝐼
(𝑊2𝐼𝑆 −𝑊0𝐼𝑆)
(𝑊0𝐼𝑆 + 2𝑊1𝐼 +𝑊2𝐼𝑆)
=
𝜎𝐼𝑆
𝜌𝐼𝑆
 (2.2) 
Where σ is the cross-relaxation and ρ is the dipolar longitudinal relaxation rate constant. The cross-
relaxation rate determines the intensity of the cross-peaks and is of major interest. It is positive if 
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W2IS dominates W0IS, and negative in the opposite scenario, which is in correlation to what may be 
found from Figure 2.3. The transition probabilities, or spectral densities, may be calculated from the 
dipolar interaction Hamiltonian to give the formula for cross-relaxation shown in equation (2.3),
7
 
where it is utilized that the transition probabilities are proportional to the chemical shift frequencies 
of the nuclei as the αβ↔βα transition corresponds to a frequency of |(ωI-ωS)| and the αα↔ββ 
transition corresponds to a frequency of (ωI+ωS), which may also be realized from Figure 2.3. 
 
𝜎𝐼𝑆 = 𝑊2𝐼𝑆 −𝑊0𝐼𝑆 =
1
10
𝐾2𝜏𝑐 (
6
1 + (𝜔𝐼+𝜔𝑆)2𝜏𝑐2
−
1
1 + (|𝜔𝐼−𝜔𝑆|)2𝜏𝑐2
) 
       =
1
10
𝐾2𝜏𝑐 (
6
1 + (𝜔𝐼+𝜔𝑆)2𝜏𝑐2
− 1) 
𝐾 = (
𝜇0
4𝜋
) ℏ𝛾𝐼𝛾𝑆𝑟
−3 
(2.3) 
Where γ is the gyromagnetic ratio of the nuclei and r is the distance between the involved nuclei, μ0 
is the vacuum permeability constant and ħ the reduced Planck constant. Equation (2.3) exploits that 
the difference between ωI and ωS is much lower than one, especially in the narrow chemical shift 
range of protons. In the same manner the dipolar longitudinal relaxation rate may be calculated.
7
 
All of these equations are based on the steady state experiment which is seldom used today, but 
more easily explained. The more utilized experiments to obtain NOE spectra is based on inversion, 
where nuclear spin-population differences are inverted across the transitions, which leads to kinetic 
NOEs. The method is the most frequently utilized due to fewer artifacts.
7
 The kinetic NOE is used 
to determine the rate of which the steady state is reached instead of performing measurements on 
the steady state itself, and is implemented as either the truncated NOE (TOE) or as the transient 
NOE.
7
 In transient NOE experiments, which are used throughout this thesis, the resonances are 
initially inverted and the NOE evolves without RF irradiation for a fixed period, termed the mixing 
time τm. After the evolution an observe pulse is applied to sample the population distribution and 
obtain the NOE spectra. In this type of NOESY experiment the NOE enhancements initially build 
up linearly, reach a maximum where linearity is lost and then decay back to zero.  
2.1.2 The ROESY experiment 
The rotating frame NOE (ROESY) experiment, initially dubbed CAMELSPIN (cross-relaxation 
appropriate for mini-molecules emulated by spin-locking) is a related experiment to the NOESY 
experiments which evolves the enhancements between elements of transverse magnetization instead 
of longitudinal magnetization.
7,12–14
 For this purpose, a spin-lock from continuous wave (CW) or a 
pulse train of multiple 180° pulses (T-ROESY) is used for a fixed period of time. The spin-lock 
period is similar to the mixing time of the transient NOESY experiments. This is advantageous for 
small molecular NMR, as the ROESY variant of the NOESY longitudinal cross-relaxation depends 
differently on the rotational correlation time as seen in given in equation (2.4) for CW-ROESY and 
(2.5) for T-ROESY. 
7,12,13,15
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 𝜎𝐼𝑆 =
1
10
𝐾2𝜏𝑐 (
3
1 + 𝜔2𝜏𝑐2
+ 2) (2.4) 
 𝜎𝐼𝑆 =
1
20
𝐾2𝜏𝑐 (
6
1 + 4𝜔2𝜏𝑐2
+
3
1 + 𝜔2𝜏𝑐2
+ 1) (2.5) 
For small- and medium size molecules at a certain rotational correlation time, the NOE 
enhancement is zero, which is avoided in the ROESY experiments as seen in Figure 2.4 for NOE 
and T-ROE. 
 
Figure 2.4. The theoretical cross-relaxation rate (σ) of NOE (―) and T-ROE (- -) experiments at 500 MHz, for a distance of 
2.5 Å. Note that the crossover point is dependent on the field strength. The cross-relaxation rate is shown in contrast to the oft 
depictured maximum homonuclear enhancement, as the cross-relaxation rate is the actual observable parameter in NOE 
experiments. Calculated using equations (2.3) and (2.5). 
While there are clear cases where the utilization of ROESY experiments are advantageous due to a 
better signal to noise ratio, ROESY spectra suffer from TOCSY transfers and a offset-dependency 
of the spin-lock, which needs to be accounted for.
7,12
 This makes the ROESY data harder to analyze 
and NOESY spectra were generally used where possible in this thesis. For more on NOE/ROE 
theory, related to τc, see Section 3.5.  
2.1.3 NOE in structure determination 
The NOE correlations are usually used qualitatively to determine stereochemistry or confirm the 
assignment of nuclei in novel or known compounds.
7,16
 The information is highly local due to a 1/r
6
 
dependence on the intensity of the observed signal and distances up to 4-5 Å are usually observed, 
depending on the compound size in the form of the rotational correlation time of the nuclei pair. 
The rotational correlation time is dependent on the size of the molecule, the temperature, the shape 
and flexibility of a structure and the viscosity of the solvent. The signal from NOE spectroscopy 
may be quantified if care is taken in the experimental setup and some approximations are made, 
presented below. 
In general, two methods are available for obtaining quantitative distances from NOE data; with or 
without the use of a relaxation matrix.
17–21
 The difference between these methods is in short the 
approach to handling multi-spin effects such as unwanted spin diffusion. Spin diffusion may be 
explained from a situation where three spins (Ha, Hb and Hc) are considered, as in Figure 2.5.  
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Figure 2.5. Spin diffusion explained. a) Three spins are considered (Ha, Hb and Hc). Hb is positioned between Ha and Hc, and 
is involved in NOE relaxation with both, while Ha and Hc are far from each other with negligible cross-relaxation. 
Magnetization is transferred from Ha to Hb, and once sufficient magnetization has built up on Hb, magnetization transfers (or 
diffuse) from spin Hb to Hc. b) An illustration of a 1D- or slice of a 2D NOESY spectrum shows the NOE cross-peak intensity 
increasing with an increase in the used mixing times. 
Spin diffusion will create a cross-signal between A and C with a stronger intensity than expected 
from the inter-proton distance, and the signal may lead to a false stereochemistry or experimental 
distance. This problem may be avoided or diminished by using short mixing times as magnetization 
has less time to build on B in Figure 2.5.
7,22
 When determining whether to use a relaxation matrix 
method or not, it is important to consider the system; for large molecules where spin diffusion is 
rapid, it should be included in the calculations. For small molecules, using short mixing times, spin 
diffusion is less of a problem. Thus, using a matrix that also includes a multitude of approximations 
may not be needed or beneficial. 
Another important consideration in the experimental setup is the utilized delay time between scans, 
which is true for all quantitative NMR. If inadequate T1 relaxation is achieved for any protons 
during the delay, the intensity of subsequent scans will be altered accordingly leading to wrong 
relative intensities and thus wrong distances, see below. 
2.1.4 Quantitative calculations 
The nuclear Overhauser effect (NOE) gives through-space correlations from dipolar relaxation 
between nuclei. The relationship between cross-relaxation, σ, and distance, r, is given in equation 
(2.3) and rewritten below to match most litterature.
7
 
 𝜎𝐼𝑆 = (
𝜇0
4𝜋
)
2 ℏ2𝛾𝐼
2𝛾𝑆
2
10
𝑟−6 (
6𝜏𝑐
1 + 4𝜔2𝜏𝑐2
− 𝜏𝑐) 
(2.3) 
This is easily simplified, assuming identical nuclei in all experiments, to equation (2.6), where k 
covers the constants in (2.3) and is identical for all observed NOEs. 
 𝜎𝐼𝑆 = 𝑘 𝑟
−6 (
6𝜏𝑐
1 + 4𝜔2𝜏𝑐2
− 𝜏𝑐) 
(2.6) 
Assuming identical correlation time for all nuclei pairs, it is further simplified to equation (2.7). 
Again k covers constants and is equal for all NOEs. 
 𝜎𝐼𝑆 = 𝑘 𝑟
−6 (2.7) 
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The cross-relaxation rate for transient NOEs is correlated to the observed intensity, η, by equation 
(2.8).  
 𝜂𝐼𝑆 = 𝜎𝐼𝑆𝜏𝑚 
(2.8) 
Where τm is the mixing time used in the experiment. If identical mixing times are used, the 
relationship of intensities and distances between two nuclei pairs may be defined as in equation 
(2.9). 
 
𝜂1
𝜂2
=
𝑘 𝑟1
−6
𝑘 𝑟2−6
→ 𝑟1 = 𝑟2 (
𝜂1
𝜂2
)
−
1
6
 
(2.9) 
Thus, if a single distance is known, others may be calculated from their relative intensity. This 
relationship is known either as the isolated spin-pair approximation (ISPA) or initial rate 
approximation (IRA).
22,23
 As indicated this is an approximation due to a couple of factors.  
1. It is approximated that all rotational correlation times are equal, and unknown dynamics thus 
affect the NOE.  
2. It is assumed that the acquired mixing time is short, eliminating any effect from spin 
diffusion. 
3. The cross-relaxations of multiple involved spins are assumed to behave as isolated spins.  
In order to avoid the inclusion of spin diffusion contribution to the NOE intensities in calculations, 
the mixing time may be varied to construct build-up curves to ensure that the utilized mixing time is 
in the linear regime, exemplified in Figure 2.6. For spin diffusion the onset of magnetization 
buildup will be later than for “true” NOE cross-peaks making them easily distinguishable. This also 
allows for the elimination of possible noise or artifact signals in the subsequent analysis, as these 
signals will be completely independent of the mixing time. 
There are two methods to proceed once the linear range has been established. One is to use the 
cross-relaxation rate which may be determined directly from the lower graph of Figure 2.6 (right) as 
the intersection with the y-axis. The other is to utilize a fixed mixing time in the linear range. While 
the first method will effectively average out some of the internal intensity errors in the spectra, the 
latter is usually used in this thesis, due to interferences from COSY-type artifacts in the spectra, 
especially at low mixing times due to the lower NOE intensities.
7
 To use points within the linear 
range, where the scalar coupling contribution is negligible, leads to the inclusion of more NOEs and 
thus more information and the associated errors were always evaluated to be within the general 
error of the experiments. It is here utilized that the scalar coupling intensities are less dependent on 
the mixing time than the NOE cross-peak intensities. 
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Figure 2.6. a) 1D slide from 2D NOESY spectrum of epi-10,23-dihydro-24,25-dehydroaflavine (see Section 3.2.2). The 
dependence of the intensity on the mixing time (τm) is seen in the enlargement (b) and is plotted on the right in a buildup 
curve for the exemplified NOE (c and d). 
In theory, any distance may be used as reference distance, as all distances are used relative to each 
other. In practice, the most common distances chosen are those known to be static; diastereotopic 
protons (~1.78 Å) or neighboring aromatic protons (~2.48 Å). The signal intensity of both of these 
may be modulated due to scalar couplings, which should be kept in mind. Furthermore, a 
dependence on the value of the chosen reference distance and the error distribution has been 
reported, as the distances of the same size resulted in a better fit between experimental and back-
calculated data.
7
 That being said, excellent fits have been reported utilizing e.g. diastereotopic 
protons, which are on the low side of relative distances in organic structures.
21
 Note that the set 
distance of the reference may be allowed to differ (e.g. up to 5 % error), to obtain the best possible 
correlation between experimental and 3D structure distances. This is most easily achieved on rigid 
systems, with multiple fixed distances. 
2.1.5 The 1D NOESY/ROESY (PANIC) approach 
The PANIC or Peak Amplitude Normalization for Improved Cross-relaxation method is, other than 
a testament of the creative acronyms created by the NMR community, a straight forward 
implementation of the ISPA approach.
23
 It is based on the work of Macura et al. discussed in the 
next section, but is used primarily for 1D NOESY/ROESY data.
17
 It is used that the linear range of 
the NOE buildup curve is quite remarkably extended by implementing the auto-relaxation of the 
irradiated nuclei into the measurement of the NOE intensities in equation (2.10).
17,23
  
 𝜂𝐼𝑆
𝑃𝐴𝑁𝐼𝐶 =
𝜂𝐼𝑆
𝜂𝐼
 (2.10) 
In practice this is easily achieved by setting the integral of the irradiated peak to be equal among all 
1D spectra obtained and these “PANIC intensities” are compared in the ISPA method. The resulting 
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relative intensities are thus corrected for auto-relaxation. The irradiated peak is set to a value of -
1000, chosen for convenience as this makes the relative magnitude of the cross-peaks in the order of 
0-500 for small molecules, dependent on τc and τm. 
2.1.6 The 2D NOESY/ROESY approach 
As mentioned in the previous section, the PANIC approach is based on the work of Macura et al. 
for 2D spectra.
17,23
 Thus, when dealing with 2D NOESY or ROESY spectra the methodology 
outlined here is used. It is essentially equal to the PANIC approach, but instead of using a single 
irradiated peak as reference, the cross-peaks (ηIS) are normalized by the average of the two 
appropriate diagonal peaks (ηI and ηS) as in equation (2.11). 
 𝜂𝐼𝑆
𝑛𝑜𝑟𝑚 =
𝜂𝐼𝑆
½(𝜂𝐼 + 𝜂𝑆)
 (2.11) 
If a lack of resolution leads to overlap in the diagonal peaks, equation (2.12) may be used, as it is 
assumed that ηI and ηS are close to identical for equal mixing time and equal nuclei.  
 𝜂𝐼𝑆
𝑛𝑜𝑟𝑚 =
𝜂𝐼𝑆
𝜂𝐼
=
𝜂𝐼𝑆
𝜂𝑆
 (2.12) 
In practice it may be beneficial to divide overlapping diagonal peaks by the number of protons 
present, as the auto-relaxation is more likely to be equal for an identical electronic environment and 
use this average diagonal peak in the calculations.
24
 
2.1.7 Relaxation matrix approach 
The relaxation matrix approach was not generally utilized in the work described in this thesis, 
though it was evaluated initially. A short introduction will thus suffice. The Solomon equation, 
which is given in equation (2.1), may be re-written in matrix form where cross-peak intensities are 
considered as a function of mixing time, τm.
7,22,25,26
 
 
𝜕𝐴(𝜏𝑚)
𝜕𝜏𝑚
= −𝑅𝐴(𝜏𝑚) 
(2.13) 
 𝐴(𝜏𝑚) = 𝐴0𝑒
−𝑅𝜏𝑚 (2.14) 
Where A(τm) is the matrix of cross-peak intensities at τm, and R is the symmetrical relaxation rate 
matrix given in equation (2.15). A0 is a diagonal matrix consisting of the cross-peak intensities at τm 
= 0 s. 
 𝑅 = [
𝜌1 𝜎12 ⋯
𝜎21 𝜌2 ⋯
⋮ ⋮ ⋱
] (2.15) 
The diagonal elements of the relaxation matrix are the dipolar longitudinal relaxation rate constants, 
ρ, and the off-diagonal elements are the cross-relaxation rate constants, σ. From these the inter-
proton distance between nuclear spins may be obtained. 
This may be re-arranged to (2.16) to express the relaxation rates in terms of NOE intensities. 
 −ln (
𝐴
𝐴0
) 𝜏𝑚 = 𝑅 
(2.16) 
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Which may be expressed and solved as (2.17), where the matrix E contains the eigenvector matrix 
and N contains the eigenvalues of A/A0.  
 
−𝐸 ln𝑁 𝐸−1
𝜏𝑚
= 𝑅 (2.17) 
Cross-relaxation rates can thus be derived and used to obtain inter-nuclear distances.  The NOE 
intensities may also be back-calculated from a molecular 3D structure using the inverse of this 
method to generate a theoretical NOE spectrum, which can be iteratively compared to the 
experimental NOE spectrum for structure refinement and verification.
22,25,26
 
If the matrix works perfectly in its implementation the method takes multi-spin effects, such as spin 
diffusion, into account.  It is thus most relevant when dealing with macromolecular systems where 
multi-spin effects are generally more prevalent.  Problems can occur for full relaxation matrix 
analysis where incomplete data sets (e.g. due to spectral overlap or spectral noise) make derivation 
of the full intensity matrix difficult. This is circumvented by combining experimental data with 
cross-peak intensities calculated from a theoretical model by programs that utilize the full relaxation 
matrix method such as CORMA (Complete Relaxation Matrix Analysis) and MARDIGRAS 
(Matrix Analysis of Relaxation for discerning the Geometry of an Aqueous Structure).
22,26
 
2.1.8 Averaging of NOE data 
When an average of different nuclei is observed, e.g. from overlapping resonances of methylene- or 
methyl groups, averaging methods are needed in order to cope. In non-methyl cases, equation (2.18) 
is used in distance calculations. 
 𝜂𝐼(𝑆𝑎+𝑆𝑏) = 𝑘 (𝑟𝐼𝑆𝑎
−6 + 𝑟𝐼𝑆𝑏
−6) (2.18) 
For methyl groups another approach is taken. The traditional methods to average methyl groups are 
derived for protein NMR and are split in two, dependent of the relative local rotational correlation 
time of the methyl group compared to the rest of the structure, given in equations (2.19) and 
(2.20).
27
 
 𝜂𝐼𝑀𝑒 = 𝑘 〈𝑟𝐼𝑀𝑒
−3〉2 (2.19) 
 𝜂𝐼𝑀𝑒 = 𝑘 〈𝑟𝐼𝑀𝑒
−6〉 (2.20) 
If the methyl group is spinning much faster than the rotational correlation time for the general 
molecule, the NOE is averaged as (2.19) and if the effective rotational correlation times are close to 
equal (2.20) is used.
27
 In practice (2.20) is only used for very small molecules in very low viscosity 
solvents. 
2.1.9 Handling of rigid and flexible molecules 
NOE distance analysis has proven very accurate for small molecules when few conformers are 
present.
21,28–30
 From NOE distances another low abundance conformer was thus shown to be present 
for strychnine.
30
 For more flexible compounds it is beneficial to rely on less optimized structures or 
on centroids which represent the full conformational space. The usage of centroids is a laborious 
task though; one may need to use many centroids if the compound is very flexible. One also has to 
identify precisely what parts are of interest for the structure as the nuclei used in establishing the 
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centroids. The inclusion of multiple structures requires means of averaging a vast amount of 
structures in a sensible way. Overfitting or fitting of data to a wrong conformational average may 
here present a problem since multiple different conformational populations may correlate well to 
the distances obtained from the experimentally observed NOEs.
31,32
 It is thus recommended to 
couple the NOE data to other types of NMR data, being either J-coupling or residual dipolar 
coupling, see Sections 2.2 and 5.1. This will alleviate some problems due to the difference in the 
averaging mechanisms for the different data; averaging distances, dihedral angle, angles etc. 
When comparing multiple structures to NOE derived distances, the average distances are calculated 
by equation  
 𝑟𝑎𝑣𝑒 = 〈𝑝𝑖𝑟𝑖
−6〉−1/6 (2.21) 
Where pi is the population with a given distance. The averaging result in a larger influence of 
shorter distances to the observed average distance.
30
 
In this thesis, multiple approached are used, each suited to the amount of flexibility expected, and 
indicated from simulations, for the given structure. For more information see the experimental 
section and the sections included in Chapter 3.  
2.1.10 Error analysis 
Though widely regarded a disadvantage or limitation, the distance to intensity relationship of r
-6
 
may actually be viewed as a clear advantage of the NOE over other 3D observables (J-coupling 
constants, RDCs etc.). This is due to the relationship between experimental error and resulting 
distance error, illustrated in Table 2.1.  
Table 2.1. Theoretical relationship between the error of the observed intensity and the error in the calculated distance both in 
%. Calculated using equation (2.3). 
Observed 
η error [%] 
Resulting 
r error [%] 
Observed 
η error [%] 
Resulting 
r error [%] 
-10 -1.8 10 1.6 
-20 -3.8 20 3.0 
-30 -6.1 30 4.3 
-40 -8.9 40 5.5 
-50 -12.2 50 6.5 
 
This effectively means that rather large experimental errors, as a product of e.g. faulty assumptions 
of equal correlation times, spin diffusion or spectra with low S/N, will often result in quite small 
errors in the calculated distances, making the NOE approach highly favorable compared to other 
experimental methods. The difference on whether a too large or small NOE intensity is observed is 
due to the favoring of small distances from the r
-6
 dependency.  
The decrease in NOE intensities for longer distances will result in longer distances being more 
prone to errors, since the NOE intensity will approach the spectral noise and the experimentally 
obtained data will more easily differ considerably from the actual NOE. 
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 J-coupling constants 2.2
The next method used to obtain 3D structural information is by indirect dipole-dipole couplings, in 
the form of scalar or J-couplings. The phenomenon was first reported as “low beats” in an echo 
from spin echo methods for ethanol by Hahn in 1950.
33
 The origin of the observations was disputed 
until the Ramsey and Purcell formally introduced the J-coupling constant definition a couple of 
years later.
34–36
 
Scalar couplings are magnetic interactions transmitted by the bonding electrons by which the spins 
are indirectly connected.
6,37
 The coupling occurs as the magnetic moment of the nuclei polarizes 
electrons involved in the bond slightly, and this polarization is transmitted by overlapping orbitals 
to other nuclei. This leads to the spin state of one nucleus to influence the effective external 
magnetic field of neighboring nuclei and thus line splitting. The interaction is independent of the 
applied magnetic field since it only depends on the spin orientation and the orientation of the 
electrons which are paired due to the Pauli exclusion principle.
11
 
The situation is depicted in Figure 2.7 over one bond for two bonded nuclei. The resulting signal 
will be a doublet due to the two different energy states, with a positive J-coupling constant.
11
 The J-
coupling constant is positive if the spin-spin coupling increases the energy when spin polarizations 
are parallel (triplet spin state) and decreases the energy when the spin polarizations are anti-parallel 
(singlet spin state).
11,36
 Negative J-coupling constants have an opposite dependence. This assumes 
an equal sign of the gyromagnetic ratio of the two nuclei.
11
 
 
Figure 2.7. Mechanism of scalar coupling between two neighboring spins (over one bond). The black arrows are the spin 
angular momentums and the grey arrows are the electron spins, paired due to the Pauli principle. The nuclear spins affect 
the spin of the electrons, and opposite polarizations of the nuclear spins are favored energetically as the electron spin 
polarizations are kept opposite. An equal nuclear spin polarization is high in energy as no favorable spin orientation may be 
achieved. Inspired by Levitt.
11
   
The energy of the spin-spin interaction, given as the Hamiltonian, depends on the magnetic 
moments and the position of nuclear spin vectors (I) of the involved nuclei as given in equation 
(2.22).
6,11,38
  
 ℋ̂𝐼𝑆
𝐽 = 𝐽𝐼𝑆 Î𝐼 ∙ Î𝑆 
(2.22) 
Implicit in the J-coupling constant is the product of the magnetogyric ratios of the involved nuclei 
and the reduced constant K is sometimes used, where this dependence is eliminated.
6
 K is not used 
in this thesis.   
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Ramsey identified three interactions, which contribute to the J-coupling with the first being the 
most dominant:
36
  
1. Fermi contact (FC) interaction of electronic and nuclear spins. 
2. The electron orbital motion with nuclear spin. 
3. Dipolar terms involving electronic and nuclear spins. 
For the FC term which may be seen as a direct contact term of electrons and nuclei, σ electrons play 
a significant role in transmission while π electrons are mostly involved due to exchange interactions 
between the σ- and π-electronic systems.39  
The scalar couplings lead to the observed multiplets in e.g. 1D 
1
H spectra and may be used in 
structure elucidation. Scalar couplings are also the foundation of most NMR experiments which 
employ coherent magnetization transfers e.g. COSY (mostly 
2/3
JHH), HSQC (
1
JCH) or HMBC (
n
JCH) 
type experiments.
6
 
2.2.1 3JHH-coupling constants 
The JHH-coupling constants in the form of 
n
JHH (n=2,3), are arguably the easiest 3D structural 
parameter to extract as they are present in simple 1D 
1
H spectra, and may be extracted when the 
resonances are not overlapping. If other types of coupling constants or a higher resolution, due to 
congested 1D spectra, are wanted, tailored experiments are usually needed; see Chapter 4 for a 
more elaborate discussion. The size of the J-coupling constants is, as mentioned above, based on the 
distance and degree of orbital overlap between the relevant nuclei. The influence of orbital overlap 
is the basis for the sinusoidal relationship between the size of coupling constants and a dihedral 
angle, which for 
3
JHH-coupling constants are given by the semi-empirical Karplus or Karplus-like 
equations as illustrated in Figure 2.8.
6,40
  
 
 
Figure 2.8. Left: Dihedral angle between protons (red) three bonds apart, blue may be carbons or heteroatoms. Right: 
Dependence of 
3
J-coupling constant on dihedral angle for peptide data as given by Karplus equations.
40
 
The constants present in the Karplus equations have generally been determined empirically from 
experimental data, though computational data may also be used, if e.g. less experimental data is 
present or to fully cover the given Karplus curve.
40
 The relative size of the J-coupling constants is 
also dependent on the nuclei involved, e.g. HN-CH versus HC-CH coupling constants due to the 
difference in magnetic moment, and the properties of surrounding nuclei. This dependence is 
utilized in e.g. the Haasnoot, De Leeuw and Altona (HLA) or Altona equation.
40–42
 Also the H-C-C 
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internal angle, the C-C and N-H bond length and structural strain have been shown to influence the 
size of the coupling constants.
11,36,43–45
 The Karplus equations generally take the form of equation 
(2.23).
40
 
 𝐽3 HH(𝜃) = 𝐴 cos
2 𝜃 + 𝐵 cos 𝜃 + 𝐶 (2.23) 
Where θ is the dihedral angle and the constants A, B and C depend on the type of coupling as 
addressed above.
40
 The equation was derived based on peptide moieties, and the amide version was 
used for NH-CH coupling constant calculations where A = 6.4, B = -1.4 and C = 1.9.  
An example of a more elaborate equation is the HLA equation given in equation (2.24), which was 
established to take the electronegativity of the neighboring nuclei into account.
42
 
 
𝐽3 HH(𝜃) = 𝑃1 cos
2 𝜃 + 𝑃2 cos 𝜃 + 𝑃3 +∑𝜆𝑖(𝑃4 + 𝑃5 cos
2(𝜀𝑖𝜃 + 𝑃6|𝜆𝑖|)) 
𝜆𝑖 = (𝑋𝛼 − 𝑋𝐻) + 𝑃7∑(𝑋𝛽 − 𝑋𝐻) 
(2.24) 
This is the equation used for CHn-CHm coupling constants in this thesis unless stated otherwise, 
used with the appropriate constants from Table 2.2.  
Table 2.2. Left: Constants for use in HLA calculations for different substitution patterns of the carbon atoms. Right: 
Relative orientation of substituents included in the HLA calculations. 
Type P1 P2 P3 P4 P5 P6 P7 
CH3-CH2R, CH3-CHR2, 
RCH2-CH2R 
13.70 -0.73 0.00 0.56 -2.47 16.90 0.14 
R2CH-CH2R 13.22 -0.99 0.00 0.87 -2.46 19.90 0.00 
R2CH-CHR2 13.24 -0.91 0.00 0.53 -2.41 15.50 0.19 
 
  
The post P3 term is the sum of the attached groups and is dependent on the electronegativity (X) of 
the substituents (S1-4), see Table 2.2 for clarifications. εi is equal to 1 for S1 and S3, and -1 for S2 and 
S4. 
Unlike the more complicated averaging of NOEs presented in the previous section, J-coupling 
constants are usually averaged over multiple structures as the weighted average of the J-coupling 
constants for the different conformers. It is thus not averaged as the weighted average of the 
dihedral angle, an important distinction to make. The averaging of J-coupling constants may thus be 
considered orthogonal to the averaged NOEs. 
 Evaluating data 2.3
To evaluate e.g. back-calculated distances from 3D structures to the relative distances obtained 
from NOEs, the mean absolute error (MAE) is used directly or on the percentage error, equations 
(2.25) and (2.26). The MAE is also used for J-coupling constants. 
 MAE =
1
𝑛
∑|𝑥𝑖
𝑒𝑥𝑝 − 𝑥𝑖
𝑐𝑎𝑙𝑐| (2.25) 
 MAE(%) =
1
𝑛
∑
|𝑥𝑖
𝑒𝑥𝑝 − 𝑥𝑖
𝑐𝑎𝑙𝑐|
𝑥𝑖
𝑒𝑥𝑝  
(2.26) 
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 Introduction to computational chemistry 2.4
Often 3D structures are desired for discussing observation such as NMR data, biological assays or 
chemical properties in structural terms.
46–48
 For the generation of optimized structures a plurality of 
methods are available.
49
 In the literature multiple approaches have been proposed which may be 
used for structural calculation, and since the rationale behind the approaches taken in this thesis is 
discussed elsewhere in the text, only a short introduction is included here.
49,50
 Also, the theories, 
quantum chemistry and formula which govern the methods are only very briefly touched upon. 
2.4.1 Molecular mechanics and dynamics 
Molecular mechanics (MM) and molecular dynamics (MD) is a force field (FF) method, where the 
chemical bonds are described by classical mechanics where the positions of the nuclei are 
considered. MM is used in calculating the energy of a given system and e.g. differences in lengths 
(Estr), angles (Ebend) and dihedral angles (Etors) between structures are scored in order to identify the 
lowest energy structure(s).
49
 Non-bonded interactions such as electrostatic (Eel) and van der Waals 
(Evdw) interactions are also included. The energy of the structure will thus increase by deviations in 
distances, angles etc., and the overall energy of the system will be determined by an energy 
calculation as the one given in (2.27).
49
 
 𝐸𝐹𝐹 = 𝐸𝑠𝑡𝑟 + 𝐸𝑏𝑒𝑛𝑑 + 𝐸𝑡𝑜𝑟𝑠 + 𝐸𝑣𝑑𝑤 + 𝐸𝑒𝑙 + 𝐸𝑐𝑟𝑜𝑠𝑠 
(2.27) 
The term Ecross essentially covers combinations of the bonded interactions to further improve the 
force field when matched to experimental data. For example, the force field used in this thesis for 
organic solvents, MMFF, uses a combination of stretch and bend interactions for this term.
49
 In the 
work of this thesis, the MM calculations were always coupled to conformational sampling, e.g. by 
Monte Carlo methods where the geometry is perturbed by varying e.g. torsion angles at random 
before minimization, or MD, see below.
49,50
 This results in optimized structures which generally 
should be good approximations to actual minima, but as each force field may score parameters 
differently, minima will be force-field dependent. It is thus not assumed that the relative energy 
between different compounds or conformers may be taken as accurate measures, and the structures 
are always compared to experimental data. It is thus important that the used methods result in 
structures of the global as well as local minima, and that the conformational space is thoroughly 
sampled.  
Also MD was used for simulations. In short, MD simulations treat the molecules as classical 
Newtonian systems, where the different interactions in between nuclei, such as bonds, produce a 
force on the nuclei. The system is then evolved for a given time, and the equations are continuously 
calculated in given time-steps.
49,50
 Since the time-steps are often short a great dependence on 
starting structure is often found for the simulations, and simulated annealing, where the temperature 
is varied (usually from high to low) may help this, as the structures may traverse larger energy 
barriers.
49
 
The solvents are included in the simulations, since the experimental properties observed by NMR in 
this thesis are observed in the liquid state. The treatment of solvents in MM calculations, as well as 
Density Functional Theory (DFT) calculations is complex, and will not be discussed. Briefly, the 
solvent implementation may either implicit, where the solvent is treated as a continuous medium, 
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usually where the properties of the solvent is given by a dielectric constant that interact with the 
molecule, or explicit where multiple solvent molecules are included in MD simulations and evolved 
with the molecule of interest.
49,50
 
2.4.2 Density functional theory 
Density Functional Theory (DFT) is a computational approach for calculation of electron energies. 
Here, approximations are needed as the electron energy cannot be determined or estimated by 
classical mechanics, and a set of functions is used to determine the energy of a system by the 
electron density of said system.
49,50
 
The basis of DFT calculations is formed by the functionals which are the series of formulae used to 
describe and solve the electron density. Multiple functionals have been derived and are available, 
often from a combination of different exchange and correlation functionals.
49
 The DFT functionals 
used in this study are the Becke Three Parameter Hybrid Functionals (B3LYP), probably the most 
widely used method for small molecules, and MPW1PW91, which is a single parameter functional 
developed in part for NMR calculations.
49,51
 Both are hybrid functionals and include a mixture of 
Hartree-Fock exchange and DFT exchange-correlation.
49
 
The functionals use basis sets which may also be varied according to the investigated problem. A 
basis set consists of predetermined functions which are used to describe molecular orbitals centered 
at each nuclei using a linear combination of Gaussian type orbitals (GTOs).
49
 The GTOs are used to 
approximate Slater-type orbitals (STOs) by linear combinations. STOs are not determined directly 
due to computational inefficiency. The basis set may be augmented by polarization functions or 
diffuse functions. Polarization functions add another orbital to the initially used orbitals for a given 
nucleus. For a nucleus with and outer p-orbital a d-orbital may thus be added, which allows of more 
asymmetry around the nucleus. Diffuse functions are Gaussian functions added to better describe 
the electron density far from the nucleus.
49
 
When applying DFT calculations to structural challenges the Pople basis set was used throughout 
this thesis. These basis sets are built as exemplified for 6-31g(d); the core orbitals are described by 
six GTOs, the inner part of the valence orbitals are described by three GTOs and the outer part of 
the valence orbitals by one GTO. The (d) means that a polarization function is used and a d-type 
polarization function is added to the heavy atoms. Other type of basis sets could be the correlation 
consistent basis sets e.g. cc-pVDZ. The correlation consistent basis sets differ from the Pople set as 
they are designed to converge towards the basis set limit, where properties are described as if using 
an infinite basis. As such a greater basis set should always lead to better calculations of the property 
of interest. It was recently reported that the basis set limit, where the calculated properties converge, 
was reached for the calculation of NMR properties, which should lead to an even stronger coupling 
of experimental NMR spectroscopy and computational chemistry.
52
 
It is important to choose a basis set that serves the need of the system in question. Larger basis sets 
may lead to increase in accuracy if the orbitals are better described but will also increase the 
computational time. The increase in accuracy is not always realized though as an observable may be 
better parameterized by a smaller basis set when using the Pople basis sets. It is thus often useful to 
screen different DFT functionals and basis sets in order to obtain a match for a given challenge, or 
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to take inspiration for methods which have been shown to work well for small molecules by 
others.
47,53,54
 For the optimization of structures it is always useful to slowly increase the basis set as 
the computational time increases with size starting from e.g. output from FF methods. The 
computation time may thus be minimized by submitting already optimized structures to the more 
expensive calculations. After optimization the resulting structures were used for the calculations of 
NMR observable properties, namely chemical shifts and J-coupling constants. Whether it is needed 
to optimize structures to a DFT-level of theory for chemical shift calculations has been questioned, 
but it seems to be needed for calculations of J-coupling constants.
54–58
 
2.4.3 Chemical shifts 
The chemical shift is defined as the difference in shielding tensors of nuclei compared to the 
shielding tensor of a reference, which for 
1
H and 
13
C nuclei are the shielding tensors of 
tetramethylsilane (TMS). Similarly the calculated property from DFT calculations is the NMR 
shielding tensor, which is a second order magnetic property, defined as the energy derivate of the 
nuclear magnetic moment μI with respect to the applied magnetic field, B.
52
 
 𝜎𝐼 = 𝜕
2𝐸/𝜕𝜇𝐼𝜕𝐵|𝐵,𝑀𝐼=0 
(2.28) 
The calculations of shielding tensors are based on the interaction of the applied magnetic field, the 
magnetic field generated by the nuclei and the magnetic field generated by the rapid movement of 
the electrons in a molecule. 
47,54,58,59
 
The first two terms are termed static fields and perturb the kinetic energy of the Hamiltonian so that 
if a finite basis set is used to model the electron distribution, the operator depends on the origin of 
the coordinate system known as the gauge. This is circumvented by either the GIAO (gauge 
invariant atomic orbitals) method, which uses basis functions that have an explicit field dependence, 
or the CSGT (continuous set of gauge transformation) which performs a gauge transformation at 
each point in space. It has been shown that for the nuclei involved in NMR the two methods work 
equally well, but that the GAIO method converges faster.
47
 
Generally two methods are available for correlating experimental chemical shifts to the calculated 
GIAO nuclear magnetic shielding tensors. One is to calculate the tensors for TMS and use these 
tensors as reference in comparison to an internal standard for liquid NMR. There is a possible 
caveat as the GIAO tensors of TMS must be calculated for each functional and basis set used, and 
the silicon in TMS is not necessarily parameterized well in all of the used basis sets, a problem 
especially for smaller basis sets.
47
 The second, and more general, approach is to linearly correlate 
the shielding tensors to the observed chemical shifts, as in (2.29).
54,58
 
 𝛿𝑠𝑐𝑎𝑙𝑒𝑑 =
𝜎𝐺𝐼𝐴𝑂 − 𝑏
𝑎
 (2.29) 
Where a is the slope and b the intercept of the correlation of observed shifts and calculated 
shielding tensor. The approach is simpler and less computationally demanding but could potentially 
result in overfitting of the data, as each structure is individually scaled to experimental data. The 
approach is used in this thesis in line with most literature.
47,54,58
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2.4.4 J-coupling constants  
Nuclear spin-spin coupling constants between two nuclei are calculated by the second derivatives of 
the energy with regard to their magnetic moments as seen in equation (2.30).
39,53
  
 𝐽𝐼𝑆,𝑥𝑦 = 𝜕
2𝐸/𝜕𝜇𝐼,𝑥𝜕𝜇𝑆,𝑦 (2.30) 
As mentioned in an earlier section the coupling of the nuclei is comprised of the sum of 
contributions of different terms covering different mechanisms: The spin hyperfine interaction and 
the spin-orbit (SO) coupling.
39,53
 The SO interactions may be divided into a diamagnetic (DSO) and 
a paramagnetic (PSO) component and depend on the magnetic moments created by the movement 
of electrons. The hyperfine interactions are comprised of the Fermi contact (FC) term and the spin-
dipole (SD) operator and depend on the interaction of an electron’s spin with the local magnetic 
field of the nuclei.
53
 The FC term describes the interaction at the nucleus and is usually, dependent 
of the nature and environment of the nuclei, by far the largest contribution to the total coupling 
constant. For proton-proton coupling constants all other terms than the FC may be neglected, and 
the result is scaled to correct for this and other possible inherent errors, an approach which has been 
shown to work well for small molecules.
53
 The coupling constants are returned in Hz and are thus 
immediately comparable to the experimental data. Unlike shielding, scalar coupling calculations 
will be very sensitive to the shape of the electronic wave-functions near the nucleus, which should 
be modelled as accurately as possible for the FC term. The calculations are thus more demanding 
than the chemical shift calculations, as this is hard to simulate using GTOs.
39
 The methods used for 
the calculations of J-coupling constants are discussed in the text in Chapter 4.
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3 Application of NOEs and 3JHH-couplings in 3D structure 
determination 
 Natural products 3.1
The experimental work of this section is based on the articles below. The structures of 
homomorphosin A-F were elucidated during work done on the Master’s Thesis “Chemistry of Black 
Aspergilli” by the author. A description of the purification and elucidation of the compounds is thus 
not included here, and relevant information may be found in the articles given below. The 
elucidation of the 3D structural features of homomorphosin A and homomorphosterol was achieved 
during the timeframe of this thesis. The structural elucidation and 3D structural calculations of the 
cyclomorhosins were done entirely during the timeframe of this thesis.  
Appendix A11: Dereplication Guided Discovery of Secondary Metabolites of Mixed Biosynthetic Origin from 
Aspergillus aculeatus 
Appendix A11: Homomorphosins A-F, novel diketopiperazines 
3.1.1 Introduction to natural products 
Natural products are the collected term of metabolites from natural sources, usually microbes (fungi 
or bacteria) or plants. Metabolites may be primary, those crucial for the growth of the organism and 
thus shared by many species, or secondary metabolites (SMs), where the latter are generally small 
to medium sized molecules with another purpose than growth.
60,61
 The functions of the SMs are not 
always known, but e.g. defence mechanisms, attractants or
 
colouring agents have been 
suggested.
62,63
 The discovery of penicillin in 1929 spurred the interest of in SMs due to their 
applicability as drugs and still the majority of approved drugs are of biological origin or derivatives 
of natural products.
64,65
 
The SMs are divided into classes as polyketides, terpenes, non-ribosomal peptides and alkaloids, 
based on the origin of the precursors for the SMs and the genes utilized in the biosynthesis.
60
 The 
biosynthesis is catalysed by enzymes such as polyketide synthases and non-ribosomal peptide 
synthetases, where covalent acyl-enzyme intermediates are formed and followed by condensations 
and tailoring to give the desired product, which are often enantiomerically pure compounds with 
many stereocenters and complex ring systems.
61,66,67
 The molecules, and derivatives thereof, have 
usually been synthesised by total synthesis for further investigations, but the emerge of synthetic 
biology, where the machinery of the microbes are used to biosynthesise the wanted compound is a 
possible future in drug discovery.
68
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3.1.2 Aspergillus homomorphus 
Aspergillus homomorphus (A. homomorphus) is a fungus residing in the Aspergillus section Nigri 
(black aspergilli), seen in Figure 3.1.
69,70
 It is geographically highly specific and has only been 
identified from soil in the Dead Sea area and from an Argentinian vineyard.
71,72
 It is thus a 
relatively rare fungus and the metabolic profile was previously only sparsely described.
73
 
  
Figure 3.1. A. homomorphus fungi grown for 7 days on YES media, left is top- and right bottom view. 
3.1.3 Homomorphosin A-F 
The homomorphosins A-F are depicted in Figure 3.2. They are all diketopiperazines made from 
tryptophan and either valine, 2-aminobutyrate or alanine, and attached isoprene units. For the 
elucidation of the structures, the reader is referred to Appendix A11. 
 
Figure 3.2. Novel NRPs from A. homomorphus; Homomorphosin A-F (1-6). Homomorphosin A (1) is the main secondary 
metabolite produced by A. homomorphus. 
Homomorphosin A is the most predominant metabolite produced by A. homomorphus on any 
growth medium, and was subjected to a 3D structural analysis to verify the structure and to obtain 
structural insights. The calculations may also serve as an introduction to the techniques utilized 
throughout this chapter, from the simplicity of the structure. Distances from NOEs were obtained as 
described in the theory, by relative intensities in the linear range. The solvent was DMSO-d6.
I
 
Using a single structure approach, the best fit of the experimental data and a 3D structure is seen in 
Table 3.1 for NOEs and in Table 3.2 for J-coupling constants. Major violations in the NOE derived 
distances were observed for the flexible parts of the molecule which needed to be averaged.  
                                                 
 
I
 Note that the solvents when acquiring NMR experiments throughout this thesis are always 
deuterated, unless explicitly stated otherwise. 
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Table 3.1. Comparison of the distances from NOE intensities and 3D 
structures using a single structure, with the lowest MAE, optimized to 
B3LYP/6-31g(d) (τm = 200 ms). All distances in Å. Lower and upper bounds 
are defined as ± 10 % of the distances from the 3D structures. Rigid 
distances are in bold. 
a
Reference distance used. 
H1 H2 
Exp. 
dist. 
Lower 
bound 
Violation 
Upper 
bound 
Violation 
1 8 2.66 2.39 
 
2.92 
 
1 21 2.88 4.18 1.30 5.11 
 
1 23/24 2.44 2.10 
 
2.56 
 
6 25a 2.78 2.70 
 
3.30 
 
6 26 2.92 2.71 
 
3.31 
 
6 29 3.67 3.32 
 
4.05 
 
7 8 2.48
a
 2.23 
 
2.73 
 
11 15 2.46 2.20 
 
2.69 
 
14 15 2.72 2.46 
 
3.00 
 
14 17 2.94 3.33 0.39 4.07 
 
15 18 3.05 3.17 0.12 3.88 
 
15 19 2.58 2.25 
 
2.75 
 
15 17 2.53 2.27 
 
2.77 
 
17 18 2.30 2.08 
 
2.54 
 
17 19 2.30 2.07 
 
2.53 
 
21 23/24 2.47 2.26 
 
2.77 
 
21 12a 2.87 2.44 
 
2.98 
 
21 30 2.80 2.96 0.16 3.62 
 
22b 23/24 2.28 2.07  2.53 
 
22b 18 4.30 3.69 
 
4.51 
 
25b 29 2.59 2.46 
 
3.00 
 
25b 12b 2.26 1.88 
 
2.30 
 
26 28 2.39 2.15 
 
2.63 
 
30 23/24 2.41 2.38 
 
2.91 
 
30 12a 2.84 1.92 
 
2.35 0.49 
30 25b 2.95 2.89  3.53 
  
Table 3.2. Comparison of experimental J-
coupling constants and calculated 
constants by the HLA equation from 3D 
structures using best fit single structure, 
in Hz. 
H1 H2 J exp. J calc. Diff 
11 12b 7.3 8.0 0.7 
15 17 2.0 2.3 0.3 
11 12a 11.5 10.3 1.2 
 
 
 
 
 
If multiple structures were used the correlation between the NMR and structural data was much 
better, and it was verified that the observed differences in distances for a single structure originated 
from structural flexibility, see Table 3.3, Table 3.4 and Figure 3.3. The utilization of multiple 
structures allowed the assignment of the “pro-chiral” methyl groups 18 and 19 as well as the 
diastereotopic protons 25 from an increase in MAE upon inversion, see Appendix A4. A constraint 
in the rotational space of the valine side-chain was initially suggested due to the low Hα-Hβ 
coupling constant and the difference in the methyl chemical shifts and which was confirmed from 
the NOE distances. The methyl groups 23/24 were not solved due to similar and slightly 
overlapping intensities, and they are treated as the summed intensities in the calculations.  
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Table 3.3. Comparison of the distances from NOE intensities 
and 3D structures using multiple structures from MM (τm = 
200 ms). All distances in Å. 
a
Reference. 
H1 H2 
Exp. 
dist. 
3D 
Dist. 
Diff (Å) Diff (%) 
1 8 2.61 2.66 0.05 1.9 
1 21 2.88 2.96 0.08 2.7 
1 23/24 3.34 3.37 0.03 0.9 
6 25a 2.78 2.76 0.03 0.9 
6 26 2.79 2.80 0.01 0.3 
6 29 4.41 4.42 0.01 0.1 
7 8 2.48
a
 2.48 0.00 0.0 
11 15 2.53 2.44 0.09 3.7 
14 15 2.72 2.73 0.00 0.1 
14 17 2.94 2.93 0.01 0.5 
15 18 3.42 3.50 0.08 2.3 
15 17 2.25 2.52 0.27 12.1 
15 19 2.76 3.01 0.25 9.1 
17 18 2.81 2.62 0.20 7.0 
17 19 2.75 2.61 0.14 5.0 
21 12a 2.87 2.96 0.09 3.1 
21 23/24 3.10 3.28 0.18 5.8 
21 30 2.77 2.89 0.12 4.2 
22b 18 4.71 4.67 0.04 0.8 
22b 23/24 3.05 3.16 0.11 3.6 
25b 12b 2.18 2.27 0.09 4.1 
25b 29 3.11 3.07 0.04 1.3 
26 28 2.96 2.82 0.14 4.6 
30 12a 2.84 2.75 0.09 3.1 
30 23/24 3.09 3.35 0.26 8.5 
30 25b 2.81 2.92 0.11 4.0 
      
   MAE 0.10 3.5 
 
Table 3.4. Comparison of experimental J-coupling 
constants and calculated constants by the HLA equation 
from 3D structures using multiple structures from MM, 
in Hz. 
H1 H2 J exp. J calc. Diff 
11 12b 7.3 6.5 0.8 
11 12a 11.5 10.2 1.3 
15 17 2.0 2.0 0.0 
 
 
Figure 3.3. Representation of the structural space 
inhabited by homomorphosin A, suggested from NOE 
and J-coupling constant data. The heavy atoms in the 
tetracyclic system of the 10 most highly populated 
conformers are overlain. Only the hydrogens of polar 
groups are shown. 
 
In conclusion the 3D structural investigation confirmed the structure obtained from other NMR 
experiments including the usage of qualitative NOEs. This is not surprising due to the rigid 
structure, but still the ability to determine the distances reliably dismisses any doubts. Also the 
accuracy is a good example of the degree of correlation between experimental and theoretical data 
that may be envisioned for the following small molecules, including the fact that rotatable bonds 
will be harder to fit than rigid parts, which is not surprising. Still, a pretty good fit of the 
experimental data was obtained from groups that exhibit freely rotatable bonds, and it is shown that 
allowing multiple conformers lead to a better fit of these parts, enabling supported suggestions to be 
made regarding stereochemistry. The ability to average over multiple conformers will be needed in 
the following sections. 
The absolute stereochemistry was solved by Marfey’s reaction as the valine was L-valine. Thus all 
stereocenters could be solved in relation.  
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3.1.4  
3.1.5 Cyclomorphosins 
Two compounds were isolated with the molecular masses [M+H]
+
 of 850.3307 and 866.3611 m/z, 
determined from HRMS analyses. This translated into multiple possible molecular formulae for 
each structure, as the number of possibilities increase with size due to an increase in possible nuclei 
and associated isotope patterns. The most probable constituent formulae were C46H43N9O8 or 
C45H47N5O12 and C47H47N9O8 or C46H51N5O12, respectively for the two masses. In each case the 
latter constituent formulae were identified as the correct ones from NMR spectroscopy. 
Structural elucidation 
The structural elucidation process is exemplified for cyclomorphosin A (CM-A), and a similar 
approach was used to elucidate the structure of B, but from a significantly lower amount of 
compound. The structures of both NRPs are shown in Figure 3.4. 
 
Figure 3.4. Novel NRPs from A. homomorphus: Cyclomorphosin A (left) and B (right). 
The 1D 
1
H spectrum of CM-A is found in Figure 3.5. The difficulty of elucidation was increased by 
the presence of a major and a minor conformer in the ratio 3:1 as illustrated in the inset of Figure 
3.5. For CM-B the ratio was determined to be approximately 10:1. The appearance of the 
resonances is the result of a second conformational species being present which interchanges slowly 
with the primary conformational species on the NMR chemical shift time scale. Luckily, only few 
resonances overlap between the conformers making it possible to unambiguously assign the shifts 
to each conformer.  
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Table 3.5. Chemical shifts and HMBC correlations, assigned for CM-A and CM-B in DMSO-d6. 
 CM-A  CM-B  
# δH  [ppm] (Int, mult, J [Hz]) δC [ppm] HMBC δH [ppm] (Int, mult, J [Hz]) δC [ppm] HMBC 
1 12.76 (1H,s) -  ND -  
2 - 172.6  - ND  
3 4.60 (1H,ddd,11.5,8.5,4.7) 51.0 2,33 4.50 (1H,td,10.1,3.6) 52.2  
4 8.03 (1H,d,8.7) - 5,33 7.83 (1H,d,9.4) -  
5 - 170.6  - 168.3  
6 4.75 (1H,d,6.7) 58.9 34,35,36 4.19 (1H,dd,8.0,6.2) 57.5 5,8,34,35 
7 - -  6.87 (1H,d,6.8) -  
8 - 165.8  - 170.0  
9 3.73 (1H,t,4.4) 55.9 8,37,38 4.13 (1H,t,8.7) 58.1 8,37,39 
10 7.60 (1H,d,4.6) - 8,9,11 8.53 (1H,d,9.4) - 11 
11 - 168.2  - 169.2  
12 4.90 (1H,t,9.6) 58.0 11,14,26 4.66 (1H,dd,9.7,7.3) 58.6 14,26 
13 8.21 (1H,d,10.2) - 14 8.33 (1H,d,9.9) - 14 
14 - 169.4  - 169.3  
15 4.14 (1H,dt,9.2,7.9) 52.5 14,40 4.39 (1H,dt,9.3,8.0) 51.7 17 
16 6.56 (1H,d,9.1) - 15,17 6.48 (1H,d,9.5) -  
17 - 169.9  - 169.1  
18 3.75 (1H,d,5.5) 74.1 17,49 3.75 (1H,mult) 74.2  
19 5.95 (1H,s) 78.2 17,18,20,49,52 5.93 (1H,s) 78.7 49,50/52 
20 - 155.7  - 155.6  
21 7.04 (1H,mult) 116.3 23,25 7.04 (1H,mult) 116.9 20,25 
22 7.19 (1H,dd,8.1,2.6) 129.6 20,24,26 7.01 (1H,mult) 128.9 24 
23 7.02 (1H,mult) 120.3 21,,25 7.06 (1H,d,8.5) 120.6 21,25 
24 7.42 (1H,mult) 127.6 20,22,26 7.46 (1H,d,8.5) 126.8 22 
25 - 131.6  - 132.2  
26 5.44 (1H,d,8.9) 79.4 11,12,22,24,25,27 5.53 (1H,d,7.2) 78.9 11,22,24,25,27 
27 - 155.0  - 155.2  
28 6.82 (1H,dd,8.2,2.4) 118.8 27,30,32 6.76 (1H,d,6.8) ND  
29 7.01a (1H,mult) 127.8 27,31 6.98 (1H,mult) ND  
30 7.01b (1H,mult) 113.8 28,32 6.76 (1H,d,6.8) ND  
31 6.93 (1H,dd,8.3,1.1) 129.5 27,29,33 6.98 (1H,mult) ND  
32 - 129.6  - ND  
33a 2.82 (1H,dd,14.3,11.9) 34.9 3,29,32 2.54 (1H,mult) 36.4  
33b 3.18 (1H,dd,14.3,4.1) 34.9 3,29,32 3.09 (1H,dd,13.3,3.6) 36.4  
34a 1.92 (1H,mult) 20.8 5,35,36 3.75 (1H,mult) 65.8 8 
34b 1.79 (1H,mult) 20.8 5,6,341 - -  
35a 1.92 (1H,mult) 30.3 5,34,36 0.95 (3H,d,6.2) 19.7 6,34 
35b 1.79 (1H,mult) 30.3 5,6,362 - -  
36a 3.38 (1H,mult) 45.9 34 4.61 (1H,d,5.1) - 34,35 
36b 3.52 (1H,mult) 45.9 34,35 - -  
37 4.19 (1H,mult) 64.8 8 1.66 (1H,mult) 36.5  
38 0.85 (3H,d,6.4) 17.4 9,37 0.75 (1H,d,6.7) 15.1 9,34,39 
39a 4.93 (1H,s) -  0.98 (1H,mult) 24.4  
39b - -  1.30 (1H,mult) 24.4  
39’ - -  0.74 (1H,d,7.3) 15.1 37,39 
40a 2.31 (1H,td,13.7,7.0) 38.3 14,15,41,42 2.33 (1H,d,13.9,7.2) 37.9 14,15,41,42/44 
40b 2.49 (1H,mult) 38.3 14,15,42 2.49 (1H,mult) 37.9 41,42/44 
41 - 126.5  - 126.5  
42 6.78 (2H,d,8.4) 129.5 40,41,42/44,43/45,46 6.80 (1H,d,8.4) 129.6 40,42/44,46 
43 6.51 (1H,mult) 114.4 41,43/45,46 6.51 (1H,d,8.3) 114.4 41,43/45,46 
44 6.78 (2H,d,8.4) 129.5 40,41,42/44,43/45,46 6.80 (1H,d,8.4) 129.6 40,42/44,46 
45 6.50 (1H,mult) 114.4 41,43/45,46 6.51 (1H,d,8.3) 114.4 41,43/45,46 
46 - 155.5  - 155.4  
47 9.13 (1H,s) - 43/45 9.08 (1H,s) - 43/45,46 
48 6.02 (1H,d,4.5) -  6.01 (1H,d,6.6) - 17,18,19 
49 - 140.4 17,19 - 140.6  
50 7.59 (2H,mult) 126.5 19,54 7.59 (1H,d,7.6) 126.6 19,50/52,54 
51 7.41 (1H,mult) 127.7 49 7.40 (1H,t,7.5) 127.9 49,51/53 
52 7.59 (2H,mult) 126.5 19,54 7.59 (1H,d,7.6) 126.6 19,50/52,54 
53 7.39 (1H,mult) 127.7 49 7.40 (1H,t,7.5) 127.9 49,51/53 
54 7.33 (1H,t,7.2) 127.3 50/52 7.32 (1H,t,7.3) 127.2 50/52 
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Figure 3.5. 1D spectrum of cyclomorphosin A (CM-A) in DMSO-d6 at 800 MHz. A carboxylic acid resonance at 12.76 ppm is 
omitted. Residual solvent and water peaks are cut off. Inset: Two slowly exchanging conformers of CM-A. 
The amino acid residues were identified as distinct spin systems from DQF-COSY and HSQC-
TOCSY spectra, and these spin systems were connected by HMBC correlations and qualitative 
NOEs as indicated in Figure 3.6. A very low J-coupling constant between H-18 and H-19 made this 
connection difficult to assign due to a lack of correlations in e.g. the DQF-COSY experiment. The 
joint was thus determined from HMBC correlations, NOEs and a process of elimination of possible 
connectivities of the nuclei. The data is summarized in Table 3.5 and Appendix A4. 
 
Figure 3.6. Left: DFQ-COSY and HSQC-TOCSY (▬) spin systems and key HMBCs (→) of CM-A. Right: Key NOEs of the B 
ring of CM-A.  
The two NRPs are each made of five amino acids and a building block which may originate from an 
intermediate in the shikimate pathway.
74
 Both structures exhibit a bi-cyclic motif, Figure 3.7, none 
of which have previously been reported from any fungal sources. Similar structures to the 14-
membered ring (A), from different sets of amino acids, have previously been reported from 
3 Application of NOEs and 
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plants.
75–79
 The 17-membered ring (B) is a completely novel motif from natural sources. Both ring 
structures were rather rigid due to the rigidity of aromatic systems and amide bonds, especially the 
14-membered ring with a smaller ring size.  
 
Figure 3.7. Motif of the 14- (A) and 17-membered ring (B) of cyclomorphosin A and B. Colors illustrate the different 
putative building blocks. 
The structures of the cyclomorphosins have nine chiral centers in the structure. Multiple examples 
of D-amino acids have been reported in NRPs, including A. homomorphus, and the stereochemistry 
may not simply be ascribed to L-amino acids.
67,80
 The relative orientation of the chiral centers was 
solved by first decimating the amount of possible diastereomers from qualitative NOE analysis, 
applying distances obtained from relative NOE intensities to the remaining diastereomers and 
identifying the best fit to the data.  
Aspects of the relative stereochemistry in ring A around the oxidized tyrosine was directly read 
from qualitative NOEs as illustrated in Figure 3.8. NOEs indicate that H-26 and H-19 are positioned 
on the same face of the structure, while H-26 and H-12 are positioned on opposite faces, resulting in 
very different NOEs for these neighboring protons. 
The differences in observed NOEs between H-12 and H-26 may not be proof of the relative 
stereochemistry, but considering a rather large J-coupling constant of 9.6 Hz between the two 
protons, a conformation displaying the observed NOEs while the protons are on the same face of 
the rings is impossible. From the HLA equation, the dihedral angles that result in a coupling 
constant of 9.6 Hz are ±3 and ±156 degrees. The first is not compatible with the NOE data, the 
latter is only possible if on opposite faces of the rings. It was also realized through computational 
simulations that the angle was rarely near 0° for the threo structures while it was often near ±155° 
for the erythro conformations.  
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Figure 3.8. Above: DQF-COSY (red and blue) and 
NOESY (green) spectra of CM-A. The spectra illustrates 
that H-26 and H-19 are situated on the same face (a) of 
the structure, while H-26 and H-12 are situated on 
opposite faces (b). Note that parts of the spectra, along 
the indirect axis in the left spectrum and the direct axis in 
the right, have been removed for convenience.  
c) Key NOEs of the A ring of CM-A. The orientation 
indicated for amide protons show the orientation of the 
protons compared to the face of the ring. Dashed arrows 
are weak NOEs.  
 
In a similar fashion, it was realized that the H-19 and H-26 had to be on the same face of the ring. 
This led to four possible diastereomers of the A ring, while the B ring, with four unknown 
stereocenters, has eight possible diastereomers. 
Quantitative NOE calculations 
When approaching quantitative NOE calculations of CM-A the fact that two slowly exchanging 
conformers were present could have been a considerable problem, as overlapping signals would be 
a sum of the two distinct conformational averages. The few overlapping signals present were thus 
excluded in the calculations. 
Ring A 
The stereochemistry of the A ring was apparent from the observations mentioned above and from 
simulated structures, due to differences in MAEs of the diastereomers and the rigidity for the ring. 
Selected distances from NOEs are presented in Table 3.6. The distances were selected as they are 
involved in NOEs and J-coupling constants which include protons in the backbone of the ring. 
When these are compared to 3D structures the fits are as given in Table 3.7. 
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Table 3.6. Used distances and J-
coupling constants for the deter-
mination of the stereochemistry of 
ring A (τm = 200 ms). 
a
Reference 
distance.  
H1 H2 Dist. [Å] 
12 24 2.57 
13 15 2.18 
13 22 3.10 
13 26 2.37 
15 16 3.13 
15 41a 2.69 
15 41b 2.80 
16 18 3.26 
16 41a 3.04 
18 19 2.51 
19 21 2.02 
22 26 2.30 
41a 41b 1.75a 
H1 H2 J [Hz] 
12 13 9.9 
12 26 9.3 
15 16 9.2 
15 40a 7.5 
15 40b 7.9 
18 19 0.0 
 
Table 3.7. MAEs from iteratively fitting back-calculated distances to experimental 
data, by minimizing MAE, for ring A to MM structures from simulations of 
diastereomers as indicated. 
Diastereomer 
Distance [%] J-coupling [Hz] 
MAE Max MAE Max 
12S,15S,18R,19S,26S 3.2 7.6 (H12-H24) 0.4 1.1 (H15-H41a) 
12S,15R,18R,19S,26S 6.2 18.5 (H16-H18) 1.0 1.7 (H18-H19) 
12S,15S,18S,19S,26S 7.8 33.7 (H16-H18) 1.9 9.8 (H18-H19) 
12S,15R,18S,19S,26S 6.5 21.4 (H19-H21) 1.6 5.2 (H18-H19) 
12R,15S,18R,19S,26R 7.6 23.0 (H19-H21) 0.6 1.4 (H12-H13) 
 
 
 
 
It is evident that the differences in distance were not that big between the different diastereomers of 
CM-A. While the change of stereochemistry at position 18 was problematic due to the increase in 
the possible J-coupling constant between H-18 and H-19, the differentiation of the diastereomer of 
15 was more challenging. Still the fit of the data to the L-diastereomer was markedly better, 
especially if one identifies the distances which were not observed but should yield NOEs for the D-
diastereomer. For example the distance of H-15 to H-18, which was 2.16 Å for the 15-D 
diastereomer, from the populations obtained by fitting the data, had no corresponding observed 
NOE in the spectra, which correlated well with the 15-L diastereomer. 
 
Figure 3.9. The motif of ring A for the 
12S,15S,18R,19S,26S-diastereomer (with the lowest 
MAE between experimental and theoretical data), 
determined from the fitting of NOE and J-coupling 
constant data to multiple 3D structures. 
 
Once it was established that the ring was quite rigid, another approach to determine the 
configuration might be to assign stereocenters at random and use constraints from NOE and J-
coupling constant data and floating chirality. This has been proposed by Baran et al.
81
 A similar 
approach could be used in the Schrödinger Suite using MacroModel. A couple of measures needed 
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to be taken; the chirality should be allowed to change, a mix of torsional and low-mode sampling 
needed to be sued, and the maximum low-mode steps needed to be quite big. In the current work, a 
minimum of 5 Å and a maximum of 25 Å was used (standard values are 3 Å and 6 Å, respectively). 
This allowed the molecule to easily switch chirality in the low mode steps, and due to the energy 
penalties on constraints the low energy output structures should primarily be the correct 
diastereomer. The distances in Table 3.6 were used as constraints with a penalty of 25 kJ/mol Å
2
, 
and the J-coupling constants of H12-H13, H12-H26, H15-H16 and H18-H19 from Table 3.6 were 
translated to dihedral angles by 180 ± n (n=180±f (J)) or 0 ± n (n=0±f (J)) which is needed in 
MacroModel.  The stereoisomer 12S,15R,18S,19R,26S was chosen as the starting structure, and 
after the simulation the major diastereomer was
 
12S,15S,18R,19S,26S which constituted  67 % of 
the structures determined in a window of 50 kJ/mol and 95 % in a window of 25 kJ/mol from the 
determined energy minimum (3,111 total structures), see Table 3.8 for more details. 
Table 3.8. Result of floating chirality simulation, as described in the text, of ring A using distance and dihedral constraints 
from Table 3.6, using different energy cut-offs. 
Diastereomer 
Population [%] 
50 kJ/mol 25 kJ/mol 10 kJ/mol 
12S,15S,18R,19S,26S 67.0 95.0 100.0 
12S,15R,18R,19S,26S 32.7 5.0 0.0 
12S,15S,18S,19S,26S 0.0 0.0 0.0 
12S,15R,18S,19S,26S 0.3 0.0 0.0 
12R,15S,18R,19S,26R 0.0 0.0 0.0 
 
Ring B 
The B ring was more difficult to solve due to a higher degree of flexibility originating from the 
reduced rigidity, and a larger conformational space for the larger ring size. Since the diastereomers 
of ring A were solved, the three remaining chiral centers in the ring were varied and the best 
minimum MAE identified. The assignments of the diastereotopic protons of C-33 in the ring were 
allowed to interchange to best fit the data. Again, only select distances were used following the 
same selection criteria as for ring A. Also, distances between the protons of proline were ignored as 
these are shared between all possible conformers due to ring strain in the five-membered ring, and 
major resonance overlaps between protons in the ring. 
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Table 3.9. Used distances and J-
coupling constants for the deter-
mination of the stereochemistry of ring 
B (τm = 200 ms). 
a
Reference distance. 
H1 H2 Dist. [Å] 
3 29 2.42 
3 31 2.94 
3 33b 2.42 
4 6 2.34 
4 29/31 3.16 
4 33a 2.84 
4 33b 3.76 
6 9 2.06 
6 37 2.73 
9 10 2.71 
9 37 2.53 
10 12 2.22 
10 13 2.96 
10 38 2.98 
26 30 2.07 
29 33a 2.64 
29 33b 2.55 
31 33a 2.27 
33a 33ba 1.75 
37 38 2.56 
H1 H2 J [Hz] 
3 4 8.8 
3 33a 11.7 
9 10 4.5 
9 37 4.4 
 
Table 3.10. MAEs from iteratively fitting back-calculated distances to 
experimental data, by minimizing MAE, for ring B to MM structures from 
simulations of diastereomers as indicated. 
Diastereomer 
Distance [%] J-coupling [Hz] 
MAE Max MAE Max 
3S,6S,9S,12S,26S 4.6 11.4 (H29-H33b) 0.0 0.1 (H9-H10) 
3R,6S,9S,12S,26S 6.6 21.1 (H29-H33b) 1.2 1.2 (H3-H4) 
3S,6R,9S,12S,26S 6.8 15.9 (H4-H6) 0.0 0.5 (H3-H33a) 
3S,6S,9R,12S,26S 6.4 21.2 (H6-H9) 0.2 0.2 (H3-H4) 
3R,6R,9S,12S,26S 8.2 25.2 (H3-H29) 0.5 0.5 (H3-H4) 
3R,6S,9R,12S,26S 6.6 20 (H26-H30) 0.3 0.3 (H3-H4) 
3S,6R,9R,12S,26S 6.0 17.9 (H6-H9) 0.8 0.8 (H3-H4) 
3R,6R,9R,12S,26S 6.7 17.9 (H26-H30) 0.0 0 (-) 
 
 
 
 
The resulting MAEs from all diastereomers were almost equal, and it was found more illustrious to 
compare the increase or decrease in correlation to the individual distances of the data. This is done 
in Table 3.11 as the difference between back-calculated and experimental distances (in %) and J-
coupling constants (in Hz) for the relevant diastereomers. The all S diastereomer had the lowest 
MAE, and interchanging chiral centers led to several rather big errors in many distances and J-
coupling constants between experiments and calculations. The two diastereomers 3S,6R,9R,12S,26S 
and 3R,6R,9R,12S,26S were the hardest diastereomers to dismiss by the data. The first one 
(3S,6R,9R,12S,26S ) could be dismissed from the increase in the distance between H6 and H9 which 
translates to two alpha protons being too far apart in space. The latter diastereomer 
(3R,6R,9R,12S,26S) had an increase in the error of H26 distance to the aromatic ring in addition to 
an error in the H6-H9 distance. 
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Table 3.11. Error in distances/J-coupling constants in %/Hz compared to the 3S,6S,9S,12S,26S-diastereomer. Diastereomers 
varied as indicated. Red/blue indicates an increase/decrease in error of more than 5 %/0.5 Hz. 
Change in distance errors [%] 
H1 H2 3R 6R 9R 3R6R 3R9R 6R9R 3R6R9R 
3 29 10.2 -1.9 8.5 18.6 6.0 -0.8 5.0 
3 31 2.3 -0.4 3.0 9.7 -0.5 -0.1 1.7 
3 33b -1.7 1.1 -2.3 -2.5 -1.0 -1.9 -0.2 
4 6 6.7 14.4 2.9 0.6 11.0 4.8 1.4 
4 33a 5.1 4.2 4.3 4.8 2.4 1.8 3.4 
4 33b -1.9 -1.8 -1.2 -0.4 -0.9 -0.8 -1.2 
6 9 -0.9 6.3 11.7 13.3 2.7 8.4 6.4 
9 10 -1.2 -1.2 0.5 -2.5 -1.3 0.0 0.1 
9 37 1.7 0.1 1.7 0.6 3.4 5.7 4.5 
10 12 -1.0 2.0 -0.3 4.7 1.5 3.5 3.2 
10 13 1.4 15.1 3.8 0.9 2.4 -0.3 2.1 
10 38 -2.5 1.7 2.2 4.4 -4.5 -2.4 0.3 
26 30 5.9 1.2 -0.9 12.5 13.7 4.4 11.5 
29 33a -6.3 1.5 0.6 -4.9 -3.8 1.6 -5.3 
29 33b 9.7 -2.0 -3.2 -0.8 0.4 0.0 1.2 
31 33a 9.1 0.5 0.7 5.7 5.0 1.2 3.2 
37 38 0.0 -0.1 0.2 0.1 0.2 -0.2 0.1 
Change in J-coupling constants [Hz] 
H1 H2 3R 6R 9R 3R6R 3R9R 6R9R 3R6R9R 
3 4 1.2 0.0 0.2 0.5 0.3 0.8 0.0 
3 33a 0.0 0.5 0.0 0.0 0.1 0.0 0.0 
9 10 0.0 -0.1 -0.1 -0.1 -0.1 -0.1 -0.1 
9 37 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
 
A possible path to gain more certainty of the stereochemistry was assume a better accuracy in the 
relative energies of the MMFFs force field, and limit the amount of structures based on energies. If 
the window was shrunk, from including structures within 50 kJ/mol of the identified minimum for 
each conformation, to 15 kJ/mol (which translates to a Boltzmann distribution population of       
~0.2 %), the stereochemistry is much more easily solved, as seen in Table 3.12. 
Table 3.12. Fit, obtained by iteratively minimizing MAE, of NOE derived distances for ring B to those of MM structures from 
simulations of diastereomers. Structures within 30 kJ/mol of the global minimum used. 
Diastereomer 
Distance [%] J-coupling [Hz] 
MAE Max MAE Max 
3S,6S,9S,12S,26S 5.0 14.2 (H10-H38) 0.1 0.3 (H9-H10) 
3R,6S,9S,12S,26S 11.4 38.4 (H10-H13) 1.1 3.3 (H9-H10) 
3S,6R,9S,12S,26S 16.3 120.2 (H6-H9) 1.0 3.6 (H9-H10) 
3S,6S,9R,12S,26S 16.7 122.1 (H6-H9) 0.9 3.4 (H9-H10) 
3R,6R,9S,12S,26S 16.0 121.6 (H6-H9) 0.9 3.6 (H9-H10) 
3R,6S,9R,12S,26S 14.5 120.4 (H6-H9) 0.9 2.6 (H9-H10) 
3S,6R,9R,12S,26S 8.7 20.8 (H6-H9) 1.2 2.5 (H9-H10) 
3R,6R,9R,12S,26S 8.5 30.2 (H26-H30) 0.2 0.7 (H3-H4) 
The resulting structure consisted of all L-amino acids. To verify the assignment of L-amino acids, 
Marfey’s analysis was performed and the proline was determine as L-proline.82,83 Proline was 
chosen, as acidic amino acids are less suitable for Marfey’s analysis due to poor separation.82 
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Full structure 
The fitting of 3D structures to the full set of NMR data for the proposed diastereomer is illustrated 
in Table 3.13, Table 3.14 and Figure 3.10, and a representation of the structural space occupied (by 
multiple structures) is found in Appendix A4. The MAE was comparable to the MAE obtained from 
the much more rigid homomorphosin A, which was slightly surprising due to the more flexible 
nature of the compound. This could be a sign of overfitting, which is a problem when fitting 
multiple structures.  
Table 3.13. Comparison of the distances from NOE 
intensities and 3D structures using multiple structures from 
MM (τm = 200 ms). All distances are in Å. 
a
Reference 
distance. 
H1 H2 
Exp. 
dist. 
3D 
Dist. 
Diff (Å) Diff (%) 
3 29 2.52 2.52 0.00 0.2 
3 31 3.06 3.07 0.01 0.4 
3 33b 2.52 2.51 0.01 0.5 
4 6 2.43 2.34 0.09 3.8 
4 33a 2.96 2.83 0.14 4.6 
4 33b 3.91 3.85 0.06 1.5 
4 35b 3.29 3.08 0.22 6.5 
4 36b 3.46 3.47 0.02 0.5 
6 9 2.15 2.31 0.16 7.3 
6 34a 2.39 2.35 0.04 1.7 
6 34b 2.59 2.73 0.14 5.5 
9 10 2.82 2.80 0.01 0.5 
9 37 2.64 2.69 0.05 1.8 
10 12 2.31 2.17 0.14 6.1 
10 13 3.08 3.01 0.07 2.2 
10 38 3.11 3.32 0.21 6.7 
12 24 2.57 2.75 0.19 7.3 
13 15 2.18 2.13 0.05 2.5 
13 22 3.10 3.23 0.13 4.2 
13 26 2.75 2.92 0.17 6.0 
15 16 3.13 2.99 0.15 4.6 
15 40a 2.66 2.73 0.06 2.3 
15 40b 2.80 2.76 0.05 1.6 
16 18 3.26 3.29 0.02 0.6 
16 40a 3.04 2.86 0.18 5.8 
18 19 2.51 2.64 0.50 5.2 
19 21 2.02 2.14 0.13 5.9 
22 26 2.30 2.32 0.12 0.9 
26 30 2.16 2.19 0.02 1.2 
29 33a 2.75 2.92 0.03 6.3 
29 33b 2.65 2.80 0.17 5.6 
31 33a 2.36 2.48 0.15 5.0 
33a 33b 1.82 1.75 0.12 4.0 
34b 36b 2.40 2.43 0.07 1.3 
35b 36a 2.30 2.42 0.03 4.9 
37 38 2.67 2.62 0.11 1.7 
38 43/45 3.60 3.64 0.05 1.1 
40a 40b 1.75a 1.75 0.05 0.0 
      
   MAE 0.10 3.4 
 
Table 3.14. Comparison of experimental J-coupling 
constants and calculated constants by the Karplus or 
HLA equation in Hz, from 3D structures using multiple 
structures from MM. 
H1 H2 J exp. J calc. Diff 
3 4 8.8 8.6 0.2 
3 33a 11.7 11.8 0.1 
9 10 4.5 4.8 0.3 
9 37 4.4 4.4 0.0 
12 13 9.9 9.4 0.5 
12 26 9.3 9.7 0.4 
15 16 9.2 9.1 0.0 
15 40a 7.5 7.4 0.0 
15 40b 7.9 7.9 0.0 
18 19 0 0.8 0.8 
 
 
Figure 3.10. Highest populated structure from the NOE 
and J-coupling constant data. Used as a representative 
structure for the structural space inhabited by 
cyclomorphosin A, suggested from NOE and J-coupling 
constant data.  
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The stereochemistry of the novel NRP was thus solved based on NOEs and J-coupling constants. 
While the A ring is considered solved beyond doubt, the B ring proved more troublesome. The 
obtained solution yields by far the best correlation to the experimental data though, leaving it as the 
best possible solution. The problem would not have been properly addressed using a single structure 
due to the degree of flexibility and resulting high differences of data to 3D structures for all 
diastereomers leading to poor discrimination of their consistency with the NMR data.  
Due to a very limited amount of compound, a similar analysis of CM-B was not possible, and not 
even all 
13
C resonances were observed in the spectra. The assignment is thus based on the very 
similar chemical shifts, spin systems and NOEs at long mixing times. The A ring is deemed of 
identical, or fully reversed, stereochemistry due to very similar J-coupling constants and chemical 
shifts, while the stereochemistry of the B ring was not solved due to differences in the amino acids 
and an increased flexibility from substituting a proline to a threonine. The minor conformer 
observed in the CM-B spectra was in the ratio 10:1, which is contributed to relieved strain in the B 
ring from removal of the proline, and it is suggested that the minor conformation is based in 
changes in the B ring for both structures. 
3.1.6 Homomorphosterol 
The novel sterol homomorphosterol, see Figure 3.11, was isolated from A. homomorphus. In the 
work of the Master Thesis “Chemistry of Black Aspergilli” the stereochemistry was wrongfully 
assigned, and the determination of the right diastereomer is thus included here. This is a good case 
of usage of quantum chemical calculations in solving the stereochemistry of rigid compounds. 
 
Figure 3.11. The structure of homomorphosterol (left) and the spin systems as determined by DQF-COSY and HSQC-
TOCSY (right). Arrows indicate observed 
5
J-coupling constants. 
As indicated in Figure 3.11 large 
5
J-coupling constants of 6 and 5 Hz were observed which has also 
previously been reported for various sterols.
84
 This feature should be possible to address with the 
usage of computational chemistry. Featured important HMBC correlations and NOEs are depicted 
in Figure 3.12, and while the stereochemistry is in principle solvable from qualitative NOE analysis 
more certainty was desired. It should be noted that only data with a mixing time of 800 ms were 
available, and with no build-up curve and probably a too long mixing time, quantitative NOE 
analysis was not pursued due to a probable, ultimately unknown, degree of spin diffusion. 
3 Application of NOEs and 
3
JHH-couplings in 3D structure determination 
 
 
 
35 
 
Figure 3.12. Selected HMBC connectivities (left) and NOEs (center) of homomorphosterol. The grey arrow indicates that 
scalar coupling induced artifacts in the NOESY spectra made it impossible to judge if an NOE was present. Right: The three 
stereo-clusters in the cyclic part of homomorphosterol. Stereocenters within the green and blue circles are thought equal to 
the stereochemistry of ergosterol. 
An approach to solve the stereochemistry of rigid compounds is by DFT calculation of chemical 
shifts and J-coupling constants. The utilization of chemical shifts and a probability function was 
deemed useful in this case.
58
 It should be noted that homomorphosterol features three clusters of 
stereocenters as indicated in Figure 3.12. It was proposed that the biosynthesis of 
homomorphosterol involved a Diels-Alder like reaction from an oxidized ergosterol and two of the 
clusters, blue and green in Figure 3.12, are structurally most likely identical to the structure of 
ergosterol.
85
 A similar compound was previously reported where a similar biosynthesis as the one 
suggested in Figure 3.13 was proposed, utilizing maleimide instead of maleic or fumaric acid.
86
 
 
 
Figure 3.13. Top: The suggested bio-synthetic pathway to 
homomorphosterol. First a proton is removed from 
ergosterol to give a conjugated system, and the resulting 
triene react with either maleic or fumaric acid in a Diels-
Alder-like reaction to gain the final structure.  
Left: Resulting stereochemistry of a Diels-Alder reaction 
with the triene. 
 
 
This leaves essentially three stereocenters to be solved; H-3 and H-6 (which are coupled), H-30 and 
H-31. DFT-optimized structures of truncated diastereomers, with the flexible side-chain at C-17 
changed to a methyl group as given in Figure 3.14, were used in a DP4 probability analysis, as 
calculated by equation (3.1).
58
 
 𝑃(𝑖|𝛿𝑁) =
∏ 1 − 𝑇𝑣(|𝛿𝑠𝑐𝑎𝑙𝑒𝑑,𝑘
−𝑖 − 𝛿𝑒𝑥𝑝,𝑘 − 𝜇|/𝜎)
𝑁
𝑘=1
∑ ∏ 1 − 𝑇𝑣(|𝛿𝑠𝑐𝑎𝑙𝑒𝑑,𝑘
−𝑖 − 𝛿𝑒𝑥𝑝,𝑘 − 𝜇|/𝜎)
𝑁
𝑘=1
𝑚
𝑗=1
 (3.1) 
Where μ = 0, v = 11.38 (13C) or 14.18 (1H) and σ = 2.306 (13C) or 0.185 (1H) ppm. 
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Only a single conformer was identified for each diastereomer due to the highly rigid nature of the 
compound. The rigidity also results in rather big differences in the spatial structure for each 
diastereomer as illustrated in Figure 3.14, which accordingly yields differences in theoretical 
chemical shifts and J-coupling constants. 
 
Figure 3.14. Left: Overlay of the eight stereoisomers. A quite big differences in the occupied structural space is observed. 
Right: The stereoisomer (RRRS) which showed the best correlation to the available data. All structures are truncated at C-18 
to focus on the rigid core. 
The chemical shifts are collected in Appendix A4. The comparison of the DP4 probability of 
experimental versus theoretical chemical shifts of the diastereomers is given in Table 3.15, which 
clearly shows that the (RRRS) structure was favored. Especially the proton chemical shifts were 
discriminative which was surprising since the carbon chemical shifts hold a larger chemical shift 
range and thus could potentially be more discerning. This may be due to the added electronic 
complexity when modelling the 
13
C nuclei compared to the much simpler protons. The MAE for the 
(RRRS) diastereomer was 0.12 ppm for 
1
H and 1.68 ppm for 
13
C chemical shifts which resembles 
the 20 times larger chemical shift range of 
13
C and might explain why the proton chemical shifts 
were more discerning. This is in good agreement with findings from the literature.
47,54,58
 
Table 3.15. DP4 probability analysis of stereoisomers of homomorphosterol (values in %). The first row covers 
13
C and 
1
H 
chemical shifts. The best and worst fit to the data is marked in blue and red respectively. Shielding tensors calculated by 
MPW1PW91/6-311+G(2d,p) using GIAO from B3LYP/6-31g(d) optimized structures. 
 (RRSS) (RRRS) (RSRS) (RSSS) (SRSR) (SRRR) (SSSR) (SSRR) 
DP4 13C/1H 0 99.9 0.1 0 0 0 0 0 
DP4 13C 0.1 58.8 11.5 8.1 0.7 3.9 16.8 0 
DP4 1H 0 99.7 0.3 0 0 0 0 0 
 
Also the J-coupling constants, including the large long-range constants, were investigated and gave 
the same conclusion for the stereochemistry, see Table 3.16. As the (RRRS) structure did not 
violate any qualitative NOE correlations, this structure was assumed to be valid. For more 
discussion on the DFT calculation of J-coupling constants see Section 4.2.1. 
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Table 3.16. Experimental and theoretical J-coupling constants in Hz for stereoisomers of homomorphosterol. Indented 
numbers are the absolute difference compared to the measured couplings. Coupling constants were measured from a 1D 
1
H 
spectrum or DQF-COSY(*). The best and worst fits to the data are marked in blue and red, respectively. Theoretical 
coupling constants calculated by B3LYP/6-31g(d,p) u+1s from B3LYP/6-31g(d) optimized structures. 
J [Hz] Meas. (RRSS) (RRRS) (RSRS) (RSSS) (SRSR) (SRRR) (SSSR) (SSRR) 
H3-H31 9.9 
9.7 
0.4 
10.0 
0.1 
10.9 
0.8 
9.8 
0.3 
11.5 
1.4 
9.2 
0.9 
11.3 
1.2 
4.2 
5.9 
H6-H30 6.9 
4.2 
2.7 
7.7 
0.8 
11.0 
4.1 
10.3 
3.4 
10.8 
3.9 
10.8 
3.9 
8.5 
1.6 
10.8 
3.9 
H30-H31 5.7 
4.4 
1.3 
5.3 
0.4 
11.4 
5.7 
12.0 
6.3 
11.5 
5.8 
7.4 
1.7 
6.2 
0.5 
4.3 
1.4 
H6-H9a* 6.0 
6.9 
0.9 
6.1 
0.1 
6.1 
0.1 
7.0 
1.0 
3.5 
2.5 
3.5 
2.5 
4.0 
2.0 
4.9 
1.1 
H3-H14* 5.0 
5.2 
0.2 
4.6 
0.4 
4.8 
0.2 
5.1 
0.1 
5.2 
0.2 
5.4 
0.4 
5.3 
0.3 
4.3 
0.7 
 
In conclusion the stereochemistry of a novel steroid was determined from calculations of NMR 
properties, based on a priori knowledge of the dominating biosynthetic pathway of steroids in 
fungi, and qualitative NOEs. Note that the a priori knowledge can lead to the absolute 
stereochemistry if the assumptions are correct. If incorrect, the relative stereochemistry is still 
upheld from qualitative NOEs and the calculations above. The rigid structure was here a necessity 
to avoid too many structures per stereoisomer, though averaging is possible.
54
 This is a prime 
example of how DFT computation of NMR observables can be a crucial method in solving 
unknown structures, a method which will only find increased usage with the introduction of more 
observables, e.g. in the form of more long-range coupling constants as described in Chapter 4. 
 Other natural products 3.2
In addition to the compounds isolated from A. homomorphus, other natural compounds were 
investigated. Some of these are included briefly in the following. 
3.2.1 Aculenes 
The aculenes, as well as the epi-10,23-dihydro-24,25-dehydroaflavine discussed in the next section, 
are small molecules isolated by Dr. Lene M. Pedersen, for which the 3D structure were determined 
from J-coupling constants, structural calculations and select qualitative NOEs.
87
 The compounds 
were isolated from another black aspergillus; the fungus A. aculeatus.
69,70
 
 
Figure 3.15. The structures of aculene A-D with the determined stereochemistry shown. 
The stereochemistry of the aculenes was determined mostly from J-coupling constants. It was 
evident that the two stereocenters in the 7-membered ring of aculene A needed to be (R)/(S) from 
theoretical J-coupling constants, see Table 3.17. This is independent of the assignment of the 
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diastereotopic protons at C-8, as an exchange of conformation would not improve the fit to the data 
of any stereoisomer. From the J-coupling constants it was suggested that the minor conformer was 
lowly populated. The stereochemistry of the proline was solved by Marfey’s reagent, but as it may 
rotate freely around the C7-O bond, it was not possible to correlate the stereocenter to the remaining 
structure. 
Table 3.17. Measured and theoretical J-coupling constants in Hz for the possible stereoisomers of the aculene A. Theoretical 
coupling constants calculated by B3LYP/6-31g(d,p) u+1s from B3LYP/6-31g(d) optimized structures. 
H1 H2 Exp. 
(RS) or (SR) (RR) or (SS) 
major minor major minor 
7 8 4.4 4.5 11.0 9.3 11.3 
7 8’ 2.8 2.6 5.2 0.6 5.9 
Due to a quite plausible biosynthetic relationship of the aculene A, B and C, and similar J-coupling 
constants and NOEs, the stereochemistry was thought to be identical. The remaining stereocenter of 
aculene B was determined qualitatively from NOEs. It should be noted that aculene D was not 
isolated but suggested from HRMS data, and thus no NMR data were available in support. 
 
Figure 3.16. Qualitative NOEs used for solving the structures of aculene A and B (τm = 800 ms).  
3.2.2 Epi-10,23-dihydro-24,25-dehydroaflavine 
The stereochemistry of epi-10,23-dihydro-24,25-dehydroaflavinine was solved by the use of NOEs 
and J-couplings. The relative stereochemistry of epi-10,23-dihydro-24,25-dehydroaflavinine was 
established by performing conformational searches on different diastereomers and by comparing 
observed distances to the back-calculated distances from ISPA, and by comparison of experimental 
3
J-couplings to HLA back-calculations. The relative stereochemistry was determined to be equal to 
that of the original 10,23-dihydro-24,25-dehydroaflavinine,
88,89
 but as the optical rotation was of the 
opposite sign, compared to the literature, the enantiomer was most likely isolated. The structure that 
resulted in the lowest MAE was further optimized by HF and DFT to give the reported structure. 
Again a lower error was obtained if the rotating groups, the isopropylene and the alcohol, were 
allowed to rotate, see Table 3.19 and Table 3.20, as the inclusion of multiple structures eliminated 
most of the observed errors when using only to a single structure. It should be noted that while the 
single structure was optimized to a DFT level, the multiple structures are used directly from the 
force field simulations, accounting for some of the differences in the fit of the rigid parts and in the 
reference distance.  
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By using the ISPA approach it was possible to unambiguously assign the diastereomer of the 
compound. This might have been possible using qualitative data and a model, which was how the 
enantiomer was previously solved,
89
 but the complicated geometry of the structure made ISPA an 
easier approach, where one did not have to guess whether the stereochemistry was actually the best 
possibility. While the alcohol and vinyl groups were rotating in the identified conformer 
populations, the orientation of the indole ring was fixed, in good correlation to the force field 
energies, where a reorientation of the indole ring of 180° gave rise to an approximate rise in energy 
of 16 kJ/mol (a population of ~0.16 %). Even with the discriminative properties of NOEs this 
population should not be detected. While the force field energies may be prone to errors, the 
obtained population of fitting the rotamers correlated pretty well to that of the energies, as seen in 
Table 3.18.  
Table 3.18. Population of the minimum energy conformation (1) and different rotamers of C-23 (2), C-19 (3) and both (4). 
Populations from force field energies and NOE data.  
Conformer Rel. E 
[kJ/mol] 
 
Rel. FF pop. 
[%] 
Rel. NOE pop. 
[%] 
1 0 
 
46 56 
2 1.26 
 
28 12 
3 2.65 
 
16 23 
4 3.89 
 
10 9 
 
In order to confirm the assignment of the diastereomer a constrained conformer search with floating 
chirality, using only data between methine and methyl protons was also conducted, following the 
procedure given for cyclomorphosin A, which resulted in only the given diastereomer in a 50 
kJ/mol window. 
 
Figure 3.17. 3D structure of epi-10,23-dihydro-24,25-dehydroaflavine with the best correlation to the NMR data. 
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Table 3.19. Comparison of the distances from NOE intensities 
and from 3D structures using a single DFT optimized structure 
(B3LYP/6-31g(d)) or multiple structures from MM (τm = 150 
ms). All distances in Å. 
a
Reference.  
  Single Mult 
H1 H2 
Exp.  
Dist. 
Calc.  
Dist. 
% 
 
Exp.  
Dist. 
Calc.  
Dist. 
% 
1 2 2.64 2.50 5.6 
 
2.62 2.48 5.5 
1 5 3.03 2.83 7.1 
 
3.01 2.81 6.7 
5 18 2.72 2.40 13.3 
 
2.70 2.46 8.8 
5 11 2.41 2.37 1.7 
 
2.40 2.62 9.3 
5 10 2.54 2.67 4.9 
 
2.53 2.56 1.5 
2 27 2.89 2.96 2.4 
 
2.88 2.99 3.5 
2 23 2.58 2.46 4.9 
 
2.56 2.56 0.1 
2 25 3.01 2.96 1.7 
 
3.00 3.04 1.3 
25 23 2.39 2.31 3.5 
 
2.37 2.39 0.9 
25 10 2.78 4.58 39.3 
 
2.77 2.82 2.0 
25 25’ 1.85 1.85 0.0 
 
1.84 1.85 0.6 
19 26 3.57 3.53 1.0 
 
3.56 3.64 2.3 
19 18’ 2.33 2.43 3.3 
 
2.33 2.45 5.0 
19 22 2.02 2.14 5.6 
 
2.01 2.23 10.7 
19 18 2.32 2.41 3.7 
 
2.31 2.44 5.5 
19 11 3.37 2.83 19.1 
 
3.35 2.95 12 
19 10 1.95 1.88 3.7 
 
1.93 2.01 3.8 
30 29 3.45 3.39 1.8 
 
3.44 3.65 6.0 
30 18’ 2.34 3.32 25.3 
 
2.33 2.41 3.5 
30 22 2.68 2.25 19.1 
 
2.66 2.70 1.3 
30 21 2.65 2.06 28.6 
 
2.64 2.54 3.6 
10 26 2.28 2.33 2.1 
 
2.72 2.86 5.4 
10 11 2.24 2.32 3.4 
 
2.23 2.33 4.7 
23 27 2.06 2.05 0.5 
 
2.40 2.49 3.7 
11 12 2.12 2.24 5.4 
 
2.18 2.28 4.5 
11 13 2.70 2.61 3.4 
 
2.68 2.67 0.3 
11 16 1.86 2.21 15.8 
 
1.85 2.00 7.7 
16 28 2.68 2.84 5.9 
 
2.67 2.60 2.6 
21 29 2.46 2.61 6.0 
 
2.45 2.64 7.6 
16 17’ 2.10 2.44 13.9 
 
2.09 2.16 3.4 
16 13 1.93 2.02 4.5 
 
1.91 2.09 9.0 
22 22' 1.75 1.74 0.6 
 
1.74 1.74 0.0 
17 29 2.77 2.79 0.9 
 
2.76 2.84 3.0 
17 17’ 1.74 1.75 0.6 
 
1.71 1.75 2.3 
21’ 27 2.58 2.52 2.4 
 
2.57 2.62 1.7 
13 13’ 1.75a 1.75 0.0 
 
1.74a 1.74 0.0 
17’ 28 2.82 2.95 4.5 
 
2.81 2.87 2.1 
14’ 28 2.54 2.60 2.3 
 
2.53 2.70 6.8 
25’ 26 2.85 2.92 2.5 
 
2.84 2.88 1.2 
         
 MAE   6.9    4.1 
 
Table 3.20 Comparison of experimental J-coupling 
constants and calculated constants by the HLA 
equation or DFT calculation from a single DFT 
optimized 3D structure, in Hz. 
H1 H2 Exp. HLA DFT 
10 23 13.3 12.7 12.4 
10 11 5.0 4.3 5.1 
21' 22 13.5 12.6 11.9 
22 23 13.5 11.9 13.7 
16 17 11.3 12.5 13.7 
17 18 11.3 13.4 14.1 
21' 22' 3.4 4.8 4.4 
21 22 4.3 4.5 4.4 
22' 23 5.6 4.8 5.3 
 
 
 
 
Figure 3.18. Numbered structure of epi-10,23-
dihydro-24,25-dehydroaflavine.  
 
  
3 Application of NOEs and 
3
JHH-couplings in 3D structure determination 
 
 
 
41 
 Synthetic peptides 3.3
The experimental parts of this section are based on the articles below. More space is used 
discussing the results from NMR spectroscopy than the various biological roles and otherwise 
exiting potential of the included compounds, which will only be briefly touched upon. For a more in 
depth description the reader is referred to the articles below and the articles referred to in the text. 
Appendix A11: Methyl Effect in Azumamides Provides Insight Into Histone Deacetylase Inhibition by 
Macrocycles  
Appendix A11: Specific Electrostatic Molecular Recognition in Water 
3.3.1 Azumamides 
The azumamides are natural products, originally isolated from the marine sponge Mycale izuensis.
90
 
The compounds are cyclic non-ribosomal peptides (NRPs), illustrated in Figure 3.19, which were 
shown to inhibit histone deacetylase (HDAC) activity.
90
  
 
 R1 R2 R3 
A: NH2 H Me 
B: NH2 OH Me 
C: OH OH Me 
D: NH2 H H 
E: OH H Me 
 
 
 
Figure 3.19. The structure of the natural azumamides A-E with indicated pharmacophore, and a schematic pharmacophore 
of HDAC inhibitors.
90,91
 
HDACs are a group of enzymes with the common trait that they deacetylate the N-ε-position of 
lysine residues at the N-terminal tail of histones.
91,92
 In groups of eight, histones proteins form the 
nucleosome; the repeating unit in chromatin, which is the highly ordered structures that store DNA 
in eukaryotic cells.
91,92
 Gene-transcription is regulated by interactions between the N-terminal end 
of the histones and DNA, and the interactions are modulated by e.g. the degree of histone 
acetylation, methylation or phophorylation.
91,92
 Histone acetylation will therefore affect gene 
transcription as the degree of histone acetylation correlates positively with transcription,
92
 and a 
decrease in acetylation has been linked to cancer due to a lower expression of regulatory genes.
91
 
Compounds that inhibit HDAC activity may thus be used as anti-cancer agents, spurring the interest 
in understanding and improving the activity of the compounds. Humans have 18 HDACs, of which 
11 are Zn
2+
 dependent and were the focus of the study. 
The mode of action of most HDAC inhibitors is by interacting with Zn
2+
 in the binding site of the 
HDAC enzymes, effectively blocking the active site. HDAC inhibitors are structurally quite 
different compounds but generally have a pharmacophore as indicated in Figure 3.19.
91
  
The group of Professor Christian A. Olsen (CAO), then DTU now University of Copenhagen, were 
interested in investigating analogues of the natural azumamides, synthesized in lab from total 
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synthesis, to develop novel anti-cancer compounds, and it was in that regard desired to correlate 
structural features to HDAC inhibition. Thus an NMR study of natural and unnatural analogues of 
azumamides was conducted in collaboration with Dr. Alex Maolanon and Dr. Jesper Villadsen both 
from the group of CAO, who synthesized the investigated molecules, and Dr. Niels Christensen 
from the group of Associate Professor Peter Fristrup, who performed the calculations and 
theoretical docking studies. For more information regarding the comprehensive synthetic work, 
activity testing and docking results the reader is referred to the article.
93
 
Prior work 
A lot of work has been put towards total synthesis and HDAC activity of the native azumamides as 
well as structural analogues thereof.
94,95
 This, often synthetic or biological work, is mostly outside 
the scope of this thesis and it was chosen to keep the focus relevant to the presented work – namely 
3D structural information from NMR spectroscopy. The 3D structures of azumamide E
94,95
 and an 
unnatural analogue 2S,3R azumamide E
95
 have previously been published from constrained MD 
calculations. The comparable structures of azumamide E are alike; the amide protons NH-1,3 and 4 
points upwards from the plane of the ring while NH-2 points slightly downwards and the phenyl 
ring is superimposing the ring akin to a lid. These structures are used for comparison in the 
following sections. 
Investigated structures 
Three structures were chosen for NMR investigation; the natural azumamide A (azu A) and two 
unnatural analogues desmethyl-azumamide C and epimethyl-azumamide E (des D and epi E). The 
structures are given in Figure 3.20.   
 
 R1 R2 R3 
Azu A: NH2 (S)-Me H 
Des C: OH H OH 
Epi E: OH (R)-Me H 
 
Figure 3.20. Structure of the investigated structural analogues azumamide A (azu A), des-azumamide C (des C) and epi-
azumamide E (epi E). Stereochemistry, including the diastereotopic protons important for the 3D structural investigation, is 
indicated.  
The structural analogues exhibited in vitro activity in the order azumamides > des-methyl 
azumamides >> epi-methyl azumamides.
93
 It was proposed that conformational differences in the 
ring conformation could be the reason for the differences in activity. The slight differences in the 
groups R1-R3 (Figure 3.20) were deemed of lesser importance for the ring conformation, and the 
general conformational spaces occupied by the structures. Unfortunately the in vitro activity was 
not retained in in vivo studies of a human Burkitt’s lymphoma cancer cell line. 
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As the interesting properties of the azumamides are all occurring in an aqueous environment, it 
would be beneficial to obtain data in water. Attempts to dissolve the compounds in water and in a 
water/DMSO-d6 mixture with up to 15 % DMSO-d6 resulted in very low S/N ratios, and spectra 
acquired in pure DMSO-d6 were used for further investigations. It is acknowledged that this may 
lead to errors in the structure compared to that of a biological environment, but it could not be 
averted. 
Assignment of diastereotopic protons 4 and 13 
The diastereotopic protons at C-4 and C-13 were not easily assigned due to possible free rotation 
around the bonds C3-C4 and C12-C13. It was realized from NOE-derived distances and J-coupling 
constants, that free rotation was generally not present, due to differences in NOE intensities and the 
size of J-coupling constants to the diastereotopic protons, allowing assignment of the protons. Only 
the rotation around C3-C4 of the des-methyl variant was observed to be unrestricted. The protons 
were thus assigned by minimizing the error of NOEs and J-coupling constants. This might not lead 
to the right answer, but without an assignment a lot of data and information was lost, and both data 
types suggest the given assignments unambiguously, making it the most viable option. 
The assignment results in structures that fit the NMR data displaying the aromatic ring of Phe or 
Tyr outside the cylinder of the ring, in contrast to previously published structures, which is in good 
correlation with docking studies, vide infra. 
Constrained versus unconstrained calculations 
Constrained MD using experimental observables such as relative NOE intensities and J-coupling 
constants has been a favored method of obtaining 3D structures.
94,95
 While the approach has validity 
for macromolecules, where the amount of flexibility is beyond what even modern computational 
chemistry can reasonably be expected to handle, for relatively ordered systems a lot of information 
will inevitable be lost. This is in part due to the constrains being applied as distances and dihedral 
angles, while the observables are in fact NOEs and J-coupling constants, which will lead to a faulty 
averaging of the data, see equations (3.2)-(3.5). Here it should be noted that not all structural 
simulation programs are capable of performing an averaging routine; it is obvious that information 
is lost if averaging is disregarded. The distinction in (3.2)-(3.5) may seem of less importance but 
will lead to large error in conformational populations. 
 𝜂𝑜𝑏𝑠,𝑖 = 𝑘 𝑟𝑖
−6   for  𝑖 = 1 (3.2) 
 𝜂𝑜𝑏𝑠,𝑖 = 𝑘 〈𝑟𝑖
−6〉   for  𝑖 > 1   not    𝜂𝑜𝑏𝑠,𝑖 = 𝑘 〈𝑟𝑖〉
−6 (3.3) 
 𝐽𝑜𝑏𝑠,𝑖 = 𝑓(𝜃𝑖)   for  𝑖 = 1 (3.4) 
 𝐽𝑜𝑏𝑠,𝑖 = 〈𝑓(𝜃𝑖)〉   for  𝑖 > 1   not    𝐽𝑜𝑏𝑠,𝑖 = 𝑓(〈𝜃𝑖〉) 
(3.5) 
The other possibility is to use unconstrained simulations and structural averaging of conformers. 
This is an approach used earlier in this thesis that is gaining popularity and being applied in a 
slightly altered form also in macromolecular NMR.
96
 To achieve this, a couple of requirements are 
apparent. First the simulations need to cover the structural space that the actual in vitro compounds 
occupy. But if too much space is covered it may hamper the fitting of the experimental data to the 
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3D structures. This means that while an amount of conformational flexibility is a good thing, too 
much flexibility may lead to unsolvable systems. Also one has to accept a couple of 
approximations; that the correlation time is independent of conformation and that the averaging 
motions are of a timescale that allows the usage of r
-6
 averaging. For the azumamides, due to an at 
least somewhat restricted conformational space due to the cyclic system, it should be possible to use 
unconstrained simulations and increase the coverage of the conformational space and thus 
obtainable molecular knowledge. For comparison both strategies were tried. 
Constrained structure 
Constraints in the form of NOE distances (Table 3.21) were applied to a structure of azumamide A, 
and the structure was optimized, depicted in Figure 3.21. This structure was in good correlation to 
the published structures of azumamide E from constrained optimizations, with the exception of the 
orientation of the aromatic ring as described earlier, and the extension of the linker chain, which 
was generally less ordered, and was not considered beyond the double-bond.
94,95
 
 
Figure 3.21. Representational 3D structure from the constrained optimization of azumamide A. Structures of azumamide E 
are available from the literature for comparison.
94,95
 
When investigating the NOE data, the constrained structure was in clear violation of multiple 
distances around the NH-2 site, which indicated that this structure was probably not that good a 
representation of the data, see Appendix A4. 
Unconstrained structures 
Unconstrained simulations were conducted in water and DMSO for the three azumamide analogues. 
The resulting conformational spaces were overlapping and the structures from water were used. 
Most distances and J-coupling constants were comparable between the three analogues, though 
some differences were observed. When fitting the NMR data to multiple structures this was 
translated to a mostly identical conformational space between the analogues. The correlations of the 
data to the simulated structures were good with MAE% of 3.1 %, 3.5 % and 3.7 % for Azu A, Des 
C and Epi E respectively. Also the J-coupling constants exhibited a good correlation between 
experimental and back-calculated values. The structures from unconstrained simulations were thus 
deemed to be better representations of the NMR data than the structures from constrained 
simulations and further conclusion were based on these. The experimental distances and back-
calculated values, obtained by optimizing the correlation of 2,500 structures from molecular 
dynamics iteratively, are shown in Table 3.21. 
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Table 3.21. Experimental and back-calculated distances in Å, including differences in %, and J-coupling constants in Hz for 
the azumamide analogues (τm = 150 ms). 
a
Reference. Based on 2,500 structures each, from MD simulations. 
Azumamide A 
H1 H2 Exp.  Calc. % 
N1 N2 2.13 2.15 1.3 
N1 N4 3.11 3.11 0.0 
N1 3 2.62 2.66 1.4 
N1 4a 3.12 3.12 0.0 
N1 4b 3.06 3.06 0.0 
N1 10 2.75 2.80 1.8 
N1 13a 2.49 2.49 0.0 
N1 13b 2.42 2.44 0.7 
N2 13a 2.64 2.64 0.0 
N2 13b 2.89 2.89 0.0 
N2 21 2.61 2.86 8.8 
N2 22 2.83 3.15 9.9 
N3 N4 2.38 2.35 1.0 
N3 22 2.80 2.97 5.6 
N3 21 2.71 2.87 5.5 
N3 25 2.45 2.45 0.0 
N3 26/27 3.13 3.13 0.0 
N4 2 3.24 3.33 2.5 
N4 10 2.67 2.49 7.3 
N4 24 2.96 2.97 0.4 
N4 25 3.07 2.68 14.7 
N4 26/27 3.17 2.97 7.0 
2 10 2.59 2.68 3.2 
2 3 2.13 2.39 10.7 
2 4a 2.76 2.76 0.0 
4b 4a 1.82 1.82 0.0 
4a 10 2.71 2.97 8.7 
4b 10 3.52 3.51 0.3 
12 15 2.65 2.65 0.0 
13a 15 2.50 2.44 2.5 
13b 15 2.47 2.47 0.0 
21 22 2.77 2.77 0.1 
24 25 2.98 2.85 4.7 
24 26/27 2.62 2.81 6.9 
25 26/27 2.50 2.43 2.7 
     
MAE% 3.1 
     
J-coupling constants 
H1 H2 Exp. Calc. Diff 
N1 3 8.0 8.0 0.0 
N2 12 9.1 8.9 0.2 
N3 21 8.7 8.2 0.5 
N4 24 8.3 8.3 0.0 
2 3 3.8 3.8 0.0 
3 4a 8.1 8.1 0.0 
3 4b 6.4 6.4 0.0 
12 13a 9.4 8.8 0.6 
12 13b 6.7 6.7 0.0 
24 25 10.1 10.1 0.0 
 
Des-azumamide C 
H1 H2 Exp. Calc. % 
N1 N3 2.79 2.80 0.4 
N1 2b 2.29 2.49 7.8 
N1 3 2.73 2.70 1.0 
N1 4a/4b 3.11 3.00 3.6 
N1 12 2.98 3.11 4.5 
N1 13a 2.79 2.72 2.3 
N1 13b 2.99 3.00 0.6 
N1 N2 1.99 1.91 4.4 
N2 N3 2.21 2.20 0.0 
N2 13a 2.56 2.59 1.2 
N2 13b 2.89 2.90 0.3 
N2 21 3.38 3.55 4.8 
N2 22 2.83 2.87 1.3 
N3 N4 2.30 2.37 2.7 
N3 22 2.94 2.96 0.6 
N3 24 3.36 3.45 2.6 
N3 25 2.88 2.99 3.6 
N3 26/27 3.78 3.79 0.2 
N4 2b 2.02 2.18 7.1 
N4 25 2.59 2.56 1.1 
N4 26/27 3.07 3.07 0.0 
2b 2a 1.79a 1.79 0.0 
3 2a/4a/4b 1.99 2.07 3.8 
5 3 2.96 2.94 0.5 
6 7 2.45 2.45 0.2 
12 15 3.02 2.86 5.7 
13b 13a 2.08 1.70 22.1 
13a 15 2.72 2.44 11.3 
13b 15 2.66 2.47 8.0 
15 22 4.31 4.25 1.4 
21 22 2.60 2.62 0.5 
24 25 2.44 2.56 4.8 
24 26/27 3.02 3.19 5.4 
25 26/27 2.74 2.59 5.7 
     
     MAE% 3.5 
     
J-coupling constants 
H1 H2 Exp. Calc. Diff 
N1 3 7.3 7.4 0.1 
N2 12 9.6 9.1 0.4 
N3 21 9.7 9.0 0.7 
N4 24 6.8 6.8 0.0 
2b 3 12.4 12.4 0.0 
2a 3 3.6 3.6 0.0 
3 4a 6.5 6.5 0.0 
3 4b 6.5 6.6 0.1 
12 13a 9.3 9.3 0.0 
12 13b 5.8 5.8 0.0 
24 25 6.7 6.8 0.1 
 
Epi-azumamide E 
H1 H2 Exp. Calc. % 
N1 N2 1.88 1.91 1.1 
N1 2 2.50 2.49 0.3 
N4 2 2.15 2.12 1.1 
N2 13a 2.92 2.92 0.1 
N2 22 3.12 3.13 0.3 
N3 N4 2.39 2.29 4.2 
N4 25 2.98 2.99 0.1 
N4 26/27 2.93 2.75 6.6 
2 3a 3.00 3.00 0.0 
2 10 2.82 2.74 3.1 
3 4a 2.34 2.35 0.5 
3 4b 2.53 2.62 3.3 
3 10 3.05 3.07 0.6 
4b 10 2.86 2.90 1.4 
6 7 2.16 2.32 6.9 
12 15 2.92 2.80 4.2 
21 22 2.65 2.78 4.6 
24 25 2.57 2.66 3.4 
24 26/27 2.71 2.87 5.4 
25 26/27 2.59 2.43 6.5 
     
     
     
     
     
     
     
     
     
     
     
     
     
     
MAE% 2.9 
     J-coupling constants 
H1 H2 Exp. Calc. Diff 
N1 3 8.7 9.5 0.8 
N2 12 8.9 10.9 2 
N3 21 9.1 11.6 2.5 
N4 24 8.5 9.4 0.9 
2 3 12.4 13.0 0.6 
3 4a 4.6 4.6 0.0 
3 4b 5.6 5.6 0.0 
12 13a 10.0 10.5 0.5 
12 13b 5.2 5.4 0.2 
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Structural differences 
Using unconstrained simulations, the difference in the ring conformation between the three 
compounds was diminishing. It would seem as if the natural compound had more flexibility in the 
ring, but the majority of the conformers which fitted the NMR data had NH-2 pointing upwards, in 
line with the synthetic structures. The best correlation to the data had NH-2 pointing upwards 
approximately 90 % of the time, and downwards 10 %. This is proposed to be translated to the 
intermediate position in the constrained calculations. A similar distribution was also seen for Des C. 
The multiple conformer approach led to a much better fit for the ring, than the constrained 
simulations – still with errors around the NH-2 though, see Table 3.21.  
 
 
Figure 3.22. Top: The best fit structure of the three analogues overlain; grey: Azu A, green: Des C, yellow: Epi E. Bottom: 
NH-CαH dihedral angles of the conformers used in the NOE and J-coupling constant fit of azu A (grey), des C (white) and epi 
E (black). 
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The ring conformation was thus essentially unaffected by the inversion or removal of the methyl 
group, in good correlation to the NMR data and simulations. This led to the search for, and 
identification of, other differences between the three analogues. 
Side-chain orientation 
The side-chain orientation was the only major difference between the different compounds. While 
the distances between the side-chains and the ring generally differed more than the ring proton 
distances, it was only translated into major differences in the orientation for the linker side-chain, 
which in turn is arguably the most important side-chain considering the involvement in reaching the 
binding site.
91
 
The side-chain of the linker was thus the only clear difference in NMR observables between the 
three compounds. This was also apparent from the simulations, but is more pronounced, and 
experimentally confirmed, in the NMR data. The populations of the orientations for the different 
structural analogues are found in Figure 3.23. 
 
Figure 3.23. The population in % of the orientations of 
the side-chain at C-3, illustrated by the dihedral angle 
H3-C3-C4-C5 (θ), for the natural azu  A (a), and the 
synthetic des C (b) and epi  E (c).  
Grey: Population that fit the NMR data the best. 
White: Full simulation (2,500 structures).  
 
 
Azu A:R1=-Me R2=-H R3=-CH=CHCH2CONH2 ___ 
Des C:R1=-H R2=-H R3=-CH=CHCH2CONH2 ______ 
Epi E:R1=-H R2=-Me R3=-CH=CHCH2CONH2 
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The natural compound, which is the most active, had an orientation of the linker side-chain centered 
on θ = ±60°. The des-methyl analogue displayed an orientation shared between the three sites in a 
three jump model, while the epi-methyl, the least active analogue, displayed an orientation centered 
on θ = -80° and 180°. It may thus be proposed that favorable activity would be obtained when the 
orientation of the linker was at θ = +60° in the binding pocket, as this would correlate well to the 
activity data. This result was compared to results from the theoretical docking studies. 
Docking results 
The chosen HDAC to be used in the theoretical docking was HDA3, as a crystal structure of a co-
repressor complex was available to dock into. The resulting azumamide structures had all amide 
protons directed to the same face and toward the carboxylate side-chain of Asp93, in agreement 
with solution data. The orientation of the aromatic side-chain also correlated well to the solution 
conformations. The linker side-chain had a dihedral angle of either 180° or 60°, except for 
azumamide E where a dihedral of 110° was prevalent. It was thus not possible to correlate the 
preferable dihedral angle from NMR to the docking studies, and since no docked crystal structure is 
available, a possible connection must be regarded as a possibility and supported speculations. It is 
of course not necessary for the bound compound to be of the same conformation as in the free liquid 
state, but it would lead to a potentially lower energy penalty upon binding. From theoretical 
calculations of the binding interactions, it was determined that the differences in activity should 
probably be contributed to a large methyl effect from interactions to Phe200 of the enzyme. 
Minor conformer 
It was apparent from the spectra that a minor conformational average was present in solution that 
averaged slowly on an NMR time scale from multiple resonances in the spectra. The data was thus 
catered for as discussed earlier for the natural compound CM-A. In contrast to CM-A, where the 
minor conformer was not investigated further, it was speculated that the minor conformer could be a 
cis-amide arrangement of one of the amide bonds in the ring. This is supported experimentally by 
an observed strong NOE between H-12 and H-21, leading to the cis-amide bond being between N-2 
and C-20, the most flexible amide bond in the major conformational average. The 3D structures of 
these conformations were not determined due to weak NOE intensities. The differences between the 
ratios of the conformations were not significant between the different analogues and could thus not 
be used to explain the differences in the activity.  
Conclusion 
Solution state structures of natural and analogues of representative azumamides were investigated 
by NOE and J-coupling constants leading to knowledge of the structural space inhabited by the 
molecules. The ring structures of all were more or less equal with few differences between 
analogues. The orientation of the β3-chain differed from natural azumamide to the unnatural 
structures, but this could not be correlated to theoretical docked structures. Still the knowledge of 
the structure was increased by applying a non-constrained methodology compared to previous 
publications, where a constrained simulation approach was utilized. 
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3.3.2 Molecular recognition 
Molecular recognition is defined as a specific non-covalent interaction of two or more molecules 
and is an essential part of many highly important biological functions, from protein folding, enzyme 
reactivity and our immune system to the structural organization of cells.
97–99
 Due to the widespread 
dependence on molecular recognition in human biology, gaining further understanding on the 
involved processes is important in the development of drugs that e.g. interfere with specific protein-
protein interactions.
100
 
PhD student Ming Li of the group of Professor Morten Meldal (MM), University of Copenhagen, 
developed a methodology of identifying peptide partners which bound with high specificity from on 
bead pairing of a large library of approximately 78,125 compounds. The bead-based screening 
protocol, developed in the lab of MM, allows for a simultaneous screening of up to 10
12 
peptide-
peptide interactions on the biocompatible poly(acryloyl-bis-(aminopropyl)polyethylene glycol) 
(PEGA) resins.
101,102
 The screening was setup as to identify peptides which bound from electrostatic 
interactions, which was investigated using competitive binding condition, where salt concentrations 
were shown to influence the binding. Lastly the binding was evaluated by fluorescence microscopy 
using a custom-made flow-cell.
103
 For more information regarding the comprehensive work of 
developing and utilizing the screening method, the reader is referred to the article.
104
 Multiple 
binding partners were identified and a condensed conclusion of their findings is found in Table 3.22 
which displays the best binding partners for the peptide Target 20. 
Table 3.22. Binding constants of various peptides (ligands) with Target 20. 
Ligand # Structure kd [μM] 
7 EDYEVEEG 0.658±0.029 
17 EDDWDDG 3.37±0.25 
18 EDYEVDDG 6.95±1.49 
19 EDYEWEEG 0.661±0.059 
The structural build of the best binding partners were all conserved, as amino acids with negatively 
charged side-chains in both ends and a single hydrophobic amino acid in the middle of the peptide, 
suggesting an electrostatic interaction. This is in contrast to many previous reports on molecular 
recognition, where hydrophobic interactions in water is usually the principal driving force towards 
binding.
100,105–108
 The C-terminal was kept a glycine due to easier coupling and cleavage of the 
peptide and resin.  
NMR study 
From the screening two peptides were chosen for structural elucidation; Target 20 (T20) and Ligand 
7 (L7), shown in Figure 3.24, which had shown a high degree of specific binding. T20 consists of 
ten amino acids while L7 consists of eight. The 3D structures of these compounds were investigated 
using distances from NOE data.  
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Figure 3.24. Top: The structure of Target 20 (T20). Bottom: The structure of Ligand 7 (L7). 
The two peptides display a specific binding interaction with a kD of 0.7 μM. NMR data were 
obtained for the two molecules in isolation and of a mixture of the two. The assignments of the 
compound resonances are found in Appendix A4. Upon mixing the chemical shifts were almost 
unchanged, especially for T20, though some changes were observed in the form of differentiation of 
chemical shifts of overlapped peaks for L7, see Figure 3.25. In contrast to the determined low 
binding constant, no intermolecular NOE correlations were observed. Some changes in distances of 
the individual peptides were observed upon mixing, but the changes were in most cases minor. 
 
Figure 3.25. Change in chemical shifts in the amide region upon mixing T20 and L7 at pH 6. The top spectrum is the mix, the 
middle spectrum is L7 and bottom spectrum is T20. 
Differences in the rotational correlation time 
An indication of interaction was an apparent increase in the rotational correlation time (τc) for both 
peptides upon mixing. This would be in correlation with an interaction so that both peptides behave 
as bigger molecules in solution. This may be shown utilizing the work of Macura et al. (equations 
(2.3) and (2.11)), making (3.6) valid for short mixing times.
17
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𝜂𝐼𝑆(𝑡𝑚)
½[𝜂𝐼(𝑡𝑚) + 𝜂𝑆(𝑡𝑚)]
= −(𝑊2𝐼𝑆 −𝑊0𝐼𝑆)𝑡𝑚 = 𝜎𝐼𝑆𝑡𝑚 
𝜎𝐼𝑆 = (
𝜇0
4𝜋
)
2 ℏ2𝛾2
10
(𝜏𝑐 −
6𝜏𝑐
1 + 4𝜔2𝜏𝑐2
) 𝑟𝐼𝑆
−6 
(3.6) 
Equation (3.6) is a revisit from Section 2.1 and is valid for homonuclear NOEs, where ω is approximately 5∙109 rad/s at 800 
MHz. As seen, the value of σIS is dependent on the distance r and τc. For e.g. methylene proton pairs where the distance is 
known, the correlation time can be calculated. The shift in τc was immediately visible in the NOESY spectra as the cross-peak 
to diagonal-peak intensity was significantly higher for the mixture compared to the single peptides, while the summed 
concentration was equal and thus lower for the individual peptide. Since the NOEs were in-phase with the diagonal and thus 
higher than the crossover correlation time, an increase in the size of the peptide would increase the NOE intensities as given 
in equation (3.6) and thereby correlated to a longer τc (see Figure 2.4 p. 6). It was observed that the σ for proton pairs 
generally increased, especially for T20, which translates to either a majority of the distances being shorter or a difference in 
τc; the latter being the most probable. Both scenarios indicated an interaction between the peptides though. For the 
methylene proton pairs τc could be calculated by assuming a fixed distance of 1.78 Å for methylene protons. Comparisons are 
found in Table 3.23 and  
Table 3.24 for the Target, Ligand and the mix of the two.  
Table 3.23. Rotational correlation times (τc) and differences in cross-relaxation rate constants for protons in of T20, in 
complex with L7 and alone. 
H 1 H 2 σIS (Mix) σIS (Single) 
Increase 
[%] 
τc (Single) 
[10
-10
 s
-1
] 
τc (Mix) 
[10
-10
 s
-1
] 
Arg(8)-βH2 Arg(8)-βH3 0.644 0.346 46 3.5 4.8 
Thr(2)-NH Gln(1)-αH 0.048 0.023 53   
Arg(3)-NH Thr(2)-αH 0.107 0.212 -98   
Thr(4)-NH Arg(3)-αH 0.100 0.101 -1   
Asn(5)-NH Thr(4)-αH 0.150 0.063 58   
His(7)-NH Thr(6)-αH 0.218 0.223 -2   
Arg(8)-NH His(7)-αH 0.173 0.122 29   
Asp(9)-NH Arg(8)-αH 0.229 0.125 45   
Gly(10)-NH Asp(9)-αH 0.085 0.007 92   
His(7)-NH Thr(6)-NH 0.115 0.133 -16   
Thr(6)-αH Thr(6)-γH2 0.186 0.091 51   
 
 
Table 3.24. Rotational correlation times (τc) and differences in cross-relaxation rate constants for protons in of L7, in 
complex with T20 and alone. 
H 1 H 2 σIS (Mix) σIS (Single) 
Increase 
[%] 
τc (Single) 
[10
-10
 s
-1
] 
τc (Mix) 
[10
-10
 s
-1
] 
Tyr(3)-βH2 Tyr(3)-βH3 0.783 0.490 37 4.1 5.4 
Asp(2)-NH Glu(1)-αH 0.126 0.096 24   
Asp(2)-NH Asp(2)-αH 0.190 0.125 34   
Glu(6)-NH Val(5)-αH 0.206 0.126 39   
Tyr(3)-NH Asp(2)-αH 0.097 0.121 -25   
Val(5)-NH Glu(4)-αH 0.245 0.082 67   
Gly(8)-NH Glu(7)-αH 0.074 0.036 52   
Glu(4)-NH Tyr(3)-αH 0.172 0.131 24   
 
It is of course possible that the rotational correlation time was increased by a difference in the 
viscosity of the solvent. It is thus important to state that the samples were acquired at the same 
temperature and pH and that any small differences in the two are not likely to give rise to the rather 
big increase in intensity. The possibility cannot completely be disregarded though.  
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Titration 
To verify that a plausible interaction was present a titration study was performed, but no binding 
constant was obtainable, which would also be impossible to be studied with NMR due to a kD far 
below a minimum of 10
-5
 suggested from the literature.
109
 It was observed that the change in 
relative chemical shifts of the Ligand 7 was dependent on the presence of Target 20, by performing 
a titration of L7 with T20, as seen in Figure 3.26, and afterwards diluting the sample to regain the 
original shifts. 
  
Figure 3.26. Left: 1D 
1
H spectra of the titration of L7 with T20 at pH 6.5. Note that the resonances of T20 were not observed 
at this pH due to exchange with the solvent. Right: Dilutions of the sample after titration. 
Structures from MD simulations 
The structures of Target 20 and Ligand 7 were identified to be too flexible to fit conformers from 
unconstrained simulations to the data due to too many and too different conformers. It was clear 
that some degree of order was present from multiple NH-CαH distances corresponding or 
approaching those of β-strands (2.2 Å) and long distances for both compounds, given in Table 3.25, 
and constrained simulations were used in order to get backbone structures which correlated well to 
the NOE data.
110
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Table 3.25. Experimental distances of NHi-CαHi-1 for T20 and L7, as individual peptides and when mixed. Determined by 
setting the distance of a diastereotopic proton pair to 1.78 Å (T20: Arg(8)-β, L7: Tyr(3)-β). 
H1 H2 Dist. [Å] H1 H2 Dist. [Å] 
Target 20, individual peptide Target 20, mixture 
Thr(2)-NH Gln(1)-αH 3.21 Thr(2)-NH Gln(1)-αH 2.94 
Arg(3)-NH Thr(2)-αH 2.42 Arg(3)-NH Thr(2)-αH 2.50 
Arg(3)-NH Thr(4)-NH 3.29 - - - 
Thr(4)-NH Arg(3)-αH 2.38 Thr(4)-NH Arg(3)-αH 2.54 
Asn(5)-NH Thr(4)-αH 2.43 Asn(5)-NH Thr(4)-αH 2.37 
His(7)-NH Thr(6)-αH 2.30 His(7)-NH Thr(6)-αH 2.22 
His(7)-NH Thr(6)-NH 2.55 His(7)-NH Thr(6)-NH 2.38 
Arg(8)-NH His(7)-αH 2.16 Arg(8)-NH His(7)-αH 2.31 
Asp(9)-NH Arg(8)-αH 2.46 Asp(9)-NH Arg(8)-αH 2.21 
Gly(10)-NH Asp(9)-αH 3.19 Gly(10)-NH Asp(9)-αH 2.60 
Ligand 7, individual peptide Ligand 7, mixture 
Asp(2)-NH Glu(1)-αH 2.44 Asp(2)-NH Glu(1)-αH 2.44 
Tyr(3)-NH Asp(2)-αH 2.35 Tyr(3)-NH Asp(2)-αH 2.55 
Glu(4)-NH Tyr(3)-αH 2.32 Glu(4)-NH Tyr(3)-αH 2.31 
Glu(4)-NH Val(5)-NH 2.96 Glu(4)-NH Val(5)-NH 2.98 
Val(5)-NH Glu(4)-αH 2.51 Val(5)-NH Glu(4)-αH 2.18 
Glu(6)-NH Val(5)-αH 2.33 Glu(6)-NH Val(5)-αH 2.25 
Glu(6)-NH Val(5)-NH 3.04 Glu(6)-NH Val(5)-NH 2.89 
Gly(8)-NH Glu(7)-αH 2.88 Gly(8)-NH Glu(7)-αH 2.66 
Gly(8)-NH Glu(7)-NH 2.99 - - - 
 
The resulting backbone structures fit well to the data and are shown in Figure 3.27 but it is 
imperative to stress that these are representations of the conformational space.  
 
Figure 3.27. Representative 3D structure of T20 (left) and L7 (right) from constrained simulations using NOE-derived 
distances.  
The two structures both exhibited a turn, in good agreement with NH-NH distances from the NOE 
data. The two structures were found undergo small adaptations upon interacting, but the changes 
were minor, and largest for L7, again in good correlation to the NMR data, illustrated in Figure 
3.28. Four water molecules were entrapped in a cavity between the two structures in the 
simulations, which established a hydrogen bonding network with both T20 and L7, while 
electrostatic interactions and topological complementarity between the structures was observed 
along the rim of the cavity. Note that the water molecules are not shown in Figure 3.28. The 
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interaction was thus based on side-chain to side-chain interactions, and water mediated hydrogen 
bonds, which could be the reason for the lack of intermolecular NOEs. Another suggestion could be 
a high on-off rate which could hamper the buildup of NOE signal. 
 
Figure 3.28. The interaction between Target 20 (teal) and Ligand 7 (orange) from MD simulations using constraints from 
NOE distances. Interactions are dominated by charged side-chain interactions. Water molecules in the cavity of the peptides 
omitted. 
Conclusion 
Two peptides were investigated by NMR spectroscopy to obtain information of a highly specific 
binding interaction, suggested from binding data. It was not possible to identify the interaction from 
inter-peptide NOEs, but several indices suggested that the peptides interact, including shift in 
proton chemical shifts upon mixing, a shift in the rotational correlation time and small changes in 
NOE intensities. The peptides were modelled based on distances obtained from the relative NOE 
intensities, and two complementing structures were identified, which fitted the backbone data well, 
and also theoretically bind well, primarily by interactions of the outermost parts of side-chains. The 
fact that the peptides contained a potential for much more flexibility, led to the need for constrained 
simulations to obtain good structures, and the given structures are given as representatives of the 
conformational space the peptides occupy.     
 Other compounds 3.4
This and the following Section cover a couple of projects and points from my external stay in the 
group of Craig Butts at the University of Bristol. This first section covers the usage of NOEs 
coupled to DFT optimized or clustered structures to gain knowledge of conformer populations. The 
NOE work is based on the PANIC approach, covered in Section 2.1.5.  
3.4.1 Population analysis of quinine 
The alkaloid quinine has been thoroughly investigated due to interesting biological activities and 
usage in chiral synthesis.
111–114
 The conformational populations have previously been solved from 
Gibbs free energies from Hatree-Fock and DFT calculation and the J-coupling constants of H8-
H9.
115,116
 The related compound cinchonidine, varied only by missing the methoxy group at the 
aromatic position 6’ (Figure 3.29), was recently investigated using DFT calculations and NOEs, 
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although a limited set of NOEs was used (only < 3 Å included) and the conclusions were negative 
in correlating the theoretical energy populations to the NOE populations.
117
 It could thus be 
interesting to see if a conclusion could be reached for quinine by the usage of the PANIC approach 
and a full NOE dataset. When investigating the spectra only three distances above 3 Å were 
available, all of which were fixed distances due to structural rigidity, so the difference between 
datasets is not expected to be significant. 
The group of Craig Butts had previously investigated quinine and determined the conformers from 
relative conformer energies at a B3LYP/6-31g(d) level of theory in implicit chloroform, and the 
conformers are compared to those reported by Urakawa et al. for cinchonidine, see Table 3.27 and 
Figure 3.30.
117
 
Table 3.26. Distances used in the conformational 
analysis of quinine. 
a
Reference 
H1 H2 Exp. Dist. [Å] 
2' 3' 2.42 
9 3' 2.85 
9 5' 2.11 
9 6a 2.51 
9 8 2.55 
9 7a 2.82 
6a 6b 1.79a 
6a 5a 2.31 
6a 5b 3.10 
8' 7' 2.54 
3 2a 2.36 
3 6b 3.14 
3 4 2.55 
3 5b 2.49 
8 3' 2.76 
8 5' 2.36 
2a 2b 1.71 
8 7a 2.82 
8 7b 2.29 
2b 3 2.92 
6b 5a 3.11 
6b 5b 2.38 
 
 
Figure 3.29. Structure of quinine. 
Table 3.27. Populations in % from the literature and from the group 
of Craig Butts. 
 Dihedral Angles (°) % Population 
Conformer τ1 τ2 τ3 Urakawa
117 ButtsII 
C1 249 50 175 10 8 
C2 60 60 180 4 2 
C7 17 53 173 11 10 
O3 99 150 278 72 73 
O4 260 140 272 0 4 
O8 20 150 278 0 3 
O10 102 268 38 3 0 
 
Most of the distances were between rigid parts of the molecule, and should not influence the 
determined populations. The non-rigid distances of the seven relevant conformers which influenced 
the obtained populations are given in Table 3.28. All distances are included in Appendix A4. 
                                                 
 
II
 Unpublished work of the group of Dr. Craig Butts 
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Table 3.28. Experimental distances between non-rigid proton pairs and distances determined from the seven relevant 
conformers of quinine. Structures were optimized using MPW1PW91/6-311+g(d,p). 
H1 H2 Exp. C1 C2 O3 C7 O8 O4 O10 
9 3' 2.9 2.28 3.68 3.65 3.55 3.62 3.62 3.61 
9 5' 2.1 3.79 2.09 2.13 2.34 2.29 2.29 2.07 
9 6a 2.5 2.13 2.16 2.67 2.23 2.69 2.69 3.97 
9 8 2.6 3.04 3.04 2.56 3.05 2.53 2.53 2.24 
9 7a 2.8 2.60 2.71 3.63 2.44 3.65 3.65 2.85 
8 3' 2.7 2.75 2.72 3.83 2.33 2.19 2.19 2.45 
8 5' 2.4 2.41 2.22 2.44 3.98 3.70 3.70 3.30 
 
 
Figure 3.30. The most abundant conformers of quinine (B3LYP/6-31g(d) and literature
117
). 
Initially the populations of the six conformations identified in the group of Craig Butts were 
compared to the NOE data. The populations of single conformers were fixed individually and the 
remaining conformers were optimized to give the best fit to the data. It was realized that the MAE 
was not discriminative, since the MAEs of most populations were generally low. Instead the 
maximum difference for the populations was used, as a better discriminator of the actual correlation 
between NOE distances and 3D structures see Figure 3.31. 
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Figure 3.31. Population analyses, by fixing a conformer population and optimizing the rest, of the six conformers C1(×), 
C2(×), C7(×), O3(○), O4(●) and O8(●). The dotted line is the value using only C1, C7 and O3.  
NOE distances dictated that the O3 conformer was indeed the dominating one, in accordance with 
all DFT calculations, and that the remaining conformers were populated 0-20 %. Due to overlap in 
the conformational space between the conformers only three conformers were needed in order to 
obtain a good fit to the data, to a good approximation, namely O3, C1 and C7. There was no solid 
experimental evidence that the rest of the conformations are present in solution, probably due to 
structural similarities within open and closed conformations. 
When adding the seventh conformation, O10, to the available structures as given by the population 
analysis of Urakawa et al., it led to a slightly better fit, considering the MAE, while the maximum 
difference in the distances was almost unaffected. The NOE populations were generally worse 
compared to the theoretical populations, and akin to C2, O4 and O8, the conformer was not proven 
needed in the fitting due to a low dependence on the inclusion of the conformer, Figure 3.32.  
 
Figure 3.32 Population analyses, by fixing a conformer population and optimizing the rest,  of the seven conformers C1(×), 
C2(×), C7(×), O3(○), O4(●), O8(●) and O10(+). 
In Table 3.29 the conformational populations using the different sets of structures are shown, which 
may be compared to the data in Table 3.27. 
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Table 3.29. Experimental population of the conformers from NOE distances, using different sets of conformers as indicated. 
 Exp. Population [%]  
Conformer 6 structures 7 structures Essential 3 
C1 15 16 13 
C2 7 16 - 
C7 14 4 21 
O3 59 41 66 
O4 4 0 - 
O8 1 0 - 
O10 - 23 - 
MAE [%] 2.54 2.43 2.70 
Max diff [%] 6.31 5.45 6.73 
 
In conclusion it was difficult to determine the populations from the data, as the introduction of the 
O10 conformer led to large differences between experimental and theoretical populations. The 
problems arise from overlaps of the conformational space between conformers, leading to few 
distances that may actually differentiate conformers. There were seven distances identified between 
rotatable parts of the structure, which, compared to up to seven conformers, leads to an 
underdetermined system when trying to determine a population of each conformer. It might be more 
interesting to fit the dihedral angles around the rotatable bonds, which is seen in Figure 3.33. 
 
Figure 3.33. The population of dihedral angles associated with the rotatable bonds in quinine. White: Urakawa (energy), 
grey: Butts (energy), black: 7 structures (NOE), red: 6 structures (NOE), blue: 3 structures (NOE). 
The only really different populations were observed when including the seventh conformer which 
seemed to be severely overestimated. The populations of quinine are revisited in Chapter 0. 
 Inclusion of correlation time in NOE calculations 3.5
On my external stay I was involved in a project where the goal was to utilize calculation of 
correlation times to improve on the accuracy of NOE calculations for small organic molecules. This 
was tried achieved in multiple ways, I will include only the parts where I was directly involved. 
3.5.1 Theory 
A major assumption in the ISPA methodology, is equality of correlation time (τc) for all nuclei 
pairs, it would seem that including relative correlation times would increase the accuracy of the 
calculations, as proposed in the literature.
15,118–122
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The actual parameter of interest is the effective rotational correlation time, which covers the overall 
rotational correlation time of the molecule (τo) and the relative intramolecular movements (τs) as 
given in (3.7).
118
 
 
1
𝜏𝑐
=
1
𝜏𝑜
+
1
𝜏𝑠
 (3.7) 
Note that the effective correlation time is also called τe  or τi in the literature but covers the same 
parameter.
118,119
 
Values of τc may be obtained in four different ways:
7,123
 
1. By estimation from the size of the molecule (correlate with molecular weight of proteins). 
2. By estimating correlation times from T1 relaxation (only possible for 
13
C). 
3. Utilizing NOE and ROE spectra at the same field strength. 
4. Comparing NOEs at two field strengths.  
The first two methods will not be discussed while the formula needed for the two latter methods are 
included in equations (3.8) to (3.16), starting from the differences in NOE and ROE observables in 
(3.8) and (3.9).
7,118–120
 Note a small overlap with theory in Chapter 2. 
 𝜎𝑁𝑂𝐸 = 𝐾 ∙ 𝑟
−6 ∙ [6𝐽(2𝜔) − 𝐽(0)] = 𝑘 ∙ 𝑟−6 ∙ 𝜏𝑐 (
6
1 + 4𝜔2𝜏𝑐2
− 1) (3.8) 
 
𝜎𝑅𝑂𝐸 = 𝐾 ∙ 𝑟
−6 ∙ [3𝐽(𝜔) + 2𝐽(0)] = 𝑘 ∙ 𝑟−6 ∙ 𝜏𝑐 (
3
1 + 𝜔2𝜏𝑐2
+ 2) 
𝐾 = (
𝜇0
4𝜋
)
2 ℏ2𝛾𝐻
4
10
 
(3.9) 
In practice the most utilized ROE experiment is the T-ROE, due to the less demanding spin lock 
utilized. In T-ROE the magnetization may be viewed as shared between longitudinal and transverse 
during the mixing time as given in (3.10).
14,124
 
 𝜎𝑇−𝑅𝑂𝐸 =
cos 𝜃𝑖 cos 𝜃𝑗 𝜎𝑁𝑂𝐸 + (1 + sin 𝜃𝑖 sin 𝜃𝑗)𝜎𝑅𝑂𝐸
2
 
(3.10) 
With tanθ = (ωi - ωT)/γB1. ωi is the chemical shift of i in rad/s (or Hz, need to match γB1), ωT is the 
chemical shift of spin-lock transmitter offset in rad/s (or Hz), γB1 is the spin-lock field in rad/s (or 
Hz). If the assumption is made that θi and θj → 0, then cosθi and cosθj → 1 and sinθi and sinθj → 0. 
This is the most abundant approach used in the literature on the subject.
15,118–122
 This leads to (3.11). 
 
𝜎𝑇−𝑅𝑂𝐸 =
𝐾
2
∙ 𝑟−6 ∙ [6𝐽(2𝜔) + 3𝐽(𝜔) + 𝐽(0)] 
               =
𝐾
2
∙ 𝑟−6 ∙ 𝜏𝑐 (
6
1 + 4𝜔2𝜏𝑐2
+
3
1 + 𝜔2𝜏𝑐2
+ 1) 
(3.11) 
It is fairly obvious that this assumption is not valid for most systems. If one only wants to utilize the 
T-ROE intensities for distance calculations the approximation may work just fine due to the 
aforementioned r
-6
 relationship, but the influence of τc may be problematic.  With a 𝛾𝐵1 of 5500 Hz 
at 500 MHz, a proton 4 ppm from the offset with its “partner” proton on the offset resonance will 
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need a correction of 𝜎𝑅𝑂𝐸 of ≈ 5 %. If the two protons reside at ± 4 ppm of the offset resonance a 
correction of 𝜎𝑅𝑂𝐸 of ≈ 25 % is needed. 
From equations (3.8) to (3.11) the ratios of NOE to (T-)ROE may be given as equation (3.12) and 
(3.13).
119,125
 
 
𝜎𝑁𝑂𝐸
𝜎𝑅𝑂𝐸
=
5 + 𝜔2𝜏𝑐
2−4𝜔4𝜏𝑐
4
5 + 22𝜔2𝜏𝑐2+8𝜔4𝜏𝑐4
 (3.12) 
 
𝜎𝑁𝑂𝐸
𝜎𝑇−𝑅𝑂𝐸
=
10 + 2𝜔2𝜏𝑐
2−8𝜔4𝜏𝑐
4
10 + 23𝜔2𝜏𝑐2+4𝜔4𝜏𝑐4
 (3.13) 
Note again that the latter is only true if θi and θj → 0. Still, even with this restriction, this is what is 
utilized in the literature.
118,119,125
 Experimental data that suggests the need for the correction is 
presented in Appendix A9 in the form of different, albeit correctable, obtained T-ROE intensities at 
different pulsed field strengths and offsets. The relative NOE to ROE intensities are illustrated in 
Figure 3.34. 
 
Figure 3.34. The theoretical relative cross-relaxation rate (σ) of NOE and ROE (―) or T-ROE (- -) experiments at 500 MHz 
for a proton pair. Calculated using (3.12) and (3.13). 
If NOE and T-ROE data is acquired the corrected ROE part of T-ROE can be extracted by (3.14) 
 𝜎𝑅𝑂𝐸 =
2𝜎𝑇−𝑅𝑂𝐸 −cos 𝜃𝑖 cos 𝜃𝑗 𝜎𝑁𝑂𝐸
(1 + sin 𝜃𝑖 sin 𝜃𝑗)
 (3.14) 
From (3.12) and (3.13) the correlation time may be calculated by (3.14) and (3.15) for σNOE > 0 and 
defining that σNOE/σ(T-)ROE = ∇𝜎. 
 
𝜏𝑐
𝑁𝑂𝐸/𝑅𝑂𝐸 = 
1
4
√2√(2∇𝜎 + 1)(−22∇𝜎 + 1 + 3√36∇𝜎2 + 4∇𝜎 + 9
(2∇𝜎 + 1)𝜔
 
(3.15) 
 
𝜏𝑐
𝑁𝑂𝐸/𝑇−𝑅𝑂𝐸 = 
1
4
√2√(∇𝜎 + 2)(−23∇𝜎 + 2 + 3√41∇𝜎2 − 28∇𝜎 + 36
(∇𝜎 + 2)𝜔
 
(3.16) 
For two field NOE analysis only (3.8) is needed. If data is acquired at field x and y, and assuming 
σNOE,x > σNOE,y, equations (3.17) to (3.19) may be used.
122
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 𝜎𝑁𝑂𝐸,𝑥 = 𝐾 ∙ 𝑟
−6 ∙ 𝜏𝑐 (
6
1 + 4𝜔𝑥2𝜏𝑐2
− 1) (3.17) 
 𝜎𝑁𝑂𝐸,𝑦 = 𝐾 ∙ 𝑟
−6 ∙ 𝜏𝑐 (
6
1 + 4𝜔𝑦2𝜏𝑐2
− 1) (3.18) 
 
𝜎𝑁𝑂𝐸,𝑥
𝜎𝑁𝑂𝐸,𝑦
=
(4𝜔𝑥
2𝜏𝑐
2 − 5)(4𝜔𝑦
2𝜏𝑐
2 + 1)
(4𝜔𝑥2𝜏𝑐2 + 1)(4𝜔𝑦2𝜏𝑐2 − 5)
 (3.19) 
From this the correlation time may be determined. 
After the correlation time is determined the distances need to be calculated. There are different 
possibilities in doing this; first by using (3.8) to (3.11) directly as all parameters but the distance is 
known. Another method is using a PANIC like approach, exemplified in (3.20). 
 𝑟𝑖 = 𝑟𝑟𝑒𝑓
(
 
 𝜎𝑖
𝜎𝑟𝑒𝑓
𝜏𝑐,𝑟𝑒𝑓 (
6
1 + 4𝜔2𝜏𝑐,𝑟𝑒𝑓2
− 1)
𝜏𝑐,𝑖 (
6
1 + 4𝜔2𝜏𝑐,𝑖2
− 1)
)
 
 
−1/6
 (3.20) 
It should be noted that in most cases where correlation times are used, they are not included in the 
distance calculations but compared and deemed identical. It is thus used more as a validation that 
the ISPA approach is appropriate.
119,125
 
For the sake of inclusion, the last major equation which should be mentioned in regard to rotational 
correlation time is based in the rotational correlation times for 13C which may be calculated from 
the T1 relaxation time as shown in (3.21).
7
 
 
1
𝑇1( C
13 )
= (
𝜇0
4𝜋
)
2
𝑁ℏ2𝛾𝐻
2𝛾𝐶
2𝑟−6𝜏𝑐 (3.21) 
Where r is the C-H distance (~1.1 Å) and N is the number of attached protons. The usage of this 
formula will of course approximate that the, at least relative, rotational correlation times are equal 
for bound protons and carbons, which may be a good approximation, though it was not thoroughly 
investigated. 
3.5.2 Inclusion of correlation times for small molecular NMR 
To test if the inclusion of the rotational correlation time would improve the correlation between 
experimental NOE derived distances and distances from 3D structures of small organic molecules 
in organic solvents, three compounds were used; rigid, and more importantly here, spherical 
strychnine, rigid but flat progesterone and more flexible quinine. While data of strychnine was only 
acquired in chloroform, data for the remaining two compounds were also acquired in DMSO.  
Strychnine 
Due to the spherical structure and excellent fit between experimental and 3D structure distances of 
strychnine it was not anticipated that including the rotational correlation time would lead to an 
overall better structural distance correlation. Experimentally, many of the observed T-ROEs were of 
lower intensity than the NOE counterparts, which is not theoretically possible, if assuming that the 
formulae in the previous section are valid. This is problematic and results in a significantly smaller 
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number of NOEs which are compared in Table 3.30. The fit between experimental and 3D structure 
distances was not improved but seem to be corrected more or less at random. 
 
Table 3.30. Theoretical and experimental distances between protons in strychnine using NOEs or τc corrected distances using 
the NOE/T-ROE methodology (τm = 300 ms). Structure optimized to MPW1PW91/6-311+g(d,p). Only distances where 
NOE<T-ROE intensities are included. 
a
Reference distance. 
H1 H2 
3D struct. 
[Å] 
Experimental distances [Å] τc 
[ps] NOE Diff [%] NOE/T-ROE Diff [%] 
4 3 2.49 2.55 2.26 2.52 1.10 31.1 
13 8 3.00 3.17 5.74 3.27 9.09 41.5 
13 12 2.35 2.34 0.24 2.45 4.27 45.6 
13 14 2.41 2.38 1.32 2.55 5.68 55.1 
13 15a 2.24 2.31 2.73 2.28 1.65 31.3 
15a 13 2.24 2.23 0.71 2.29 1.83 39.8 
15a 15b 1.75a 1.75 0.20 1.75 0.20 33.5 
15a 14 2.54 2.52 0.89 2.55 0.09 35.8 
15a 16 2.47 2.44 0.98 2.48 0.66 37.5 
18b 8 2.30 2.19 4.79 2.22 3.43 36.9 
18b 18a 1.77 1.82 3.01 1.79 1.34 30.1 
18b 22 3.12 2.99 4.30 3.20 2.35 54.5 
        
   MAE[%] 2.26  2.64  
It was realized that the problem was the low values of the rotational correlation time for strychnine. 
Thus the theoretical differences between NOE and T-ROE intensities were lower than the 
experimental error. This is in good agreement with the observations; the values of τc were probably 
in the correct interval, but small differences were not translated well to distances. This problem is 
further addressed in explained in Table 3.31. Remember that a resulting distance error of 2 or 5 % 
translates to the intensity theoretically being either ~11 or 25 % low or high, or ~13 or 36 % too 
high. The values or 2 and 5 % were chosen as the average error approaches 2 % for strychnine and 
the maximum single distance error approaches 5 %. The errors in observed intensities were thus 
easily above the differences from differences in rotational correlation times. For comparison an 
intensity error of 2 % translates to a difference in 0.33 % in distances, which is the precision needed 
for NOE calculations to obtain a better fit in the case of strychnine. 
Table 3.31. Theoretical PANIC intensities of different distances at 500 MHz assuming τc = 30 ps. 
r ηNOE ηT-ROE Diff [%] 
1.75 128.8 131.2 1.9 
2.25 30.2 30.8 2.0 
2.50 13.6 13.9 2.2 
 
Slightly discouraged by this result, the fact that strychnine is spherical and that chloroform has a 
low viscosity and thus expected short τc, prompted for the investigation into other compounds 
which could be investigated in multiple solvents, chosen to be chloroform and DMSO due to large 
differences in viscosity. Salts of strychnine may be dissolved in DMSO, which was attempted, but 
low solubility gave inconclusive results that are not included.  
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Progesterone 
The second compound to investigate was the steroid progesterone. The structure of progesterone is 
flat and asymmetrically extended in virtue of being a steroid. It was thus proposed that the 
rotational correlation time would differ significantly dependent on whether the distance vector 
would lie along the long (L or 1), short (S or 2) axis or in plane (3), see Figure 3.35 for clarification.   
 
Figure 3.35. The structure of progesterone, with the three proposed major rotation axis are indicated. In the following the 
term “L” will cover 1 and 3, and “S” 2. 
A theoretical dependence was identified as two distinct groups, correlating to rotation 1 and 2, the 
first also including 3, with grouped distance errors. In practice it was troublesome to couple this to 
the actual rotational correlation time in chloroform, and only minor improvements were obtained 
when tested in DMSO. 
Chloroform 
The data obtained from chloroform is seen in Table 3.32. The direction of the distance vector were 
divided into long (L) and short (S) from assessment of a 3D structure (see Figure 3.35, where L = 1 
and 3, and S = 2). The theoretically optimized experimental distances (Exp Theo) gives 
experimental distances from theoretically optimized values of τc of these two groups which 
identified to be L = 37 and S = 20 ps (from optimizations using the Excel solver function), which 
gives a correction factor of 1.10 between the two. The experimental distances were corrected by the 
τc
 
determined from the NOE/ROE intensities (Exp. Corr.). The differences between experimental 
and theoretical distances for corrected compared to uncorrected data is given by the subtracting the 
error of the corrected data from the uncorrected (Impr.); positive is an improved and negative a 
decreased fit between experimental and 3D structure distances by correcting the data. 
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Table 3.32. Progesterone in CDCl3. NOESY and T-ROESY data used for calculation of τc (τm = 300 ms). Structure optimized 
to MPW1PW91/6-311+g(d,p). *NOE/ROE was not solvable as INOE > IROE. H7b-H7a was used as reference. See text for 
further explanations. 
H1 H2 Dir Calc. Exp. Diff Exp. Theo. τc [ps] Exp. Corr. Impr. 
4 6a L 2.36 2.15 0.21 2.36 36 2.22 0.07 
17 16a S 2.27 2.32 -0.05 2.32 21 2.21 -0.02 
17 12a L 2.43 2.24 0.19 2.46 42 2.37 0.13 
17 14 L 2.46 2.16 0.29 2.38 40 2.27 0.10 
6a 4 L 2.36 2.04 0.32 2.24 38 2.12 0.08 
6a 7b L 2.46 2.16 0.30 2.37 54 2.35 0.19 
6a 7a L 2.45 2.32 0.12 2.55 46 2.48 0.09 
16b 16a S 1.76 1.75 0.01 1.75 60 1.93 -0.17 
16b 15b L 2.31 2.19 0.12 2.40 97 2.52 -0.10 
7b 6b L 2.44 2.33 0.11 2.56 45 2.48 0.06 
7b 6a L 2.46 2.20 0.26 2.41 63 2.44 0.24 
7b 8 S 2.46 2.48 -0.02 2.48 76 2.81 -0.33 
7b 15b L 2.78 2.47 0.31 2.71 64 2.75 0.28 
7b 7a S 1.76 1.74 0.03 1.74 64 1.93 -0.15 
8 6b L 2.58 2.34 0.24 2.57 37 2.43 0.09 
8 7b S 2.46 2.56 -0.10 2.56 86 2.93 -0.37 
8 15b L 2.68 2.56 0.12 2.81 -*   
15b 16b L 2.31 2.16 0.15 2.37 76 2.45 0.01 
15b 7b L 2.78 2.34 0.44 2.57 -*   
15b 15a S 1.77 1.77 0.00 1.77 -*   
15b 8 L 2.68 2.48 0.20 2.72 61 2.75 0.13 
7a 6a S 2.45 2.43 0.02 2.43 27 2.41 -0.03 
7a 7b S 1.76 1.76 0.00 1.76 29 1.76 0.00 
7a 15a L 3.05 2.64 0.41 2.90 92 3.03 0.39 
9 1b L 2.29 2.08 0.20 2.29 42 2.20 0.11 
   
  
  
   
MAE [%] 
St. dev. [%] 
6.63 
 
2.52  5.50  
4.71 
 
2.03  4.76  
 
The directionality of the distance vectors were assessed from a model and some may correspond 
more to a situation represented by rotation 3 in Figure 3.35. Still, when comparing the experimental 
to the theoretical distances, there seem to be a correlation between the assigned rotation axis and the 
fit. This was translated into theoretical τc values, and led to a much improved fit of the experimental 
distances. In practice the determined τc seem to be distributed at random, and though the 
experimental distances generally correlate better to the 3D structure, multiple distances had 
increased differences to the 3D structure. Also, as for strychnine, some τc values where not possible 
to identify due to a lower ROESY intensity compared to the relevant NOESY signal, which result in 
unsolvable equations. This may, as for strychnine, be caused by to the experimental error being 
larger than the theoretical difference between the NOESY and ROESY intensities, see Section 0 for 
further discussion. 
 
 
  
3 Application of NOEs and 
3
JHH-couplings in 3D structure determination 
 
 
 
65 
DMSO 
The data obtained from DMSO is found in Table 3.33.  
Table 3.33. Progesterone in DMSO-d6. NOESY and T-ROESY data used for calculation of τc (τm = 300 ms). Structure 
optimized to MPW1PW91/6-311+g(d,p). H7b-H7a was used as reference. See text regarding CDCl3 for further explanations. 
H1 H2 Dir Calc. Exp. Diff Exp. Theo. τc [ps] Exp. Corr. Impr. 
4 6a L 2.29 2.25 0.04 2.31 85 2.22 -0.02 
17 12b S 2.73 2.84 -0.11 2.84 83 2.81 0.03 
17 16a S 2.36 2.36 0.00 2.36 95 2.36 0.00 
17 12a L 2.37 2.34 0.03 2.40 105 2.34 0.01 
17 14 L 2.36 2.27 0.09 2.34 138 2.28 0.01 
2b 1a S 2.49 2.49 0.00 2.49 135 2.50 -0.01 
6b 7b L 2.44 2.39 0.06 2.45 96 2.38 0.00 
6b 8 L 2.59 2.47 0.12 2.54 123 2.48 0.01 
6b 7a S 3.05 3.07 -0.02 3.07 135 3.08 -0.01 
6a 7b L 2.51 2.42 0.09 2.49 143 2.43 0.00 
6a 7a L 2.48 2.37 0.11 2.44 102 2.37 0.00 
2a 1a S 2.51 2.60 -0.09 2.60 158 2.59 0.01 
2a 1b L 2.47 2.42 0.06 2.48 125 2.43 0.01 
7b 6b L 2.44 2.36 0.09 2.42 97 2.36 0.00 
7b 6a L 2.51 2.42 0.09 2.49 134 2.43 0.01 
7b 15b L 2.50 2.53 -0.03 2.60 153 2.52 0.01 
7b 8 S 2.46 2.44 0.02 2.44 154 2.52 0.01 
7b 14 S 2.61 2.54 0.08 2.54 131 2.54 0.01 
7b 7a S 1.76 1.76 0.00 1.76 98 1.76 0.00 
  
  
   
   
MAE [%] 
St. dev. [%] 
2.34 
 
1.40  2.28  
1.36 
 
1.25  1.32  
 
As for chloroform the directionality of the distance vectors were assessed from a model. In DMSO 
it is less obvious that one may correlate experimental distances to markedly different τc. It was done 
though and led to an improvement in the already excellent fit between experimental distances and 
distances obtained from a 3D structure. In practice the determined τc seem to be distributed at 
random again, and the MAE is essentially unchanged. It is obvious that the higher viscosity of 
DMSO leads to a longer τc and that the experimental data fit better to the calculated data. This may 
be contributed to the signal intensity being less dependent of τc for this rotational time regime.  
The same analysis may be done by the two-field (2F) methods, to much the same conclusion. A 
comparison of the τc values from NOE/ROE and 2F analysis is found in Table 3.34, and the 
rotational correlation times are markedly different, which is problematic. In most cases the 
rotational correlation times are in the same general regime though, and the differences between 
corrected distances are negligible. This is currently under assessment in the group of Dr. Craig 
Butts and will not be further elaborated on. 
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Table 3.34. Progesterone in DMSO-d6. Comparison of experimental τc from NOE/ROE and two-field analysis (τm = 300 ms). 
NOESY and T-ROESY data used for calculation of τc at 500 or 600 MHz using a spinlock field of 5452 Hz with an offset at 5 
ppm. 
H1 H2 
τc [ps] 
NOE/ROE 2F NOE 
4 6a 85 88 
17 16a 95 63 
17 12a 105 97 
17 14 138 130 
6a 7b 143 90 
6a 7a 102 165 
2a 1a 158 124 
2a 1b 125 119 
7b 6b 97 255 
7b 6a 134 165 
7b 8 154 134 
7b 7a 98 93 
 
Quinine 
From a general assessment of the structure of quinine, it was postulated that the two rigid systems 
might experience different τc and that the inter-rigid NOEs would most certainly experience a τc 
different than that of the rigid NOEs, see Figure 3.36 for clarification and the structure of quinine. 
Quinine was investigated in chloroform and DMSO, but in this text only the chloroform data is 
analyzed, as the outcome and conclusions are very similar for data acquired in the two solvents. 
First the rigid parts of quinine was investigated, Table 3.35, and there seem to be a slight difference 
in the rotational correlation time. 
Table 3.35. Quinine in CDCl3. NOESY and T-ROESY data used for calculation of τc. Only rigid distances shown. Exp. 
Corr. is the distances corrected by the experimental τc values. Impr is the differences between experimental and 
theoretical distances for corrected minus uncorrected data; positive is an improved and negative a decreased fit between 
experimental and 3D structure distances by correcting the data. H6a-H6b was used as reference. Structures optimized to 
MPW1PW91/6-311+g(d,p). 
H1 H2 τc [ps] Exp. Exp. Corr. Calc. Impr. 
2' 3' 188 2.48 2.45 2.49 -0.03 
8' 7' 178 2.56 2.54 2.52 0.02 
3' 2' 186 2.43 2.40 2.49 -0.03 
3 2a 166 2.39 2.39 2.33 0.00 
3 6b 162 3.13 3.14 3.32 0.01 
3 4 149 2.53 2.55 2.49 -0.03 
3 5b 156 2.48 2.49 2.44 -0.02 
2a 2b 167 1.72 1.72 1.77 0.00 
2a 3 163 2.32 2.33 2.33 0.01 
8 7b 137 2.26 2.30 2.31 0.03 
6b 6a 171 1.79 1.79 1.76 0.00 
2b 2a 174 1.69 1.69 1.76 -0.01 
2b 3 207 3.02 2.92 2.93 0.07 
6b 5b 148 2.36 2.38 2.36 -0.02 
6a 6b 169 1.78 1.78 1.76 0.00 
6a 5a 143 2.29 2.32 2.35 0.03 
       
MAE [%] 
St. dev [%] 
2.13 2.06 
  
1.37 1.42 
   
 
Figure 3.36. The structure of quinine 
indicating the rotatable bonds connecting the 
rigid ring systems. 
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The fit, in the form of the MAE, is slightly improved by incorporating the τc term in the 
calculations, but again the distances are not generally improved, and the structural fit is already 
excellent.  
The inter-rigid distances and their τc are found in Table 3.36. It should be noted that the populations 
were optimized in both instances from the structures discussed in Section 3.4.1, and that the 
populations only varied slightly. 
Table 3.36. Quinine in CDCl3. NOESY and T-ROESY data used for calculation of τc (τm = 300 ms). Only non-rigid distances 
shown and conformer populations were optimized before comparison. Exp. Corr. is the distances corrected by the 
experimental τc values. Impr is the differences between experimental and theoretical distances for corrected minus 
uncorrected data; positive is an improved and negative a decreased fit between experimental and 3D structure distances by 
correcting the data. H6a-H6b was used as reference. 
H1 H2 τc [ps] Exp. Exp. Corr. Calc. Impr. 
8 3' 136 2.73 2.73 2.81 0.00 
8 5' 178 2.39 2.39 2.51 0.00 
8 9 180 2.55 2.55 2.65 0.00 
9 3' 181 2.89 2.86 2.96 -0.03 
9 5' 157 2.10 2.12 2.22 0.02 
9 6a 145 2.53 2.56 2.43 -0.03 
9 8 176 2.59 2.58 2.65 -0.01 
9 7a 122 2.78 2.83 2.89 0.05 
6a 9 143 2.45 2.48 2.43 -0.03 
       
MAE [%] 
St. dev. [%] 
3.35 3.49 
  
1.33 1.13 
   
The τc was not markedly different for these flexible proton pairs than τc determined for the rigid 
parts, in contrast to our assumptions, and the MAE was actually slightly worsened by including the 
rotational correlation time in the calculations. When determining the populations, the difference 
between the NOE and NOE/T-ROE data sets are diminishing as illustrated in Figure 3.37. Similarly 
the difference is minute in population determined from six or seven structures. 
 
Figure 3.37. The populations of quinine conformers from NOE (white) and NOE/T-ROE (grey) distances using the three 
essential conformers identified in Section 3.4.1. 
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3.5.3 Conclusion and problems in including correlation times 
While it would seem that including more data is always beneficial, the problem with the rotational 
correlation time is the erroneous methods that may be used to determine τc. The robustness of the 
NOE methods, due to the r
-6
 relationship, is thus reduced by introducing the correlation time, which 
does not benefit from a similar relationship. Due to generally low rotational correlation times in 
especially chloroform, any errors in NOESY and/or ROESY data will lead to large errors in the 
experimentally determined τc, as seen Figure 3.38, due to only minor differences between the 
observables. As a consequence, an acceptable experimental error in the relative PANIC intensity of 
one to two will often be larger than the expected differences in PANIC intensities from 
NOESY/ROESY or two-field analysis experiments. For longer distances especially the introduction 
of the rotational correlation time into the equations is problematic, due to a larger influence of 
errors on the resulting distances. 
 
Figure 3.38. Theoretical PANIC intensities from NOESY and T-ROESY or two-field NOESY analyses. Calculated from (3.8) 
and (3.11) using ω = 500 MHz (NOE/T-ROE), or ω1 = 500 MHz (B0
1
) and ω2 = 600 MHz (B0
2
). r given in the figures. A 
spinlock field of 5452 Hz with an offset at 5 ppm was assumed for the T-ROESY calculations. 
The promise of more exact distances is present from these types of analyses. As seen in Figure 3.39 
the influence on the rotational correlation time on the distances obtained may be rather large, if the 
correlation time is sufficiently different. It is an enigma though, as the biggest difference from small 
rotational correlation time differences is in the regions where τc is hardest to measure correctly. In 
most cases it is thus not preferable to introduce the corrections into the equations for small 
molecules as this will only lead to more errors. It is also quickly evident that care should be taken in 
the NOESY crossover region, and that the ROESY experiment is not just superior in the relative 
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intensity, but also in a minimal dependence on the rotational correlation time in the crossover region 
(these two observations are coupled but maybe not always realized). Of course ROESY type 
experiments have their own challenges in this regard and may be in need of correcting before being 
used quantitatively. 
In conclusion the attempt to obtain experimental distances with a higher correlation to those of 3D 
structures was not successful. While the methods may be used to estimate τc and check the 
assumption of roughly equal τc between proton pairs, direct usage of τc in distance calculations is 
not recommended.  
 
Figure 3.39. Theoretical distance correction factors as a fucntion of the rotational correlation time (in ms) for NOESY and T-
ROESY. Calculated from (3.8) and (3.11) using ω = 500 MHz, and a spinlock field of 5452 Hz with an offset at 5 ppm. 
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 Experimental 3.6
General on structural calculations 
The theory used for obtaining distances from NOESY and ROESY experiments is outlined in the 
theory section (Section 2.1). A build up curve was always established using (25), 50, 100, 150 and 
200 (and 300) ms mixing times for each cross-peak and each curve were evaluated. Standard setups 
for all NMR experiments and the spectrometers used are found in Appendix A1. 
All J-coupling constants were extracted from 1D 
1
H spectra, or DQF-COSY spectra if necessary 
due to overlapping resonances. 
Fungal extraction 
Solvents used 
The solvents used were all HPLC grade. The water used was milliQ water from the milliQ Water 
Purification system by Merck Millipore. 
Media used 
The media used was yeast extract sucrose agar (YES) obtained from the stock at the Department of 
Systems Biology.  
Fungi 
Aspergillus homomorphus, IBT 21893 (or CBS 101889), originating from soil in the area of the 
Dead Sea in Israel. Inoculated by three point stabs. All plates were kept at 30 °C in darkness after 
inoculation for 7 days. 
Extraction 
Fungi were collected in double bagged stomacher bags; ten plates to a bag. 150 mL EtOAc (1 % 
FA) was added and the content processed in a Stomacher for 30 to 60 seconds. After one hour the 
extract was decanted into vials or flasks through a filter, the solvent was removed using N2 and 
rotary evaporators. The bags were refilled with 150 mL EtOAc (1 % FA) and left over night before 
being re-collected as described.  
The precipitate from the pooled extracts were dissolved in 200 mL 9:1 MeOH:H2O and extracted 
with 180 mL heptane. The MeOH/H2O phase was added 160 mL H2O and extracted 5 times with 
100 mL DCM. All phases were dried using N2 and rotary evaporators. 
Isolera One 
An Isolera One flash chromatography system by Biotage with auto-fractionation was used for 
fractioning.  The column was a 120 g Biotage Snap KP-C18-HS with a column volume of 132 mL 
and fractions of 115 mL (max) were collected, with a flow speed was 40 mL/min. 
Waters 
A semi-preparative HPLC was used for further purification; the Waters 600 Controller coupled to a 
Waters 996 Photodiode Array Detector by Waters with a flow rate of 5 mL/min, using a Luna II 
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C18, 5 μm, 250 × 10 mm column by Phenomenex. The runs are found Table 3.37. The samples were 
dissolved in MeOH before injection. 
Table 3.37. Waters runs. a: + 50 ppm TFA. b: isocratic run. 
Run 
Fraction Column 
Gradient
 
MeCN
a
/H2O
a 
Run time 
[min] 
Fraction 
name 
Name 
Amount 
isolated 
CHO012206 Luna II 30-40 % MeCN 17 CHO013409 CM-B 1.1 mg 
CHO013406 Luna II 20-60 % MeCN 20 CHO013801 CM-A 2.3 mg 
NMR – natural compounds 
All compounds were dissolved in DMSO-d6 in 3 mm (180 μL) or 5 mm (500 μL) NMR tubes. 
Standard pulse sequences used for structural elucidation, at either 500 or 800 MHz as described in 
Appendix A1. 2D ROESY spectra were used for distances calculations of homomorphosin A (23 
mM) using τm = 200 ms and 2D NOESY spectra for cyclomorphosin A (15 mM), τm = 200 ms. For 
epi-10,23-dihydro-24,25-dehydroaflavine (43 mM) 2D NOESY spectra were used, τm = 150 ms. 
The remaining natural products, homomorphosterol (12 mM), aculene A (19 mM), aculene B (23 
mM) and aculene C (18 mM) were solved from 1D 
1
H and DQF-COSY spectra. 
Simulations 
The modelling suite Maestro version 10.2.010 (2015) by Schrödinger was used for force field 
calculations,
126
 using the program MacroModel version 10.8.
127,128
 The MMFFs force field was 
used. To generate structures which should cover the conformational space of compounds, a 
conformational search was performed for each structure by the program MacroModel using 
torsional sampling with an energy cutoff of 50 kJ/mol, 100,000 steps and CPRG minimization.
127,129
 
The method will alter the dihedral angle of bonded nuclei by random Monte Carlo simulations, 
before it minimizes the new structure and, if it is indeed new as defined by relative atom position 
and within a given energy of the minimum, saves the structure. Also low-mode was used in certain 
simulations when stated in the text. Low mode sampling is based on an assumption that low-
frequency vibrational mode eigenvectors connect energy minima by low-energy paths on the 
conformational energy surface. Thus by moving coordinates along a path given by the low-
frequency modes, large energy barriers between energy minima may be traversed. These minima 
might not be identified by other methods due the large energy barriers connecting the minima. If 
moving along the low-mode eigenvector result in a new energy well, energy minimization is 
performed as for any other conformational sampling.
130
  
Gaussian version 09 revision B.01 was used for DFT calculations including optimizations and NMR 
calculations.
131
 Structures were optimized to a B3LYP/6-31(d) level of theory unless otherwise 
stated. NMR shielding tensors were calculated by MPW1PW91/6-311+G(2d,p) using GIAO and the 
PCM-SCRF model for implicit solvent.
47
  
JHH were calculated by B3LYP/6-31g(d,p) u+1s considering only the Fermi Contact term. This is 
practically done by inserting the following in the Gaussian input file: nmr=fconly 
iop(3/10=1100000) 
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Rigid to semi-rigid 
For rigid compounds which may be described by one to ten distinct conformers, e.g. quinine, DFT 
optimized structures are used as the basis of distance and J-coupling constant calculations. This is 
feasible due to the small amount of conformers, and the higher level of theory used should lead to 
more appropriate bond lengths, angles etc. This is equal to the approach utilized with much success 
in the group of Craig Butts, whom I visited on my external stay.
21,28–30
 In general the populations of 
the conformers may here be described in detail from an iterative fitting of data from conformer 
populations to the experimental data. If multiple structures were used (e.g. quinine) the Excel 
Solver was used for conformer population analysis, using the evolutionary solving method. The 
reference distance was here allowed to differ by up to 5 % to fit the data the best, except for the one 
structure data of homomorphosin A and Epi-10,23-dihydro-24,25-dehydroaflavine.  
Flexible 
For more flexible compounds, where the amount of conformers is large and/or ill described, an 
approach based in DFT calculations is not feasible. One could use centroids and optimize these, but 
a lot of subtleties are lost, and the choice of centroids will introduce a bias into the data. The 
approach used was taken out of necessity, but the robustness of the approach makes it highly 
favorable. It was realized that the systems could not be described from a few representative 
conformers, and the approach instead compares the NOE/J data to a large amount of conformers 
from MD or MM simulations. The conformers are fitted iteratively to give the best correlation 
between data from the averaged conformers to the experimental data with no regards to the relative 
energy or other properties of the conformers. This means that the output conformations should be 
seen as representative of the conformational space inhabited by the compound. While the approach 
will by design be less discriminative in e.g. determining relative stereochemistry, due to the 
disregard of relative energy, it is less prone to misinterpretation due to faulty energy determination. 
Like all approaches it does rely on the different force field methods to output meaningful 
conformers, but by disregarding the energy of these, it is more likely that conformational space is 
covered. The cutoff of 50 kJ/mol was chosen for standard MM simulations to hopefully cover all of 
conformational space, and the NMR data was then used gain information of the actual 
conformational space. The high cutoff is used to diminish the influence of errors in the calculations. 
Since the NOE data is dominated by short distances, the average distances observed may be 
changed dramatically by short distances in lowly populated conformers, and thus excluding these 
may severely influence the conclusions. 
The comparison of experimental data to that of 3D structures was performed by an in house written 
Matlab
®
 script which iteratively minimizes the MAE using 10,000 steps. In the structural evaluation 
and iterative identification of the structures which gave the highest correlation to the NOE and J-
coupling constants, both datasets were fitted independently and mixed, by weighing the differences 
as ∆=∆(NOE)+1/10∆(J). The latter data is shown throughout. Thus the unconstrained NMR 
structures were determined by averaging only the conformations that contributed to a best overall 
correlation to the data, by the lowest RMSD in both distances and coupling constants. The reference 
distance was here always equal to that of the averaged structures. The averaging was performed as 
described in Section 2.1.9 and 2.2.1. 
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Marfey’s reagent 
100 µg of homomorphosin A, cyclomorphosin A or aculene A and B were hydrolyzed with 200 µL 
6 M HCl in a 2 mL vial at 110 °C for approximately 24 h. The solvent was removed at N2 
evaporator. To the vials, and vials with 50 µL (2.5 µmol) L- or D-amino acids (valine or proline), 
were added 50 µL H2O, 20 µL 1 M NaHCO3 and 100 µL 1 % 1-fluoro-2,4-dinitrophenyl-5-L-
alanineamide (FDAA) in acetone. The vials were left for 40 °C for 1 h. The solvent was removed at 
N2 evaporator, MeOH added and HPLC-DAD-MS data acquired. 
Synthetic compounds 
The synthetic compounds were supplied by the group of Prof. Christian A. Olsen (azumamides) or 
Prof. Morten Meldal (molecular recognition) 
Azumamides 
The azumamide analogues were dissolved in DMSO-d6 in 3 mm tubes (180 μL). Spectra were 
acquired at 500 MHz and 800 MHz using 2D NOESY (500 and 800 MHz) and 2D ROESY (500 
MHz) sequences, τm = 150 ms. 2D ROESY spectra at 500 MHz were used due to a superior S/N.  
4096 data points were recorded in the direct and 512 in the indirect dimension. Relaxation delays 
were from 2 to 4 s, tested up to 7 s (>5 × T1). Most nuclei were determined to have T1 values up to 
approximately 1 s to 1.3 s relaxation times. All J-couplings were extracted from 1D 
1
H or DQF-
COSY spectra, and J-couplings from dihedral angles were calculated by the Karplus equation or the 
HLA equation for the β-peptide protons. 
Constrained simulations in implicit DMSO were conducted in MacroModel using the force field 
MMFFs or in implicit water using OPLS2005. DMSO was treated as a dielectric constant of 47.0. A 
conformational search was performed by the program MacroModel using torsional/low-mode 
sampling with an energy cutoff of 30 kJ/mol, 30,000 steps and CPRG minimization.
127,129
 The 
distances from NOE intensities were applied to the structure and allowed to differ 20% governed by 
a force constant of 100 kJ/Å2.  
Molecular dynamics simulations of azumamide A, desmethyl-azumamide C and epi-azumamide E 
were performed by the program Desmond, carried out by Post. Doc. Niels Christensen.
128
 
Individual structures were solvated in a TIP3P or DMSO box using a 10Å buffer, and neutralized 
by a single Na
+
 counter ion. The default minimization protocol in Desmond was used, consisting of 
minimization with solute constraints, minimization without constraints, Berendsen NVT simulation 
at T = 10 K with small time steps and constraints on heavy solute atoms, Berendsen NPT simulation 
at T = 10 K with constraints on heavy solute atoms, Berendsen NPT simulation with constraints on 
heavy solute atoms, and unrestrained Berendsen NPT simulation. In the MD production runs, 250 
ns NPT simulations with periodic boundary conditions were run for each system. The Nose-Hoover, 
8 chain thermostat was used to regulate temperature to 300 K with a relaxation time of 1.0 ps. The 
Martyna-Tobias-Klein barostat was used to regulate pressure to 1 bar with isotropic coupling and a 
relaxation time of 2.0 ps. Equations of motion were integrated using the RESPA10 integrator with 
bonded (2.0 fs), near (2.0 fs), and far (6.0 fs) time steps. Non-bonded interactions were subjected to 
a 9 Å cut-off. Long-range electrostatics was treated with the smooth-particle mesh Ewald method . 
All atomic coordinates for the simulations were saved at 10 ps intervals. 
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Molecular recognition 
The Target 20 (33 mM) and Ligand 7 (34 mM) were dissolved in H2O/10% D2O in 5 mm tubes (0.5 
mL). The pH was adjusted by NaOH (0.1 M). Spectra were acquired at 800 MHz using 2D NOESY 
and 2D ROESY sequences using water suppression using either presaturation or watergate. 
Distances obtained from both types of water suppressions were compared and the differences were 
negligible. 2D NOESY spectra using presaturation were used, τm = 200 ms. Prior to acquisition N2 
was bubbled through the sample to remove O2. The solutions were mixed, 0.5 mL transferred to a 
NMR tube and the acquisitions repeated as for the isolated peptides. 
Titrations of ligand 7 with target 20 were performed at pH 5.5 and 6.5. Both solutions of the 
peptides were adjusted to the target pH prior to titrations, which were performed in 3 mm NMR 
tubes. 0.9 (pH 5.5) or 0.7 (pH 6.5) mg of Ligand 7 was dissolved in 180 μL 10% D2O/H2O and 
adjusted to the target pH with 0.1 M NaOH and double the molar amount of Target 20 was 
dissolved in 100 μL 10% D2O/H2O and pH adjusted with 0.1 M NaOH. Titrations were then 
performed stepwise by adding the amount stated (e.g. 10 % equals to 4.8 μL Target solution added) 
in the figures, and 1D 
1
H spectra were acquired with 128 scans. 
The structures, Target 20 and Ligand 7, were built in MOE and both subjected to constrained 
dynamics in water from NOE derived distances by Prof. Morten Meldal. Starting from several 
rounds of 3 ns annealing from 700 to 300 K, using AMBER 12 force field, the resulting structures 
were simulated at 300 K for 5 ns and energy minimized. The NOE-constraints from the complex 
were used for the initially as the set of distances were larger and presented better S/N than those of 
the individual compounds. The individual structures were manually interacted assuming 
interactions of arginines and carboxylates, and the resulting complexes were subjected to molecular 
dynamics. Two orientations, out of six attempted, gave no significant violation of NOE’s or change 
of structure. These two orientations were subjected to extended molecular dynamics for 5 ns with 
the constraints maintained. One orientations lead to productive binding and surface 
complementarity and gave a significantly lower calculated energy compared to the other. In this 
structure all backbone distances constraints determined from relative NOE intensities were 
accommodated. The complex was optimized again without NOE constraints, and only minor 
adjustments of the two structures were observed.  
NOE constraints from for individual Target 20 and Ligand 7 experiments, was employed to 
structures from the optimized complex, which were then subjected to annealing from 700 to 300 K. 
The Target 20 was essentially unchanged the Ligand 7 changed to a partially opened. 
Other compounds 
Spectra of strychnine (124 mM), progesterone (127 mM) and quinine (123 mM) were all acquired 
in 5 mm tubes (0.5 mL), dissolved in the solvents given in the text (concentration in CDCl3, similar 
in DMSO-d6). 1D NOESY and 1D ROESY experiments were used and only resonances with good 
baseline separation were used as irradiated peaks, τm = 300 ms. For the ROESY experiments a 
spinlock field of 5452 Hz with an offset at 5 ppm was used at 500 MHz. For two-field analyses the 
other field was 600 MHz. All structures were optimized to a MPW1PW91/6-311+g(d,p) level of 
theory. 
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4 Development of NMR experiments for determination of long-
range J-coupling constants 
The experimental data presented in this chapter concerns the work on novel NMR experiments to 
extract coupling constants from small organic molecules, and is based on the following two 
articles. Work on the first article was performed in collaboration with Ole W. Sørensen, Louise 
Kjaerulff and Andrew J. Benie, and work for the second article was performed in collaboration with 
Ole W. Sørensen. Louise Kjærulff presented the work of combining the five pulse sequences in the 
original S
3
 HMBC, vide infra, in details in her PhD thesis “NMR structural studies of 
oligosaccharides and other natural products”,132 and the topics will be mostly outlined in this text. 
Appendix A11: S3 HMBC: Spin-State-Selective HMBC for accurate measurement of homonuclear coupling 
constants. Application to strychnine yielding thirteen hitherto unreported JHH 
Appendix A11: S3 HMBC hetero: Spin-State-Selective HMBC for accurate measurement of long-range 
heteronuclear coupling constants. 
 
 3D structural information from long-range J-coupling constants 4.1
The most commonly used 3D structural information obtained from J-coupling constants is based on 
data from 
3
JHH, which was discussed in Section 2.2.1 where general scalar coupling theory is also 
found. The focus on 
3
JHH-coupling constants is mainly due to in the ease of extraction of the 
coupling constants and the availability of a plethora of Karplus- or Karplus-like equations, which 
makes dihedral information readily obtainable.
40,42,133
 While the more generalized Karplus-like 
equations may be less accurate than e.g. DFT, the ease of calculation is a major benefit, and the 
scope of use is continually extended by specific equations for specific tasks.
134
  
For long-range J-coupling constants, defined as 
n
JXH, with n > 3 for 
1
H and n > 1 for 
13
C, the 
coupling constants are not generally easily obtained nor easily correlated to a 3D structural 
parameter. While some Karplus equations have been developed for 
2
JCH and 
3
JCH systems, they are 
generally very specific and used in only a few fields, perhaps due to difficulties in accessing the 
coupling constants or lack of general applicability of the equations.
46,135–137
 It has been suggested to 
utilize a strong/medium/weak coupling constant approach, in spiritual resemblance to NOE work 
for macromolecules.
46
 This approach is a viable option for rigid structures, but difficulties may be 
envisioned from an increase in flexibility, even though some examples of flexible structures were 
presented.
46
 For other long-range coupling constants (
n
JXH, n > 3, X=H,C) Karplus equations are 
complicated by addition of extra bond and thus extra dihedral angles to the equations, though very 
specific equations were empirically derived for specific cases of 
4
JHH-coupling constants.
138,139
  
The data from the long-range coupling constants is thus usually compared to more time-consuming 
theoretical DFT calculations to gain structural information.
53,140,141
 While this may limit the amount 
of conformers included in theoretical data calculations, access to increasingly larger computers 
decreases the calculation time and has made the information increasingly accessible. Since any 
increase in information of structural parameters will inevitably lead to more structural knowledge, 
the information from long-range coupling constants holds considerable value and should not be 
discarded.
6
 
4.1  3D structural information from long-range J-coupling constants 
 
 
76 
4.1.1 Published methods to extract long-range coupling constants 
This section will serve as a brief introduction to the currently available NMR experiments which 
may be used the extraction of long-range coupling constants. Regarding the extraction of long-range 
homonuclear coupling constants, E.COSY type experiments or standard 1D 
1
H or DQF-COSY 
sequences may be used by simulation of coupling patterns or displacement of resonances.
142–144
 In 
the DQF-COSY case the measurements described were performed on rigid structures with larger 
long-range coupling constants.
144
  
In comparison, a plethora of experiments has been developed for the extraction of heteronuclear 
coupling constants, but the NMR community has still to decide on a golden standard, akin to the 1D 
1
H spectra for homonuclear coupling constants.
145,146
 Characteristics for a golden standard is, per 
Parella and Espinosa,
145
 an experiment which displays good sensitivity and high resolution, is 
generally applicable, accurate, sign-selective and simple to run and analyze. This experiment could 
of course be the coupled 1D
 13
C spectrum, but here the analysis is cumbersome and NMR 
simulations are usually necessary due to the complexity of the multiplets.
147–149
 The lack of a 
reference experiment, in addition to the differences between heteronuclear coupling constants 
determined from the available experiments, may in principle lead to overfitting of data. This will be 
discussed vide infra.  
The experiments for determining long-range heteronuclear coupling constants may be, coarsely, 
divided into two categories, as being either COSY/TOCSY or purely HMBC/HSQMBC based.
145
 
Note that the experiments in TOCSY category of course also utilize long-range heteronuclear 
coupling constants and may thus also be perceived as e.g. HSQMBC based. A schematic 
representation between the TOCSY and HMBC/HSQMBC based coupling topologies is found in 
Figure 4.1. 
 
Figure 4.1. The J-coupling transfer mechanism leading to spin correlations of COSY/TOCSY and HMBC/HSQMBC type 
experiments. The observed coupling constants are indicated by the observed nuclei in the F1 and F2 dimension. The 
COSY/TOCSY type utilizes an 
n
JCH-coupling to build a correlation which is propagated to neighboring protons from 
n
JHH-
coupling. The HMBC/HSQMBC type utilizes only the 
n
JCH-coupling. Grey: 
1
H, black 
13
C. Inspired from literature
145
 
The NMR experiments currently present vary with respect to how the J-coupling constants are 
extracted, from J-quantitative (comparison of cross-peak volume) to peak-splittings measured as in- 
or antiphase (IP or AP), IPAP, J-resolved, E.COSY type and TROSY patterns, exemplified in 
Figure 4.2.
145
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Figure 4.2. Illustration of cross-peaks and cross sections from the different methods for the extraction of coupling constants. 
Inspired from literature.
145
 
The determination of the coupling constants from the coupling patterns, range from integration, 
direct measurements of peak-splitting and displacement of subspectra to more or less complicated 
theoretical simulations of multiplets.
145
 For experiments where the J-coupling constants are 
measured in the F1 (indirect) dimension, the resolution is determined by number of increments and 
spectral width, which will often lead to excessively long experiment times. To alleviate this 
problem, the J-coupling constants are usually scaled by a factor k, which may be chosen according 
to the minimum required discrimination of observable J-coupling constants. For example; if 
coupling constants of approximately 1 Hz need to be determined and k = 15, the FID resolution in 
F1 needs to be 15 Hz per point. The size of k is restricted by the fact that the coupling evolution 
time increases with k, and thus large values may be problematic due to T2 relaxation of the nuclei 
and concurrent losses in sensitivity.  
Some of the published experiments are given in Table 4.1 to exemplify the peak patterns, 
measurement method, and general considerations. Advantages and disadvantages of the presented 
experiments will differ depending of the information needed, and are to some extent subjective.  
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Table 4.1. Examples of experiments for the determination of long-range coupling constants. Peak pattern (see Figure 4.2 for 
examples), type and references are given. Note that several experiments may also be used for determination of 
n
JNH as well 
as 
n
JCH-coupling constants. The table is inspired by Parella et al.
145
 
Name Peak pattern Type Comments Ref. 
Quantitative HMBC J-quantitative nJCH 
Compares the HMBC peaks by volume and 
calculation is needed.  
Not sign-selective. 
150,151 
EXSIDE J-resolved nJCH 
Not sign-selective.  
F1 dimension limit resolution. 
Selective version exists to e.g. increase 
resolution.  
152,153 
XLOC E.COSY nJHH
 HH in F2 dimension.  
Not sign-selective. 
154 
J-HMBC J-resolved nJCH 
Not sign-selective.  
F1 dimension limit resolution. J-scaling is 
used. 
154 
HECADE E.COSY nJCH 
CH in F2 dimension.  
Sign-selective 
155 
P.E.HSQMBC E.COSY 
nJCH 
nJHH 
CH and HH coupling constants.  
Sign-selective for HH. Not sign-selective for 
CH. 
Complicated patterns.  
CH in F1 dimension. J-scaling is used. 
156 
HSQC-TOCSY In-phase/IPAP nJCH 
CH in F2 dimension.  
Sign-selective version exists. 
157–
159 
HSQMBC 
In-phase/ anti-phase 
/IPAP 
nJCH 
CH in F2 dimension.  
Not sign-selective. 
160,161 
Phase sensitive 
HMBC 
Anti-phase nJCH 
CH in F2 dimension.  
Not sign-selective. 
Simulations of cross-peaks needed.  
162 
HSQMBC-
COSY/TOCSY 
IPAP nJCH 
Sign-selective.  
CH in F2 dimension.  
Selective versions are available. 
163 
 
The presented list is not complete, nor are the given comments, and multiple experiments not 
mentioned here are available in the literature and e.g. various reviews include additional 
examples.
145,164
 In the following sections, NMR experiments that provide easy access to 
n
JHH as 
well as 
n
JCH including the relative sign of the coupling constants will be described. 
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 S3 HMBC homo 4.2
The spin-state selective (S
3
) HMBC homo (homonuclear in regards to the determined J-coupling 
constants) pulse sequence was developed in order to measure long-range homonuclear coupling 
constants utilizing the S
3
 or E.COSY methodology of subspectra displacement.
165,166
 The practical 
determination of coupling constants is thus in line with the IPAP method described in the previous 
section.
145
 The subspectra are linear combinations of spectra of a standard HMBC pulse sequence 
and a second pulse sequence with an additional π/2 Sz rotation under the one bond coupling 
evolution. The selected multiplicity edited pulse sequences are the improved multiplicity edited 
HMBC as the standard (a-c) and the HAT HMBC as the second (d,e) pulse sequence, see Figure 4.5 
and equation (4.1).
167–170
 The experiment was thus written as a pseudo 3D experiment, running five 
2D experiments from the five pulse sequences found in Figure 4.5. The linear combinations of the 
five resulting spectra that give rise to the S
3
 HMBC subspectra are given by equation (4.1). 
 
{𝑎 ±
1
2
[𝑏 + 𝑐]}⏟        
odd/even
± {𝑑 ± 𝑒}⏟    
odd/even⏟                
S3
 
(4.1) 
As indicated in equation (4.1) the terms 𝑎 ± 1
2
[𝑏 + 𝑐] and 𝑑 ± 𝑒 are used to achieve multiplicity 
editing, while inter-brace addition/subtraction leads to S
3
 editing of the active coupling constants. 
The active coupling is here defined comparable to DQF-COSY, where active couplings are anti-
phase and passive in-phase, as the active coupling is observed between subspectra and the passive 
couplings are observed in a sub-spectrum, sometimes in the form of line-broadening. In the S
3
 
HMBC homo the active coupling is thus the long-range proton-proton coupling constants and the 
passive couplings are the long-range heteronuclear coupling constant and possibly coupling 
constants to other protons. 
The spectra could in principle be combined in eight different manners but odd and even data are not 
mixed in practice, and the four are used where the sign in odd/even braces matches in equation 
(4.1). For clarification the spectrum with e.g. methine/methyl carbons from (a-½[b+c]+[d-e]) will 
be referred to as “add” or “+” and (a-½[b+c]-[d-e]) as “subtract” or “-“ in this text.  
The result is eight distinct HMBC spectra as given in Figure 4.3, where four (5-8) are used for 
coupling constant extraction, and the other four may be used as standard multiplicity edited 
improved or HAT HMBC spectra. The sorting of the spectra is performed automatically by an in 
house developed AU-program which works seamlessly with Topspin, and the numbers in Figure 4.3 
correlate to spectrum number of from the script. 
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Figure 4.3. The eight (numbered) output spectra from the S
3
 HMBC homo experiment as given by the AU program.  The 
chemical shift of carbon 1 is along F1, the chemical shift of proton 3 along F2 and the S
3
 edited coupling constant of protons 
2 and 3 is the displacement between the resonances in the add/subtract spectra. It is assumed that JCH > JHH and that the 
multiplets shown are a CH···H(singlet) and a CH2···H(singlet). 
The resulting subspectra are used to extract the long-range coupling constants including the value 
and relative sign. The coupling constants are determined from displacement (or direct 
measurements) of the peaks in matching +/- subspectra. The extracted coupling constant is between 
proton 2 in Figure 4.3, attached to the carbon with chemical shift in F1, and the observed proton 3 
with chemical shift in F2. The proton 3 and carbon 1 are coupled from the long-range heteronuclear 
coupling constant between the two, which is observed as a passive splitting in the spectra. A 
schematic representation of the S
3
 editing is indicated in Figure 4.3 and further explained in Figure 
4.4.  
 
Figure 4.4. Principle of the S
3
 editing of  CH--H in the S
3
 HMBC experiment. Addition and subtraction of the edited- and 
HAT HMBC spectra leads to subspectra which, in magnitude mode, may be used to extract the 
n
JHH-coupling constant. The 
second coupling constant present in the spectra is the 
n-1
JCH-coupling constant. It is assumed that JCH > JHH and that the 
multiplet is a CH···H(singlet). 
The absolute sign may be determined by keeping track of the S
3
 add- and subtract spectra. The 
coupling is positive when the obtained subtract spectrum is positioned downfield relative to the add 
spectrum, if it is upfield the coupling constant is negative. This is governed by the sign of the 
1
JCH-
coupling constant which is always positive. For practicalities; if the subtract spectrum is used for 
displacement in Topspin, the size and sign of the coupling constants are extracted directly as 
presented in the program.  
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The five pulse sequences were used as previously published, with minor modifications to the HAT 
sequences.
167–170
 In order to ensure equal length between the five sequences, delays were added. An 
initial delay of τ + ε’/2 was added before, and τ/2 just after, the first 1H π/2 pulse of the HAT 
experiments, see the Figure 4.5 caption for a definition of the delays. A decoupling period of τ + 
ε’/2 + 1H π/2 was also implemented in accordance with the three standard HMBC experiments. 
Lastly, a delay of τ/2 was added after the last 13C π/2 pulse. This led to pulse sequences which 
uphold basic conditions for combinatory pulse sequences, as the time from first 
1
H π/2 pulse to FID 
and the chemical shift and coupling constant evolution match between all five sequences. The 
magnetization thus experiences identical times of relaxation in all five sequences. The pulse 
sequences were programmed to run interleaved, with [b] and [c] spectra alternating to satisfy 
equation (4.1) without an initial need for scaling and thus an optimized run time versus S/N. 
In practice the spectra are usually scaled though, due to high editing accuracy of the edited HMBC 
and HAT HMBC experiments. By employing the linear combinations [b + c] and [d ± e] the 
magnetization components in the sequences that could give rise to out-of-phase error terms are 
diminished. This results in slightly lower intensities for these spectra compared to (a), except for 
cases of CHn pairs where τ in the sequences is exactly matched to (2 
1
JCH)
-1
. By scaling [b + c] by a 
constant k and [d ± e] by (2k/[k+1])
½
, the level of J cross talk is reduced. This is hardly needed due 
to an already low level of cross talk, but slight improvements were obtained when using a small 
scaling constant (usually in the order of k = 1.05). While it is possible to scale the cross-peaks 
individually to get optimal line shapes, this was not identified to be experimentally needed.  
The add/subtract nature of the spectra is beneficial when considering the acquisition time, where 
four interleaved HMBC spectra may sound like a very long experiment to actually implement in 
normal acquisition setups. While a minimum of four scans are needed for each sequence, essentially 
setting a minimum time, the fact that the resonances are added to and subtracted from each other 
result in a gain of S/N in the final spectrum from every single scan. The broadband nature of the 
experiment and the fact that the coupling constants are measured in the F2 dimension also helps to 
keep the acquisition time short, due to only having to run one experiment per sample and the 
inherent high resolution. 
For the comparison of long-range coupling constants, especially those of very low absolute values, 
to theoretical values from 3D structures, a problem has often been obtaining a high degree of 
accuracy. Thus dividing the coupling constants into categories such as low, medium, or high has 
been practiced.
46
 This is in general a viable route for rigid structures, while it is problematic in e.g. 
conformational population determination. The accuracy of the extracted coupling constants is thus 
of utmost importance. In the following, extracted coupling constants will be compared to theoretical 
coupling constants with a high degree of correlation, even for very small coupling constants. To 
ensure that the displacements were not reliant on the human eye of the spectroscopist, in this case 
the author, a Matlab script was developed which automatically identifies and extracts coupling 
constants from the spectra, see Appendix A6. 
The pulse sequence was tested on multiple compounds, including strychnine and isopinocampheol 
(IPC), and selected results and points are included vide infra. 
4.2  S3 HMBC homo 
 
 
82 
 
Figure 4.5. S
3
 HMBC homo pulse 
sequence comprised by a-c; the edited 
HMBC sequences, and d,e; the HAT 
HMBC sequences, all shown with a 
2nd-order low-pass J filter (LPJF), 
which may be exchanged to 3rd-order 
LPJF or removed.
166
 
Filled and open bars refer to π/2 and π 
pulses, respectively, and the dashed 
open boxes represent 
13
C decoupling. 
τ = (2 1JCH)
-1
 or (
1
Jmax + 
1
Jmin)
-1
 
δ is a gradient delay 
ε = 2 t1/2,min+t(πH) 
ε’ = ε + t(πC) 
τ1 = ½[
1
Jmin + 0.146 (
1
Jmax - 
1
Jmin)]
-1
 
τ3 = ½[
1
Jmax - 0.146 (
1
Jmax - 
1
Jmin)]
-1
 
Δ is the delay for evolution under 
heteronuclear long-range couplings 
and is set to (2∙8 Hz) -1 as standard.  
Phase cycling is performed as 
φ1 = {x, -x, -x, x} 
φ2 = {x, x, 4(-x), x, x} 
φ3 = {4(x), 4(y), 4(-x), 4(-y)}. 
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4.2.1 Computation of long-range homonuclear coupling constants 
The computation of homonuclear coupling constants may be achieved by two methods as 
previously discussed; Karplus type equations or density functional theory (DFT) methods.
40,42,53
 No 
appropriate Karplus equations were identified for the long-range coupling constants and DFT 
methods were used. The taken approach is largely based on an article of Bally and Rablen, which 
establishes a good practice in calculating standard homonuclear coupling constants.
53
 Since most 
studies of homonuclear coupling constants have focused on the easily accessible dihedral and 
germinal coupling constants, the applicability of methods and functionals to the long-range 
coupling constants needed to be evaluated, and S
3
 HMBC homo data compared to multiple different 
functionals is found in Appendix A6.  
In line with the results from Bally and Rablen, the optimal low-cost method of calculating 
homonuclear coupling constants was identified as optimization to B3LYP/6-31G(d), and calculation 
of the FC term of the coupling constants at a B3LYP/6-31G(d,p) level of theory. The function was 
augmented with four compact 1s functions to give more accurately calculate the FC term by using 
the input iop(3/10=1100000) in Gaussian.
53
 The resulting J-coupling constants were scaled by 
0.9117 in accordance with the literature.
53
 The correlation between experimental and theoretical 
coupling constants is surprising in that the literature study included only few long-range coupling 
constants, and none as small as observed from S
3
 HMBC homo – and still the fit is excellent.  
4.2.2 Results 
The S
3
 HMBC homo experiment resulted in spectra from which the long-range coupling constants 
were easily extracted; see Figure 4.6 for examples and full spectrum in Appendix A6. Many 
3
JHH-
coupling constants were extracted, making the S
3
 HMBC homo an excellent experiment for 
obtaining exact 
3
JHH-coupling constants in spectra of compounds with a crowded proton dimension 
due to the extra resolution obtained by utilizing the carbon chemical shift range. 
 
Figure 4.6. Excerpts and cross-sections through F1 of cross-peaks of S
3
 HMBC homo for strychnine (300 mM). Chosen as n > 
3 for the associated 
n
JHH-coupling constants.  
A total of 34 coupling constants were determined for strychnine. As a testament to the novelty of 
extracting small long-range homonuclear coupling constants, 13 coupling constants were extracted 
from this much utilized model compound, which were not reported in the literature. The extracted 
long-range coupling constants of strychnine are compared to theoretical values in Table 4.2. 
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Table 4.2. Left: Experimental and theoretical 
n
JHH-coupling constants of strychnine measured at 400 MHz (
a
800 MHz). Bold 
indicates coupling constants only published from S
3
 HMBC. Theoretical coupling constants calculated by B3LYP/6-31g(d,p) 
u+1s from B3LYP/6-31g(d) optimized structures. *The protons of 17ab overlap and a combined value was used. Right: 
Numbered structure of strychnine and experimental versus DFT coupling constants, where the line represents a perfect fit. 
Fit of data: a = 1.01, b = 0.00, R
2
 = 0.997.  
H1 H2 
S
3
 HMBC 
[Hz] 
Theoretical 
[Hz] 
n 
1 2 7.68 7.61 3 
1 3 1.50, 1.28 1.13 4 
1 4 0.65, 0.66 0.55 5 
2 4 1.07, 1.24 0.97 4 
2 3 7.55a 7.47 3 
3 4 8.16 8.28 3 
8 12 -0.16, -0.01 -0.10 4 
8 13 10.58, 10.54 9.96 3 
8 16 -0.32, -0.20 -0.27 4 
11a 12 8.54 8.43 3 
11a 13 -0.46 -0.31 4 
11b 12 3.35 3.75 3 
12 13 3.23 3.58 3 
12 14 -0.20 -0.20 4 
12 15a -0.13 -0.09 5 
12 23a -0.10 -0.09 4 
12 23b -0.16 -0.02 4 
13 14 3.11 3.27 3 
13 15a 0.27 0.38 4 
13 15b -0.40 -0.28 4 
14 15a 4.95 4.60 3 
14 15b 1.91 1.93 3 
14 16 0.65 0.54 4 
14 20b -0.49 -0.50 4 
14 22 -2.91 -3.03 4 
15a 16 4.01 3.89 3 
15b 16 2.15 2.02 3 
16 17a - 0.04 - 
16 17b - -0.18 - 
16 17ab* -0.20 -0.14 4 
16 18a -0.54 -0.49 4 
16 18b 0.08 0.06 4 
16 20b -0.26 -0.33 4 
20a 22 -1.36 -1.82 4 
20b 22 -0.59 -0.58 4 
22 23a 6.98 6.86 3 
22 23b 6.14 6.14 3 
 
 
 
 
 
 
 
It was only possible to obtain one coupling constant for some methine to methine correlations due 
to spectral overlap. When two coupling constants were identified, they were generally in good 
correlation with a maximum deviation of 0.22 Hz. In principle it is possible to extract coupling 
constants to methylene protons from a multiplet containing both coupling constants. In practice, the 
coupling constants to the methylene protons need to be large and different in order to determine 
coupling constants with a good correlation to the methine data, shown in Section 4.4.4. The general 
correlation of the data was excellent with a RMSD of 0.21 Hz for the full data set and, rather 
surprisingly, 0.15 Hz if only long-range coupling constants were considered. This was in part due to 
the values being lower, and relative to the size of the extracted coupling constants the differences 
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were larger. It is also an indication of the high accuracy of the experiments though, and that the 
theoretical calculations that work well for 
3
JHH seemed to also correlate well to the long-range 
coupling constants. As indicated in Table 4.2, mostly 3- and 4-bond coupling constants were 
observed, and the novel coupling constants from the S
3
 HMBC were all 4- or 5-bond and all below 
1 Hz in magnitude. 
 S3 HMBC hetero 4.3
An extended version of the homonuclear S
3
 HMBC was developed to extract long-range 
heteronuclear coupling constants. As mentioned above, the heteronuclear coupling constants are 
generally less utilized than their homonuclear counterparts, in part due to difficulty of extraction. 
The potential for structural information it huge however, as the number of 
2-4
JCH-coupling constants 
will be larger than the number of 
2-5
JHH-coupling constants for the majority of organic compounds. 
An example could be strychnine, which is a proton rich compound with the molecular formula 
C21H22N2O2, which has 96 possible 
2-5
JHH and 198 possible 
2-4
JCH-coupling constants. In practice 
only a fraction of these coupling constants is measureable due to e.g. low coupling constants 
leading to no signal or overlap of chemical shifts. For proton deficient compounds, which are 
usually hard to solve, the larger abundance of heteronuclear coupling constants is more pronounced. 
In determining heteronuclear coupling constants, the sign-selective nature of the S
3
 HMBC is 
imperative as 
2
JCH ranges from approximately -6 to 8 Hz while 
3
JCH ranges from 0 to 9 Hz.
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4.3.1 Changes needed 
In order to change the observed coupling constant from 
n
JHH to 
n
JCH a new pulse sequence element 
needed to be implemented. This element needed to be able to exchange the polarization from proton 
to carbon (or from βα to αβ) in e.g. 13C-1H pairs, as illustrated in Figure 4.7, where a zero-quantum 
pulse transfers the polarization from spin 2 (C-H) to spin 1 (C-H) to access the long-range 
heteronuclear coupling constant. A similar approach was used in the original S
3
 work.
171–174
  
 
Figure 4.7. Representation of the change in polarization 
between the two S
3
 pulse sequences.  
Top: Relevant (numbered) spins.  
Middle: The energy levels (not to scale) of the 3 spins, the 
observed transitions in the homo (red) and hetero (blue) 
experiments (black transition is shared and used in both 
experiments) and the effect of the zero quantum (ZQ) pulse 
sequence. The associated linear combination is indicated by 
+ and -.  
Bottom: The active couplings in the homo (red) and hetero 
(blue) experiment are indicated in a coupling tree for spin 3 
for a case where JHH > JCH. 
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The new pulse train was established from the needed zero-quantum coherence polarization transfer. 
Theoretically there are two zero-quantum operators, 2ÎyŜy+2ÎxŜx and 2ÎyŜx-2ÎxŜy, and the operator 
2ÎyŜy+2ÎxŜx was chosen.
37,175
 This needed to be translated into a pulse sequence, which was achieved 
by the following equations, starting from the ZQx operator in equation (4.2) and (4.3). The 
transformations used are exemplified here, and explained further in Appendix A6.  
𝑍𝑄𝑥 = 2𝐼𝑦?̂?𝑦 + 2𝐼𝑥?̂?𝑥 
(4.2) 
𝑒−𝑖𝜋𝑍𝑄𝑥 = 𝑒−𝑖𝜋(2𝐼𝑦?̂?𝑦+2𝐼𝑥?̂?𝑥) = 𝑒−𝑖𝜋(2𝐼𝑦?̂?𝑦)𝑒−𝑖𝜋(2𝐼𝑥?̂?𝑥) (4.3) 
The operator 𝑒−𝑖𝜋(2𝐼𝑦?̂?𝑦) was extended to equation (4.4), as eke-k = 1. 
𝑒−𝑖𝜋(2𝐼𝑦?̂?𝑦) = 𝑒−𝑖
𝜋
2(𝐼𝑥+?̂?𝑥)𝑒𝑖
𝜋
2(𝐼𝑥+?̂?𝑥)𝑒−𝑖𝜋(2𝐼𝑦?̂?𝑦)𝑒−𝑖
𝜋
2(𝐼𝑥+?̂?𝑥)𝑒𝑖
𝜋
2(𝐼𝑥+?̂?𝑥) 
(4.4) 
The 𝑒𝑖
𝜋
2
(𝐼𝑥+?̂?𝑥)𝑒−𝑖𝜋(2𝐼𝑦?̂?𝑦)𝑒−𝑖
𝜋
2
(𝐼𝑥+?̂?𝑥) part was rewritten in equation (4.5).
175
 
𝑒𝑖
𝜋
2(𝐼𝑥+?̂?𝑥)𝑒−𝑖𝜋(2𝐼𝑦?̂?𝑦)𝑒−𝑖
𝜋
2(𝐼𝑥+?̂?𝑥) = 𝑒
[−𝑖𝜋𝑒
𝑖
𝜋
2(?̂?𝑥+?̂?𝑥)(2𝐼𝑦?̂?𝑦)𝑒
−𝑖
𝜋
2(?̂?𝑥+?̂?𝑥)]
= 𝑒
[−𝑖𝜋𝑒
𝑖
𝜋
2(?̂?𝑥)𝑒
𝑖
𝜋
2(?̂?𝑥)(2𝐼𝑦?̂?𝑦)𝑒
−𝑖
𝜋
2(?̂?𝑥)𝑒
−𝑖
𝜋
2(?̂?𝑥)]
 
(4.5) 
Using that e
iφB
Ae
-iφB 
= Acosφ-i[A,B]sinφ, the eiφBAe-iφB 𝑒𝑖
𝜋
2
(?̂?𝑥)(2ÎyŜy)𝑒
−𝑖
𝜋
2
(𝐼𝑥) part of equation (4.5) 
was equal to equation (4.6).
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𝑒𝑖
𝜋
2
(𝐼𝑥)(2𝐼𝑦?̂?𝑦)𝑒
−𝑖
𝜋
2
(𝐼𝑥) = −𝑖[𝐼𝑥, 2𝐼𝑦?̂?𝑦] = −𝑖𝑖[2𝐼𝑧?̂?𝑦] = [2𝐼𝑧?̂?𝑦] 
(4.6) 
Similarly, 
𝑒𝑖
𝜋
2
(?̂?𝑥)(2𝐼𝑧?̂?𝑦)𝑒
−𝑖
𝜋
2
(?̂?𝑥) = −𝑖[?̂?𝑥, 2𝐼𝑧?̂?𝑦] = −𝑖𝑖[2𝐼𝑧?̂?𝑧] = [2𝐼𝑧?̂?𝑧] 
(4.7) 
These answers were returned to equation (4.5), which was now equal to equation (4.8). 
𝑒
[−𝑖𝜋𝑒
𝑖
𝜋
2(?̂?𝑥)𝑒
𝑖
𝜋
2(?̂?𝑥)(2𝐼𝑦?̂?𝑦)𝑒
−𝑖
𝜋
2(?̂?𝑥)𝑒
−𝑖
𝜋
2(?̂?𝑥)]
= 𝑒−𝑖𝜋(2𝐼𝑧?̂?𝑧) 
(4.8) 
Which led to the first operator in equation (4.3) being equal to equation (4.9). 
𝑒−𝑖𝜋(2𝐼𝑦?̂?𝑦) = 𝑒−𝑖
𝜋
2(𝐼𝑥+?̂?𝑥)𝑒−𝑖𝜋(2𝐼𝑧?̂?𝑧)𝑒𝑖
𝜋
2(𝐼𝑥+?̂?𝑥) 
(4.9) 
A similar approach was used throughout, done in Appendix A6, which led to equation (4.10). 
𝑒−𝑖𝜋(2𝐼𝑦?̂?𝑦+2𝐼𝑥?̂?𝑥) = 𝑒−𝑖𝜋(2𝐼𝑦?̂?𝑦)𝑒−𝑖𝜋(2𝐼𝑥?̂?𝑥)
= 𝑒−𝑖
𝜋
2(𝐼𝑥+?̂?𝑥)𝑒−𝑖𝜋(2𝐼𝑧?̂?𝑧)𝑒𝑖
𝜋
2(𝐼𝑥+?̂?𝑥)𝑒−𝑖
𝜋
2(𝐼𝑦+?̂?𝑦)𝑒−𝑖𝜋(2𝐼𝑧?̂?𝑧)𝑒𝑖
𝜋
2(𝐼𝑦+?̂?𝑦)
= 𝑒−𝑖
𝜋
2(𝐼𝑥+?̂?𝑥)𝑒−𝑖𝜋(2𝐼𝑧?̂?𝑧)𝑒−𝑖
𝜋
2(𝐼𝑦+?̂?𝑦)𝑒𝑖
𝜋
2(𝐼𝑧+?̂?𝑧)𝑒−𝑖𝜋(2𝐼𝑧?̂?𝑧)𝑒𝑖
𝜋
2(𝐼𝑦+?̂?𝑦)
= 𝑒−𝑖
𝜋
2
(𝐼𝑥+?̂?𝑥)𝑒−𝑖𝜋(2𝐼𝑧?̂?𝑧)𝑒−𝑖
𝜋
2(𝐼𝑦+?̂?𝑦)𝑒−𝑖𝜋(2𝐼𝑧?̂?𝑧)𝑒𝑖
𝜋
2
(𝐼𝑥+?̂?𝑥) 
(4.10) 
Finally, it was used that –x = 270° x = 90° x + 180° x etc. to convert the operators into the pulse 
train seen in Figure 4.8. The optimal delays between the new pulses are τ/2 or (4 1JCH)
-1
, in 
accordance with polarization transfer of methine groups.
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Figure 4.8. The new zero quantum coherence pulse sequence element, which converts the polarization of the S
3
 HMBC homo 
to achieve the hetero experiment. φ1 = {x, -x, -x, x}, φ2 = {y, -y, -y, y}. 
4.3.2 Pulse sequences 
The initial proposal for the S
3
 HMBC hetero was to substitute the final 
13
C π/2 pulse in the original 
S
3
 HMBC homo experiment with a new pulse train, as seen in Figure 4.9. Note that the first π/2 
pulse is omitted in the carbon channel, since the carbon spins need to be aligned along z before 
detection. 
 
Figure 4.9. The extended pulse sequence which replaces the final π/2 Sx pulse of the S
3
 HMBC to get the hetero experiment. 
φ1 = {x, -x, -x, x}, φ4 = {y, -y, -y, y}. 
In addition to inserting the new pulse sequence, the gradients of the S
3
 HMBC homo experiment (a) 
in Figure 4.5, had to be adjusted, by extension to select G1(H
-1
/C
+1
)-G2(H
-1
/C
-1
)-G3(H
-1
/C
0
) instead 
of G1(H
-1
/C
+1
)-G2(H
-1
/C
-1
). This was achieved by using a gradient power ratio of 2:-2:1 instead of 
5:-3 for echo, and -2:2:1 compared to -3:5 for anti-echo. Upon appending the new pulse train to 
obtain a new pulse sequence it was necessary to ensure that the carbon chemical shifts are refocused 
between the first 
13
C π/2 (disregarding the low pass J-filter), and the first 13C π/2 pulse in the new 
pulse train. This was in principle achieved in two ways which should both lead to refocusing, as 
illustrated in Figure 4.10, using sequence (a) as an example. In short, the first version withdraws the 
time of a 
1
H π/2 pulse from the delay after the first 13C π pulse to ensure refocusing of δC, while the 
π/2 pulses in the pulse train are offset in the second version in a manner that ensures refocusing. 
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Figure 4.10. Representation of two possible methods to obtained 
needed adjustments of the delays for carbon chemical shift 
refocusing, exemplified for sequence (a). 
 
 
Figure 4.11. Example of methine and quaternary 
carbon displacement in the S
3
 HMBC hetero 
methine/methyl spectrum of strychnine (180 mM). 
General rules when combining data for pulse sequences needed to be obeyed as well: 
1. The 13C chemical shift was refocused for the minimum t1. 
2. Sample heating due to decoupling was equal. 
3. The evolution times for δH, JHH and JCH were equal. 
4. The lengths of the sequences were identical. 
All of these requirements were met in the S
3
 HMBC, and since an identical pulse train was 
appended, all should be met by design. 
Unfortunately this strategy was not successful. While the polarization transfer worked and led to 
extraction of 
n
JCH-coupling constants, the refocusing of carbon chemical shifts was imperfect. The 
refocusing problems for methine groups were negligible and resulted only in slight broadening of 
the resonances in the F1 dimension in the add/subtract spectra. For quaternary carbons the problem 
was more pronounced, which is exemplified in Figure 4.11, and even though these are of no interest 
in this experiment, the problem needed to be solved, to ensure the extraction of correct coupling 
constants throughout. Note also that the elimination of quaternary carbons in the methine/methyl 
spectra by the multiplicity editing did not work properly as a consequence. 
The next approach taken was to append the new pulse train after the entirety of the original 
homonuclear S
3
 HMBC, as the refocusing here worked perfectly, leading to inherent refocusing of 
the new pulse sequence. The gradients were rearranged to achieve an assumed clean coherence 
selection as seen in Figure 4.12, top left. This adjustment did not initially give the desired 
refocusing of carbon chemical shifts though. The gradient selection was identified to be the cause of 
the problem, as the top right sequence in Figure 4.12 led to messy but refocused spectra. Thus, a 
new gradient scheme was developed in order to alleviate this problem, as illustrated in Figure 4.12 
bottom left for sequence (a), while similar corrections were made for sequence (b-e). Note that a 
similar gradient scheme was not possible for the first proposed pulse sequence, due to a mismatch 
of gradient duration and delays in some of the sequences. 
4 Development of NMR experiments for the determination of long-range J-coupling constants 
 
 
 
89 
 
 
Figure 4.12. Appending the pulse train to the S
3
 
HMBC hetero sequences. Sequence (a) used for 
example.  
Top left: Initial attempt of appending the new 
sequence which leads to displacement of 
13
C. ____ 
Top right: Second attempt, with no displacement of 
13
C but more noise (expected). ________________ 
Bottom left: Final sequence; no displacement and S/N 
in level of S
3
 HMBC homo.  
 
 
It is not clear why the new gradient scheme is superior, as the chosen coherence pathway is 
supposedly identical between all sequences. The coherence selection by the gradients in the two 
first sequences in Figure 4.12 is G1(H
-1
/C
+1
)-G2(H
-1
/C
-1
)-G3(H
-1
/C
0
). In the final sequence an extra 
gradient pair was added to choose coherence G1(H
-1
/C
+1
)-G2(H
-1
/C
-1
)-G3(H
-1
/C
0
)-G4(H
-1
/C
0
), or in 
words, make sure that the change in coherence order was zero for both protons and carbons across 
the new pulse train. Experimental evidence showed that it was needed to gain this further control of 
the coherence selection, which in practice was achieved by using gradients as in the S
3
 HMBC, only 
changing sequence (a) as earlier described, and inserting new gradients around the new pulses with 
opposite signs. The first new gradient is added to the last existing gradient from the S
3
 HMBC homo 
sequence, as indicated in Figure 4.12.  
Appending the new pulse train led to an increase in the phase cycle compared to just exchanging the 
last 
13
C π/2 pulse, as the phases of the new element were cycled independently of φ1. This was not 
strictly needed as the spectra and coupling constants using φ1 = φ5 and φ1 ≠ φ5 were essentially 
identical. It is thus recommended that for four scan (ns) experiments φ1 is set equal to φ5, while φ1 
should be cycled independently of φ5 for ns > 4 scans. In both cases φ2 and φ3 were cycled 
independently and should be changed accordingly. Since the pulse train was appended and identical 
for all pulse sequences, previously mentioned requirements for combining pulse sequences were 
inherently met. 
The new pulse sequences are found in Figure 4.16 and the result of the change in polarization is 
exemplified in Figure 4.13 by the simple compound vinyl acetate. The coupling constants are 
compared to 1D and reference values to an excellent correlation in Figure 4.14 and Table 4.3.
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Table 4.3. Comparison of S
3
 HMBC coupling constants of vinyl acetate to 1D 
1
H spectra (a) and literature (b).
176
 
 
3
JHH
a 
[Hz]
 2
JCH
b 
[Hz]
 
 S
3
 HMBC homo Ref. S
3
 HMBC hetero Ref. 
H-4a +6.3 6.2 +7.4 +7.6 
H-4b +14.0 14.0 -7.9 -7.9 
 
 
 
Figure 4.13. Left: Comparison of S
3
 HMBC homo and S
3
 HMBC hetero spectra for C(H)-3 of vinyl acetate (220 mM). 
To better understand the coupling pattern of the homo- and heteronuclear variants of the S
3
 HMBC 
the cross-peaks of C-3/H-4b and C-3/H-4a are explained in Figure 4.14. As seen both JCH and JHH 
were part of the multiplet in both experiments and if the (+) and (–) spectra were overlaid, the 
combined shape of the multiplets was almost identical.  
 
Figure 4.14. Comparison of S
3
 HMBC homo (blue/red) and S
3
 HMBC hetero (green/brown) multiplet for H-4b and H-4a 
of vinyl acetate. Black lines in coupling tree indicate S
3
 editing. The coupling trees are offset slightly horizontally to better 
distinguish colors.  
 
The in-phase JH4bH4a coupling constant was determined to be larger for both experiments than the 
1.5 Hz determined from a 
1
H spectrum, possibly due to a lack of resolution of the S
3
 HMBCs with 
2.5 Hz/point (4k versus 64k points acquired for 1D
 1
H spectrum). As expected the coupling trees 
were alike with the difference being the coupling constant leading to S
3
 editing, where sign 
determination was possible.  
J-crosstalk was experimentally more apparent, for a few resonances, compared to the native S
3
 
HMBC where J-crosstalk was always in the noise level. The J-crosstalk may alter the 
experimentally determined coupling constants and will always lead to the extraction of smaller 
coupling constants and needed to be addressed. As for the homonuclear experiment, the J-crosstalk 
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could be minimized by scaling [b+c] with a factor k and [d+e] with (2k/[k+1])
½
. If scaling was not 
sufficient the crosstalk was diminished by scaled combinations of the α and β spectra, as described 
earlier for S
3
 experiments.
165
 The subspectra of vinyl acetate were the only spectra where J-
crosstalk was immediately apparent, even when subspectra of other compounds were scrutinized. In 
Figure 4.15 the standard editing of the spectra is compared to spectra edited by a scaled 
combinations of the α and β spectra to decrease J-crosstalk.165 Most importantly the extracted J-
coupling constants varied by less than 0.1 Hz, and thus the differences were lower than the expected 
experimental uncertainty of these kinds of experiments. It is acknowledged that the difference may 
be larger for different compounds as described in the literature.
177
 
 
Figure 4.15. Comparison of the J-crosstalk in standard and edited spectra of the C3-H4a cross-peak of vinyl acetate (220 
mM). Edited by αS = α - kS·β and βS = β - kS·α. The difference in the extracted JCH-coupling constant is below 0.1 Hz. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.16. Next page. S
3
 HMBC hetero pulse sequence comprised by modified sequences a-c; edited HMBC sequences, and 
d,e; HAT HMBC sequences, all shown with a 2nd-order LPJF, which may be exchanged to 3rd-order LPJF or removed.  
Filled and open bars refer to π/2 and π pulses, respectively, and the dashed open boxes represent 13C decoupling. τ = (2 1JCH)
-1
 
or (
1
Jmax + 
1
Jmin)
-1, δ = gradient delay, ε = 2 t1/2,min+t(πH), ε’ = ε + t(πC), τ1 = ½[
1
Jmin + 0.146 (
1
Jmax - 
1
Jmin)]
-1
, τ2 = ½[
1
Jmax - 0.146 
(
1
Jmax - 
1
Jmin)]
-1, Δ = delay for heteronuclear long-range coupling evolution. (2∙8 Hz) -1 is standard.  
Phase cycles. φ1 = {x, x, 4(-x), x, x}, φ2 = {4(x), 8(-x), 4(x)}, φ3 = {8(x), 8(y), 8(-x), 8(-y)}, φ4 = {x, -x, -x, x}, φ5 = {y, -y, -y, y} 
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4.3.3 Computation of long-range heteronuclear coupling constants 
Unlike the homonuclear long-range coupling constants, the heteronuclear variants have been more 
extensively investigated.
46,55,135,145,146
 Unfortunately, a study similar to that of Bally and Rablen was 
not found, and the reported calculations use a wide variety of methods and functionals, some of 
which seem to benefit from scaling.
53,55
 This is in principle not a problem, but the lack of a true and 
tried methodology and scaling factor may lead to overfitting as the computed coupling constants are 
scaled to fit only the current data or a couple of datasets. However the method of “local scaling” is 
generally used in the calculation of chemical shifts, as discussed in Section 2.4.3.
47,54,178
 
Investigating and correlating calculations of long-range heteronuclear coupling constants to a large 
set of experimental data was not a part of the work; in part due to discrepancies between methods to 
extract coupling constants. It should be noted though, that scaling is often required for accurate 
determination of NMR observable from DFT calculation, probably due to a constant and inherent 
error in the calculations. It is thus often advantageous to use the correlation factor to assess the fit 
between experimental and theoretical data, as the correlation factor is independent of needed 
scaling. 
Two methods were investigated with different functionals; B3LYP, which worked nicely for 
homonuclear coupling constants, and MPW1PW91, which is very often used specifically to better 
calculate NMR properties.
46,47,53,54,179,180
 For both methods it was apparent that a larger basis set 
improved the correlation between experimental and calculated data, while e.g. diffuse functions had 
little to no effect. It was necessary to use the full theoretical J-coupling constants and not just the 
Fermi contact (FC) to get the best results, while the FC term was still dominating in the 
calculations. This was in contrast to the method used for calculations of JHH by DFT. For more on 
different components used in J-coupling constants calculations by DFT see Section 2.4.4. 
MPW1PW91 generally resulted in a better correlation to the experimental data when used to 
calculate coupling constants while the difference between optimized structures from B3LYP and 
MPW1PW91 differed little, as long as identical basis sets were used. In the end MPW1PW91/6-
311G(d,p) was used for both optimization and J-coupling constant calculations as this resulted in 
the better reproduction of the experimental J-coupling constants. Comparisons may be found in 
Appendix A6. 
4.3.4 Results 
The S
3
 HMBC hetero experiment was as the homonuclear variant tested on strychnine. The 
coupling constants were easily extracted from displacements of 1D slices from cross-peaks 
equivalent to the homonuclear S
3
 HMBC. Examples of cross-peaks as well as 1D slices are found in 
Figure 4.17 and a full spectrum in Appendix A6. 
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Figure 4.17. Excerpts and cross-sections through F1 of cross-peaks of S3 HMBC hetero for strychnine (180 mM). Note that 
the sign of the coupling constants are apparent from the relative position of the cross-peaks in the subspectra.  
The extracted coupling constants correlate well to theoretical coupling constants, especially if the 
calculations are scaled, and a comparison to theoretical as well as literature values is presented in 
Table 4.4 and Figure 4.18. 
Table 4.4. Experimental S
3
 HMBC hetero, literature and theoretical 
n
JCH-coupling constants for strychnine.
153,160,181,182
 All J-
coupling constants are in Hz. Both optimization and J-coupling constant calculations were performed at a MPW1PW91/6-
311+g(d,p) level of theory. Calculated coupling constants are given without scaling and linearly scaled to the experimental 
data as Jscaled = (Jcalc-b)/a. a = 0.92, b = -0.14. 
H C Experimental (Hz) Theoretical (Hz) 
n 
# # 
S3 HMBC 
hetero 
[160] [181] [153] [182] Calc. Scaled 
1 3 7.4 7.5,7.2 
   
6.7 7.4 3 
2 4 7.9 
    
7.0 7.8 3 
3 1 8.9 8.9,9.3 
   
8.1 8.9 3 
4 2 7.7 
 
7.5,7.4 7.9 
 
7.1 7.8 3 
8 12 6.4 5.8,5.6 5.5,5.6 5.3 
 
5.6 6.2 3 
8 13 -1.7 
 
 
  
-1.7 -1.6 2 
11b 12 -7.1 6.9,-6.9 7,6.9 6.8 
 
-6.9 -7.3 2 
13 8 -6.3  6.3,6.4,6.3 6.2  -6.0 -6.3 2 
13 14 -4.9 5.5,-4.5 4.6,4.7 4.5 4.7 -4.7 -5.0 2 
15a 13 7.7 
 
8,8.1 8.0 7.9 7.0 7.7 3 
15a 14 -2.9 1.2,-2.9 1.8,2.8,2.8 2.0 3.2 -2.5 -2.6 2 
15a 16 -4.6 
 
4.5,4.3 4.0 
 
-4.3 -4.5 2 
15b 14 -3.2 2.3,-2.6 3.2,3.6 2.8 4.8 -3.1 -3.2 2 
15b 16 -1.9 
 
2.7,3 1.4 
 
-2.1 -2.2 2 
16 14 6.2 6.7,6.4  
 
6.4 5.8 6.4 3 
20a 14 1.4     1.3 1.6 3 
20a 22 5.6 4.7,5 6.1,5.8 5.1 
 
4.6 5.1 3 
20b 14 5.5 5.7,5.4 5.4,5.3 5.1 5.5 4.7 5.2 3 
20b 16 7.8 
 
6.9,6.9 6.7 
 
6.3 6.9 3 
20b 22 4.6 5.1,5.5 4.5,4.6 4.2 
 
4.6 5.1 3 
22 14 8.5 8.5,8.6 7.9,8.5,8.6 8.8 8.9 8.0 8.8 3 
23a 22 -3.8 4.2,-3.8 3.8,4 
  
-3.8 -3.9 2 
23b 22 -3.4 3.6,-3.4 4,3.9 
  
-3.0 -3.1 2 
     RMSD 0.53 0.22  
     R2 0.999  
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Figure 4.18. Experimental versus DFT-calculated 
coupling constants, where the line represents a perfect fit. 
Calculated coupling constants are linearly scaled to the 
experimental data as Jscaled = (Jcalc-b)/a. a = 0.92, b = -0.14. 
 
 
The extracted coupling constants were in excellent agreement with previously published data and 
scaled theoretical calculations, with an RMSD of 0.22 Hz when comparing to the latter. This is 
almost equal to the RMSD determined for homonuclear coupling constants from S
3
 HMBC (0.21 
Hz), indicating the same general precision of the two methods. When comparing to the theoretical 
calculations, note also the high correlation factor. This is in support of the differences between 
experimental and calculated coupling constants being due to an inherent and consequent error in the 
DFT calculations, which may be alleviated by scaling consistent with literature findings.
53
 A 
conclusion, which was supported by differences in scaling factors a and b between functionals, 
while a high R
2
 was generally retained. It could of course also be the product of a constantly 
erroneous extraction of coupling constants but good correlation to literature values contradicts 
this.
153,160,181,182
 It would have been beneficial to have a golden standard for comparison as to 
determine whether the deviation was a result of the experiment or the theoretical method utilized. 
Like the homonuclear S
3 
HMBC it was possible to extract coupling constants across heteroatoms, 
which is important in e.g. carbohydrate 3D structural investigations.
15,135,183
 This is a nice feature of 
HMBC compared to TOCSY type experiments, as the latter utilizes 
3
JHH to generate the long-range 
coupling constants.
145
 
The S
3
 HMBC hetero experiment, and in large regard also the homonuclear S
3
 HMBC experiment, 
has one inherent flaw; it is only really a viable option for coupling constants involving methine 
carbons. While this may limit widespread usage, the high accuracy, ease of extraction and sign-
selective nature of the experiment should cater for a lot of fields where the resulting information 
will immediately increase the structural knowledge. An obvious field is that of carbohydrate 
chemistry, where coupling constants across the glycosidic linkage may be used for conformer 
analysis.
119,135,183,184
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 Perspectives 4.4
As interesting as the possibility to obtain the long-range coupling constants was, the greater 
question is whether the observed long-range coupling constants could actually discern 
stereoisomers. The determined long-range JHH values were small and the information may be non-
discerning and thus of lesser value. To assess this, a probability function was considered attractive. 
4.4.1 Establishing a probability function for J 
The DP4 is in the opinion of the author, a very informative way to evaluate diastereomers from 
chemical shift differences, see Section 3.1.6.
58
 A similar probability function, here dubbed JP4, 
would be desirable for J-coupling constants especially as DFT calculations become easier available.  
A probability function was thus established from coupling constants obtained from the literature, as 
determining these from scratch was not in the scope of the project and was deemed too time 
consuming. The dataset published by Bally and Rablen was used as the combined dataset of test and 
the two probe sets (combined to 228 coupling constants from multiple structures).
53
 The standard 
deviation from the J-coupling constants of their dataset is 0.51 Hz.
53
 The intercept of the dataset 
was 0.0026 Hz, and is approximated to 0 Hz in the following. The degrees of freedom (v) parameter 
was harder to determine and it was only estimated in the current work.
III
 The data set was fitted to a 
standard student t-test curve to a value where the difference in the fit of v and v-1 was below 0.01. 
This equals a value of 8.76 (~9). It should be noted that v does not drastically influence the result of 
the evaluation, except when a very low or extremely high value is chosen. The formula for the 
resulting “JP4” probability function is given in (4.11). 
 𝑃(𝑖|𝐽𝑁) =
∏ 1 − 𝑇𝑣(|𝐽𝑠𝑐𝑎𝑙𝑒𝑑,𝑘
−𝑖 − 𝐽𝑒𝑥𝑝,𝑘 − 𝜇|/𝜎)
𝑁
𝑘=1
∑ ∏ 1 − 𝑇𝑣(|𝐽𝑠𝑐𝑎𝑙𝑒𝑑,𝑘
−𝑖 − 𝐽𝑒𝑥𝑝,𝑘 − 𝜇|/𝜎)
𝑁
𝑘=1
𝑚
𝑗=1
 (4.11) 
With μ = 0, v = 9 and σ = 0.51 Hz. The number of data points compared to the DP4 probability 
function was rather sparse with 228 J-coupling constants compared to 1717 
13
C and 1794 
1
H, and 
thus the resulting probability will be prone to more errors. The JP4 value will thus never be used 
alone, but it is a very intuitive way to compare experimental and theoretical data sets. It should also 
be noted that this is of course only valid if the methodology of Bally and Rablen is used.
53
 The 
output of the JP4 function is the probability in percent that a given stereoisomer is correct according 
to the data.  
4.4.2 Differentiation of stereoisomers by S3 HMBC 
To check whether the long-range coupling constants were discerning of stereoisomers the data was 
purposely calculated for wrong assignment of diastereotopic protons for strychnine.  
Starting from the homonuclear coupling constants the correlation between the full and a reduced set 
of experimental coupling constants and theoretical values are seen in Table 4.5. The reduced set is 
                                                 
 
III
 v was determined from a statistics program based on the data set in the original DP4 publication, 
which was not available to the author. v(
1
H) = 11.38, v(
13
C) = 14.18.
58
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the data with all 
3
JHH-coupling constants removed, as these could on the most part be extracted with 
other methods. 
Table 4.5. Comparison of correct and incorrect assignment of the diastereotopic protons in strychnine. The full set includes 
all coupling constants extracted by S
3
 HMBC homo, while 
3
JHH-coupling constants have been removed in the reduced set. 
The number on the left indicates the diastereotopic protons which are switched compared to the correct assignment.  
 Full Reduced 
Switched # MAE JP4 MAE JP4 
Right 0.15 99.9 0.06 47.9 
Dia-11 0.38 0.0 0.08 0.9 
Dia-15 0.38 0.0 0.09 0.0 
Dia-18 0.17 0.1 0.09 0.0 
Dia-20 0.23 0.0 0.15 0.0 
Dia-23 0.18 0.0 0.06 51.2 
Dia-All 0.75 0.0 0.22 0.0 
 
The mean average error (MAE) was not necessarily a good method to differentiate the datasets as it 
was hard to evaluate whether the differences were within expected errors. Here the JP4 function 
made it much easier to quickly evaluate the data. Even without the 
3
JHH-coupling constants it was 
possible to assign all diastereotopic proton pairs using the JP4 probability function except for two: 
17, where the protons overlap, and 23, where the two observed coupling constants available were 
almost equal (both expected to be positive and under 0.1 Hz). It should be noted that, as it is a 
probability function, the values of the right assignment and the misassignment of 23 meant that they 
could not be discerned. Still, it was a testimony to the high degree of accuracy and the importance 
of identifying the sign in long-range coupling constant experiment that the remaining diastereomers 
could be differentiated, underlining the vast possibilities for using this experiment for 3D structural 
elucidation. All of the coupling constants in the reduced set were thus between -3.0 and 1.1 Hz, and 
very exact coupling constants were needed to facilitate differentiation. 
In a similar fashion the diastereotopic protons of strychnine were again switched for the 
heteronuclear data, and the experiment was clearly discriminating, as seen in Table 4.6.  
Table 4.6. Comparison of right and wrong assignment of the diastereotopic protons in strychnine using 
n
JCH-coupling 
constants from the S
3
 HMBC hetero experiment.  
# MAE JP4 
- 0.24 94.1 
11 0.88 0.0 
15 0.66 0.0 
20 0.75 0.0 
18 1.02 0.0 
23 0.29 5.9 
All 2.63 0.0 
 
It is recognized that using the JP4 probability function for comparison is clearly problematic; and 
that the value holds little meaning. But, as the standard deviation from the strychnine data was 
smaller than for the dataset used in the setup of the JP4 probability (and equal to coupling constants 
from the homonuclear S
3
 HMBC variant),
53
 and if a comparable degrees of freedom value is 
assumed, it is indicative of the discriminative prowess of the long-range JCH-coupling constants.  
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The 
n
JCH- and 
n+1
JHH-coupling constants were clearly discriminative of diastereomers and the two 
experiments are believed to greatly increase the amount of available structural data and resulting 
structural knowledge.  
4.4.3 nJCqH-coupling constants from S
3
 HMBC homo 
The major drawback of the S
3
 HMBC hetero experiment was the inability to measure coupling 
constants to methylene or quaternary carbons. Especially the latter is problematic, as the structural 
knowledge gained from 
n
JCH-coupling constants is increasingly needed as the proton-to-heteroatom 
ratio decreases. In that regard it is appreciable that JCqH coupling constants are implicitly embedded 
in the add spectrum of methylene and quaternary carbons in both S
3
 HMBC experiments, without 
sign due to the lack of S
3
 editing.
IV
 The multiplet became complicated in cases where the proton 
couples to other protons, but in proton deficient compounds where the proton multiplets should be 
simple, maybe even singlets, the size of the coupling constants may be easily extracted and used in 
structure elucidation. An example of a rather complicated situation is given in Figure 4.19 where 
1D slices from S
3
 HMBC homo of strychnine are compared to theoretically simulated spectra using 
the given coupling constants. Theoretical heteronuclear coupling constants are, in order from left: 
1.2, -5.1 and -7.3 Hz, calculated at a MPW1PW91/6-311+g(d,p) level of theory and scaled 
according to the methine data. The extracted coupling constants could thus be used in a large-
medium-small analysis as suggested by Bifulco et al if not used directly.
46
 In-phase homonuclear 
coupling constants were initially those from Table 4.2 and varied slightly to increase the fit between 
the experimental and theoretical spectra. The 
2
JHH-coupling constant was estimated from 1D 
1
H 
spectra. 
 
Figure 4.19. 1D slices of couplings to C-10 in strychnine (300 mM) from S
3
 HMBC homo. Experimental data (blue) 
compared to simulated spectra (red). Theoretical heteronuclear coupling constants are (from left): 1.2, -5.1 and -7.3 Hz. 
Spectral resolution in the S
3
 HMBC homo was 2.5 Hz/point. Simulated using the coupling constants given above the 
resonances with a line broadening of 2.5 Hz using the Daisy utility in Topspin.  
                                                 
 
IV
 Quaternary carbons cannot have their polarization interchanged from 
1
H to 
13
C, for obvious 
reasons. 
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4.4.4 Extraction of coupling constants to methylene (C)H 
Unlike the easy extraction of coupling constants to methine groups, extraction of constants to 
methylene and methyl groups is more problematic, making this experiment a poorer choice for 
extractions of this kind of data. It seldom posed a significant problem in practice, since coupling 
constants that involve a methine and e.g. a methylene group in most cases could be extracted easily 
from the methine carbon. A simple approach to extract approximate coupling constants to 
methylene protons was identified, and given in equation (4.12), from measured distances between 
in-phase peaks (j1 and j2), illustrated in Table 4.7. It is especially easy when the passive coupling 
constants were small.  
 𝐽𝐻𝐻
1𝑛 =
𝑗1 + 𝑗2
2
, 𝐽𝐻𝐻
2𝑛 = | 𝐽𝐻𝐻
1𝑛 − 𝑗2| 
(4.12) 
The equation yields the coupling constants as two active coupling constants lead to S
3
 editing per 
coupling pattern, while the remaining coupling constants are in-phase and thus appear in both 
subspectra. The overlaid cross-peaks will thus have a pattern where the splitting in one sub-
spectrum is equal to 
n
JHH
1 
+ 
n
JHH
2
 and the other |
n
JHH
1 
- 
n
JHH
2
|. Coupling constants extracted by this 
method are given in Table 4.7 and compared to methine data when possible.  
Table 4.7. Comparison of long-range coupling constants to methylenes in S
3
 HMBC homo. Compared to the values extracted 
to methines from Table 4.2. *Theoretical coupling constants calculated as in Table 4.2. Right: The extraction of j1 and j2 
from the 1D slices of cross-peaks.  
(C)H1 H2 j1 [Hz] j2 [Hz] J1 [Hz] J2 [Hz] Jmethine [Hz] Other [Hz] 
4a/b 3 20.3 7.5 13.9 6.4 14.0,6.3 2JCH=9.4 
11a/b 12 12.2 6.8 9.5 2.7 8.5, 3.4 2JCH=1.4, 
3JHH=2.5 
15a/b 16 5.7 3.3 4.5 1.2 4.0,2.2 2JCH=1.3 
23a/b 22 13.2 0.4 6.8 6.4 7.0,6.1 2JCH=6.8, 
4JHH=4.0 
17a/b 18a 10.1 2.6 6.3 3.7 7.5,0.5* 2JCH=1.0, 
2JHH=8.8 
17a/b 18b 19.1 1.3 10.2 8.9 12.1,6.3* 2JCH=3.1, 
2JHH=10.1 
18a/b 17a/b 16.2 4.8 10.5 5.7 - - 
 
 
 
In Figure 4.20 examples of simulated spectra based in coupling constants to methylene protons are 
depicted, from the determined values found in Table 4.7. When the coupling constants were large 
and different they were easily extracted, as seen on the left for vinyl acetate. As soon as the 
coupling constants became smaller and/or more equal, the extractions were much more challenging 
(right). Especially when more passive coupling constants were added to the in-phase coupling 
patterns, complications ensued.  
4.5  Conclusion 
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Figure 4.20. Experimental and simulated multiplicity patterns for vinyl acetate (left, 220 mM) and strychnine (right, 300 
mM). The simulated peaks are all obtained from a manual fitting in MestreNova. Coupling trees are indicative. Coupling 
constants found in Table 4.7. 
It was also possible to extract coupling constants between the 17 and 18 protons, as seen in Figure 
4.21. The theoretically most complicated peak that includes 17a/b and 18a/b was seemingly the 
most simple as the 
2
J methylene coupling constants were not observed and the coupling constants 
seemed to average.  
 
Figure 4.21. Experimental and simulated multiplicity patterns from strychnine (300 mM). The simulated peaks are all 
obtained from a manual fitting of coupling constants in MestreNova. Coupling trees a indicative. Coupling constants found 
in Table 4.7. 
In conclusion, while it was possible to extract coupling constants to methylenes, the results should 
be considered approximates if using equation (4.12). More elaborate simulations of the spectra, e.g. 
by the program Spinach,
185
 is expected to yield better results, but was not performed. 
 Conclusion 4.5
Two new pulse sequences were introduced; the S
3
 HMBC homo and the S
3
 HMBC hetero for the 
determination of long-range homo- and heteronuclear coupling constants respectively, including 
size and sign. The pulse sequences were tested on the alkaloid strychnine and resulted in excellent 
fit of the experimental data to theoretical and reported coupling constants alike. 
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 Experimental 4.6
The experimental setup, with relevant information is included in the various tables and figures 
throughout this chapter and standard pulse sequence setups are found in Appendix A1.  
Acquisition 
For strychnine the setup of the S
3
 HMBC experiments were: ns = 16, ss = 32, si = 4096, ni = 256 
Jmin = 124 Hz, Jmax = 169 Hz, τ = 3.4 ms, ∆ = 65 ms or 62.5 ms. 
For vinyl acetate the setup of the S
3
 HMBC experiments were: ns = 16, ss = 32, si = 4096, ni = 256 
Jmin = 130 Hz, Jmax = 190 Hz, τ = 3.1 ms, ∆ = 62.5 ms. 
5 mm tubes were used throughout (0.5 mL). For all compounds the 
1
JCH-coupling constants were 
determined prior to acquisition to input minimum and maximum 
1
JCH-coupling constants into the 
setup of the S
3 
HMBC experiments. 
Simulations 
Structures were generated by the modelling suite Maestro version 10.2.010 (2015) by Schrödinger 
for force field calculations,
126
 using the program MacroModel version 10.8.
127,128
 The MMFFs force 
field was used. To generate structures which should cover the conformational space of compounds, 
a conformational search was performed for each structure by the program MacroModel using 
energy cutoff of 50 kJ/mol, 100,000 steps and CPRG minimization.
127,129
  
Gaussian version 09 revision B.01 was used for DFT calculations including optimizations and NMR 
calculations.
131
 Structures were optimized to a B3LYP/6-31(d) level of theory unless otherwise 
stated. 
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5 Theory – 3D structural information from NMR, part 2 
The following chapters all concern the use of residual dipolar coupling constants to obtain 3D 
structural information. Theory on the subject is thus presented below. 
 Residual dipolar coupling 5.1
Residual dipolar coupling constants (RDCs) have gradually made the move from macromolecules 
to small molecules over the last couple of decades. In 2000, Courtieu et al. reported 
enantiodiscriminating properties of poly-γ-benzyl-L-glutamate (PBLG) for the very small molecule 
1-chloropropan-2-ol (CP), one of the methods being RDC analysis.
186
 In the following years, Thiele 
and coworkers showed the possibility of solving the pro-chirality of the methylene groups in 
strychnine, illustrating the possibility of discerning stereoisomers of small molecules.
187,188
 Later 
again, the groups of e.g. Thiele and Reggelin started to investigate the enantiodiscriminating 
properties of PBLG and other, novel, liquid crystals.
189–192
 In parallel, pioneered by the work of 
Kessler et al. in 2004, an investigation into the usage of swollen polymers as alignment media for 
small molecules began, utilizing an easier scalability of experimental RDCs as well as a weaker 
degree of alignment.
193,194
 
The basis of the residual dipolar couplings is the direct dipolar coupling constant (D). Akin to the 
NOE relaxation, D-couplings operate through space via magnetic dipole-dipole interactions from 
the magnetic fields generated by the spins.
11
 In contrast to NOEs and J-coupling constants, which 
are products of interactions between the nuclear spins, dipolar couplings depend on the direct 
influence of the external magnetic field on internuclear vectors.
11,195,196
 D-coupling constants 
depend on the gyromagnetic ratio (γ) of the involved nuclei, the cubed length of the inter-nuclear 
vector (r) and the angle of said vector to the magnetic field (θ).V The other constants are the vacuum 
permeability constant (μ0) and the reduced Planck constant (ħ).  The relevant formula is given in 
equations (5.1) and (5.2).
11,195–197
 
 ℋ̂𝐼𝑆
𝐷𝐷,𝑓𝑢𝑙𝑙
= −
𝜇0
8𝜋2
ℏ𝛾𝐼𝛾𝑆
𝑟𝐼𝑆
3 (3[𝐼𝐼 ∙ 𝑒𝐼𝑆][𝐼𝑆 ∙ 𝑒𝐼𝑆] − 𝐼𝐼 ∙ 𝐼𝑆)  
(5.1) 
Where eIS is a vector through the two involved nuclei defined so that eIS·eIS = 1. For two spin ½ 
nuclei and using that the scalar product of the internuclear vector and the magnetic field vector is  
equal to cos θIS, equation (5.1) may be rewritten to equation (5.2).
VI
 
 𝐷𝐼𝑆 = −
ℏ𝛾𝐼𝛾𝑆𝜇0
16𝜋2
〈
1
𝑟𝐼𝑆
3 (3cos
2𝜃𝐼𝑆 − 1)〉 = −𝐷𝑚𝑎𝑥 〈
1
𝑟𝐼𝑆
3 (3cos
2𝜃𝐼𝑆 − 1)〉 (5.2) 
In anisotropic liquid conditions the observed angle is an average the dipolar coupling over all 
orientations. The dependence on the angle to the magnetic field may be used in determining the 3D 
                                                 
 
V
Note that θ changes definition from dihedral angle to angle with magnetic field dependent on 
whether J-coupling constants or RDCs are the current subject.  
VI
 Compared to the notation by Levitt, the dipolar coupling is divided by 2π to gain values in Hz 
instead to radians/s.  
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structures of molecules as it will establish angular knowledge of internuclear vectors even far apart 
in structure, as exemplified in Figure 5.1, which may be utilized by back-calculation and fitting of 
experimental data to a proposed structure.  
 
 
Figure 5.1. Left: Correlation of the angle between two internuclear vectors (φ) from the angle of the internuclear vectors to 
the magnetic field (θ). Right: The relative dependence of RDCs on the angle θ. 
This can make it possible to correlate clusters of stereo-centers in a given structure that are not 
connected by protons in close proximity, which is impossible using NOEs and J-coupling constants 
due to their local nature. 
In isotropic tumbling, i.e. where the molecules are freely moving in solution, the term (3 cos
2 θIS – 
1) averages to zero and no RDCs are observed, taking into account that all orientations have equal 
probability, in equation (5.3).
11
 
 𝐷𝐼𝑆 = ∫ sin 𝜃𝐼𝑆 (3cos
2𝜃𝐼𝑆 − 1) 𝑑𝜃𝐼𝑆
𝜋
0
= 0 (5.3) 
This implies that D-coupling constants may not be observed in isotropic liquid NMR spectroscopy 
as signal splittings, and a surplus of a given alignment to the magnetic field needs to be introduced 
making the sample anisotropic. The anisotropic sample is here characterized by a preferred 
molecular orientation as well as rapid translational motions of the molecules.
11
 The result is that 
intramolecular dipoles give rise to dipolar coupling constants, while intermolecular dipole 
interactions will still average to zero as a result of translational motions, at least to a good 
approximation and for short (and thereby larger observed) intermolecular dipole interactions.
11
 
Were all molecules equally aligned, the full dipolar coupling would be observed and the constants 
from equation (5.2) yield D-coupling constants with a magnitude of tens of thousands Hz for 
1
DCH 
(Dmax/r
-3
 ~ 11,350 Hz). This would make them hard to measure, and the sign next to impossible to 
determine, when comparing to 
1
JCH (typically +100 to +200 Hz).
196,197
 Of course other problems 
such as intermolecular dipolar couplings and broader line-shapes due to a multitude of large long-
range dipolar couplings etc. may also be envisioned. Thus the alignment needs to create a smaller 
surplus of one orientation, with the observed value being the residual dipolar coupling (RDC), 
preferably in the magnitude of tens of Hz which translates to a ~10
-3
 fraction of alignment. This is 
in practice achieved by using alignment media in liquid solutions which align only an appropriate 
amount of molecules leading to average coupling constants of the desired maximum absolute 
values. Note that D will refer to a residual dipolar coupling constant in the rest of this thesis. 
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In an anisotropic sample the D-coupling constants are extracted from the difference between the 
observed total coupling (T) and the J-coupling from isotropic tumbling as in equation (5.4). 
 𝐷 = 𝑇 − 𝐽  (5.4) 
The sum of dipolar interactions is observed due to identical form of the respective Hamiltonians of 
the spin parts of J and D. The J-coupling constants are considered unaltered as they are almost 
independent of the orientation to the magnetic field.
11
 The anisotropic part of the J-coupling 
(termed the J-anisotropy) is small and usually ignored, even in solids NMR.
11
 The line-splitting is 
thus a summation of the two dipolar coupling contributions, and it should be noted that also T = J + 
2D is used in the literature.
195
 While this will of course alter the observed RDCs, it will not 
influence the conclusions from back-calculation of RDCs from 3D structures, since all RDCs are 
scaled equally.
195
 An example of an extraction is illustrated in Figure 5.2. The J- and T-coupling 
constants are determined by displacement of peaks to maximum overlay throughout the thesis. 
 
Figure 5.2. 1D slices of rows (δC indicated) extracted from a CLIP-HSQC of reserpine (see Section 0) under isotropic 
conditions yielding J-coupling constants (red) and anisotropic conditions yielding total coupling constant (blue). Aligned in 
PDMAA (Polymer 8.2). The values of the RDCs are shown above the doublets.  
To investigate the degree of alignment, the quadrupolar splitting of deuterium nuclei in the 
deuterated NMR solvents is often used. From the quadrupolar splitting it may be e.g. evaluated 
whether the alignment is stable across long experiments, and there is a correlation between the 
quadrupolar splitting and the size of the observed RDCs for many alignment media.
198,199
 The linear 
correlation between the size of RDCs and 
2
H-splitting is compound and alignment media 
dependent. Not all alignment media give rise to observable quadrupolar splittings, especially the 
more polar solvents, such as DMSO, seem to exhibit smaller splittings, which may be hidden in the 
linewidth.
200
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Figure 5.3. Examples of the 
2
H quadrupolar splitting for CDCl3 of an isotropic sample (black), and aligned samples in the 
liquid crystal PBLG (red) and the stretched polymer PDMAA (blue). The size of the splitting is indicated above at 400 MHz 
(
1
H frequency). 
The measured RDCs are compared to 3D structures of the investigated molecule by back-
calculation, where experimental data is compared to already rendered 3D structure(s). For bio-
macromolecules, RDCs are also used in the optimization and simulation of structures, but the 
method has not caught on within the small molecule community and will not be elaborated on.
201
 
The preferred back-calculation of RDCs from 3D structures for small molecules is singular value 
decomposition (SVD),
202–204
 which has proven reliable and generally applicable for the structures 
frequently used in the literature. They generally all share a common feature: They are rigid. The 
requirement of rigidity in the structure is a major problem for general usage of RDCs, which is 
addressed in Chapter 0, along with a more detailed introduction to SVD. Other methods have also 
been proposed such as prediction of alignment based on e.g. shape of the molecule, but these are 
generally less utilized in the small molecule literature.
203–205
 
The used experiment for determining 
1
JCH and 
1
TCH was generally the CLIP experiment, which 
exhibit the line splitting of the coupling constant in the direct (F2) dimension.
206,207
 Other groups 
have shown that using the indirect (F1) dimension may be advantageous due to e.g. that 
homonuclear coupling constants will not influence the line splitting in the indirect dimension, 
resulting in potentially sharper lines.
195,208
 The experimental time is increased though due to the 
lower resolution in F1, even when J-scaling is used. The author experimented slight differences in 
the extracted coupling constants between the F1 and F2 experiments, and it was thought 
advantageous to keep to one type of experiment throughout. 
5.1.1 Alignment media 
The available alignment media for small molecules in organic solvents are generally divided into 
two classes: Liquid crystals (LCs) and stretched polymers (SPs).
195,196
 The latter class is also termed 
strain-induced alignment in a gel (SAG) effect alignment media. The amount of alignment media is 
different compared to those for macromolecules due to a need for applicability in organic solvent. 
Thus e.g. filamentous phages, rod-shaped cellulose particles or charged acrylamide gels are not 
generally applicable.
209
 The interaction with the alignment media is generally thought to be solely 
steric, unless a charged alignment media is used.
203,210
 A list of alignment media and the solvents in 
which they may be used is found in Table 5.1.
197
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Table 5.1.  Examples of liquid crystal (LC) and stretched polymers (SP) alignment media and the most utilized solvents used 
for alignment in the media. Inspired by Thiele
197
 
LC Solvent Chiral Ref. 
PBLG CDCl3 Yes 
186,198,211 
PELG CDCl3 Yes 
188 
Guanidines CDCl3 Yes 
212 
Acetylenes CDCl3 Yes 
189,192 
Graphene DMSO No 213,214 
 
SP Solvent Chiral Ref. 
PS CDCl3 No 
193,215 
PDMS CDCl3 No 
216 
PMMA CDCl3 No 
194 
PVAc CDCl3 
CD3OD 
DMSO 
No 200 
PH/PAA D2O 
DMSO 
No 217,218 
PDMAA/(R/S)-APhES DMSO Yes 210 
Gelatin D2O Yes 
219 
  
Multiple alignment media are available, and an outline of advantages and limitations of LCs and 
SPs is given below, as a detailed discussion of all would be beyond the scope of this text. General 
consideration focused on enantiodiscrimination will also be touched upon as an introduction to 
Chapter 7. The work concerning enantiodiscrimination of organic molecules has primarily been 
centered on LCs.
189,191,192,198,212
 These include PBLG, polyacetylenes and polyguanidines. For 
comparison only a single stretched radical-initiated crosslinked polymer has been published,
210
 
while crosslinked amino acid based stretched polymers such as gelatin have also been shown to 
possess enantiodiscriminative properties.
219
 
5.1.2 Liquid Crystals 
LCs for the application as small molecular alignment media are typically made of long polymeric 
single strands that possess a secondary structure. The LCs are normally helical but sheet structures 
have been reported in the form of graphene layers.
198,213
 The most prominent member of the class is 
arguably PBLG, and this is also the only LC the author has worked with.  
The anisotropy is introduced by dissolving of the LC in the given solvent.
190,198,220
 By repeatedly 
transferring the solution from one end of the NMR tube to the other, e.g. by use of rotor, the 
solution is homogenized. The homogeneity along the length of the NMR tube is verified by 
measuring the quadrupolar splitting of the deuterium signal. The anisotropy is induced by 
interactions of the molecules and the vertically aligned helices as illustrated in Figure 5.4. 
 
Figure 5.4. Illustration of the alignment of molecules in liquid crystals (LC), based on PBLG.  The induced anisotropy is 
indicated. 
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The main disadvantage of the LCs is that they are hardly scalable, though different molecular 
weight PBLG was shown to result in differences in the alignment strength.
198
 Also the alignment is 
strong, leading to larger RDCs, which may lead to problems and limit the scope of usage.
198
 An 
advantage is that many LCs are readily available from vendors, the sample preparation of the 
alignment media is easy and the line shapes of aligned compounds are, based on experimental 
experience with PBLG of the author, sharper than when using stretched polymers. Also, most of the 
LCs are inherently chiral and enantiomeric pure, leading to better discrimination between 
enantiomers.
189,192,198,212
 
While PBLG is probably the most utilized LC for RDC extraction, the enantiodiscriminative 
prowess of the polymer is not great compared to other reported LCs. It was shown though, that the 
alignment of (+)- and (-)-IPC, and thus the observed RDCs, was affected by the amount of PBLG 
versus PBDG (the enantiomeric polymer), and that differentiation was indeed possible.
190,198
 Also 
cross-linked PBLG (which could in theory be considered a stretched polymer) was shown to 
differentiate IPC.
191
 It was actually reported that the differentiation was increased by crosslinking 
the LC.  
Other liquid crystals have been published with greater enantiodiscriminative properties. The first 
was a polyguanidine which showed much differences in the orientation of the enantiomers of 
IPC.
212
 This was followed by two polyacetylenes which also showed great differentiation.
189,192
 
Interestingly, one of the polyacetylenes was reported to exhibit enantiodiscriminative properties 
even after the temperature was varied to a point where circular dichroism showed no left- or right-
handedness of the helical backbone, suggesting that the enantiodiscriminative properties may in part 
be due to side-chain chirality.
192
 This was surprising since the enantiodiscriminative properties of 
the LCs were thought to originate mostly from their helical structure, while this finding suggest an 
interaction to the chiral center presented at the side-chain.
189,190,192,212
 
 
Figure 5.5. Examples of chiral LCs from the literature. All give rise to helixes in solution.
189,190,192,198,212
 
5.1.3 Stretched Polymers 
Stretched polymers cover crosslinked polymers that swell in the used solvents. The term stretched 
polymers is fitting especially for polymers which are mechanically scaled using an amply named 
stretching apparatus.
199,221–223
 The stretching apparatus consists of a rubber tube and clams which 
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uniformly stretches the gel inside the tube, and may be used to tune the alignment. Rubber tubes for 
different solvents have been introduced to allow the usage of e.g. chloroform.
199
 
Another method of swelling the polymer is by synthesizing polymers of a size which limits swelling 
to be either radially or vertically in the NMR tube. The polymer stick is then swollen in a suitable 
solvent and the result is an anisotropic environment as illustrated in Figure 5.6.
194,200
 The 
anisotropic environment may be simplified to the steric interactions with the irregular distribution 
of interaction surfaces with either horizontal or vertical surface in excess, formed once the polymer 
is swollen.
194
 In practice, the polymers were synthesized polymers in either 5 mm (vertical 
swelling) or 3 mm (radial swelling) NMR tubes, and subsequently swollen in 5 mm NMR tubes.
194
 
 
Figure 5.6. Schematic representation of the alignment of molecules in stretched polymers, either swollen vertically or radially 
in an appropriate solvent. The anisotropy of the polymers upon swelling is indicated. 
The alignment strength may often not be altered once swollen, but may be tuned by the amount of 
cross-linker used during synthesis and the size of chosen polymer stick.
194,200
 It should be noted that 
the synthesis of these polymers seems much easier than that of e.g. PBLG (though the latter was not 
attempted by the author),
198
 and it is hardly problematic that scaling depends on cross-linker 
content. The vertical swelling was first introduced, but the time needed to reach full swelling is 
generally long, up to several weeks.
194
 Thus the concept of radial swelling of thin polymers which 
were vertically restricted was introduced.
194
 Some of the polymers may be shifted from constricted 
to un-constricted multiple times while other do not possess this property and should not be relaxed 
after swelling.
194,210
 
The amount of stretched polymers which will differentiate enantiomers is, as mentioned previously, 
lower than the number for LCs. Polymers are based on crosslinked amino acids, such as gelatin and 
the underlying biopolymer of gelatin, collagen, were shown to differentiate diastereomers in 
aqueous solution.
219,223,224
 A more classic ( i.e. radical initiated) polymer based on a chiral monomer 
alike to the achiral AMPS monomer, (R/S)-2-acrylamido-2-methylpropane-1-sulfonic acid 
(APhES), and the achiral monomer (N,N)-dimethylacrylamide (1:1) was later introduced, which 
was shown to differentiate compounds that possess a charged amine group under acidic conditions 
in DMSO.
210,217
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Figure 5.7. Example of a chiral stretched polymer from the literature. Was showed to work only by interactions to a charged 
amine moiety of the analyte.
210
 
5.1.4 Evaluation of RDCs  
To evaluate the experimental RDCs in comparison to the given 3D structure(s), the Q-factor is 
utilized as given in equation (5.5).
203,204
 
 𝑄 = √
∑(𝐷𝑖
𝑒𝑥𝑝 − 𝐷𝑖
𝑐𝑎𝑙𝑐)
2
∑𝐷𝑖
𝑒𝑥𝑝2
 (5.5) 
The Q-factor approaches zero when the difference between experimental and back-calculated 
values approaches zero and the size of the extracted RDCs is included in the calculations, which 
leads to easy comparison of fits between dataset of different degrees of alignment. 
5.1.5 Parameters used to investigate enantiodiscrimination 
Some different parameters have been proposed in order to compare the alignment of different 
enantiomers. One is the 5D or generalized cosine β (GCB) angle, which directly compare the 
alignment tensors from e.g. SVD fittings, given in equation (5.6) as the normalized scalar product 
between the alignment tensors (see Section 8.1 for the theory of SVD and alignment tensors).
192,225
 
 
𝐺𝐶𝐵 =
〈𝐴1|𝐴2〉
〈𝐴1|𝐴1〉½〈𝐴2|𝐴2〉½
 
〈𝐴1|𝐴2〉 =∑𝐴𝑖𝑗
1 𝐴𝑖𝑗
2
𝑖,𝑗
 
(5.6) 
An F-test has also been utilized to check whether the actual RDC values are statistically different, 
using the null hypothesis that there is no significant difference (standard for the F-test).
210
 The F-
test is used to compare variance of the data and the difference in variance between datasets of 
different and identical enantiomers are compared. It should be noted that the F-test is generally 
quite sensitive toward non-normality and it is not used in this thesis.  
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6 Determination of long-range residual dipolar coupling constants 
A major hindrance in the scope of utilizing RDCs for structural studies of small molecules is an 
inherent lack of internuclear vectors to measure and compare to 3D structures. Whereas 
1
DXH are 
plentiful for macromolecules, only utilizing the one bond couplings is a limitation for small 
molecule RDCs. Thus it would be beneficial to increase the number of vectors by including long-
range RDCs. For this purpose, the S
3
 HMBC experiments may prove very useful. While SVD is 
reviewed in Chapter 0, it is worth mentioning that it is the most widely used back-calculation 
method used for small organic molecules, and that a minimum of five linearly independent 
internuclear vectors are needed to obtain a fit between RDC data and a rigid 3D structure. If 
multiple moving parts of a structure need to be investigated independently, five independent 
internuclear vectors are needed per moving part, which may be a concern for small molecules.
202,226
 
 Utilized alignment media 6.1
It was not straight forward to implement the usage of the S
3
 HMBC experiments in RDCs due to 
inherent problems with the used alignment media. This may be attributed to the change in T2 
relaxation for the small molecules in aligned samples. A decrease in T2 time due to interactions to 
the solid-like alignment media leads to a rapid loss of magnetization and the longer, compared to 
e.g. HSQC-type experiments, S
3
 HMBC experiments resulted in a lack of signal to detect. Thus the 
search for an alignment medium which proved advantageous was initiated. Essentially two factors 
were deemed the most important: 
1. Alignment should be weak enough to allow sufficient tumbling so that T2 relaxation allows 
signal detection 
2. Alignment strong should  enough that long-range RDCs are larger than the experimental 
error 
As one might suspect, these requirements are contradicting and some alignment media may be 
readily discarded.  
The initial choice of alignment media illustrates this dilemma; the liquid crystal PBLG and 
stretched PMMA and PVAc polymers.
194,198,200
 Spectra of IPC and strychnine from PBLG failed to 
obtain an S/N ratio where RDCs could be determined in the author’s hands. This is contributed to 
the strong alignment of the medium, perhaps best illustrated by the large observed 
1
DCH-coupling 
constants. On the contrary, PMMA and pVAc would give rise to observable RDCs, but weak 
alignment strength and thus low RDCs, gave rise to a large possible influence from experimental 
errors and low discriminative prowess. This was somewhat relieved by altering the amount of cross-
linker in order to increase the size of the RDCs. 
In the end, an alignment medium that best satisfied the needs was identified; a new stretched 
polymer made from crosslinked DMAA (PDMAA). It should be noted that a similar polymer has 
been published, e.g. the PH/PAA polymer where 2-(acrylamido)-2-methylpropanesulfonic acid is 
used in addition to DMAA (in a molar fraction of 1:1) and crosslinker.
210,217
 This is supposedly 
done to facilitate swelling in DMSO. 
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It was advantageous to swell PDMAA using the confinement method, where vertical swelling is 
restricted and the polymer is allowed to swell radially. PDMAA swell easily in both chloroform and 
DMSO with observed coupling constants in the order of 20-30 Hz, and is thus very well suited for 
the purpose of aligning small organic molecules. The observed RDCs were easily scalable by 
differentiation of the amount of cross-linker in line with other stretched polymers.
194
 This is 
advantageous, native to stretched polymers over LC, as the optimal alignment of different 
compounds was found by a singular polymer constitution, and that the alignment strength differed 
between compounds in the same polymer, even when comparable structures were aligned. 
 Results - S3 HMBC homo 6.2
The S
3
 HMBC hetero experiment was a relatively late addition to the work, and was finalized while 
writing the thesis. Thus, long-range heteronuclear results from aligned samples are not included and 
this section will focus solely on S
3
 HMBC homo.  
RDCs were extracted from spectra of aligned and isotropic samples of strychnine and IPC. The 
basis of the alignment tensors for the structures was 
1
DCH-coupling constants from CLIP-HSQC 
spectra, since the long-range 
n
DHH-coupling constants are inherently smaller than 
1
DCH-coupling 
constant due to the r
-3
 relationship. While much focus has been on measuring long-range 
heteronuclear coupling constants in the case of J-coupling constants,
145,146
 long-range homonuclear 
RDCs are more interesting than their hetereonuclear counterparts due to the ~4:1 ratio of the 
gyromagnetic ratios of 
1
H and 
13
C, as illustrated in Table 6.1. As a result quite long distances 
between protons have identical potential values as the shortest of long-range heteronuclear RDCs 
(
2
DCH). While examples of homonuclear RDCs are available in the literature, they generally seem 
sparsely used.
227–229
 
Table 6.1. Comparison of theoretical relative D-coupling constants to that of 
1
DCH for different distances (r) calculated using 
equation (5.2). Identical angle to the magnetic field is assumed. Examples of nuclei pairs with an internuclear vector of the 
used distances are given. 
r [Å] DCH DHH Example 
1.1 1.00 - r(1DCH) 
1.8 0.24 0.94 r(2DHH) 
2.2 0.13 0.50 r(2DCH) 
2.6 0.06 0.24 - 
3.0 0.04 0.15 - 
 
The number of RDCs obtained from S
3
 HMBC homo was generally lower than the number of J-
coupling constants extracted from isotropic samples, possibly due to an increase in T2 relaxation in 
the anisotropic samples. Another explanation could be altered long-range heteronuclear coupling 
constants leading to a too low or high coupling constants compared to the length of the delay used 
in the pulse sequence. The latter might possibly be alleviated by using an array of delays, but this 
was not tested. 
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6.2.1 IPC 
The structure of IPC is much used, probably due to favorable rather weak alignment in most media, 
the rigid structural scaffold and multiple non-parallel vectors.
189,190
  
 
Figure 6.1. Structure of (+)-IPC. Stereochemistry of chiral centers and diastereotopic protons indicated. 
IPC was aligned in PMMA, using the confinement method to introduce anisotropy. The measured 
one-bond and long-range RDCs are given in Table 6.2. Note that most of the “long-range” coupling 
constants were in fact 
3
DHH, which could be obtained from other experiments, though the S
3
 HMBC 
homo provide an accurate and easy method of performing the measurements. Also some 
4
DHH were 
extracted. The correlation of the data is generally good, though the Q-factor increased upon 
including the extra RDC data. 
Table 6.2. Experimental and back-calculated RDCs of IPC using 
1
DCH from CLIP-HSQC only and including 
n
DHH from S
3
 
HMBC homo. When no experimental data (-) is given the 
theoretical values are calculated from the existing data. Aligned 
in PMMA (Polymer 6.1) 
Nuc 1 Nuc 2 Exp [Hz] Comp [Hz] 
Exp 
[Hz] 
Comp 
[Hz] 
C1 H1 16.3 16.7 16.3 18.2 
C2 H2 -11.6 -9.6 
-
11.6 
-8.8 
C3 H3 14.6 14.2 14.6 12.5 
C4 H4a -4.8 -4.8 -4.8 -6.1 
C4 H4b 15.5 14.2 15.5 16.1 
C5 H6 -7.4 -7.8 -7.4 -5.8 
C7 H7a -21.7 -23.2 
-
21.7 
-23.8 
C7 H7b 4.9 5.2 4.9 2.7 
H1 H6 - 0.7 1.0 0.9 
H1 H7a - 0.2 0.5 0.0 
H2 H3 - 3.7 3.7 4.0 
H2 H4b - 0.5 1.5 0.8 
H3 H4a - 1.4 1.6 1.1 
H3 H4b - -1.7 -2.1 -1.0 
H3 H6 - -0.4 -0.3 -0.5 
H4a H6 - -7.5 -7.0 -7.9 
  Q-factor 0.076  0.147 
 
 Table 6.3. Q-factors of back-calculations of IPC of 
correct assignment and with switched chirality of 
diastereotopic protons. 
Switched Q-factor 
 
1DCH Ratio 
1DCH+
nDHH Ratio 
Right 0.076 1.0 0.147 1.0 
Dia-2 0.661 8.7 0.806 5.5 
Dia-3 0.305 4.0 0.432 2.9 
Dia-4 0.201 2.6 0.662 4.5 
Dia-7 0.659 8.7 0.668 4.5 
Dia-2+3 0.655 8.6 0.759 5.2 
Dia-4+7 0.440 5.8 0.678 4.6 
Dia-2+4+7 0.284 3.7 0.339 2.3 
Dia-2+3+4+7 0.283 3.7 0.375 2.6 
 
The additional information from the homonuclear coupling constants was used in an attempt to 
determine the diastereomer of the known structure. The result is found in Table 6.3 and Figure 6.2, 
and the additional information led to little or no differentiation compared to only using the one bond 
coupling constants, as the lower values of the long-range RDCs correlate well to all 3D structures.    
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Figure 6.2. Comparison of 
experimental and back-calculated 
RDCs of IPC. Black dots: only 
1
DCH 
data. Open circles: 
1
DCH and 
n
DHH 
data used, with 
1
DCH in black and 
n
DHH in grey. Aligned in PMMA 
(Polymer 6.1)   
a) Correct stereochemistry.  
b) 2-stereoisomer.  
c) 3-stereoisomer.  
d) 2- and 3-stereoisomer.   
 
6.2.2 Strychnine 
Strychnine was also utilized to showcase the scope of the new S
3
 experiments. The alignment 
medium was PDMAA which was identified to result in the highest number of coupling constants 
from S
3
 HMBC homo versus alignment strength ratio. While PMMA gave rise to similar magnitude 
1
DCH-coupling constants as DMAA, only a few 
n
DHH-coupling constants could be extracted from 
the S
3
 HMBC homo spectra in PMMA. Examples of extracted RDCs are given in Figure 6.3. 
 
Figure 6.3. Comparison of S
3
 HMBC homo spectra of strychnine in CDCl3 under isotropic (green and brown) and 
anisotropic (blue and red) conditions. Aligned by PDMAA (Polymer 6.2). The extracted coupling constants and associated 
RDCs are given. 
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The general findings were similar to those of IPC, with the addition of the extra coupling constants 
leading to a slightly worse Q-factor. Many long-range coupling constants were extracted, more than 
doubling the available number of internuclear vectors included in the back-calculations of the data 
(26
 n
DHH in addition to 18 
1
DCH) which is illustrated in Figure 6.4, values given in Appendix A4. 
While the extra internuclear vectors were not needed in the fitting of strychnine, it showed the 
potential of using the S
3
 HMBC experiments in extracting RDCs. 
 
Figure 6.4. A graphical representation of the experimental (white) and back-calculated (grey) RDCs of strychnine. When 
RDCs were extracted from two directions the average is given and the difference indicated with error bars. Anisotropy 
induced by PDMAA (Polymer 6.2). 
When comparing experimental data to back-calculated values from wrongfully assigned 
diastereotopic protons as seen in Figure 6.5, the best correlation between experimental and back-
calculated RDCs was the correct assignment, and only the diastereomers of 15a/15b was virtually 
indistinguishable due to very similar RDCs. The stereochemistry of the diastereotopic protons 
23a/23b could not be solved without the additional data from 
n
DHH-coupling constants due to 
overlap of the resonances in the CLIP-HSQC. This is alleviated by the usage of add and subtract 
spectra in the S
3
 HMBC homo as the coupling constants are not in-phase and thus the resonances 
are more easily differentiated. A similar distinction might be possible using the CLIP/CLAP-HSQC 
approach.
206
 The differentiation of the diastereotopic protons was facilitated by a favorable (and 
lucky) orientation of the aligned molecules, where the internuclear vectors that include H23a/b had 
rather large and different RDCs compared to the remaining long-range RDCs.  
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Figure 6.5. Comparison of 
experimental and back-calculated 
RDCs of strychnine. Red dots: only 
1
DCH data. Open circles: 
1
DCH and 
n
DHH from S
3
 HMBC homo.  Upper 
left is right stereochemistry, and 
the diastereotopic protons are 
switched in the rest as indicated in 
the plots. Anisotropy induced by 
PDMAA (Polymer 6.2). 
Tables with the data are found in 
Appendix A4. 
 
 Conclusion and perspectives 6.3
The S
3
 HMBC homo may be used to extract long-range homonuclear RDCs accurately and, if 
aligned by a suitable alignment media, in a large number. It should of course be noted here, that the 
chosen compounds both have a high proton to carbon ratio. The increase in available internuclear 
vectors may greatly impact for small molecular NMR spectroscopy, where the number of one-bond 
RDCs is often limited. The length of the pulse sequence may be a limitation, presumably due to a 
faster T2 relaxation induced by the alignment media, but alignment media were identified which 
enable extraction of the total coupling constants.  
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 Experimental 6.4
Synthesis of achiral polymers 
The syntheses presented are generally inspired from the literature.
192,194,210,215
 All commercially 
bought monomers and crosslinkers (except N,N-methylenbisacrylamide which is a solid) were 
purified prior to the synthesis to remove the polymerization inhibitor by passing the neat liquid 
through a pipette filled with basic alumina. 
PDMAA 
 
To 1 mL of N,N-dimethyl acrylamide (9.7 mmol) was added 1.6 mg (0.009 mmol) N,N-
methylenbisacrylamide and 1.5 mg azobisisobutyronitrile (AIBN) (0.009 mmol). N2  was bubbled 
through the solution for 5 minutes to remove O2 and the solution was transferred to 3 mm (or 5 mm) 
NMR tubes. Air was removed under vacuum and N2 backfilled into the tubes three times and the 
tubes were left at 60 °C overnight (approx. 14-16 h) to polymerize. 
A solvent (CDCl3, DCM, acetone-d6) may be added before transfer, and was usually used in 1:2 
ratio of solvent:N,N-dimethyl acrylamide (v:v). 
PMMA 
 
The protocol of Gil et al. was generally followed.
194
 
10 mL MMA (61.0 mmol), was added 2 mL acetone-d6 and 2.5 mg AIBN (0.015 mmol). 10 mL 
were taken out and mixed with 40 μL ethylene glycol dimethylacrylate (EGDMA) (0.42 mmol). 
The solution was transferred to 3 or 5 mm NMR tubes evacuated and back-filled with N2 three 
times. The cycle was repeated 3 times, and the tubes were left at 50 °C overnight (approx. 14-16 h). 
Swelling of polymers 
5 mm sticks 
The tubes were left for a couple of hours without lid after being cooled to room temperature. The 
polymers could usually be removed easily from the tubes without need of breakage. If stuck the 
tubes were carefully broken though. The polymers were then cut to appropriate length (2 cm) and 
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inserted into a 5 mm NMR tube. The solvent and analyte was added and the polymer was left to 
swell. Depending on the polymer the swelling time varied from approximately one week to several 
weeks. The degree of alignment was carefully monitored from the quadrupolar splitting of the 
deuterated solvent. 
3 mm sticks 
The tubes were carefully broken and left overnight to dry. This was especially beneficial for the 
more sticky chiral polymers. The glass was carefully removed from the polymers and the resulting 
polymer sticks were cut into the appropriate length (4 cm). The cut polymer stick was inserted into 
a 5 mm NMR tube and the analyte was dissolved in 0.3 mL solvent and added. A plug was quickly 
inserted to prevent vertical swelling. Samples should be left for at least 5 h (CDCl3), 1 d (DMSO-
d6) or 2-3 d (MeOD) for swelling. To make sure that complete swelling was achieved, a minimum 
1d (CDCl3), 3 d (DMSO-d6) or 5 d (MeOD) was always used.  
In the table below the constituents in the synthesis of the relevant polymers are given.  
Name Analyte 
(c [mM]) 
Solvent Monomer 
 
Crosslinker 
(mol%) 
Monomer:solvent in 
synthesis (v:v) 
Field 
[MHz] 
Polymer 6.1 IPC (553.6) CDCl3 PMMA EGDMA (0.38) 4.5:1 acetone-d6 800 
Polymer 6.2 Strychnine (216.5) CDCl3 DMAA MBAA (0.34) - 800 
NMR experiments 
The CLIP-HSQC experiments was used for the determination of one-bond CH coupling constants, 
using standard setup as described in Appendix A1. Isotropic spectra of IPC (145 mM) and 
strychnine (144 mM) were acquired in 5 mm tube (0.5 mL) 
The S
3
 HMBC homo was used for long-range homonuclear coupling constants as described in 
Chapter 4, using standard setup as described in Appendix A1. 
Total coupling constants were extracted from aligned samples, while J-coupling constants were 
extracted from isotropic samples, in order to determine the RDCs, as described in Section 5.1. 
Simulations 
Structures were generated by the modelling suite Maestro version 10.2.010 (2015) by Schrödinger 
for force field calculations,
126
 using the program MacroModel version 10.8.
127,128
 The MMFFs force 
field was used. To generate structures which should cover the conformational space of compounds, 
a conformational search was performed for each structure by the program MacroModel using 
energy cutoff of 50 kJ/mol, 100,000 steps and CPRG minimization.
127,129
  
Gaussian version 09 revision B.01 was used for DFT calculations including optimizations and NMR 
calculations.
131
 Structures were optimized to a B3LYP/6-31(d) level of theory unless otherwise 
stated.  
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7 Chiral alignment media for enantiodiscrimination 
Nature is chiral – and most biological molecules are chiral structures.230,231 Usually one enantiomer 
of a given macromolecule or small molecule is universally present in an organism, leading to highly 
specific chiral environments. In line with the inherent chirality of nature, the chirality of target 
molecules in organic synthesis, as well as molecules isolated from natural sources, is of utmost 
importance. This is a consequence of the compounds often being interesting due to interactions with 
a natural target.
230,231
 The practical importance may be exemplified by a drug hoping to reach the 
US market. To be qualified for approval, the FDA demands that the compound is enantiomeric 
pure, or that both enantiomers are evaluated.
232
 This is due to often very different pharmacological 
properties of enantiomers caused by the chiral environment of the human body.
230
  
While chiral centers may usually be solved from a single known stereocenter, and diastereomers 
thus may be separated, enantiomeric structures are much harder to resolve. Similar physical 
properties of the enantiomers result in identical observables in the achiral environments where small 
molecules are usually investigated, be that utilizing MS, IR, UV or NMR methods. One of the 
major selling points for RDCs in small molecular NMR, besides providing an orthogonal method to 
e.g. NOE connectivities and J-coupling constants in obtaining 3D structural information, is a 
promise of differentiation of enantiomers. This is arguably the most challenging stereochemical 
problem to solve in organic as well as natural product chemistry, and thus a premium goal for NMR 
spectroscopy. 
 Methods of enantiodiscrimination 7.1
Due to the important functional differences of enantiomers, the differentiation of these has been a 
major research topic for years. RDCs are a relatively new approach, and other methods will thus 
briefly be mentioned. While NMR spectroscopy is utilized in some of the methods, many utilize 
different analytical tools.  
The probably most utilized method of discerning enantiomers is by optical rotation, where it is 
utilized that the enantiomers will rotate plane-polarized light in opposite directions.
233
 The analysis 
is carried out by shining single-wavelength, plane-polarized light through a solution of the analyte 
and the rotation is measured; a negative value means a rotation to the left, and a positive to the 
right. The specific rotation [α] is given by equation (2.1), at 20 °C and using a sodium lamp of 
wavelength 589 nm. 
 [𝛼]𝐷
20 =
𝛼
𝑐 ∙ 𝑙
 (7.1) 
Where α is the observed rotation, c is the concentration of the analyte and l is the path length of the 
light. The rotation is dependent on chirality as well as other structural features and a reference of 
known chirality is needed to determine the absolute stereochemistry.
233
 
Another widespread method to distinguish enantiomer is by chemical derivatization, where a 
specific functional group is derivatized using a chiral building block of known absolute 
stereochemistry. The derivatization changes the enantiomers to diastereomers, which may be 
separated by e.g. standard HPLC systems, an may lead to different resonances in NMR spectra. A 
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multitude of reagents are available dependent on the nature of the compound which is 
investigated.
234–238
 Some of the more well-known include Mosher’s reagent for, primarily, 
derivatization of secondary alcohols and Marfey’s reagent for amino acids.82,83 Using Marfey’s 
reagent as an example, the diastereomers are compared to diastereomers of known chirality, 
synthesized from pure amino acids, as illustrated in Figure 7.1. The subsequent separation on a 
HPLC column obtained by Marfey’s reagent is increased by steric differences in the structures 
resulting in stronger intramolecular hydrogen bonds of the L-isomer.
82
  
 
Figure 7.1. Top: Marfey’s reagent, made from 1,5-Difluoro-2,4-dinitrobenzene and L-alanine-NH2 which is reacted with an 
amino acid. Bottom: The difference in the spatial properties of the complex when reacted with L- or D-amino acids. 
Of methods to differentiate enantiomers by NMR other than RDCs, paramagnetic lanthanide 
chemical shift reagents and chiral solvating agents should be mentioned.
237,238
 The lanthanide 
reagents are complexes of enantiomerically pure organic structures, e.g. based on camphor 
derivatives, coordinated to a lanthanide ions (Eu, Pr, Yb are mostly used). Coordination to the 
lanthanide complex will result in a change in chemical shifts of the nuclei in the analyte dependent 
on the distance of said nuclei to the lanthanide, and enantiomers will interact differently with the 
chiral complex, leading to enantiodiscrimination.
237
 Diamagnetic chiral solvating agents work in a 
similar way, though the induced differences in chemical shifts are usually smaller. Here a chiral 
additive is added to the solvent, which form complexes with the analyte and will result in a change 
in chemical shifts dependent on the enantiomer, due to differences in interactions. The chiral 
solvating agents rely heavily on the magnetic anisotropy induced by aromatic groups in the 
structure of the additives.
237,238
 
Also chiral HPLC columns, single crystal X-ray crystallography and vibrational or electronic 
circular dichroism may be used to discern enantiomers.
232
 
 Synthesis of media 7.2
To widen the pool of enantiodiscriminating alignment media, the focus was decided to be on 
stretched polymers, since quite good enantiodiscriminative alignment media are available in the LC 
pool, and due to the inherent problems of strong alignment of LCs. It was thought useful if the 
enantiodiscrimination of more general compounds than charged amines would be possible utilizing 
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stretched polymers, and it was proposed to accomplish this by combining the conclusions reported 
for the polyacetylenes and chiral APhES polymers.
192,210
 
The chiral media synthesized were all based on a simple strategy; a chiral building block was 
attached to a double bond and polymerized with a cross-linker, as illustrated in Figure 7.2. Thus the 
chiral center is situated in the side-chain of the polymer, while the backbone must be considered a 
racemic mixture of stereocenters. It is realized that a set chiral center on a side-chain may influence 
the chirality of the stereocenter set during polymerization, but the tacticity of the polymers was not 
investigated further.
239–243
 The differentiation of enantiomers is proposed to be based on differences 
in interaction to the chiral centers of the static polymer, leading to a different average orientation in 
space between enantiomers in the aligned samples. 
 
Figure 7.2. Reaction scheme of the polymerization of chiral monomers (cross-linker not shown). 
The attachment of the double bond to the chiral molecule was achieved by reaction of a secondary 
alcohol or amine and an acid chloride. This was followed by polymerization in presence of a cross-
linker and possibly a co-monomer, using azobisisobutyronitrile (AIBN) as the initiator, outlined in 
Figure 7.3. 
 
Figure 7.3. Polymerization reaction using AIBN as an initiator, followed by propagation prolonging the chain until the 
polymerization is terminated from reaction to a second radical. The initial reaction is induced by heating. 
The chiral molecules used are depicted in Figure 7.4. The molecules were chosen to resemble 
previously successfully employed monomers from LC and SP alike.
189,192,210
 It was important that 
the dispersion of resonances from the polymer was as small as possible, as residual signals were 
present in the spectra upon alignment. This limited the amount of possible chiral building blocks to 
simple structures, or structures with many overlapping shifts, e.g. from long homogenous chains. 
The importance of this is illustrated in Figure 7.8 page 124, where a spectrum of an aligned sample 
of strychnine in chloroform is shown. The chosen monomers displayed resonances in two specific 
regions of NMR spectra: one in the aromatic region and one in the aliphatic region. 
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Figure 7.4. The structures of the chiral building blocks used in the work of this thesis. From left: 1-phenyl ethanol (PhEtO), 
1-phenyl ethylamine (PhEtN), C10H21-phenylalanine (C10-Phe) and methyl-trietyleneglycol-phenylalanine (TEG-Phe). 
The first two chiral building blocks used, (S)-1-phenyl ethanol (PhEtO) and (R)-1-phenyl 
ethylamine (PhEtN), were readily available as pure enantiomers, while the remaining two were 
based on L- or D-phenylalanine and dubbed C10H21-phenylalanine (C10-Phe) and methyl-
trietyleneglycol-phenylalanine (TEG-Phe) in the following, synthesized as indicated in Figure 7.5.  
 
Figure 7.5. Condensation reaction of phenylalanine under acidic conditions.  
For more on the synthetic condition see the experimental section. 
 Results 7.3
The swelling properties of the resulting polymers were evaluated similarly to the achiral polymers 
described in Section 6.1. In all cases, in line with available literature and previous findings for the 
PDMAA polymer, the radial swelling of a thin polymer was superior to vertical swelling of a short 
polymer, see Figure 5.6 for an illustration.
194,210
 This is in part contributed to the fact that the thicker 
polymer sticks used for vertical swelling formed a plug when solvent was added, which hindered 
further vertical swelling. Thus only very small RDCs were observed. The nature of the study, 
comparing enantiomers, also required a high degree of reproducibility, where radial swelling was 
determined to be inherently superior due to more control of the swelling. Experiments showed that 
it was much easier to cut the right length of a polymer stick and swell this under identical 
restriction, than hoping that the polymers would stop swelling at identical lengths. One could of 
course restrict vertical swelling as well, had plugs not been formed upon the addition of solvent. 
Another argument in favor of using the radial swelling approach was the time needed for swelling. 
While vertical swelling may take weeks to months for certain polymers,
191,194
 radial swelling was 
visibly finished and experimentally stable, in regards to the extracted RDCs, in a matter of 5-10 
hours in chloroform and 1-2 days in DMSO. No to minor 
2
H-splitting of the solvent was observed 
for the polymers in all solvents, in contrast to the native achiral polymers, which for the most part 
was PDMAA (see Section 6.1). 
Interfering differences in observed RDCs were determined for identical compounds aligned in 
identical polymers, which were contributed to random errors as well as small differences in the 
length of the utilized polymer sticks. This was corrected by choosing a reference RDC across all 
samples and comparing the relative differences in the observed RDCs, and led to better 
reproducibility. As the difference in RDCs between enantiomers is proposed to be their relative 
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orientation compared to the magnetic field, and scaling all RDCs is equal to altering the alignment 
strength Da, using the relative RDCs will lead to the right conclusion, while eliminating errors from 
e.g. different polymer lengths. The reference RDC was chosen as a large RDC with a low variance 
between all data sets, regardless of stereochemistry. The comparison was made utilizing a setup as 
explained in Figure 7.6. 
 
Figure 7.6. The evaluation of enantiodiscrimination of 
the alignment media was made by comparing 
enantiomers, (+) or (-), aligned in polymers from a 
single polymer stick (red dotted boxes). This was 
repeated using multiple polymer sticks (2,3…), so that 
the variation for identical compounds between 
polymers was also evaluated (black dotted box).  
This gives rise to two comparisons which are made and 
depicted in the following sections:  
1. The averages and standard deviations of 
RDCs from each black box are compared. 
2. The RDCs of the red boxes are compared as 
averages and standard deviations of RDC(+) - 
RDC(-) for each red box. This is equal to the 
difference in alignment, disregarding any 
possible differences in the alignment between 
polymer sticks. 
 
 PhEtO, PhEtN and C10-Phe polymers 7.4
It was realized that no enantiodiscrimination could be attributed to the polymers made from (S)-1-
phenyl ethanol, (R)-1-phenyl ethylamine and L-C10H21-phenylalanine or at least the 
enantiodiscrimination was below the experimental error and differences between identical 
compounds. Thus the results will only be shortly presented.  
 
Figure 7.7. Comparison of RDCs from enantiomers in different chiral media, as given in the plots. Error bars indicate that a 
mean is used with standard deviation of three datasets for each enantiomer.  
It was possible to synthesize a polymer made entirely of (R)-PhEtO, as the monomer was a liquid 
and solubility was not an issue. The differentiation of enantiomers was not observed though, as 
illustrated using the enantiomers of IPC in Figure 7.7. The variance between identical compounds 
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was 0.72 Hz and 0.47 Hz between enantiomers, and it was concluded that enantiodiscrimination 
was not achieved.  
The same trend was observed for the (R)-PhEtN polymer, and since it was structurally alike to the 
(R)-PhEtO polymer, while having some solubility difficulties during synthesis, further evaluation 
was not made. The (R)-PhEtN polymer swelled in chloroform, DMSO-d6 and methanol-d4, giving 
rise to quite different size and sign of RDCs between the apolar and polar solvents.  
The (L)-C10-Phe polymer may differentiate enantiomers, but reproducibility was difficult due to 
poor solubility of the monomer during synthesis, which resulted in brittle polymers and ultimately 
large differences in the observed RDCs. A similar LC to the (L)-C10-Phe polymer has been reported 
to work well, even at temperatures where no backbone order was supposedly present, and it was 
surprising that such a low, if any, differentiation was observed.
192
 The low solubility of the 
monomer may be the problem, as the ratio of chiral to achiral monomer might have been too low to 
achieve observable differentiation.  
The solubility problem of the (L)-C10-Phe polymer was alleviated by using methyl-tri-ethylene 
glycol as the long ester chain and more of this monomer could be incorporated into the polymer. 
TEG-phenylalanine based polymers showed minor enantiodiscriminative properties and the results 
are included below. 
 The TEG-Phe polymer 7.5
The (L)-TEG-Phe polymer exhibited much better solubility properties compared to the (L)-C10-Phe 
polymer, while retaining approximately the same size of the ester group (though the structure of the 
chain in solution may vary). This polymer became the focus of the study, and a more in depth 
analysis of the alignment properties is included. The polymer swelled in chloroform, DMSO-d6 and 
methanol-d4 giving rise to RDCs in the same general magnitude, but only chloroform and DMSO-d6 
was investigated in depth. Similar to the PhEtN polymer, a big difference in extracted relative 
RDCs was observed between apolar and polar solvents, leading to a proposed difference in 
alignment, vide infra. 
The polymer displayed residual resonances grouped in an aromatic (~7-7.5 ppm/120-125 ppm) and 
a TEG part (~3-4.5 ppm/60-75 ppm) with the latter leading to the most intense signals, illustrated in 
Figure 7.8. The backbone-, α- and β-resonances were much less pronounced in the spectra, possibly 
due to less flexibility leading to a shorter T2. The observed analyte resonances were broadened, 
which may be problematic, due to an increased uncertainty in the extracted coupling constants in 
the F2 dimension. The determination of the coupling constants was performed by displacement of 
1D slices, where the peaks are overlaid to access the values, and the broad peaks should thus not be 
that problematic as long as they are symmetric. 
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Figure 7.8. Spectrum of strychnine in 
CDCl3 aligned in 3 mm TEG-
Phe/DMAA polymer stick. Residual 
polymer signals are highlighted. The 
only indeterminable strychnine 
resonance due to spectral overlap is 
C3-H3 in the aromatic region. The 
polymer resonances are well 
contained in small regions of the 
spectra. (800 MHz, 16 scans, rd=1.5 s, 
4k×256 zero-filled to 16k×1k) 
 
Alignment and differentiation of the enantiomers of the small molecules IPC and menthol was 
pursued, and a single enantiomer of strychnine was also investigated, using polymers of opposite 
side-chain chirality.  
7.5.1 Menthol 
Menthol is a molecule with a rigid chair conformation due to three substituents in equatorial 
positions. A problem in using menthol in RDC comparisons, using only 
1
DCH-coupling constants, is 
that only four non-parallel internuclear vectors are present, unless the isopropyl orientation is 
considered known, see Figure 7.9. Consequently, SVD fittings were only illustratively performed 
from the data. For more details on SVD, the reader is referred to Section 8.1. 
 
Figure 7.9. The structure of menthol. Equally colored CH-bonds indicate that the bonds are parallel.  
The general trends of the extracted RDCs could be investigated though, and it was observed that the 
equatorial protons of the enantiomers had different signs in DMSO. This is a clear sign of 
enantiodiscrimination as the angle to the magnetic field must differ, independent of alignment 
strength. A similar trend of differentiation of the equatorial protons, although less pronounced, was 
determined from alignment in chloroform. Though the structure may not be fixed in space by SVD, 
the data suggested that the structure was aligned differently between the two solvents, from the sign 
of the RDCs of the axial protons. Reproducing the RDC results was more difficult in chloroform 
compared to DMSO, which may be contributed to rapid swelling in the solvent. This correlates well 
to an observation of the RDCs being markedly different if the insert in the tube had visibly moved. 
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All samples with a displaced insert were discarded, but small displacement, unnoticeable to the 
human eye cannot be dismissed.  
 
Figure 7.10. Comparison of RDCs from enantiomers of menthol in (L)-TEG-Phe/DMAA. Solvent is DMSO-d6 in a) and b), 
and chloroform in c) and d). In DMSO  three datasets were used for (+)-IPC and two for (-)-IPC. In CDCl3 two datasets were 
used for each. b) and d) displays values of (-)-menthol subtracted from (+)-menthol in rods cut from identical polymer sticks. 
A mean is displayed with standard deviation of three datasets for each enantiomer.*Omitted due to overlap with polymer 
resonances. **Overlaps with CH-7.  
The data was fitted using SVD, though the fit is underdetermined and the structure is placed due to 
minor difference in bond lengths and angles for parallel vectors in the chair-conformation. Thus 
experimental errors will have a huge effect. The difference in the experimental RDCs, defined as 
the generalized cosine β angle (GCB), between identical stereoisomers was 0.996±0.001 or 
4.8±0.8° and 0.943±0.007 or 19.3±1.3° between enantiomers, illustrated in Figure 7.11 by 3D 
structures of (+)-menthol turned into the alignment frames. The definition of GCB is given in 
Section 5.1.4 page 109. 
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Figure 7.11. Comparison of the alignment from RDCs of (+)- and (-)-menthol in DMSO-d6 aligned in (L)-TEG-Phe/DMAA. 
Both datasets were applied to the structure of (+)-menthol, green are (-)-menthol and blue (+)-menthol datasets. 
In conclusion, menthol was differentiated by alignment in the (L)-TEG-Phe polymer, especially 
apparent in DMSO, while the exact difference in alignment frame was not accurately determined. 
7.5.2 IPC 
The small molecule IPC was also investigated in DMSO and chloroform. Similar comments to 
those of menthol on the reproducibility between solvents may be made, and only the data from 
DMSO are presented.  
  
Figure 7.12. Structure of (+)-IPC. 
The RDCs of aligned enantiomers in DMSO are compared in Figure 7.13, with the dataset 
including three repetition for each enantiomer. The differences in observed RDCs were small, and 
again the differences in the used polymer sticks were eliminated by subtraction the RDCs of (-)-IPC 
from those of (+)-IPC, aligned in sticks cut from the same polymer. A pattern was identified, 
though the deviations were substantial compared to the observed differences. The GCB between 
enantiomers was determined to be 0.987±0.005, compared to 0.997±0.002 for identical compounds. 
This is equal to a difference in angle between alignment frames of 8.9±2.0° between enantiomers 
compared to 4.4±1.6° for identical compounds. It is thus not a significant differentiation, and it may 
be argued that the differences are too low to support enantiodiscrimination of IPC due to 
comparable differences between enantiomers and the reproducibility of the data. Compared to the 
GCB of PBLG, which have been reported as 0.991, the presented polymer seems to be a slightly 
better enantiodiscriminator, but exhibit less reproducibility, limiting the credibility.
189,192
 The 
alignment frames of the enantiomers are compared in Figure 7.14. 
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Figure 7.13 Comparison of RDCs from enantiomers of IPC in (L)-TEG-Phe/DMAA (left). Solvent is DMSO-d6. Right: Values 
of (-)-IPC subtracted from (+)-IPC in rods cut from identical polymer sticks. A mean is used with standard deviation of three 
datasets for each enantiomer.  
 
Figure 7.14. Comparison of the alignment from RDCs of (+)- and (-)-IPC in CDCl3 aligned in (L)-TEG-Phe/DMAA. Both 
datasets were applied to the structure of (+)-IPC, green are (-)-IPC and blue (+)-IPC datasets. The enantiomers are grouped 
in two, slightly overlapping groups. 
7.5.3 Enantiomeric polymers 
It is possible to synthesize monomers starting from both enantiomers of phenylalanine and it was 
thus possible to check whether e.g. strychnine, where only one enantiomer is readily available, 
could be differentiated by the polymers. Comparing RDCs from the D-polymer for (+/-)-menthol to 
data of the enantiomers from the L-polymer, indeed opposite RDCs were obtained, shown in Figure 
7.15, where RDCs of (-)-menthol in D-TEG-Phe are similar to those of (+)-menthol in L-TEG-Phe 
and vice versa. For the IPC enantiomers the result was less convincing, as seen in Table 7.1. An 
increase in the GCB of IPC enantiomers in different media was observed compared to identical 
compounds in identical media, especially for (+)-IPC in L-TEG-Phe and (-)IPC in D-TEG-Phe, 
where the difference nears the difference between the enantiomers in both polymers. While this 
translates to a difference in orientation between the enantiomeric polymers, identical trends in 
RDCs were observed. Again it would seem that the enantiomers of IPC were not significantly 
differentiated. This also shows that conclusions based on RDCs obtained between enantiomeric 
polymers needed to be made carefully. 
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Figure 7.15. Left: Comparison of RDCs from enantiomers of menthol in TEG-Phe/DMAA. Solvent is DMSO-d6. Grey (+) 
and white (-) are the enantiomers in L-Phe based polymers, while black (-) and red (+) are enantiomers in D-Phe based 
polymers. Right: Values of (-)-menthol subtracted from (+)-menthol in rods cut from identical polymer sticks. Grey is L-Phe 
and white is D-Phe based polymer. A single dataset for the enantiomers in D-Phe based polymers was used. 
Table 7.1. Comparison of the alignment tensors of enantiomers of IPC from L and D-variant of the TEG-Phe based 
alignment media. The comparison is performed by the GCB. Comparisons which should lead to equal alignment are marked 
in blue, and different alignments in red, if enantiodiscrimination is achieved. Dataset of L-polymers include three sets of 
RDCs for each enantiomer, for the D-polymer two are included. 
  L-Phe D-Phe 
  (+)-IPC (-)-IPC (+)-IPC (-)-IPC 
L
-P
h
e (+)-IPC 5.0±1.7° 8.9±2.0° 9.6±3.1° 8.2±2.0° 
(-)-IPC  1.7±1.5° 4.1±1.3° 9.9±2.2° 
D
-P
h
e (+)-IPC   6.4° 9.7±3.0° 
(-)-IPC    4.8° 
 
7.5.4 Strychnine 
As the enantiomeric polymers aligned single enantiomers differently, at least in the case of menthol, 
a theoretical differentiation of enantiomer of strychnine was approached, similar to the work of 
Schmidt et al.
210
 Not all one-bond vectors were used for comparison, as the resonance of C3-H3 
were overlapped with polymer resonances in the CLIP-HSQC spectra and the RDCs could not be 
determined. The resonances of C-15 were weak and slightly distorted compared to the other 
resonances and were omitted (the extracted RDCs were of equal size between all samples). The 
resonances of C-23 were not separated, in line with experiences from other media (Section 6.2). As 
a result 15 RDCs were extracted, and a difference was observed between the polymers based on L- 
and D-phenyl alanine, as illustrated in Figure 7.16.  
The data was based on a triple study, using three different L- and D-polymer sticks. While it was 
not possible to compare alignment from equal polymer sticks, as an identical enantiomer of 
strychnine was used throughout, the alignment was compared based on the succession of obtain 
data, i.e. polymer L1 is compared to D1, L2 to D2 and L3 to D3, in Figure 7.16. The used polymers 
sticks were synthesized from the same bulk reaction mixture, but polymerized in different tubes, as 
to take differences in polymerization into account. 
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Figure 7.16. Left: Comparison of RDCs from strychnine in (L)-TEG-Phe/DMAA (grey) and (D)-TEG-Phe/DMAA (white). 
Solvent is CDCl3. Right: Values obtained by subtracting polymer D1 from L1, D2 from L2 and D3 to L3. A mean is used with 
standard deviation of three datasets for each enantiomeric polymer. 
Rather big differences in RDCs between strychnine aligned in the two media were observed, and 
enantiodiscrimination was, cautiously, considered achieved. Examples of 1D slices through the 
CLIP-HSQC are found in Figure 7.17. 
 
Figure 7.17. 1D slices from a CLIP-HSQC of strychnine in (L)-TEG- Phe/DMAA (blue) and (D)-TEG-Phe/DMAA (red) and 
the differences in the RDCs between the polymers. The total coupling constants were determined by displacement of peaks 
and comparison to extracted J-coupling constants (isotropic spectra not shown). 
However, a problem was identified. While the SVD correlations of the experimental to back-
calculated data for IPC enantiomers were generally good, with Q-factors between 0.085 and 0.210 
(average 0.135), the correlation of the data to a strychnine 3D structure was bad, with Q-factors 
between 0.247 and 0.374 (average 0.314). It was investigated whether the problem could arise from 
the strychnine data being acquired at 800 MHz, compared to 400 MHz for IPC and menthol. When 
comparing datasets from 400 MHz to those of 800 MHz, the values varied slightly with an RMSD 
of 2.0 Hz, but the resulting correlation between experimental data and 3D structure was not 
improved compared to that of the 800 MHz data. Multiple resonances were less resolved at 400 
MHz, the reason for acquiring the dataset at 800 MHz initially, and if these RDCs are omitted in the 
comparison the RMSD is 1.1 Hz between the two field strengths. The cause of the large difference 
between experimental and back-calculated data was not identified, and the reproducibility 
contradicts a conclusion of the difference being a product of erroneous extraction of RDCs. Also 
known parallel vectors (e.g. C1-H1 and C4-H4) have equal RDCs, which initially indicated that 
experimental RDCs would fit back-calculated values.  
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When comparing alignment tensors, which will be less accurate due to the bad correlation between 
experimental RDCs and the SVD calculations, a difference between the two polymers was 
identified. The alignment frames from RDCs differ comparable to e.g. IPC in DMSO, with a GCB 
of 0.990±0.006 or 7.4±2.7° between identical media. Between different media the GCB was 
calculated to be much lower (resulting in a larger angle): 0.940±0.037 or 19.0±6.2°.   
 
Figure 7.18. Comparison of the alignment from RDCs of strychnine in (L)-TEG-Phe/DMAA (green) and (D)-TEG-
Phe/DMAA (orange).  
The alignment is markedly different compared to the PDMAA polymer, the pure polymer of the co-
polymer used with TEG-Phe, as seen in Figure 7.19. This may not be surprising due to the low 
amount of DMAA used in polymerization (10 mol% for strychnine). Back-calculation of RDCs in 
PDMAA placed the structure with the largest surface horizontal compared to the magnetic field, 
while the TEG-Phe polymer placed the largest surface parallel to B0, perhaps best envisioned by the 
sign of the RDCs of C1-H1 and C4-H4 in Figure 7.19. Since identical experimental procedures 
were followed, restricted swelling of 3 mm rods, this could translate to the TEG-chains extending 
from the surface with the analyte situated between the chains. The situations are illustrated by a 
cartoon in Figure 7.19. 
 
  
Figure 7.19. Left: Example of RDCs from strychnine aligned in PDMAA (grey) and (L)-TEG-Phe/DMAA (white). Right: A 
possible scenario of alignment which explains the differences in RDCs. Red figures are analytes, the grey surface is an near-
infinite polymer surface and the polymer side-chains and alignment of analytes are indicated. 
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When stretched in DMSO, the polymer aligned solutes, such as IPC and menthol, perpendicular to 
the results in chloroform and more alike to the DMAA polymer (which also swells in DMSO).  
 Perspectives 7.6
For RDCs to impact the small molecule community in regard to enantiodiscrimination a couple of 
challenges need to be addressed, none of which are solved by the polymers introduced in this thesis. 
The largest problem is the need for both enantiomers of an analyte in comparison, due to a low 
difference in alignment between enantiomers. This is a problem in determining an unknown 
absolute stereochemistry of e.g. a natural product. For this feat to be realized, RDCs need to be 
more integrated with computational chemistry. The possibility to couple computational chemistry to 
RDCs and determine the absolute stereochemistry has been disputed, and it is acknowledged that 
the technology is not yet available to achieve this.
244
  
If the difference in alignment is large between enantiomers, as for e.g. shown for IPC aligned in the 
acetylenes,
189,192
 and with further development of the methodology of Luy et al. where the 
alignment was determined including a polymer strand in simulation of strychnine, the possibilities 
are enticing.
245
 If simulations could capture the differences in interactions of enantiomers to a chiral 
polymer strand, it should be possible to determine the absolute stereochemistry from a single 
enantiomer. This would require a difference in theoretical GCB of more than the 10-20° determined 
in this study, to get useful and trustworthy results and to negate errors from simulations and 
determined RDCs. 
It would be interesting to investigate whether the TEG-Phe group, which showed better properties 
in stretched polymer, would retain those properties if utilized in LCs. This might be in LCs such as 
the acetylenes,
189,192
 where an LC that align molecules in both chloroform and DMSO might be 
obtained. A proposed synthesis is outlined in Figure 7.20.  
 
Figure 7.20. Possible synthetic route to obtain an acetylene-based LC that might work in DMSO and CDCl3, based on the 
stretched polymer work presented in this thesis. a) see experimental section. b)-d) see work of Krupp and Reggelin.
192
 
Also other LCs might be of interest. Griesinger et al. recently published a LC made of graphene 
oxide with attached polymer brushes made of trifluoroethyl methacrylate, which displayed very 
interesting properties such as very narrow line widths and effectively no residual polymer signals.
214
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The utilized solvent is DMSO, and due to the swelling properties, and thus solubility, of the TEG-
Phe polymer in this solvent, it could easily be envisioned as an enticing prospect of adding chirality 
to the achiral graphene sheets and possibly obtain enantiodiscrimination.  
Based on the assumption that the (L)-C10-Phe polymer failed to discriminate enantiomers due to a 
low amount of the chiral monomer incorporated into the polymers, it was not consistently tried to 
synthesize polymer with a molar fraction of TEG-Phe below 80 %. In retrospect, it might be that a 
lower degree of the larger chiral monomer would lead to better access to the chiral centers, and thus 
better differentiation. An optimal molar fraction of chiral monomer for differentiation may thus be 
lower than the ones tested, which should be investigated further. 
 Conclusions 7.7
In conclusion a polymer was identified that possess minor enantiodiscriminating properties 
comparable to PBLG in chloroform and DMSO. In principle a similar differentiation should be 
possible in methanol as the polymers align compounds in this solvent at an equal magnitude of 
alignment strength as DMSO, but this was not attempted. The line width might be problematic and 
further studies are needed to verify the differentiation. While being minor, the differentiation of 
enantiomers show promise and this is the first uncharged radical-initiated polymer that has been 
shown to possess enantiodiscriminative properties. As for all alignment media, it is still a 
requirement to have each enantiomer as a standard for comparison, which renders the technology 
difficult and slow to use compared to e.g. optical rotation, which will result in similar, and possibly 
more significant, information regarding absolute chemistry. 
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 Experimental 7.8
Synthesis of chiral polymers 
The chemicals used were commercially available and the solvents used were all HPLC grade. Dry 
solvents were obtained from. All flasks were dried over a Bunsen flame under vacuum before any 
reactant or solvent was added. All flasks (or NMR tubes) were equipped with a rubber septum, and 
chemicals were transported by syringe. All commercially bought monomers and crosslinkers 
(except N,N-methylenbisacrylamide which is a solid) were purified prior to the synthesis to remove 
the polymerization inhibitor by passing the neat liquid through a pipette filled with basic alumina. 
Preparation of (triethylene glycol methyl ether)-L-phenylalaninate 
 
10 g L-phenylalanine (61 mmol) was suspended in 250 mL toluene, followed by 10.4 mL 
triethylene glycol methyl ether (67 mmol) and 13.8 g p-toluenesulfonic acid monohydrate (73 
mmol). The suspension was fitted to with a Dean and Stark water trap and heated to reflux until the 
calculated amount of water was collected (2.4 mL). The mixture was concentrated to dryness under 
reduced pressure to yield a yellowish oil. 250 mL DCM was added and the solution washed with 
2x150 mL saturated aqueous sodium carbonate solution and once with 100 mL water, dried over 
Na2SO4 and concentrated to yield a yellowish oil. Yield: 15.6 g (75 %).  
 
[α]D
20
  = +28.1 (c = 0.006, MeOH). MS (ESI): m/z: 312.2 [M+H]
+
. m/z calcd. for C19H32NO2 
[M+H]
+
: 312.18. 
1
H NMR (CDCl3, 400 MHz, 298 K): δ = 2.19 (2H(1), m), 2.96 (1H(3b), dd, J=13.5,7.6 Hz), 3.15 
(1H(3a), dd, J=13.5,5.3 Hz), 3.40 (3H(15), s), 3.57 (2H(14), m), 3.68 (6H(11-13), m), 3.71 (2H(10), 
m), 3.83 (1H(2), broad-t, m), 4.30 (2H(9), t, J=4.8 Hz), 7.25 (2H(5), m), 7.26 (1H(7), m), 7.32 
(2H(6), m)  
13
C NMR (CDCl3, 125 MHz, 298 K): δ = 40.7 (C-3b) , 40.7 (C-3a) , 55.6 (C-2) , 59.0 (C-15) , 64.0 
(C-9) , 69.1 (C-10) , 70.7 (C-11-13) , 72.0 (C-14) , 127.0 (C-7) , 128.8 (C-6) , 129.4 (C-5) , 137.1 
(C-4) , 174.7 (C-8)  
Preparation of (triethylene glycol methyl ether)-D-phenylalaninate 
As for (triethylene glycol methyl ether)-L-phenylalaninate described above. 
 [α]D
20
  = -17.1 (c = 0.007, MeOH). 
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Preparation of (triethylene glycol methyl ether)-acryloyl-L-phenylalaninate 
 
4.5 g (Triethylene glycol methyl ether)-L-phenylalaninate (15 mmol) and 2.4 mL TEA (18 mmol) 
was added to 200 mL dry DCM in a flame dried round-bottomed flask under argon and the solution 
was cooled to 0 °C. 1.3 mL acryloyl chloride (16 mmol) was added drop wise over approximately 
30 min. The solution was kept at 0 °C for 2 h and was then left at rt for an additional 2 h. The 
solution was washed with 2x100 mL 0.5 M HCl and once with 50 mL water, dried over Na2SO4 and 
concentrated to a yellowish oil. Freeze dried to yield a white solid. Yield: 4.5 g (84 %).  
 
[α]D
20
  = +33.2 (c = 0.004, MeOH). MS (ESI): m/z: 366.2 [M+H]
+
. m/z calcd. for C19H32NO2 
[M+H]
+
: 366.19. 
1
H NMR (CDCl3, 400 MHz, 298 K): δ = 3.19 (2H(3), m), 3.35 (3H(15), s), 3.53 (2H(14), m), 3.64 
(6H(11-13), m), 3.68 (2H(10), m), 4.28 (2H(9), m), 4.99 (1H(2), dt, J=7.7,5.6 Hz), 5.65 (1H(18b), 
dd, J=10.3,1.3 Hz), 6.09 (1H(17), dd, J=17.0,10.3 Hz), 6.15 (1H(1), d, J=7.8 Hz), 6.28 (1H(18a), 
dd, J=16.9,1.4 Hz), 7.12 (2H(5), dd, J=7.8,1.2 Hz), 7.23 (1H(7), m), 7.26 (2H(6), m) 
13
C NMR (CDCl3, 125 MHz, 298 K): δ = 37.7 (C-3), 53.1 (C-2), 58.9 (C-15), 64.6 (C-9), 68.8 (C-
10), 70.6 (C-11-13), 71.9 (C-14), 127.1 (C-7), 127.2 (C-18), 128.7 (C-6), 129.3 (C-5), 130.5 (C-17), 
135.7 (C-4), 164.8 (C-16), 171.5 (C-8) 
Preparation of (triethylene glycol methyl ether)-acryloyl-D-phenylalaninate 
As for (triethylene glycol methyl ether)-acryloyl-L-phenylalaninate described above. 
[α]D
20
  = -24.7 (c = 0.003, MeOH). 
Preparation of poly-(triethylene glycol methyl ether)-acryloyl-L-phenylalaninate/N,N-
dimethyl acrylamide (p-TEGPhe/DMAA) 
0.533 g of (Triethylene glycol methyl ether)-acryloyl-L-phenylalaninate (1.5 mmol) was dissolved 
in 0.7 mL CDCl3. 0.2 mL N,N-dimethylacrylamide (0.1 mmol) and 3.4 mg N,N-
methylenbisacrylamide (0.01 mmol) was added. 1.5 mg AIBN (0.001 mmol) was added and N2 
bubbled through the solution for 5 minutes to remove O2. The solution was transferred to 3 mm (or 
5 mm) NMR tubes. Air was removed under vacuum and N2 backfilled into the tubes three times and 
the tubes were left at 60 °C overnight (approx. 14-16 h) to polymerize. 
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Preparation of decyl-L-phenylalaninate 
10 g L-phenylalanine (61 mmol) was suspended in 250 mL toluene, followed by 12.7 mL decanol 
(67 mmol) and 13.8 g p-toluenesulfonic acid monohydrate (73 mmol). The suspension was fitted to 
with a Dean and Stark water trap and heated to reflux until the calculated amount of water was 
collected (2.3 mL). The mixture was concentrated to dryness under reduced pressure to yield a 
yellowish oil. 250 mL DCM was added and the solution washed with 2x150 mL saturated aqueous 
sodium carbonate solution and once with 100 mL water, dried over Na2SO4 and concentrated to 
yellowish oil. Re-crystalized from EtOH twice. Yield: 10.0 g (HCl salt) (48.3 %). 
 
[α]D
20
  = +14.7 (c = 0.008, CHCl3). MS (ESI): m/z: 306.2 [M+H]
+
. m/z calcd. for C19H32NO2 
[M+H]
+
: 306.24. 
1
H NMR (CDCl3, 400 MHz, 298 K): δ = 0.88 (3H(18), t, J=7.0), 1.19-1.35 (14H(11-17), m), 1.59 
(2H(10), m), 2.53 (2H(1), broad s), 2.94 (1H(3a), dd, J=13.7,7.7), 3.11 (1H(3b), dd, J=13.6,5.7), 
3.80 (1H(2), dd, J=7.3,5.6), 4.09 (2H(9), t, J=6.7 Hz), 7.17-7.33 (5H(5-7), m) 
13
C NMR (CDCl3, 125 MHz, 298 K): δ = 14.2 (C-18), 22.4 (C-17), 25.7, 29.3, 31.8 (C-11-16), 28.4 
(C-10), 40.3 (C-3), 55.4 (C-2) , 65.2 (C-9) , 126.8, 128.5, 129.2 (C-5-7), 136.6 (C-4), 174.1 (C-8) 
Preparation of decyl-acryloyl-L-phenylalaninate 
1.5 g decyl-L-phenylalaninate (4.9 mmol) and 0.82 mL TEA (5.9 mmol) was added to 200 mL dry 
DCM in a flame dried round-bottomed flask under argon and the solution was cooled to 0 °C. 0.44 
mL acryloyl chloride (5.4 mmol) was added drop wise over approximately 30 min. The solution 
was kept at 0 °C for 2 h and was then left at rt for an additional 2 h. The solution was washed with 
2x100 mL 0.5 M HCl and once with 50 mL water, dried over Na2SO4 and concentrated to white 
solid. Yield: 1.77 g (95.2 %).  
 
[α]D
20
  = +17.2 (c = 0.005, CHCl3). MS (ESI): m/z: 360.3 [M+H]
+
. m/z calcd for C22H34NO3 
[M+H]
+
: 360.25. 
1
H NMR (CDCl3, 400 MHz, 298 K): δ = 0.89 (3H(18), t, J=7.1), 1.20-1.35 (14H(11-17), m), 1.59 
(2H(10), m), 3.17 (2H(3), m), 4.11 (2H(9), m), 4.96 (1H(2), dt, J=7.7,5.8 Hz), 5.68 (1H(20a), dd, 
J=10.3,1.4 Hz), 6.02 (1H(1), d, J=7.4 Hz), 6.09 (1H(19), dd, J=17.0,10.3 Hz), 6.29 (1H(20b), dd, 
J=16.9,1.3 Hz), 7.09 (2H(5), m), 7.22-7.31 (3H(6-7), m) 
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13
C NMR (CDCl3, 125 MHz, 298 K): δ = 13.8 (C-18), 22.4 (C-17), 25.7, 29.3, 31.8 (C-11-16), 28.3 
(C-10), 37.9 (C-3), 52.9 (C-2) , 65.8 (C-9) , 127.1 (C-20), 127.2, 128.5 (C-6-7), 129.2 (C-5), 130.3 
(C-19), 135.7 (C-4), 164.6 (C-16), 171.8 (C-8) 
Preparation of poly-decyl-acryloyl-L-phenylalaninate/N,N-dimethyl acrylamide (p-
C10Phe/DMAA) 
1.93 g of decyl-acryloyl-L-phenylalaninate (5.4 mmol) was dissolved in 1.5 mL CDCl3. 1.5 mL 
N,N-dimethylacrylamide (14.6 mmol) and 13.0 mg N,N-methylenbisacrylamide (0.08 mmol) was 
added. 2.9 mg AIBN (0.002 mmol) was added and N2 bubbled through the solution for 5 minutes to 
remove O2. The solution was transferred to 3 mm (or 5 mm) NMR tubes. Air was removed under 
vacuum and N2 backfilled into the tubes three times and the tubes were left at 60 °C overnight 
(approx. 14-16 h) to polymerize. 
Preparation of (R)-N-(1-phenylethyl)-acrylamide 
2.86 g (R)-1-phenylethylamine (23.5 mmol) and 3.9 mL TEA (28.3 mmol) was added to 200 mL 
dry DCM in a flame dried round-bottomed flask under argon and the solution was cooled to 0 °C. 
2.11 mL acryloyl chloride (25.9 mmol) was added drop wise over approximately 30 min. The 
solution was kept at 0 °C for 2 h and was then left at rt for an additional 2 h. The solution was 
washed with 2x100 mL 0.5 M HCl and once with 50 mL water, dried over Na2SO4 and 
concentrated in vacuo to yield a white solid. Yield: 4.03 g (97.6 %).  
 
[α]D
20
  = +22.2 (c = 0.009, MeOH). MS (ESI): m/z: 176.1 [M+H]
+
. m/z calcd for C11H14NO 
[M+H]
+
: 176.11. 
1
H NMR (DMSO-d6, 400 MHz, 298 K): δ = 1.38 (3H(3), d, J=7.3), 5.0 (1H(2), p, J=7.5), 5.60 
(1H(10a), dd, J=10.1,2.2), 6.08 (1H(10b), dd, J=17.1,2.2), 6.29 (1H(9), dd, J=17.1,10.2), 7.21 (1H, 
m), 7.29-7.39 (4H(5-6), m), 7.76 (1H(1), d, J=7.8 Hz) 
13
C NMR (CDCl3, 125 MHz, 298 K): δ = 22.7 (C-3), 48.2 (C-2), 125.7 (C-10), 126.4 (C-5), 127.2 
(C-7), 128.7 (C-6), 132.2 (C-9), 144.9 (C-4), 163.9 (C-8) 
Preparation of poly-(R)-N-(1-phenylethyl)-acrylamide/N,N-dimethyl acrylamide (p-
PhEtN/DMAA) 
0.23 g of (R)-N-(1-phenylethyl)-acrylamide (1.3 mmol) was dissolved in 0.2 mL acetone-d6. 0.25 
mL N,N-dimethylacrylamide (2.4 mmol) and 2.7 mg N,N-methylenbisacrylamide (0.02 mmol) was 
added. 2.8 mg AIBN (0.002 mmol) was added and N2 bubbled through the solution for 5 minutes to 
remove O2. The solution was transferred to 3 mm (or 5 mm) NMR tubes. Air was removed under 
vacuum and N2 backfilled into the tubes three times and the tubes were left at 60 °C overnight 
(approx. 14-16 h) to polymerize. 
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Preparation of (S)-1-phenylethyl methacrylate 
2.0 mL (S)-1-phenylethanol (16.5 mmol) and 2.8 mL TEA (19.9 mmol) was added to 200 mL dry 
DCM in a flame dried round-bottomed flask under argon and the solution was cooled to 0 °C. 1.8 
mL methacryloyl chloride (18.2 mmol) was added drop wise over approximately 30 min. The 
solution was kept at 0 °C for 2 h and was then left at rt for an additional 2 h. The solution was 
washed with 2x100 mL 0.5 M HCl and once with 50 mL water, dried over Na2SO4 and 
concentrated in vacuo to yield a reddish oil. Yield: 2.54 g (80.5 %).  
 
[α]D
20
  = -29.4 (c = 0.008, MeOH). MS (ESI): m/z: 191.1 [M+H]
+
 m/z calcd for C12H15O2 [M+H]
+
: 
191.11.  
1
H NMR (CDCl3, 400 MHz, 298 K): δ = 1.50 (3H(3), d, J=6.7), 1.89 (3H(11), broad s), 5.49 
(1H(10a), p, J=1.7), 5.87 (1H(2), q, J=6.6), 6.08 (1H(10b), dq, J=1.6,0.8), 6.29 (1H(9), dd, 
J=17.1,10.2), 7.21 (1H, m), 7.24-7.32 (4H(5-6), m) 
13
C NMR (CDCl3, 125 MHz, 298 K): δ = 18.3 (C-11), 22.3 (C-3), 72.4 (C-2), 125.4 (C-10), 126.0 
(C-5), 127.8 (C-7), 128.5 (C-6), 136.6 (C-9), 141.7 (C-4), 166.6 (C-8) 
Preparation of poly-(S)-O-(1-phenylethyl)-methacrylate (p-PhEtO) 
0.57 g of (S)-1-phenylethyl methacrylate (3.0 mmol) was dissolved in 0.17 mL acetone-d6. 1.4 μL 
EGDMA (0.007 mmol) was added. 1.3 mg AIBN (0.001 mmol) was added and N2 bubbled through 
the solution for 5 minutes to remove O2. The solution was transferred to 3 mm (or 5 mm) NMR 
tubes. Air was removed under vacuum and N2 backfilled into the tubes three times and the tubes 
were left at 60 °C overnight (approx. 14-16 h) to polymerize. 
Swelling of polymers 
See Section 6.4 regarding polymers from 3 mm NMR tubes. If the inserted plug visibly moved 
during swelling the sample was excluded from the study of chiral polymers, due to an observed 
large error between alignments of equal enantiomers when this happened. RDCs could still be 
extracted though so this is not a problem for achiral polymers.  
Also see Section 6.4 for information regarding synthesis of the PDMAA polymer. All other 
necessary information is available in figures and tables throughout this chapter. 
NMR experiments 
The CLIP-HSQC experiments was used for the determination of one-bond CH coupling constants, 
using standard setup as described in Appendix A1. The concentration of analytes was ~150 mM for 
isotropic samples and ~220 mM (strychnine) or ~320 mM (IPC/menthol) for aligned samples. 
Simulations 
Structures were generated by the modelling suite Maestro version 10.2.010 (2015) by Schrödinger 
for force field calculations,
126
 using the program MacroModel version 10.8.
127,128
 The MMFFs force 
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field was used. To generate structures which should cover the conformational space of compounds, 
a conformational search was performed for each structure by the program MacroModel using 
energy cutoff of 50 kJ/mol, 100,000 steps and CPRG minimization.
127,129
  
Gaussian version 09 revision B.01 was used for DFT calculations including optimizations and NMR 
calculations.
131
 Structures were optimized to a B3LYP/6-31(d) level of theory. 
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8 Tensor free RDC calculations 
For the theoretical basis of RDCs, the reader is referred to Chapter 5. The theory behind the actual 
back-calculations of RDCs from experimental data and 3D structures will be described briefly 
below to introduce a new method of back-calculation. The introduction will focus entirely on 
singular value decomposition (SVD), since this is by far the most utilized method in small molecule 
RDC calculations. To support a possible need for a new back-calculation method, it is important to 
understand the basics of SVD and the advantages and disadvantages involved when using this 
method.  
 Singular value decomposition 8.1
Losonczi et al. described the mathematical basis of the SVD method for back-calculation of RDCs 
of macromolecules.
202
 Here the principles of SVD are included in equations (8.1) to (8.12).  
Tensors in RDC calculations are based on an expanded form of equation (5.2), Section 5.1. Here, 
the alignment frame is allowed to shift in comparison to the direction of the magnetic field (usually 
chosen as the z-axis) and now includes an axial (Aa) and rhombic (Ar) component, see equation 
(8.1).
197,203,204,246
 
 𝐷𝐼𝑆 = −
ℏ𝛾𝐼𝛾𝑆𝜇0
16𝜋2𝑟𝐼𝑆
3 [𝐴𝑎(3cos
2𝜃𝐼𝑆 − 1) +
3
2
𝐴𝑟sin
2𝜃𝐼𝑆 cos 2𝜑𝐼𝑆] (8.1) 
Where γ is the gyromagnetic ratio, ℏ is the Planck constants divided by 2π, μ0 is the vacuum 
permeability constant, r is the cubed distance between the nuclei and θ is the angle between the 
internuclear vector and the magnetic field. φ is the azimuthal angle that describes the projection of 
the RDC vector to the xy-plane with respect to the x-axis, as illustrated Figure 8.2, left. 
This will lead to an averaging of the internuclear vectors positioned along the x-axis and is needed 
to unambiguously place the molecules in the alignment frame. Four possible alignments are always 
present due to equal theoretical RDCs of the alignments as illustrated in Figure 8.1.  
 
Figure 8.1. The four positions of a 
molecule (here represented by 
three vectors) which will give 
equal RDC values from tensor 
RDC calculations. All of the 
indicated rotations are 180° 
around the axis. 
 
8.1  Singular value decomposition 
 
 
140 
In Figure 8.2 left, the direction of the magnetic field is along the z-axis, and the length of the a 
vector will serve as the degree of alignment (Aa). But the direction of the magnetic field will also be 
along the x-axis to some degree, and the length of b determines how much it is aligned here (Ar). 
The probability, or degree, of the shift is given by the rhombicity (R) given in equation (8.1). 
 
Figure 8.2. Left: The scaling vectors and angles involved in the extended formula for tensor RDC calculations, equation (8.1). 
Right: The molecular axis compared to the direction of the magnetic field, including the angles used in SVD fitting. The 
angles θ are the angles between the molecular axis and the magnetic field, and the angles φ are the angles between an 
internuclear vector and the molecular axis, see equations (8.1) to (8.12). 
Without introducing the rhombicity, the theoretical fit between experimental and back-calculated 
data would be worse for most alignments since some averaging is present in the experimental data, 
and the compound would not be specifically placed in space but only by an angle to the magnetic 
field with free rotation around the magnetic field vector. An experimental dataset which back-
calculates to a structure with a low rhombicity is thus averaged less along the x-axis than a structure 
with a high rhombicity.  
 𝐴𝑎 =
𝑆𝑧𝑧
2
 (8.2) 
 𝐴𝑟 =
1
3
(𝑆𝑥𝑥 − 𝑆𝑦𝑦) 
(8.3) 
 𝑅 =
𝐴𝑟
𝐴𝑎
=
2
3
𝑆𝑥𝑥 − 𝑆𝑦𝑦
𝑆𝑧𝑧
 (8.4) 
To establish a tensor the equations (8.1)-(8.4) are used to produce an order matrix as a 
representation of the anisotropic averaging leading to dipolar couplings, given in equation (8.5) and 
(8.6) Figure 8.2, right is a good reference to keep track of the angles used in the following. 
 𝐴 = [
𝑆𝑥𝑥 𝑆𝑥𝑦 𝑆𝑥𝑧
𝑆𝑦𝑥 𝑆𝑦𝑦 𝑆𝑦𝑧
𝑆𝑧𝑥 𝑆𝑧𝑦 𝑆𝑧𝑧
] (8.5) 
 𝑆𝑖𝑗 = 〈3cos𝜃𝑖cos𝜃𝑗 − 𝑘𝑖𝑗〉 (8.6) 
Where kij is the Kronecker delta (kij = 1 if i = j and kij = 0 if i ≠ j). The matrix is symmetric (Sij = Sji) 
and traceless (Sxx + Syy + Szz = 0). Thus only five elements are needed to obtain the full matrix A, 
chosen to be Syy, Szz, Sxy, Sxz and Syz. The five elements translate to three angles (which need to be 
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non-parallel) the alignment strength and the rhombicity. The equations (8.5) and (8.6), if used 
directly on a 3D structure, suppose a situation where the alignment frame and the molecular frame 
have an identical orientation which is not generally true. To correlate the molecular frame to the 
alignment frame, the equation is thus extended into equation (8.7) and further to (8.8) where φi is 
angle between the two frames. 
 𝐷
𝑚 = 𝐷𝑚𝑎𝑥
𝑚 ∑ 𝑆𝑖𝑗cos𝜑𝑖
𝑚cos𝜑𝑗
𝑚
𝑖𝑗=𝑥,𝑦,𝑧
 (8.7) 
 𝐷𝑟𝑒𝑑
𝑚 =
𝐷𝑚
𝐷𝑚𝑎𝑥
𝑚 = ∑ 𝑆𝑖𝑗cos𝜑𝑖
𝑚cos𝜑𝑗
𝑚
𝑖𝑗=𝑥,𝑦,𝑧
 (8.8) 
Where D
m
max is -μ0γIγSℏr
-3
/(16π2). This equation is then used to setup a set of linear equations, as 
seen in (8.9). Note that the φ angles are always known from a 3D structure and the matrix is easily 
established. 
 [
𝐷𝑟𝑒𝑑
1
⋮
𝐷𝑟𝑒𝑑
𝑛
] =
[
 
 
 
 
𝑆𝑦𝑦
𝑆𝑧𝑧
𝑆𝑥𝑦
𝑆𝑥𝑧
𝑆𝑦𝑧]
 
 
 
 
[
𝑐𝑜𝑠2𝜑𝑦
1 − 𝑐𝑜𝑠2𝜑𝑥
1 𝑐𝑜𝑠2𝜑𝑧
1 − 𝑐𝑜𝑠2𝜑𝑥
1 2𝑐𝑜𝑠𝜑𝑥
1𝑐𝑜𝑠𝜑𝑦
1
⋮ ⋮ ⋮
𝑐𝑜𝑠2𝜑𝑦
𝑛 − 𝑐𝑜𝑠2𝜑𝑥
𝑛 𝑐𝑜𝑠2𝜑𝑧
𝑛 − 𝑐𝑜𝑠2𝜑𝑥
𝑛 2𝑐𝑜𝑠𝜑𝑥
1𝑐𝑜𝑠𝜑𝑦
𝑛
    
2𝑐𝑜𝑠𝜑𝑥
1𝑐𝑜𝑠𝜑𝑧
1 2𝑐𝑜𝑠𝜑𝑦
1𝑐𝑜𝑠𝜑𝑧
1
⋮ ⋮
2𝑐𝑜𝑠𝜑𝑥
1𝑐𝑜𝑠𝜑𝑧
𝑛 2𝑐𝑜𝑠𝜑𝑦
1𝑐𝑜𝑠𝜑𝑧
𝑛
] (8.9) 
For n > 5 the system will be overdetermined, while it will be unsolvable for n < 5. As a 
consequence, RDCs of five non-parallel vectors are needed to describe a system using this method. 
If n = 5 the system is solvable as five equations with five unknowns, but this situation is not 
particularly interesting as one could in principle fit almost anything to “perfection”. Thus SVD was 
introduced as a mean to solve the overdetermined set of linear equations, and to find the order 
tensor with the best overall fit to the data in a least square sense. 
It is used that the N×M matrix [B] in equation (8.10), from the matrix in (8.9), may be described by 
the product of an M×N matrix [U], an N×N diagonal matrix [W], with non-negative diagonal 
elements, and the transpose of a N×N orthogonal matrix [V], which allows the definition of [B]
-1
 as 
can be seen in equation (8.11).  
 [
𝐷𝑟𝑒𝑑
1
⋮
𝐷𝑟𝑒𝑑
𝑛
] =
[
 
 
 
 
𝑆𝑦𝑦
𝑆𝑧𝑧
𝑆𝑥𝑦
𝑆𝑥𝑧
𝑆𝑦𝑧]
 
 
 
 
[𝐵] (8.10) 
 [𝐵] = [𝑈] [
𝜔1 0 0
0 ⋱ 0
0 0 𝜔𝑛
] [𝑉𝑇]  ↔  [𝐵]−1 = [𝑉][𝑑𝑖𝑎𝑔(1/𝜔𝑖)][𝑈]
𝑇 (8.11) 
This may then be used to solve equation (8.9) as equation (8.12). 
 
[
 
 
 
 
𝑆𝑦𝑦
𝑆𝑧𝑧
𝑆𝑥𝑦
𝑆𝑥𝑧
𝑆𝑦𝑧]
 
 
 
 
= [
𝐷𝑟𝑒𝑑
1
⋮
𝐷𝑟𝑒𝑑
𝑛
] [𝑉][𝑑𝑖𝑎𝑔(1/𝜔𝑖)][𝑈]
𝑇 (8.12) 
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SVD is implemented as a function in mathematical programs such as Matlab
®
, making the 
decomposition easy.
247
 
The result is a least square fit of the experimental data to the 3D structure, which will rotate the 
structure into the alignment frame and scale the RDC values according to the experimental data.
202
 
It is thus a back-calculation method where a 3D structure is needed to determine the order tensors. 
For rigid structures SVD works very well and is a powerful, albeit simple, tool in macromolecular 
and small molecule work alike.
187,195,197,248
 
The drawback of this method is evident only if investigating flexible compounds. The arising 
problems are caused by establishing order tensors in the first place and are not a flaw in the SVD 
fitting as such. Since order tensors will determine a rotation of the structure the implementation for 
multiple structures is not straightforward but may still be approached. In general two methods have 
been applied; the multi conformer multi tensor (MCMT) and multi conformer single tensor (MCST) 
methods.
248
 The MCMT method builds on the assumption that one may describe the orientation of 
flexible systems by obtaining order tensors for each conformer. As this method involves multiple 
order tensors, 5n RDCs are needed per conformation, with n being the number of conformers of the 
system.
202
 This approach is thus rarely feasible for flexible small molecules.
202,248
 
8.1.1 Multi conformer single tensor 
The MCST method assumes that a single tensor is sufficient to describe the alignment of all 
conformers.
248
 In other words it is assumed, that all conformers are aligned equally in space – or at 
least parts of the conformers. This may be a good approximation in certain situations, when the 
structural flexibility is limited to small groups in regard to an overall structure or to small 
movements. This is an obvious limitation, since a reference frame needs to be established and all 
structures are linked to this reference frame when rotated into the alignment frame.
248
 The resulting 
back-calculated RDCs are thus dependent on the original overlay of the input structures, and parts 
of the molecule need to be identified that are independent in the orientation in space between the 
conformers. While a rigid part may be identified for the majority of organic compounds (if not a 
different set of problems will be more pressing in 3D structure determination) it may be harder to 
identify a part of a molecule that, independent of conformation, is situated evenly in space 
compared to the rest of the structure. A general approach to identify the optimal overlay of 
structures has yet to be reported. An approach could be to overlay vectors with the largest absolute 
RDCs, as these are probably the most static in their orientation to B0. Whether this is better than e.g. 
identifying large static surfaces of the compound is not known, and was not thoroughly 
investigated. 
The methodology is thus limited to specific cases and over-interpretation is deceptively easy, which 
will be showed vide infra. It may be implemented in different ways; here the focus will on be the 
implementation utilized in the program MSPIN.
204
 Here the population is iteratively fitted to the 
experimental RDCs, by constructing alignment tensors from the populations and the evaluating the 
correlation of experimental and calculated RDCs.  
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8.1.2 RDCs of methylene and methyl groups 
When dealing with overlying resonances such as methylene groups that do not split and methyl 
groups, various methods have been proposed to back-calculate the RDCs.  
1
DCH3 values are usually obtained from spectra and, while not immediately useful, are converted to 
the associated 
1
DCCH3 coupling constant, which is easier to implement in the given types of back-
calculations. This is achieved by assuming a 3-jump model and that the methyl group is a perfect 
tetrahedral in equation (8.13).
249,250
 This assumption makes a conversion from a theoretical CH 
vector to the actual CC vector possible using equation (8.14). 
 𝐷1 𝐶𝐻3 =
3cos2𝜑 − 1
2
𝐷∥ = −
1
3
𝐷∥ 
(8.13) 
 𝐷1 𝐶𝐶𝐻3 =
𝛾𝐶
𝛾𝐻
𝑟𝐶𝐻
3
𝑟𝐶𝐶3
𝐷∥ → 𝐷∥ = −
3𝛾𝐶
𝛾𝐻
𝑟𝐶𝐻
3
𝑟𝐶𝐶3
𝐷1 𝐶𝐻3 
(8.14) 
Where φ is the angle of the CH vector and the rotation axis of the methyl group, D|| is a virtual CH 
vector pointing in the direction of the CC vector, γ is the gyromagnetic ratio and r is the length of 
the corresponding bonds. 
For methylene groups it has been shown that if an average coupling constant is extracted, the data 
may still be used in the fitting of experimental data to 3D structures, by calculating the theoretical 
average from the individual CH vectors.
208
 
 Tensor free calculations of RDCs 8.2
Tensor free calculation of RDCs, also dubbed the ϑ-method, has been shown to work well for 
macromolecules but has not directly been adopted in the small molecule community.
251,252
 In a 
publication by Luy et al. in 2015, a resembling although different methodology is utilized.
245
 For 
macromolecules the ϑ-method is used implicitly in the 3D structure generation as constraints.251,252 
This is not necessarily wanted for small molecules due to similar reasons as discussed in e.g. 
Section 3.3.1 for NOE calculations: In short, the use of constrains may limit or disturb the 
conformational space. 
We thus set out to translate the method into one more suitable for conformational investigation of 
small molecules. In the following description this method is called the θ-method, for distinction and 
recognition of inspiration.
251,252
 
 The θ-method 8.3
The θ-method is simplistic in its origin; it utilizes only the standard equation for dipolar couplings, 
equation (8.15) reiterated from equation (5.2) Section 5.1, with no tensors to correlate the alignment 
frame to the molecular frame, as shown in Figure 8.2.  
 𝐷𝐼𝑆 = −
ℏ𝛾𝐼𝛾𝑆𝜇0
16𝜋2
〈
1
𝑟𝐼𝑆
3 (3cos
2𝜃𝐼𝑆 − 1)〉  (8.15) 
This equation may be shortened to (8.16). 
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  𝐷𝐼𝑆 = 𝐷𝑚𝑎𝑥
𝐼𝑆 𝐷𝑎〈3cos
2𝜃𝐼𝑆(𝑅) − 1〉 = 𝐷𝑚𝑎𝑥
𝐼𝑆 𝐷𝑎∫𝑃(𝑅)(3cos
2𝜃𝐼𝑆(𝑅) − 1)𝑑𝑅  
(8.16) 
R covers external (rotational) and intramolecular (conformational) motion, Da is the degree of 
alignment and κ is the constants of (8.16) assuming that only 1DCH data is used and r is constant. If 
this is not the case the equation is expanded to (8.17).  
   𝐷𝐼𝑆 = 𝐷𝑟,𝑚𝑎𝑥
𝐼𝑆 𝐷𝑎 〈
3cos2𝜃𝐼𝑆(𝑅) − 1
𝑟(𝑅)3
〉 = 𝐷𝑟,𝑚𝑎𝑥
𝐼𝑆 𝐷𝑎∫𝑃(𝑅) (
3cos2𝜃𝐼𝑆(𝑅) − 1
𝑟(𝑅)3
)𝑑𝑅 (8.17) 
This may in principle be solved if all conformers and a rotational preferences are known. Luy et al. 
showed this approach worked on a system where strychnine was simulated in the presence of a 
polymer strand which induced overall alignment.
245
 
Instead of including explicit orienting media in the simulations or orienting the molecular frame to 
an alignment frame, a novel approach was taken; all conformers from a simulation are rotated in 
space, using rotation matrices as in (8.18).  
 𝑅𝑜𝑡𝑧(𝜑) = [
𝑐𝑜𝑠𝜑 −𝑠𝑖𝑛𝜑 0
𝑠𝑖𝑛𝜑 cos 𝜑 0
0 0 1
] , 𝑅𝑜𝑡𝑥(𝜔) = [
1 0 0
0 𝑐𝑜𝑠𝜑 −𝑠𝑖𝑛𝜑
0 𝑠𝑖𝑛𝜑 cos 𝜑
] (8.18) 
To get full rotational sampling in 3D space compared to one axis (here z), a combination of only 
two matrices are needed; x and y, x and z or y and z (for similar reasons as outlined in Figure 8.1). 
Here, x and z were chosen, so that the first rotation is around the z axis, which is also the chosen B0 
axis, and the second rotation is around the x axis, as illustrated in Figure 8.3. In practice, one of the 
rotations only needs to be 180° as to avoid repeating magnetic field angles, while the other is 360°. 
 
Figure 8.3. An illustration showing the effect of z- and subsequent x-rotation on an internuclear vector. While the angle to the 
magnetic field is equal for all vectors after z-rotation, the angle is different for the vectors after equal x-rotation (unless a 
vector is parallel to z-axis). 
The angle of the RDC vectors from the rotated coordinates to the magnetic field was then 
determined along with the length of the vector, which in most cases is constant since 
1
DCH-coupling 
constants are used. From the length and angle RDCs of all conformers and rotations are easily 
calculated after Da is determined, vide infra. The RDC data sets of the rotated structures are then 
fitted to the data iteratively, by minimizing the Q-factor (Q) in (8.19), using only the conformations 
and rotations that lead to an increased correlation of the found average RDCs to the experimental. 
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 𝑄 =
∑ 𝐷𝑖
𝑐𝑎𝑙𝑐 − 𝐷𝑖
𝑒𝑥𝑝
𝑖
∑ 𝐷𝑖
𝑒𝑥𝑝
𝑖
, 𝐷𝑖
𝑐𝑎𝑙𝑐 =
∑ 𝐷𝑖,𝑛
𝑐𝑎𝑙𝑐
𝑛
𝑛
 (8.19) 
Thus, all conformers may be aligned differently, if the data permits. This is at a first glance a 
possibly problematic approach with multiple open questions:  
1. Would the approach give reasonable fits between experimental data and 3D structures?  
2. Would the calculation procedure make it possible to discern stereoisomers?  
3. And most importantly, will this method fit populations of flexible compounds?  
The easiest way to verify the method is to test it on a compound where the answer is already known 
and return to rigid compounds to establish prove of concept. Multiple tests were thus conducted on 
multiple data sets of strychnine, vide infra. 
If long-range RDCs were needed the length of the vector of the different conformations need to be 
calculated and averaged as well. This was in practice easily implemented by incorporating the 
distance information into the theoretical RDCs, as in equation (8.17). 
 Estimating Da 8.4
As mentioned above the strength of alignment needed to be determined or estimated. Here 
inspiration from macromolecular  literature was used.
253
 The difference of the approach taken here 
lies in the fact that Da is not used for tensor determination and is not split into an axial (Da) and a 
rhombic component (Dr) and the rhombicity is thus not estimated as it is not needed due to implicit 
inclusion in tensor free calculations. Even though the two Da parameters are used differently, their 
contribution to the calculations is equal in giving the maximum possible values of the RDCs, and 
they may be cautiously compared. 
Initially it is assumed that the vectors in the molecules are non-parallel and of equal length (neither 
assumptions are strictly necessary, but simplify the following)
VII
, and that at least one random 
vector is either parallel or perpendicular to the magnetic field, B0. That particular vector would then 
have the minimum (Dexp,min) or maximum (Dexp,max) experimental RDC respectively from equation 
(8.15) or (8.16). From the equation it is evident that the equations in (8.20) are true, as the constant 
k covers all other contributions to the RDCs than the angle to the magnetic field. 
 
 𝐷𝑒𝑥𝑝,𝑚𝑖𝑛=−𝑘 (3cos
2𝜃𝐼𝑆−1)=−𝑘 (3cos
20−1)=−2𝑘  
𝐷𝑒𝑥𝑝,𝑚𝑎𝑥 = −𝑘(3cos
2𝜃𝐼𝑆 − 1) = −𝑘(3cos
2𝜋 − 1) = 1𝑘 
𝐷𝑒𝑥𝑝,𝑚𝑎𝑥 = −𝐷𝑒𝑥𝑝,𝑚𝑖𝑛 2⁄  
𝑅𝐷 = −𝐷𝑒𝑥𝑝,𝑚𝑖𝑛 2𝐷𝑒𝑥𝑝,𝑚𝑎𝑥⁄  
(8.20) 
                                                 
 
VII
 If all vectors are parallel, Da may not be estimated, but the angles between internuclear vectors 
(which are already known) may in principle be solved and the molecule will be fitted with all 
internuclear vectors either parallel of perpendicular to the magnetic field, dependent on the sign of 
the RDCs.   
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From these equations Da may be estimated; if RD > 1 then Da is -Dexp,min/2, and if RD ≤ 1, Da is 
Dexp,max, divided by Dmax of the given vector. The determined Da is thus the minimum Da that could 
possibly lead to the experimental data. It is crude, but may be refined later if needed by up- or 
down-scaling Da. It is assumed that Da is equal for all conformers. This approximation is actually a 
prerequisite for most RDC back-calculation theory; it translates to assuming that the interaction 
with the alignment media is independent of conformation, and thus does not influence the 
conformational average. Since that requirement is necessary to obtain any meaningful 
conformational data from RDCs this assumption is hopefully upheld. There is a larger possibility of 
finding a vector that is perpendicular to the magnetic field, easily realized by the fact that the 
probability of finding a vector with an angle θ to the magnetic field is proportional to sinθ.11,253 This 
is generally not considered in the following, since the value of Da is scaled, but it could be 
introduced to the calculation. 
 Implementation 8.5
The θ-method was implemented in Matlab®. The overall methodology of the script is described 
above or found in Appendix A7. The script handles RDCs, NOEs and J-coupling constants, 
individually or in combination, given input files and a structure file with one or more structures 
(.pdb, .mol2 or .sdf supported). Examples of the different inputs are given in the experimental 
section. 
 Results 8.6
In this section the θ-method is utilized to back-calculate RDCs of several compounds and the results 
are compared to SVD calculations using the MCST approximation when appropriate. But first a 
couple of questions needed to be answered in order to establish a proof of concept of the method. 
8.6.1 Proof of Concept - Strychnine 
Several questions needed to be answered, in order to evaluate the applicability of the θ-method, and 
are addressed below. Since the method is based on existing methods, the proof of concept part is 
more a study in the limitations than whether the method is possible, though that is also investigated. 
To achieve proof of concept the structure of strychnine will be utilized below. Strychnine is rigid 
with multiple 
1
DCH vectors, and is thus generally utilized for many purposes. Two datasets of 
strychnine were investigated with correlating results. One of the sets is used as an example in the 
following. 
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Initial fitting of strychnine 
The structure of strychnine was easily fitted to the RDC data using either SVD or the θ-method, as 
seen in Table 8.1. 
Table 8.1. Experimental versus calculated RDCs for the major 
conformer of strychnine. Calculated by SVD in MSPIN and the θ-
method. Aligned in PDMAA (Polymer 8.1). 
Nuc 1 Nuc 2 Exp. θ-method SVD 
C1 H1 26.6 26.3 26.2 
C2 H2 13.8 13.7 13.9 
C3 H3 23.8 20.1 20.3 
C4 H4 28.3 26.6 26.6 
C8 H8 -14.4 -14.1 -14.4 
C11 H11a 12.3 13.8 13.7 
C11 H11b -25.8 -28.6 -28.9 
C12 H12 -28.4 -29.3 -29.3 
C13 H13 -4.3 -4.5 -4.7 
C14 H14 -27.9 -29.1 -29.0 
C15 H15a 7.0 5.6 5.5 
C15 H15b 7.5 7.4 7.3 
C16 H16 15.2 14.2 14.2 
C18 H18a 1.6 -0.4 -0.5 
C18 H18b 14.7 13.6 13.6 
C20 H20a -16.0 -14.5 -14.6 
C20 H20b -4.1 -3.4 -3.6 
C22 H22 0.7 3.7 3.6 
     
Q-factor 0.092 0.092 
 
 
Figure 8.4. The major conformer of 
strychnine 
The resulting back-calculated RDCs were very much alike with an RMSD of 0.13 Hz and a MAE of 
0.06 Hz between the two methods. While this was reassuring the work relied heavily on the 
following. The general alignment is compared in Figure 8.5, but as the averaging is implicit in SVD 
and explicit in the θ-method, the comparison is of only the most abundant alignment. 
 
Figure 8.5. The alignment frame from and SVD fitting of strychnine (left) and the molecular frame of the most abundant 
alignment to the magnetic field from a θ-method fitting. Both alignments have the z-axis aligned with the magnetic field. Note 
that the x- and y-axis are without influence in the θ-method, and the alignments are almost identical. Aligned in PDMAA 
(Polymer 8.1). 
Rotation angle φ 
The first potential drawback of the method is caused by the fact that a rotation must be defined, and 
thus the back-calculation of RDCs is based on a finite number of rotations. It is not possible to 
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make the rotation angle infinitely small due to computer memory and time of calculations. In 
comparison the SVD method rotates the structure into the linear best fit with a theoretical infinite 
rotational resolution. Conditions were tested to establish that it was possible to find a rotation angle 
which give reliable results and is computationally viable.  
To investigate this, the 3D structure of the major conformer of strychnine was used. When 
optimized this structure has a random orientation in space and randomly 100 structures were 
generated from 100 random rotation angles of the structure along the z- and x-axis (using a 
rotational resolution below 0.0001 degrees). The 100 randomly chosen structures were rotated by 
90, 60, 30, 10, 1, 0.5 or 0.1 degrees and back-calculated RDCs compared to the experimental data. 
The summary of this may be found in Figure 8.6 and Table 8.2.  
The lowest rotation angle used in the further investigation was 0.1 degree which is a practical 
decision; to decrease an order of magnitude from 0.1 degree one would need ~227 GB of RAM, 
way above standard computer setups (and even clusters).
VIII
 This could probably be alleviated by 
saving and loading the structures continuously in the Matlab
®
 script, but this was not a feasible 
solution due to increased calculation times.  
 
Table 8.2. Statistics of the Q-factor of an RDC fitting of 
strychnine using different rotation steps (φ) starting from 
100 different rotations. Data set used for strychnine is 
Polymer 8.1. 
φ/° Mean St. dev. Median Min Max 
- 1.6290 0.4154 1.6950 0.4767 2.2857 
90 0.8156 0.1986 0.8910 0.2060 0.9981 
60 0.2829 0.1195 0.2835 0.0934 0.5357 
30 0.1016 0.0123 0.0963 0.0919 0.1468 
10 0.0919 0.0002 0.0919 0.0916 0.0924 
1 0.0918 0.0002 0.0917 0.0915 0.0921 
0.5 0.0917 0.0002 0.0916 0.0915 0.0921 
0.1 0.0917 0.0001 0.0916 0.0915 0.0921 
 
Figure 8.6. Q-factor of an RDC fitting of strychnine using 
different rotation steps (φ) in degrees. Mean and 
standard errors (error bars) shown. Data set used for 
strychnine is Polymer 8.1. 
 
It should be addressed that a rotation of 10 or even 30 degrees fitted the data just as well as lower 
rotational steps. It is unlikely that a rotation of 30 degrees will produce a structure that is situated 
rightly in the alignment frame, and the generally low Q-factor is attributed to the fact that the 
rotational average is optimized. It is thus possible to construct data from multiple aligned structures 
which averages in line with the observed data. If a rotation by 1 degree or lower is utilized, the 
possibility to be in the alignment frame is vastly increased, and the minor averaging needed may 
                                                 
 
VIII
 This is a result of the script where all rotations of all vectors are saved in matrices. Estimated as 
RAM(0.1° rot.)×10×10. 
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even correlate well to what is actually observed in experiments. Due to the vast increase in 
computational requirements when decreasing the rotation step size by an order of magnitude, a 
rotation of 1 degree was used to perform the back-calculations and fittings in the remainder of this 
thesis.  
Da estimations 
To do the calculations as outlined in (8.16) and (8.17) it was a prerequisite that Da may be 
estimated. The theoretical approach was already explained in (8.20). In order to test whether the 
approach was viable, Da was scaled by a constant SDa in the fitting to experimental data and the 
resulting Q-factor was evaluated. An example of this, using strychnine again, is seen in Figure 8.7. 
 
Figure 8.7. Q-factor of an RDC fitting of strychnine using a Da obtained by the approach outlined in Section 8.4 and scaled by 
SDa. Data set used for strychnine is Polymer 8.1. 
The assumptions used in estimating Da seemed to be valid for strychnine in the experimentally 
obtained alignment frame, as an increase in Da did not lead to a better correlation to the 
experimental data. A decrease in Da led to a worse correlation, in good correlation to the fact that 
the larger observed RDCs, independent of sign, are no longer obtainable. The fact that SDa = 1 was 
the optimum means that a vector was situated perpendicular or parallel to B0. In the current case it 
was the vector of C4-H4 which was determined to be perpendicular to the magnetic field. This will 
not be true for all structures or alignments, and thus each aligned dataset was treated as above to 
determine if the approximated Da value is appropriate for the data, and the value was scaled 
accordingly for the specific dataset if needed. 
Differentiation of stereoisomers 
Strychnine has previously been used for RDC calculations and multiple studies have shown that it is 
possible to assign the diastereotopic protons of strychnine by RDCs.
187,188,208
 To probe whether the 
θ-method may be used to differentiate stereoisomers, the diastereotopic protons of strychnine were 
switched, fitted to the data set and compared to the right assignment. This was compared to the 
results of a fitting of the same data using SVD as implemented in the commercial program MSPIN. 
The comparison is found in Table 8.3. 
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Table 8.3. Comparison of the distinction of right and wrong assignment of the diastereotopic protons in strychnine by the θ-
method and SVD. The diastereotopic protons are switched as stated, and may be compared to the right assignment in the 
top row. Aligned in PDMAA (Polymer 8.1). 
 
Q-factor Ratio 
Switch # θ-method SVD θ-method SVD 
Right 0.093 0.087 1.0 1.0 
Dia-11 0.688 0.565 7.4 6.5 
Dia-15 0.097 0.088 1.0 1.0 
Dia-18 0.243 0.209 2.6 2.4 
Dia-20 0.191 0.180 2.1 2.1 
Dia-23 0.523 0.458 5.6 5.3 
 
 
 
The distinction was just as good for the θ-method as for SVD. The reason that the diastereotopic 
protons of C-15 were indistinguishable is due to very similar observed RDCs, and thus lies in the 
orientation of the molecules in the alignment media and not the method. Since the θ-method may 
easily be used in tandem with J-coupling constant and/or NOE data, the combined data was 
compared to 3D structures by addition of RMSDs between all experimental and theoretical data, 
allowing the differentiation of H-15a/H-15b, see Table 8.4. This may of course also be done for 
SVD fittings by separate investigation of the other parameters, but this approach slightly more 
cumbersome. 
Table 8.4. RMSD of RDC data, alone or coupled to NOE and/or J-coupling constant data for the diastereotopic protons at 
C15 of strychnine if assigned right or wrong. Only NOEs and J-coupling constants involving H15a/b were used. 
 
RMSD 
 
Right Dia-15 
RDC 1.247 1.266 
RDC/J 1.853 3.207 
RDC/NOE 1.287 2.247 
RDC/J/NOE 1.877 4.186 
 
Determining low level conformers of strychnine 
A low level conformer of strychnine was previously published from NOE data, and recently 
attempts were made to use the MCST approach to determine the population of the two conformers 
from RDCs.
30,248
 The attempt showed varying results and as a consequence the performance of the 
θ-method was tested. Data from the study above as well as another dataset used in Section 6 were 
tried which may be compared to the literature.
248
 
 
Figure 8.8. The major (left) and minor (right) conformer of strychnine. It is noted that a third conformer has been 
presented, but this conformer is present well below one percent and not used for comparison.
30,248,254
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In line with the MCST SVD fittings in the literature, the studies here also concluded that it was hard 
to obtain a meaningful conformational population for the structures of strychnine by the first set of 
RDCs. The two methods gave more or less exactly the same populations from the first dataset, 
using MCST and the θ-method alike, with an overestimation of the minor conformer as given in 
Table 8.5. For the second dataset the population is the same when using the θ-method while the 
MCST performs significantly better. Compared to the literature study by Thiele et al. the 
populations were in good agreement as the population of conformer 1 was populated from around 
0.8 to 1 for multiple literature datasets.
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Table 8.5. Populations of the two conformers of strychnine, using only one bond RDCs or including long-range RDCs. 
Scaled SVD covers the usage of “SVD Hz scaling” option in MSPIN, where the larger RDCs contribute more to the fit. This 
was needed to obtain good Q-factors when using the full datasets. (Dataset 1: Polymer 8.1, dataset 2: Polymer 6.2). 
 
1
DCH 
1
DCH+
n
DHH 
 Conf. 1 Conf. 2 Q-factor Conf. 1 Conf. 2 Q-factor 
Dataset 1 
SVD 0.79 0.21 0.081 1.00 0.00 0.223 
SVD, scaling 0.81 0.19 0.080 0.96 0.04 0.168 
θ-method 0.81 0.19 0.072 0.88 0.12 0.164 
Dataset 2 
SVD 0.96 0.04 0.079 0.98 0.02 0.296 
SVD, scaling 0.96 0.04 0.079 1.00 0.00 0.119 
θ-method 0.84 0.16 0.073 0.95 0.05 0.118 
       
NOE30 0.98 0.02  0.98 0.02  
 
To test whether the population fit would be improved by utilizing the additional vectors from the S
3
 
HMBC homo, see Chapter 6, back-calculation were performed which included these data. The 
reasoning behind a possible better fit was that the additional data involve internuclear vectors 
involving the protons 23a/23b, which will differ in length between the conformations. Due to the r
-3
 
dependence of the resulting RDC this was thought to greatly influence the resulting populations 
from the data. Indeed, the inclusion of long-range RDC data generally improved the populations for 
both methods, as seen in Table 8.5, compared to the expected population.  
The MCST approach seemed to be slightly better for this simple system. This could be attributed to 
the fitting procedure, where MCST uses iterative population fitting, while the θ-method is forced to 
rely on an additive best fit approach due to the amount of “structures” generated from the rotations. 
It is also beneficial for MCST that the changes in the overall structure were minor between the two 
conformations, and thus the overlay of the structures was easily determined. In conclusion both 
methods seemed to be inferior to an NOE approach, which was not surprising due to the r
-6
 
dependence leading to a huge impact by small changes in distances on the NOE intensities, while 
also minimizing contributions from errors. 
To test the scope of the θ-method other organic compounds were tested by fitting of experimental 
RDCs to multiple conformers. These will be presented below. 
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8.6.2 Reserpine 
Reserpine is a plant alkaloid which features a linear pentacyclic system, see figure in Table 8.6. At 
least one strained ring conformation is present at all time which was thought to lead to flexibility by 
differences in ring conformation between conformers. Unlike strychnine, where the molecular 
structure is very rigid and very few structures were identified, reserpine had have many different 
conformations in the simulation, though a single conformer of the ring system was identified which 
is populated approximately 90 % from force field energies. The evaluation of many conformers 
could be problematic in an SVD fitting in MSPIN as the computational time increases rapidly with 
the number of structures. One approach could be to determine the relative energies from more 
accurate DFT calculations, or trust those of the force field method and remove conformers below a 
certain threshold, and thereby limit the amount of structures. In Figure 8.9 the conformational space 
of reserpine is illustrated, with focus on the pentacyclic system.  
 
Figure 8.9. Conformational space covered by the pentacyclic ring of reserpine. 
All conformers were included in the fitting procedure disregarding any energy differences 
determined in the FF minimization. This should test the prowess of the θ-method and see if the 
correct conformer was obtained. The correlation obtained from the θ-method, and those using SVD, 
between experimental and back-calculated data, is found in Table 8.6. For the first SVD a single 
structure, representing the pentacyclic system with the lowest energy was used. For the second 
structures that represented the conformational averaging of the pentacyclic system were used, due to 
the amount of structures else needing fitting. The θ-method utilized structures covering a much 
larger conformational space (114 conformers). Both methods identified the correct major 
conformer, but some observations indicated that the SVD method was problematic: The correlation 
to experimental data was markedly worse and the Da for the multiple-conformers fitting was much 
higher than in the two other cases. This may be contributed to the overlay of the structures, where 
the heavy atoms in the pentacyclic system were used. It was not possible to establish a better 
overlay, so this may not be the problem. Also the limited number of input structures could have 
been problematic. Still, the ability to input all conformations in the θ-method, rendered all post-
simulation pre-fitting considerations, such as overlay of atoms, unnecessary, as a big dataset with 
many structures could easily and quickly be fitted to experimental data without prior 3D structural 
assumptions.  
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Table 8.6. Experimental and back-calculated RDCs for reserpine in Hz. Calculated by SVD in MSPIN and the θ-method. The 
data from SVD was compared to a single structure or conformers representing the core pentacyclic system and 3-jump 
models of the rotatable groups. Da is scaled by 1.3 in the θ-method. (Polymer 8.2). Right: Structure of reserpine.  
C H Exp θ-method SVDsingle SVDmult 
1 1 -36.3 -36.1 -33.4 -35.2 
2 2 -35.5 -36.3 -35.7 -37.1 
3 3 -38.5 -37.5 -30.7 -24.3 
4 4 12.5 14.5 13.9 16.1 
5 5a -18.9 -20.4 -22.9 -18.2 
5 5b 22.5 20.2 13.7 20.7 
6 6 -28.5 -28.9 -27.3 -29.2 
10 10 2.3 2.1 2.9 2.8 
12 12 27.4 29.7 30.6 40.4 
13 13 2.4 1.7 2.5 2.7 
16 16a -55.7 -57.0 -41.3 -56.0 
16 16b 36.9 33.6 31.5 23.7 
17 17a/17b -37.6 -31.0 - - 
19 19a 15.8 15.4 12.5 6.5 
19 19b -17.6 -17.5 -22.0 -20.2 
20 20 -33.4 -33.2 -30.8 -35.7 
21 21a -27.5 -27.1 -26.5 -23.8 
21 21b -22.9 -23.4 -24.0 -16.0 
25/29 25/29 -16.8 -15.7 - - 
31 31 0.4 0.5 8.9 -7.4 
34 34 7.4 7.6 6.0 0.9 
36 36 -1.5 -1.8 -0.1 -12.2 
40 40 -2.0 -3.4 -1.9 -3.9 
  Q-factor 0.055 0.165 0.259 
 Q (rigid) 0.041 0.144 0.175 
  Da 1.04E-03 1.02E-03 2.18E-03 
 
 
 
The extracted RDCs were more than adequate to discern the low from the high energy structures 
using both methods, and almost only structures representing the lowest relative energy of the ring 
system were present. The structural average correlated much better to experimental J-coupling 
constants and NOE correlations than did an average over all the structures. The major conformer 
from the RDC, NOE and J-coupling constant data parameters are found in Figure 8.10, where the 
pentacyclic system is clearly identical. The conformational populations of the pentacyclic rings are 
visualized in Figure 8.11 by the three dihedral angles given, as it was assumed that the indole 
system is rigid.  
 
Figure 8.10. The 3D structure which best fit the NMR data. Green: RDC data, blue: J-coupling constant data (RMSD = 
0.024 compared to RDC) and orange NOE data (RMSD= 0.013 compared to RDC). The RMSD is based on the heavy atoms 
in the pentacyclic system only. 
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Figure 8.11. Comparison of dihedral angles representing 
the ring-conformation of the pentacyclic system as found 
from θ-method (black), NOEs (white), J-coupling 
constants (grey), SVD (blue) and all possible structures 
(red). Groups cover ±20° and no populations were found 
below 0°. All structures in a 50 kJ/mol window were 
included in the fit as equally probable structures. 
 
 
The θ-method differentiated all diastereomers and most diastereotopic protons, other than 17 due to 
spectral overlap, and 21 due to similar RDCs, as seen in Table 8.7. This feat was performed 
including quite different conformations from all diastereomers, which could all be used to favor a 
wrong diastereomer. This easily demonstrates the ability to find a meaningful conformational 
average from multiple possible structures utilizing the θ-method and solving complex 3D structural 
problems such as the determination of stereochemistry. The same calculations were performed 
using NOE and J-coupling constant data. The data complemented each other well, and the RDCs 
were just as discriminative as the other data. In the case of the diastereotopic protons at C-16, RDCs 
were actually needed in order to discern the two. This was caused by the overlap of the resonances 
of H17a and H17b which led to no discerning NOE correlations of H-16a/b, and also no J-coupling 
constants involving H-16a/b were determined. If all of the data types are utilized, the 
stereochemistry of all chiral and pro-chiral centers was easily solved. 
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Table 8.7. RDC: Q-factors and ratios of Q-
factors for wrongly assigned diastereomers of 
reserpine versus right assignment. Calculated 
by θ method. 17 not included due to spectral 
overlap of protons. Red: easily distinguished.  
Switch # Q-factor Ratio 
Right 0.071 1.0 
Dia-1 0.630 8.9 
Dia-2 0.518 7.3 
Dia-3 0.129 1.8 
Dia-4 0.574 8.1 
Dia-6 0.709 10.0 
Dia-20 0.768 10.8 
Dia-5 0.188 2.6 
Dia-16 0.457 6.4 
Dia-19 0.108 1.5 
Dia-21 0.070 1.0 
 
 Table 8.8. NOE: MAE% and ratios of MAE% for wrongly assigned 
diastereomers of reserpine versus right assignment from NOE 
(ISPA). Red: easily distinguished. 
Switch # MAE% Ratio 
Right 5.6 1.0 
Dia-1 22.3 4.0 
Dia-2 9.3 1.7 
Dia-3 10.1 1.8 
Dia-4 12.8 2.3 
Dia-6 14.0 2.5 
Dia-20 18.5 3.3 
Dia-5 7.1 1.3 
Dia-16 7.7 1.4 
Dia-19 8.5 1.5 
Dia-21 10.2 1.8 
 
  
Table 8.9. J-coupling constants: MAE and 
ratios of MAE for wrongly assigned 
diastereomers of reserpine versus right 
assignment. Calculated by HLA. Red: easily 
distinguished. 
Switch # MAE Ratio 
Right 1.0 1.0 
Dia-1 6.0 6.0 
Dia-2 2.3 2.3 
Dia-3 2.0 2.0 
Dia-4 3.8 3.8 
Dia-6 1.3 1.3 
Dia-20 4.8 4.8 
Dia-5 1.7 1.7 
Dia-16 - - 
Dia-19 1.0 1.0 
Dia-21 2.4 2.4 
 
Table 8.10. Including NOEs, Js and RDCs in the fitting of wrongly assigned 
diastereomers of reserpine versus right assignment. Calculated by ISPA, 
HLA or θ method. Σ=MAENOE+MAEJ/10+QRDC. Red: easily distinguished. 
Switch NOE J RDC Ratio 
# MAE% MAE% Q Σ NOE J RDC Σ 
Right 6.0 15.7 0.112 0.38 1.0 1.0 1.0 1.0 
Dia-1 24.8 55.4 0.636 1.77 4.1 3.5 5.7 4.7 
Dia-2 9.4 30.4 0.533 1.03 1.6 1.9 4.8 2.7 
Dia-3 10.1 28.8 0.136 0.61 1.7 1.8 1.2 1.6 
Dia-4 12.8 49.8 0.594 1.22 2.1 3.2 5.3 3.2 
Dia-6 10.0 18.9 0.544 0.96 1.7 1.2 4.9 2.5 
Dia-20 18.6 53.5 0.764 1.68 3.1 3.4 6.8 4.4 
Dia-5 7.6 22.9 0.264 0.66 1.3 1.5 2.4 1.7 
Dia-16 6.6 15.1 0.545 0.84 1.1 1.0 4.9 2.2 
Dia-19 8.9 14.6 0.185 0.54 1.5 0.9 1.7 1.4 
Dia-21 18.2 28.0 0.089 0.75 3.0 1.8 0.8 2.0 
 
The methoxy-groups could rotate and were all implicitly averaged in the fitting of the data, both 
using the θ-method and SVD fitting to a single tensor in MSPIN. Information regarding the 
methoxy ester could be discarded as only minor differences in back-calculated RDCs in a 3-jump 
model were observed due to similar angles to the magnetic field, as the ester bond was static. The 
phenol alcohol could be described as a two jump model. The population percentages of each 
position are found in Table 8.11 and are in good correlation with NOE populations.  
Table 8.11. Orientation of the C36 methyl group as determined from RDC (θ-method, SVD) and NOE data.  
Conf. 
θ method 
[%] 
MSPIN 
[%] 
NOE 
[%] 
1 66 74 67 
2 34 26 33 
 
 
A 3-jump model was assumed for the methoxy group C31 and the populations are seen in Table 
8.12. While there are discrepancies between the RDC and NOE data, the RDC data consisted of a 
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single internuclear vector, while three NOE correlations were involved in the population 
determination. The NOE data was thus deemed more trustworthy.  
Table 8.12. Orientation of the C31 methyl group as determined from RDC (θ-method, SVD) and NOE data. 
Conf. 
θ method 
[%] 
MSPIN 
[%] 
NOE 
[%] 
1 54 44 85 
2 8 10 10 
3 38 46 5 
 
It should be stressed that the θ-method, while slower for single compounds compared to SVD 
calculations, performed much faster when optimizing fits of multiple structures to experimental data 
where the SVD optimization procedure is slow. The ability to quickly screen multiple conformers 
and identify the correct ones is important, and while it is in principle possible to decrease 
calculation times for SVD methods by screening a lot of conformers in sequence, it is cumbersome, 
and does not really evaluate a possible fit of multiple structures. The θ-method may here be 
employed to quickly select the structures which fit experimental data.  
8.6.3 Cinchona alkaloids 
The cinchona alkaloid, named from their natural source, exhibit similar structural features with 
multiple rotational bonds connecting rigid parts. Possibly due to their usage in e.g. organic synthesis 
all structures are described quite well in literature.
111–114
 Three alkaloids were investigated in order 
to test more flexible compounds: Quinine, cinchonine and cinchonidine. The conformational space 
of these compounds has been previously examined, and the literature thus provides reference 
studies.
111,112
 The cinchona alkaloid quinine was also investigated using NOEs in Section 3.4.1. 
Cinchonidine 
The alkaloid cinchonidine is related to quinine and the structures share molecular features only 
differing in a methoxy group at C-8. The RDC data were fitted to multiple structures using the θ-
method, see Table 8.13 and Table 8.14. 
 
Figure 8.12. Structure of cinchonidine and the orientation of diastereotopic protons for all cinchona alkaloids included in this 
thesis. 
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Table 8.13. Experimental versus back-calculated RDCs for 
cinchonidine. Calculated by θ-method or SVD. (Polymer 8.3). 
C H Exp [Hz] θ-method SVD 
2 2a 3.9 4.7 5.8 
2 2b 10.8 8.3 5.3 
3 3 24.5 23.2 24.1 
4 4 27.9 23.1 22.0 
5 5a -18.5 -21.2 -20.9 
5 5b 29.7 25.8 26.0 
6 6a -38.6 -37.7 -39.1 
6 6b 5.0 9.0 8.8 
7 7a -21.0 -20.3 -22.4 
7 7b -22.7 -22.3 -22.0 
8 8 -5.3 -7.0 -9.2 
9 9 15.8 16.1 18.0 
10 10 26.2 23.9 21.0 
11 11a -27.0 -28.8 -23.4 
11 11b 21.3 24.4 21.1 
2' 2' 22.3 24.3 23.5 
3' 3' 23.5 22.3 22.3 
5' 5' 27.8 25.2 28.1 
6' 6' 25.1 23.0 23.1 
7' 7' 20.9 21.5 22.6 
8' 8' 25.6 25.1 26.5 
     
  Q-factor 0.100 0.127 
  Da 8.42e-04 1.06e-3 
 
Table 8.14. Q-factors and ratios of Q-factors for wrongly 
assigned diastereomers of cinchonidine versus the right 
assignment. Calculated by the θ-method. 
Switch # Q-factor Ratio 
Right 0.100 1.0 
Dia-9 0.331 3.1 
Dia-7 0.102 1.0 
Dia-2 0.106 1.0 
Dia-5 0.372 3.5 
Dia-6 0.410 3.8 
Dia-11 0.497 4.6 
 
 
 
The conformations of cinchonidine were previously investigated from energy computations and 
NMR data, primarily via J-coupling constants by Bürgi et. al.
111
 and Urakawa et al.
117
 These studies 
were based on a few optimized structures and their relative energies. The approach of this study 
thus differs, as the relative energy was disregarded and multiple conformers were used, but still the 
data are compared in Table 8.15. Since multiple conformers were used, and more dihedral angles 
are possible, the dihedral angles reported are centered on the angles determined from DFT studies. 
This may be viewed as the DFT structures being centroids. 
Table 8.15. Conformational populations which exhibit dihedrals τ, defined as the value ±20 degrees, in percent (%). τ1: C3-
C4-C9-C8, τ2: C4-C9-C8-N, τ3: H9-C8-C9-H8. Population fitting used in MSPIN. The population of an NOE fit is used in 
comparison, using that of quinine, which has a similar structure as discussed in Section 3.4.1. *Other conformations 
identified, does not sum to 100.
a
See text. (CDCl3: Polymer 8.3, DMSO-d6: Polymer 8.4). 
 τ1  τ2  τ3   
 80 -100 40 150 -50 -90 50 -80 70 40 180 Q Da 
CDCl3              
Ref, energy(1) 87 13 - 74 - - 26 74 -  26 - - 
Ref, energy(2.1) 80 11 9 69 - 7 24 69 - 7 24 - - 
Ref, energy(2.2) 89 6 5 77 - 12 11 77 - 12 11 - - 
θ method, no scaling 48 26 26 86 - - 14 86 -  14 0.168 6.48e-4 
θ method, scaled by 1.3 58 14 28 75 - - 25 75 -  25 0.100 8.42e-4 
SVD 55 45 - 100 - - - 100 - - - 0.159 1.06e-3 
NOE (p. 54, quinine) 67 12 21 67 - - 33 67 - - 33 - - 
DMSO-d6              
Ref, energy (water)a 72 27 - 45 - - 54 45 - - 54 - - 
θ method, scaled by 1.2 39 46 15 28 20 - 52 28 20 - 52 0.052 3.96e-4 
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It is noted that the SVD method, while giving a reasonable Q-factor did not result in a 
conformational population that correlated to the rest of the NMR data. The overlay was made using 
the heavy atoms in the aromatic system, since it exhibited the largest absolute RDCs (after 
correction for the fact that the values of RDCs of parallel vectors to the magnetic field are doubled 
compare to perpendicular vectors). The θ-method on the other hand resulted in surprisingly good 
populations compared to the relative energies, and compared to the NOE data of quinine, a similar 
structure investigated in Section 3.4.1 differing only by a methoxy group at C4’, the populations fit 
very well between the different data types. 
For comparison RDCs were also obtained from DMSO. The populations in water were used, as no 
data in DMSO was identified in the literature, and the energies of water and acetone are almost 
equal while the dielectric constant of DMSO is almost just between the two. Also the J-coupling 
constant of H11-H12 is almost equal in water and DMSO, 7.5 and 7.4 Hz respectively.  
Theoretically, from calculations and the J-coupling constant of 7.4 Hz, the ratio of τ3 dihedral angle 
populations should now be opposite compared to chloroform populations, which was indeed 
observed. The J-coupling constants for H11 to H12 were measured to be 3.0 Hz in chloroform and 
7.4 Hz in DMSO. The back-calculated J-coupling constants, as the average of the J-coupling 
constants of the structures determined from the RDC data by the HLA method, gave 3.2 and 5.9 Hz 
respectively for chloroform and DMSO in good agreement to the theoretical values. 
Cinchonine 
Cinchonine was compared to the work of Kowalik et al.
112
 As for the other structures, 
diastereomers of internuclear vectors with numerically similar RDCs were hard to differentiate. 
Also differentiation of the correct assignment and the diastereomer epi-cinchonine could not 
initially be done based in the RDC data, Table 8.16. It should be noted that this was due to the 
choice of using all structures with no regard to their simulated energy, which was in this case not a 
preferable approach. If a cutoff was chosen at below 30 kJ/mol, it was possible to discern the 
stereoisomers, and it is in principle possible to solve the stereochemistry from RDCs and 
knowledge of relative energies between conformers.  
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Table 8.16. Experimental versus back-calculated RDCs for cinchonine and the 
wrong diastereoisomer epi-cinchonine. Calculated by θ method, Da scaled by 1.3. 
J-coupling constants calculated using the HLA equation and the conformer 
populations from the RDC fit. (Polymer 8.5). 
C H Exp [Hz] 
θ method 
Cinchonine 
(50 kJ/mol) 
Cinchonine 
(30 kJ/mol) 
Epi-cinch. 
(50 kJ/mol) 
Epi-cinch. 
(30 kJ/mol) 
2 2a -33.1 -33.4 -33.4 -33.3 -36.6 
2 2b 9.0 7.6 7.6 8.1 13.8 
3 3 -1.5 -0.7 -0.7 -0.3 1.6 
4 4 3.7 6.9 6.9 7.5 2.1 
5 5a -5.3 -3.0 -3.0 -3.4 -1.3 
5 5b -3.6 -1.2 -1.2 -1.5 -0.2 
6 6a 19.2 21.1 21.1 20.2 21.5 
6 6b 8.1 8.6 8.6 8.8 14.7 
7 7a -10.6 -7.5 -7.5 -7.3 -6.1 
7 7b -17.0 -13.1 -13.1 -12.9 -9.2 
8 8 3.2 0.9 0.9 1.9 7.2 
9 9 13.8 13.9 13.9 13.8 6.8 
10 10 -7.6 -7.3 -7.3 -7.6 -7.6 
2' 2' 30.1 29.8 29.8 29.9 27.7 
3' 3' 24.7 24.8 24.8 24.6 20.7 
5' 5' 23.9 24.6 24.6 24.7 17.6 
6' 6' 29.5 29.5 29.5 29.3 28.4 
7' 7' 23.0 23.4 23.4 23.0 19.0 
8' 8' 24.8 24.2 24.2 24.0 17.5 
       
  Q-factor 0.096 0.097 0.095 0.250 
  Da 8.30E-04 8.30E-04 8.30E-04 8.30E-04 
Resulting J 4.8 Hz  2.7 Hz  
 
Table 8.17. Q-factors and ratios of Q-
factors for wrongly assigned dia-
stereomers of cinchonine versus right 
assignment. Calculated by the θ method.  
Switch # Q-factor Ratio 
Right 0.096 1.0 
Dia-9 0.095 1.0 
Dia-7 0.098 1.0 
Dia-2 0.373 3.9 
Dia-6 0.167 1.7 
Dia-5 0.099 1.0 
 
 
Another approach is to utilize the J-coupling constant between H11 and H12.  For epi-cinchonine 
this J-coupling constant is reported as 9.9 Hz in chloroform compared to 4.0 Hz for cinchonine, and 
the diastereomers could be distinguished from the conformational differences and the associated 
value of the average coupling constant, where the wrong assignment (epi-cinchonine) utilized 
conformations which led to a markedly different J-coupling constant, Table 8.16.
112
 Populations 
determined of the two diastereomers from the cinchonine RDC data is found in Table 8.18. 
Table 8.18. Conformational populations which exhibit dihedrals τ, defined as the value ±20 degrees, in percent (%). τ1: C3-
C4-C9-O, τ2: O-C9-C8-C7. Population fitting used in MSPIN. *Other conformations identified, does not sum to 100.  aSVD 
fitting hold little meaning due to high Da, see text. (Polymer 8.5). 
 τ1 τ2   
Cinchonine 40 -135 80 55 -60 160 Q Da 
Ref, energy112 95 5 - 19 74 6 - - 
θ method, scaled by 1.6 54 33 13 34 52 7* 0.096 8.304E-04 
SVD 39 48 13 47 30 12* 0.095 4.761E-03a 
 τ1 τ2   
Epi-cinchonine -35 130 -110 55 -65 175   
Ref, energy112 51 49 - - 32 68 - - 
θ method, scaled by 1.6 54 15 31 12 73 15 0.095 8.300E-04 
 
It was possible to fit the multiple conformers to the data using SVD to give a reasonable result, but 
there was a major concern. The alignment strength was much higher using SVD, which is rather 
problematic as this correlate to the individual conformers having theoretical RDCs in the hundreds 
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of Hz, which then averages to give reasonable back-calculated RDCs. This does not seem 
reasonable but the cause of this was not definitely determined. It is speculated that this was caused 
by the rigidity in the alignment as introduced by the MCST methodology. Since all structures are 
overlaid pre-fitting the conformers are not allowed to average RDCs individually and an overall 
average is constructed instead. In that regard it should be noted that the tensor is averaged along a 
fixed axis and it may well be that the axis differs between individual structures, leading to bad fit of 
the system. The problem was not alleviated by overlaying another part of the structure.  
One could maybe limit the possible alignment strength determined by the SVD fitting, but the 
author has no suggestions as to how, as any limitation will result in a worse fit between 
experimental and back-calculated values in a natively best fit method. It was tried to utilize the 
alignment tensors of the individual structures as a base, by an in house written Matlab
®
 script. 
Unfortunately this always resulted in the structure by which the alignment tensor was established, 
being by far the best fit. Also linear combinations of the alignment tensors were tried, which always 
resulted in worse fit compared to the native alignment tensors, and there is no theoretical evidence 
that this should be a viable approach. 
The populations from the θ method correlated less well to the theoretical populations than those of 
cinchonidine, but still the fit to the theoretical populations was reasonably good, also considering 
the differences observed between energy calculations and NOE conformer populations for quinine.  
Quinine 
The final cinchona alkaloid to be investigated by RDCs using the θ-method is quinine. The 
conformational space of quinine was already discussed in Section 3.4.1 obtained using NOE 
distances. As DFT optimized conformers of quinine were already obtained, quinine was chosen to 
determine the effect of having either a few, highly optimized structures (centroids) or multiple 
structures. 
Table 8.19. Experimental versus calculated RDCs for quinine. Calculated by θ-method using structures from MM or DFT 
optimized structures. Da was scaled by 1.6. For SVD only DFT optimized structures were used, overlaid by the aromatic (a) 
or the bridged (b) part. (Polymer 8.6). 
C H Exp [Hz] 
θ method SVD 
MM DFT SVD
a
 SVD
b
 
3 3 12.3 12.6 12.7 12.8 12.7 
4 4 9.6 10.5 11.3 9.8 11.3 
6 6a -26.5 -25.5 -25.2 -24.8 -25.2 
6 6b 2.0 3.2 3.3 2.8 3.3 
8 8 -2.8 -2.0 -1.3 -1.7 -1.3 
9 9 10.1 10.2 9.9 10.4 9.9 
2' 2' 16.3 16.6 16.4 16.6 16.4 
3' 3' 15.5 14.9 14.1 14.7 14.1 
5' 5' 14.6 14.3 14.3 16.9 14.3 
7' 7' 13.2 13.7 14.5 14.4 14.5 
8' 8' 13.5 13.7 13.6 11.9 13.6 
  Q-factor 0.048 0.071 0.079 0.107 
  Da 5.54E-04 5.45E-04 4.50E-03 1.19E-03 
 
 
Figure 8.13. Structure of quinine. 
 
The RDC data was fitted to the seven structures that were used to describe the conformational space 
of quinine for NOEs in Section 3.4.1.  
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The populations are seen in Table 8.20, comparing to theoretical conformer populations and those 
from the θ-method and SVD. 
Table 8.20. Conformational populations which exhibit dihedrals τ, defined as the value ±20 degrees, in percent (%). τ1: C3-
C4-C9-C8, τ2: C4-C9-C8-N, τ3: H9-C8-C9-H8. Da was scaled by 1.5.  Population fitting used in MSPIN. 
a
SVD fitting hold 
little meaning due to high Da, see text. (Polymer 8.6). 
 τ1 τ2 τ3   
 100 -100 20 150 -70 50 -80 60 180 Q Da 
Urakawa, energy117 79 11 10 72 3 25 72 3 25   
Butts, energyIX 75 13 12 79 0 21 79 0 21   
θ-method, no scaling 78 22 0 56 0 44 56 0 44 0.138 3.405e-4 
θ-method scaled by 1.6 59 31 0 31 7 62 31 7 62 0.071 5.448e-4 
SVD (arom)a 34 51 15 29 37 34 29 37 34 0.079 4.50E-03 
SVD (bridge) 75 9 16 42 0 58 47 0 58 0.107 1.19E-03 
NOE (p. 54) 67 12 21 67 0 33 67 0 33   
 
Analogues to the SVD fitting of cinchonine, the degree of alignment for quinine was much too high 
when using the aromatic system to overlay the structures, and a bit better when using the bridged 
system. For both the θ method and SVD, the general populations were acceptable for the rotation of 
the aromatic system, while the rotation around the C9-C8 bonds was not populated as expected, 
when compared to energy- or NOE derived populations. It was thus tried to include more structures, 
departing the centroids, in the approach that worked well for the cinchona alkaloids previously 
investigated. A reason for a worse population fit could be that the dataset was the smallest of the 
investigated cinchona alkaloids, due to structural overlaps and being acquired at 400 MHz, which 
might be problematic in the population fitting. 
Entering more structures from force field calculations resulted in populations that were more alike 
to that of cinchonine and cinchonidine, where populations given by the rotation around C2-C9 did 
not correlate well to energies, but okay to populations from NOE distances, while the conformer 
population given by the rotation around the C8-C9 bond fitted reasonably well to the theoretical and 
NOE data, see Table 8.21. Thus the inclusion of multiple structures from force field simulations led 
to populations which correlate much better to energy- and NOE derived populations, largely 
comparable to the populations from the data of cinchonidine.  
Table 8.21. Conformational populations which exhibit dihedrals τ, defined as the value ±20 degrees, in percent (%). τ1: C3-
C4-C9-C8, τ2: C4-C9-C8-N, τ3: H9-C8-C9-H8. *Other conformations identified, does not sum to 100. (Polymer 8.6). 
 τ1 τ2 τ3   
 90 -100 20 150 -80 50 -80 60 180 Q Da 
Urakawa, energy117 79 11 10 72 3 25 72 3 25   
Butts, energyIX 75 13 12 79 0 21 79 0 21   
θ-method, no scaling 43 16 41 91 - 9 91 - 9 0.144 3.46e-4 
θ-method scaled by 1.6 55 18 27 55 17 27* 55 17 27* 0.048 5.54e-4 
NOE (p. 54) 67 12 21 67 - 33 67 - 33 - - 
 
                                                 
 
IX
 See Section 3.4.1. 
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It was difficult to pinpoint the rather large differences between populations identified using few and 
many conformers, other than the fact that multiple conformers may better illustrate the actual 
structural space. Still it markedly limits the usage of the θ-method, and more data is needed to test 
reproducibility of the RDC data.  
Generally the populations identified from RDC data for the cinchona alkaloids correlate nicely to 
energies and, especially, other NMR observables. This was actually rather surprising and the results 
are promising, since the cinchona alkaloids are more flexible than the structures usually investigated 
by RDCs, and it actually may be that RDCs hold useful non-redundant information on population of 
such systems.   
8.6.4 8-phenyl-methol 
The possible pitfall of utilizing an SVD based mulita-conformer analysis, in the form of overfitting, 
should be addressed. For this a literature study is re-calculated by the θ-method, to investigate 
assumptions of overfitting. 
The structural conformation of 8-phenylmenthol was previously determined.
255
 Here the assignment 
of the pro-chiral methyl groups was explored by RDCs; see Table 8.22 for the structure. Three 
conformers were identified by DFT calculations, which are representing a 3-jump model, i.e. 
conformers with the phenyl-group at all three positions indicated in Table 8.22. The RDC data were 
fitted to the conformers, with no assumptions of populations, in a least squares sense, from the 
values calculated by SVD from a common alignment tensor. The result is surprising in that the 
populations are almost equal and thus unaffected by the assignment of the methyl groups. This 
finding leads to one assignment being a better fit to the RDC data and the authors use this finding to 
speculate that it may be used in differentiation of the assignment. The fit between populations and 
RDCs seem puzzling to the current author as it is non-obvious that the population should be equal 
between assignments, and an identical fit should be possible from both pro-chiral assignments by 
inversion of the populations. It should be noted that the conclusions of the publication is not 
disputed, as other data is used in support.  
For the investigation of the data by the θ-method, the published RDC data were compared to back-
calculated values obtained from the published conformers as well as eight conformations covering a 
3-jump model with slight variations in the rotation. The phenyl group was treated as a 2-jump 
model, in practice averaging the RDCs of ortho- and meta-
13
C-
1
H vectors in accordance with the 
original publication. A scaling factor of 1.2 was used for Da, positioning the ring firmly in space. 
The results are summarized in Table 8.22. 
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Table 8.22. Experimental
255
 versus calculated RDCs for 8-phenyl-methol. Calculated by θ-method. The orientation of the 
methyl groups 9 and 10 are interchanged between stereoisomers as indicated to the right. Eight structures centered on a 3-
jump model for the rotation around the C2-C8 bond or three structures previously reported were used in the fit.
255
 The 
rotation of the C2-C8 bond is named given by the orientation of the phenyl group: Anti (blue), G+ (green) and G- (red). 
C H Exp [Hz] 
8 structures [Hz] 3 structures [Hz]
255
 
Stereo 1 Stereo 2 Stereo 1 Stereo 2 
1 1 113.5 111.8 111.0 110.9 110.2 
2 2 114.3 114.3 113.4 112.9 114.8 
4 4eq 7.7 5.9 6.6 8.2 7.4 
4 4ax 112.0 113.6 112.0 113.1 111.9 
5 5 103.8 103.5 103.4 106.4 105.2 
6 6eq 8.1 6.0 7.2 7.5 7.6 
6 6ax 112.4 111.4 114.1 110.8 112.5 
7 7 33.9 38.0 38.8 37.9 37.3 
9 9  -32.6 -32.7 -32.2 -30.7 -31.5 
10 10  -13.0 -13.3 -13.6 -12.0 -13.1 
ortho ortho 105.3 100.2 101.1 103.8 104.2 
meta meta 102.4 105.1 105.5 101.1 101.7 
para para -16.9 -16.2 -16.2 -16.5 -16.9 
       
  Q-factor 0.021 0.021 0.023 0.018 
  Da 3.76E-03 3.76E-03 3.01E-03 3.01E-03 
Populations 
  Anti 0.03 0.00 0.00 0.00 
  G+ 0.16 0.62 0.20 0.62 
  G- 0.81 0.38 0.80 0.38 
 
 
 
 
 
When fitting the conformations with the θ-method excellent fits of experimental and back-
calculated RDCs for both methyl assignments were determined. The assumption that the 
conformational population of G+ and G- could be inverted to fit the data between methyl 
assignments was confirmed. This makes it impossible to differentiate the two pro-chiral methyl 
groups, in good correlation to the experimental data. Unless one can unambiguously establish the 
alignment of the chair, the free rotation of the group should make the data possible for both. Also, it 
should be noted that since the chair only has four non-parallel vectors, the rotation of the group is 
used in establishing the alignment tensor, and thus relative alignment of the two groups is hardly 
established.  
This is a prime example of how MCST fitting will at times lead to the overfitting of data. It should 
be noted that the authors offer another likely method of differentiation; by chemical shift 
calculations as the aromatic ring will shift resonances due to the inductive effect.
255
 This makes the 
G- conformer the most likely highly populated of the G+ and G- conformers, and thus the 
assignment in structure 1 (Table 8.22) is the most likely assignment, in line with the conclusions 
reached in the original publication. Thus coupling of different data may be used to differentiate the 
two pro-chiral methyl groups; RDCs alone may not. 
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 The Combination of Multiple Methods 8.7
The three NMR observables primarily utilized in this thesis, NOEs, 
3
J-coupling constants and 
RDCs, are highly compatible and orthogonal methods to gain information of 3D structures, due to 
differences in the mechanisms which give rise to the observables and in the averaging functions. 
For small molecules the three observables are seldom combined and most literature is centered on 
either NOEs and J-coupling constants or RDCs. A reason for this may be that RDCs are not yet 
widespread in the small molecule community and may be seen as cumbersome to obtain. Another 
might be that multiple programs are used for the respective calculations that do not necessarily 
interface well. Also the averaging of structures for RDC calculations, as well as NOEs and J-
coupling constant calculations to a large extent, is not always straightforward if large numbers of 
structures are obtained.  
The θ-method utilizes RDC data so that it may be easily coupled to data from NOEs and J-coupling 
constants, and it is expected that this may lead to an increase of structural knowledge and ease of 
calculations. The three data types have been programmed to be compared to, and converge with, 
each other, in order to investigate 3D structures of organic compounds. This is done through the 
ISPA method, Karplus equations (including HLA) and the θ-method. It is here utilized that all three 
methods are easily interfaced with each other, for single or multiple conformer systems alike.   
 Conclusion and perspectives 8.8
Population fitting of flexible compounds from RDCs still lies in the future. More data from a larger 
number of structures are needed to determine the proper method for structural averaging in RDC 
calculations. The θ-method is a possible solution, where the spectroscopist or (computational) 
chemist is relieved from making decisions of overlays of structures and thus effectively parts of the 
molecule that are situated equally in space across conformers, thus easing the work. Whether the 
assumptions that Da may be determined from the experimental data and that a finite rotation will 
lead to a good representation of data holds true, may need to be finally determined from more data, 
but the present results are very promising. The θ-method discerned stereoisomers just as well as 
SVD, for the relatively rigid compounds investigated. The populations from the θ-method for the 
cinchona alkaloids correlated well to theoretical energy calculations as well as NOE populations. 
This is actually a little surprising but it seems to confirm an approximation made initially; that the 
conformer population is independent of the alignment media and Da is identical for all conformers. 
Whether this hold true for more compounds will need to be investigated in future work. 
It is readily realized that more flexibility is needed in small molecule RDC calculations, if the 
technique is to find widespread usage. Otherwise the more easily accessible observables will be 
used instead, and for the very rigid structures that are routinely used in RDC publications, even 
chemical shift calculation may be an equally good and much easier alternative. This is not the case 
regarding flexible structures, where NOEs, J-coupling constants and RDCs are needed for structural 
information. It is thus imperative that methods are developed which may cope for structural 
flexibility, and this especially true for RDCs. From most data obtained thus far, which is also the 
data presented herein, the θ-method works well, leading to meaningful conformations as well as 
populations, while easily handling inputs of multiple structures.  
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 Experimental 8.9
Polymers 
See Section 6.4 for information regarding synthesis of the PDMAA polymer. All other necessary 
information is available in figures and tables throughout this chapter. 
In the table below the constituents in the synthesis of the relevant polymers are given.  
Name 
Analyte 
(c [mM]) 
Solvent 
Monomer 
 
Crosslinker 
(mol%) 
Monomer:solvent in 
synthesis (v:v) 
Field 
[MHz] 
Polymer 8.1 Strychnine (269.1) CDCl3 DMAA MBAA (0.34) - 800 
Polymer 8.2 Reserpine (132.4) CDCl3 DMAA MBAA (0.17) 1:1 CDCl3 800 
Polymer 8.3 Cinchonidine (277.1) CDCl3 DMAA MBAA (0.17) 1:1 CDCl3 800 
Polymer 8.4 Cinchonidine (288.7) DMSO-d6 DMAA MBAA (0.16) 5:1 CDCl3 400 
Polymer 8.5 Cinchonine (219.4) CDCl3 DMAA MBAA (0.17) 1:1 CDCl3 600 
Polymer 8.6 Quinine (219.5) CDCl3 DMAA MBAA (0.17) 1:1 CDCl3 400 
NMR experiments 
The CLIP-HSQC experiments was used for the determination of one-bond CH coupling constants, 
using standard setup as described in Appendix A1. Isotropic spectra of strychnine (132 mM), 
reserpine (53 mM), cinchonidine (77 mM), cinchonine (86 mM) and quinine (89 mM) were 
acquired in 5 mm tube (0.5 mL) 
Simulations 
The modelling suite Maestro version 10.2.010 (2015) by Schrödinger was used for force field 
calculations,
126
 using the program MacroModel version 10.8.
127,128
 The MMFFs force field was 
used. To generate structures which should cover the conformational space of compounds, a 
conformational search was performed for each structure by the program MacroModel using energy 
cutoff of 50 kJ/mol, 100,000 steps and CPRG minimization.
127,129
  
Gaussian version 09 revision B.01 was used for DFT calculations including optimizations and NMR 
calculations.
131
 Structures were optimized to a B3LYP/6-31(d) level of theory unless otherwise 
stated.  
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9 Overall perspective and conclusions 
Many techniques were utilized throughout this project, all focused on increasing the structural 
knowledge of organic and natural compounds, utilizing different parts of the NMR experimental 
toolbox. Large parts of the work have been focused on model compounds, usually strychnine. The 
true test to whether the reported methods, being NMR experiments (S
3
 HMBCs) or RDC 
calculations or alignment medias (θ-method and chiral media), will lead to actual useful information 
still lies ahead; when data of novel and/or biologically or otherwise interesting structures are 
investigated. The compounds of actual interest, natural products and synthetic peptides, were all 
investigated using NOEs and 
3
JHH-coupling constants. These observables enabled the determination 
of stereochemistry of novel compounds that would have been difficult by use of a purely qualitative 
analysis, and led to novel insights into molecular structures in solution. 
The first part of Chapter 3 concerns the elucidation of 3D structural features, primarily 
stereochemistry, of the novel natural compounds from fungal sources. While some of the structures 
might have been solved from qualitative data, quantitative distances added to credibility and made 
flexible systems solvable. Flexible used in the most rigid definition, that is. Some order is needed to 
gain a handle on the compounds, but the multi-structure approach, coupled to the sturdiness of the 
NOEs and orthogonality of the J-coupling constants, led to interesting results. A slight overfitting is 
inevitable, but the alternative of using too few structures is undesirable and limits information to a 
level where one could utilize only computational chemistry – and modern spectrometers and 
experiments are sturdy enough to avoid major errors. The natural products are followed by synthetic 
peptides of biological importance. Again NOEs and J-couplings led to structural knowledge, as 
either structural differences between the three HDAC inhibiting azumamides, including more 
knowledge of the conformational space in solution, or knowledge of the interactions between two 
peptides that exhibit a high degree of specific structural recognition. In the structural recognition, 
back-calculated distances were not the prime source of information. Instead the distances were used 
to limit conformational space in simulations – leading to two complimentary structures. An 
important lesson learned was, that while very rigid and ordered structures may be “boring” and “too 
easily solved”, very flexible and chaotic structures are hardly solvable at all. In both cases NMR 
spectroscopy may help, but the approach has to be varied to fit the task at hand. The last part of the 
chapter focuses mostly on the biggest assumption taken, namely that the rotational correlation time 
is equal among all nuclei pairs. While the approaches utilized in the literature for water may work 
well to give an estimate to the rotational correlation time in organic solvents, care should be taken 
when trying to implement the rotational correlation time in calculations for organic solvent. This is 
largely still a work in progress. 
The next chapter, Chapter 4, presents two novel NMR experimental approaches to obtain homo- or 
heteronuclear long-range coupling constants. These S
3
 HMBC experiments led to easily 
interpretable spectra and very precise extraction of coupling constants. Especially the homonuclear 
variant is unrivaled in the information obtained, while the larger amount of experiments for long-
range heteronuclear couplings leads to the experiment being an excellent addition to an already 
extensive pool. The fact that only couplings to methine carbons may be extracted is limiting, but 
great sensitivity, ease of use and high correlation of the extracted coupling constants to theoretical 
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values are significant upsides to the experiments. Both experiments are prime candidates for being 
used extensively in the field of carbohydrate chemistry, as methines are abundant and long-range 
coupling constants an already established important structural parameter, as well as more general 
structural elucidation. 
The last three chapters (6-0) concern residual dipolar coupling constants (RDC) and their usage in 
structural elucidation of small molecules. The chapters may largely be seen as trying to solve the 
absolute and relative stereochemistry – the first for rigid structures and the latter for “flexible”. 
Flexible is probably an overstatement, but the structures investigated were very flexible compared 
to the rigid compounds usually published. A considerably amount of long-range RDCs were 
extracted by utilizing S
3
 HMBC homo, which may lead to a just as large amount of information, 
especially envisioned for more flexible small molecules. Enantiodiscrimination was achieved, but to 
a minor degree, using stretched polymers. While the prospect of utilizing stretched polymers for 
absolute stereochemical assignments is exciting, the current polymers do not perform to a degree 
where they will overtake the LC lead in the field anytime soon. But it is a start. The novel θ-method 
led to more information on conformer populations than the routinely utilized SVD for flexible 
compounds, or equal amount of information in much less time for less flexible structures. While 
this technique is not suited for certain tasks, e.g. enantiodiscrimination, a method of gaining 
population information from RDCs has been searched for, since they were introduced to small 
molecules. While better methods may emerge, the θ-method is easily implemented, relies on only 
the most simple of RDC formulae, and resulted in structural population information almost rivaling 
the NOEs. Not quite though, due to optimal averaging conditions for determining conformers of 
NOE distances. 
All in all many challenges were faced and tried resolved. Some projects need more work, some are 
finished with structural knowledge gained, while other will need to stand the test of letting other 
users try to utilize the methods, hopefully with success. The S
3
 HMBC experiments are “plug and 
play” experiments, which will hopefully lead to an immediate utilization in the small molecular 
NMR community. The θ-method is, though promising, not expected to replace SVD and other 
tensor based methods due to assumptions taken up front, but may be used as a complementary 
method in NOE and J-coupling constants investigations – easily interfaced in a coupled approach to 
gain structural insights. 
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A1. NMR 
A1.1. Spectrometers 
DTU 
All spectra were acquired at one of the five NMR spectrometers given below. Spectra were acquired using 
standard pulse sequences at 25 °C unless stated otherwise. The spectra were recorded using 5 mm NMR 
tubes when possible (solvent volume 500 µL) or 3 mm tubes (solvent volume 180 µL). Chemical shifts are 
always given in ppm, and coupling constants in Hz. 
- Varian Inova 500 MHz with a 5 mm HCP probe (499.87 MHz for 1H, 125.70 MHz for 13C).  
- Bruker Avance III 400 MHz with a 5 mm BBO smartprobe (400.23 MHz for 1H, 100.64 MHz for 
13C). 
- Bruker Ascend 400 MHz with a 5 mm H-br.band dual channel z-gradient Prodigy cryoprobe (400.13 
MHz for 1H, 100.61 MHz for 13C). 
- Bruker DRX 600 MHz with a 5 mm BBO smartprobe (600.13 MHz for 1H, 150.92 MHz for 13C). 
- Bruker Avance 800 MHz with a 5 mm TCI cryoprobe (798.80 MHz for 1H, 200.86 MHz for 13C). 
External stay 
The NMR spectrometers used for acquisitions at the University of Bristol are given below. 
- Varian VNMRS DirectDrive 500 MHz with a broadband two-channel OneNMR probe (499.66 MHz 
for 1H, 125.64 MHz for 13C)  
- Varian VNMRS DirectDrive 600 MHz spectrometer equipped with an indirect observe cryoprobe 
(600.05 MHz for 1H, 150.88 MHz for 13C). 
A1.2. Solvents 
The solvents used are given below along with the solvent resonances used for referencing the spectra.1 
Chemical shifts (δ) are in ppm and scalar couplings are reported in hertz (Hz). 
Solvent δH [ppm] δC [ppm] 
DMSO-d6 2.50 39.5 
CDCl3 7.26 77.2 
CD3OD 3.31 49.0 
D2O 4.79 - 
A1.3. Acquisition 
Examples of the basic setup of the most used literature experiments are found below. The pulse sequence 
given are examples of sequences often used on Bruker spectrometers. 
1D 
1
H experiments (w/wo water suppression) were used to acquire 1D proton spectra. A standard acquisition 
was as follows: si (Fourier transform size) = 64k, rd (relaxation delay) = 1.0 s, ns (number of scans) = 32, ds 
(number of dummy scans)= 8. (zg30) 
CLIP-HSQC experiment was used to acquire f2-coupled HSQC spectra for the extraction of 1JCH and 
1TCH 
(RDCs). A standard acquisition was as follows: si = 4096 , ni (number of increments) = 256, rd = 1.0 s, ns = 
8, ds = 16. The spectra were zero filled to 16k in the F2 and 1k in the F1 dimension. Coupling constants were 
extracted by overlay of 1D slices through F1. (CLIP_hsqcetgp, pulse sequence acquired from 
http://www.ioc.kit.edu/luy/110.php website of Prof. Dr. Burkhard Luy, Institut für Organische Chemie, 
Karlsruher Institut für Technologie)2 
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NOESY experiments (w/wo water suppression) were used to acquire 2D NOESY spectra. A standard 
acquisition was as follows: si = 4096 , ni = 256, ns = 8, ds = 32. The mixing time was usually 50-300 ms and 
the relaxation delay depends on the T1 of the protons (usually around 1-5 s used). The spectra were zero 
filled to 8k in the F2 and 1k in the F1 dimension. Integrals were determined from the spectra in Topspin. 
(noesyph, noesyphpr, noesygpph19)3–6 
ROESY experiments (w/wo water suppression) were used to acquire 2D T-ROESY spectra. A standard 
acquisition was as follows: si = 4096 , ni = 256, ns = 8, ds = 32. The mixing time was usually 50-300 ms and 
the relaxation delay depends on the T1 of the protons (usually around 1-5 s used). The spectra were zero 
filled to 8k in the F2 and 1k in the F1 dimension. Integrals were determined from the spectra in Topspin. 
(roesyph.2, roesyphpr.2, roesygpph19.2)7,8,5,6 
DPFGSE NOESY (double-pulsed-field-gradient-spin-echo) or SPFGSE NOESY (single-pulsed-field-
gradient-spin-echo) experiment was used for 1D NOESY experiments. A standard acquisition was as 
follows: si = 64k, rd = 1.0 s, ns = 128, ds = 8. The mixing time was usually 300-500 ms. The spectra were 
zero filled to 128k. Integrals were determined by setting the integral of the irradiated resonance equal to        
-1,000 and determining the other relative integrals (PANIC approach). 
DQF-COSY experiments were used to acquire 2D COSY spectra. A standard acquisition was as follows: si 
= 4096 or 8096 , ni = 512, ns = 8, ds = 32, rd = 1.0 s. The spectra were zero filled to 8k in the F2 and 1k in 
the F1 dimension. (cosygpmfphpp)9–12 
gHSQC experiments were used to acquire multiplicity edited HSQC spectra. A standard acquisition was as 
follows: si = 2048, ni = 256, ns = 8, ds = 32, rd = 1.0 s. The spectra were zero filled to 8k in the F2 and 1k in 
the F1 dimension. (hsqcedetgpsisp2.3)13–18 
gHMBC experiments were used to acquire HSQC spectra. A standard acquisition was as follows: si = 2048, 
ni = 256, ns = 8, ds = 32, rd = 1.0 s, JHMBC=8 Hz. The spectra were zero filled to 8k in the F2 and 1k in the 
F1 dimension. (hmbcetgpl3nd)19,20 
S
3
 HMBC homo experiments were used to acquire S3 edited HMBC spectra for extraction of homonuclear 
coupling constants. A standard acquisition was as follows: si = 4096, ni = 256, ns = 8 or 16, ds = 32, rd = 1.0 
s, JHMBC=8 Hz. The spectra were zero filled to 16k in the F2 and 1k in the F1 dimension. 
S
3
 HMBC hetero experiments were used to acquire S3 edited HMBC spectra for extraction of heteronuclear 
coupling constants. A standard acquisition was as follows: si = 4096, ni = 256, ns = 8 or 16, ds = 32, rd = 1.0 
s, JHMBC=8 Hz. The spectra were zero filled to 16k in the F2 and 1k in the F1 dimension.  
The new pulse sequences of S3 HMBC homo/hetero are not included, but are provided upon request, and 
the acquisition data are given in the thesis. 
A2. Other equipment 
Analytical RP-UPLC-MS analyses were performed on a Waer Aquity RP-UPLC system with a diode array 
detector (DAD) coupled to a SQD mass spectrometer. The ionization method was ESI. The column was a 
Aquity UPLC BEH C18 column (1.7 μm, 2.1×50mm, 0.6 mL/min, 65 °C) Eluents were water and MeCN 
(both added 0.1 % HCO2H), and a linear gradient of 5-100 % MeCN over aprox. 2.6 min was used. 
Analytical RP-UPLC-HRMS data were recorded on a Maxis 3G UHR-QTOF-MS by Bruker  Daltonics with 
an UltiMate 3000 Rapid Separation LC by system Thermo Scientific Dionex. The ionization method was 
ESI and UV spectra from the DAD were collected at wavelengths from 200-700 nm. The column used was a 
Software 
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Kinetex C18 (2.6 µm, 100x2.1 mm, 0.4 mL/min, 40 °C). Solvents were MeCN and water (both added 20 
mM HCO2H), and a linear gradient of 10-100 % MeCN in 10 minutes followed by 100 % MeCN for 3 
minutes was used. 
Optical rotation was measured on a Perkin-Elmer 341polarimeter, with a 100 mm cell of 1 mL, with a 
sodium lamp (589 nm, 20 °C). 
A3. Software 
A3.1. DataAnalysis 
To analyse obtained HPLC-DAD-MS spectra, the program DataAnalysis by Bruker was used. An internal 
standard was used to gain higher mass accuracy. SmartFormula was used to generate and evaluate 
constituent formulas for a given mass.  
A3.2. Gaussian 
The program Gaussian version 09 revision B.01 by Gaussian was used for DFT calculations including 
optimizations and NMR calculations.21  
A3.3. Maestro 
The modelling suite Maestro version 10.2.010 (2015) by Schrödinger was used for force field calculations.22 
The programs MacroModel version 10.8 and Desmond version 4.2 were used.23,24 
A3.4. Matlab 
The program Matlab version R2015a (2015) by The MathWorks Inc. was used for scripting and automating 
processes. The scripts were all made in house utilizing the general available scripts imbedded in the program.  
The script RBNMR by Niels Nyberg was used to load NMR spectral data into Matlab. 
A3.5. MestReNova 
The obtained 1D and 2D NMR spectra from my external stay were processed in MestReNova v. 6.2.1 by 
MestReLab Research S. L. 
A3.6. MSPIN 
The software MSPIN version 1.3.3-79 (2013) by MestReLab Research S. L. was generally used for RDC 
(SVD) back-calculations.25 The program may also be used for NOE and J coupling constant calculation but 
this was not generally used, though it was used to check the HLA calculations of the scripts. The NOE 
calculations were not used as the program uses a matrix approach.  
A3.7. PALES 
The RDC software PALES was initially used and compared to MSPIN.26 The latter program was used 
throughout and the two programs were found to give comparable results.  
A3.8. Topspin 
The obtained 1D and 2D NMR spectra were generally processed in Topspin version 3.1 (2012) by Bruker 
BioSpin. 
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A4. NMR Assignments 
A4.1. Natural products 
A4.1.1. Homomorphosin A 
 
Table A4-1. NMR assignment of homomorphosin A 
# δH [ppm] (int,mult,J [Hz]) δC [ppm] 
1 6.72 (1H,s) - 
2 - 90.8 
3 - 89.1 
4 - 127.3 
5 - 139.3 
6 6.47 (1H,d,7.6) 119.3 
7 6.99 (1H,t,7.7) 129.4 
8 6.56 (1H,d,7.8) 107.8 
9 - 149.6 
10 - 
 
11 3.66 (1H,dd,11.5,7.3) 57.0 
12a 2.54 (1H,m) 34.6 
12b 2.62 (1H,dd,13.0,7.4) 34.6 
13 - 170.4 
14 7.95 (1H,s) - 
15 3.77 (1H,d,1.9) 60.4 
16 - 171.8 
17a 2.32 (1H,septd,7.1,2.0) 26.7 
17b - - 
18 0.86 (3H,d,6.8) 15.8 
19 0.98 (3H,d,7.2) 18.1 
20a - 44.6 
20b - - 
21 6.27 (1H,dd,17.6,10.8) 145.2 
22a 4.85 (1H,m) 110.6 
22b 4.85 (1H,m) 110.6 
23 1.17 (3H,s) 24.2 
24 1.20 (3H,s) 24.5 
25a 3.33 (1H,m) 28.6 
 
Table A4-2. ROE intensities of homomorphosin A (τm = 150 ms) 
H1 H2 ηnorm Rel 
1 8 0.0135 0.74 
1 21 0.0075 0.41 
1 23/24 0.0185 1.01 
1 23/24 0.0185 1.01 
6 25a 0.0092 0.50 
6 26 0.0091 0.50 
6 29 0.0017 0.09 
7 8 0.0183 1.00 
11 16 0.0162 0.89 
15 17 0.0065 0.36 
15 16 0.0105 0.57 
16 17 0.0327 1.79 
16 18 0.0079 0.43 
16 19 0.0291 1.59 
17 18 0.0259 1.42 
17 19 0.0298 1.63 
21 12a 0.0076 0.42 
21 23/24 0.0288 1.57 
21 23/24 0.0288 1.57 
21 30 0.0094 0.51 
22b 18 -0.0012 -0.06 
22b 23/24 -0.0316 -1.73 
22b 23/24 -0.0316 -1.73 
25b 12b -0.0395 -2.16 
25b 29 -0.0140 -0.77 
26 28 0.0191 1.04 
30 12a 0.0081 0.45 
30 23/24 0.0293 1.60 
30 23/24 0.0293 1.60 
30 25b 0.0087 0.48 
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Table A4-3. Experimental distances in Å from relative ROE intensities and J-coupling constants in Hz compared to best fit of multiple 
structures for the assignment used and by interchanging the prochiral methyl groups 18 and 19, or the diastereotopic protons of C25 (τm = 
150 ms) 
NOE 
  
Right Dia-CH3-18/19 Dia-25 
H1 H2 Exp Calc Diff % Calc Diff % Calc Diff % 
15 17 2.94 2.93 0.01 0.5 2.59 0.36 12.2 2.91 0.03 1.1 
15 16 2.72 2.73 0.00 0.1 2.72 0.00 0.1 2.73 0.00 0.1 
7 8 2.48 2.48 0.00 0.0 2.48 0.00 0.0 2.48 0.00 0.0 
1 21 2.88 2.96 0.08 2.7 2.86 0.02 0.6 3.03 0.15 5.2 
1 23/24 3.34 3.37 0.03 0.9 3.36 0.02 0.7 3.36 0.02 0.7 
6 25a 2.78 2.76 0.02 0.9 2.74 0.04 1.4 2.72 0.06 2.3 
6 26 2.79 2.80 0.01 0.3 2.84 0.05 1.7 2.76 0.03 1.2 
6 29 4.41 4.42 0.01 0.1 4.42 0.01 0.1 4.44 0.03 0.6 
30 23/24 3.09 3.35 0.26 8.5 3.37 0.28 8.9 3.35 0.26 8.4 
30 12a 2.84 2.75 0.09 3.1 2.76 0.08 2.7 2.64 0.20 6.9 
30 25b 2.81 2.92 0.11 4.0 2.91 0.10 3.7 2.89 0.08 2.8 
26 28 2.96 2.82 0.14 4.6 2.82 0.14 4.7 2.82 0.14 4.6 
22b 23/24 3.05 3.16 0.11 3.6 3.16 0.11 3.6 3.15 0.10 3.4 
21 23/24 3.10 3.28 0.18 5.8 3.28 0.18 5.7 3.30 0.20 6.3 
21 12a 2.87 2.96 0.09 3.1 2.92 0.05 1.7 3.02 0.15 5.2 
21 30 2.77 2.89 0.12 4.2 2.88 0.11 3.9 2.92 0.15 5.4 
22b 18 4.71 4.67 0.04 0.8 4.69 0.02 0.4 4.63 0.08 1.6 
16 18 3.42 3.50 0.08 2.3 3.21 0.22 6.3 3.49 0.07 2.0 
16 19 2.76 3.01 0.25 9.1 3.18 0.42 15.3 3.01 0.26 9.3 
16 17 2.25 2.52 0.27 12.1 2.52 0.27 12.1 2.52 0.27 12.1 
25b 29 3.11 3.07 0.04 1.3 3.22 0.10 3.3 3.40 0.29 9.2 
25b 12b 2.18 2.27 0.09 4.1 2.33 0.15 6.8 2.21 0.03 1.2 
11 16 2.53 2.44 0.09 3.7 2.44 0.10 3.8 2.44 0.10 3.8 
17 18 2.81 2.62 0.20 7.0 2.61 0.20 7.2 2.62 0.20 7.0 
17 19 2.75 2.61 0.14 5.0 2.61 0.14 5.0 2.61 0.14 5.0 
1 8 2.61 2.66 0.05 1.9 2.66 0.05 1.8 2.66 0.05 1.9 
  
MAE 0.1 3.5 
 
0.1 4.4 
 
0.1 4.1 
            
J-coupl 
          
H1 H2 Exp Calc Diff 
 
Calc Diff 
 
Calc Diff 
 
12b 11 7.3 6.5 0.8 
 
6.5 0.8 
 
6.6 0.8 
 
15 17 2.0 1.9 0.1 
 
1.9 0.1 
 
1.9 0.1 
 
12a 11 11.5 10.2 1.3 
 
10.2 1.3 
 
10.2 1.3 
 
   
MAE 0.2 
  
0.2 
  
0.2 
 
  
  Natural products 
 
 
A-8 
A4.1.2. Cyclomorphosin A 
Table A4-4. NMR assignment of cyclomorphosin A 
# δH [ppm] (int,mult,J [Hz]) δC [ppm] COSY HMBC NOESY (800 ms) 
1 12.76 (1H, s) 
   
39,47,48 
2 
 
172.6 
   
3 4.60 (1H, dt = 15.4,7.1) 51 4,33a,33b 2,33 33a,33b 
4 8.03 (1H, d = 8.7) 
 
3 3,5 3,6,9,1,33a,33b,34a,35a,34b,35b 
5 
 
170.6 
   
6 4.75 (1H, d = 6.7) 58.9 34a 34,35,36 9, 37, 38,34a,35a,34b,35b,36a 
7 - 
    
8 
 
165.8 
   
9 3.73 (1H, t=4.4) 55.9 10,37 37,38 38,34a,35a,34b,35b 
10 7.60 (1H, d = 4.6) 
 
9 8, 9,11 9,12,15,38 
11 
 
168.2 
   
12 4.90 (1H, t = 9.6) 58 13,26 11,14,26 
 
13 8.21 (1H, d = 10.2) 
 
12 14 10, 12, 15, 22, 26,40a,40b 
14 
 
169.4 
   
15 4.14 (1H, q=7.9) 52.5 16,40a,40b 14,40 40a,40b 
16 6.56 (1H, d=9.1) 
 
15 15,17 15, 18,40a,40b 
17 
 
169.9 
   
18 3.75 (1H, d=5.5) 74.1 48 17,49 
 
19 5.95 (1H, s) 78.2 
 
17,41,49 18,36a 
20 
 
155.7 
   
21 7.04 (1H, m) 116.3 22 23,25 19 
 
22 7.19 (1H, dd=8.1,2.6) 129.6 21 20,24,26 15,19,26 
23 7.02 (1H, m) 120.3 24 21,25 18,19 
24 7.42 (1H, m) 127.6 23 20,26,31,49 12,29 
25 
 
131.6 
   
26 5.44 (1H, d = 8.9) 79.4 12 11,12,22,25 
 
27 
 
155 
   
28 6.82 (1H, dd=8.2,2.4) 118.8 29 22,27,30 26 
 
29 7.01a (1H, m) 127.8 31,30 27,33 3, 26,33a,33b 
30 7.01b (1H, m) 113.8 28 28 3, 26,33a,33b 
31 6.93 (1H, dd=8.3,1.1) 129.5 29,30 27, 29,33 3,33a,33b 
32 
 
129.6 
   
33a 2.82 (1H, dd = 14.3,11.9) 34.9 3,33b 3,22,29 
 
33b 3.18 (1H, dd = 14.3,4.1) 34.9 3,33a 3,22 33a 
 
34a 1.92 (1H, m) 20.8 6,34b,35b,36a,36b 5,35,36 
 
35a 1.92 (1H, m) 30.3 6,34b,35b,36a,36b 5,34,36 
 
34b 1.79 (1H, m) 20.8 34a,35a,36a 5,6,36 
 
35b 1.79 (1H, m) 30.3 34a,35a,36a 5,6,36 
 
36a 3.38 (1H, m) 45.9 34a,34b,36b 34 38,34a,35a,34b,35b 
36b 3.52 (1H, m) 45.9 34a,36a 34,35 34a,35a,34b,35b 
37 4.19 (1H, m) 64.8 9,38 
 
9,38 
38 0.85 (3H, d= 6.4) 17.4 37 9,37 
 
39 4.93 (1H, s) 
 
37 
 
1,47,48 
40a 2.31 (1H, td = 13.7,7.0) 38.3 15,40b 14,15,31,41 
 
40b 2.49 (1H, m) 38.3 15,40a 14,15,31,41 
 
41 
 
126.5 
   
42 6.78 (1H, d=8.4) 129.5 43,45 22, 43, 46,40 15,40a,40b 
43 6.51 (1H, m) 114.4 
 
41,43,46 38,36a 
44 6.78 (1H, d=8.4) 129.5 43,45 22, 43, 46,40 15,40a,40b 
45 6.50 (1H, m) 114.4 42,44 41,43,46 38,36a 
46 
 
155.5 
   
47 9.13 (1H, s) 
  
43 12,43,48 
48 6.02 (1H, d = 4.5) 
 
18 17,18 
 
49 
 
140.4 
   
50 7.59 (1H, m) 126.5 53 19 18,19,53 
51 7.41 (1H, m) 127.7 54 20,26,31,49 12,29 
52 7.59 (1H, m) 126.5 53 19 18,19,53 
53 7.39 (1H, m) 127.7 50,52 20,26,31,49 12,29 
54 7.33 (1H, t=7.2) 127.3 51 
  
NMR Assignments 
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All distances 
Table A4-5. NOE intensities of cyclomorphosin A (τm = 200 ms) 
H1 H2 ηnorm Rel 
3 29 0.0403 0.11 
3 31 0.0125 0.03 
3 33b 0.0401 0.11 
4 6 0.0497 0.14 
4 33a 0.0153 0.04 
4 33b 0.0029 0.01 
4 35b 0.0061 0.02 
4 36b 0.0081 0.02 
6 9 0.1048 0.29 
6 34a 0.0547 0.15 
6 34b 0.0343 0.09 
9 10 0.0206 0.06 
9 37 0.0306 0.08 
10 12 0.0679 0.19 
10 13 0.0121 0.03 
10 38 0.0115 0.03 
12 24 0.0361 0.10 
13 15 0.0964 0.27 
13 22 0.0117 0.03 
13 26 0.0237 0.07 
15 16 0.0110 0.03 
15 40a 0.0288 0.08 
15 40b 0.0212 0.06 
16 18 0.0085 0.02 
16 40a 0.0131 0.04 
18 19 0.0411 0.11 
19 21 0.1532 0.42 
22 26 0.0696 0.19 
26 30 0.1017 0.28 
29 33a 0.0241 0.07 
29 33b 0.0297 0.08 
31 33a 0.0599 0.16 
33a 33b 0.2816 0.77 
34b 36b 0.0537 0.15 
35b 36a 0.0689 0.19 
37 38 0.0288 0.08 
38 43/45 0.0047 0.01 
40a 40b 0.3635 1.00 
 
 
 
 
 
 
 
 
  
  Natural products 
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Ring A distances 
Table A4-6. Experimental distances in Å from relative NOE intensities compared to best fit of multiple structures for possible diastereomers 
of ring A, cyclomorphosin A (τm = 200 ms) 
Exp. 
12S,15S,18R, 
19S,26S 
12S,15R,18R, 
19S,26S 
12S,15S,18S, 
19S,26S 
12S,15R,18S, 
19S,26S 
12R,15S,18R, 
19S,26R 
2.57 2.76 2.71 2.82 2.65 2.89 
2.18 2.12 2.45 2.12 2.48 2.39 
3.10 3.20 3.44 3.21 3.27 3.22 
2.75 2.91 2.85 2.93 2.97 3.02 
3.13 2.99 2.90 2.94 2.93 2.97 
2.67 2.69 2.72 2.70 2.74 2.62 
2.80 2.80 2.73 2.79 2.73 2.78 
3.27 3.31 2.66 2.16 2.79 3.35 
3.04 2.92 2.99 2.89 3.03 2.67 
2.51 2.65 2.55 3.09 2.65 2.68 
2.02 2.14 2.29 2.15 2.45 2.49 
2.30 2.32 2.32 2.34 2.30 2.58 
1.75 1.75 1.75 1.75 1.75 1.75 
 
Figure A4.1. Representative structures of ring A. Grey: 
12S,15S,18R,19S,26S, orange: 12S,15R,18R,19S,26S, turquoise: 
12S,15R,18S,19S,26S, purple: 12S,15S,18S,19S,26S, green: 
12R,15S,18R,19S,26R, 
 
Ring B distances 
Table A4-7. Experimental distances in Å from relative NOE intensities compared to best fit of multiple structures for possible diastereomers 
of ring B, cyclomorphosin A (τm = 200 ms) 
Exp. 
3S,6S,9S, 
12S,26S 
3R,6S,9S, 
12S,26S 
3S,6R,9S, 
12S,26S 
3S,6S,9R, 
12S,26S 
3R,6R,9S, 
12S,26S 
3R,6S,9R, 
12S,26S 
3S,6R,9R, 
12S,26S 
3R,6R,9R, 
12S,26S 
2.42 2.58 2.82 2.53 2.78 3.02 2.73 2.56 2.70 
2.94 2.96 3.02 2.93 3.05 3.24 2.95 2.92 3.01 
2.42 2.56 2.51 2.59 2.50 2.50 2.54 2.51 2.55 
2.33 2.37 2.52 2.71 2.23 2.38 2.63 2.48 2.27 
2.84 2.77 2.62 2.65 2.65 2.63 2.71 2.72 2.67 
3.75 3.83 3.75 3.76 3.72 3.69 3.80 3.80 3.78 
2.06 2.26 2.24 2.39 2.50 2.53 2.32 2.43 2.39 
2.70 2.81 2.77 2.78 2.59 2.67 2.64 2.60 2.60 
2.53 2.53 2.57 2.54 2.57 2.51 2.62 2.68 2.65 
2.22 2.24 2.21 2.29 2.20 2.34 2.16 2.32 2.31 
2.96 2.94 2.89 2.49 2.82 2.91 3.05 2.94 2.87 
2.98 3.27 3.19 3.32 3.33 3.40 3.14 3.20 3.28 
2.07 2.20 2.32 2.23 2.18 2.46 2.49 2.29 2.44 
2.63 2.86 2.69 2.91 2.88 2.73 2.77 2.91 2.72 
2.54 2.84 3.08 2.79 2.75 2.81 2.85 2.84 2.87 
2.26 2.48 2.68 2.49 2.49 2.60 2.59 2.50 2.55 
1.75 1.75 1.75 1.75 1.75 1.75 1.75 1.75 1.75 
2.56 2.62 2.61 2.61 2.62 2.62 2.62 2.61 2.62 
NMR Assignments 
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Figure A4.2. Representative structures of the conformational space covered by CM A. 
Only best structure used 
Table A4-8. Lowest MAE found between experimental distances from relative NOE intensities and distances of the single structure for 
possible diastereomers of ring A and B, cyclomorphosin A (τm = 200 ms) 
MAE NOE [Å] Js [Hz] 
Ring A 
12S,15S,18R,19S,26S 0.16 4.3 
12S,15R,18R,19S,26S 0.44 4.0 
12S,15S,18S,19S,26S 0.38 8.0 
12S,15R,18S,19S,26S 0.54 5.8 
12R,15S,18R,19S,26R 0.80 3.6 
Ring B 
3S,6S,9S,12S,26S 0.70 0.4 
3R,6S,9S,12S,26S 0.84 1.2 
3S,6R,9S,12S,26S 0.76 1.0 
3S,6S,9R,12S,26S 0.53 1.6 
3R,6R,9S,12S,26S 0.81 0.6 
3R,6S,9R,12S,26S 0.69 2.2 
3S,6R,9R,12S,26S 0.57 1.7 
3R,6R,9R,12S,26S 0.65 1.4 
 
  
  Natural products 
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A4.1.3. Cyclomorphosin B 
Table A4-9. NMR assignment of cyclomorphosin B 
# 
δH [ppm] 
(int,mult,J [Hz]) 
δC 
[ppm] 
COSY HMBC 
NOESY 
(800 ms) 
1 - 
    
2 
     
3 4.50 (1H,td=10.1,3.6) 52.2 4,33a 
 
33b 
4 7.83 (1H,d=9.4) 
 
3 
 
6 
5 
 
168.3 
   
6 4.19 (1H,dd=8.0,6.2) 57.5 7 5, 8,34,35 4,7 
7 6.87 (1H,d=6.8) 
   
10 
8 
 
170 
   
9 4.13 (1H,t=8.7) 58.1 10,37 8, 37,39 10,38 
10 8.53 (1H,d=9.4) 
 
9 11 7,12 
11 
 
169.2 
   
12 4.66 (1H,dd=9.7,7.3) 58.6 13,26 14,26 10,22 
13 8.33 (1H,d=9.9) 
 
12 14 15,21 
14 
 
169.3 
   
15 4.39 (1H,dt=9.3,8.0) 51.7 16,40a,40b 
 
13, 16,40b 
16 6.48 (1H,d=9.5) 
 
15 
 
15,48 
17 
 
169.7 
   
18 3.75b (1H,m) 74.2 48 
  
19 5.93 (1H,s) 78.7 
 
49,50 21,50 
20 
 
155.6 
   
21 7.06 (1H,d=8.5) 120.6 22 23,25 13,19,22,26 
22 7.46 (1H,d=8.5) 126.8 21 24 12,21 
23 7.04 (1H,m) 116.9 
 
20,25 
 
24 7.01 (1H,m) 128.9 23 22 
 
25 
 
132.2 
   
26 5.53 (1H,d=7.2) 78.9 12 11,22,24,25,27 21,28 
27 
 
155.2 
   
28 6.76 (1H,d=6.8) 
 
29 
 
26 
29 6.98 (1H,m) 
 
28 
  
30 6.76 (1H,d=6.8) 
 
29 
  
31 6.98 (1H,m) 
 
28 
  
32 
     
33a 2.54 (1H,m) 36.4 3,33b 
 
33b 
33b 3.09 (1H,dd=13.3,3.6) 36.4 33a 
 
3,33a 
34 3.75a (1H,m) 65.8 35,36 
 
6,16,19,35,48 
35 0.95 (3H,d=6.2) 19.7 
 
6,34 
 
36 4.61 (1H,d=5.1) 
  
34,35 
 
37 1.66 (1H,m) 36.5 9,38 
  
38 0.75 (1H,d=6.7) 15.1 37 9, 37,39 
 
39a 0.98 (1H,m) 24.4 39b,39’ 
  
39b 1.30 (1H,m) 24.4 39a,39’ 
  
39’ 0.74 (1H,d=7.3) 15.1 39a,39b 37,39 
 
40a 2.33 (1H,d=13.9,7.2) 37.9 15,40b 14,15,41,42 
 
40b 2.49 (1H,m) 37.9 15,40a 41,42 
 
41 
 
126.5 
   
42 6.80 (1H,d=8.4) 129.6 43 42,46 43 
43 6.51 (1H,d=8.3) 114.4 42 41,43,46 42 
44 6.80 (1H,d=8.4) 129.6 43 42,46 43 
45 6.51 (1H,d=8.3) 114.4 42 41,43,46 42 
46 
 
155.4 
   
47 9.08 (1H,s) 
  
43,46 
 
48 6.01 (1H,d=6.6) 
  
17,18,19 16 
49 
 
140.6 
   
50 7.59 (1H,d=7.6) 126.6 51 19,50,54 51 
51 7.40 (1H,t=7.5) 127.9 50,54 49,51 50,54 
52 7.59 (1H,d=7.6) 126.6 51 19,50,54 51 
53 7.40 (1H,t=7.5) 127.9 50,54 49,51 50,54 
54 7.32 (1H,t=7.3) 127.2 51 50 51 
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Cyclomorphosin A and B, other data 
Cyclomorphosin A: HRMS:  m/z = 850.3307. [M+H]+, calculated for [C46H43N9O8+H]
+: m/z = 850.3307. 
Adducts: 872 [M+Na]+, 425 [M+2H]2+. [𝛼]589.3
20  = -0.02°. UVmax: 225 nm, 276 nm. 
Cyclomorphosin AB: HRMS:  m/z = 866.36a1. [M+H]+, calculated for [C47H47N9O8+H]
+: m/z = 866.36b0. 
Adducts: 888 [M+Na]+, 883 [M+NH3]
+, 433 [M+2H]2+. [𝛼]589.3
20  = 0.3°. UVmax: 226 nm, 271 nm. 
 
A4.1.4. Homomorphosterol 
Table A4-10. NMR assignment of homomorphosterol 
# δH [ppm] (int,mult,J [Hz]) δC [ppm] 
1a 1.06 (1H,dd, 13.3,2.7) 35.5 
1b 1.66 (1H,m) 35.5 
2a 1.32 (1H,m) 31.4 
2b 1.72 (1H,m) 31.4 
3 3.25 (1H,m) 68.9 
4a 2.08b (1H,m) 41.9 
4b 2.29 (1H,dd, 13.9, 2.8) 41.9 
5  143.5 
6 5.29 (1H, br. s) 120.4 
7 2.58 (1H, br. s) 35.5 
8  127.4 
9 1.80 (1H,m) 46.8 
10  36.3 
11a 1.48 (1H,m) 19 
11b 1.52 (1H,m) 19 
12a 1.30 (1H,m) 38.3 
12b 1.97 (1H,12.4, 2.8) 38.2 
13  42 
14  145.7 
15 2.38 (1H, td, 10.1, 3.8) 36 
16a 1.58 (1H,m) 35.3 
16b 1.74 (1H,m) 35.3 
17 1.25 (1H,m) 54.1 
18 0.92 (3H,m) 19.7 
19 0.78 (3H,m) 17.8 
20 2.08a (1H,m) 38.4 
21 1.00 (3H,d, 6.6) 20.6 
22 5.19 (1H,m) 135.1 
23 5.25 (1H,m) 131.6 
24 1.87 (1H,q, 6.0) 42.1 
25 1.46 (1H,m) 32.5 
26 0.80b (3H,m) 19.6 
27 0.80a (3H,m) 19.6 
28 0.89 (3H,d, 7.0) 17.2 
30 2.16 (1H, dd, 5.7,10.1) 49.9 
31 2.91 (1H,dd, 6.9,5.7) 47.2 
32  175 
33  176.6 
OH 4.64 (1H,s) - 
COOH 12.12 (1H, br. s) - 
 
 
 
 
  Natural products 
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Table A4-11. Chemical shifts of homomorphosterol compared to theoretical shielding constants of possible diastereomers, calculated by 
mPW1PW91/6-311+G(2d,p) using GIAO.  
 Shielding constants 
Exp. 1H δ (ppm) (RRSS) (RRRS) (RSRS) (RSSS) (SRSR) (SRRR) (SSSR) (SSRR) 
1.25 -30.2 -29.9 -30.1 -30.1 -29.9 -30.0 -29.9 -30.0 
1.58 -30.0 -29.8 -30.3 -30.1 -29.9 -29.8 -29.9 -29.9 
1.74 -30.1 -29.7 -29.7 -30.1 -30.2 -30.4 -30.2 -30.0 
2.38 -28.3 -29.1 -28.7 -28.1 -29.0 -28.8 -29.1 -28.8 
2.58 -28.4 -28.6 -28.9 -28.8 -28.3 -28.3 -28.3 -27.9 
5.29 -25.6 -25.6 -25.9 -25.9 -25.7 -25.9 -25.9 -25.6 
2.29 -29.2 -29.2 -29.3 -29.2 -29.3 -29.3 -29.3 -29.4 
2.08 -29.5 -29.3 -29.5 -29.5 -29.4 -29.4 -29.5 -29.4 
3.25 -27.9 -28.0 -27.9 -27.9 -28.0 -28.0 -27.9 -28.0 
1.32 -29.9 -30.0 -30.0 -29.9 -30.0 -30.0 -29.9 -29.9 
1.72 -30.1 -30.1 -30.1 -30.2 -30.2 -30.2 -30.1 -30.1 
1.06 -30.5 -30.5 -30.4 -30.4 -30.5 -30.5 -30.5 -30.5 
1.66 -29.9 -29.9 -29.8 -29.9 -29.9 -29.9 -29.8 -29.9 
1.80 -29.9 -29.7 -29.7 -29.7 -29.4 -29.4 -29.4 -29.3 
1.48 -30.0 -30.1 -30.0 -30.0 -30.0 -30.1 -30.0 -29.9 
1.52 -30.0 -29.9 -29.9 -30.1 -29.9 -29.9 -29.9 -29.8 
1.03 -30.5 -30.4 -30.4 -30.4 -30.5 -30.6 -30.5 -30.5 
1.97 -29.9 -29.7 -29.7 -29.8 -29.8 -29.8 -29.7 -29.9 
0.92 -31.0 -31.1 -31.1 -31.1 -31.1 -31.1 -31.1 -30.9 
0.78 -31.0 -30.9 -30.9 -31.0 -30.9 -30.9 -31.0 -31.1 
2.91 -28.2 -28.1 -28.7 -29.1 -29.1 -28.8 -28.3 -28.1 
2.16 -28.3 -29.1 -29.0 -28.2 -28.6 -28.3 -28.9 -28.5 
a 1.23 1.19 1.12 1.14 1.14 1.14 1.15 1.21 
b -31.86 -31.81 -31.73 -31.73 -31.77 -31.75 -31.75 -31.79 
 
 
Shielding constants 
Exp. 13C δ (ppm) (RRSS) (RRRS) (RSRS) (RSSS) (SRSR) (SRRR) (SSSR) (SSRR) 
35.3 -146.6 -147.0 -145.4 -148.1 -148.4 -149.7 -148.3 -149.2 
36.0 -147.4 -141.7 -145.4 -147.0 -138.5 -143.3 -141.1 -139.1 
145.7 -32.1 -30.3 -29.1 -34.1 -31.5 -34.3 -31.5 -36.2 
127.4 -54.5 -48.2 -48.7 -49.6 -48.6 -48.2 -49.9 -51.0 
35.5 -142.4 -144.5 -142.7 -142.8 -147.2 -147.5 -145.7 -145.7 
120.4 -56.2 -59.1 -59.3 -59.2 -56.4 -57.5 -59.1 -56.3 
143.5 -31.3 -30.0 -29.1 -29.6 -30.5 -30.1 -29.0 -34.4 
41.9 -144.7 -144.2 -144.6 -144.1 -144.3 -144.4 -144.4 -144.7 
68.9 -112.4 -112.1 -112.6 -112.0 -111.8 -111.5 -112.0 -111.1 
31.4 -152.1 -151.4 -152.0 -151.3 -151.9 -151.3 -152.0 -152.0 
35.5 -148.4 -148.0 -148.0 -148.6 -148.3 -148.6 -148.0 -147.7 
36.3 -145.3 -144.4 -144.8 -145.1 -144.0 -143.8 -144.7 -141.5 
46.8 -134.1 -134.6 -136.0 -134.5 -137.1 -136.4 -136.8 -137.3 
19.0 -163.6 -164.7 -165.1 -163.9 -164.4 -164.7 -165.2 -163.3 
38.3 -147.7 -147.6 -148.2 -147.4 -149.3 -148.8 -148.6 -149.8 
42.0 -138.8 -139.4 -139.6 -139.0 -142.1 -139.8 -141.2 -140.7 
19.7 -166.0 -167.7 -168.0 -166.3 -167.0 -167.1 -166.6 -167.9 
17.8 -170.2 -168.7 -169.8 -170.1 -167.5 -167.5 -167.1 -167.6 
47.2 -139.7 -135.1 -134.8 -138.7 -133.6 -132.9 -132.1 -134.4 
49.9 -136.2 -134.0 -133.1 -134.1 -130.8 -135.8 -131.5 -141.4 
a 1.06 1.07 1.08 1.06 1.07 1.07 1.07 1.05 
b -185.79 -185.66 -186.26 -185.79 -185.68 -185.96 -185.53 -185.05 
 
  
NMR Assignments 
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Table A4-12. Chemical shifts of homomorphosterol compared to theoretical chemical shifts, determined by linear scaling of the shielding 
tensors, of possible diastereomers, calculated by mPW1PW91/6-311+G(2d,p) using GIAO. Differences given in parentheses. 
 
Theoretical 
1H δ (ppm) 
Exp. 1H δ (ppm) (RRSS) (RRRS) (RSRS) (RSSS) (SRSR) (SRRR) (SSSR) (SSRR) 
1.25 1.39 (0.14) 1.64 (0.39) 1.47 (0.22) 1.46 (0.21) 1.61 (0.36) 1.56 (0.31) 1.66 (0.41) 1.49 (0.24) 
1.58 1.54 (0.04) 1.7 (0.12) 1.31 (0.27) 1.43 (0.15) 1.63 (0.05) 1.7 (0.12) 1.66 (0.08) 1.59 (0.01) 
1.74 1.48 (0.26) 1.77 (0.03) 1.81 (0.07) 1.46 (0.28) 1.34 (0.4) 1.22 (0.52) 1.32 (0.42) 1.46 (0.28) 
2.38 2.88 (0.5) 2.31 (0.07) 2.72 (0.34) 3.2 (0.82) 2.42 (0.04) 2.56 (0.18) 2.34 (0.04) 2.5 (0.12) 
2.58 2.8 (0.22) 2.74 (0.16) 2.56 (0.02) 2.59 (0.01) 3.04 (0.46) 3 (0.42) 2.98 (0.4) 3.2 (0.62) 
5.29 5.07 (0.22) 5.23 (0.06) 5.2 (0.09) 5.15 (0.14) 5.3 (0.01) 5.16 (0.13) 5.1 (0.19) 5.09 (0.2) 
2.29 2.19 (0.1) 2.18 (0.11) 2.21 (0.08) 2.27 (0.02) 2.14 (0.15) 2.14 (0.15) 2.14 (0.15) 1.95 (0.34) 
2.08 1.9 (0.18) 2.1 (0.02) 1.98 (0.1) 2.01 (0.07) 2.03 (0.05) 2.04 (0.04) 2 (0.08) 1.94 (0.14) 
3.25 3.26 (0.01) 3.21 (0.04) 3.41 (0.16) 3.34 (0.09) 3.31 (0.06) 3.3 (0.05) 3.35 (0.1) 3.16 (0.09) 
1.32 1.6 (0.28) 1.51 (0.19) 1.59 (0.27) 1.6 (0.28) 1.57 (0.25) 1.53 (0.21) 1.6 (0.28) 1.54 (0.22) 
1.72 1.41 (0.31) 1.41 (0.31) 1.42 (0.3) 1.36 (0.36) 1.35 (0.37) 1.37 (0.35) 1.41 (0.31) 1.37 (0.35) 
1.06 1.13 (0.07) 1.09 (0.03) 1.17 (0.11) 1.2 (0.14) 1.14 (0.08) 1.09 (0.03) 1.09 (0.03) 1.1 (0.04) 
1.66 1.62 (0.04) 1.58 (0.08) 1.69 (0.03) 1.61 (0.05) 1.66 (0) 1.62 (0.04) 1.72 (0.06) 1.58 (0.08) 
1.8 1.63 (0.17) 1.8 (0) 1.84 (0.04) 1.81 (0.01) 2.03 (0.23) 2.05 (0.25) 2.04 (0.24) 2.09 (0.29) 
1.48 1.52 (0.04) 1.46 (0.02) 1.59 (0.11) 1.49 (0.01) 1.55 (0.07) 1.47 (0.01) 1.54 (0.06) 1.6 (0.12) 
1.52 1.49 (0.03) 1.57 (0.05) 1.66 (0.14) 1.44 (0.08) 1.62 (0.1) 1.59 (0.07) 1.58 (0.06) 1.61 (0.09) 
1.3 1.13 (0.17) 1.2 (0.1) 1.18 (0.12) 1.22 (0.08) 1.11 (0.19) 1.06 (0.24) 1.12 (0.18) 1.11 (0.19) 
1.97 1.59 (0.38) 1.79 (0.18) 1.78 (0.19) 1.71 (0.26) 1.69 (0.28) 1.68 (0.29) 1.76 (0.21) 1.54 (0.43) 
0.92 0.72 (0.2) 0.64 (0.28) 0.57 (0.35) 0.55 (0.37) 0.63 (0.29) 0.61 (0.31) 0.54 (0.38) 0.73 (0.19) 
0.78 0.75 (0.03) 0.73 (0.05) 0.72 (0.06) 0.67 (0.11) 0.74 (0.04) 0.73 (0.05) 0.65 (0.13) 0.59 (0.19) 
2.91 3.02 (0.11) 3.1 (0.19) 2.73 (0.18) 2.32 (0.59) 2.38 (0.53) 2.57 (0.34) 2.99 (0.08) 3.04 (0.13) 
2.16 2.92 (0.76) 2.28 (0.12) 2.43 (0.27) 3.15 (0.99) 2.76 (0.6) 2.99 (0.83) 2.46 (0.3) 2.75 (0.59) 
MAE 0.19 0.12 0.16 0.23 0.21 0.22 0.19 0.22 
  
 
Theoretical 
13C δ (ppm) 
Exp. 13C δ 
(ppm) 
(RRSS) (RRRS) (RSRS) (RSSS) (SRSR) (SRRR) (SSSR) (SSRR) 
35.3 36.9 (1.6) 36 (0.7) 37.7 (2.4) 35.4 (0.1) 34.6 (0.7) 33.9 (1.4) 34.7 (0.6) 34.2 (1.1) 
36 36.2 (0.1) 41 (5) 37.8 (1.8) 36.5 (0.4) 44 (8) 39.9 (3.9) 41.6 (5.6) 44 (8) 
145.7 146.9 (1.2) 146 (0.3) 147.6 (1.9) 144 (1.7) 146.2 (0.5) 143.4 (2.3) 146.2 (0.5) 143.5 (2.2) 
127.4 125.3 (2.1) 129.1 (1.7) 129.1 (1.7) 129.2 (1.8) 129.9 (2.5) 130.2 (2.8) 128.6 (1.2) 129.2 (1.8) 
35.5 40.9 (5.4) 38.3 (2.8) 40.3 (4.8) 40.5 (4.9) 35.8 (0.3) 36 (0.4) 37.2 (1.7) 37.6 (2.1) 
120.4 123.7 (3.3) 118.8 (1.6) 119.1 (1.3) 120.1 (0.4) 122.4 (2) 121.4 (1) 119.8 (0.6) 124.1 (3.7) 
143.5 147.6 (4.1) 146.3 (2.8) 147.6 (4.1) 148.3 (4.8) 147.2 (3.7) 147.4 (3.9) 148.6 (5.1) 145.3 (1.7) 
41.9 38.7 (3.2) 38.6 (3.3) 38.5 (3.4) 39.1 (2.8) 38.5 (3.4) 38.8 (3.1) 38.5 (3.4) 38.6 (3.3) 
68.9 69.8 (0.9) 68.9 (0) 68.7 (0.2) 69.8 (0.9) 69.5 (0.6) 70.1 (1.1) 69.3 (0.4) 71.1 (2.2) 
31.4 31.6 (0.2) 31.8 (0.4) 31.5 (0.1) 32.3 (0.9) 31.3 (0.1) 32.3 (0.9) 31.2 (0.2) 31.5 (0.1) 
35.5 35.2 (0.3) 35 (0.5) 35.3 (0.2) 34.8 (0.7) 34.6 (0.9) 34.9 (0.6) 35 (0.5) 35.7 (0.2) 
36.3 38.1 (1.8) 38.5 (2.2) 38.3 (2) 38.2 (1.9) 38.8 (2.5) 39.4 (3.1) 38.1 (1.8) 41.7 (5.4) 
46.8 48.9 (2.1) 47.7 (0.9) 46.6 (0.2) 48.3 (1.5) 45.4 (1.4) 46.4 (0.4) 45.7 (1.1) 45.7 (1.1) 
19 20.6 (1.6) 19.3 (0.3) 19.2 (0.2) 20.3 (1.3) 19.3 (0.3) 19.6 (0.6) 18.6 (0.4) 20.6 (1.6) 
38.3 35.8 (2.5) 35.5 (2.8) 35.1 (3.2) 36 (2.3) 33.7 (4.6) 34.7 (3.6) 34.4 (3.9) 33.6 (4.7) 
42 44.4 (2.4) 43.1 (1.1) 43.3 (1.3) 44 (2) 40.6 (1.4) 43.2 (1.2) 41.5 (0.5) 42.4 (0.4) 
19.7 18.3 (1.4) 16.5 (3.2) 16.4 (3.3) 18 (1.7) 16.8 (2.9) 17.3 (2.4) 17.3 (2.4) 16.1 (3.6) 
17.8 14.2 (3.6) 15.6 (2.3) 14.7 (3.1) 14.4 (3.5) 16.4 (1.4) 16.9 (0.9) 16.7 (1.1) 16.4 (1.4) 
47.2 43.5 (3.7) 47.2 (0) 47.8 (0.6) 44.3 (2.9) 48.7 (1.5) 49.7 (2.5) 50.1 (2.9) 48.5 (1.3) 
49.9 46.9 (3) 48.3 (1.6) 49.4 (0.5) 48.7 (1.2) 51.4 (1.5) 47 (2.9) 50.7 (0.8) 41.8 (8.1) 
MAE 2.23 1.68 1.82 1.89 2.01 1.95 1.74 2.7 
  
  
  Natural products 
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A4.1.5. Aculenes 
Table A4-13. NMR assignment 1H of the azumamides 
 Aculene A  
# δH [ppm] 
(int,mult,J [Hz]) 
δC 
[ppm] 
1 - - 
2 3.15 (m) 45.1 
2’ 3.09 (m) 45.1 
3 1.83 (m) 22.3 
3’ 1.67 (m) 22.3 
4 1.94 (m) 27.6 
4’ 1.46 (m) 27.6 
5 4.23 (t 7.7) 58.4 
6 - 168.0 
7 5.33 (dd 4.4, 2.4) 72.9 
8 2.82 (d 20.8) 36.5 
8’ 2.55 (m) 36.5 
9 - 141.7 
10 5.98 (d 7.4) 120.0 
11 6.24 (d 7.4) 118.5 
11’ - 118.5 
12 - 142.5 
13 - 175.3 
14 6.03 (s) 125.3 
15 - 205.8 
16 - 51.7 
17 0.96 (s) 17.9 
18 1.85 (s) 26.9 
19 2.551 (m) 20.1 
20 1.16 (t 7.4) 12.0 
-
OH 
- - 
 
 Aculene B 
# δH [ppm] 
(int,mult,J [Hz]) 
δC 
[ppm] 
1 - - 
2 3.21 (m) 44.7 
2’ 3.14 (m) 44.7 
3 1.84 (m) 22.3 
3’ 1.76 (m) 22.3 
4 2.05 (m) 27.6 
4’ 1.55 (m) 27.6 
5 4.31 (dd 2.4, 5.5) 58.3 
6 - 167.8 
7 5.28 (dd 5.3, 2.3) 73.5 
8 2.67 (d 19.1) 35.5 
8’ 2.37 (m) 35.5 
9 - 130.7 
10 5.56 (d 5.5) 122.7 
11 2.12 (t 15.2) 24.9 
11’ 2.52 (m) 24.9 
12 3.31 (m) 44.6 
13 - 183.8 
14 5.81 (q 1.8) 122.8 
15 - 208.2 
16 - 54.4 
17 0.96 (s) 17.1 
18 1.68 (s) 28.3 
19 2.39 (m) 23.1 
20 1.11 (t 7.3) 10.8 
-
OH 
- - 
 
 Aculene C 
# δH [ppm] 
(int,mult,J [Hz]) 
δC 
[ppm] 
1 - - 
2 - - 
2’ - - 
3 - - 
3’ - - 
4 - - 
4’ - - 
5 - - 
6 - - 
7 3.95 (t 3.5) 67.6 
8 2.52 (br. d 20.1) 40.2 
8’ 2.31 (m) 40.2 
9 - 142.5 
10 5.87 (d 7.3) 119.7 
11 6.08 (d 7.4) 117.8 
11’ - 117.8 
12 - 144.3 
13 - 174.3 
14 5.93 (s) 125.6 
15 - 208.2 
16 - 53.6 
17 0.79 (s) 18.3 
18 1.82 (s) 27.1 
19 2.48 (m) 19.8 
20 1.14 (t 7.4) 11.8 
-
OH 
4.43 (s) - 
 
 
 
 
 
 
 
  
NMR Assignments 
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A4.1.6. Epi-10,23-dihydro-24,25-dehydroaflavine 
Table A4-14. NMR assignment 1H of the azumamides 
Table A4-15. Experimental NOE intensities and J-coupling constants of the azumamides (τm = 150 ms) 
# δH [ppm] 
(int,mult,J [Hz]) 
δC 
[ppm] 
1 10.66 - 
2 7.07 (d 2.0) 122.7 
3 - 114.4 
4 - 126.7 
5 7.38 (d 7.8) 116.8 
6 6.96 (t 7.2) 117.7 
7 7.02 (t 7.3) 120.0 
8 7.29 (d 8.0) 110.9 
9 - 135.5 
10 3.59 (dd 13.3, 5.0) 33.4 
11 2.47 (m) 37.6 
12 1.27 (m) 28.9 
13 1.53 (m) 28.1 
13’ 0.81 (d 12.9) 28.1 
14 1.46 (m) 27.4 
14’ 1.08 (d 13.7) 27.4 
15 - 38.2 
16 2.04 (m) 30.4 
17 1.71 (m) 24.8 
17’ 1.22 (m) 24.8 
18 1.99 (d 11.3) 29.6 
18’ 1.74 (m) 29.6 
19 4.64 (s) 65.6 
20 - 42.9 
21 2.07 (m) 23.5 
21’ 1.65 (m) 23.5 
22 1.85 (m) 26.6 
22’ 1.54 (m) 26.6 
23 3.13 (m) 42.3 
24 - 149.8 
25 4.81 (d 1.8) 110.4 
25’ 4.58 (d 1.8) 110.4 
26 1.45 (s) 17.7 
27 1.21 (s) 21.1 
28 0.71 (d 6.7) 15.4 
29 0.92 (s) 17.7 
30 4.28 (d 4.3) - 
 
H1 H2 ηnorm Rel 
1 2 0.0047 0.08 
1 8 0.0021 0.04 
2 23 0.0054 0.10 
2 25 0.0021 0.04 
2 27 0.0080 0.14 
5 10 0.0059 0.11 
5 11 0.0081 0.14 
5 18 0.0039 0.07 
10 11 0.0126 0.22 
10 19 0.0294 0.52 
10 25 0.0034 0.06 
10 26 0.0115 0.20 
11 12 0.0143 0.25 
11 13 0.0042 0.07 
11 16/18 0.0380 0.67 
11 16/18 0.0380 0.67 
11 19 0.0011 0.02 
13 13’ 0.0563 1.00 
14’ 28 0.0178 0.32 
16 13 0.0313 0.56 
16 28 0.0128 0.23 
16/18 17’ 0.0184 0.33 
16/18 17’ 0.0184 0.33 
17 17’ 0.0608 1.08 
17 29 0.0105 0.19 
17’ 28 0.0094 0.17 
18 19 0.0101 0.18 
18’ 19 0.0096 0.17 
18’ 30 0.0097 0.17 
19 22 0.0233 0.41 
19 26 0.0023 0.04 
21 29 0.0212 0.38 
21 30 0.0046 0.08 
21’ 27 0.0160 0.28 
22 22’ 0.0551 0.98 
22 30 0.0043 0.08 
23 25 0.0086 0.15 
23 27 0.0240 0.43 
25 25’ 0.0400 0.71 
25’ 26 0.0088 0.16 
29 30 0.0028 0.05 
 
 
 
  
  Synthetic peptides 
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A4.2. Synthetic peptides 
A4.2.1. Azumamides 
Table A4-16. NMR assignment 1H of the azumamides 
Azu A δH (int,mult,J)  Des C δH (int,mult,J)  Epi E δH (int,mult,J) 
N1 7.10 (1H,d,8.0) 
 
N1 7.24 (1H,d,7.1) 
 
N1 7.35 (1H,d,9.5) 
N2 7.71 (1H,d,9.1) 
 
N2 7.54 (1H,d,9.6) 
 
N2 7.69 (1H,d,10.9) 
N3 7.68 (1H,d,8.7) 
 
N3 7.41 (1H,d,9.7) 
 
N3 7.42 (1H,d,11.6) 
N4 7.41 (1H,d,8.2) 
 
N4 7.85 (1H,d,6.8) 
 
N4 7.87 (1H,d,9.4) 
1 - 
 
1 - 
 
1 - 
2 2.53 (1H,qd,7.4,3.8) 
 
2a 2.28 (11.3,3.8) 2 2.63 (1H, dq,13.0,6.6) 
  
 
2b 2.46 (14.0,12.4)   
3 4.00 (1H,qd,7.4,3.7) 
 
3 3.92 (1H,m) 
 
3 3.73 (1H, m) 
4a 2.21 (1H,14.5,8.1) 
 
4a 2.25 (2H,m) 
 
4a 2.24 (1H,m) 
4b 2.40 (1H,dt,14.2,6.4) 
 
4b 2.25 (2H,m) 
 
4b 2.40 (1H,dt,14.5,4.6) 
5 5.27 (1H,m) 
 
5 5.36 (1H,m) 
 
5 5.48 (1H,m) 
6 5.40 (1H,m) 
 
6 5.47 (1H,m) 
 
6 5.36 (1H,m) 
7 2.26 (2H,m) 
 
7 2.25 (2H,m) 
 
7 2.26 (2H,m) 
8 2.09 (2H,m) 
 
8 2.25 (2H,m) 
 
8 2.09 (2H,m) 
9 - 
 
9 - 
 
9 - 
10 1.23 (3H,d,7.5) 
 
  
 
10 1.01 (3H,d,6.8) 
11 - 
 
11 - 11 - 
12 4.14 (1H, m) 
 
12 4.15 (1H,td,9.4,5.9) 12 4.26 (1H,m) 
13a 2.93 (1H,13.6,9.4) 
 
13a 2.68 (1H,dd,13.9,9.3) 13a 2.76 (1H,dd,13.9,10.5) 
13b 3.01 (1H,13.7,6.7) 
 
13b 2.81 (1H,dd,13.9,5.7) 
 
13b 2.93 (1H,dd,13.9,5.4) 
14 - 
 
14 - 
 
14 - 
15 7.25 (2H,d,7.2) 
 
15 6.93 (2H,d,8.4) 
 
15 7.14 (1H,d,7.3) 
16 7.18 (2H,m) 
 
16 6.63 (2H,d,8.4) 
 
16 7.18 (1H,dd,7.7,7.0) 
17 7.19 (1H,m) 
 
17 - 
 
17 7.25 (1H,t,7.1) 
20 - 
 
20 - 21 - 
21 4.13 (1H, m) 
 
21 4.26 (1H,dq,9.7,7.4) 
 
21 4.26 (1H,m) 
22 1.16 (3H,d,7.3) 
 
22 1.15 (3H,d,7.3) 
 
22 1.13 (3H,d,7.4) 
23 - 
 
23 - 23 - 
24 3.73 (1H, dd,10.1,9.2) 
 
24 3.79 (1H,t, 6.6) 24 3.76 (1H,dd,9.4,6.5) 
25 2.11 (1H,m) 
 
25 1.93 (1H,m) 
 
25 1.96 (1H,m) 
26 0.86 (3H,d,6.3) 
 
26 0.90 (3H,d,6.8) 
 
26 0.90 (3H,d,6.8) 
27 0.88 (3H,d,6.3) 
 
27 0.92 (3H,d,6.8) 
 
27 0.92 (3H,d,6.8) 
CONH1 6.73 (1H,br. s) 
 
OH 9.22 (1H,s) 
   
CONH2 7.26 (1H,br. s)  COOH 12.07 (1H,br. s)  COOH 12.07 (1H,br. s) 
 
 
 R1 R2 R3 
Azu A: NH2 (S)-Me H 
Des C: OH H OH 
Epi E: OH (R)-Me H 
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Table A4-17. Experimental ROE intensities and J-coupling constants of the azumamides (τm = 200 ms) 
Azumamide A 
H1 H2 ηnorm Rel 
N1 N4 0.0044 0.04 
N1 3 0.0124 0.11 
N1 4a 0.0043 0.04 
N1 4b 0.0049 0.04 
N1 10 0.0277 0.25 
N1 13a 0.0169 0.15 
N1 13b 0.0198 0.18 
N2 N1 0.0431 0.39 
N2 13a 0.0117 0.11 
N2 13b 0.0068 0.06 
N2 21 0.0127 0.12 
N2 22 0.0230 0.21 
N3 N4 0.0221 0.20 
N3 21 0.0101 0.09 
N3 22 0.0248 0.23 
N3 25 0.0185 0.17 
N3 26/27 0.0125 0.11 
N4 2 0.0034 0.03 
N4 10 0.0331 0.30 
N4 24 0.0060 0.05 
N4 25 0.0047 0.04 
N4 26/27 0.0117 0.11 
2 3 0.0423 0.39 
2 4a 0.0091 0.08 
2 10 0.0395 0.36 
4a 4b 0.1092 1.00 
4a 10 0.0299 0.27 
4b 10 0.0064 0.06 
12 15 0.0115 0.11 
21 22 0.0260 0.24 
24 25 0.0057 0.05 
24 26/27 0.0373 0.34 
25 26/27 0.0499 0.46 
 
Des-azumamide C 
H1 H2 ηnorm Rel 
N1 N2 0.0844 0.52 
N1 N3 0.0113 0.07 
N1 2b 0.0366 0.23 
N1 3 0.0130 0.08 
N1 4a/4b 0.0118 0.07 
N1 12 0.0077 0.05 
N1 13a 0.0114 0.07 
N1 13b 0.0075 0.05 
N2 N3 0.0462 0.29 
N2 13a 0.0191 0.12 
N2 13b 0.0091 0.06 
N2 21 0.0036 0.02 
N2 22 0.0311 0.19 
N3 N4 0.0356 0.22 
N3 22 0.0245 0.15 
N3 24 0.0037 0.02 
N3 25 0.0092 0.06 
N3 26/27 0.0109 0.07 
N4 2b 0.0776 0.48 
N4 25 0.0177 0.11 
N4 26/27 0.0379 0.23 
2a 2b 0.1616 1.00 
3 2a/4a/ 
4b 
0.0848 0.52 
3 5 0.0079 0.05 
6 7 0.0489 0.30 
15 12 0.0139 0.09 
15 13a 0.0263 0.16 
15 13b 0.0297 0.18 
15 22 0.0050 0.03 
21 22 0.0511 0.32 
24 25 0.0254 0.16 
24 26/27 0.0420 0.26 
25 26/27 0.0750 0.46 
 
Epi-azumamide E 
H1 H2 ηnorm Rel 
N1 N2 0.0945 16.28 
N1 2 0.0173 2.98 
N2 22 0.0137 2.36 
N2 13a 0.0068 1.17 
N3 N4 0.0227 3.91 
N4 2 0.0429 7.39 
N4 25 0.0060 1.03 
N4 26/27 0.0198 3.41 
2 3 0.0058 1.00 
2 10 0.0250 4.30 
3 10 0.0156 2.69 
3 4a 0.0259 4.47 
3 4b 0.0159 2.74 
4a 4b 0.0550 9.47 
4b 10 0.0231 3.98 
6 7 0.0414 7.13 
13b 13a 0.0538 9.27 
15 12 0.0068 1.17 
15 13a 0.0052 0.89 
15 13b 0.0069 1.19 
21 22 0.0364 6.27 
24 25 0.0146 2.51 
24 26/27 0.0317 5.47 
25 26/27 0.0422 7.28 
 
H1 H2 J 
N1 3 8.0 
N2 12 9.1 
N3 21 8.7 
N4 24 8.3 
3 2 3.8 
3 4a 8.1 
3 4b 6.4 
12 13a 9.4 
12 13b 6.7 
24 25 10.1 
 
H1 H2 J 
N1 3 7.3 
N2 12 9.6 
N3 21 9.7 
N4 24 6.8 
2a 3 3.6 
2b 3 12.4 
3 4a 6.5 
3 4b 6.5 
12 13a 9.3 
12 13b 5.8 
24 25 6.7 
 
H1 H2 J 
N1 3 9.5 
N2 12 10.9 
N3 21 11.6 
N4 24 9.4 
2 3 13.0 
3 4b 5.6 
3 4a 4.6 
12 13a 10.5 
12 13b 5.4 
 
 
 
 
 
  Synthetic peptides 
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Table A4-18. Experimental distances from relative ROE intensities and J-coupling constants compared to best fit of multiple structures for 
the azumamides (τm = 200 ms) 
Azumamide A 
H1 H2 NOE Calc Diff % 
N1 N2 2.13 2.15 0.03 1.3 
N1 N4 3.11 3.11 0.00 0.0 
N1 3 2.62 2.66 0.04 1.4 
N1 4a 3.12 3.12 0.00 0.0 
N1 4b 3.06 3.06 0.00 0.0 
N1 10 2.75 2.80 0.04 1.8 
N1 13a 2.49 2.49 0.00 0.0 
N1 13b 2.42 2.44 0.02 0.7 
N2 13a 2.64 2.64 0.00 0.0 
N2 13b 2.89 2.89 0.00 0.0 
N2 21 2.61 2.86 0.25 8.8 
N2 22 2.83 3.15 0.26 9.9 
N3 N4 2.38 2.35 0.02 1.0 
N3 22 2.80 2.97 0.14 5.6 
N3 21 2.71 2.87 0.16 5.5 
N3 25 2.45 2.45 0.00 0.0 
N3 26/27 3.13 3.13 0.00 0.0 
N4 2 3.24 3.33 0.08 2.5 
N4 10 2.67 2.49 0.15 7.3 
N4 24 2.96 2.97 0.01 0.4 
N4 25 3.07 2.68 0.39 14.7 
N4 26/27 3.17 2.97 0.17 7.0 
2 10 2.59 2.68 0.07 3.2 
2 3 2.13 2.39 0.26 10.7 
2 4a 2.76 2.76 0.00 0.0 
4b 4a 1.82 1.82 0.00 0.0 
4a 10 2.71 2.97 0.22 8.7 
4b 10 3.52 3.51 0.01 0.3 
12 15 2.65 2.65 0.00 0.0 
13a 15 2.50 2.44 0.06 2.5 
13b 15 2.47 2.47 0.00 0.0 
21 22 2.77 2.77 0.00 0.1 
24 25 2.98 2.85 0.13 4.7 
24 26/27 2.62 2.81 0.16 6.9 
25 26/27 2.50 2.43 0.06 2.7 
      
   MAE 0.08 3.1 
      
H1 H2 Exp Calc Diff  
N1 3 8.0 8.0 0.0  
N2 12 9.1 8.9 0.2  
N3 21 8.7 8.2 0.5  
N4 24 8.3 8.3 0.0  
2 3 3.8 3.8 0.0  
3 4a 8.1 8.1 0.0  
3 4b 6.4 6.4 0.0  
12 13a 9.4 8.8 0.6  
12 13b 6.7 6.7 0.0  
24 25 10.1 10.1 0.0  
 
Des-azumamide C 
H1 H2 NOE Calc Diff % 
N1 N3 2.79 2.80 0.01 0.4 
N1 2b 2.29 2.49 0.19 7.8 
N1 3 2.73 2.70 0.03 1.0 
N1 4a/4b 3.11 3.00 0.11 3.6 
N1 12 2.98 3.11 0.14 4.5 
N1 13a 2.79 2.72 0.06 2.3 
N1 13b 2.99 3.00 0.02 0.6 
N1 N2 1.99 1.91 0.08 4.4 
N2 N3 2.21 2.20 0.00 0.0 
N2 13a 2.56 2.59 0.03 1.2 
N2 13b 2.89 2.90 0.01 0.3 
N2 21 3.38 3.55 0.17 4.8 
N2 22 2.83 2.87 0.04 1.3 
N3 N4 2.30 2.37 0.06 2.7 
N3 22 2.94 2.96 0.02 0.6 
N3 24 3.36 3.45 0.09 2.6 
N3 25 2.88 2.99 0.11 3.6 
N3 26/27 3.78 3.79 0.01 0.2 
N4 2b 2.02 2.18 0.16 7.1 
N4 25 2.59 2.56 0.03 1.1 
N4 26/27 3.07 3.07 0.00 0.0 
2b 2a 1.79 1.79 0.00 0.0 
3 2a/4a/4b 1.99 2.07 0.08 3.8 
5 3 2.96 2.94 0.01 0.5 
6 7 2.45 2.45 0.00 0.2 
12 15 3.02 2.86 0.16 5.7 
13b 13a 2.08 1.70 0.38 22.1 
13a 15 2.72 2.44 0.28 11.3 
13b 15 2.66 2.47 0.20 8.0 
15 22 4.31 4.25 0.06 1.4 
21 22 2.60 2.62 0.01 0.5 
24 25 2.44 2.56 0.12 4.8 
24 26/27 3.02 3.19 0.17 5.4 
25 26/27 2.74 2.59 0.15 5.7 
      
      
   MAE 0.09 3.5 
      
H1 H2 Exp Calc Diff  
N1 3 7.3 7.4 0.1  
N2 12 9.6 9.1 0.4  
N3 21 9.7 9.0 0.7  
N4 24 6.8 6.8 0.0  
2b 3 12.4 12.4 0.0  
2a 3 3.6 3.6 0.0  
3 4a 6.5 6.5 0.0  
3 4b 6.5 6.6 0.1  
12 13a 9.3 9.3 0.0  
12 13b 5.8 5.8 0.0  
24 25 6.7 6.8 0.1  
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Epi-azumamide E 
H1 H2 Calc NOE Diff Diff % 
N1 N2 1.88 1.91 0.02 1.1 
N1 2 2.50 2.49 0.01 0.3 
N4 2 2.15 2.12 0.02 1.1 
N2 13a 2.92 2.92 0.00 0.1 
N2 22 3.12 3.13 0.01 0.3 
N3 N4 2.39 2.29 0.10 4.2 
N4 25 2.98 2.99 0.00 0.1 
N4 26/27 2.93 2.75 0.151 6.6 
2 3 3.00 3.00 0.00 0.0 
2 10 2.82 2.74 0.07 3.1 
3 4a 2.34 2.35 0.01 0.5 
3 4b 2.53 2.62 0.09 3.3 
3 10 3.05 3.07 0.02 0.6 
4a 4b 2.06b 1.71 0.35 20.4 
4b 10 2.86 2.90 0.03 1.4 
6 7 2.16 2.32 0.16 6.9 
12 15 2.92 2.80 0.12 4.2 
13b 13a 2.07b 1.70 0.37 21.5 
13a 15 3.05b 2.46 0.59 23.9 
13b 15 2.91b 2.50 0.41 16.4 
21 22 2.65 2.78 0.11 4.6 
24 25 2.57 2.66 0.09 3.4 
24 26/27 2.71 2.87 0.13 5.4 
25 26/27 2.59 2.43 0.13 6.5 
      
  MAE  0.13 6.11 
      
H1 H2 Calc Exp Diff  
N1 3 9.5 8.7 0.8  
N2 12 10.9 8.9 2  
N3 21 11.6 9.1 2.5  
N4 24 9.4 8.5 0.9  
2 3 13.0 12.4 0.6  
3 4a 4.6 4.6 0.0  
3 4b 5.6 5.6 0.0  
12 13a 10.5 10.0 0.5  
12 13b 5.4 5.2 0.2  
 
 
Azumamide A, constrained 
H1 H2 Exp Calc Diff % 
N1 10 2.19 2.3 5.0 
N1 4a 2.99 3.29 10.0 
N1 4b 2.92 3.34 14.4 
N1 13a 2.38 2.345 1.5 
N1 13b 2.32 2.535 9.3 
N1 3 2.51 2.89 15.1 
N2 22 2.26 3.87 71.2 
N2 13a 2.53 2.69 6.3 
N2 13b 2.76 3.535 28.1 
N2 21 2.49 2.825 13.5 
N2 N1 2.03 2.145 5.7 
N3 26/27 2.5 2.915 16.6 
N3 22 2.23 2.7 21.1 
N3 25 2.34 2.09 10.7 
N3 21 2.59 2.975 14.9 
N3 N4 2.27 2.675 17.8 
N4 26/27 2.53 2.755 8.9 
N4 10 2.13 2.22 4.2 
N4 25 2.94 2.535 13.8 
N4 2 3.1 3.555 14.7 
N4 24 2.83 2.975 5.1 
N4 N1 2.97 2.12 28.6 
2 10 2.06 2.28 10.7 
2 4a 2.64 2.945 11.6 
3 2 2.04 2.435 19.4 
4a 10 2.16 2.325 7.6 
4b 10 2.8 3.71 32.5 
4b 4a 1.745 1.745 0.0 
15 13a 2.39 3.755 57.1 
15 13b 2.37 2.615 10.3 
15 12 2.54 2.865 12.8 
21 22 2.21 2.34 5.9 
24 25 2.85 3.075 7.9 
24 26/27 2.08 2.31 11.1 
25 26/27 1.98 2.065 4.3 
 
 
  
  
  Synthetic peptides 
 
 
A-22 
 
Figure A4.3. Representative structures of the conformational space covered by azumamide A. 
 
 
Figure A4.4. Representative structures of the conformational space covered by des-azumamide C. 
 
 
Figure A4.5. Representative structures of the conformational space covered by epi-azumamide E. 
  
NMR Assignments 
 
 
A-23 
A4.2.2. Molecular recognition 
Table A4-19. NMR assignment of Target 20 and Ligand 7 
Target 20 
Name δH [ppm] (int,mult,J [Hz]) δC [ppm] 
Gln(1)-NH - - 
Gln(1)-αH 4.05 (1H,m) 52.4 
Gln(1)-βH 2.06 (2H,m) 26.5 
Gln(1)-γH 2.35 (2H,m) 29.9 
Thr(2)-NH 8.71 (1H,m) - 
Thr(2)-αH 4.27 (1H,broad s) 59.4 
Thr(2)-βH 4.06 (1H,m) 67.0 
Thr(2)-γH2 1.13 (1H,d,6.3) 18.7 
Arg(3)-NH 8.55 (1H,d,7.0) - 
Arg(3)-αH 4.35 (1H, q, 7.4) 53.4 
Arg(3)-βH2 1.69 (1H,m) 28.0 
Arg(3)-βH3 1.78 (1H,m) 28.0 
Arg(3)-γH2 1.57 (1H,m) 24.2 
Arg(3)-γH3 1.52 (1H,m) 24.2 
Arg(3)- δH 3.11 (1H,m) 40.4 
Arg(3)-ε/ηH 7.13 (1H,m) - 
Thr(4)-NH 8.22 (1H,d,7.7) - 
Thr(4)-αH 4.23 (1H,m) 59.1/53.4 
Thr(4)-βH2 4.09 (1H,m) 67.2 
Thr(4)-γH 1.08 (1H,d,6.3) 18.6 
Asn(5)-NH 8.48 (1H,m) - 
Asn(5)-αH 4.69 (1H,m) 50.3 
Asn(5)-βH2 2.77 (1H,dd,16.5,7.0) 35.8 
Asn(5)-βH3 2.68 (1H,m) 35.8 
Thr(6)-NH 8.06 (1H,d,7.6) - 
Thr(6)-αH 4.17 (1H,m) 59.2 
Thr(6)-βH 4.10 (1H,m) 66.8 
Thr(6)-γH2 1.05 (1H,d,6.7) 18.6 
His(7)-NH 8.43 (1H,d,7.6) - 
His(7)-αH 4.56 (1H,m) 52.8/51.5 
His(7)-βH2 3.18 (1H,dd,15.2,6.5) 25.9 
His(7)-βH3 3.10 (1H,m) 25.9 
His(7)-δH 7.17 (1H,s) 117.5 
His(7)-εH 8.49 (1H,m) 133.7 
Arg(8)-NH 8.29 (1H,d,8.2) - 
Arg(8)-αH 4.23 (1H,m) 59.1/53.4 
Arg(8)-βH2 1.73 (1H,m) 28.1 
Arg(8)-βH3 1.63 (1H,m) 28.1 
Arg(8)-γH2 1.52 (1H,m) 24.1 
Arg(8)-γH3 1.49 (1H,m) 24.1 
Arg(8)- δH 3.09 (1H,m) 40.4 
Arg(8)-ε/ηH 7.12 (1H,m) - 
Asp(9)-NH 8.40 (1H,d,7.6) - 
Asp(9)-αH 4.56 (1H,m) 52.8/51.5 
Asp(9)-βH2 2.51 (1H,dd,15.9,8.9) 38.3 
Asp(9)-βH3 2.66 (1H,m) 38.3 
Gly(10)-NH 7.82 (1H,t,5.5) - 
Gly(10)-αH2 3.63 (1H,dd,17.2,5.7) 43.4 
Gly(10)-αH3 3.70 (1H,dd,17.0,5.8) 43.4 
 
Ligand 7 
Name δH [ppm] (int,mult,J [Hz]) δC [ppm] 
Glu(1)-NH - - 
Glu(1)-αH 3.85 (1H, broad m) 52.6 
Glu(1)- βH 1.88 (2H,m) 26.7 
Glu(1)-γH 2.19 (2H,m) 31.5 
Asp(2)-NH 8.67 (1H,d,6.7) - 
Asp(2)-αH 4.53 (1H, broad m) 51.0 
Asp(2)-βH2 2.59 (1H,dd,17.0,3.5) 37.7 
Asp(2)-βH3 2.46 (1H,dd,16.9,9.4) 37.7 
Tyr(3)-NH 8.17 (1H,m) - 
Tyr(3)-αH 4.43 (1H, broad m) 55.0 
Tyr(3)-βH2 2.94 (1H,dd,13.5,5.1) 35.8 
Tyr(3)-βH3 2.81 (1H,dd,13.3,8.9) 35.8 
Tyr(3)-γH 6.99 (2H,d,7.5) 130.5 
Tyr(3)-εH 6.69 (2H,d,7.5) 115.5 
Glu(4)-NH 8.14 (1H,m) - 
Glu(4)-αH 4.18 (1H, broad m) 53.0 
Glu(4)-βH2 1.81 (1H,m) 26.6 
Glu(4)-βH3 1.92 (1H,m) 26.6 
Glu(4)-γH 2.19 (1H,m) 31.4 
Val(5)-NH 7.99 (1H,m) - 
Val(5)-αH 3.91 (1H, broad m) 59.5 
Val(5)-βH 1.93 (1H,m) 29.9 
Val(5)-γH2 0.82 (3H,d,6.3) 18.1 
Val(5)-γH3 0.80 (3H,d,6.8) 18.1 
Glu(6)-NH 8.32 (1H,m) - 
Glu(6)-αH 4.24 (1H, broad m) 53.1 
Glu(6)-βH2 1.84 (1H,m) 26.4 
Glu(6)-βH3 1.97 (1H,m) 26.4 
Glu(6)-γH 2.27 (1H,m) 31.2 
Glu(7)-NH 8.32 (1H,m) - 
Glu(7)-αH 4.24 (1H, broad m) 53.1 
Glu(7)-βH2 1.84 (1H,m) 26.4 
Glu(7)-βH3 1.97 (1H,m) 26.4 
Glu(6)-γH 2.27 (1H,m) 31.2 
Gly(8)-NH 8.00 (1H,m) - 
Gly(8)-αH 3.65 (2H, m) 42.9 
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Table A4-20. Experimental distances from relative NOE intensities for Target 20 and Ligand 7 as individual peptides (τm = 200 ms).  
Target 
 
 Ligand   
Nuc 1 Nuc2 Dist (Å) Nuc 1 Nuc2 Dist (Å) 
Thr(2)-NH Gln(1)-αH 3.21 Asp(2)-NH Glu(1)-αH 2.44 
Arg(3)-NH Thr(2)-βH 3.13 Asp(2)-NH Asp(2)-βH3 2.86 
Arg(3)-NH Thr(2)-αH 2.42 Asp(2)-NH Asp(2)-βH2 3.30 
Asn(5)-NH Thr(4)-αH 2.43 Tyr(3)-NH Asp(2)-αH 2.35 
Asn(5)-NH Thr(4)-βH2 2.83 Tyr(3)-NH Tyr(3)-βH3 2.88 
His(7)-NH Thr(6)-αH 2.30 Tyr(3)-NH Tyr(3)-βH2 2.94 
His(7)-NH Thr(6)-βH 2.98 Glu(4)-NH Tyr(3)-αH 2.32 
Asp(9)-NH Arg(8)-αH 2.46 Glu(4)-NH Glu(4)-βH2 2.99 
Arg(8)-NH His(7)-αH 2.16 Glu(4)-NH Glu(4)-βH3 3.53 
Thr(4)-NH Thr(4)-βH2 2.85 Glu(4)-NH Val(5)-NH 2.96 
Thr(4)-NH Arg(3)-αH 2.38 Val(5)-NH Glu(4)-αH 2.51 
Thr(6)-NH Thr(6)-βH 2.81 Val(5)-NH Val(5)-βH 2.65 
Gly(10)-NH Asp(9)-αH 3.19 Val(5)-NH Val(5)-γH2 3.05 
His(7)-NH His(7)-βH3 2.82 Glu(6)-NH Val(5)-αH 2.33 
His(7)-NH His(7)-βH2 2.77 Glu(6)-NH Val(5)-NH 3.04 
His(7)-NH Asp(9)-βH2 3.42 Glu(7)-NH Glu(7)-βH2 2.67 
Asn(5)-NH Asn(5)-βH3 2.94 Gly(8)-NH Glu(7)-αH 2.88 
Asn(5)-NH Asn(5)-βH2 2.98 Gly(8)-NH Glu(7)-NH 2.99 
Arg(3)-NH Arg(3)-βH2 2.79 Tyr(3)-αH Tyr(3)-βH2 2.54 
Arg(3)-NH Arg(3)-βH3 3.09 Tyr(3)-γH Tyr(3)-βH3 3.14 
Asp(9)-NH Asp(9)-βH2 3.03 Tyr(3)-γH Tyr(3)-βH2 3.22 
Asp(9)-NH Asp(9)-βH3 3.75 Tyr(3)-βH2 Tyr(3)-βH3 1.78 
Arg(8)-NH Arg(8)-βH3 2.81    
Arg(8)-NH Arg(8)-βH2 3.05    
His(7)-NH Thr(6)-NH 2.55    
Arg(3)-NH Thr(4)-NH 3.29    
Thr(2)-αH Thr(2)-γH2 4.04    
Thr(4)-αH Thr(4)-γH 3.36    
Thr(6)-αH Thr(6)-γH2 3.20    
Arg(8)-βH2 Arg(8)-βH3 1.78    
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Table A4-21. Experimental distances from relative NOE intensities for Target 20 and Ligand 7 upon mixing the peptides (τm = 200 ms) 
Target 20 
  
Ligand 7   
H1 H2 Dist  (Å) H1 H2 Dist (Å) 
Thr(2)-NH Gln(1)-αH 2.94 Asp(2)-NH Glu(1)-αH 2.44 
Arg(3)-NH Thr(2)-βH 2.95 Asp(2)-NH Asp(2)-βH3 3.16 
Arg(3)-NH Thr(2)-αH 2.50 Asp(2)-NH Asp(2)-βH2 3.02 
Arg(3)-NH Arg(3)-δH 3.60 Tyr(3)-NH Asp(2)-αH 2.55 
Arg(3)-NH Thr(2)-γH2 3.36 Tyr(3)-NH Tyr(3)-βH2 2.94 
Arg(3)-NH Arg(3)-γH 2.64 Tyr(3)-NH Tyr(3)-βH3 2.77 
Arg(3)-NH Arg(3)-βH2 2.72 Tyr(3)-NH Glu(1)-βH2/Asp(2)-βH2 3.26 
Arg(3)-NH Arg(3)-βH3 3.28 Tyr(3)-NH Tyr(3)-γH 3.64 
Thr(4)-NH Thr(4)-βH2 2.94 Glu(4)-NH Tyr(3)-αH 2.31 
Thr(4)-NH Arg(3)-αH 2.54 Glu(4)-NH Glu(4)-βH3 3.45 
Thr(4)-NH Thr(4)-γH 3.31 Glu(4)-NH Glu(1)-γH/Glu(4)-γH 3.49 
Thr(4)-NH Arg(3)-γH 3.08 Glu(4)-NH Tyr(3)-βH3 3.24 
Thr(4)-NH Arg(3)-βH2 3.34 Glu(4)-NH Tyr(3)-βH2 3.26 
Asn(5)-NH Thr(4)-αH 2.37 Glu(4)-NH Val(5)-NH 2.98 
Asn(5)-NH Thr(4)-γH 3.28 Val(5)-NH Glu(4)-αH 2.18 
Asn(5)-NH His(7)-δH 3.37 Val(5)-NH Tyr(3)-αH 3.84 
Thr(6)-NH Thr(6)-βH 2.67 Val(5)-NH Val(5)-γH2 3.47 
Thr(6)-NH Thr(6)-γH2 2.99 Val(5)-NH Glu(4)-βH2 3.52 
Thr(6)-NH Asn(5)-βH2 3.21 Val(5)-NH Glu(4)-βH3 2.97 
His(7)-NH Thr(6)-αH 2.22 Glu(6)-NH Val(5)-αH 2.25 
His(7)-NH Thr(6)-βH 2.65 Glu(6)-NH Val(5)-γH2 3.71 
His(7)-NH His(7)-βH2 2.59 Glu(6)-NH Val(5)-βH 3.03 
His(7)-NH Thr(6)-NH 2.38 Glu(6)-NH Glu(6)-βH3 2.67 
His(7)-NH Thr(6)-γH2 3.24 Glu(6)-NH Val(5)-NH 2.89 
Arg(8)-NH His(7)-αH 2.31 Gly(8)-NH Glu(7)-αH 2.66 
Arg(8)-NH Arg(8)-βH3 2.60 Tyr(3)-αH Tyr(3)-βH2 2.64 
Arg(8)-NH Arg(8)-βH2 2.44 Val(5)-αH Val(5)-γH2 3.30 
Arg(8)-NH His(7)-βH2 2.91 Val(5)-αH Glu(4)-βH3 3.26 
Arg(8)-NH His(7)-βH3 2.81 Glu(4)-βH3 Val(5)-γH2 3.03 
Arg(8)-NH Arg(8)-γH3 2.73 Val(5)-βH Glu(6)-βH3 2.28 
Asp(9)-NH Arg(8)-αH 2.21 Glu(6)-βH3 Val(5)-βH 2.64 
Asp(9)-NH Asp(9)-βH2 2.53 Glu(6)-βH3 Val(5)-βH 2.39 
Asp(9)-NH Asp(9)-βH3 2.70 Asp(2)-NH Glu(1)-αH 2.63 
Asp(9)-NH Arg(8)-γH3 2.96 Asp(2)-NH Asp(2)-βH3 2.66 
Asp(9)-NH Arg(8)-βH3 2.85 Tyr(3)-βH2 Tyr(3)-βH3 1.78 
Asp(9)-NH Arg(8)-βH2 2.76    
Asp(9)-NH Gly(10)-NH 2.74    
Gly(10)-NH Asp(9)-αH 2.60    
Gly(10)-NH Asp(9)-βH2 3.22    
Gly(10)-NH Asp(9)-βH3 3.10    
Arg(3)-αH Arg(3)-βH2 2.98    
Thr(4)-αH Thr(4)-γH 2.78    
Thr(6)-αH Thr(6)-γH2 2.64    
Arg(8)-αH His(7)-βH3 2.46    
Asp(9)-αH Asp(9)-βH3 2.43    
His(7)-δH Arg(8)-δH 2.84    
His(7)-δH Arg(8)-αH 3.86    
His(7)-δH His(7)-αH 3.36    
His(7)-εH Thr(6)-βH 2.99    
His(7)-εH Asn(5)-βH3 3.15    
His(7)-εH Asn(5)-βH2 3.29    
His(7)-βH3 Arg(8)-βH3 2.54    
Arg(8)-δH Arg(8)-βH2 2.48    
Arg(8)-βH2 Arg(8)-βH3 1.78    
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Table A4-22. Differences in chemical shifts of Target 20 observed upon mixing the peptide Target 20 and Ligand 7 
Target 20 δH Δδ [Hz] Δδ [ppm]  δH Δδ [Hz] Δδ [ppm] 
Gln(1)-NH -   Thr(6)-NH 8.06 2.7 0 
Gln(1)-αH 4.05 11.4 0 Thr(6)-αH 4.17 6.3 0.01 
Gln(1)-βH 2.06 13.1 0.02 Thr(6)-βH 4.10 8.0 0 
Gln(1)-γH 2.35   Thr(6)-γH2 1.05 6.8 0.01 
Thr(2)-NH 8.71 0 0 His(7)-NH 8.43 4.4 0 
Thr(2)-αH 4.27   His(7)-αH 4.56 10.8 0.01 
Thr(2)-βH 4.06 11.4 0.01 His(7)-βH2 3.18 9.7 0.01 
Thr(2)-γH2 1.13 11.4 0.01 His(7)-βH3 3.10 9.1 0.01 
Arg(3)-NH 8.55 0 0 His(7)-δH 7.17 10.5 0.01 
Arg(3)-αH 4.35 9.1 0.01 His(7)-εH 8.49 11.7 0.01 
Arg(3)-βH2 1.69   Arg(8)-NH 8.29 2.4 0 
Arg(3)-βH3 1.78   Arg(8)-αH 4.23 2.1 0 
Arg(3)-γH 1.57   Arg(8)-βH2 1.73   
Arg(3)-γH 1.52   Arg(8)-βH3 1.63   
Arg(3)-δH 3.11   Arg(8)-γH2 1.52   
Arg(3)-δH 7.13   Arg(8)-γH3 1.49   
Thr(4)-NH 8.22 1.3 0 Arg(8)-δH2 3.09 9.1 0.01 
Thr(4)-αH 4.23 9.1 0.01 Arg(8)-δH3 7.12 0 0 
Thr(4)-βH2 4.09   Asp(9)-NH 8.40 5.1 0.01 
Thr(4)-γH 1.08 8.4 0.01 Asp(9)-αH 4.56 10.8 0.01 
Asn(5)-NH 8.48 3.2 0 Asp(9)-βH2 2.51 7.4 0.01 
Asn(5)-αH 4.69   Asp(9)-βH3 2.66 7.4 0.01 
Asn(5)-βH2 2.77 8.6 0.01 Gly(10)-NH 7.82 6.2 0.01 
Asn(5)-βH3 2.68 8.6 0.01 Gly(10)-αH2 3.63 8.6 0.01 
    Gly(10)-αH3 3.70 5.1 0.01 
 
Table A4-23. Differences in chemical shifts of Ligand 7 observed upon mixing the peptide Target 20 and Ligand 7 
Ligand 1 δH Δδ [Hz] Δδ [ppm]  δH Δδ [Hz] Δδ [ppm] 
Glu(1)-NH -   Val(5)-NH 7.99 25.6 0.03 
Glu(1)-αH 3.85 3.1 0 Val(5)-αH 3.91 15.1 0.02 
Glu(1)-βH2 1.88   Val(5)-βH 1.93  0 
Glu(1)-γH 2.19   Val(5)-γH2 0.81 7.3 0.01 
Asp(2)-NH 8.67 2.6 0 Glu(6)-NH 8.32 33.4 0.04 
Asp(2)-αH 4.53 4.7 0.01 Glu(6)-αH 4.24 11.0 0.01 
Asp(2)-βH2 2.59 15.1 0.02 Glu(6)-βH2 1.84   
Asp(2)-βH3 2.46 17.2 0.02 Glu(6)-βH3 1.97   
Tyr(3)-NH 8.17 21.9 0.03 Glu(6)-γH 2.27   
Tyr(3)-αH 4.43 17.2 0.02 Glu(7)-NH 8.32 24.0 0.03 
Tyr(3)-βH2 2.94 9.9 0.01 Glu(7)-αH 4.24 11.0 0.01 
Tyr(3)-βH3 2.81 3.1 0 Glu(7)-βH2 1.84   
Tyr(3)-γH 6.99 5.2 0.01 Glu(7)-βH3 1.97   
Tyr(3)-γH 6.69 6.3 0.01 Glu(7)- γH 2.27   
Glu(4)-NH 8.14 1.6 0 Gly(8)-NH 8.00 3.1 0 
Glu(4)-αH 4.18 8.4 0.01 Gly(8)-αH 3.65 6.8 0.01 
Glu(4)-βH2 1.81       
Glu(4)-βH3 1.92       
Glu(4)-γH 2.19       
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Ligand titrations with target/dilutions 
 
Figure A4.6. Titration of Ligand 7 with Target 20, amide region at pH 5.5. 
 
Figure A4.7. Titration of Ligand 7 with Target 20, amide region at pH 6.5. 
 
Figure A4.8. Titration of Ligand 7 with Target 20, alpha region at pH 6.5. 
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Figure A4.9. Dilution of mixture of Ligand 7 and Target 20, amide region at pH 6.5. 
 
Figure A4.10. Dilution of mixture of Ligand 7 and Target 20, alpha region at pH 6.5. 
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A4.3. Other compounds 
A4.3.1. Strychnine 
Table A4-24. NMR assignment of strychnine 
 # δH [ppm] (int,mult,J [Hz]) δC [ppm] 
1 7.12, 1H, d, 7.6 122.3 
2 7.05, 1H, t, 7.6, 124.3 
3 7.21, 1H, t, 7.8 128.6 
4 8.05, 1H, d, 8.0 116.2 
5 - 142.3 
6 - 132.9 
7 - 51.9 
8 3.82, 1H, d, 10.4 60.1 
9-N - - 
10 - 169.4 
11a 3.09, 1H, m 42.4 
11b 2.63, 1H, dd, 17.5, 3.4 42.4 
12 4.25, 1H, dt, 8.2, 3.4 77.5 
13 1.23, 1H, dt, 10.5, 3.2 48.1 
14 3.10, 1H, m 31.5 
15a 2.31, 1H, dt, 14.4, 4.3 26.7 
15b 1.41, 1H, br. d, 14.5 26.7 
16 3.90, 1H,  br. s 60.1 
17a/b 1.84, 2H, m 42.8 
18a 3.15, 1H, m 50.2 
18b 2.83, 1H, m 50.2 
19-N - - 
20a 3.66, 1H, d, 14.9 52.6 
20b 2.69, 1H, d, 14.6 52.6 
21 - 140.6 
22 5.86, 1H, m 127.3 
23a 4.10, 1H, dd, 13.7, 7.1 64.6 
23b 4.02, 1H, dd, 13.7, 5.9 64.6 
 
 
 
  
  Other compounds 
 
 
A-30 
NOE 
Table A4-25. τc determination. PANIC NOE and ROE intensities for strychnine (τm = 300 ms). Corr. factor given by equation 3.14 in the 
thesis. Corr. rel is the correction by including τc compared to the normal PANIC approach. 
H1 H2 
PANIC 
Corr. factor ROE NOE/ROE τc [ps] Corr. Rel 
Rel. NOE 
NOE T-ROE NOE NOE/ROE 
4 3 13.6 13.9 1.00 14.15 0.96 31.09 0.99 1.45 1.44 
15a 13 30.2 31.3 0.99 32.21 0.94 39.83 1.03 1.27 1.31 
15a 15b 128.8 131.8 1.00 134.81 0.96 33.52 1.00 1.00 1.00 
15a 14 14.4 14.8 1.01 15.19 0.95 35.83 1.01 1.44 1.45 
15a 16 17.4 17.7 1.02 18.43 0.94 37.46 1.02 1.40 1.42 
13 15a 24.6 25.2 1.00 25.63 0.96 31.25 0.99 1.32 1.30 
13 14 20.4 21.7 1.01 23.03 0.89 55.05 1.07 1.36 1.46 
13 8 3.7 3.7 1.02 3.91 0.93 41.54 1.03 1.81 1.87 
13 12 22.5 23.1 1.03 24.44 0.92 45.64 1.05 1.34 1.40 
18b 17b 15.2 15.5 1.00 15.75 0.96 29.90 0.98 1.43 1.40 
18b 18a 100.9 102.9 1.00 104.73 0.96 30.07 0.98 1.04 1.02 
18b 8 33.7 34.6 1.00 35.64 0.95 36.89 1.01 1.25 1.27 
18b 22 5.2 5.4 1.04 5.84 0.89 54.45 1.07 1.71 1.83 
20a 20b 109.6 108.0 1.00 106.92 1.02 - - 1.03 - 
20a 15b 32.5 31.8 1.01 31.41 1.03 - - 1.26 - 
16 1 23.4 21.1 1.05 19.63 1.19 - - 1.33 - 
16 15b 13.2 12.9 1.01 12.70 1.04 - - 1.46 - 
16 17a 9.6 9.3 1.02 9.09 1.06 - - 1.54 - 
16 15a 13.7 12.8 1.03 12.31 1.11 - - 1.45 - 
12 23a 22.6 22.4 1.00 22.34 1.01 - - 1.34 - 
12 11a 29.9 29.0 1.01 28.29 1.06 - - 1.28 - 
12 11b 3.8 3.8 1.01 3.79 1.00 - - 1.80 - 
12 13 22.3 20.6 1.04 19.83 1.12 - - 1.34 - 
22 23b 14.5 14.1 1.01 13.80 1.05 - - 1.44 - 
22 20b 18.3 17.7 1.04 17.73 1.03 - - 1.38 - 
8 18b 25.5 25.1 1.00 24.75 1.03 - - 1.31 - 
8 17a 17.8 16.9 1.02 16.27 1.09 - - 1.39 - 
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RDC 
Table A4-26. RDC extraction of strychnine (Polymer 6.2 in the 
thesis). 2H splitting = 112.3 Hz (CDCl3)  
Polymer 6.2    
Nuc 1 Nuc 2 J [Hz] T [Hz] D [Hz] 
C1 H1 158.3 184.9 26.6 
C2 H2 160.7 174.5 13.8 
C3 H3 159.8 183.6 23.8 
C4 H4 168.5 196.8 28.3 
C8 H8 144.9 130.6 -14.4 
C11 H11a 135.5 147.9 12.3 
C11 H11b 125.7 99.9 -25.8 
C12 H12 149.3 120.9 -28.4 
C13 H13 125.0 120.7 -4.3 
C14 H14 131.6 103.7 -27.9 
C15 H15a 131.6 138.6 7 
C15 H15b 130.4 137.8 7.5 
C16 H16 146.5 161.7 15.2 
C18 H18a 146.4 147.9 1.6 
C18 H18b 131.2 145.9 14.7 
C20 H20a 138.5 122.5 -16 
C20 H20b 138.2 134.1 -4.1 
C22 H22 159.4 160.1 0.7 
H20a H20b -14.8 -51.7 -36.9 
H11a H11b -17.2 -39.3 -22.1 
H3 H4 8.4 12.8 4.4 
H3 H2 7.4 11.0 3.6 
H3 H1 1.5 3.1 1.7 
H22 H23a 6.8 15.5 8.8 
H22 H20b -0.7 5.8 6.5 
H2 H4 1.0 1.2 0.2 
H1 H3 1.3 2.5 1.2 
H1 H2 7.1 11.9 4.8 
H4 H3 7.5 13.1 5.7 
H4 H2 1.1 2.8 1.8 
H12 H23a -0.3 -1.0 -0.7 
H12 H11b 3.3 -1.1 -4.5 
H16 H20b -0.3 0.1 0.4 
H16 H15a 3.9 -3.0 -6.9 
H16 H15b 2.2 -0.1 -2.3 
H8 H13 10.5 7.6 -3 
H8 H12 -0.1 -1.8 -1.7 
H16 H18a -0.3 -4.2 -4 
H13 H14 -0.4 2.3 2.7 
H13 H15a 0.4 2.0 1.6 
H13 H15b -0.6 4.5 5.1 
H14 H22 -3.0 -3.4 -0.3 
H14 H20b -0.5 -0.7 -0.2 
H14 H15b 1.9 4.6 2.7 
 
Table A4-27. RDC extraction of strychnine (Polymer 8.1 in the 
thesis). 2H splitting = 103.4 Hz (CDCl3) 
Polymer 8.1    
C H J [Hz] T [Hz] D [Hz] 
C1 H1 158.3 177.3 19 
C2 H2 160.7 174.7 14 
C3 H3 159.8 178.7 18.8 
C4 H4 168.5 187.2 18.7 
C8 H8 144.9 134.0 -11 
C11 H11a 135.5 140.6 5.1 
C11 H11b 125.7 104.1 -21.7 
C12 H12 149.3 124.1 -25.2 
C13 H13 125.0 121.2 -3.8 
C14 H14 131.6 106.5 -25.1 
C15 H15a 131.6 134.6 3.1 
C15 H15b 130.4 136.5 6.1 
C16 H16 146.5 161.4 15 
C18 H18a 146.4 143.5 -2.9 
C18 H18b 131.2 144.4 13.2 
C20 H20a 138.5 124.1 -14.4 
C20 H20b 138.2 134.7 -3.5 
C22 H22 159.4 159.4 0.1 
H1 H2 7.2 11.1 3.9 
H1 H3 1.3 2.9 1.6 
H2 H3 7.4 10.8 3.4 
H2 H4 1.1 1.4 0.3 
H3 H4 8.3 12.9 4.6 
H8 H12 0.1 -3.2 -3.3 
H8 H13 10.5 6.3 -4.2 
H8 H16 -0.1 2.0 2.1 
H12 H11b 3.3 0.0 -3.2 
H12 H23a -0.2 1.2 1.5 
H12 H23b -0.4 9.1 9.4 
H13 H14 -0.5 2.3 2.8 
H13 H15a 0.6 2.7 2.1 
H13 H15b -0.6 7.5 8.1 
H14 H15b 1.8 5.6 3.8 
H14 H16 0.7 1.8 1.1 
H14 H20b -0.6 -1.0 -0.4 
H14 H22 -3.1 -3.7 -0.7 
H16 H15a 3.9 0.9 -3 
H16 H15b 2.2 -0.3 -2.5 
H16 H17a/H17b -0.1 -4.2 -4.1 
H16 H18a -0.2 -1.9 -1.7 
H16 H20b -0.3 1.6 1.9 
H22 H20b -0.7 4.7 5.4 
H22 H23a 7.0 12.3 5.3 
H22 H23b 6.0 3.9 -2.1 
 
 
  
  Other compounds 
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Table A4-28. RDCs in Hz back-calculated from different assignments of strychnine using SVD (Polymer 6.2 in the thesis).  
C H Exp. Right Dia-11 Dia-15 Dia-18 Dia-20 Dia-23 
C1 H1 19.0 18.0 11.4 18.4 19.8 18.8 18.0 
C2 H2 14.0 14.8 13.6 14.4 9.1 13.9 14.8 
C3 H3 18.8 18.2 15.5 17.8 18.1 15.8 18.2 
C4 H4 18.7 18.3 11.7 18.7 20.0 19.2 18.3 
C8 H8 -11.0 -10.3 -0.8 -10.6 -12.1 -10.5 -10.3 
C11 H11b 5.1 7.5 -12.9 7.2 11.5 6.0 7.5 
C11 H11a -21.7 -23.7 -2.3 -23.8 -23.4 -22.8 -23.7 
C12 H12 -25.2 -25.5 -25.7 -25.7 -21.8 -25.8 -25.5 
C13 H13 -3.8 -3.6 0.4 -4.3 -2.5 -5.8 -3.6 
C14 H14 -25.1 -24.2 -24.3 -24.2 -21.6 -24.0 -24.2 
C15 H15a 3.1 3.2 5.7 5.2 3.1 6.7 3.2 
C15 H15b 6.1 5.9 6.2 4.3 7.7 3.0 5.9 
C16 H16 15.0 14.1 12.7 13.9 9.0 13.8 14.1 
C18 H18a -2.9 -4.3 -10.7 -4.8 8.4 -6.5 -4.3 
C18 H18b 13.2 13.6 12.9 13.4 1.5 13.5 13.6 
C20 H20a -14.4 -12.5 -3.7 -11.5 -13.8 -5.5 -12.5 
C20 H20b -3.5 -3.1 0.1 -3.8 -1.4 -8.1 -3.1 
C22 H22 0.1 2.2 2.5 1.4 4.9 -0.7 2.2 
  Q-factor 0.079 0.547 0.096 0.334 0.201 0.079 
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Table A4-29. RDCs in Hz back-calculated from different assignments of strychnine using SVD (Polymer 6.2 in the thesis).  
Nuc 1 Nuc 2 Exp. Right Dia-11 Dia-15 Dia-18 Dia-20 Dia-23 
C1 H1 19.0 15.8 13.4 19.2 16.8 16.1 14.7 
C2 H2 14.0 14.5 15.5 12.1 11.8 15.8 14.4 
C3 H3 18.8 17.9 17.4 18.4 18.5 14.8 20.3 
C4 H4 18.7 16.0 13.6 19.5 17.0 16.5 14.9 
C8 H8 -11.0 -7.9 -3.6 -9.7 -10.4 -6.4 -4.0 
C11 H11b 5.1 4.6 -17.1 5.4 7.1 2.1 6.2 
C11 H11a -21.7 -21.1 1.5 -22.3 -22.6 -19.2 -18.3 
C12 H12 -25.2 -25.5 -26.3 -27.1 -23.3 -27.0 -25.4 
C13 H13 -3.8 -2.5 -0.1 -3.8 -2.9 -4.3 3.5 
C14 H14 -25.1 -24.1 -25.1 -25.7 -22.2 -25.1 -25.6 
C15 H15a 3.1 3.6 3.1 5.7 3.5 6.7 -1.0 
C15 H15b 6.1 6.2 7.2 7.5 6.6 3.0 12.1 
C16 H16 15.0 13.7 14.5 12.0 11.1 15.5 13.1 
C18 H18a -2.9 -6.2 -8.2 -6.1 10.5 -9.9 -2.3 
C18 H18b 13.2 13.3 14.4 11.7 -3.2 15.4 12.7 
C20 H20a -14.4 -10.5 -8.7 -8.2 -12.2 -4.5 -14.9 
C20 H20b -3.5 -2.2 -0.1 -3.3 -2.2 -5.4 4.0 
C22 H22 0.1 2.4 3.4 1.9 3.2 -1.0 8.7 
H1 H3 1.5 1.1 1.0 1.4 1.3 1.0 1.2 
H1 H3 1.6 1.1 1.0 1.4 1.3 1.0 1.2 
H1 H2 3.9 6.0 5.8 6.1 6.2 4.9 6.8 
H2 H3 3.1 5.3 4.5 6.5 5.6 5.5 4.9 
H2 H4 0.2 0.9 0.9 0.9 0.8 1.0 0.8 
H2 H3 3.6 5.3 4.5 6.5 5.6 5.5 4.9 
H2 H4 0.3 0.9 0.9 0.9 0.8 1.0 0.8 
H3 H4 4.4 4.8 5.1 4.0 3.9 5.2 4.7 
H3 H4 4.8 4.8 5.1 4.0 3.9 5.2 4.7 
H8 H12 -3.3 -2.1 -2.3 -2.3 -1.8 -2.3 -2.0 
H8 H16 2.1 0.6 0.7 0.7 0.4 0.9 0.5 
H8 H13 -3.8 -5.1 -4.6 -5.4 -5.1 -5.1 -4.5 
H8 H13 -4.6 -5.1 -4.6 -5.4 -5.1 -5.1 -4.5 
H11a H12 -3.2 -5.2 0.8 -5.1 -5.3 -4.6 -6.0 
H12 H23a 1.5 1.1 1.3 1.0 1.1 0.8 8.3 
H12 H23b 9.4 7.6 7.1 8.1 8.0 6.3 1.8 
H13 H14 2.8 4.2 3.6 5.0 4.6 3.9 3.3 
H13 H15a 2.1 1.7 1.5 6.5 1.8 1.9 1.5 
H13 H15b 8.1 5.5 5.4 2.2 4.8 7.0 4.3 
H14 H15b 3.8 4.4 4.4 4.3 3.9 4.2 4.3 
H14 H16 1.1 0.1 -0.1 -0.1 0.1 0.0 0.0 
H14 H20b -0.4 -0.7 -0.7 -0.7 -0.5 0.3 -0.3 
H14 H22 -0.7 -0.7 -0.4 -0.8 -0.8 -0.8 -0.2 
H15a H16 -3.0 -4.4 -4.9 -4.7 -3.9 -4.7 -5.5 
H15b H16 -2.5 -4.3 -5.1 -5.0 -3.3 -5.3 -3.7 
H16 H17a/H17b -4.1 -5.0 -5.4 -6.2 -6.1 -5.9 -5.0 
H16 H18a -1.7 -1.6 -1.2 -1.7 -0.4 -1.5 -1.1 
H16 H20b 1.9 1.1 1.2 0.9 1.0 1.7 1.3 
H20b H22 5.4 4.9 4.5 4.6 4.5 1.6 4.5 
H22 H23a 5.3 4.1 3.0 4.6 4.7 3.7 -0.7 
H22 H23b -2.1 -1.5 -1.8 -1.5 -1.0 -2.3 4.1 
  Q-factor 0.162 0.555 0.214 0.365 0.272 0.366 
  
  Other compounds 
 
 
A-34 
Chiral polymer (L-TEG-Phe/DMAA) 
Table A4-30. Output from MSPIN upon entering the extracted RDCs of strychnine aligned in the L-TEG-Phe/DMAA 
1 Exp Hz Comp Hz 2 Exp Hz Comp Hz 3 Exp Hz Comp Hz 
C22,H45 0.9 -1.2 C22,H45 2.2 -1.1 C22,H45 2.1 -0.94 
C2,H27 8.2 9.5 C2,H27 8.5 10.1 C2,H27 7.8 9.94 
C1,H26 -21.1 -19.6 C1,H26 -22.6 -20.5 C1,H26 -25.1 -22.68 
C4,H29 -22.9 -19.9 C4,H29 -22.7 -20.8 C4,H29 -26.4 -23.07 
C12,H33 10.4 13.8 C12,H33 10.5 14.5 C12,H33 10.9 15.35 
C16,H38 7.5 7.7 C16,H38 7.6 8.1 C16,H38 7.9 7.36 
C8,H30 9.7 14.8 C8,H30 11.3 14.7 C8,H30 10.7 14.29 
C20,H43 1.7 -2.1 C20,H43 -0.4 -3.2 C20,H43 -1.4 -4.21 
C20,H44 8.2 4.9 C20,H44 7.6 5.0 C20,H44 5.3 5.09 
C18,H41 5.6 -1.0 C18,H41 3.9 -0.8 C18,H41 5.9 -1.45 
C18,H42 13.0 7.7 C18,H42 12.8 8.0 C18,H42 11.3 7.14 
C13,H34 2.9 6.4 C13,H34 1.7 6.5 C13,H34 2.4 6.62 
C11,H32 -9.1 -6.3 C11,H32 -7.5 -6.2 C11,H32 -9.9 -7.58 
C11,H31 17.3 16.7 C11,H31 17.3 16.4 C11,H31 17.3 16.01 
C14,H35 13.5 13.0 C14,H35 15.3 13.7 C14,H35 15 15.1 
Q-factor 
 
0.284 Q-factor 
 
0.247 Q-factor 
 
0.259 
Alignment tensor 
 
Alignment tensor 
 
Alignment tensor 
 
A'x=-1.263e-04 
 
A'x=-1.421e-04 
 
A'x=-1.544e-04 
 
A'y=-2.468e-04 
 
A'y=-2.444e-04 
 
A'y=-2.456e-04 
 
A'z= 3.732e-04 
 
A'z= 3.865e-04 
 
A'z= 4.001e-04 
 
Saupe tensor 
 
Saupe tensor 
 
Saupe tensor 
 
S'x=-1.895e-04 
 
S'x=-2.131e-04 
 
S'x=-2.317e-04 
 
S'y=-3.703e-04 
 
S'y=-3.666e-04 
 
S'y=-3.684e-04 
 
S'z= 5.597e-04 
 
S'z= 5.797e-04 
 
S'z= 6.001e-04 
 
Alignment tensor eigenvectors Alignment tensor eigenvectors Alignment tensor eigenvectors 
e[x]=( 0.765,-0.639, 0.081) e[x]=( 0.780,-0.626, 0.021) e[x]=(-0.820, 0.561, 0.115) 
e[y]=( 0.143, 0.046,-0.989) e[y]=( 0.103, 0.095,-0.990) e[y]=( 0.015,-0.180, 0.983) 
e[z]=( 0.628, 0.768, 0.127) e[z]=( 0.618, 0.774, 0.138) e[z]=( 0.572, 0.808, 0.139) 
Alignment tensor in laboratory 
coordinates: 
Alignment tensor in laboratory 
coordinates: 
Alignment tensor in laboratory 
coordinates: 
[ 6.845e-05,2.401e-04,5.679e-05] [ 5.839e-05,2.517e-04,5.550e-05] [ 2.714e-05,2.567e-04,4.290e-05] 
[ 2.401e-04,1.677e-04,5.403e-05] [ 2.517e-04,1.739e-04,6.611e-05] [ 2.567e-04,2.047e-04,7.866e-05] 
[ 5.679e-05,5.403e-05,-2.361e-04] [ 5.550e-05,6.611e-05,-2.323e-04] [ 4.290e-05,7.866e-05,-2.319e-04] 
SVD condition number is 1.742e+00 SVD condition number is 1.742e+00 SVD condition number is 1.742e+00 
Axial component Aa = 5.597e-04 Axial component Aa = 5.797e-04 Axial component Aa = 6.001e-04 
Rhombic component Ar = 1.205e-04 Rhombic component Ar = 1.024e-04 Rhombic component Ar = 9.119e-05 
rhombicity R = 2.153e-01 
 
rhombicity R = 1.766e-01 
 
rhombicity R = 1.520e-01 
Asimmetry parameter etha =3.230e-01 Asimmetry parameter etha =2.648e-01 Asimmetry parameter etha =2.279e-01 
GDO = 6.630e-04 
  
GDO = 6.810e-04 
  
GDO = 7.019e-04 
 
Euler Angles (degrees) 
 
Euler Angles (degrees) 
 
Euler Angles (degrees) 
Set 1 
   
Set 1 
   
Set 1 
  
(80.6,-38.9,10.6) (79.9,-38.1,7.5) (80.2,-34.9,178.9) 
Set 2 
   
Set 2 
   
Set 2 
  
(-99.4,218.9,-169.4) (-100.1,218.1,-172.5) (-99.8,214.9,-1.1) 
 
  
NMR Assignments 
 
 
A-35 
Chiral polymer (D-TEG-Phe/DMAA) 
Table A4-31. Output from MSPIN upon entering the extracted RDCs of strychnine aligned in the D-TEG-Phe/DMAA 
4 Exp Hz Comp Hz 5 Exp Hz Comp Hz 6 Exp Hz Comp Hz 
C22,H45 3.3 1.0 C22,H45 3.1 0.4 C22,H45 3.5 0.45 
C2,H27 6.0 6.5 C2,H27 6.3 6.7 C2,H27 7.6 8.35 
C1,H26 -13.7 -12.0 C1,H26 -14.2 -14.2 C1,H26 -15.5 -14.47 
C4,H29 -12.5 -12.2 C4,H29 -15.3 -14.5 C4,H29 -16.9 -14.73 
C12,H33 6.9 10.5 C12,H33 8.4 12.1 C12,H33 6.8 11.11 
C16,H38 5.8 6.0 C16,H38 6.1 5.9 C16,H38 7.3 7.27 
C8,H30 9.5 13.4 C8,H30 11.1 13.4 C8,H30 10.2 13.27 
C20,H43 0.8 -0.9 C20,H43 -0.5 -1.4 C20,H43 -1.6 -2.65 
C20,H44 10.1 5.7 C20,H44 10.4 5.5 C20,H44 8.9 5.4 
C18,H41 7.4 2.4 C18,H41 7.1 2.0 C18,H41 8.2 1.36 
C18,H42 10.0 6.2 C18,H42 9.1 6.0 C18,H42 10.6 7.3 
C13,H34 0.8 6.8 C13,H34 -1.2 6.6 C13,H34 -2 6.57 
C11,H32 -4.9 -1.8 C11,H32 -6.9 -2.8 C11,H32 -6.8 -2.9 
C11,H31 17.3 15.3 C11,H31 17.3 15.5 C11,H31 17.3 14.52 
C14,H35 9.9 8.3 C14,H35 12.6 10.2 C14,H35 10.1 9.49 
Q-factor  0.347 Q-factor  0.345 Q-factor  0.374 
Alignment tensor  Alignment tensor  Alignment tensor  
A'x=-6.623e-05  A'x=-7.895e-05  A'x=-9.995e-05  
A'y=-2.233e-04  A'y=-2.305e-04  A'y=-2.125e-04  
A'z= 2.896e-04  A'z= 3.095e-04  A'z= 3.124e-04  
Saupe tensor  Saupe tensor  Saupe tensor  
S'x=-9.935e-05  S'x=-1.184e-04  S'x=-1.499e-04  
S'y=-3.350e-04  S'y=-3.457e-04  S'y=-3.187e-04  
S'z= 4.344e-04  S'z= 4.642e-04  S'z= 4.686e-04  
Alignment tensor eigenvectors Alignment tensor eigenvectors Alignment tensor eigenvectors 
e[x]=(-0.633, 0.761,-0.143) e[x]=(-0.696, 0.714,-0.072) e[x]=( 0.692,-0.705, 0.159) 
e[y]=(-0.231,-0.009, 0.973) e[y]=(-0.169,-0.065, 0.984) e[y]=( 0.239, 0.016,-0.971) 
e[z]=( 0.739, 0.649, 0.182) e[z]=( 0.698, 0.697, 0.166) e[z]=( 0.682, 0.709, 0.180) 
Alignment tensor in laboratory 
coordinates: 
Alignment tensor in laboratory 
coordinates: 
Alignment tensor in laboratory 
coordinates: 
[ 1.196e-04,1.702e-04,8.310e-05] [ 1.060e-04,1.872e-04,7.006e-05] [ 8.516e-05,1.989e-04,7.658e-05] 
[ 1.702e-04,8.363e-05,4.343e-05] [ 1.872e-04,1.089e-04,5.455e-05] [ 1.989e-04,1.075e-04,5.424e-05] 
[ 8.310e-05,4.343e-05,-2.032e-04] [ 7.006e-05,5.455e-05,-2.149e-04] [ 7.658e-05,5.424e-05,-1.927e-04] 
SVD condition number is 1.742e+00 SVD condition number is 1.742e+00 SVD condition number is 1.742e+00 
Axial component Aa = 4.344e-04 Axial component Aa = 4.642e-04 Axial component Aa = 4.686e-04 
Rhombic component Ar = 1.571e-04 Rhombic component Ar = 1.515e-04 Rhombic component Ar = 1.125e-04 
rhombicity R = 3.617e-01  rhombicity R = 3.265e-01  rhombicity R = 2.401e-01 
Asimmetry parameter etha =5.426e-01 Asimmetry parameter etha =4.897e-01 Asimmetry parameter etha =3.601e-01 
GDO = 5.372e-04   GDO = 5.672e-04   GDO = 5.584e-04  
Euler Angles (degrees)  Euler Angles (degrees)  Euler Angles (degrees) 
Set 1    Set 1    Set 1   
(74.4,-47.6,-159.9) (76.6,-44.3,-166.4) (75.8,-43.0,19.1) 
Set 2    Set 2    Set 2   
(-105.6,227.6,20.1) (-103.4,224.3,13.6) (-104.2,223.0,-160.9) 
 
  
  Other compounds 
 
 
A-36 
Table A4-32. Comparison of the alignment frames obtained from MSPIN upon entering the extracted RDCs of strychnine aligned in the L- 
or D-TEG-Phe/DMAA 
GCB 1 2 3 4 5 6 GCB 1 2 3 4 5 6 
1 1.000 0.999 0.984 0.938 0.970 0.986 1 0 2.87 10.26 20.36 14.11 9.65 
2  1.000 0.992 0.920 0.957 0.977 2  0 7.41 23.14 16.95 12.20 
3   1.000 0.862 0.911 0.943 3   0 30.51 24.35 19.38 
4    1.000 0.994 0.980 4    0 6.44 11.38 
5     1.000 0.994 5     0 6.18 
6      1.000 6      0 
 
A4.3.2. Quinine 
Table A4-33. NMR assignment of quinine 
 # δH [ppm] (int,mult,J [Hz]) δC [ppm] 
2' 8.47 (1H,d,4.6) 147.2 
3' 7.44 (1H,d,4.6) 118.4 
4'  148.0 
5' 7.21 (1H,m) 121.3 
6'  157.7 
7' 7.26 (1H,m) 101.2 
8' 7.88 (1H,d,9.1) 131.2 
9'  143.4 
10'  126.8 
2a 3.03 (1H,dd,13.7,10.1) 56.9 
2b 2.61 (1H,m) 56.9 
3 2.23 (1H,br. t,10.0) 39.8 
4 1.77 (1H,m) 27.8 
5a 1.70 (1H,m) 21.5 
5b 1.45 (1H,m) 21.5 
6a 3.42 (1H,dddd,12.9,10.6,5.0,2.2) 43.1 
6b 2.60 (1H,m) 43.1 
7a 1.72 (1H,m) 27.6 
7b 1.49 (1H,m) 27.6 
8 3.07 (1H,m) 59.9 
9 5.51 (1H,d,3.2) 71.6 
10 5.74 (1H,ddd,17.3,10.1,7.5) 141.7 
11a 4.96 (1H,m) 114.3 
11b 4.92 (1H,m) 114. 
OMe 3.9 (3H,s) 55.6 
OH 4.72 (1H,br. s)  - 
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NOE 
Table A4-34. Experimental distances in Å from relative NOE intensities compared to distances of the relevant structures for quinine (τm = 
300 ms) 
H1 H2 PANIC NOE Rel. Distance Exp. Distance 
Theoretical distances 
C1 C2 O3 C7 O8 O4 O10 
2' 3' 14.43 1.39 2.47 2.49 2.50 2.50 2.49 2.47 2.47 2.48 
9 3' 5.89 1.62 2.86 2.28 3.68 3.65 3.55 3.62 3.62 3.61 
9 5' 39.25 1.18 2.09 3.79 2.09 2.13 2.34 2.29 2.29 2.07 
9 6a 13.02 1.42 2.51 2.13 2.16 2.67 2.23 2.69 2.69 3.97 
9 8 11.35 1.45 2.57 3.04 3.04 2.56 3.05 2.53 2.53 2.24 
9 7a 7.36 1.56 2.76 2.60 2.71 3.63 2.44 3.65 3.65 2.85 
6a 9 15.87 1.37 2.43 2.13 2.16 2.67 2.23 2.69 2.69 3.97 
6a 6b 105.52 1.00 1.77 1.76 1.76 1.77 1.76 1.77 1.77 1.75 
6a 5a 23.46 1.28 2.28 2.35 2.34 2.33 2.37 2.33 2.33 2.33 
6a 5b 3.85 1.74 3.07 2.97 2.98 2.92 2.92 2.92 2.92 2.97 
8' 7' 11.89 1.44 2.55 2.52 2.52 2.52 2.52 2.52 2.52 2.49 
3' 2' 16.16 1.37 2.42 2.49 2.50 2.50 2.49 2.47 2.47 2.48 
3 2a 18.01 1.34 2.38 2.33 2.33 2.33 2.33 2.33 2.33 2.30 
3 6b 3.59 1.76 3.11 3.32 3.38 3.15 3.09 3.14 3.14 3.39 
3 4 12.9 1.42 2.51 2.49 2.48 2.51 2.52 2.51 2.51 2.46 
3 5b 14.5 1.39 2.46 2.44 2.43 2.45 2.45 2.45 2.45 2.39 
8 3' 8.2 1.53 2.71 2.75 2.72 3.83 2.33 2.19 2.19 2.45 
8 5' 18.39 1.34 2.37 2.41 2.22 2.44 3.98 3.70 3.70 3.30 
8 9 11.33 1.45 2.57 3.04 3.04 2.56 3.05 2.53 2.53 2.24 
2a 2b 129.71 0.97 1.71 1.77 1.77 1.77 1.77 1.77 1.77 1.75 
2a 3 21.61 1.30 2.31 2.33 2.33 2.33 2.33 2.33 2.33 2.30 
8 7a 6.65 1.59 2.81 3.01 3.02 2.97 2.95 2.99 2.99 3.02 
8 7b 24.92 1.27 2.25 2.31 2.31 2.29 2.30 2.31 2.31 2.29 
6b 6a 101.88 1.01 1.78 1.76 1.76 1.77 1.76 1.77 1.77 1.75 
2b 2a 142.21 0.95 1.68 1.76 1.76 1.76 1.74 1.76 1.76 1.73 
2b 3 4.46 1.69 3.00 2.93 2.92 2.97 2.98 2.97 2.97 2.88 
6b 5a 4.01 1.72 3.05 2.92 2.89 2.95 2.97 2.95 2.95 2.86 
6b 5b 19.58 1.32 2.34 2.36 2.37 2.36 2.36 2.36 2.36 2.35 
  
  Other compounds 
 
 
A-38 
NOE/ROE 
Table A4-35. τc determination. PANIC NOE and ROE intensities for quinine (τm = 300 ms). Corr. factor given by equation 3.14  in the thesis. 
Corr. rel is the correction by including τc compared to the normal PANIC approach. 
H1 H2 
PANIC 
Corr. factor ROE NOE/ROE τc [ps] Corr Rel. 
Rel. NOE 
NOE T-ROE NOE NOE/ROE 
2' 3' 14.4 28.3 0.96 40.4 0.36 187.8 0.99 1.39 1.37 
9 3' 5.9 10.7 1.00 15.5 0.38 180.5 0.99 1.62 1.60 
9 5' 39.3 62.2 1.00 85.2 0.46 157.4 1.01 1.18 1.19 
9 6a 13.0 19.2 1.01 25.7 0.51 145.3 1.01 1.42 1.43 
9 8 11.4 19.8 1.01 28.6 0.40 175.6 1.00 1.45 1.44 
9 7a 7.4 9.5 1.04 12.2 0.60 121.5 1.02 1.56 1.58 
6a 9 15.9 23.2 1.01 30.8 0.52 143.2 1.01 1.37 1.39 
6a 6b 105.5 180.2 0.98 250.7 0.42 168.6 1.00 1.00 1.00 
6a 5a 23.5 34.8 0.99 45.5 0.52 143.2 1.01 1.28 1.30 
8' 7' 11.9 21.8 0.97 30.7 0.39 178.3 0.99 1.44 1.43 
3' 2' 16.2 31.3 0.96 44.7 0.36 186.4 0.99 1.37 1.35 
3 2a 18.0 30.5 0.98 41.9 0.43 166.0 1.00 1.34 1.34 
3 6b 3.6 6.0 0.97 8.1 0.44 162.4 1.00 1.76 1.76 
3 4 12.9 20.1 0.97 26.3 0.49 149.5 1.01 1.42 1.43 
3 5b 14.5 23.5 0.96 31.2 0.46 156.4 1.01 1.39 1.40 
8 3' 8.2 11.2 1.06 15.1 0.54 136.4 1.01 1.53 1.55 
8 5' 18.4 31.7 1.05 47.3 0.39 177.9 0.99 1.34 1.33 
8 9 12.3 22.1 1.01 32.4 0.38 180.3 0.99 1.43 1.42 
2a 2b 129.7 220.7 0.98 305.1 0.43 167.4 1.00 0.97 0.97 
2a 3 21.6 35.9 0.98 49.0 0.44 162.9 1.00 1.30 1.31 
8 7b 24.9 36.1 0.98 46.3 0.54 137.3 1.01 1.27 1.29 
6b 6a 101.9 176.3 0.98 246.5 0.41 170.8 1.00 1.01 1.00 
2b 2a 142.2 252.2 0.98 354.3 0.40 174.2 1.00 0.95 0.95 
2b 3 4.5 10.0 0.96 15.0 0.30 207.3 0.97 1.69 1.64 
6b 5b 19.6 30.2 0.97 39.5 0.50 148.2 1.01 1.32 1.34 
 
RDC 
Table A4-36. RDC extraction of quinine (Polymer 8.6 in the thesis). 2H splitting = 49.5 Hz (CDCl3) 
Quinine 
    
C H J [Hz] T [Hz] D [Hz] 
3 3 138.2 150.5 12.3 
4 4 129.8 139.3 9.6 
6 6a 140.4 113.9 -26.5 
6 6b 137.1 139.1 2 
8 8 135.2 132.4 -2.8 
9 9 142.2 152.3 10.1 
2' 2' 177.7 194 16.3 
3' 3' 162.8 178.2 15.5 
5' 5' 161.5 176.1 14.6 
7' 7' 158 171.2 13.2 
8' 8' 162.6 176.1 13.5 
 
  
NMR Assignments 
 
 
A-39 
A4.3.3. Progesterone 
Table A4-37. NMR assignment of progesterone 
 # 1H δ [ppm],mult, J [Hz] 13C δ[ppm] 
1a 2.02  (1H,m) 35.6 
1b 1.69 (1H,m) 35.6 
2a 2.35 (1H,m) 33.9 
2b 2.39 (1H,m) 33.9 
3  208.8 
4 5.72 (1H,s) 123.9 
5  170.7 
6a 2.24  (1H,ddd,14.5,3.7,2.4) 32.7 
6b 2.38 (1H,m) 32.7 
7a 1.06 (1H,m) 31.9 
7b 1.95  (1H,m)  31.9 
8 1.55 (1H,m) 35.5 
9 0.98 (1H,m) 53.7 
10  43.9 
11a 1.62 (1H,m) 21 
11b 1.44 (1H,m) 21 
12a 1.43 (1H,m) 38.6 
12b 2.03 (1H,m) 38.6 
13  38.5 
14 1.15 (1H,m) 56 
15a 1.78 (1H,m) 24.5 
15b 1.17 (1H,m) 24.5 
16a 1.66 (1H,m) 22.7 
16b 2.15 (1H,dt,16.7,3.4) 22.7 
17 2.54 (1H,t,9.1) 63.4 
18Me 0.56 (3H,s) 13.37 
19Me 1.13 (3H,s) 17.3 
20  199.3 
21Me 2.06 (3H,s) 31.4 
 
 
 
 
  
  Other compounds 
 
 
A-40 
NOE/ROE 
CDCl3 
Table A4-38. τc determination. PANIC NOE and ROE intensities for progesterone in CDCl3 (τm = 300 ms). Corr. factor given by equation 
3.14  in the thesis. Corr. rel is the correction by including τc compared to the normal PANIC approach. 
H1 H2 
PANIC 
Corr. factor ROE NOE/ROE τc [ps] Corr. rel 
Rel. NOE 
NOE T-ROE NOE NOE/ROE 
4 6a 16.2 16.3 1.05 17.1 0.95 36.0 1.03 1.22 1.26 
17 16a 10.3 10.4 1.00 10.5 0.98 21.4 0.95 1.32 1.26 
17 12a 12.7 13.1 1.00 13.6 0.93 42.4 1.06 1.27 1.35 
17 14 15.6 16.1 1.00 16.6 0.94 39.7 1.05 1.23 1.29 
6a 4 22.4 22.5 1.05 23.7 0.94 38.3 1.04 1.16 1.21 
6a 7b 15.9 16.9 0.99 17.8 0.89 53.7 1.09 1.23 1.34 
6a 7a 10.2 10.7 1.00 11.1 0.92 46.4 1.07 1.32 1.41 
16b 16a 55.6 60.1 0.99 64.0 0.87 59.8 1.10 0.99 1.10 
16b 15b 14.5 17.7 0.98 20.4 0.71 96.8 1.15 1.24 1.43 
7b 6b 9.9 10.4 1.00 10.8 0.92 44.9 1.06 1.33 1.41 
7b 6a 14.2 15.4 0.99 16.5 0.86 63.1 1.11 1.25 1.39 
7b 8 6.9 7.8 0.98 8.6 0.80 75.9 1.13 1.41 1.59 
7b 15b 7.1 7.7 0.99 8.3 0.85 64.5 1.11 1.40 1.56 
7b 7a 58.6 64.1 0.99 68.7 0.85 64.2 1.11 0.99 1.10 
8 6b 9.8 10.1 1.00 10.3 0.95 37.2 1.04 1.33 1.38 
8 7b 5.7 6.6 0.98 7.4 0.76 85.8 1.14 1.46 1.66 
15b 16b 15.7 17.7 0.99 19.5 0.80 76.2 1.13 1.23 1.39 
15b 8 6.9 7.5 0.99 7.9 0.86 61.1 1.11 1.41 1.56 
7a 6a 7.8 7.9 1.00 8.0 0.97 27.3 0.99 1.38 1.37 
7a 7b 54.0 54.9 1.00 55.9 0.97 29.2 1.00 1.00 1.00 
7a 15a 4.8 5.7 0.98 6.5 0.73 91.8 1.15 1.50 1.72 
9 1b 19.5 20.3 0.99 21.0 0.93 41.9 1.05 1.18 1.25 
 DMSO-d6 
Table A4-39. τc determination. PANIC NOE and ROE intensities for progesterone in DMSO-d6 (τm = 300 ms). Corr. factor given by equation 
3.14  in the thesis. Corr. rel is the correction by including τc compared to the normal PANIC approach. 
H1 H2 
PANIC 
Corr. factor ROE NOE/ROE τc [ps] Corr. rel 
Rel. NOE 
NOE T-ROE NOE NOE/ROE 
4 6a 27.7 31.2 1.04 36.2 0.77 84.8 0.99 1.27 1.26 
17 12b 6.7 7.7 0.99 8.6 0.77 82.5 0.99 1.61 1.59 
17 16a 20.0 24.0 0.99 27.7 0.72 94.6 1.00 1.34 1.34 
17 12a 21.3 26.7 0.99 31.6 0.68 105.2 1.00 1.33 1.33 
17 14 25.1 36.5 0.98 46.7 0.54 137.6 1.00 1.29 1.30 
6b 6a 117.8 134.6 0.99 150.1 0.78 80.2 0.99 1.00 0.99 
2b 2a 123.6 162.5 0.98 197.9 0.62 116.7 1.01 0.99 1.00 
2b 1a 14.6 20.9 0.98 26.6 0.55 135.2 1.00 1.42 1.42 
6b 7b 18.8 22.7 0.99 26.3 0.72 95.7 1.00 1.36 1.35 
6b 8 15.3 20.7 0.98 25.6 0.60 123.2 1.01 1.40 1.41 
6b 7a 4.2 6.0 0.97 7.6 0.55 134.9 1.00 1.74 1.75 
6a 7b 17.3 25.8 0.97 33.4 0.52 142.8 1.00 1.38 1.38 
6a 7a 19.7 24.3 0.98 28.4 0.69 101.6 1.00 1.35 1.35 
2a 1a 11.3 18.4 0.97 24.7 0.46 158.1 1.00 1.48 1.47 
2a 1b 17.5 23.9 0.98 29.7 0.59 125.5 1.01 1.37 1.38 
7b 6b 20.3 24.6 0.99 28.5 0.71 96.7 1.00 1.34 1.34 
7b 6a 17.3 24.7 0.98 31.3 0.55 133.8 1.00 1.38 1.38 
7b 15b 13.3 21.1 0.97 27.8 0.48 152.7 1.00 1.44 1.43 
7b 8 13.5 21.6 0.96 28.6 0.47 154.3 1.00 1.43 1.43 
7b 14 13.3 18.9 0.97 23.6 0.56 131.5 1.00 1.44 1.44 
7b 7a 117.1 143.4 0.98 165.8 0.71 98.2 1.00 1.00 1.00 
NMR Assignments 
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A4.4. RDC compounds 
A4.4.1. IPC 
Table A4-40. NMR assignment of IPC 
 # δH [ppm] (int,mult,J [Hz]) δC [ppm] 
1 1.78 (1H, td, 5.9,1.4) 47.72 
2 1.94 (1H, m) 47.56 
3 4.06 (1H, dt, 9.5,4.8) 69.8 
4a 2.50 (1H, dddd,13.4,10.0,3.1,2.7) 38.9 
4b 1.69 (1H, ddd, 13.9,4.5,2.6)  
5 1.93 (1H, m) 41.8 
6  39.2 
7a 1.03 (1H, d, 10.0) 34.1 
7b 2.36 (1H, dtd, 9.4,6.4,2.7)  
8 1.22 (3H, s) 28.0 
9 0.94 (3H, s) 24.0 
10 1.11 (3H, d, 7.2) 21.1 
OH 4.63  
 
 
RDC 
Table A4-41. RDC extraction of IPC (Polymer 6.1 in the thesis). 2H splitting = 44.2 Hz (CDCl3) 
IPC 
    
Nuc 1 Nuc 2 J [Hz] T [Hz] D [Hz] 
C1 H1 140.4 156.7 16.3 
C2 H2 126.6 114.9 -11.6 
C3 H3 142.3 156.9 14.6 
C4 H4a 126.9 122.2 -4.8 
C4 H4b 126.6 142.1 15.5 
C5 H5 141.4 134 -7.4 
C7 H7a 147.2 125.5 -21.7 
C7 H7b 135.2 140.2 4.9 
H1 H5 2.5 3.5 1 
H1 H7a 1.8 2.3 0.5 
H2 H3 5.3 9.0 3.7 
H2 H4b -0.7 0.8 1.5 
H3 H4a 4.7 6.3 1.6 
H3 H4b 9.2 7.1 -2.1 
H3 H5 -0.2 -0.5 -0.3 
H4a H5 2.8 -4.2 -7 
 
  
  RDC compounds 
 
 
A-42 
Table A4-42. RDCs in Hz back-calculated from different assignments of IPC using SVD (Polymer 6.1 in the thesis).  
Nuc 1 Nuc 2 Exp Right Dia-2 Dia-3 Dia-2+3 Dia-2+4+7 Dia-2+3+4+8 
C1 H1 16.3 16.7 20.7 16.2 17.7 20.5 16.4 
C2 H2 -11.6 -9.6 -7.8 -4.0 -14.3 -6.4 -16.3 
C3 H3 14.6 14.2 -0.7 10.7 -1.9 9.6 7.9 
C4 H4a -4.8 -4.8 -11.2 -10.5 -9.4 -8.2 -0.4 
C4 H4b 15.5 14.2 7.3 18.2 8.9 15.9 14.7 
C5 H6 -7.4 -7.8 -7.9 -10.1 -8.6 -5.1 -5.4 
C7 H7a -21.7 -23.2 -6.1 -18.2 -5.5 -18.3 -19.7 
C7 H7b 4.9 5.2 6.4 5.8 5.0 9.0 9.4 
  Q-factor 0.076 0.661 0.305 0.655 0.284 0.283 
 
Table A4-43. RDCs in Hz back-calculated from different assignments of IPC using SVD (Polymer 6.1 in the thesis).  
Nuc 1 Nuc 2 Exp Right Dia-2 Dia-3 Dia-2+3 Dia-2+4+7 Dia-2+3+4+8 
C1 H1 16.3 18.2 14.0 13.6 22.5 16.5 13.0 
C2 H2 -11.6 -8.8 -6.0 2.6 -7.7 -4.3 -4.1 
C3 H3 14.6 12.5 -11.0 11.5 -8.2 12.4 11.2 
C4 H4a -4.8 -6.1 -6.0 -6.8 -6.5 -8.6 -2.9 
C4 H4b 15.5 16.1 8.1 15.6 6.3 12.7 9.9 
C5 H6 -7.4 -5.8 -0.7 -5.3 -3.5 -1.8 -0.5 
C7 H7a -21.7 -23.8 -11.2 -19.0 -11.0 -16.9 -18.9 
C7 H7b 4.9 2.7 -1.7 0.9 -0.7 10.8 11.2 
H1 H6 1.0 0.9 1.0 0.7 1.2 1.4 1.3 
H1 H7a 0.5 0.0 0.0 -0.7 0.8 -0.3 -1.0 
H2 H3 3.7 4.0 6.3 7.5 2.7 3.5 5.0 
H2 H4b 1.5 0.8 0.7 0.7 1.1 1.9 1.0 
H3 H4a 1.6 1.1 -0.9 0.7 -2.4 0.2 1.4 
H3 H4b -2.1 -1.0 -0.8 -0.5 -1.4 -2.6 -2.3 
H3 H6 -0.3 -0.5 -0.6 -0.3 -0.6 -0.5 -0.5 
H4a H6 -7.0 -7.9 -2.8 -6.3 -1.6 -6.2 -6.8 
  Q-factor 0.148 0.809 0.426 0.762 0.340 0.377 
  
NMR Assignments 
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Chiral polymers 
Table A4-44. Chirality of IPC and polymers in the following tables 
 L-TEGPhe/DMAA D-TEGPhe/DMAA 
(+)-IPC 1,2,3 9,10 
(-)-IPC 4,5,6 7,8 
 
Table A4-45. Output from MSPIN upon entering the extracted RDCs of IPC aligned in the L/D-TEG-Phe/DMAA 
1 Exp Hz Comp Hz 2 Exp Hz Comp Hz 3 Exp Hz Comp Hz 
C3,H3 -12 -11.1 C3,H3 -13 -12.28 C3,H3 -14 -12.66 
C1,H1 -9.9 -9.49 C1,H1 -9 -7.85 C1,H1 -8.7 -7.42 
C2,H2 0.6 -0.86 C2,H2 -2.1 -2.12 C2,H2 -1.4 -1.71 
C5,H6 -0.3 0.73 C5,H6 -1.6 0.03 C5,H6 -1.5 -0.22 
C4,H4 -17.2 -16.1 C4,H4 -16.8 -16.07 C4,H4 -15.7 -15.62 
C4,H5 3.1 3.22 C4,H5 1.3 2.08 C4,H5 2.3 2.07 
C7,H8 5.5 5.74 C7,H8 5.8 7.07 C7,H8 6.1 6.58 
C7,H7 13.5 15.32 C7,H7 13.5 14.8 C7,H7 13.5 15.16 
C9,H9 -4.64 -5.67 C9,H9 -6.43 -6.14 C9,H9 -5.44 -6.11 
C8,H8 3.43 3.55 C8,H8 4.31 3.91 C8,H8 4.64 3.99 
C10,H10 1.25 1.49 C10,H10 2.18 1.92 C10,H10 2.57 2.11 
Q-factor  0.112 Q-factor  0.106 Q-factor  0.107 
Conformer 1  Conformer 1  Conformer 1  
Alignment tensor  Alignment tensor  Alignment tensor  
A'x= 7.648e-05  A'x= 9.749e-05  A'x= 1.049e-04  
A'y= 2.528e-04  A'y= 2.439e-04  A'y= 2.381e-04  
A'z=-3.292e-04  A'z=-3.414e-04  A'z=-3.431e-04  
Saupe tensor  Saupe tensor  Saupe tensor  
S'x= 1.147e-04  S'x= 1.462e-04  S'x= 1.574e-04  
S'y= 3.791e-04  S'y= 3.659e-04  S'y= 3.572e-04  
S'z=-4.939e-04  S'z=-5.122e-04  S'z=-5.146e-04  
Alignment tensor eigenvectors Alignment tensor eigenvectors Alignment tensor eigenvectors 
e[x]=(-0.000, 0.040,-0.999) e[x]=(-0.035, 0.103,-0.994) e[x]=(-0.043, 0.146,-0.988) 
e[y]=(-0.503, 0.863, 0.035) e[y]=(-0.468, 0.877, 0.107) e[y]=(-0.472, 0.869, 0.149) 
e[z]=( 0.864, 0.503, 0.020) e[z]=( 0.883, 0.469, 0.018) e[z]=( 0.881, 0.472, 0.031) 
Alignment tensor in laboratory 
coordinates: 
Alignment tensor in laboratory 
coordinates: 
Alignment tensor in laboratory 
coordinates: 
[-1.818e-04,-2.529e-04,-1.005e-05] [-2.129e-04,-2.417e-04,-1.429e-05] [-2.130e-04,-2.410e-04,-2.175e-05] 
[-2.529e-04,1.053e-04,1.248e-06] [-2.417e-04,1.139e-04,1.014e-05] [-2.410e-04,1.055e-04,1.065e-05] 
[-1.005e-05,1.248e-06,7.653e-05] [-1.429e-05,1.014e-05,9.904e-05] [-2.175e-05,1.065e-05,1.075e-04] 
SVD condition number is 2.411e+00 SVD condition number is 2.411e+00 SVD condition number is 2.411e+00 
Axial component Aa = -4.939e-04 Axial component Aa = -5.122e-04 Axial component Aa = -5.146e-04 
Rhombic component Ar = -1.763e-04 Rhombic component Ar = -1.465e-04 Rhombic component Ar = -1.332e-04 
rhombicity R = 3.570e-01 rhombicity R = 2.860e-01 rhombicity R = 2.588e-01 
Asimmetry parameter etha =5.354e-
01 
Asimmetry parameter etha =4.290e-
01 
Asimmetry parameter etha =3.882e-
01 
GDO = 6.098e-04  GDO = 6.180e-04  GDO = 6.162e-04  
Euler Angles (degrees) Euler Angles (degrees) Euler Angles (degrees) 
Set 1   Set 1   Set 1   
(87.7,-59.8,-90.0)  (87.8,-62.0,-94.2)  (86.2,-61.7,-95.2)  
Set 2   Set 2   Set 2   
(-92.3,239.8,90.0)  (-92.2,242.0,85.8)  (-93.8,241.7,84.8)  
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4 Exp Hz Comp Hz 5 Exp Hz Comp Hz 6 Exp Hz Comp Hz 
C3,H3 -12.3 -10.41 C3,H3 -12.6 -10.65 C3,H3 -12.5 -10.84 
C1,H1 -10.1 -8.44 C1,H1 -11.5 -10.51 C1,H1 -10.4 -9.84 
C2,H2 -0.7 -0.08 C2,H2 2.8 1.3 C2,H2 2.9 1.01 
C5,H6 -1.3 -0.83 C5,H6 -1.2 -0.33 C5,H6 -1.2 -0.52 
C4,H4 -11.7 -13.44 C4,H4 -13.3 -13.24 C4,H4 -13.8 -13.36 
C4,H5 3.1 1.41 C4,H5 1.4 0.2 C4,H5 1.7 0.67 
C7,H8 7.2 6.72 C7,H8 8 7.45 C7,H8 7.7 7.05 
C7,H7 13.5 14.64 C7,H7 13.5 15.93 C7,H7 13.5 15.84 
C9,H9 -5.61 -5.73 C9,H9 -5.56 -6.15 C9,H9 -5.02 -6.06 
C8,H8 3.3 3.28 C8,H8 4.44 3.33 C8,H8 3.37 3.38 
C10,H10 1.54 2.23 C10,H10 2.66 2.68 C10,H10 2.33 2.6 
Q-factor  0.148 Q-factor  0.147 Q-factor  0.143 
Conformer 1  Conformer 1  Conformer 1  
Alignment tensor  Alignment tensor  Alignment tensor  
A'x= 1.119e-04  A'x= 1.328e-04  A'x= 1.299e-04  
A'y= 2.115e-04  A'y= 2.214e-04  A'y= 2.184e-04  
A'z=-3.234e-04  A'z=-3.542e-04  A'z=-3.483e-04  
Saupe tensor  Saupe tensor  Saupe tensor  
S'x= 1.678e-04  S'x= 1.991e-04  S'x= 1.949e-04  
S'y= 3.173e-04  S'y= 3.321e-04  S'y= 3.275e-04  
S'z=-4.851e-04  S'z=-5.313e-04  S'z=-5.224e-04  
Alignment tensor eigenvectors Alignment tensor eigenvectors Alignment tensor eigenvectors 
e[x]=(-0.038, 0.034, 0.999) e[x]=(-0.092, 0.178, 0.980) e[x]=(-0.066, 0.111, 0.992) 
e[y]=( 0.489,-0.871, 0.048) e[y]=( 0.510,-0.837, 0.200) e[y]=( 0.508,-0.851, 0.129) 
e[z]=( 0.872, 0.490, 0.017) e[z]=( 0.855, 0.518,-0.014) e[z]=( 0.859, 0.512, 0.000) 
Alignment tensor in laboratory 
coordinates: 
Alignment tensor in laboratory 
coordinates: 
Alignment tensor in laboratory 
coordinates: 
[-1.950e-04,-2.283e-04,-3.949e-06] [-2.005e-04,-2.535e-04,1.473e-05] [-1.998e-04,-2.487e-04,5.763e-06] 
[-2.283e-04,8.300e-05,-7.673e-06] [-2.535e-04,6.426e-05,-1.136e-05] [-2.487e-04,6.845e-05,-9.774e-06] 
[-3.949e-06,-7.673e-06,1.120e-04] [ 1.473e-05,-1.136e-05,1.362e-04] [ 5.763e-06,-9.774e-06,1.314e-04] 
SVD condition number is 2.411e+00 SVD condition number is 2.411e+00 SVD condition number is 2.411e+00 
Axial component Aa = -4.851e-04 Axial component Aa = -5.313e-04 Axial component Aa = -5.224e-04 
Rhombic component Ar = -9.966e-05 Rhombic component Ar = -8.866e-05 Rhombic component Ar = -8.845e-05 
rhombicity R = 2.054e-01 rhombicity R = 1.669e-01 rhombicity R = 1.693e-01 
Asimmetry parameter etha =3.081e-
01 
Asimmetry parameter etha =2.503e-
01 
Asimmetry parameter etha =2.540e-
01 
GDO = 5.733e-04  GDO = 6.230e-04  GDO = 6.129e-04  
Euler Angles (degrees) Euler Angles (degrees) Euler Angles (degrees) 
Set 1   Set 1   Set 1   
(88.1,-60.6,94.4)  (91.5,-58.8,100.2)  (90.0,-59.2,97.4)  
Set 2   Set 2   Set 2   
(-91.9,240.6,-85.6)  (-88.5,238.8,-79.8)  (-90.0,239.2,-82.6)  
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7 Exp Hz Comp Hz 8 Exp Hz Comp Hz 
C3,H3 -6.5 -5.74 C3,H3 -6 -5.68 
C1,H1 -5.4 -4.42 C1,H1 -4.5 -3.99 
C2,H2 -0.9 -0.18 C2,H2 -1.4 -1.05 
C5,H6 -1.7 -1.24 C5,H6 -2 -1.62 
C4,H4 -6.9 -7.71 C4,H4 -8.4 -8.62 
C4,H5 1.7 1.24 C4,H5 2.1 2.09 
C7,H8 3.8 3.98 C7,H8 3.9 4.19 
C7,H7 8.1 8.47 C7,H7 8.1 8.32 
C9,H9 -2.7 -3.3 C9,H9 -2.6 -3.34 
C8,H8 2.1 1.81 C8,H8 2.4 1.84 
C10,H10 1.2 1.3 C10,H10 1.2 1.07 
Q-factor  0.131 Q-factor  0.085 
Conformer 1  Conformer 1  
Alignment tensor  Alignment tensor  
A'x= 6.359e-05  A'x= 5.180e-05  
A'y= 1.205e-04  A'y= 1.314e-04  
A'z=-1.841e-04  A'z=-1.832e-04  
Saupe tensor  Saupe tensor  
S'x= 9.538e-05  S'x= 7.771e-05  
S'y= 1.808e-04  S'y= 1.970e-04  
S'z=-2.761e-04  S'z=-2.747e-04  
Alignment tensor eigenvectors Alignment tensor eigenvectors 
e[x]=(-0.086, 0.063, 0.994) e[x]=(-0.094, 0.020, 0.995) 
e[y]=( 0.461,-0.882, 0.096) e[y]=( 0.428,-0.902, 0.059) 
e[z]=( 0.883, 0.467, 0.047) e[z]=( 0.899, 0.432, 0.076) 
Alignment tensor in laboratory coordinates: Alignment tensor in laboratory coordinates: 
[-1.174e-04,-1.253e-04,-7.703e-06] [-1.234e-04,-1.219e-04,-1.399e-05] 
[-1.253e-04,5.387e-05,-1.024e-05] [-1.219e-04,7.270e-05,-1.189e-05] 
[-7.703e-06,-1.024e-05,6.357e-05] [-1.399e-05,-1.189e-05,5.073e-05] 
SVD condition number is 2.411e+00 SVD condition number is 2.411e+00 
Axial component Aa = -2.761e-04 Axial component Aa = -2.747e-04 
Rhombic component Ar = -5.691e-05 Rhombic component Ar = -7.956e-05 
rhombicity R = 2.061e-01 rhombicity R = 2.896e-01 
Asimmetry parameter etha =3.092e-01 Asimmetry parameter etha =4.343e-01 
GDO = 3.264e-04  GDO = 3.319e-04  
Euler Angles (degrees) Euler Angles (degrees) 
Set 1   Set 1   
(84.3,-62.0,100.6)  (80.1,-64.0,102.3)  
Set 2   Set 2   
(-95.7,242.0,-79.4)  (-99.9,244.0,-77.7)  
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9 Exp Hz Comp Hz  10 Exp Hz Comp Hz 
C3,H3 -5.8 -5.01  C3,H3 -6.3 -5.42 
C1,H1 -6.2 -5.36  C1,H1 -6.1 -5.45 
C2,H2 -0.5 0.28  C2,H2 -0.4 0.35 
C5,H6 -1 -0.96  C5,H6 0.5 -0.02 
C4,H4 -6 -7.23  C4,H4 -5.4 -7.15 
C4,H5 1.5 0.6  C4,H5 1.8 0.27 
C7,H8 4.7 4.44  C7,H8 4.8 3.91 
C7,H7 8.1 8.23  C7,H7 8.1 8.02 
C9,H9 -2.4 -3.28  C9,H9 -2.3 -3.15 
C8,H8 2 1.6  C8,H8 1.6 1.71 
C10,H10 0.9 1.32  C10,H10 0.8 1.25 
Q-factor  0.16  Q-factor  0.21 
Conformer 1   Conformer 1  
Alignment tensor   Alignment tensor  
A'x= 6.133e-05   A'x= 6.263e-05  
A'y= 1.212e-04   A'y= 1.177e-04  
A'z=-1.826e-04   A'z=-1.803e-04  
Saupe tensor   Saupe tensor  
S'x= 9.200e-05   S'x= 9.395e-05  
S'y= 1.819e-04   S'y= 1.766e-04  
S'z=-2.739e-04   S'z=-2.705e-04  
Alignment tensor eigenvectors  Alignment tensor eigenvectors 
e[x]=(-0.134, 0.236, 0.963)  e[x]=(-0.063, 0.143, 0.988) 
e[y]=( 0.466,-0.842, 0.271)  e[y]=( 0.508,-0.847, 0.155) 
e[z]=( 0.875, 0.485, 0.003)  e[z]=( 0.859, 0.511,-0.020) 
Alignment tensor in laboratory coordinates: Alignment tensor in laboratory coordinates: 
[-1.122e-04,-1.269e-04,6.895e-06] [-1.025e-04,-1.305e-04,8.406e-06] 
[-1.269e-04,4.652e-05,-1.404e-05] [-1.305e-04,3.863e-05,-4.787e-06] 
[ 6.895e-06,-1.404e-05,6.573e-05] [ 8.406e-06,-4.787e-06,6.386e-05] 
SVD condition number is 2.411e+00 SVD condition number is 2.411e+00 
Axial component Aa = -2.739e-04 Axial component Aa = -2.705e-04 
Rhombic component Ar = -5.990e-05 Rhombic component Ar = -5.507e-05 
rhombicity R = 2.187e-01  rhombicity R = 2.036e-01 
Asimmetry parameter etha =3.281e-01 Asimmetry parameter etha =3.054e-01 
GDO = 3.246e-04   GDO = 3.195e-04  
Euler Angles (degrees)  Euler Angles (degrees) 
Set 1    Set 1   
(89.6,-61.0,106.0)   (92.2,-59.2,97.0)  
Set 2    Set 2   
(-90.4,241.0,-74.0)   (-87.8,239.2,-83.0)  
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Table A4-46. Comparison of the alignment frames obtained from MSPIN upon entering the extracted RDCs of IPC aligned in the L- or D-
TEG-Phe/DMAA 
GCB 1 2 3 4 5 6 7 8 9 10 
1 1 0.995 0.993 0.991 0.981 0.985 0.987 0.982 0.982 0.987 
2  1 0.999 0.995 0.982 0.987 0.993 0.99 0.985 0.986 
3   1 0.995 0.983 0.988 0.994 0.989 0.984 0.986 
4    1 0.995 0.998 0.998 0.986 0.996 0.997 
5     1 0.999 0.988 0.967 0.996 0.999 
6      1 0.992 0.973 0.996 0.999 
7       1 0.994 0.995 0.99 
8        1 0.981 0.971 
9         1 0.997 
10          1 
 
Table A4-47. Comparison of the alignment frames obtained from MSPIN upon entering the extracted RDCs of IPC aligned in the L- or D-
TEG-Phe/DMAA 
GCB 1 2 3 4 5 6 7 8 9 10 
1 0 5.89 6.85 7.6 11.06 9.87 9.31 10.77 10.76 9.36 
2  0 2.12 5.91 10.91 9.39 6.58 7.94 9.88 9.56 
3   0 5.64 10.7 9.01 6.21 8.34 10.13 9.71 
4    0 5.57 3.92 4.01 9.61 4.87 4.75 
5     0 1.87 8.83 14.82 5.29 2.17 
6      0 7.29 13.34 4.99 2.46 
7       0 6.39 5.85 8.26 
8        0 11.06 13.75 
9         0 4.75 
10          0 
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A4.4.2. Menthol  
Table A4-48. NMR assignment of menthol in CDCl3 
# δH [ppm] (int,mult,J [Hz]) δC [ppm] 
1 3.39 (1H,td,10.5,4.3) 71.4 
2 1.09 (1H,12.4,9.8,2.8) 50.1 
3a 0.95 (1H,m) 
 3e 1.59 (1H,dq,12.9.3.1) 22.9 
4a 0.83 (1H,m) 
 4e 1.64 (1H,m) 34.4 
5 1.40 (1H,m) 31.6 
6a 0.93 (1H,m) 
 6e 1.95 (1H,dtd,12.0,3.8,1.7) 44.8 
7 0.91 (3H,d,7.2) 22.2 
8 2.16 (1H,sept-d,7.0.2.8) 25.7 
9 0.79 (3H,d,7.0) 15.8 
10 0.89 (3H,d,6.4) 21 
OH 1.6 (1H,br. s)   
 
Chiral polymers 
Table A4-49. Comparison of extracted RDCs (1DCH) in Hz 
of menthol aligned in the L/D-TEG-Phe/DMAA (1,2 = (+) 
and 3,4 = (-)) 
H 1 2  3 4 
1 0.4 0.4  0.5 0.4 
2 2.6 2.6  2.6 2.6 
6e 4.7 0.5  0.4 4.5 
6a -4.3 -2.5  -1.8 -0.9 
4e 3.1 1.8  0.2 1.8 
4a -10.4 -7.4  -4.4 -6.9 
5 0.3 1.9  0.8 1.0 
7 4.0 1.3  1.5 2.7 
3e -0.7 -1.1  -2.2 -2.7 
3a -2.7 -2.2  -1.2 -2.2 
8 -6.2 -5.8  -4.0 -4.0 
9 -0.5 -0.2  -0.4 0.8 
10 -1.2 -0.4  0.6 0.4 
 
 
 Table A4-50. NMR assignment of menthol in DMSO-d6 
 # δH [ppm] (int,mult,J [Hz]) δC [ppm] 
1 3.15 (1H, ddd, 15.2,10.1,5.1) 69.3 
2 0.97 (1H, m) 49.3 
3a 0.88 (1H, m) 22.5 
3e 1.50 (1H, dq, 12.4,3.0) 22.5 
4a 0.75 (1H, m) 34.1 
4e 1.59 (1H, dq, 12.3,2.3) 34.1 
5 1.34 (1H,m) 30.9 
6a 0.84 (1H, m) 45 
6e 1.81 (1H, dq, 12.2, 4.6) 45 
7 0.85 (3H, d, 7.0) 22 
8 2.18 (1H, sept-d, 7.0,2.4) 24.7 
9 0.72 (3H, d, 7.1) 15.7 
10 0.84 (3H, d, 7.0) 20.7 
OH 4.28 (1H,br. s)   
 
Chiral polymers 
Table A4-51. Comparison of extracted RDCs (1DCH) in Hz of 
menthol aligned in the L/D-TEG-Phe/DMAA (1,2,3 = (+) 
and 3,4 = (-)) 
H 1 2 3  4 5 
1 -8.5 -9.5 -9.4  -8.8 -10.7 
2 -11.4 -11.4 -11.4  -11.4 -11.4 
3a -7.0 -8.0 -10.0  -5.6 -5.2 
3e 1.4 0.8 0.6  -0.9 -2.1 
4a -8.3 -7.2 -9.7  -7.3 -8.0 
4e 1.5 0.5 1.5  -1.9 -1.4 
5 -6.4 -5.8 -6.5  -3.9 -6.0 
6a -7.3 -7.3 -9.1  -6.3 -7.2 
6e 0.0 0.9 0.9  -1.0 -1.8 
7 -2.0 -1.9 -1.9  -1.8 -2.0 
8 -0.1 -1.4 -1.2  -0.9 -2.5 
9 1.6 1.4 1.7  0.9 1.4 
10 0.1 -0.2 0.8  0.4 0.8 
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A4.4.3. Reserpine 
Table A4-52. NMR assignment of reserpine 
 # δH [ppm] (int,mult,J [Hz]) δC [ppm] 
1 4.99 (1H, ddd, 11.6,9.2,5.1) 77.7 
2 3.85 (1H, m) 77.8 
3 2.64 (1H, dd, 11.2,4.9) 51.7 
4 1.99 (1H, dt, 12.9,5.3) 32.0 
5a 2.28 (1H, m) 24.3 
5b 1.77 (1H, m) 24.3 
6 4.43 (1H, br. s) 53.7 
7  129.9 
8 7.58 (1H, s)  
9  136.2 
10 6.78 (1H, d, 1.9) 95.2 
11  156.2 
12 6.73 (1H, dd, 6.8,2.0) 109.1 
13 7.27 (1H, m) 118.6 
14  122.1 
15  108 
16a 2.89 (1H, m) 16.6 
16b 2.45 (1H, m) 16.6 
17a 3.12 (1H, m) 51.1 
17b 3.12 (1H, m) 51.1 
18   
19a 2.95 (1H, m) 48.9 
19b 2.41 (1H, m) 48.9 
20 1.85 (1H, br. d, 13.1) 33.8 
21a 2.31 (1H, m) 29.6 
21b 1.93 (1H, dt, 13.1,4.2) 29.6 
22   
23  165.4 
24  125.3 
25 7.26 (1H, s) 106.8 
26  152.8 
27  142.1 
28  152.8 
29 7.26 (1H, s) 106.8 
30   
31 3.44 (3H,s) 60.7 
32  172.7 
33   
34 3.76 (3H,s) 51.8 
35   
36 3.78 (3H,s) 55.7 
37   
38 3.85 (3H,s) 56.2 
39   
40 3.85 (3H,s) 60.8 
41   
42 3.85 (3H,s) 56.2 
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RDC 
Table A4-53. Experimental distances from relative NOE intensities in Å and J-coupling constants in Hz compared to best fit of multiple 
structures for reserpine (τm = 150 ms) 
H1 H2 ηnorm Exp Calc Diff % 
1 3 0.00693 2.62 2.70 -0.08 2.9 
1 31 0.00211 3.83 3.74 0.09 2.5 
1 20 0.00695 2.62 2.66 -0.04 1.6 
1 21a 0.01079 2.43 2.42 0.02 0.7 
1 21b 0.00179 3.28 3.01 0.27 8.3 
2 5b/21b 0.02338 2.14 2.28 -0.14 6.4 
2 31 0.01881 2.66 2.67 -0.01 0.4 
3 4 0.01017 2.46 2.37 0.08 3.4 
3 31 0.00356 3.53 3.63 -0.11 3.0 
4 8 0.00234 3.14 3.31 -0.16 5.2 
4 19a 0.00725 2.60 2.66 -0.06 2.4 
5a 5b 0.05216 1.87 1.75 0.12 6.6 
5a 6 0.00910 2.50 2.59 -0.09 3.8 
5a 8 0.00879 2.52 2.34 0.18 7.1 
5b 6 0.01457 2.31 2.33 -0.02 0.7 
6 17a/17b 0.01551 2.29 2.46 -0.17 7.5 
6 19b 0.00139 3.42 3.17 0.25 7.2 
6 8 0.00135 3.44 3.17 0.27 7.8 
10 36 0.00868 3.03 2.72 0.31 10.2 
12 36 0.00496 3.33 3.23 0.10 2.9 
13 16b 0.00217 3.18 2.94 0.24 7.6 
16a 16b 0.06682 1.80 1.77 0.03 1.4 
16a 19a 0.00432 2.83 2.52 0.32 11.1 
19a 19b 0.07092 1.78 1.76 0.02 1.2 
19a 20 0.01054 2.45 2.33 0.12 4.9 
20 3 0.00864 2.52 2.58 -0.06 2.5 
20 19b 0.00465 2.80 2.54 0.26 9.4 
21a 19b 0.00382 2.89 2.48 0.42 14.4 
21a 21b 0.05533 1.85 1.74 0.11 6.0 
 
H1 H2  Exp Calb  Diff 
1 2  9.2 8.0 1.2 
1 21a  5.2 4.9 0.3 
1 21b  11.6 10.9 0.7 
2 3  11.2 11.2 0.0 
3 4  4.9 4.1 0.8 
4 5a  5.6 5.6 0.0 
4 5b  12.9 11.2 1.6 
6 5b  6.7 6.5 0.2 
6 5a  7.7 5.8 1.9 
19a 20  4.6 6.8 -2.2 
19b 20  4.7 2.6 2.1 
20 21b  13.9 12.4 1.5 
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Table A4-54. RDC extraction of reserpine (Polymer 8.2 in the thesis). 2H splitting = 90.4 Hz (CDCl3) 
Reserpine 
    
C H J [Hz] T [Hz] D [Hz] 
1 1 148.7 112.4 -36.3 
2 2 143.7 108.3 -35.5 
3 3 131.1 92.6 -38.5 
4 4 131.2 143.7 12.5 
5 5a 127.4 108.6 -18.9 
5 5b 127.5 149.9 22.5 
6 6 140.2 111.8 -28.5 
10 10 158 160.3 2.3 
12 12 159 186.5 27.4 
13 13 158.8 161.1 2.4 
16 16a 133.5 77.8 -55.7 
16 16b 129.7 166.6 36.9 
17 17a/17b 138.6 101 -37.6 
19 19a 132.1 147.9 15.8 
19 19b 136.8 119.2 -17.6 
20 20 128.2 94.8 -33.4 
21 21a 132.7 105.2 -27.5 
21 21b 128.1 105.2 -22.9 
25/29 25/29 163.1 146.3 -16.8 
31 31 141.9 142.3 0.4 
34 34 147 154.5 7.4 
36 36 143.4 142 -1.5 
40 40 145.2 143.2 -2.0 
 
  
  RDC compounds 
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Table A4-55. NOE-distances in Å back-calculated from different assignments of reserpine using ISPA.  
NOE   Right Dia4 Dia6 Dia19 Dia2 Dia1 Dia21 Dia17 Dia3 Dia5 Dia20 Dia16 
Nuc 1 Nuc 2 Exp Calc Calc Calc Calc Calc Calc Calc Calc Calc Calc Calc Calc 
8 5b 2.52 2.35 2.29 2.38 2.42 2.41 2.34 2.67 2.36 2.27 2.82 2.28 2.35 
8 4 3.14 3.36 4.49 4.52 3.41 3.19 4.82 2.93 3.36 3.03 3.48 3.02 3.33 
8 34 5.00 4.91 5.48 5.39 5.14 5.05 4.62 4.77 4.92 6.36 4.87 6.86 4.84 
8 6 3.44 3.15 3.13 3.15 3.12 3.15 3.08 2.83 3.15 3.21 3.14 3.21 3.15 
8 10 3.24 2.78 2.89 2.89 2.78 2.90 2.89 2.78 2.78 2.88 2.78 2.89 2.78 
12 36 3.33 3.23 2.68 2.68 3.23 2.59 2.59 3.06 3.23 2.70 3.19 2.59 3.23 
1 3 2.62 2.68 2.62 2.63 2.75 2.44 3.84 2.69 2.68 3.84 2.75 4.24 2.70 
1 31 3.83 3.35 3.46 3.39 3.22 4.53 4.85 3.00 3.35 3.98 3.49 2.94 3.36 
1 20 2.62 2.62 2.48 2.62 2.62 2.47 3.81 3.29 2.62 2.62 2.66 3.83 2.65 
1 21b 2.43 2.43 2.45 2.43 2.44 2.46 3.03 2.99 2.43 2.43 2.47 2.49 2.44 
6 17a17b 2.29 2.48 2.42 2.41 2.51 2.39 2.42 2.61 2.48 2.32 2.49 2.32 2.47 
6 19b 3.42 3.15 3.59 3.62 3.79 2.71 2.40 3.71 3.13 4.17 2.80 4.16 3.13 
6 5a 2.31 2.33 3.06 2.83 2.34 2.33 3.05 2.92 2.33 2.35 2.67 2.34 2.34 
6 5b 2.50 2.60 2.49 2.54 2.63 2.64 2.52 2.39 2.60 2.50 2.36 2.50 2.59 
19a 20 2.45 2.33 3.06 2.44 2.64 2.28 2.44 2.49 2.33 2.36 2.33 3.04 2.35 
19a 4 2.60 2.70 2.60 2.58 3.79 2.78 4.24 2.47 2.70 2.57 2.81 2.57 2.71 
17a17b 19b 2.02 2.38 2.23 2.23 2.49 2.34 2.46 2.26 2.38 2.40 2.38 2.40 2.40 
19a 19b 1.78 1.76 1.76 1.75 1.75 1.75 1.75 2.61 1.76 1.75 1.76 1.75 1.76 
16a 16b 1.79 1.77 1.75 1.75 1.77 1.74 1.75 2.66 1.77 1.74 1.77 1.74 1.77 
3 4 2.46 2.40 3.05 2.39 2.39 2.36 2.29 2.29 2.40 2.54 2.38 2.36 2.38 
21a 21b 1.85 1.74 1.75 1.74 1.74 1.75 1.74 1.76 1.74 1.74 1.74 1.74 1.74 
5a 5b 1.87 1.75 1.75 1.74 1.75 1.73 1.74 2.04 1.75 1.74 1.75 1.74 1.75 
20 3 2.52 2.58 2.59 2.52 2.63 2.52 4.22 1.75 2.58 3.82 2.67 3.85 2.61 
21b 19b 2.89 2.49 2.51 2.53 3.19 2.48 3.92 2.63 2.49 2.53 2.55 2.54 2.52 
20 19b 2.80 2.56 2.46 2.48 2.32 2.62 3.05 1.74 2.56 2.48 2.63 2.45 2.57 
5a21a 2 2.14 2.26 2.72 2.31 2.28 3.48 4.18 1.76 2.25 2.16 2.71 3.73 2.27 
3 31 3.51 3.40 3.39 3.42 3.28 4.73 2.83 2.87 3.40 3.57 3.46 3.19 3.46 
21a 6 2.36 2.72 4.32 4.19 2.62 2.90 5.09 2.56 2.70 3.78 2.83 5.53 2.85 
21a 1 3.28 3.05 3.04 3.04 3.06 3.04 2.46 4.35 3.05 3.05 3.05 2.36 3.03 
16b 13 3.18 2.93 2.93 3.34 2.91 2.96 2.96 2.75 2.93 3.00 2.92 3.00 3.26 
31 2 2.66 2.74 2.75 2.76 2.78 2.66 2.72 3.71 2.74 2.72 2.71 2.72 2.73 
10 36 3.03 2.72 3.34 3.34 2.72 4.50 4.49 2.40 2.72 3.25 2.73 4.49 2.72 
16a 19a 2.83 2.55 4.70 4.83 3.51 2.56 4.15 3.47 2.55 2.32 2.66 2.31 3.96 
 
Table A4-56. J-coupling constants in Hz back-calculated from different assignments of reserpine using HLA.  
J-coupl   Right Dia4 Dia6 Dia19 Dia2 Dia1 Dia21 Dia17 Dia3 Dia5 Dia20 Dia16 
Nuc 1 Nuc 2 Exp  Calc  Calc  Calc  Calc  Calc  Calc  Calc  Calc  Calc  Calc  Calc  Calc 
1 2 9.2 7.9 8.9 8.4 7.6 2.6 2.4 7.4 7.9 9 7.5 2.3 7.7 
1 21b 5.2 4.8 4 4.9 4.7 3.9 4.2 9.2 4.8 4.7 4.5 1.6 4.9 
1 21a 11.6 11 11.6 11 11 11.6 11.4 5.1 11 11.2 10.9 3.4 10.5 
2 3 11.2 11 12.4 12.5 9.7 2 0.7 10.8 11 5.3 9.3 0.5 10.9 
3 4 4.9 4.1 14.2 3.6 4.1 4 5.6 5 4.1 1.2 4.1 4.7 4.4 
4 5b 5.6 4.6 3.3 5.6 5.3 4.7 6.4 4.8 4.6 2.9 9.4 2.8 4.5 
4 5a 12.9 11.8 12.5 10.3 11.3 11.5 1.3 10.2 11.8 12.6 5.3 12.6 11.4 
6 5a 6.7 6 12 9.8 5.9 5.8 2.9 5.4 6 5.3 5.9 5.1 5.6 
6 5b 7.7 4.1 3.2 5 5 5.6 12 5.2 4.2 2.6 5.3 2.7 4.1 
19a 20 4.6 5.3 3.5 3.4 4 6.8 3.3 5.1 5.4 3.9 5.4 12 5 
19b 20 4.7 3.1 12 3.2 5.8 2.7 12 4.4 3.1 2.9 4.7 4 3.8 
20 21a 13.9 12.4 12.6 12.5 12.2 12.6 5.4 3.7 12.4 12.4 11.7 12.5 11.9 
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Table A4-57. RDCs in Hz back-calculated from different assignments of reserpine using the θ-method (Polymer 8.2 in the thesis).  
RDC   Right Dia4 Dia6 Dia19 Dia2 Dia1 Dia21 Dia17 Dia3 Dia5 Dia20 Dia16 
C H Exp  Calc  Calc  Calc  Calc  Calc  Calc  Calc  Calc  Calc  Calc  Calc  Calc 
13 13 2.4 1.7 7.3 9.6 0.7 2.9 -0.2 2.8 2.0 3.1 2.3 6.5 4.1 
12 12 27.4 29.4 16.6 15.5 28.8 24.9 31.9 28.8 29.2 24.9 27.6 11.0 31.9 
25/29 25/29 -16.8 -18.8 -18.6 -26.9 -17.7 1.3 -17.3 -17.2 -18.9 -17.6 -17.4 -11.8 -13.2 
10 10 2.3 2.2 7.2 9.8 0.8 3.0 -0.2 2.9 2.4 3.3 2.6 6.5 4.7 
2 2 -35.5 -39.5 -26.6 -27.6 -39.0 11.8 -24.2 -38.2 -39.5 -35.9 -34.5 27.6 -27.3 
1 1 -36.3 -36.4 -25.8 -30.7 -32.3 -31.2 -10.2 -36.8 -36.3 -35.2 -31.8 -17.6 -26.0 
40 40 -2.0 -2.4 -3.3 -4.5 -5.1 0.6 -2.0 -1.9 -2.5 -2.1 -5.2 -4.3 -2.6 
31 31 0.4 0.3 -0.9 -2.7 2.3 -5.0 1.9 1.6 0.1 0.8 2.7 -3.4 -4.1 
36 36 -1.5 -2.0 -3.8 -6.5 -1.9 -8.4 -10.6 -1.9 -1.9 -4.9 -1.6 -3.4 -1.2 
6 6 -28.5 -30.9 -19.9 -5.2 -31.2 -26.5 -33.7 -28.7 -30.6 -31.3 -29.7 -16.0 -12.0 
34 34 7.4 5.8 7.7 5.4 2.0 0.1 4.0 6.6 5.9 5.5 1.7 -0.8 1.5 
3 3 -38.5 -34.9 -20.7 -25.2 -44.3 -32.1 -7.4 -36.4 -34.4 -37.0 -37.6 -14.3 -26.0 
17 17a/17b -37.6 -29.5 -22.5 -14.3 -27.0 -22.0 -20.1 -30.2 -29.2 -27.0 -28.9 -18.0 -6.9 
19 19a 15.8 12.5 -19.3 -2.8 5.8 21.5 -2.9 12.7 12.4 16.8 -2.7 6.5 21.3 
19 19b -17.6 -20.5 -21.8 -20.3 -11.6 -24.5 -34.3 -20.0 -20.0 -20.7 -11.7 -16.8 -4.0 
20 20 -33.4 -32.5 -25.6 -22.7 -29.5 -30.2 -31.7 -33.7 -32.5 -35.6 -35.8 7.5 -27.6 
4 4 12.5 16.9 -24.3 -3.7 18.4 17.6 -11.2 15.6 17.2 19.0 12.0 7.9 23.7 
21 21b -22.9 -24.8 -21.3 -18.3 -24.6 -28.3 -3.8 -23.5 -24.6 -24.5 -25.8 7.6 -22.0 
21 21a -27.5 -25.3 -18.0 -22.0 -22.9 -9.3 -7.9 -27.0 -25.3 -30.8 -23.7 -19.4 -17.4 
5 5b 22.5 19.3 -17.4 7.7 15.6 20.5 -4.0 19.6 19.2 16.2 3.8 7.2 27.3 
5 5a -18.9 -23.3 -23.9 -33.3 -17.2 -11.0 -31.9 -21.0 -22.8 -23.7 -6.4 -20.5 1.2 
16 16a -55.7 -55.7 -44.1 -14.5 -48.9 -46.7 -31.0 -56.3 -55.2 -54.1 -55.3 -38.4 -22.0 
16 16b 36.9 33.6 27.2 43.1 38.7 7.6 9.8 33.2 33.9 34.3 30.2 29.3 4.8 
  RDC compounds 
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A4.4.4. Cinchonidine 
Table A4-58. NMR assignment of cinchonidine 
 # δH [ppm] (int,mult,J [Hz]) δC [ppm] 
2' 8.80 (1H,d,4.5) 150.1 
3' 7.61 (1H,m) 118.3 
4'  149.1 
5' 7.95 (1H,d,8,4) 122.9 
6' 7.60 (1H,m) 129.0 
7' 7.30 (1H,t,8.0) 126.6 
8' 8.05 (1H,d,8.4) 12.30 
9'  147.7 
10'  125.6 
2a 3.11 (1H,dd,13.4,10.2) 56.5 
2b 2.71 (1H,m) 56.5 
3 2.32 (1H,br. t,9.8) 39.3 
4 1.85 (1H,m) 27.6 
5a 1.83 (1H,m) 27.0 
5b 1.54 (1H,m) 27.0 
6a 3.66 (1H,td,10.1,3.3) 43.2 
6b 2.68 (1H,m) 43.2 
7a 1.83 (1H,m) 20.9 
7b 1.52 (1H,m) 20.9 
8 3.13 (1H,m) 60.2 
9 5.81 (1H,d,3.0) 70.7 
10 5.68 (1H,ddd,17.3,10.1,7.3) 141.0 
11a 4.95 (1H,m) 114.8 
11b 4.92 (1H,m) 114.8 
OH - - 
 
 
RDC 
Table A4-59. RDC extraction of cinchonidine (Polymer 8.3 in the thesis). 2H splitting = 67.4 Hz (CDCl3) 
Cinchonidine 
   
C H J [Hz] T [Hz] D [Hz] 
2 2a 139.6 143.5 3.9 
2 2b 138.5 149.2 10.8 
3 3 130.1 154.5 24.5 
4 4 139.1 167.1 27.9 
5 5a 131 112.4 -18.5 
5 5b 128.1 157.8 29.7 
6 6a 141.6 103 -38.6 
6 6b 137.8 142.7 5 
7 7a 131 110 -21 
7 7b 129.8 107 -22.7 
8 8 136.4 131.1 -5.3 
9 9 142.9 158.7 15.8 
10 10 151 177.2 26.2 
11 11a 158.4 131.4 -27 
11 11b 153.4 174.7 21.3 
2' 2' 177.7 200 22.3 
3' 3' 163.7 187.2 23.5 
5' 5' 159.4 187.2 27.8 
6' 6' 160.4 185.5 25.1 
7' 7' 160.8 181.7 20.9 
8' 8' 162.2 187.8 25.6 
NMR Assignments 
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Table A4-60. RDCs in Hz back-calculated from different assignments of cinchonidine using the θ-method (Polymer 8.3 in the thesis).  
C H Epx Right Dia-9 Dia-7 Dia-2 Dia-6 Dia-5 Dia-11 
2' 2' 22.3 24.3 20.1 23.9 24.6 24.3 23.8 23.9 
10 10 26.2 23.9 22.7 24.0 23.8 21.2 23.1 7.1 
8' 8' 25.6 25.1 18.4 25.3 25.3 24.2 25.3 23.4 
6' 6' 25.1 23.0 20.7 22.6 23.3 23.2 23.3 23.3 
7' 7' 20.9 21.5 15.4 21.4 21.1 19.8 22.6 20.6 
5' 5' 27.8 25.2 18.0 25.4 25.4 24.1 24.9 23.9 
3' 3' 23.5 22.3 15.4 22.2 22.0 20.6 22.1 21.0 
11 11b 21.3 24.4 24.1 24.6 24.6 25.9 24.8 -1.3 
11 11a -27.0 -28.8 -26.7 -28.2 -28.1 -24.0 -27.8 2.5 
9 9 15.8 16.1 -1.7 16.2 16.7 16.7 15.2 16.2 
8 8 -5.3 -7.0 -2.2 -7.3 -5.3 -10.9 -12.2 -4.9 
2 2a 3.9 4.7 13.0 4.9 6.5 3.9 11.2 4.9 
2 2b 10.8 8.3 15.9 8.5 8.2 -13.4 7.9 6.1 
6 6a -38.6 -37.7 -41.3 -37.9 -37.1 -14.4 -35.2 -27.7 
6 6b 5.0 9.0 14.8 9.1 6.7 -2.0 9.4 6.8 
3 3 24.5 23.2 25.3 23.3 23.0 20.9 3.1 18.3 
4 4 27.9 23.1 12.5 23.2 22.4 17.5 21.2 14.6 
5 5a -18.5 -21.2 -12.9 -21.9 -20.6 -19.0 1.5 -24.9 
5 5b 29.7 25.8 23.4 25.8 24.4 23.0 7.3 17.1 
7 7a -22.7 -22.3 -15.7 -21.5 -21.2 -23.3 -19.7 -4.3 
7 7b -21.0 -20.3 -17.3 -21.3 -20.0 -19.3 -5.6 -24.5 
          
  Q-factor 0.100 0.331 0.102 0.106 0.372 0.410 0.497 
 
Table A4-61. RDC extraction of cinchonidine (Polymer 8.4 in the thesis). 2H splitting = N/A (DMSO-d6) 
Cinchonidine 
   
C H J [Hz] T [Hz] D [Hz] 
2' 2' 177.6 190.1 12.5 
10 10 150.8 162.7 11.9 
8' 8' 161.6 175.8 14.2 
6' 6' 160.1 173.3 13.2 
7' 7' 160.4 170.0 9.6 
5' 5' 160.7 176.3 15.6 
3' 3' 162.7 173.5 10.8 
11 11b 153.8 157.8 4.0 
9 9 141.4 140.4 -1.0 
8 8 135.6 136.9 1.4 
2 2b 138.5 139.5 1.1 
2 2a 136.7 138.3 1.6 
6 6a 138.6 132.0 -6.6 
6 6b 137.5 136.5 -1.1 
3 3 129.8 133.8 4.1 
4 4 138.1 147.2 9.2 
5 5a 130.8 137.7 6.9 
5 5b 129.1 128.8 -0.3 
 
  RDC compounds 
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A4.4.5. Cinchonine 
Table A4-62. NMR assignment of cinchonine 
 # δH [ppm] (int,mult,J [Hz]) δC [ppm] 
2' 8.90 (1H,d,4.4) 150.2 
3' 7.64 (1H,m) 118.2 
4'  148.4 
5' 7.98 (1H,d,8.4) 122.9 
6' 7.45 (1H,d,8.4) 126.8 
7' 7.68 (1H,t,7.2) 129.0 
8' 8.12 (1H,d,8.2) 130.3 
9'  148.0 
10'  125.3 
2a 2.97 (1H,m) 49.3 
2b 3.41 (1H,ddd,12.8,8.3,1.2) 49.3 
3 2.28 (1H,q,8.3) 39.6 
4 1.80 (1H,br. s) 28.0 
5a 1.57 (1H,m) 25.9 
5b 1.54 (1H,m) 25.9 
6a 2.83 (1H,m)  50.0 
6b 2.94 (1H,m) 50.0 
7a 2.06 (1H,dd,12.1,10.4) 20.9 
7b 1.18 (1H, dqd, 13.5,4.6,1.1) 20.9 
8 3.14 (1H,td,8.9,3.9) 60.0 
9 5.84 (1H,d,4.0) 71.2 
10 6.03 (1H,ddd,17.8,9.7,7.7) 140.0 
11a 5.02 (1H,m) 114.8 
11b 5.01 (1H,m) 114.8 
OH 2.15 (1H,br. s) - 
 
 
RDC 
Table A4-63. RDC extraction of cinchonine (Polymer 8.5 in the thesis). 2H splitting = 56.5 Hz (CDCl3) 
Cinchonine 
   
C H J [Hz] T [Hz] D [Hz] 
2 2a 140.6 107.5 -33.1 
2 2b 138.9 147.9 9 
3 3 129 127.5 -1.5 
4 4 139.8 143.5 3.7 
5 5a 130.8 125.5 -5.3 
5 5b 128.3 124.7 -3.6 
6 6a 137.6 156.7 19.2 
6 6b 137.5 145.5 8.1 
7 7a 130.9 120.3 -10.6 
7 7b 128.8 111.8 -17 
8 8 135.7 139 3.2 
9 9 143.7 157.6 13.8 
10 10 151.9 144.4 -7.6 
2' 2' 177.7 207.8 30.1 
3' 3' 163.4 188.1 24.7 
5' 5' 159.2 183.1 23.9 
6' 6' 160.3 189.8 29.5 
7' 7' 167.3 190.3 23 
8' 8' 162.3 187 24.8 
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Table A4-64. RDCs in Hz back-calculated from different assignments of cinchonine using the θ-method (Polymer 8.5 in the thesis).  
C H Exp Right Dia-9 Dia-7 Dia-2 Dia-6 Dia-5 Dia-11 Right-30kJ/mol Dia-9-30kJ/mol 
2' 2' 30.06 29.8 29.9 29.9 29.5 30.1 29.9 30.0 29.9 27.7 
10 10 -7.57 -7.3 -7.6 -7.3 -7.4 -7.8 -7.3 -7.5 -7.5 -7.6 
8' 8' 24.76 24.2 24.0 24.2 23.8 24.1 24.1 24.0 24.1 17.5 
7' 7' 22.97 23.4 23.0 23.1 22.6 22.7 23.1 22.9 23.0 19.0 
6' 6' 29.45 29.5 29.3 29.5 29.2 29.7 29.6 29.8 29.6 28.4 
5' 5' 23.89 24.6 24.7 24.7 23.9 24.7 24.5 24.5 24.4 17.6 
3' 3' 24.68 24.8 24.6 24.4 24.1 24.4 24.7 24.4 24.3 20.7 
9 9 13.83 13.9 13.8 13.6 13.3 13.6 13.7 13.5 13.6 6.8 
8 8 3.23 0.9 1.9 1.3 2.7 -1.6 1.1 0.6 0.5 7.2 
6 6a 19.15 21.1 20.2 21.5 15.6 14.2 21.3 20.8 21.1 21.5 
6 6b 8.06 8.6 8.8 9.1 -12.2 13.1 8.6 9.3 9.3 14.7 
2 2a -33.14 -33.4 -33.3 -33.4 -19.0 -33.0 -33.0 -34.0 -33.9 -36.6 
2 2b 9.03 7.6 8.1 8.0 0.4 13.5 7.9 8.3 7.9 13.8 
3 3 -1.5 -0.7 -0.3 -0.6 0.7 1.5 -1.3 -0.6 -0.6 1.6 
4 4 3.67 6.9 7.5 6.1 2.7 7.3 6.9 6.8 6.9 2.1 
5 5a -5.29 -3.0 -3.4 -6.2 -1.7 -3.0 -2.5 -2.9 -3.1 -1.3 
5 5b -3.59 -1.2 -1.5 -1.4 5.8 0.2 -2.2 -1.2 -1.4 -0.2 
7 7a -16.98 -13.1 -12.9 -12.0 -8.3 -12.1 -12.9 -13.1 -12.8 -9.2 
7 7b -10.63 -7.5 -7.3 -7.2 -7.9 -6.4 -6.8 -7.4 -7.9 -6.1 
            
  Q-factor 0.096 0.095 0.098 0.373 0.167 0.099 0.098 0.097 0.250 
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A5. NMR spectra 
A5.1. 1D spectra 
A5.1.1. Natural compounds 
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A5.1.2. Synthetic compounds 
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A5.1.3. S3 HMBC 
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A5.1.4. RDC 
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A5.1.5. Synthesized monomers 
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A5.2. Examples of isotropic and aligned spectra 
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A6. S3 HMBC 
 
Figure A6.1. CH/CH3 S
3 HMBC homo spectra of strychnine. Add spectrum in blue and subtract spectrum in red. Subtract spectrum is offset 
in F1 dimension. 
 
Figure A6.2. CH2/Cq S
3 HMBC homo spectra of strychnine. Add spectrum in blue and subtract spectrum in red. Subtract spectrum is offset 
in F1 dimension. 
 
S3 HMBC 
 
 
A-75 
 
Figure A6.3. CH/CH3 S
3 HMBC hetero spectra of strychnine. Add spectrum in blue and subtract spectrum in red. Subtract spectrum is offset 
in F1 dimension. 
 
Figure A6.4. CH2/Cq S
3 HMBC hetero spectra of strychnine. Add spectrum in blue and subtract spectrum in red. Subtract spectrum is offset 
in F1 dimension. 
  
  Examples of isotropic and aligned spectra 
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Nuc 1 Nuc 2 Exp SVD Exp SVD SVD scaled 
C1 H1 19.0 18.0 19.0 16.5 17.6 
C2 H2 14.0 14.8 14.0 15.3 14.3 
C3 H3 18.8 18.2 18.8 16.9 17.2 
C4 H4 18.7 18.3 18.7 16.8 17.9 
C8 H8 -11.0 -10.3 -11.0 -8.0 -9.9 
C11 H11a 5.1 7.5 5.1 5.4 7.5 
C11 H11b -21.7 -23.7 -21.7 -21.3 -22.8 
C12 H12 -25.2 -25.5 -25.2 -25.6 -24.6 
C13 H13 -3.8 -3.6 -3.8 -3.0 -3.5 
C14 H14 -25.1 -24.2 -25.1 -24.3 -23.4 
C15 H15a 3.1 3.2 3.1 3.6 3.1 
C15 H15b 6.1 5.9 6.1 5.4 5.6 
C16 H16 15.0 14.1 15.0 14.7 13.8 
C18 H18a -2.9 -4.3 -2.9 -6.1 -4.0 
C18 H18b 13.2 13.6 13.2 14.3 13.3 
C20 H20a -14.4 -12.5 -14.4 -10.4 -12.0 
C20 H20b -3.5 -3.1 -3.5 -2.8 -3.1 
C22 H22 0.1 2.2 0.1 1.7 2.0 
H1 H2 - 6.1 3.9 5.6 5.7 
H1 H3 - 1.2 1.6 1.1 1.2 
H2 H3 - 6.0 3.4 5.6 5.9 
H2 H4 - 1.0 0.3 1.0 1.0 
H3 H4 - 4.9 4.6 5.0 4.7 
H8 H12 - -2.0 -3.3 -2.0 -1.9 
H8 H13 - -5.5 -4.2 -5.2 -5.3 
H8 H16 - 0.6 2.1 0.7 0.6 
H11b H12 - -5.7 -3.2 -5.3 -5.5 
H12 H23a - 1.0 1.5 1.0 1.0 
H12 H23b - 7.8 9.4 7.1 7.4 
H13 H14 - 4.3 2.8 3.9 4.0 
H13 H15a - 1.9 2.1 1.8 1.9 
H13 H15b - 5.9 8.1 6.0 5.8 
H14 H15b - 4.5 3.8 4.5 4.3 
H14 H16 - 0.2 1.1 0.1 0.2 
H14 H20b - -0.6 -0.4 -0.7 -0.6 
H14 H22 - -0.9 -0.7 -0.7 -0.8 
H15a H16 - -4.4 -3.0 -4.5 -4.3 
H15b H16 - -3.7 -2.5 -4.2 -3.5 
H16 H17a/H17b - 4.8 -4.1 -4.54* -4.76* 
H16 H18a - -1.8 -1.7 -1.6 -1.7 
H16 H20b - 1.0 1.9 1.1 1.0 
H20b H22 - 5.6 5.4 5.4 5.5 
H22 H23a - 5.2 5.3 4.5 5.1 
H22 H23b - -1.2 -2.1 -1.5 -1.2 
       
   Q-factor 0.080 0.149 0.126 
   Da 7.293e-04 6.937e-04 7.021e-04 
 
Table A6-1. Experimental data from 
CLIP-HSQC and S3 HMBC homo of 
strychnine compared to back-
calculated RDCs using SVD or SVD Hz 
scaling in the program MSPIN. When 
no experimental data (-) is given the 
theoretical values are calculated from 
the existing data. *The values were 
treated as the average and not included 
in the back-calculated fit, though the 
values are included in the Q-factor. 
Polymer 6.2. 
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A6.1. Automatic bias-free S3 HMBC J-coupling extraction  
The script package rbnmr (Nils Nyberg, Copenhagen University, 2013) was used to import data from 
Topspin files into Matlab. Two scripts were written in Matlab to aid in the extraction of couplings.  
The first will determine a coupling constant, given an input row number and peak boundaries. The second 
script will find peaks and determine couplings from the 2D spectra and consists of two main parts; a module 
to locate and match the involved peaks and a module which extract the coupling constants. 
The script will first read the 2D data spectra and identify the peaks involved in couplings. The row number 
with the coupling constants(s), defined as the highest intensity for the resonances of a given constant, will be 
outputted to help in deciding which rows to manually extract if intended. Data will be saved as “1D” data 
slices defining the individual peaks involved in couplings. The second module will then match the peaks 
from the two spectra and overlay these. The overlay is scored by equation (6.1), the minimum is identified 
and the displacement given in Hz. 
   ∑|𝑝+,𝑖 − 𝑝−,𝑖|
𝑖
+ |𝑝+,𝑚𝑎𝑥 − 𝑝−,𝑗| + |𝑝+,𝑘 − 𝑝−,𝑚𝑎𝑥| (6.1) 
Where p are points in the 1D slices from the + or – spectra, i is the chemical shift of p, j,k are the shift values 
of the maximum intensity of the partnering (+ for – and vice versa) slice. The max terms of the score were 
included due to necessity; if a peak is slightly br.er than its partner, the fit may be equally good for multiple 
positions. This is avoided by scoring the points of maximum intensity higher. Harsher scoring of the 
maximum points assumes that the fit is better for higher intensities, which may not be true. The approach 
was found to lead to a more intuitive fit where the peaks are always centered, and in by far the most cases the 
fit is completely independent of the term.  
The peaks are displaced by keeping p+,i constant in equation (6.1) and setting p-,i = p+,i±1. The spacing in 
between pi and pi+1 is equal to the theoretical minimum detectable coupling constant for the script and may 
be lowered by linear interpolation of the data, given the data has a reasonable F2 resolution. The value is 
usually set to a minimum of 0.01 Hz which should be well below experimental errors. Typically a cutoff of 
95 % of the maximum intensities was set for the peaks, so that the only the upper 95 % was used in the 
fitting.  
Figures of the overlays (not used for figures in the article) are made to investigate the result, where mistakes 
are immediately obvious as only the parts of the spectra used in the fitting is plotted. Lastly the couplings 
may be matched by their H- and C-shifts to a given atom numbering, if provided, to ease further analysis. 
Care should be taken when overlap of peaks are present, just as with manual extraction. Also coupling 
patterns with baseline separation in between peaks may be taken for two or more couplings. Here the second 
script may be used to manually give the boundaries and thus avoid or minimize problems.  
 Automatic bias-free S3 HMBC J-coupling 
extraction 
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Figure A6.5. Example of output of the Matlab® script. Left: fully automated identification and extraction of coupling constants. Accessed by 
overlay. Rigt: Manual regions given as input (row, minimum- and maximum δH). The minimum differentiation is 0.5 Hz, compared to 0.1 Hz 
used throughout the thesis. Exemplified by S3 HMBC homo cross-peaks. 
 
Figure A6.6. Correlation of coupling constants obtained from the Matlab® script and those manually extracted for the two S3 HMBCs.
S3 HMBC 
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A6.2. Heteronuclear coupling constant DFT 
Table A6-2. Comparison of experimental and theoretical J-coupling constants calculated as given. For each dataset the unscaled is given in the left column and a scaled set in the right. Scaled by 
linear fit to experimental data (a and b given) 
   Opt: b3lyp/6-31g(d) b3lyp/6-31g(d) b3lyp/6-31g(d) b3lyp/6-31g(d) b3lyp/6-31g(d) b3lyp/6-31g(d) 
C H Exp J-calc  b3lyp/6-31g(d)  b3lyp/6-311g(d,p)  b3lyp/6-311+g(d,p)  mpw1pw91/6-31g(d)  mpw1pw91/6-311g(d,p)  mpw1pw91/6-311+g(d,p) 
1 3 7.4  6 (1.4) 7.2 (0.2) 6.6 (0.8) 7.4 (0) 6.6 (0.8) 7.4 (0.1) 6.4 (1) 7.4 (0) 6.7 (0.7) 7.5 (0) 6.7 (0.7) 7.5 (0) 
2 4 7.9  6.2 (1.7) 7.4 (0.4) 6.9 (0.9) 7.7 (0.2) 6.9 (1) 7.7 (0.2) 6.6 (1.2) 7.7 (0.2) 7.1 (0.8) 7.8 (0.1) 7 (0.8) 7.8 (0.1) 
3 1 8.9  7.2 (1.7) 8.9 (0) 8 (0.9) 8.9 (0.1) 8 (0.9) 9 (0.1) 7.6 (1.3) 8.9 (0.1) 8.1 (0.8) 8.9 (0) 8.1 (0.8) 8.9 (0.1) 
4 2 7.7  6.2 (1.5) 7.5 (0.2) 7 (0.7) 7.8 (0.1) 7 (0.7) 7.8 (0.1) 6.6 (1.1) 7.7 (0) 7.1 (0.6) 7.9 (0.1) 7.1 (0.7) 7.8 (0.1) 
8 12 6.4  5.6 (0.9) 6.5 (0.1) 5.7 (0.7) 6.3 (0.1) 5.6 (0.8) 6.2 (0.2) 5.5 (0.9) 6.2 (0.2) 5.6 (0.8) 6.2 (0.2) 5.5 (0.9) 6.2 (0.3) 
8 13 -1.7  1.3 (2.9) 0.1 (1.8) -0.7 (1) -1.1 (0.6) -0.9 (0.8) -1.3 (0.3) 0.5 (2.2) -0.5 (1.2) -1.4 (0.3) -1.4 (0.3) -1.6 (0.1) -1.5 (0.2) 
11b 12 -7.1  -4.3 (2.9) -8.2 (1.1) -6.3 (0.8) -7.6 (0.5) -6.3 (0.8) -7.6 (0.5) -4.8 (2.3) -7.5 (0.4) -6.9 (0.2) -7.4 (0.2) -6.9 (0.2) -7.3 (0.2) 
13 8 -6.3  -2.4 (3.9) -5.4 (0.9) -5.3 (1) -6.4 (0.1) -5.4 (0.9) -6.5 (0.2) -3.1 (3.2) -5.2 (1.1) -6 (0.3) -6.3 (0) -6 (0.3) -6.4 (0.1) 
13 14 -4.9  -2.5 (2.3) -5.6 (0.8) -4.2 (0.7) -5.1 (0.3) -4.2 (0.7) -5.1 (0.3) -3.3 (1.5) -5.5 (0.7) -4.8 (0.1) -5 (0.2) -4.8 (0.1) -5 (0.2) 
15a 13 7.7  6.8 (1) 8.3 (0.6) 7.1 (0.6) 7.9 (0.2) 7.1 (0.6) 8 (0.2) 6.8 (0.9) 7.9 (0.2) 7 (0.8) 7.7 (0) 7 (0.7) 7.7 (0) 
15a 14 -2.9  0.1 (3) -1.7 (1.2) -1.9 (1) -2.5 (0.4) -1.9 (1) -2.5 (0.4) -0.5 (2.4) -1.8 (1.1) -2.5 (0.4) -2.6 (0.3) -2.5 (0.4) -2.6 (0.3) 
15a 16 -4.6  -1.6 (3) -4.2 (0.4) -3.7 (0.9) -4.6 (0) -3.7 (1) -4.5 (0.1) -2.3 (2.4) -4.1 (0.5) -4.4 (0.2) -4.6 (0) -4.3 (0.3) -4.5 (0.1) 
15b 14 -3.2  -1 (2.2) -3.4 (0.2) -2.5 (0.7) -3.1 (0.1) -2.4 (0.8) -3.1 (0.1) -1.7 (1.5) -3.4 (0.2) -3.1 (0.1) -3.2 (0) -3.1 (0.1) -3.2 (0) 
15b 16 -1.9  0.4 (2.3) -1.2 (0.7) -1.4 (0.5) -1.9 (0) -1.3 (0.5) -1.8 (0) -0.4 (1.4) -1.7 (0.2) -2.2 (0.3) -2.2 (0.3) -2.1 (0.3) -2.2 (0.3) 
16 14 6.2  5.5 (0.7) 6.4 (0.2) 5.9 (0.3) 6.5 (0.3) 6 (0.3) 6.6 (0.4) 5.5 (0.8) 6.1 (0.1) 5.7 (0.5) 6.4 (0.1) 5.8 (0.5) 6.4 (0.2) 
20a 14 1.4  0.9 (0.5) -0.5 (1.8) 1.1 (0.3) 0.9 (0.4) 1.1 (0.3) 0.9 (0.4) 1.1 (0.3) 0.3 (1.1) 1.3 (0.1) 1.5 (0.2) 1.3 (0.1) 1.5 (0.2) 
20a 22 5.6  5.9 (0.4) 7 (1.5) 4.4 (1.2) 4.8 (0.8) 4.4 (1.2) 4.8 (0.8) 6.7 (1.2) 7.8 (2.2) 4.4 (1.1) 5 (0.6) 4.4 (1.1) 5 (0.6) 
20b 14 5.5  4.1 (1.4) 4.3 (1.2) 4.7 (0.8) 5.1 (0.4) 4.7 (0.8) 5.1 (0.4) 4.2 (1.3) 4.4 (1.1) 4.7 (0.8) 5.2 (0.3) 4.6 (0.9) 5.2 (0.3) 
20b 16 7.1  5.9 (1.2) 6.9 (0.1) 6.3 (0.7) 7 (0) 6.3 (0.8) 7 (0.1) 5.9 (1.2) 6.6 (0.4) 6.2 (0.9) 6.9 (0.2) 6.1 (0.9) 6.8 (0.3) 
20b 22 4.6  4.5 (0.2) 4.9 (0.2) 4.7 (0.1) 5.2 (0.5) 4.8 (0.1) 5.2 (0.6) 4.4 (0.2) 4.7 (0.1) 4.5 (0.1) 5.1 (0.4) 4.6 (0.1) 5.1 (0.5) 
22 14 8.5  6.9 (1.7) 8.4 (0.1) 7.7 (0.8) 8.7 (0.1) 7.7 (0.8) 8.7 (0.1) 7.3 (1.2) 8.5 (0) 8 (0.5) 8.8 (0.3) 8 (0.5) 8.8 (0.3) 
23a 22 -3.8  -2.2 (1.6) -5 (1.3) -3.1 (0.7) -3.9 (0.1) -3.1 (0.7) -3.9 (0.1) -3 (0.8) -5 (1.3) -3.8 (0) -4 (0.2) -3.8 (0) -3.9 (0.2) 
23b 22 -3.4  -1.2 (2.2) -3.6 (0.2) -2 (1.4) -2.6 (0.7) -2 (1.3) -2.7 (0.7) -2.4 (1) -4.2 (0.9) -2.9 (0.5) -3 (0.4) -2.9 (0.5) -3 (0.4) 
                
   a 0.7  0.9  0.9  0.8  0.9  0.9  
   b 1.2  0.3  0.3  0.8  -0.1  -0.1  
   RMSD 2 0.86 0.8 0.35 0.81 0.35 1.52 0.79 0.56 0.25 0.58 0.25 
   R2 0.976 0.976 0.996 0.996 0.996 0.996 0.98 0.98 0.998 0.998 0.998 0.998 
 
 
 
 
  Heteronuclear coupling constant DFT 
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Opt: b3lyp/6-311+g(d,p) b3lyp/6-311+g(d,p) b3lyp/6-311+g(d,p) mpw1p/w916-31(d,p) b3lyp/6-311+g(d,p) b3lyp/6-311+g(d,p) 
J-calc  b3lyp/6-31g(d)  b3lyp/6-311g(d,p)  b3lyp/6-311+g(d,p)  mpw1pw91/6-31g(d)  mpw1pw91/6-311g(d,p)  mpw1pw91/6-311+g(d,p) 
 6 (1.4) 7.2 (0.2) 6.7 (0.8) 7.4 (0) 6.6 (0.8) 7.4 (0) 6.4 (1) 7.4 (0.1) 6.8 (0.6) 7.5 (0.1) 6.8 (0.7) 7.5 (0.1) 
 6.2 (1.7) 7.4 (0.4) 6.9 (0.9) 7.7 (0.2) 6.9 (0) 7.7 (0.2) 6.6 (1.2) 7.6 (0.2) 7.1 (0) 7.8 (0.1) 7.1 (0) 7.8 (0.1) 
 7.2 (1.7) 8.9 (0) 8 (0.9) 8.9 (0) 8 (0) 8.9 (0.1) 7.6 (1.3) 8.9 (0) 8.1 (0) 8.9 (0) 8.1 (0) 8.9 (0.1) 
 6.2 (1.5) 7.5 (0.2) 7 (0.7) 7.8 (0.1) 7 (0) 7.8 (0) 6.7 (1.1) 7.6 (0.1) 7.1 (0) 7.8 (0.1) 7.1 (0) 7.8 (0.1) 
 5.5 (0.9) 6.4 (0) 5.6 (0.8) 6.2 (0.2) 5.6 (0) 6.1 (0.3) 5.7 (0.8) 6.3 (0.1) 5.5 (0) 6.1 (0.3) 5.5 (0) 6.1 (0.3) 
 1.1 (2.8) -0.2 (1.5) -0.8 (0.9) -1.3 (0.4) -1 (0) -1.5 (0.2) 0.4 (2.1) -0.6 (1.1) -1.5 (0) -1.5 (0.2) -1.7 (0) -1.7 (0) 
 -4.3 (2.8) -8.3 (1.1) -6.4 (0.8) -7.7 (0.6) -6.3 (0) -7.7 (0.6) -4.8 (2.3) -7.5 (0.4) -7 (0) -7.4 (0.3) -6.9 (0) -7.4 (0.3) 
 -2.5 (3.8) -5.5 (0.8) -5.3 (1) -6.5 (0.2) -5.3 (0) -6.6 (0.3) -3.1 (3.2) -5.2 (1.1) -5.9 (0) -6.3 (0) -6 (0) -6.4 (0.1) 
 -2.4 (2.4) -5.5 (0.6) -4.1 (0.8) -5.1 (0.2) -4.1 (0) -5.1 (0.2) -3.3 (1.6) -5.5 (0.6) -4.7 (0) -5 (0.1) -4.7 (0) -5 (0.1) 
 6.8 (1) 8.3 (0.5) 7.1 (0.6) 7.9 (0.2) 7.1 (0) 7.9 (0.2) 6.8 (0.9) 7.8 (0.1) 7 (0) 7.7 (0.1) 7 (0) 7.7 (0) 
 0.1 (3) -1.6 (1.2) -1.8 (1.1) -2.5 (0.4) -1.8 (0) -2.4 (0.5) -0.5 (2.3) -1.8 (1) -2.5 (0) -2.6 (0.3) -2.5 (0) -2.5 (0.4) 
 -1.5 (3.1) -4.1 (0.5) -3.6 (1) -4.6 (0) -3.5 (0) -4.5 (0.1) -2.2 (2.4) -4.1 (0.5) -4.3 (0) -4.5 (0.1) -4.2 (0) -4.4 (0.2) 
 -1 (2.2) -3.3 (0.1) -2.4 (0.8) -3.1 (0.1) -2.3 (0) -3 (0.2) -1.7 (1.5) -3.4 (0.2) -3 (0) -3.2 (0) -3 (0) -3.1 (0.1) 
 0.4 (2.3) -1.2 (0.7) -1.3 (0.6) -1.8 (0) -1.2 (0) -1.8 (0.1) -0.4 (1.5) -1.7 (0.2) -2.1 (0) -2.2 (0.3) -2.1 (0) -2.1 (0.2) 
 5.5 (0.8) 6.4 (0.1) 5.9 (0.3) 6.5 (0.3) 5.9 (0) 6.5 (0.3) 5.5 (0.7) 6.1 (0.1) 5.7 (0) 6.3 (0.1) 5.7 (0) 6.4 (0.1) 
 0.9 (0.5) -0.5 (1.8) 1.1 (0.3) 0.9 (0.5) 1.1 (0) 0.9 (0.5) 1.1 (0.2) 0.4 (1) 1.3 (0) 1.5 (0.1) 1.3 (0) 1.5 (0.1) 
 6 (0.5) 7.2 (1.7) 4.5 (1) 4.9 (0.7) 4.5 (0) 4.9 (0.6) 6.9 (1.3) 7.9 (2.4) 4.6 (0) 5.1 (0.4) 4.6 (0) 5.1 (0.4) 
 4.1 (1.3) 4.4 (1.1) 4.7 (0.8) 5.1 (0.3) 4.7 (0) 5.1 (0.4) 4.2 (1.3) 4.4 (1.1) 4.7 (0) 5.2 (0.3) 4.7 (0) 5.2 (0.3) 
 5.8 (1.2) 6.9 (0.2) 6.3 (0.7) 7 (0.1) 6.2 (0) 6.9 (0.1) 6 (1.1) 6.7 (0.3) 6.2 (0) 6.8 (0.2) 6.1 (0) 6.8 (0.3) 
 4.4 (0.2) 4.7 (0.1) 4.7 (0) 5.1 (0.4) 4.7 (0) 5.1 (0.5) 4.4 (0.2) 4.7 (0.1) 4.5 (0) 5 (0.3) 4.5 (0) 5 (0.4) 
 7 (1.5) 8.6 (0.1) 7.9 (0.6) 8.8 (0.3) 7.9 (0) 8.8 (0.3) 7.2 (1.3) 8.4 (0.1) 8.2 (0) 9 (0.5) 8.2 (0) 9 (0.5) 
 -2 (1.8) -4.8 (1) -2.9 (0.9) -3.7 (0) -2.9 (0) -3.7 (0.1) -3 (0.8) -5 (1.3) -3.7 (0) -3.8 (0.1) -3.6 (0) -3.8 (0) 
 -1.3 (2.1) -3.8 (0.4) -2 (1.3) -2.7 (0.6) -2.1 (0) -2.8 (0.6) -2.5 (0.9) -4.4 (1) -2.9 (0) -3.1 (0.3) -3 (0) -3.1 (0.3) 
             
a 0.7  0.9  0.9  0.8  0.9  0.9  
b 1.2  0.3  0.3  0.9  -0.1  -0.1  
RMSD 1.98 0.84 0.81 0.33 0.82 0.33 1.51 0.81 0.55 0.23 0.57 0.24 
R2 0.977 0.977 0.996 0.996 0.996 0.996 0.979 0.979 0.998 0.998 0.998 0.998 
 
  
S3 HMBC 
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Opt: mpw1pw91/6-311+g(d,p) mpw1pw91/6-311+g(d,p) mpw1pw91/6-311+g(d,p) b3lyp6-3/11+g(d,p) mpw1pw91/6-311+g(d,p) mpw1pw91/6-311+g(d,p) 
J-calc  b3lyp/6-31g(d)  b3lyp/6-311g(d,p)  b3lyp/6-311+g(d,p)  mpw1pw91/6-31g(d)  mpw1pw91/6-311g(d,p)  mpw1pw91/6-311+g(d,p) 
 6 (1.4) 7.1 (0.3) 6.7 (0.8) 7.3 (0.1) 6.6 (0.8) 7.3 (0.1) 6.5 (0.9) 7.4 (0) 6.8 (0.7) 7.4 (0) 6.7 (0.7) 7.4 (0) 
 6.2 (1.7) 7.4 (0.5) 6.9 (0.9) 7.7 (0.2) 6.9 (1) 7.7 (0.2) 6.7 (1.2) 7.7 (0.2) 7.1 (0.8) 7.7 (0.1) 7 (0.8) 7.8 (0.1) 
 7.2 (1.7) 8.8 (0) 8 (0.9) 8.9 (0) 8 (0.9) 8.9 (0) 7.6 (1.2) 8.9 (0.1) 8.1 (0.8) 8.9 (0) 8.1 (0.8) 8.9 (0) 
 6.2 (1.5) 7.4 (0.3) 7 (0.7) 7.8 (0) 7 (0.7) 7.7 (0) 6.7 (1) 7.7 (0) 7.1 (0.6) 7.8 (0.1) 7.1 (0.7) 7.8 (0.1) 
 5.7 (0.7) 6.6 (0.2) 5.8 (0.6) 6.4 (0.1) 5.7 (0.7) 6.3 (0.1) 5.5 (0.9) 6.1 (0.3) 5.7 (0.7) 6.3 (0.1) 5.6 (0.8) 6.2 (0.2) 
 1.2 (2.9) 0 (1.6) -0.8 (0.9) -1.3 (0.4) -1 (0.7) -1.5 (0.2) 0.3 (2) -0.7 (1) -1.5 (0.2) -1.5 (0.2) -1.7 (0) -1.6 (0) 
 -4.3 (2.9) -8.2 (1.1) -6.4 (0.8) -7.6 (0.5) -6.3 (0.8) -7.6 (0.5) -4.9 (2.2) -7.6 (0.4) -7 (0.2) -7.4 (0.2) -6.9 (0.2) -7.3 (0.2) 
 -2.4 (3.9) -5.4 (0.9) -5.3 (1) -6.4 (0.1) -5.3 (0.9) -6.5 (0.2) -3.2 (3.1) -5.3 (1) -5.9 (0.4) -6.3 (0) -6 (0.3) -6.3 (0.1) 
 -2.5 (2.3) -5.6 (0.7) -4.1 (0.7) -5.1 (0.2) -4.1 (0.7) -5.1 (0.2) -3.2 (1.6) -5.4 (0.5) -4.7 (0.1) -5 (0.1) -4.7 (0.1) -5 (0.1) 
 6.8 (1) 8.2 (0.5) 7.1 (0.6) 7.8 (0.1) 7.1 (0.6) 7.9 (0.2) 6.8 (0.9) 7.8 (0.1) 7 (0.8) 7.6 (0.1) 7 (0.8) 7.7 (0) 
 0.1 (3) -1.7 (1.2) -1.9 (1) -2.5 (0.4) -1.9 (1) -2.5 (0.4) -0.6 (2.3) -1.8 (1.1) -2.5 (0.3) -2.6 (0.3) -2.5 (0.4) -2.6 (0.3) 
 -1.6 (3.1) -4.1 (0.5) -3.7 (0.9) -4.6 (0) -3.6 (1) -4.5 (0.1) -2.2 (2.4) -4 (0.6) -4.4 (0.3) -4.6 (0.1) -4.3 (0.3) -4.5 (0.1) 
 -1 (2.2) -3.3 (0.1) -2.4 (0.8) -3.1 (0.1) -2.4 (0.8) -3.1 (0.1) -1.7 (1.5) -3.4 (0.2) -3.1 (0.1) -3.2 (0) -3.1 (0.1) -3.1 (0.1) 
 0.4 (2.3) -1.2 (0.6) -1.4 (0.5) -1.9 (0) -1.3 (0.5) -1.8 (0) -0.4 (1.4) -1.7 (0.2) -2.2 (0.3) -2.2 (0.3) -2.1 (0.3) -2.2 (0.3) 
 5.6 (0.7) 6.5 (0.2) 6 (0.2) 6.6 (0.3) 6 (0.2) 6.6 (0.4) 5.4 (0.8) 6 (0.2) 5.8 (0.4) 6.4 (0.2) 5.8 (0.4) 6.4 (0.2) 
 0.9 (0.4) -0.4 (1.8) 1.1 (0.2) 1 (0.4) 1.1 (0.2) 1 (0.4) 1.1 (0.3) 0.3 (1) 1.3 (0) 1.6 (0.2) 1.3 (0) 1.6 (0.2) 
 6.1 (0.5) 7.2 (1.7) 4.5 (1) 4.9 (0.6) 4.5 (1) 4.9 (0.6) 6.8 (1.3) 7.9 (2.4) 4.6 (0.9) 5.1 (0.4) 4.6 (1) 5.1 (0.4) 
 4.2 (1.3) 4.4 (1.1) 4.8 (0.7) 5.2 (0.3) 4.7 (0.8) 5.1 (0.3) 4.2 (1.3) 4.4 (1.1) 4.7 (0.8) 5.2 (0.2) 4.7 (0.8) 5.2 (0.3) 
 6 (1.1) 7.1 (0) 6.5 (0.6) 7.1 (0.1) 6.4 (0.7) 7.1 (0) 5.8 (1.2) 6.6 (0.5) 6.3 (0.7) 7 (0.1) 6.2 (0.8) 6.9 (0.2) 
 4.5 (0.1) 4.9 (0.2) 4.8 (0.2) 5.2 (0.6) 4.8 (0.2) 5.3 (0.6) 4.3 (0.3) 4.6 (0) 4.6 (0.1) 5.1 (0.4) 4.6 (0) 5.1 (0.5) 
 6.8 (1.7) 8.3 (0.2) 7.7 (0.8) 8.6 (0) 7.7 (0.8) 8.6 (0) 7.4 (1.1) 8.7 (0.2) 8 (0.6) 8.7 (0.2) 8 (0.6) 8.7 (0.2) 
 -2.2 (1.6) -5 (1.3) -3.1 (0.7) -3.9 (0.1) -3.1 (0.7) -3.9 (0.1) -2.8 (1) -4.8 (1) -3.8 (0) -4 (0.2) -3.8 (0) -3.9 (0.2) 
 -1.3 (2.1) -3.7 (0.4) -2.1 (1.2) -2.8 (0.6) -2.2 (1.2) -2.8 (0.6) -2.6 (0.8) -4.5 (1.1) -3 (0.4) -3.1 (0.3) -3 (0.4) -3.1 (0.3) 
             
a 0.7  0.9  0.9  0.8  0.9  0.9  
b 1.2  0.3  0.3  0.8  -0.1  -0.1  
RMSD 1.99 0.86 0.77 0.31 0.78 0.31 1.5 0.79 0.53 0.22 0.54 0.22 
R2 0.976 0.976 0.997 0.997 0.997 0.997 0.98 0.98 0.998 0.998 0.998 0.998 
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A6.3. Homonuclear coupling constant DFT 
Table A6-3. Comparison of experimental and theoretical J-coupling constants calculated as given from structures optimized to B3LYP/6-31G(d). For each dataset the unscaled is given in the left 
column and a scaled set in the right. 
H1 H2 Exp B3LYP/6-31G(d,p) fconly B3LYP/6-31G(d,p) B3LYP/6-311+G(d,p) fconly B3LYP/6-311+G(d,p) B3LYP/cc-pVDZ 
1 2 7.7 8.3 (0.7) 7.6 (0.1) 8.2 (0.5) 7.5 (0.2) 9 (1.3) 8.2 (0.5) 8.6 (1) 7.9 (0.2) 8.2 (0.6) 7.5 (0.2) 
1 3 1.3 1.2 (0) 1.1 (0.2) 1.1 (0.2) 1 (0.3) 1.2 (0.1) 1.1 (0.2) 0.9 (0.3) 0.9 (0.4) 0.6 (0.7) 0.6 (0.7) 
3 1 1.5 1.2 (0.3) 1.1 (0.4) 1.1 (0.4) 1 (0.5) 1.2 (0.3) 1.1 (0.4) 0.9 (0.6) 0.9 (0.6) 0.6 (0.9) 0.6 (0.9) 
1 4 0.7 0.6 (0.1) 0.5 (0.1) 0.6 (0.1) 0.5 (0.1) 0.6 (0.1) 0.5 (0.1) 0.4 (0.2) 0.4 (0.3) 0.2 (0.5) 0.1 (0.5) 
4 1 0.7 0.6 (0) 0.5 (0.1) 0.6 (0.1) 0.5 (0.1) 0.6 (0.1) 0.5 (0.1) 0.4 (0.2) 0.4 (0.2) 0.2 (0.5) 0.1 (0.5) 
2 4 1.2 1.1 (0.2) 1 (0.3) 0.9 (0.3) 0.9 (0.4) 1 (0.2) 0.9 (0.3) 0.7 (0.5) 0.7 (0.6) 0.5 (0.8) 0.4 (0.8) 
4 2 1.1 1.1 (0) 1 (0.1) 0.9 (0.1) 0.9 (0.2) 1 (0.1) 0.9 (0.1) 0.7 (0.3) 0.7 (0.4) 0.5 (0.6) 0.4 (0.6) 
2 3 7.6 8.2 (0.6) 7.5 (0.1) 8 (0.4) 7.3 (0.3) 8.9 (1.3) 8.1 (0.5) 8.4 (0.9) 7.7 (0.1) 8 (0.5) 7.3 (0.2) 
3 4 8.2 9.1 (0.9) 8.3 (0.1) 9 (0.8) 8.2 (0) 9.7 (1.6) 8.9 (0.7) 9.3 (1.2) 8.5 (0.3) 9 (0.8) 8.2 (0) 
8 12 0.0 -0.1 (0.1) -0.1 (0.1) -0.2 (0.2) -0.2 (0.2) -0.1 (0.1) -0.1 (0.1) -0.3 (0.3) -0.3 (0.3) -0.5 (0.5) -0.5 (0.4) 
12 8 -0.2 -0.1 (0.1) -0.1 (0.1) -0.2 (0) -0.2 (0) -0.1 (0.1) -0.1 (0.1) -0.3 (0.1) -0.3 (0.1) -0.5 (0.3) -0.5 (0.3) 
8 13 10.5 10.9 (0.4) 10 (0.6) 10.9 (0.4) 9.9 (0.6) 11.1 (0.6) 10.1 (0.4) 10.6 (0.1) 9.7 (0.8) 10.2 (0.4) 9.3 (1.3) 
13 8 10.6 10.9 (0.3) 10 (0.6) 10.9 (0.3) 9.9 (0.6) 11.1 (0.5) 10.1 (0.4) 10.6 (0.1) 9.7 (0.9) 10.2 (0.4) 9.3 (1.3) 
8 16 -0.2 -0.3 (0.1) -0.3 (0.1) -0.3 (0.1) -0.3 (0.1) -0.4 (0.2) -0.3 (0.1) -0.5 (0.3) -0.5 (0.3) -0.7 (0.5) -0.6 (0.4) 
16 8 -0.3 -0.3 (0) -0.3 (0.1) -0.3 (0) -0.3 (0) -0.4 (0) -0.3 (0) -0.5 (0.2) -0.5 (0.2) -0.7 (0.4) -0.6 (0.3) 
11a 12 8.5 9.2 (0.7) 8.4 (0.1) 9.5 (0.9) 8.6 (0.1) 9.6 (1.1) 8.8 (0.2) 9.7 (1.2) 8.9 (0.3) 9.8 (1.3) 9 (0.4) 
11a 13 -0.5 -0.3 (0.1) -0.3 (0.1) -0.4 (0.1) -0.3 (0.1) -0.3 (0.1) -0.3 (0.1) -0.4 (0.1) -0.3 (0.1) -0.3 (0.1) -0.3 (0.2) 
11b 12 3.4 4.1 (0.8) 3.8 (0.4) 4 (0.7) 3.7 (0.3) 3.9 (0.6) 3.6 (0.2) 3.5 (0.2) 3.2 (0.2) 3.4 (0.1) 3.1 (0.2) 
12 13 3.2 3.9 (0.7) 3.6 (0.3) 4.2 (1) 3.8 (0.6) 4.2 (1) 3.8 (0.6) 4.5 (1.3) 4.1 (0.9) 4.7 (1.5) 4.3 (1.1) 
12 14 -0.2 -0.2 (0) -0.2 (0) -0.1 (0.1) -0.1 (0.1) -0.2 (0) -0.2 (0) 0.1 (0.3) 0.1 (0.3) 0.4 (0.6) 0.4 (0.6) 
12 15a -0.1 -0.1 (0) -0.1 (0) -0.1 (0) -0.1 (0) -0.1 (0) -0.1 (0) -0.2 (0) -0.2 (0) -0.2 (0.1) -0.2 (0.1) 
12 23a -0.1 -0.1 (0) -0.1 (0) -0.2 (0.1) -0.2 (0.1) -0.1 (0) -0.1 (0) -0.3 (0.2) -0.3 (0.2) -0.4 (0.3) -0.4 (0.3) 
12 23b -0.2 0 (0.1) 0 (0.1) 0.2 (0.4) 0.2 (0.4) -0.1 (0) -0.1 (0) 0.4 (0.5) 0.3 (0.5) 0.8 (1) 0.7 (0.9) 
13 14 3.1 3.6 (0.5) 3.3 (0.2) 3.8 (0.7) 3.4 (0.3) 3.8 (0.7) 3.4 (0.3) 4.1 (1) 3.7 (0.6) 4.2 (1) 3.8 (0.7) 
13 15a 0.3 0.4 (0.1) 0.4 (0.1) 0.4 (0.1) 0.4 (0.1) 0.5 (0.2) 0.5 (0.2) 0.4 (0.1) 0.3 (0.1) 0.3 (0) 0.2 (0) 
13 15b -0.4 -0.3 (0.1) -0.3 (0.1) 0 (0.4) 0 (0.4) -0.3 (0.1) -0.3 (0.1) 0.3 (0.7) 0.3 (0.7) 0.8 (1.2) 0.7 (1.1) 
14 15a 4.9 5 (0.1) 4.6 (0.3) 5.1 (0.2) 4.7 (0.3) 5.2 (0.3) 4.8 (0.2) 5.3 (0.4) 4.9 (0.1) 5.4 (0.4) 4.9 (0.1) 
14 15b 1.9 2.1 (0.2) 1.9 (0) 2.2 (0.2) 2 (0.1) 2.2 (0.3) 2 (0.1) 2.3 (0.4) 2.1 (0.2) 2.3 (0.4) 2.1 (0.2) 
14 16 0.7 0.6 (0.1) 0.5 (0.1) 0.6 (0.1) 0.5 (0.1) 0.6 (0.1) 0.5 (0.1) 0.4 (0.3) 0.4 (0.3) 0.2 (0.4) 0.2 (0.5) 
14 20b -0.5 -0.6 (0.1) -0.5 (0) -0.6 (0.2) -0.6 (0.1) -0.6 (0.2) -0.6 (0.1) -0.8 (0.4) -0.8 (0.3) -1 (0.5) -0.9 (0.4) 
14 22 -2.9 -3.3 (0.4) -3 (0.1) -3.4 (0.5) -3.1 (0.2) -3.3 (0.4) -3 (0.1) -3.6 (0.7) -3.2 (0.3) -3.7 (0.8) -3.4 (0.5) 
15a 16 4.0 4.3 (0.3) 3.9 (0.1) 4.4 (0.3) 4 (0) 4.5 (0.5) 4.1 (0.1) 4.6 (0.6) 4.2 (0.1) 4.6 (0.6) 4.2 (0.2) 
15b 16 2.2 2.2 (0.1) 2 (0.1) 2.3 (0.2) 2.1 (0) 2.4 (0.3) 2.2 (0) 2.5 (0.4) 2.3 (0.2) 2.6 (0.4) 2.4 (0.2) 
16 17ab -0.2 -0.2 (0) -0.1 (0.1) -0.1 (0.1) -0.1 (0.1) -0.1 (0.1) -0.1 (0.1) -0.1 (0.1) 0 (0.1) 0 (0.2) 0 (0.2) 
16 18a -0.5 -0.5 (0) -0.5 (0) -0.6 (0.1) -0.6 (0) -0.5 (0.1) -0.4 (0.1) -0.7 (0.1) -0.6 (0.1) -0.7 (0.2) -0.7 (0.1) 
16 18b 0.1 0.1 (0) 0.1 (0) 0 (0.1) 0 (0.1) 0 (0.1) 0 (0.1) -0.3 (0.4) -0.3 (0.4) -0.5 (0.6) -0.5 (0.5) 
16 20b -0.3 -0.4 (0.1) -0.3 (0.1) -0.4 (0.2) -0.4 (0.1) -0.4 (0.1) -0.3 (0.1) -0.6 (0.3) -0.5 (0.3) -0.8 (0.5) -0.7 (0.5) 
20a 22 -1.4 -2 (0.6) -1.8 (0.5) -2.1 (0.7) -1.9 (0.6) -2 (0.6) -1.8 (0.5) -2.2 (0.8) -2 (0.6) -2.1 (0.7) -1.9 (0.6) 
20b 22 -0.6 -0.6 (0) -0.6 (0) -0.4 (0.2) -0.4 (0.2) -0.6 (0.1) -0.6 (0) -0.2 (0.4) -0.2 (0.4) 0.2 (0.7) 0.1 (0.7) 
22 23a 7.0 7.5 (0.6) 6.9 (0.1) 7.8 (0.8) 7.1 (0.1) 8.1 (1.1) 7.4 (0.4) 8.3 (1.3) 7.5 (0.6) 8.1 (1.1) 7.4 (0.4) 
22 23b 6.1 6.7 (0.6) 6.1 (0) 6.5 (0.4) 6 (0.2) 6.5 (0.4) 6 (0.2) 6.1 (0) 5.6 (0.5) 5.9 (0.3) 5.3 (0.8) 
             
  
RMSD 0.36 0.21 0.40 0.26 0.55 0.27 0.57 0.41 0.66 0.59 
  
R2 0.997 0.997 0.994 0.994 0.994 0.994 0.986 0.986 0.971 0.971 
S3 HMBC 
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A6.4. Theoretical basis of the S3 HMBC hetero pulse sequence 
Theoretically there are two pure zero-quantum operators, 2ÎyŜy+2ÎxŜx and 2ÎyŜx-2ÎxŜy, and the operator 
2ÎyŜy+2ÎxŜx was chosen.
27,28 This needed to be translated into a pulse sequence which is achieved in the 
following equations, starting from the ZQx operator. For ease the operator(s) which are used in the new 
equation is given in bold. The mathematical functions, most of them very simple, in the equations (6.2) to 
(6.7) are used throughout and thus included in the box below.28 
𝑒𝐴+𝐵 = 𝑒𝐴𝑒𝐵 (6.2) 
𝑒𝑖𝜑𝐵𝐴𝑒−𝑖𝜑𝐵 = 𝐴 cos𝜑 − 𝑖[𝐵, 𝐴] sin𝜑 (6.3) 
cos
𝜋
2
= 0 
(6.4) 
sin
𝜋
2
= 0 
(6.5) 
𝑒𝑖𝜑𝐵𝑒−𝑖𝜑𝐵=1 (6.6) 
𝑈−1𝑒𝑖ℋ𝜏𝑈 = 𝑈−1 {∑
1
𝑘!
(𝑖ℋ𝜏)𝑘
∞
𝑘=0
} 𝑈 = 1 + 𝑖𝜏𝑈−1ℋ𝑈 +
(𝑖𝜏)2
2!
(𝑈−1ℋ𝑈)(𝑈−1ℋ𝑈)…
= ∑
1
𝑘!
(𝑖𝜏𝑈−1ℋ𝑈)𝑘
∞
𝑘=0
= 𝑒𝑖𝑈
−1ℋ𝑈𝜏 
(6.7) 
Starting from the zero quantum operator, and using (6.2): 
𝑍𝑄𝑥 = 2𝐼𝑦?̂?𝑦 + 2𝐼𝑥?̂?𝑥 
(6.8) 
𝑒−𝑖𝜋𝑍𝑄𝑥 = 𝑒−𝑖𝜋(2𝐼𝑦?̂?𝑦+2𝐼𝑥?̂?𝑥) = 𝒆−𝒊𝝅(𝟐?̂?𝒚?̂?𝒚)𝑒−𝑖𝜋(2𝐼𝑥?̂?𝑥) (6.9) 
The two operators are expanded in isolation, starting with 𝑒−𝑖𝜋(2𝐼𝑦?̂?𝑦), which is expanded by adding 
operators that equal 1 to both sides of the operator, (6.6). 
𝑒−𝑖𝜋(2𝐼𝑦?̂?𝑦) = 𝑒−𝑖
𝜋
2(𝐼𝑥+?̂?𝑥)𝒆𝒊
𝝅
𝟐(?̂?𝒙+?̂?𝒙)𝒆−𝒊𝝅(𝟐?̂?𝒚?̂?𝒚)𝒆−𝒊
𝝅
𝟐(?̂?𝒙+?̂?𝒙)𝑒𝑖
𝜋
2(𝐼𝑥+?̂?𝑥) 
(6.10) 
The three middle operators are manipulated, using equation (6.7) and (6.2). 
𝑒𝑖
𝜋
2(𝐼𝑥+?̂?𝑥)𝑒−𝑖𝜋(2𝐼𝑦?̂?𝑦)𝑒−𝑖
𝜋
2(𝐼𝑥+?̂?𝑥) = 𝑒
[−𝑖𝜋𝑒
𝑖
𝜋
2(?̂?𝑥+?̂?𝑥)(2𝐼𝑦?̂?𝑦)𝑒
−𝑖
𝜋
2(?̂?𝑥+?̂?𝑥)]
= 𝑒
[−𝑖𝜋𝒆
𝒊
𝝅
𝟐(?̂?𝒙)𝑒
𝑖
𝜋
2(?̂?𝑥)(𝟐?̂?𝒚?̂?𝒚)𝒆
−𝒊
𝝅
𝟐(?̂?𝒙)𝑒
−𝑖
𝜋
2(?̂?𝑥)]
 
(6.11) 
Using equation (6.3) 
𝑒𝑖
𝜋
2
(𝐼𝑥)(2𝐼𝑦?̂?𝑦)𝑒
−𝑖
𝜋
2
(𝐼𝑥) = −𝑖[𝐼𝑥 , 2𝐼𝑦?̂?𝑦] = −𝑖𝑖[2𝐼𝑧?̂?𝑦] = [2𝐼𝑧?̂?𝑦] 
(6.12) 
Returning the answer to equation (6.11) 
 𝑒𝑖
𝜋
2
(?̂?𝑥)(2𝐼𝑧?̂?𝑦)𝑒
−𝑖
𝜋
2
(?̂?𝑥) = −𝑖[?̂?𝑥 , 2𝐼𝑧?̂?𝑦] = −𝑖𝑖[2𝐼𝑧?̂?𝑧] = [2𝐼𝑧?̂?𝑧] 
(6.13) 
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Thus 
𝑒
[−𝑖𝜋𝑒
𝑖
𝜋
2(?̂?𝑥)(2𝐼𝑦?̂?𝑦)𝑒
−𝑖
𝜋
2(?̂?𝑥)]
= 𝑒−𝑖𝜋(2𝐼𝑧?̂?𝑦) 
(6.14) 
𝑒
[−𝑖𝜋𝑒
𝑖
𝜋
2(?̂?𝑥)(2𝐼𝑧?̂?𝑦)𝑒
−𝑖
𝜋
2(?̂?𝑥)]
= 𝑒−𝑖𝜋(2𝐼𝑧?̂?𝑧) 
(6.15) 
Which leads to (6.11) being equal to 
𝑒−𝑖𝜋(2𝐼𝑦?̂?𝑦) = 𝑒−𝑖
𝜋
2(𝐼𝑥+?̂?𝑥)𝑒−𝑖𝜋(2𝐼𝑧?̂?𝑧)𝑒𝑖
𝜋
2(𝐼𝑥+?̂?𝑥) 
(6.16) 
An identical approach may be taken for 𝑒−𝑖𝜋(2𝐼𝑥?̂?𝑥) giving 
𝑒−𝑖𝜋(2𝐼𝑥?̂?𝑥) = 𝑒−𝑖
𝜋
2(𝐼𝑦+?̂?𝑦)𝒆𝒊
𝝅
𝟐(?̂?𝒚+?̂?𝒚)𝒆−𝒊𝝅(𝟐?̂?𝒙?̂?𝒙)𝒆−𝒊
𝝅
𝟐(?̂?𝒚+?̂?𝒚)𝑒𝑖
𝜋
2(𝐼𝑦+?̂?𝑦) 
(6.17) 
𝑒𝑖
𝜋
2(𝐼𝑦+?̂?𝑦)𝑒−𝑖𝜋(2𝐼𝑥?̂?𝑥)𝑒−𝑖
𝜋
2(𝐼𝑦+?̂?𝑦) = 𝑒
[−𝑖𝜋𝑒
𝑖
𝜋
2(?̂?𝑦+?̂?𝑦)(2𝐼𝑥?̂?𝑥)𝑒
−𝑖
𝜋
2(?̂?𝑦+?̂?𝑦)]
= 𝑒
[−𝑖𝜋𝒆
𝒊
𝝅
𝟐(?̂?𝒚)𝑒
𝑖
𝜋
2(?̂?𝑥)(𝟐?̂?𝒙?̂?𝒙)𝒆
−𝒊
𝝅
𝟐(?̂?𝒚)𝑒
−𝑖
𝜋
2(?̂?𝑦)]
 
(6.18) 
𝑒
[−𝑖𝜋𝑒
𝑖
𝜋
2(?̂?𝑥)(2𝐼𝑦?̂?𝑦)𝑒
−𝑖
𝜋
2(?̂?𝑥)]
= 𝑒𝑖𝜋(2𝐼𝑧?̂?𝑦) 
(6.19) 
𝑒
[−𝑖𝜋𝑒
𝑖
𝜋
2(?̂?𝑦)(2𝐼𝑧?̂?𝑥)𝑒
−𝑖
𝜋
2(?̂?𝑦)]
= 𝑒−𝑖𝜋(2𝐼𝑧?̂?𝑧) 
(6.20) 
𝑒−𝑖𝜋(2𝐼𝑥?̂?𝑥) = 𝑒−𝑖
𝜋
2(𝐼𝑦+?̂?𝑦)𝑒−𝑖𝜋(2𝐼𝑧?̂?𝑧)𝑒𝑖
𝜋
2(𝐼𝑦+?̂?𝑦) 
(6.21) 
This result in equation (6.9) being expanded to  
𝑒−𝑖𝜋(2𝐼𝑦?̂?𝑦+2𝐼𝑥?̂?𝑥) = 𝑒−𝑖
𝜋
2(𝐼𝑥+?̂?𝑥)𝑒−𝑖𝜋(2𝐼𝑧?̂?𝑧)𝒆𝒊
𝝅
𝟐(?̂?𝒙+?̂?𝒙)𝒆−𝒊
𝝅
𝟐(?̂?𝒚+?̂?𝒚)𝑒−𝑖𝜋(2𝐼𝑧?̂?𝑧)𝑒𝑖
𝜋
2(𝐼𝑦+?̂?𝑦) 
(6.22) 
Next we consider the middle two operators, which are expanded by adding operators that equal 1 before the 
two operators, (6.6). 
𝑒𝑖
𝜋
2(𝐼𝑥+?̂?𝑥)𝑒−𝑖
𝜋
2(𝐼𝑦+?̂?𝑦) = 𝑒−𝑖
𝜋
2(𝐼𝑦+?̂?𝑦)𝒆𝒊
𝝅
𝟐(?̂?𝒚+?̂?𝒚)𝒆𝒊
𝝅
𝟐(?̂?𝒙+?̂?𝒙)𝒆−𝒊
𝝅
𝟐(?̂?𝒚+?̂?𝒚) 
(6.23) 
In an equal approach to the manipulation of equation (6.11), the last part gives 
𝑒𝑖
𝜋
2(𝐼𝑦+?̂?𝑦)𝑒𝑖
𝜋
2(𝐼𝑥+?̂?𝑥)𝑒−𝑖
𝜋
2(𝐼𝑦+?̂?𝑦) = 𝑒
[𝑖
𝜋
2𝒆
𝒊
𝝅
𝟐
(?̂?𝒚)𝑒
𝑖
𝜋
2
(?̂?𝑦)(?̂?𝒙+?̂?𝒙)𝒆
−𝒊
𝝅
𝟐(?̂?𝒚)𝑒
−𝑖
𝜋
2(?̂?𝑦)]
 
(6.24) 
𝑒
[𝑖
𝜋
2𝑒
𝑖
𝜋
2
(?̂?𝑦)(𝐼𝑥+?̂?𝑥)𝑒
−𝑖
𝜋
2(?̂?𝑦)]
= 𝑒𝑖
𝜋
2(𝐼𝑧+?̂?𝑥) 
(6.25) 
𝑒
[𝑖
𝜋
2𝑒
𝑖
𝜋
2
(?̂?𝑦)(𝐼𝑧+?̂?𝑥)𝑒
−𝑖
𝜋
2(?̂?𝑦)]
= 𝑒𝑖
𝜋
2(𝐼𝑧+?̂?𝑧) 
(6.26) 
And thus 
𝑒𝑖
𝜋
2(𝐼𝑥+?̂?𝑥)𝑒−𝑖
𝜋
2(𝐼𝑦+?̂?𝑦) = 𝑒−𝑖
𝜋
2(𝐼𝑦+?̂?𝑦)𝑒𝑖
𝜋
2(𝐼𝑧+?̂?𝑧) 
(6.27) 
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This result in equation (6.9) being expanded to  
𝑒−𝑖𝜋(2𝐼𝑦?̂?𝑦+2𝐼𝑥?̂?𝑥) = 𝑒−𝑖
𝜋
2(𝐼𝑥+?̂?𝑥)𝑒−𝑖𝜋(2𝐼𝑧?̂?𝑧)𝑒−𝑖
𝜋
2(𝐼𝑦+?̂?𝑦)𝑒𝑖
𝜋
2(𝐼𝑧+?̂?𝑧)𝑒−𝑖𝜋(2𝐼𝑧?̂?𝑧)𝑒𝑖
𝜋
2(𝐼𝑦+?̂?𝑦) 
(6.28) 
Finally, operators that equal 1 are appended after the last operator of the sequence, (6.6). 
𝑒−𝑖
𝜋
2(𝐼𝑥+?̂?𝑥)𝑒−𝑖𝜋(2𝐼𝑧?̂?𝑧)𝑒−𝑖
𝜋
2(𝐼𝑦+?̂?𝑦)𝑒𝑖
𝜋
2(𝐼𝑧+?̂?𝑧)𝑒−𝑖𝜋(2𝐼𝑧?̂?𝑧)𝑒𝑖
𝜋
2(𝐼𝑦+?̂?𝑦)
= 𝑒−𝑖
𝜋
2(𝐼𝑥+?̂?𝑥)𝑒−𝑖𝜋(2𝐼𝑧?̂?𝑧)𝑒−𝑖
𝜋
2(𝐼𝑦+?̂?𝑦)𝒆𝒊
𝝅
𝟐(?̂?𝒛+?̂?𝒛)𝒆−𝒊𝝅(𝟐?̂?𝒛?̂?𝒛)𝒆𝒊
𝝅
𝟐(?̂?𝒚+?̂?𝒚)𝒆−𝒊
𝝅
𝟐(?̂?𝒛+?̂?𝒛)𝒆𝒊
𝝅
𝟐(?̂?𝒛+?̂?𝒛) 
(6.29) 
Where the last part is then considered 
𝑒𝑖
𝜋
2(𝐼𝑧+?̂?𝑧)𝑒−𝑖𝜋(2𝐼𝑧?̂?𝑧)𝑒𝑖
𝜋
2(𝐼𝑦+?̂?𝑦)𝑒−𝑖
𝜋
2(𝐼𝑧+?̂?𝑧)𝑒𝑖
𝜋
2(𝐼𝑧+?̂?𝑧)
= 𝑒−𝑖𝜋(2𝐼𝑧?̂?𝑧)𝒆𝒊
𝝅
𝟐(?̂?𝒛+?̂?𝒛)𝒆𝒊
𝝅
𝟐(?̂?𝒚+?̂?𝒚)𝒆−𝒊
𝝅
𝟐(?̂?𝒛+?̂?𝒛)𝑒𝑖
𝜋
2(𝐼𝑧+?̂?𝑧) 
(6.30) 
In an equal approach to the manipulation of equation (6.11), the middle part gives 
𝑒𝑖
𝜋
2(𝐼𝑧+?̂?𝑧)𝑒𝑖
𝜋
2(𝐼𝑦+?̂?𝑦)𝑒−𝑖
𝜋
2(𝐼𝑧+?̂?𝑧) = 𝑒
[𝑖
𝜋
2𝒆
𝒊
𝝅
𝟐
(?̂?𝒛)𝑒
𝑖
𝜋
2
(?̂?𝑧)(?̂?𝒚+?̂?𝒚)𝒆
−𝒊
𝝅
𝟐(?̂?𝒛)𝑒
−𝑖
𝜋
2(?̂?𝑧)]
 
(6.31) 
𝑒
[𝑖
𝜋
2𝑒
𝑖
𝜋
2
(?̂?𝑧)(𝐼𝑦+?̂?𝑦)𝑒
−𝑖
𝜋
2(?̂?𝑧)]
= 𝑒𝑖
𝜋
2(𝐼𝑥+?̂?𝑦) 
(6.32) 
𝑒
[𝑖
𝜋
2𝑒
𝑖
𝜋
2
(?̂?𝑧)(𝐼𝑥+?̂?𝑦)𝑒
−𝑖
𝜋
2(?̂?𝑧)]
= 𝑒𝑖
𝜋
2(𝐼𝑥+?̂?𝑥) 
(6.33) 
And thus 
𝑒−𝑖
𝜋
2
(𝐼𝑥+?̂?𝑥)𝑒−𝑖𝜋(2𝐼𝑧?̂?𝑧)𝑒−𝑖
𝜋
2(𝐼𝑦+?̂?𝑦)𝑒𝑖
𝜋
2
(𝐼𝑧+?̂?𝑧)𝑒−𝑖𝜋(2𝐼𝑧?̂?𝑧)𝑒𝑖
𝜋
2(𝐼𝑦+?̂?𝑦)𝑒−𝑖
𝜋
2
(𝐼𝑧+?̂?𝑧)𝑒𝑖
𝜋
2
(𝐼𝑧+?̂?𝑧)
= 𝑒−𝑖
𝜋
2
(𝐼𝑥+?̂?𝑥)𝑒−𝑖𝜋(2𝐼𝑧?̂?𝑧)𝑒−𝑖
𝜋
2(𝐼𝑦+?̂?𝑦)𝑒−𝑖𝜋(2𝐼𝑧?̂?𝑧)𝑒𝑖
𝜋
2
(𝐼𝑥+?̂?𝑥)𝑒𝑖
𝜋
2
(𝐼𝑧+?̂?𝑧) 
(6.34) 
The last z-operator constitutes a phase shift and may be ignored. 
Thus the full transformation is finished, as equation (6.9) has been transformed to equation (6.35). 
𝑒−𝑖𝜋(2𝐼𝑦?̂?𝑦+2𝐼𝑥?̂?𝑥) = 𝑒−𝑖
𝜋
2
(𝐼𝑥+?̂?𝑥)𝑒−𝑖𝜋(2𝐼𝑧?̂?𝑧)𝑒−𝑖
𝜋
2(𝐼𝑦+?̂?𝑦)𝑒−𝑖𝜋(2𝐼𝑧?̂?𝑧)𝑒𝑖
𝜋
2
(𝐼𝑥+?̂?𝑥) 
(6.35) 
 
 
 
 
 
  
  The DICONO program 
 
 
A-86 
A7. The DICONO program 
The author is not a programmer, nor a software developer. The scripts used were crude and might certainly 
be optimized. That being said the approach is sturdy, and time was allocated to increase efficiency and 
decrease the time of calculation for multiple input structures as well as a high degree of structure rotation. 
The workflow of the program is outlined below. The actual scripts are not included but are provided upon 
request. 
 
A7.1. Input 
Structures in the input format .pdb, .mol2 and .sdf are accepted, but only the two latter formats work as 
multistructure-files. The input files need the numbering from the 3D structures, but also include a name 
column for easier interpretation of data. Examples of the different inputs (NOE, J, RDC) are given in Table 
A7-1. 
The DICONO program 
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Table A7-1. Input format for the NOE (left), J-coupling constant (center) and RDC (right) calculations. Upper line is explanation and 
should not be included in actual scripts. NOE: Upper line is the reference line number which determinates the reference. From left: Names 
of H1 and H2, number in the 3D structure of H1 and H2, the intensity from PANIC or Macura or other, used (0 use, 1 ignore). J-coupling 
constant: From left: Names of H1 and H2, number in the 3D structure of H1, X1, X2 and H2, the experimental J-coupling constant in Hz 
and the type of coupling (1: NH-CH (Kaplus), 2: CH-CH (Karplus) or 3: CH-CH (HLA)). RDC: From left: Number in the 3D structure of 
X1, X2, and the experimental RDC in Hz. 
H1 H2 N 1 N 2 η Used 
36 
     
22 20b 45 44 0.01268 0 
22 18b 45 42 0.00298 0 
22 12 45 33 0.00363 1 
12 13 33 34 0.01276 0 
 
H1 H2 N 1 
(H) 
N 2 
(X) 
N 3 
(X) 
N 4 
(H) 
J Type 
8 13 30 8 13 34 10.5 3 
11a 12 32 11 12 33 8.3 3 
11b 12 31 11 12 33 3.2 3 
12 13 33 12 13 34 3.2 3 
 
N 1 N 2 D 
3 28 23.77 
22 45 0.74 
2 27 13.76 
1 26 26.57 
  
Correlate data to structure 
The input data is evaluated and groups need averaging, e.g. methyl groups are identified.  
Extract observables 
The distances, dihedrals and vectors are determined from the input data, for RDCs the structures are rotated. 
NOE distances 
The distances of the input data are extracted and converted to r-6. Distances relative to the reference distance 
are determined. Note that the reference distance is re-evaluated during the fitting procedure, and need not be 
a static distance. 
J-coupling constants 
Dihedrals are extracted and converted to J-coupling constants for all structures using either Karplus or the 
HLA equation. The participating groups and thus constants in the HLA equation are detected automatically if 
HLA is used. 
RDCs 
The implementation is described in Chapter 8 for the θ-method. 
Fitting 
The data was fitted by averaging the properties (distances, J-coupling constants, RDCs) of the structures, and 
by iteratively adding structures that best fit the data from the pool of structures, thus constructing a best fit 
average. The RMSD of NOEs and J-coupling constants and Q-factor of RDCs were used for evaluation of 
fit. 
 
Figure A7.1. Iterative fitting of strychnine, development of Q by 
addition of structures. 
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A8. Relevant reactions not shown in the thesis 
The relevant proposed reaction mechanisms for reactions of an alcohol to an carboxylic acid and reactions 
with an acid chloride  are found below.29,30 Note that two mechanisms have been proposed when using an 
alcohol as reactant.  
  
  
Correction of τc 
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A9. Correction of τc 
Below is given the data needed to calculate the dependence of the experimental T-ROE intensity of the offset 
of the transmitter. Calculated using the formula in Section 3.5 in the thesis. The difference is reduced 
significantly by correcting the data. If no correction was needed the data at different offsets would be 
identical. 
 
γB1: 5452 Hz     
       
 
δ(H1) δ(H2) ηNOE    
 
8.42 7.42 11.94 
   
 
3.43 5.46 14.61 
   
 
3.43 2.59 87.59 
   
 
3.43 1.7 22.05 
   
       
ωT: 2498.35 Hz      
 
ηT-ROE (ωH1- ωT) [Hz] (ωH2- ωT) [Hz] θ1 θ2 ηROE 
 
31.3 1711.65 1211.65 0.30 0.22 48.34 
 
25.25 -783.35 231.65 -0.14 0.04 36.27 
 
195.74 -783.35 -1203.35 -0.14 -0.22 297.69 
 
41.38 -783.35 -1648.35 -0.14 -0.29 59.42 
       
ωT: 3497.69 Hz      
 
ηT-ROE (ωH1- ωT) [Hz] (ωH2- ωT) [Hz] θ1 θ2 ηROE 
 
28.96 712.31 212.31 0.13 0.04 45.86 
 
25.80 -1782.69 -767.69 -0.32 -0.14 36.28 
 
209.91 -1782.69 -2202.69 -0.32 -0.38 306.90 
 
42.99 -1782.69 -2647.69 -0.32 -0.45 59.10 
       
 
Corrected 
  
Uncorrected 
  
 
ηROE(2498 Hz) ηROE(3498 Hz) Diff [%] ηROE(2498 Hz) ηROE(3498 Hz) Diff [%] 
 
48.34 45.86 5.4 50.66 45.98 10.2 
 
36.27 36.28 0.0 35.89 36.99 -3.0 
 
297.69 306.90 -3.0 303.89 332.23 -8.5 
 
59.42 59.10 0.5 60.71 63.93 -5.0 
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ABSTRACT: Natural, nonribosomal cyclotetrapeptides have
traditionally been a rich source of inspiration for design of
potent histone deacetylase (HDAC) inhibitors. We recently
disclosed the total synthesis and full HDAC proﬁling of the
naturally occurring azumamides (J. Med. Chem. 2013, 56,
6512). In this work, we investigate the structural requirements
for potent HDAC inhibition by macrocyclic peptides using the
azumamides along with a series of unnatural analogues
obtained through chemical synthesis. By solving solution
NMR structures of selected macrocycles and combining these
ﬁndings with molecular modeling, we pinpoint crucial enzyme−ligand interactions required for potent inhibition of HDAC3.
Docking of additional natural products conﬁrmed these features to be generally important. Combined with the structural
conservation across HDACs 1−3, this suggests that while cyclotetrapeptides have provided potent and class-selective HDAC
inhibitors, it will be challenging to distinguish between the three major class I deacetylases using these chemotypes.
■ INTRODUCTION
Histone deacetylase (HDAC) enzymes are a group of
epigenetic modulators which catalyze the removal of ε-N-
acetylated lysine residues found in the N-terminal tails of
histone proteins.1 Furthermore, recent results have shown that
HDACs also regulate acetylation levels of a long list of
nonhistone proteins2 and may even target ε-N-acyllysine
modiﬁcations other than acetyl groups.3−7 Aberrant HDAC
expression has been associated with various types of cancer, and
these enzymes have therefore been targets in the development
of anticancer drugs.8 Thus far, two HDAC inhibitors have been
approved for clinical managing of cutaneous T-cell lymphoma
(19 and 210), several compounds are in clinical trials for
treatment of a variety of additional cancers,8 and HDAC
inhibitors have shown promise in connection with several
neurodegenerative disorders,11 memory,12 and HIV.13 Humans
have 18 HDAC enzymes, of which 11 are Zn2+-dependent
(class I: HDACs 1−3 and 8; class IIa: HDACs 4, 5, 7, and 9;
class IIb: HDACs 6 and 10; and class IV: HDAC11)14 and
seven are NAD+-dependent (class III: sirtuins 1−7).15 Because
of the rich biology aﬀected by these enzymes, there has been a
keen interest in trying to develop isoform-selective inhibitors as
chemical probes to explore these biological eﬀects in detail and
possibly to aid the development of improved therapeutic
candidates.
Small molecules exhibiting class selectivity have been
discovered, but few truly isoform-selective compounds have
surfaced,16 which may, in part, be due to the high sequence
similarity between active sites across the family of Zn2+-
dependent HDAC enzymes.14 It has therefore been suggested
that interaction with the protein surface surrounding the
entrance to the active site, which intrinsically recognizes the
acetylated protein substrate, may be favorable for achieving
selectivity.17 The cyclic depsipeptide (e.g., 2) and cyclic
tetrapeptide HDAC inihbitors (e.g., 3−5) have the ability to
interact with a signiﬁcant part of the surface area and due to
their macrocyclic nature adopt well-deﬁned three-dimensional
display of side chain functionalities. In general, macrocyclic
peptides are less susceptible to both endo- and exoproteases
than linear peptides, and historically, this class of compounds
has delivered several successful drugs such as gramicidin S,
cyclosporin A, and polymyxin.18 Peptide macrocycles have also
proven important in the HDAC ﬁeld as one of the two
currently approved drugs is the macrocyclic depsipeptide,
romidepsin (2).10 Furthermore, the ﬁrst isolations of
mammalian HDAC enzymes were achieved by using a synthetic
analogue of the cyclic tetrapeptide natural product trapoxin (3),
which enabled aﬃnity matrix pull-down of histone deacetylase
proteins from bovine thymus and human Jurkat cell lysate.19
Moreover, we found cyclopeptide HDAC inhibitors
interesting, because several examples exhibit high inhibitory
potencies without containing a strong Zn2+-binding group,20 as
for example apicidin (4)21 and the azumamides (5).22−24
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Previously, manipulation of the structures of natural cyclo-
tetrapeptides through chemical synthesis have revealed insights
into mode of binding23,25 and structure−activity relation-
ships16,17 and resulted in novel selectivity proﬁles.26,27 For these
reasons, we have chosen to explore the azumamide scaﬀold in
detail, which we envisioned could lead to a fundamental
understanding of the requirements for potent HDAC inhibition
by cyclopeptides and ultimately provide guidelines for future
design of macrocyclic HDAC inhibitors.
We recently reported the total syntheses of all ﬁve natural
azumamides as well as their proﬁling against the full panel of
recombinant human HDACs 1−11.24 In said study, we
observed a detrimental eﬀect on inhibitory potency when
changing the stereochemistry of either chiral center in the β-
amino acid residue (gray shading in Figure 1a). Although this
drastic eﬀect was not particularly surprising when changing the
stereochemistry of the extended Zn2+-binding side chain, which
must be projected into the active site, the importance of the
stereochemistry of the methyl group was less predictable.
Because a profound understanding of ligand−enzyme inter-
actions could be of value for future inhibitor design eﬀorts, we
decided to address the eﬀect of this methyl group in detail. In
addition to the natural products, we therefore prepared versions
with desmethyl and dimethyl modiﬁcation at the β2-position in
our compound series (6a−9c, Figure 1b). We also incorporated
diﬀerent naturally occurring residues at the aromatic amino acid
position, to include phenyl (a series) (trapoxins and
azumamides A, D, and E), phenol (b series) (azumamides B
and C), and indole (c series) (apicidins). The unsaturation in
the extended side chain was addressed by including a trans-
oleﬁn version as found in romidepsin (2) as well as in another
potent macrocyclic HDAC inhibitor largazole28 (side chain
highlighted by orange shading in Figure 1b). Finally, the
saturated version mimicking the linkers of trapoxins and
apicidins was also included (7a−c).
■ RESULTS
Chemistry. Each series of compounds 6a−9c required two
key synthetic challenges to be tackled, namely preparation of an
appropriate β-amino acid building block and macrocyclization
of linear intermediates to give the ﬁnal compounds. Preparation
of β-amino acid building blocks for synthesis of 6a−c and 7a−c
were prepared from commercially available Boc-L-Asp-OtBu
(10) using chemistry adapted from a literature procedure.29
The α-carboxylate of 10 was reduced to the corresponding
alcohol and subsequently oxidized under Swern conditions to
give an aldehyde, which was immediately subjected to a Wittig
reaction to produce alkene 11 (Figure 2a). Installation of the
desired side chain by cross-metathesis to give 12 was optimized
by investigating a selection of catalysts (Figure 2b). We
included a modiﬁed Hoveyda−Grubbs catalyst, which contains
a nitro substituent on the isopropoxybenzylidene ligand,
developed by Grela and co-workers,30 as this catalyst was
previously applied in a transformation similar to ours in a total
synthesis of largazole.31 In addition to the Grela catalyst (Figure
2b, entry 7), we also included the commercially available Zhan’s
catalyst 1-B (Figure 2b, entry 6), which contains a sulfonamide
as electron-withdrawing group in the same position. Com-
parable yields were obtained using Zhan 1-B, Grubbs second-
generation, and Hoveyda−Grubbs second-generation catalysts
(Figure 2b), and it was decided to apply 10 mol % Hoveyda−
Grubbs second-generation catalyst to aﬀord the desired trans-
oleﬁn in 67% yield. Acidic deprotection followed by Boc
protection of the amino functionality gave the desired building
block 13, and subsequent hydrogenation aﬀorded the second β-
amino acid building block 14 (Figure 2a).
The building block, employed for the synthesis of the
dimethylated analogues (8a−c), was prepared using conditions
recently applied in total syntheses of the azumamides.24
Analogous to the reported protocol, diastereoselective Ell-
man-type Mannich reaction between 15 (S-auxiliary) and 16
aﬀorded the desired R-isomer (17) in 58% isolated yield (dr =
77:23) as shown in Figure 2c. The absolute stereochemistry
was determined by X-ray crystallography upon desilylation with
Bu4NF to give 18. The alcohol was then elaborated to give the
Boc-protected β-amino acid 20 in 16% overall yield after just
four chromatographic steps (Figure 2c). Desmethyl-β-amino
acids 27 (Boc protected) and 28 (Fmoc protected) were
prepared by a similar route (Figure 2e), except the (R)-auxiliary
was required to give the desired stereochemistry (Figure 2d).
This selectivity is in agreement with Ellman’s original results as
well as the proposed Zimmerman−Traxler-type transition state,
where coordination to titanium is essential for the high
diastereoselectivity. This was further supported by the reversed
diastereoselectivity observed when substituting the additive to
HMPA, which sequesters lithium ions and thus hampers
coordination (Figure 2d, entries 2 and 3). Because of the lower
diastereoselectivity combined with diﬃculties in separation of
the tert-butyl ester isomers, we chose the conditions shown in
entry 1 (Figure 2d) to give 23, which was then trans-esteriﬁed
to give the desired tert-butyl ester 24 (Figure 2e). Desilylation
Figure 1. Structures of representative HDAC inhibitors (a) and target
compounds (b).
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to give 25 again enabled establishment of the absolute
stereochemistry by X-ray crystallography and elaboration of
this intermediate provided both the Boc- and Fmoc-protected
β-amino acids 27 and 28, respectively (Figure 2e).
All building blocks were incorporated into solid supported
linear tetrapeptides, which were cleaved, cyclized using HATU
under dilute conditions (0.3−0.8 mM in N,N-dimethylforma-
mide),24,27,32 and saponiﬁed to give the target compounds 6a−
9c in 2−22% isolated yields (Supporting Information, Figure
S2). We attribute these yields to two shortcomings in
particular; ﬁrst, the point of cyclization had previously been
shown to have an eﬀect on macrolactamization yield in a model
system,24 so synthesis of compound 7c was attempted by
cyclizing between the β-amino acid and D-valine (Supporting
Figure 2. Building block syntheses. (a) Preparation of building blocks 13 and 14 from aspartic acid. (b) Optimization of the cross-metathesis
reaction to give intermediate 12. (c) Preparation of dimethylated building block 20 using previously developed Mannich conditions. (d)
Optimization of the Mannich reaction to give desmethylated building blocks. aCumulative yield of both diastereomers. bDetermined by X-ray
crystallography upon deprotection and re-esteriﬁcation as tert-butyl ester. cDetermined by comparison of NMR spectra to those of the compound
from entry 1 (Supporting Information, Figure S1). (e) Preparation of desmethylated building blocks 27 and 28. Reagents and conditions: (a) N-
Methylmorpholine (1 equiv), isobutyl chloroformate (1 equiv), NaBH4 (3 equiv), MeOH, THF, −30 °C → rt, 160 min; (b) oxalyl chloride (1.7
equiv), DMSO (3.3 equiv), Et3N (5 equiv), CH2Cl2, −78 °C → −40 °C → rt, 2 h; (c) PPh3CH3Br (2.2 equiv), KHMDS (0.5 M in toluene) (2.1
equiv), THF, −78 °C→ rt, 4 h; (d) methyl 5-hexenoate (3 equiv), Hoveyda−Grubbs II catalyst (0.1 equiv), CH2Cl2, 40 °C, 24 h; (e) TFA−CH2Cl2
(1:3), 2 h; ( f) Boc2O (1.3 equiv), i-Pr2NEt (2.6 equiv), CH2Cl2; (g) H2, Pd/C (10 wt %, 0.1 equiv), THF, 19 h; (h) LDA (2.6 equiv), 16 (2.5
equiv), TiCl(OiPr)3 (4.5 equiv), THF, −78 °C, 30 min; then 15, −78 °C, 20 min; (i) AcOH (1 equiv), Bu4NF (2 equiv), THF, 0 °C→ rt, 45 min;
(j) NaHCO3 (1.5 equiv), Dess−Martin periodinane (1.5 equiv), CH2Cl2, 0 °C→ rt, 1 h; (k) KHMDS (1.9 equiv), Ph3PBr(CH2)3CO2Et, (2 equiv),
THF, −78 °C→ rt, 16 h; (l) TFA−CH2Cl2 (1:1, 10 mL, 120−190 equiv), 0 °C→ rt, 2 h; (m) HCl (4 M in dioxane, 1.8−2.5 equiv), dioxane, 1−3
h; (n) i-Pr2NEt (4 equiv), Boc2O (2 equiv), CH2Cl2, 20 h; (o) LDA (2.1 equiv), 22 (2 equiv), TiCl(O
iPr)3 (4.2 equiv), THF, −78 °C, 30 min, then
21, −78 °C, 20 min; (p) LiOH (4.5 equiv), THF−water, 17 h; (q) Boc2O (1.4 equiv), DMAP (0.3 equiv), tert-butanol, 16 h, then Boc2O (0.3
equiv), 15 h; (r) Na2CO (4 equiv), FmocOSu (1.2 equiv) water−dioxane (5:1, 6 mL), 0 °C → rt, 45 min. ND = not determined.
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Information, Figure S3). Cyclization with the less hindered and
more ﬂexible β-amino acid at the C-terminal aﬀorded a
signiﬁcant increase in isolated yield of 7 (48%, 12 steps),
underscoring the importance of point-of-cyclization. Second,
we previously demonstrated that puriﬁcation by reversed-phase
high performance liquid chromatography (RP-HPLC) fur-
nished lower yields than column chromatography (normal-
phase), albeit at the expense of compound purity,24 and
therefore envision that future syntheses of this class of
compounds may beneﬁt from puriﬁcation by normal-phase
preparative HPLC.
HDAC Proﬁling. Initially, two-dose experiments were
performed against selected class IIa enzymes (HDAC4 and
HDAC7) because the natural products had proven ineﬀective
against this class (Supporting Information, Table S1a). Also,
the dimethylated compounds (8a−c) were tested against
representative enzymes from all classes at two doses to
determine whether a full dose−response characterization was
warranted (Supporting Information, Table S1b). These experi-
ments showed poor inhibitory activities of all compounds
against HDACs 4 and 7 and furthermore showed that the
dimethylated compounds were ineﬀective against HDACs from
all classes. Thus, IC50 values were determined by full dose−
response proﬁling of compounds 6a−c, 7a−c, and 9a−c on
HDACs 1−3, 6, 8, 10, and 11 (Supporting Information, Figure
S4). Determination of Ki values was then performed using the
Cheng−Prusoﬀ equation [Ki = IC50/(1 + [S]/Km)] under the
assumption that all compounds obey a standard fast-on−fast-oﬀ
mechanism of inhibition as recently demonstrated for
azumamide C33 (Table 1).
In general, the desmethylated analogues exhibited signiﬁ-
cantly decreased activities against HDACs 1−3, 10, and 11 as
compared to the corresponding natural products containing the
same aromatic amino acid (6a, 7a, and 9a vs 5e as well as 6b,
7b, and 9b vs 5c). Interestingly, lack of this methyl group did
not aﬀect the potencies against HDACs 6 and 8, for which
signiﬁcantly higher Ki values were recorded for both natural
products and desmethylated analogues. The greatest diﬀerence
was observed on HDAC3, where 6a displayed a 56-fold
reduction in activity compared to azumamide E (5e). Generally
the trans-oleﬁn-containing analogues (6a−c) exhibited slightly
lower potencies (∼2-fold) than compounds containing the
other two types of extended side chain (i.e., cis-oleﬁn or
saturated hydrocarbon). The two latter-mentioned side chains,
on the other hand, furnished indistinguishable activities. The
tyrosine- and tryptophan-containing compounds were ∼2−3-
fold more potent against HDACs 1−3, 10, and 11 than the
corresponding phenylalanine analogues. In contrast, all Tyr-
containing compounds failed to inhibit HDAC8 at concen-
tration up to 20 μM, whereas the Phe- and Trp-containing
compounds displayed similar Ki values between 3−6 μM.
However, because all compounds were relatively poor
inhibitors of HDAC8 as compared to other class I HDACs
(1−3), we decided not to pursue this eﬀect further in the
present study.
Overall, the collective HDAC proﬁling data revealed only
minor eﬀects of the choice of aromatic residue or β3-side chain
identity, generally within an order of magnitude. On the other
hand, proﬁling data emphasized sensitivity of the β2-position to
modiﬁcation.
NMR Spectroscopy. To rationalize the proﬁling data and
gain a deeper understanding of the structural requirements for
potent HDAC inhibition, we solved the solution structures of
selected compounds by nuclear magnetic resonance (NMR)
spectroscopy combined with molecular modeling. As minute
changes in side chain topology are well-known to aﬀect
conformational space of small cyclic peptides,35,36 we suspected
that the dramatic changes in biochemical activity might be a
result of remodeling the cyclic core of these molecules. Solving
the 3D structures by NMR spectroscopy should allow us to
Table 1. Inhibition of Recombinant Human Histone Deacetylases (HDACs)a
Ki (μM)
class I class IIb class IV
compound HDAC1 HDAC2 HDAC3b HDAC8 HDAC6 HDAC10 HDAC11
6a 1.2 ± 0.3 1.7 ± 0.04 1.4 ± 0.3 6 ± 2.7 I.A.c 1.6 ± 0.03 3.2 ± 0.5
6b 0.7 ± 0.2 0.6 ± 0.3 0.5 ± 0.2 I.A.c 2.2 ± 0.8 0.7 ± 0.03 1.3 ± 0.4
6c 0.5 ± 0.06 0.4 ± 0.3 0.6 ± 0.4 3 ± 1.6 3.7 ± 0.3 0.6 ± 0.06 1.1 ± 0.5
7a 0.9 ± 0.4 0.8 ± 0.1 0.7 ± 0.2 IAc IAc 1 ± 0.2 2 ± 1.1
7b 1 ± 0.6 0.3 ± 0.2 0.2 ± 0.1 IAc 3 ± 2 0.3 ± 0.2 1 ± 0.7
7c 0.9 ± 0.01 0.3 ± 0.02 0.5 ± 0.2 4.3 ± 0.9 1.9 ± 0.3 0.17 ± 0.03 0.3 ± 0.01
9a 0.6 ± 0.2 0.9 ± 0.002 0.8 ± 0.1 IAc IAc 0.7 ± 0.003 1.5 ± 0.2
9b 0.3 ± 0.2 0.3 ± 0.2 0.3 ± 0.25 IAc 6 ± 0.6 0.3 ± 0.02 0.8 ± 0.3
9c 0.2 ± 0.1 0.3 ± 0.2 0.5 ± 0.1 4.5 ± 0.5 IAc 0.23 ± 0.09 0.9 ± 0.6
SAHA (1) 0.008 0.007 0.012 0.7 0.022 0.04 0.013
apicidin (4a)34 0.04 nM 0.12 nM 0.26 nM 0.049
AzuC (5c)24 0.032 0.04 0.014 >5 2 0.01 0.035
AzuE (5e)24 0.067 0.05 0.025 4.4 >5 0.02 0.06
epi-AzuE (36)24 IA IA IA IA IA IA IA
aIC50 values were determined from at least two individual dose−response experiments performed in duplicate, and Ki values were calculated based
on the Cheng−Prusoﬀ equation. Values are given in μM unless otherwise noted. bIn complex with the deacetylase activation domain (DAD) of
nuclear receptor corepressor (NCoR1). cIA denotes compounds that were “inactive” according to a criterium of exhibiting less than 50% inhibition
at 20 μM. Ki values were not determined for these inhibitor−enzyme combinations due to limited solubility of the ligands at higher concentrations.
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determine whether such conformational changes were respon-
sible for the signiﬁcant drop in potency observed when altering
the substitution pattern or stereochemistry of the 2-position in
the β-amino acid residue.
The compounds chosen for investigation by NMR were
azumamide A (5a), desmethylated azumamide C (9b), and the
β2-epimer of azumamide E (36; Figure 3a), which was
previously synthesized and reported to exhibit less than 50%
inhibition across the full panel of HDACs at 50 μM inhibitor
concentrations.24 Azumamide A (5a) was chosen for structure
determination over azumamide E (5e) due to more well-
resolved NMR data, although compound 5a is less potent on
account of its weak carboxamide Zn2+-binding group.20 It can
be assumed that this slight structural diﬀerence far away from
the backbone would not inﬂuence the conformation in solution
signiﬁcantly,38 and thus, compound 5a should provide a
representative three-dimensional structure of the natural
products that contain the same macrocycle. Unfortunately,
attempts to obtain NMR spectra in D2O to better simulate the
environment in biological assays were hampered by low
solubility even after addition of up to 15% (v/v) DMSO-d6;
however, subsequent molecular dynamics (MD) simulations in
DMSO and water did not show any major diﬀerences in
conformational space (vide infra). Minor slowly exchanging
conformations were indicated in all spectra, presumably due to
a cis-amide between D-Ala and D-Phe/D-Tyr/D-Trp in agree-
ment with an NOE between H12 and H21 in azumamide A. The
3D structures of these minor conformations were not
determined for any of the compounds due to low signal-to-
noise ratios.
Interproton distances were established using the isolated
spin-pair approximation (ISPA)39,40 and J-couplings were
obtained from proton 1D and DQF-COSY spectra acquired
in DMSO-d6 (Supporting Information, Tables S2−S11). The
conformation of each analogue that best ﬁt the NMR data was
obtained from unrestrained MD simulation in explicit water,
and these structures show negligible diﬀerences in the peptide
backbone (Figure 3b−d) in accordance with comparable J-
couplings as well as the relative nuclear Overhauser eﬀect
(NOE) and rotating-frame nuclear Overhauser eﬀect (ROE).
The structure of compound 5a was essentially the same as the
previously reported NMR structure of azumamide E (5e)
determined in DMSO,37 except for rotation of the amide
between D-Ala and D-Phe (gray and purple structures in Figure
3b). We therefore determined an NOE/ROE-restrained NMR
structure (cyan structure in Figure 3b), which resembled the
previously reported structure of azumamde E but exhibited
inferior overall ﬁt to our NMR data compared to the
unrestrained structure (Supporting Information, Tables S12
and S13). We attribute this to conformational averaging that
favor short distances and hence amplify the importance of the
NH(2)−H21 NOE. Overlaying the conformations that ﬁt the
NMR data best revealed that only one in 20 of these placed the
NH(2) proton in the opposite direction compared to our
unrestrained structure (Supporting Information, Figure S5a).
This strongly suggests that our NOE-restrained structure does
not represent the preferred solution conformation adequately.
In conclusion, on the basis of the high-resolution backbone
structures (RMSDs 0.32−0.36 Å), the removal or inversion of
the β2-methyl group is not likely to cause the observed drop in
biochemical activity by inducing conformational changes of the
macrocycle. The only major diﬀerences observed between the
NMR structures were the orientations of the more ﬂexible β3-
side chain as illustrated by the dihedral angle between H3−C3−
C4−C5 in Figure 3e (for ensembles, see Supporting
Information, Figure S5a). To investigate whether the
preference of this side chain projection in three-dimensional
space could explain the large diﬀerences in HDACi potencies,
we therefore performed computational studies including
molecular dynamics calculations on the macrocycles in solution
and docking to the recently reported HDAC3:SMRT X-ray
crystal structures.41
Molecular Dynamics Simulations of Macrocycles. Side
chain and backbone conformational preferences of azumamides
(azumamide E (5e), desmethyl azumamide E (9a), β2-epi-
azumamide E (36), and dimethyl azumamide E (8a)) were
addressed by performing molecular dynamics (MD) simu-
lations in both water (TIP3P) and DMSO (Supporting
Information, Methods). We measured the dihedral angles
Figure 3. NMR solution structures and dihedral angles. (a) Chemical
structure of compound 36 with numbering used for NMR assign-
ments. (b) Overlay of azumamide E (5e) from the literature
(purple),37 azumamide A (5a) from unrestricted simulation (gray),
and azumamide A from NOE-restricted simulation (cyan); RMSD =
0.358 Å for the reported NMR structure and our unrestricted
azumamide A structure. (c) Overlay of azumamide A (5a; gray) with
desmethyl compound 9b (green), RMSD = 0.318 Å. (d) Overlay of
azumamide A (5a; gray) with β2-epi-azumamide E (36; yellow),
RMSD = 0.324 Å. (e) Orientation of the β3-side chain for 5a, 9b, and
36. Dihedral angles between H3−C3−C4−C5 that ﬁt the NMR data
best are shown as blue lines, and red lines represent the full MD data
set (2500 conformations). RMSD = root-mean-square deviation (for
all backbone atoms in structural overlays prepared using the “pair-ﬁt”
command in MacPyMOL, Schrödinger Inc.).
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H−C3−N−H, H−C12−N−H, H−C21−N−H, and H−C24−N−
H, which determine the orientation of the four backbone NH
vectors, and histograms shown in Supporting Information,
Figure S6−S9 revealed excellent agreement with the NMR data
for both water and DMSO simulations. The rotation of the
valine side chain (iPr), given by the dihedral angle H24−C24−
C25−H25 (Supporting Information, Figures S5b and S10), and
the phenylalanine side chain, deﬁned by the H12−C12−C13−C14
dihedral angle (Supporting Information, Figure S5c and S11),
were also investigated. Finally, projection of the extended β3-
amino acid side chain, deﬁned by the H3−C3−C4−C5 dihedral
angle, was determined from 250 ns MD simulations in water
and DMSO for azumamide E (5e), desmethyl azumamide E
(9a), β2-epi-azumamide E (36), and dimethyl azumamide E
(8a) as shown in Supporting Information, Figure S12. For
azumamide E (5e), the major populations were 60 ± 20° (55%
of simulation time), −50 ± 20° (33%), and −150 ± 20° (6%)
placing the C4−C5 vector projections trans to the β2-methyl
group in the two major populations, and cis in the smallest
population, which may be explained by steric congestion of the
methyl group. This distribution was in agreement with the
NMR solution structure of azumamide A (5a; Figure 3e),
which is identically substituted on the macrocycle (vide supra).
Docking. HDAC3 was chosen for docking studies because
the available high-resolution X-ray crystal structure of HDAC3
is a complex with its corepressor,41 and inhibition of HDAC
activity has been shown to vary between free and complexed
enzymes.42 Docking into HDAC3A and HDAC3B were
performed using Glide (Supporting Information, Methods
and Table S14). The docked structure of azumamide E in
HDAC3B (Figure 4a and Supporting Information, Figure S13)
showed typical features shared by a homogeneous group of
poses where the backbone carbonyl oxygen atoms were
exposed to solvent and the backbone amide hydrogens were
Figure 4. Computational results and illustrations. (a) Glide pose for azumamide E docked into the HDAC3B enzyme (PDB ID: 4A69). Azumamides
are shown in ball and stick representation, enzyme residues within 6 Å are shown in tube representation beneath a partially transparent gray surface,
and the remaining protein surface is in cyan (additional poses including azumamide E analogues are shown in Supporting Information, Figure S13
and S14). (b) Ovelay of docking poses for azumamide E (5e, purple) and β2-epi-azumamide E (36; yellow) shown as sticks. The proteins are shown
in gray scale in cartoon format with Asp93 and Phe200 side chains highlighted as sticks. (c) Prime/MMGBSA binding free energies (dG) and energy
decomposition for Embrace-optimized geometries for complexes of the azumamide E (AzuE) analogues and HDAC3B. Values are in kcal/mol based
on “frozen receptor and frozen ligand” (see Supporting Information, Table S16 for details). (d) Truncated “large” models of docked complexes of
HDAC3B and azumamide E and analogues used for DFT calculations of the interaction energy between Phe200 and the azumamide β2-position.
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directed toward the carboxylate side chain of Asp93 in HDAC3.
The resulting hydrogen bonds appear to play a key role in
favorable positioning of the macrocycles for additional
interactions with HDAC3. Most importantly, the β3-side
chain was located inside the tunnel leading to the HDAC
active site and the carboxylate moiety formed a bidentate
interaction with the Zn2+ ion. The rotation of the β3-side chain
relative to the azumamide macrocycles, described by the H3−
C3−C4−C5 dihedral angles, were either ∼180 ± 20° or ∼60 ±
20° except for the complex of azumamide E:HDAC3A where it
was ∼110° (Supporting Information, Table S14). This is
diﬀerent from the preferred conformations of this side chain
observed by both NMR analysis (Figure 3e) and MD
simulations (Supporting Information, Figure S12), suggesting
that the inherently preferred projection of this side chain in
solution does not aﬀect binding aﬃnity signiﬁcantly.
The azumamide valine side chain (iPr) was solvent exposed,
and its rotation was unhindered by HDAC residues. The
aromatic phenylalanine (tyrosine in azumamide C analogues)
side chain was associated with the part of the binding pocket
surface comprised of His22 and Pro23. The orientation of the
aromatic ring described by the dihedral angle H12−C12−C13−
C14 varied from −48° to −97°, rendering it partially buried
between the azumamide core and the HDAC surface. The
docked side chain orientations agree with one of the two
populations (H12−C12−C13−C14 = −50°) that were obtained
by MD simulation of the unbound azumamide E analogues in
explicit water (Supporting Information, Figure S11) and
conﬁrmed by NMR analysis (Supporting Information, Figure
S5c). The additional orientation indicated by NMR (∼60°) was
prohibited in docked complexes due to collision with Leu266
and Pro23.
The azumamide β2-position was located in close proximity to
Phe200 in HDAC3, and substitutions at this position therefore
aﬀect the interaction with Phe200, giving rise to diﬀerent poses
(Supporting Information, Figure S14). To examine if the
observed displacements were artifacts of the rigid-receptor
assumption in Glide, we performed postdocking minimization
of the Glide poses with Embrace, allowing relaxation of both
receptor and ligand. The Embrace-optimized poses again
showed substrate dislocations away from the Phe200 side
chain for β2-epi-azumamide (36) and dimethyl azumamide (8a)
but negligible displacements for azumamide E (5e) and
desmethyl azumamide E (9a) (Figure 4b, Supporting
Information, Figure S14 and Table S15). We then proceeded
to estimate the binding energies for the azumamide E analogues
based on the poses generated with Embrace. As the Glide
docking score (XPGscore) is not suitable for quantitative
binding free energy estimation, showing errors up to ∼4 kcal/
mol (http://www.schrodinger.com/kb/793), we estimated
binding free energies (dG_Bind) with Prime/MMGBSA
calculations on the Embrace-optimized complexes (Supporting
Information, Table S16). As shown in Figure 4c, the values of
dG_Bind were in semiquantitative agreement with experimen-
tal inhibition constants and the decomposition into free energy
components showed meaningful trends. For example, the
dG_bind “packing” term (for π−π interactions) quantiﬁed the
observations from the docked structures to give the ordering
azumamide E (5e) < des-Me-azumamide E (9a) ≈ β2-epi-
azumamide E (36) < di-Me-azumamide E (8a), which was in
agreement with biochemical potencies.
Examination of β2−Phe200 Interactions by DFT
Calculations. Because of the pivotal role of substitution at
the β2-position, we then examined the interaction between
Phe200 and the β2-substitution in azumamide E and analogues
using DFT calculations on “small” and “large” model systems
obtained by truncation of the Embrace-optimized complexes
(see Methods section for details). The DFT energies showed
that the Phe200−β2-position interaction was always favorable
and varied signiﬁcantly upon substitution at the β2-position
(Supporting Information, Table S17). Omitting the empirical
dispersion correction gave mainly positive interaction energies,
conﬁrming the dispersive origin of the attraction as reported for
ab initio studies on CH−π interactions.43 The “large” model
systems (shown in Figure 4d) revealed Phe200−β2-carbon
distances for azumamide E (5e) and desmethyl azumamide E
(9a) of 4.0 and 3.9 Å, respectively, which is in agreement with
attractive interactions between CH−π centers reported for
high-resolution crystal structures (peaked at 4.2 Å).44 Addi-
tional stabilization for azumamide E could be explained by
placement of the β2-methyl group above the center of the
Phe200 ring (distance 3.7 Å). The β2-carbon atoms of β2-epi-
azumamide (36) and dimethyl azumamide (8a), on the other
hand, were again substantially displaced from the center of
phenyl group (5.2 and 5.0 Å, respectively), preventing
dispersive interactions with the β2-carbon. Whereas distances
of their methyl substituents were within a range allowing for
dispersive interactions (3.9 and 4.3 Å), the overall DFT
interaction energies were less favorable for these models
(Figure 4d).
Largazole:HDAC8 Cocrystal and other Class I HDAC
Crystal Structures. The docked poses were compared to the
crystal structure of the complex between HDAC8 and largazole
(PDB ID: 3RQD),45 which is the only available X-ray crystal
structure of a macrocyclic inhibitor in complex with an HDAC
enzyme. This revealed a number of similarities, with the
macrocycle arranged at the rim of the binding site and the
amide hydrogen atoms of largazole facing Asp101 in the
protein (analogous to Asp93 in HDAC3). After structural
superposition, the Asp101 backbone in HDAC8 coincided with
that of Asp93 in HDAC3, although the side chain was
diﬀerently oriented and formed only one hydrogen bond with a
backbone NH in largazole.45 Thus, a lack of robust interaction
between backbone NH groups and Asp101 seems to contribute
signiﬁcantly to the poor inhibitory activities of cyclopeptides
against HDAC8, which is supported by the existence of
HDAC8 crystal structures that show substantial disorder in the
loop region harboring Asp101 (PDB ID: 3SFF).46 Docking of
azumamides into this HDAC8 structure failed while docking
into the intact structure (PDB ID: 3RQD)45 furnished poses
where the azumamide ring was arranged approximately as in
the HDAC3 dockings, albeit with perturbed backbone amide
dihedral angles. Alignment of HDAC1−3 X-ray crystal
structures, on the other hand, showed very similar geometries
in the region containing this Asp residue (Supporting
Information, Figure S15), in agreement with the strong
HDAC inhibitory potencies recorded against these isozymes.
To brieﬂy address whether the interactions uncovered in this
work are generally important, we also docked largazole and
apicidin into HDAC3A and B and the obtained poses indeed
showed similar geometry and hydrogen bonding interactions
with the Asp93 residue as found to be important for
azumamide binding (Supporting Information, Methods and
Figure S16).
Finally, the natural product romidepsin (2) was docked into
HDAC3B as shown in Supporting Information, Figure S17 to
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test whether the requirements determined for binding of
azumamides would apply to this FDA approved drug. As
romidepsin lacks a substituent at the site corresponding to
position 2 in the azumamides, there is no clash with Phe200 of
HDAC3 and thus no favorable dispersive eﬀects either.
Nevertheless, the poses for both docked conformations of
romidepsin were similar and shared several key features with
the favorable poses for azumamides, including protrusion of the
Zn2+-binding side chain into the channel, leading to the
catalytic metal ion, interaction between the thiol and Zn2+, as
well as peptide backbone hydrogens to the Asp93 side chain of
HDAC3.
A more comprehensive series of computational dockings of
natural cyclopeptides to X-ray crystal structures of all the class I
HDACs is currently underway in our laboratories but is beyond
the scope of this report.
Cytotoxic Activity against Cultured Cancer Cells.
Reversal of chemoresistance caused by silencing of the
proapoptotic Bcl-2-family gene, Bim, in Burkitt’s lymphoma
cells has been demonstrated upon treatment with the HDAC
inhibitor SAHA.47 We therefore tested whether a selection of
our compounds could inﬂuence growth of the Epstein−Barr
virus (EBV)-infected human Burkitt’s lymphoma cell line, EB-3.
Cell viability upon treatment with azumamides B (5b), C (5c),
and E (5e), trans-oleﬁn (6b), saturated compound (7b),
desmethyl analogues 9a−c as well as SAHA (1) and apicidin
(4a) as controls was determined using a standard MTT assay
(Supporting Information, Methods). While SAHA and apicidin
exhibited GI50 values of 2.8 and 0.8 μM, respectively, none of
the azumamides or analogues exhibited growth inhibition (GI)
at concentrations up to 25 μM, which is surprising considering
the potent HDAC inhibitory activities exhibited by the natural
products.
■ DISCUSSION AND CONCLUSIONS
Naturally occurring macrocyclic peptide-based inhibitors of
HDAC enzymes have historically played important roles in the
HDAC ﬁeld. This compound class provides ideal starting
points for structure-based investigation of inhibitor−enzyme
interactions due to their well-deﬁned three-dimensional
structures and inherent modular assembly, which enable
ready structural manipulation through chemical synthesis. In
this work, we investigated the structural requirements for
potent HDAC inhibition by the azumamides and analogues in
detail. We ﬁrst developed eﬃcient syntheses of a series of
building blocks, which enabled the assembly of a diverse series
of analogues modiﬁed to address speciﬁc structure−activity
relationships. This compound collection was then evaluated by
biochemical proﬁling against the panel of recombinant human
HDACs, high-resolution NMR-based determination of selected
solution structures, computational evaluation of inhibitor−
enzyme complexes, and ﬁnally cytotoxic activities against
cultured cancer cells in vitro. Through this process we gained
valuable insight at a high level of detail into Nature’s way of
inhibiting this important enzyme class.
The proﬁling of our compound series revealed only subtle
eﬀects in response to the changes made to mimic the
saturation/unsaturation of the linker regions of romidepsin,
largazole, and apicidin. The identity of aromatic residues
mimicking those in apicidin and trapoxin, interestingly, gave
rise to opposite eﬀects on potency depending on the enzyme.
This is a ﬁnding that may be utilized for improving selectivity
proﬁles of macrocyclic HDAC inhibitors, although a maximum
diﬀerence of 3-fold was observed. By far the most signiﬁcant
eﬀects were found when structurally modifying the 2-position
in the β-amino acid residue. In fact, the changes in activity of
1−2 orders of magnitude resulting from altered methylation at
this β2-position may be considered a prominent naturally
evolved example of the so-called “methyl eﬀect” elegantly
discussed by Jorgensen and co-workers for drug-like com-
pounds.48 We were therefore interested in determining the root
of this eﬀect in our system and ﬁrst hypothesized that the main
contribution was conformational remodeling of the azumamide
backbone. Somewhat to our surprise, the high-resolution NMR
structures of representative ligands revealed no signiﬁcant
conformational variation in the macrocyclic backbone region.
In contrast, both NMR J-couplings and MD simulations (in
explicit water or DMSO) indicated diﬀerences in the β3-side
chain dihedral angles due to steric eﬀects of the β2-substituent.
Docking to HDAC3 X-ray crystal structures, however, showed
that diﬀerent orientations of the β3-side chain enabled
coordination to the active site Zn2+ ion without compromising
key hydrogen bond interactions, which is not entirely surprising
considering the degree of ﬂexibility expected for this region of
the molecule. Furthermore, the individual docking poses were
supported by estimation of binding energies using Prime/
MMGBSA. Thus, despite intuitive appeal, a major eﬀect of the
β2-substitution pattern on favorable preorganization of
azumamide conformation appears unlikely. Instead, distorted
complexes of epi-methyl-containing analogues (8a and 36) due
to steric displacement by Phe200 of HDAC3 resulted in partial
disruption of hydrogen bonds to Asp93 as well as overall
decrease in favorable dispersive interactions explaining their
poor potencies. Because this could not explain the decreased
activity of the desmethyl analogues, we performed ab initio
calculations on truncated model systems to address the possible
eﬀect of a β2-methyl−Phe200 interaction in HDAC3, revealing
a favorable contribution for the natural product. In summary,
our analysis show that requirements for potent inhibition
appear to involve (i) Zn2+-coordination by protrusion of the β3-
side chain into the active site tunnel, (ii) optimal hydrogen
bonding to Asp93 (Asp101 in HDAC8), and (iii) dispersive
interaction with Phe200 in HDAC3. None of the synthetic
analogues were able to satisfy all criteria as well as the natural
products were, which gave rise to the pronounced methyl eﬀect
observed on inhibitory activity. Our detailed analysis thus reveal
an intriguing example of a series of compounds where the
enthalpic contribution to binding aﬃnity is optimized without
suﬀering prototypical entropic compensation,49 presumably due
to the inherent rigidity of the cyclopeptide backbone.
Moreover, alignment of HDAC1−3 X-ray crystal structures
as well as docking of additional macrocyclic HDAC inhibitors
strongly indicate that these requirements are broadly important
for HDAC inhibition by cyclopeptides. This suggests that
drastic structural changes are necessary for these scaﬀolds to be
successfully elaborated into inhibitors exhibiting isozyme
selectivity between HDAC1−3, while these features may well
be exploited to achieve high HDAC1−3 potency and improved
class selectivity.
It is intriguing that Nature has provided these compounds,
which seem carefully optimized to bind certain members of the
HDAC family of enzymes but do not exhibit any activity when
dosed at meaningful concentrations in a cell-based assay. A
conceivable explanation for the diﬀerence in cellular activity
between azumamides C and E compared to SAHA and apicidin,
although they exhibit similar in vitro HDACi proﬁles, could
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relate to unfavorable cell-penetrating properties caused by the
carboxylate functionality in azumamides. Whether natural
prodrug versions of these compounds exist, as in the case of
largazole, can only be speculated upon. Nonetheless, ongoing
research in our laboratories is aimed at preparation of ester- or
thioester-based prodrugs of azumamides to overcome poor
intracellular delivery before we further investigate the eﬀects of
these chemotypes in cell-based assays.
■ EXPERIMENTAL SECTION
Additional synthetic procedures, compound characterization, NMR
spectra, and additional methods are provided in the Supporting
Information.
General. All chemicals and solvents were analytical grade and used
without further puriﬁcation. Vacuum liquid chromatography (VLC)
puriﬁcation was performed on silica gel 60 (particle size 0.015−0.040
μm). UPLC−MS analyses were performed using a Waters Acquity
ultra-high-performance liquid chromatography system. A gradient with
eluent I (0.1% HCOOH in water) and eluent II (0.1% HCOOH in
acetonitrile) rising linearly from 0% to 95% of II during t = 0.00−2.50
min was applied at a ﬂow rate of 1 mL/min (gradient A) or during t =
0.00−5.20 min (gradient B). All compounds were determined by
analytical HPLC analysis to be >95% pure on a [150 mm × 4.6 mm,
C18 Phenomenex Luna column (3 μm)] using an Agilent 1100 LC
system equipped with a UV detector. The gradient consisted of eluent
III (95:5:0.1, water−MeCN−TFA) and eluent IV (0.1% TFA in
acetonitrile) rising linearly from 0% to 95% of IV during t = 2−20 min
at a ﬂow rate of 1 mL/min (gradient C) or using a gradient rising
linearly from 0% to 40% of IV during t = 5−18 min, then from 40% to
95% of IV during t = 18−20 min at a ﬂow rate of 1 mL/min (gradient
D). All ﬁnal peptides were puriﬁed by preparative reversed-phase
HPLC on a 250 mm × 20 mm, C18 Phenomenex Luna column (5 μm,
100 Å) using an Agilent 1260 LC system equipped with a diode array
UV detector and an evaporative light scattering detector (ELSD). A
gradient using eluent III and IV rising linearly from 0% to 95% of IV
during t = 5−45 min was applied at a ﬂow rate of 20 mL/min
(gradient E), and fractions containing pure compound were then
pooled and lyophilized. Final compounds were kept at −20 °C. 1D
and 2D NMR spectra were recorded on a Varian INOVA 500 MHz
instrument, a Bruker Ascend 400 MHz, or a Varian Mercury 300
instrument. All spectra were recorded at 298 K. For the Varian
INOVA 500 MHz instrument and the Varian Mercury 300 instrument,
the 1D NMR spectra were recorded at 499.9 and 300 MHz for 1H and
100 and 75 MHz for 13C, respectively. The correlation spectroscopy
(COSY) spectra were recorded with a relaxation delay of 1.5 s before
each scan, a spectral width of 6k × 6k, collecting 8 FIDs and 1k × 512
data points. Heteronuclear single quantum coherence (HSQC) spectra
were recorded with a relaxation delay of 1.5 s before each scan, a
spectral width of 6k × 25k, collecting 16 FIDs and 1k × 128 data
points. Heteronuclear 2-bond correlation (H2BC) spectra were
recorded with a relaxation delay of 1.5 s before each scan, a spectral
width of 4k × 35k, collecting 16 FIDs at 295 K and 1k × 256 data
points. Heteronuclear multiple-bond correlation (HMBC) spectra
were recorded with a relaxation delay of 1.5 s before each scan, a
spectral width of 6k × 35k, collecting 32 FIDs and 1k × 256 data
points. Finally, on the Bruker Ascend 400 MHz, the 1D NMR spectra
were recorded at 400 MHz for 1H and 100 MHz for 13C. The
correlation spectroscopy (COSY) spectra were recorded with a
relaxation delay of 1.5 s before each scan, a spectral width of 3k × 3k,
collecting 4 FIDs and 1k × 128 data points. The heteronuclear single
quantum coherence (HSQC) spectra were recorded with a relaxation
delay of 1.5 s before each scan, a spectral width of 4800 × 16600,
collecting 4 FIDs and 1k × 256 data points. Chemical shifts are
reported in ppm relative to deuterated solvent peaks as internal
standards (δH, DMSO-d6 2.50 ppm; δC, DMSO-d6 39.52 ppm; δH,
CD3OD 3.31 ppm; δH, CDCl3 7.26 ppm; δC, CDCl3 77.16 ppm).
Coupling constants (J) are given in hertz (Hz). Multiplicities of 1H
NMR signals are reported as follows: s, singlet; br s, broad singlet; d,
doublet; t, triplet; q, quartet; m, multiplet.
E)-6-((2R,5R,8R,11S)-8-Benzyl-2-isopropyl-5-methyl-3,6,9,13-tet-
raoxo-1,4,7,10-tetraazacyclotridecan-11-yl)hex-5-enoic Acid (6a).
Compound 13 (31.3 mg, 0.1 mmol), HATU (38.8 mg, 0.1 mmol, 1
equiv), and 2,6-lutidine (23 μL, 0.2 mmol, 2 equiv) in DMF (1.5 mL)
were preincubated for 5 min and added to a tripeptide (D-Val-D-Ala-D-
Phe) on solid support. After 18 h, the peptide was washed with DMF
(×3), MeOH (×3), and CH2Cl2 (×3). The peptide was cleaved with
50% TFA in CH2Cl2 (2 × 30 min) and concentrated in vacuo.
Trituation in Et2O (8 mL) gave a crude tetrapeptide (88 mg), which
was dissolved in DMF (130 mL). Addition of i-Pr2NEt (140 μL, 0.8
mmol, 8 equiv) was followed by HATU (78 mg, 0.2 mmol, 2 equiv),
and the reaction was stirred for 66 h and then concentrated in vacuo.
LiOH (32 mg, 1.3 mmol, 13 equiv) in THF−H2O (4 mL, 1:1) was
added to the crude material, and the mixture was stirred for 7 h.
Preparative HPLC gave the desired product (3.8 mg, 7%, over 4 steps)
as a white solid. Two conformations were observed in 89:11 ratio
determined by integration of 1H NMR peaks. Characterization is given
for the major conformation. 1H NMR (500 MHz, DMSO-d6) δ 12.03
(s, 1H), 7.87 (d, J = 6.8 Hz, 1H), 7.61 (d, J = 9.7 Hz, 1H), 7.40 (d, J =
7.5 Hz, 2H), 7.33−7.11 (m, 5H), 5.46−5.41 (m, 2H), 4.41−4.31 (m,
1H), 4.31−4.24 (m, 2H), 3.82 (t, J = 6.6 Hz, 1H), 3.06−2.81 (m, 2H),
2.62−2.48 (m, 2H), 2.20 (t, J = 7.4 Hz, 2H), 2.07−1.97 (m, 2H),
1.97−1.87 (m, 1H), 1.66−1.48 (m, 2H), 1.15 (d, J = 7.3 Hz, 3H), 0.92
(dd, J = 9.0, 7.0 Hz, 6H). HRMS calcd for C26H36N4O6H
+ [M + H]+,
501.2708; found, 501.2716. HPLC gradient C, tR = 11.6 min (HPLC
purity >99%, 230 nm).
(E)-6-((2R,5R,8R,11S)-8-(4-Hydroxybenzyl)-2-isopropyl-5-methyl-
3,6,9,13-tetraoxo-1,4,7,10-tetraazacyclo-tridecan-11-yl)hex-5-enoic
Acid (6b). Compound 13 (31.3 mg, 0.1 mmol), HATU (38.8 mg, 0.1
mmol, 1 equiv) and 2,6-lutidine (23 μL, 0.2 mmol, 2 equiv) in DMF
(1.5 mL) were preincubated for 5 min and added to a tripeptide (D-
Val-D-Ala-D-Tyr) on solid support. After 18 h, the peptide was washed
with DMF (×3), MeOH (×3) and CH2Cl2 (×3). The peptide was
cleaved with 50% TFA in CH2Cl2 (2 × 30 min) and concentrated in
vacuo. Trituation in Et2O (8 mL) gave a crude tetrapeptide (89 mg),
which was dissolved in DMF (130 mL). Addition of i-Pr2NEt (140 μL,
0.8 mmol, 8 equiv) was followed by HATU (78 mg, 0.2 mmol, 2
equiv). The reaction was stirred for 66 h and then concentrated in
vacuo. An unsuccessful puriﬁcation provided a crude methylester (7.2
mg), which was dissolved in THF−H2O (4 mL, 1:1). LiOH (1.3 mg,
0.054 mmol, ∼4 equiv) was added, and the mixture was stirred for 18
h. Additional LiOH (4 mg, 0.15 mmol, ∼8 equiv) was added, and the
mixture was stirred for 7 h at room temperature, then 63 h at 5 °C.
Preparative HPLC gave the desired product (4.2 mg, 8% over 4 steps)
as a white solid. Two conformations were observed in 89:11 ratio
determined by integration of 1H NMR peaks. Characterization is given
for the major conformation. 1H NMR (500 MHz, DMSO-d6) δ 9.23
(s, 1H), 7.85 (d, J = 6.7 Hz, 1H), 7.52 (d, J = 9.7 Hz, 1H), 7.38 (d, J =
9.9 Hz, 1H), 7.31 (d, J = 7.3 Hz, 1H), 6.95 (d, J = 8.4 Hz, 2H), 6.66
(d, J = 8.4 Hz, 2H), 5.47−5.39 (m, 2H), 4.40−4.33 (m, 1H), 4.29 (dq,
J = 14.9, 7.6 Hz, 1H), 4.19 (td, J = 9.3, 6.0 Hz, 1H), 3.81 (t, J = 6.5 Hz,
1H), 2.84 (dd, J = 13.9, 5.8 Hz, 1H), 2.75 (dd, J = 13.8, 9.1 Hz, 1H),
2.58−2.40 (m, 2H), 2.20 (t, J = 7.4 Hz, 2H), 2.11−1.98 (m, 2H),
1.98−1.90 (m, 1H), 1.65−1.48 (m, 2H), 1.16 (d, J = 7.4 Hz, 3H), 0.92
(dd, J = 8.3, 7.2 Hz, 6H). HRMS calcd for C26H36N4O7H
+ [M + H] +,
517.2657; found, 517.2660. HPLC gradient C, tR = 10.3 min (HPLC
purity >99%, 230 nm).
(E)-6-((2R,5R,8R,11S)-8-((1H-Indol-2-yl)methyl)-2-isopropyl-5-
methyl-3,6,9,13-tetraoxo-1,4,7,10-tetraazacyclotridecan-11-yl)hex-
5-enoic Acid (6c). Compound 13 (31.3 mg, 0.1 mmol), HATU (38.8
mg, 0.1 mmol, 1 equiv), and 2,6-lutidine (23 μL, 0.2 mmol, 2 equiv) in
DMF (1.5 mL) were preincubated for 5 min and added to a tripeptide
(D-Val-D-Ala-D-Trp) on solid support. After 18 h, the peptide was
washed with DMF (×3), MeOH (×3), and CH2Cl2 (×3). The peptide
was cleaved with 50% TFA in CH2Cl2 (2 × 30 min) and concentrated
in vacuo. Trituation in Et2O (8 mL) gave a crude tetrapeptide, which
was dissolved in DMF (130 mL). Addition of i-Pr2NEt (140 μL, 0.8
mmol, 8 equiv) was followed by HATU (78 mg, 0.2 mmol, 2 equiv).
The reaction was stirred for 66 h and then concentrated in vacuo. An
unsuccessful puriﬁcation provided a crude methylester (2.9 mg), which
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was dissolved in THF−H2O (4 mL, 1:1). LiOH (0.5 mg, 0.02 mmol,
∼4 equiv) was added, and the mixture was stirred for 18 h. Additional
LiOH (1 mg, 0.04 mmol, ∼8 equiv) was added, and the mixture was
stirred for 6 h. Preparative HPLC gave the desired product (1.4 mg,
3% over four steps) as a white solid. Two conformations were
observed in 92:8 ratio determined by integration of 1H NMR peaks.
Characterization is given for the major conformation. 1H NMR (500
MHz, DMSO-d6) δ 7.82 (d, J = 6.8 Hz, 1H), 7.55 (d, J = 9.7 Hz, 1H),
7.50 (d, J = 7.8 Hz, 1H), 7.45 (d, J = 9.8 Hz, 1H), 7.37 (d, J = 7.3 Hz,
1H), 7.34 (d, J = 8.1 Hz, 1H), 7.16−7.04 (m, 2H), 6.98 (t, J = 7.5 Hz,
1H), 5.47−5.31 (m, 2H), 4.45−4.24 (m, 3H), 3.82 (t, J = 6.5 Hz, 1H),
3.09−3.00 (m, 2H), 2.48−2.37 (m, 2H), 2.19 (t, J = 7.3 Hz, 2H),
2.06−1.87 (m, 4H), 1.59−1.46 (m, 2H), 1.17 (d, J = 7.3 Hz, 3H), 0.92
(t, J = 6.4 Hz, 6H). HRMS calcd for C28H37N5O6H
+ [M + H]+,
540.2817; found, 540.2807. HPLC gradient C, tR = 11.7 min (HPLC
purity >99%, 230 nm).
6-((2R,5R,8R,11R)-8-Benzyl-2-isopropyl-5-methyl-3,6,9,13-tet-
raoxo-1,4,7,10-tetraazacyclotridecan-11-yl)hexanoic Acid (7a).
Compound 14 (25.4 mg, 0.08 mmol), HATU (36.5 mg, 0.1 mmol,
1.3 equiv), and 2,6-lutidine (18 μL, 0.16 mmol, 2 equiv) in DMF (1.5
mL) were preincubated for 5 min and added to a tripeptide (D-Val-D-
Ala-D-Phe) on solid support. After 18 h, the peptide was washed with
DMF (×3), MeOH (×3), and CH2Cl2 (×3). The peptide was cleaved
with 50% TFA in CH2Cl2 (2 × 30 min.) and concentrated in vacuo.
Trituation in Et2O (8 mL) gave a crude tetrapeptide, which was
dissolved in DMF (170 mL). Addition of i-Pr2NEt (140 μL, 0.8 mmol,
10 equiv) was followed by HATU (61 mg, 0.16 mmol, 2 equiv). The
reaction was stirred for 24 h and then concentrated in vacuo. LiOH
(34 mg, 1.5 mmol, ∼20 equiv) in THF−H2O (15 mL, 1:2) was added
to the crude compound and the mixture stirred for 4 h. Additional
LiOH (19 mg, 0.8 mmol, ∼10 equiv) was added, and the reaction was
stirred for 6 h. Then, LiOH (35 mg, 1.5 mmol, ∼20 equiv) was added,
and the reaction was stirred for additional 17 h. Preparative HPLC
gave the desired product (4.2 mg, 10% over 4 steps) as a white solid.
Two conformations were observed in 91:9 ratio determined by
integration of 1H NMR peaks. Characterization is given for the major
conformation. 1H NMR (500 MHz, DMSO-d6) δ 11.97 (s, 1H), 7.78
(d, J = 6.6 Hz, 1H), 7.55 (d, J = 8.7 Hz, 1H), 7.41 (d, J = 8.4 Hz, 1H),
7.34−7.10 (m, 6H), 4.31−4.20 (m, 2H), 3.81 (t, J = 7.0 Hz, 2H), 2.93
(dd, J = 13.7, 6.7 Hz, 1H), 2.84 (dd, J = 13.7, 8.5 Hz, 1H), 2.59−2.45
(m, 1H), 2.41−2.27 (m, 1H), 2.19 (t, J = 7.4 Hz, 2H), 1.94 (dq, J =
13.4, 6.7 Hz, 1H), 1.58−1.21 (m, 8H), 1.17 (d, J = 7.3 Hz, 3H), 0.92
(dd, J = 9.1, 7.0 Hz, 6H). HRMS calcd for C26H38N4O6H
+ [M + H]+,
503.2864; found, 503.2870. HPLC gradient D, tR = 18.3 min (HPLC
purity >99%, 230 nm).
6-((2R,5R,8R,11R)-8-(4-Hydroxybenzyl)-2-isopropyl-5-methyl-
3,6,9,13-tetraoxo-1,4,7,10-tetraazacyclo-tridecan-11-yl)hexanoic
Acid (7b). Compound 14 (25.4 mg, 0.08 mmol), HATU (36.5 mg, 0.1
mmol, 1 equiv), and 2,6-lutidine (18 μL, 0.16 mmol, 2 equiv) in DMF
(1.5 mL) were preincubated for 5 min and then added to a tripeptide
(D-Val-D-Ala-D-Tyr) on solid support. After 18 h, the peptide was
washed with DMF (×3), MeOH (×3) and CH2Cl2 (×3). The peptide
was cleaved with 50% TFA in CH2Cl2 (2 × 30 min) and concentrated
in vacuo. Trituration in Et2O (8 mL) gave a crude tetrapeptide, which
was dissolved in DMF (170 mL) and treated with i-Pr2NEt (140 μL,
0.8 mmol, 10 equiv) and HATU (61 mg, 0.16 mmol, 2 equiv). The
reaction was stirred for 24 h and then concentrated in vacuo. LiOH
(43 mg, 1.8 mmol, 23 equiv) in THF−H2O (15 mL, 1:2) was added to
the crude compound and stirred for 24 h, an additional amount of
LiOH (38 mg, 1.6 mmol, 20 equiv) was added, and the reaction was
stirred for 24 h. Preparative HPLC gave the desired product (3.1 mg,
7% over 4 steps) as a white solid. Two conformations were observed in
87:13 ratio determined by integration of 1H NMR peaks. Character-
ization is given for the major conformation. 1H NMR (500 MHz,
DMSO-d6) δ 9.21 (s, 1H), 7.77 (d, J = 7.0 Hz, 1H), 7.44 (d, J = 9.5
Hz, 1H), 7.37 (d, J = 9.8 Hz, 1H), 7.17 (d, J = 7.4 Hz, 1H), 6.94 (d, J
= 8.4 Hz, 2H), 6.65 (d, J = 8.4 Hz, 2H), 4.26 (dq, J = 14.8, 7.3 Hz,
1H), 4.19−4.14 (m, 1H), 4.00−3.74 (m, 2H), 2.80 (dd, J = 13.8, 6.6
Hz, 1H), 2.72 (dd, J = 13.8, 8.4 Hz, 1H), 2.49 (dd, J = 8.5, 6.8 Hz,
1H), 2.32 (dd, J = 14.5, 3.2 Hz, 1H), 2.20 (t, J = 7.3 Hz, 2H), 1.99−
1.90 (m, 1H), 1.67−1.21 (m, 8H), 1.18 (d, J = 7.4 Hz, 3H), 0.92 (dd, J
= 8.5, 7.1 Hz, 6H). HRMS calcd for C26H38N4O7H
+ [M + H]+,
519.2813; found, 519.2813. HPLC gradient C, tR = 10.4 min (HPLC
purity >99%, 230 nm).
6-((2R,5R,8R,11R)-8-((1H-Indol-2-yl)methyl)-2-isopropyl-5-meth-
yl-3,6,9,13-tetraoxo-1,4,7,10-tetraazacyclotridecan-11-yl)hexanoic
Acid (7c). The saturated Fmoc-β-amino acid (see, Supporting
Information) (95 mg, 0.22 mmol) was dissolved in anhydrous
CH2Cl2 (5 mL) and i-Pr2NEt (75 μL, 0.43 mmol, 2 equiv) and loaded
onto a 2-chlorotrityl resin. The resin was washed with CH2Cl2 (×3)
and then capped with i-Pr2NEt−MeOH−CH2Cl2 (1:2:7) followed by
washing. Theoretical loading of the resin was calculated to be 0.7
mmol/g. Standard Fmoc SPPS using HATU as the coupling reagent
was applied to couple D-Trp(Boc), D-Ala, and D-Val. The peptide was
cleaved by treatment with AcOH−CF3CH2OH−CH2Cl2 (1:1:3) for
2.5 h, and the mixture was then concentrated in vacuo. Trituration in
Et2O (8 mL) gave a crude tetrapeptide, half of which was cyclized in
DMF (170 mL) using i-Pr2NEt (100 μL, 0.6 mmol, ∼6 equiv) and
HATU (57 mg, 0.15 mmol, 1.5 equiv). The reaction was stirred for 2 h
and then concentrated in vacuo. LiOH (7 mg, 0.3 mmol, 3 equiv) in
THF−H2O (5 mL, 1:1) was added to the crude compound and stirred
5 h, whereafter additional LiOH (48 mg, 2 mmol, 20 equiv) was added
and the reaction was stirred for 24 h. The crude mixture was
concentrated in vacuo and dissolved in CH2Cl2 (6 mL) followed by
addition of TFA (6 mL). The reaction was stirred for 30 min and then
concentrated in vacuo. Preparative HPLC gave the desired product
(12.4 mg, 48% over 12 steps) as a white solid. Two conformations
were observed in 91:9 ratio determined by integration of 1H NMR
peaks. Characterization is given for the major conformation. 1H NMR
(500 MHz, DMSO-d6) δ 11.97 (s, 1H), 10.81 (d, J = 56.2 Hz, 1H),
7.75 (d, J = 6.8 Hz, 1H), 7.57−7.41 (m, 3H), 7.33 (d, J = 8.0 Hz, 1H),
7.22 (d, J = 7.2 Hz, 1H), 7.10−7.01 (m, 2H), 7.00−6.93 (m, 1H),
4.43−4.32 (m, 1H), 4.28 (dq, J = 15.1, 7.4 Hz, 1H), 3.87−3.77 (m,
2H), 3.04 (dd, J = 14.7, 6.8 Hz, 1H), 2.99 (dd, J = 14.8, 7.6 Hz, 1H),
2.55−2.45 (m, 1H), 2.31 (dd, J = 14.4, 3.3 Hz, 1H), 2.19 (t, J = 7.3 Hz,
2H), 2.03−1.85 (m, 1H), 1.54−1.10 (m, 8H), 1.18 (d, J = 7.4 Hz,
3H), 0.91 (t, J = 6.5 Hz, 6H). HRMS calcd for C28H39N5O6H
+ [M +
H]+, 542.2973; found, 542.2978. HPLC gradient C, tR = 11.98 min
(HPLC purity >99%, 230 nm).
(Z)-6-((2R,5R,8R,11R)-8-Benzyl-2-isopropyl-5,12,12-trimethyl-
3,6,9,13-tetraoxo-1,4,7,10-tetraazacyclotridecan-11-yl)hex-4-enoic
Acid (8a). The linear peptide 33a (35 mg, 0.08 mmol) was dissolved
in DMF (200 mL), whereafter i-Pr2NEt (140 μL, 0.80 mmol, 10
equiv) and HATU (61 mg, 0.16 mmol, 2.0 equiv) were added. The
solution was stirred for 16 h, and the reaction mixture was
concentrated in vacuo. Addition of EtOAc (200 mL) aﬀorded a
white precipitate (HOAt), which was ﬁltered oﬀ. The EtOAc was
washed with aq HCl (1.0 M, 10 mL × 3) and concentrated in vacuo to
aﬀord the crude cyclic peptide (76 mg) as brown oil. UPLC-MS
gradient B, tR = 1.92 min. MS calcd for C32H51N4O6H
+, 557.7; found,
557.2 [M + H]+. Then, LiOH (67 mg, 2.79 mmol, 35 equiv) in water
(5 mL) was added to the crude cyclic peptide in THF (5 mL), and
after 16 h, the mixture was concentrated in vacuo. The residue was
dissolved in DMF and puriﬁed by preparative HPLC to aﬀord the acid
8a (2.6 mg, 4%, 5 steps) as a white solid. Two conformations were
observed in a 91:9 ratio determined by integration of 1H NMR peaks.
Characterization is given for the major conformation. 1H NMR (500
MHz, DMSO-d6) δ 8.04 (br s, 1H), 7.38 (br s, 1H), 7.27−7.11 (m,
6H), 7.05 (d, J = 9.5 Hz, 1H), 5.16 (m, 1H), 4.99 (m, 1H), 4.40 (m,
1H), 4.14 (dq, J = 8.4, 7.9 Hz, 1H), 4.05 (m, 1H), 3.70 (dd, J = 10.1,
8.7 Hz, 1H), 3.00 (dd, J = 13.6, 8.0 Hz, 2H), 2.70 (dd, J = 13.6, 6.6 Hz,
1H), 2.16 (m, 5H), 2.01 (m, 2H), 1.15−1.3 (m, 6H), 1.04 (s, 3H),
0.85−0.84 (m, 6H). HRMS calcd for C28H40N4O6Na+ [M + Na]+,
551.2840; found, 551.2839. HPLC gradient C, tR = 12.9 min (HPLC
purity >95%, 230 nm).
(Z)-6-((2R,5R,8R,11R)-8-(4-Hydroxybenzyl)-2-isopropyl-5,12,12-
trimethyl-3,6,9,13-tetraoxo-1,4,7,10-tetraazacyclotridecan-11-yl)-
hex-4-enoic Acid (8b). The linear peptide 33b (35 mg, 0.092 mmol)
was dissolved in DMF (230 mL), whereafter i-Pr2NEt (159 μL, 0.92
mmol, 10 equiv) and HATU (70 mg, 0.19 mmol, 2.0 equiv) were
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added. The solution was stirred for 16 h, and the reaction mixture was
concentrated in vacuo. Addition of EtOAc (200 mL) aﬀorded a white
precipitate (HOAt), which was ﬁltered oﬀ. The EtOAc was washed
with aq HCl (1.0 M, 10 mL × 3) and concentrated in vacuo to aﬀord
the crude cyclic peptide (123 mg) as brown oil. UPLC-MS gradient B,
tR = 1.72 min. MS calcd for C30H43N4O7
− [M − H]−, 571.3; found,
571.3. LiOH (77 mg, 3.2 mmol, 35 equiv) in water (5 mL) was added
to the crude cyclic peptide (123 mg, ∼0.08 mmol) in THF (5 mL).
After 20 h, the mixture was concentrated in vacuo and the residue was
dissolved in DMF and puriﬁed by preparative HPLC to aﬀord the acid
8b (1.0 mg, 2%, 5 steps) as a white solid. Two conformations were
observed in 89:11 ratio determined by integration of 1H NMR peaks.
Characterization is given for the major conformation. 1H NMR (500
MHz, DMSO-d6) δ 8.03 (d, J = 8.6 Hz, 1H), 7.29 (d, J = 8.6 Hz, 1H),
7.19 (d, J = 8.3 Hz, 1H), 7.00 (d, J = 9.9 Hz, 1H), 6.95 (d, J = 8.4 Hz,
2H), 6.60 (d, J = 8.4 Hz, 2H), 5.19 (m, 1H), 5.01 (m, 1H), 4.32 (q, J =
8.0 Hz, 1H), 4.13 (pentet, J = 7.0 Hz, 1H), 4.04 (m, 1H), 3.69 (t, J =
10.1, 8.3 Hz, 1H), 2.87 (dd, J = 13.7, 8.0 Hz, 1H), 2.57 (dd, J = 13.7,
6.6 Hz, 1H), 2.18 (m, 5H), 2.00 (m, 2H), 1.15 (m, 6H), 1.03 (s, 3H),
0.84 (m, 6H). HRMS calcd for C28H40N4O7H
+ [M + H]+, 545.2970;
found, 545.2968. HPLC gradient C, tR = 11.4 min (HPLC purity
>95%, 230 nm).
(Z)-6-((2R,5R,8R,11R)-8-((1H-Indol-3-yl)methyl)-2-isopropyl-
5,12,12-trimethyl-3,6,9,13-tetraoxo-1,4,7,10-tetraazacyclotridecan-
11-yl)hex-4-enoic Acid (8c). The linear peptide 33c (43 mg, 0.059
mmol) was dissolved in DMF (150 mL), whereafter i-Pr2NEt (51.4
μL, 0.30 mmol, 5 equiv) and HATU (34 mg, 0.089 mmol, 1.5 equiv)
were added. The solution was stirred for 17 h, and the reaction mixture
was concentrated in vacuo to aﬀord the crude cyclic peptide. UPLC-
MS gradient B, tR = 1.72 min. MS calcd for C32H45N5O6H
+ [M + H]+,
595.3; found, 596.3. Then, LiOH (26 mg, 1.09 mmol, 50 equiv) in
water (4 mL) was added to the crude cyclic peptide (13 mg, ∼0.022
mmol) in THF (4 mL). After 18 h, the mixture was concentrated in
vacuo and the residue was dissolved in MeCN−water−DMF (2:2:1,
2.5 mL) and puriﬁed by preparative HPLC to aﬀord the acid 8c (2.6
mg, 6%, 5 steps) as a white solid. Two conformations are observed in a
92:8 ratio determined by integration of 1H NMR peaks. Character-
ization data are given for the major conformation. 1H NMR (500
MHz, DMSO-d6) δ 7.74 (d, J = 8.6 Hz, 1H), 7.53 (d, J = 7.8 Hz, 1H),
7.39 (d, J = 8.3 Hz, 1H), 7.32 (d, J = 8.1 Hz, 1H), 7.24 (d, J = 8.4 Hz,
1H), 7.16 (d, J = 9.2 Hz, 1H), 7.05 (m, 2H), 6.97 (m, 1H), 5.37−5.24
(m, 2H), 4.14 (m, 2H), 3.95 (td, J = 9.5, 4.1 Hz, 1H), 3.71 (dd, J =
10.0, 8.5 Hz, 1H), 3.08 (d, J = 7.6 Hz, 2H), 2.36−2.17 (m, 6H), 2.08
(m, 1H), 1.32 (s, 3H), 1.23 (d, J = 7.3 Hz, 3H), 1.09 (s, 3H), 0.88 (d, J
= 6.9 Hz, 3H), 0.87 (d, J = 7.0 Hz, 3H). HRMS calcd for
C30H41N5O6H
+ [M + H]+, 568.3130; found, 568.3135. HPLC gradient
C, tR = 11.6 min (HPLC purity >95%, 230 nm).
(Z)-6-((2R,5R,8R,11R)-8-Benzyl-2-isopropyl-5-methyl-3,6,9,13-tet-
raoxo-1,4,7,10-tetraazacyclotridecan-11-yl)hex-4-enoic Acid (9a).
The linear peptide 34a (45 mg, 0.068 mmol) was dissolved in DMF
(200 mL), and i-Pr2NEt (131 μL, 0.75 mmol, 10 equiv) and HATU
(57 mg, 0.15 mmol, 2.2 equiv) were added. The solution was stirred
for 16 h, and the reaction mixture was concentrated in vacuo. Addition
of EtOAc (200 mL) aﬀorded a white precipitate (HOAt), which was
ﬁltered oﬀ. The EtOAc was washed with aqueous HCl (1.0 M, 10 mL
× 3) and concentrated in vacuo to aﬀord the crude cyclic peptide (127
mg) as brown oil. UPLC-MS gradient A tR = 1.87 min. MS calcd for
C28H40N4O6H
+ [M + H]+, 529.3; found, 529.4. Then, LiOH (38 mg,
1.59 mmol) in water (5 mL) was added to the cyclic peptide (127 mg,
∼0.068 mmol) in THF (5 mL). To ensure a pH >10, additional LiOH
(21 mg, 0.88 mmol, 13.0 equiv) was added and the solution was stirred
for 16 h. The mixture was concentrated in vacuo and dissolved in
DMF−MeCN (8:2, 3.0 mL) before puriﬁcation by preparative HPLC
aﬀorded 9a (8.1 mg, 21%, 5 steps) as white solid. Two conformations
are observed in a 94:6 ratio determined by integration of 1H NMR
peaks. Characterization is given for the major conformation. 1H NMR
(800 MHz, DMSO-d6) δ 12.08 (s, 1H), 7.86 (d, J = 6.8 Hz, 1H), 7.66
(d, J = 9.0 Hz, 1H), 7.43 (d, J = 9.0 Hz, 1H), 7.35 (d, J = 6.6 Hz, 1H),
7.28 (m, 2H), 7.16−7.23 (m, 3H), 5.48 (m, 1H), 5.37 (dt, J = 10.5, 7.4
Hz, 1H), 4.30−4.21 (m, 2H), 3.93 (dd, J = 7.2, 3.6 Hz, 1H), 3.81 (t, J
= 6.7 Hz, 1H), 2.95 (dd, J = 13.8, 5.8 Hz, 1H), 2.82 (dd, J = 13.8, 9.5
Hz, 1H), 2.50 (m, 1H), 2.29 (m, 7H), 1.94 (m, 1H), 1.15 (d, J = 7.3
Hz, 3H), 0.94 (d, J = 6.8 Hz, 3H), 0.91 (d, J = 6.8 Hz, 3H). HRMS
calcd for C26H36N4O6H
+ [M + H]+, 501.2708; found, 501.2713.
HPLC gradient C, tR = 11.7 min (HPLC purity >95%, 230 nm).
(Z)-6-((2R,5R,8R,11R)-8-(4-Hydroxybenzyl)-2-isopropyl-5-methyl-
3,6,9,13-tetraoxo-1,4,7,10-tetraazacyclotridecan-11-yl)hex-4-enoic
Acid (9b). The linear peptide 34b (67 mg, 0.099 mmol) was dissolved
in DMF (240 mL), and i-Pr2NEt (138 μL, 0.79 mmol, 8 equiv) and
HATU (57 mg, 0.15 mmol, 1.5 equiv) were added. The solution was
stirred for 16 h, and the reaction mixture was concentrated in vacuo.
Puriﬁcation by VLC aﬀorded the protected cyclic peptide (22 mg) as a
white amorphous solid, which was used without further puriﬁcation.
UPLC-MS gradient B, tR = 1.60 min. MS calcd for C28H42N4O8H
+ [M
+ H]+, 545.3; found, 545.3. LiOH (44 mg, 1.84 mmol, 50 equiv) in
water (4 mL) was added to the cyclic peptide (20 mg, 0.037 mmol) in
THF (4 mL). After 17 h, the mixture was concentrated in vacuo,
dissolved in DMF−MeCN−water (2:1:2, 2.5 mL), and puriﬁed by
preparative HPLC to aﬀord 9b (11.2 mg, 22%, 5 steps) as a white
solid. Two conformations were observed in a 92:8 ratio determined by
integration of 1H NMR peaks. Characterization is given for the major
conformation. 1H NMR (500 MHz, DMSO-d6) δ 12.07 (br s, 1H),
7.87 (d, J = 6.9 Hz, 1H), 7.56 (d, J = 9.7 Hz, 1H), 7.43 (d, J = 9.8 Hz,
1H), 7.25 (d, J = 7.0 Hz, 1H), 6.95 (d, J = 8.4 Hz, 2H), 6.65 (d, J = 8.4
Hz, 2H), 6.52 (br s, 1H), 5.47 (m, 1H), 5.37 (m, 1H), 4.28 (dq, J =
9.7, 7.4 Hz, 1H), 4.16 (m, 1H), 3.93 (m, 1H), 3.81 (t, J = 6.6 Hz, 1H),
2.82 (dd, J = 13.9, 5.7 Hz, 1H), 2.70 (dd, J = 13.9, 9.3 Hz, 1H), 2.47
(m, 1H), 2.27 (m, 7H), 1.95 (m, 1H), 1.16 (d, J = 7.3 Hz, 3H), 0.93
(d, J = 6.9 Hz, 3H), 0.91 (d, J = 6.9 Hz, 3H). HRMS calcd for
C26H36N4O7H
+ [M + H]+, 517.2657; found, 517.2658. HPLC gradient
C, tR = 10.1 min (HPLC purity >95%, 230 nm).
(Z)-6-((2R,5R,8R,11R)-8-((1H-Indol-3-yl)methyl)-2-isopropyl-5-
methyl-3,6,9,13-tetraoxo-1,4,7,10-tetraazacyclotridecan-11-yl)hex-
4-enoic Acid (9c). The linear peptide 34c (35 mg, 0.051 mmol) was
dissolved in DMF (130 mL) and i-Pr2NEt (71 μL, 0.41 mmol, 10
equiv) and HATU (29 mg, 0.77 mmol, 1.5 equiv) were added. The
solution was stirred for 16 h, and the reaction mixture was
concentrated in vacuo. Puriﬁcation by VLC aﬀorded the protected
cyclic peptide (30 mg) as a white amorphous solid, which was used
without further puriﬁcation. UPLC-MS gradient B, tR = 2.52 min. MS
calcd for C35H49N5O8H
+ [M + H]+, 668.4; found, 668.4. LiOH (54
mg, 2.25 mmol, 50 equiv) in water (4 mL) was added to the crude
cyclic peptide (30 mg, ∼0.045 mmol) in THF (4 mL). After 17 h, the
THF was removed in vacuo and the aqueous phase was acidiﬁed to pH
1−2 with 2 M HCl and extracted with CH2Cl2 (3 × 50 mL) and
EtOAc (2 × 40 mL). The combined organic phases were pooled and
concentrated in vacuo to give the crude Boc-protected cyclic peptide
35 as orange oil. The crude cyclic peptide was dissolved in CH2Cl2 (6
mL), and TFA was added (6 mL). After 1 h of stirring, the reaction
mixture was concentrated in vacuo and the resulting residue was
dissolved in DMF−MeCN−water (1:2:2, 2.5 mL) and puriﬁed by
preparative HPLC to aﬀord 9c (2.6 mg, 5%, 6 steps) as a white solid.
Two conformations were observed in a 97:3 ratio determined by
integration of 1H NMR peaks. Characterization is given for the major
conformation. 1H NMR (500 MHz, DMSO-d6) δ 12.08 (br s, 1H),
10.87 (br s, 1H), 7.83 (m, 1H), 7.51 (m, 3H), 7.33 (d, J = 8.1 Hz, 1H),
7.27 (m, 1H), 7.08 (s, 1H), 7.06 (t, J = 7.8 Hz, 1H), 6.97 (t, J = 7.4
Hz, 1H), 5.47 (m, 1H), 5.33 (m, 1H), 4.36 (m, 1H), 4.30 (m, 1H),
3.92 (m, 1H), 3.82 (t, J = 6.5 Hz, 1H), 3.01 (m, 2H), 2.45 (m, 1H),
2.33−2.14 (m, 7H), 1.94 (m, 1H), 1.15 (d, J = 7.3 Hz, 3H), 0.92 (d, J
= 7.4 Hz, 3H), 0.90 (d, J = 7.4 Hz, 3H). HRMS calcd for
C28H37N5O6H
+ [M + H]+, 540.2817; found, 540.2814. HPLC gradient
C, tR = 10.5 min (HPLC purity >95%, 230 nm).
Biochemical Proﬁling. HDAC Assay Materials. HDAC1 (purity
≥62% by SDS-PAGE according to the supplier), HDAC2 (full length,
purity ≥94% by SDS-PAGE according to the supplier), HDAC3−
NCoR1 complex (purity ≥80% by SDS-PAGE according to supplier,
HDAC4 (purity ≥60% by SDS-PAGE according to the supplier) and
HDAC 5 (full length, purity ≥90% by SDS-PAGE according to the
supplier), HDAC8 (purity ≥90% by SDS-PAGE according to the
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supplier), HDAC9 (full length, purity ≥76% by SDS-PAGE according
to the supplier) and HDAC10 (purity ≥21% by SDS-PAGE according
to the supplier) were purchased from BPS Bioscience (San Diego, CA
92121). HDAC 7 (purity ≥90% by SDS-PAGE according to the
supplier) was purchased from Millipore (Temecula, CA 92590).
HDAC6 (purity ≥85% by SDS-PAGE according to the supplier) and
HDAC11 (purity ≥50% by SDS-PAGE according to the supplier)
were purchased from Enzo Life Sciences (Postfach, Switzerland). The
HDAC assay buﬀer (50 mM tris/Cl, pH 8.0, 137 mM NaCl, 2.7 mM
KCl, 1 mM MgCl2) was added bovine serum albumin (0.5 mg/mL).
Trypsin (10,000 units/mg, TPCK treated from bovine pancreas) was
from Sigma-Aldrich (Steinheim, Germany). All peptides were puriﬁed
to homogeneity (>95% purity by HPLC230 nm using reversed-phase
preparative HPLC), and the white ﬂuﬀy materials obtained by
lyophilization were kept at −20 °C. For assaying, peptide substrates
were reconstituted in DMSO to give 5−10 mM stock solutions, the
accurate concentration of which were determined by UV using the
extinction coeﬃcient for tyrosine and tryptophane at 280 nm; ε =
1280 M−1 × cm−1 and ε = 5690 M−1 × cm−1, respectively.
Phenylalanine-containing compounds were adjusted after coinjection
on HPLC with a Phe sample of known concentration.
In Vitro Cell Cytotoxicity Assay. Cell viability was assessed using
the MTT cell growth kit (Millipore, Billerica, MA, USA). EB-3 cells
(ATCC, Manassas, VA, USA) were seeded in 96-well ﬂat-bottom cell
culture plates (Nunc, Thermo Fischer Scientiﬁc, Roskilde, Denmark)
with a density of 2 × 104 cells in 90 μL of culture media composed of
RPMI-1640 (ATCC, Manassas, VA, USA) supplemented with 10%
fetal calf serum (FCS) (Sera Scandia, Hellerup, Denmark) and 1%
penicillin/streptomycin (Gibco, Invitrogen, Taastrup, Denmark). After
cultivation overnight at 37 °C in humid 5% CO2 atmosphere, 10 μL of
culture medium containing appropriate concentrations of the ﬁve
compounds or the vehicle (DMSO) as control were added. The 2-fold
dilution series were prepared from DMSO stock solutions (5 mM for
azumamide C and 10 mM for the remaining compounds) to give ﬁnal
assay concentrations starting from 50 μM for azumamide C, SAHA,
and apicidin while 100 μM was applied for azumamide B and
compound 9. After incubation for 3 days, MTT solution was freshly
prepared by dissolving 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetra-
zolium bromide (MTT, 50 mg) in PBS (10 mL, both supplied in the
MTT assay kit) and 10 μL of this solution was added to each well. The
cells were incubated for another 4 h at 37 °C in humid 5% CO2
atmosphere for development to take place. The purple formazan
crystals produced were dissolved by addition of 2-propanol (100 μL/
well) containing HCl (0.04 M), and the absorbance was measured at
570 nm with background subtraction at 630 nm on a Tecan Sunrise
ELISA plate reader (Tecan, Switzerland). All assays were performed
three times in duplicate.
In Vitro Histone Deacetylase Inhibition Assays. For inhibition of
recombinant human HDACs, the dose−response experiments with
SAHA as internal positive control in each plate were performed in
black low binding NUNC 96-well microtiter plates. Dilution series (3-
fold dilution, six concentrations) were prepared in HDAC assay buﬀer
from 5−10 mM DMSO stock solutions. The appropriate dilution of
inhibitor (5 μL of 5× the desired ﬁnal concentration) was added to
each well followed by HDAC assay buﬀer (10 μL) containing substrate
[Ac-Leu-Gly-Lys(Ac)-AMC (20 μM) for HDAC1, 2, 3, 6, and 11; (200
μM) for HDAC8; and Ac-Arg-His-Lys(Ac)-Lys(Ac)-AMC (5 μM) for
HDAC10]. Finally, a solution of the appropriate HDAC (10 μL) was
added, and the plate was incubated at 37 °C for 30 min. Final HDAC
concentrations: HDAC1, 6 ng/μL; HDAC2, 2 ng/μL; HDAC3−
NCoR1, 0.2 ng/μL; HDAC6, 2.4 ng/μL; HDAC8, 0.2 ng/μL;
HDAC10, 14 ng/μL; and HDAC11, 10 ng/μL. Then trypsin (25 μL,
0.4 mg/mL) was added, and the assay development was allowed to
proceed for 15−30 min at room temperature before the plate was read
using a PerkinElmer Enspire plate reader with excitation at 360 nm
and detecting emission at 460 nm. Each assay was performed in
duplicate. The data were analyzed by nonlinear regression using
GraphPad Prism to aﬀord IC50 values from the dose−response
experiments, and Ki values were determined from the Cheng−Prusoﬀ
equation [Ki = IC50/(1 + [S]/Km)] assuming a standard fast-on−fast-
oﬀ mechanism of inhibition.
NMR Spectroscopy. NMR spectra were acquired using standard
pulse sequences on a Unity Inova 500 Varian spectrometer (499.9
MHz for 1H, 125.7 MHz for 13C) or a Bruker Avance 800 MHz
spectrometer (798.9 MHz for 1H and 200.9 MHz for 13C) located at
the Danish Instrument Centre for NMR Spectroscopy of Biological
Macromolecules at Carlsberg Laboratory. The deuterated solvent used
for all compounds was DMSO-d6. For typical homonuclear 2D
experiments, 4096 data points were recorded in the direct dimension
and 512 in the indirect dimension. Typical d1 times were from 2 to 4
s, which were found to give identical results compared to 7 s (>5 × T1
of the longest T1). The T1 times were investigated for 5a and a model
compound (9c attenuated at C6), and most nuclei were found to have
T1 values up to approximately 1 s with a few aromatic protons
exhibiting up to 1.3 s relaxation times. All J-couplings were extracted
from the 1D 1H and DQF-COSY spectra. Distances were obtained
from 2D NOESY or ROESY experiments using the isolated spin pair
approximation (ISPA),39,40 and the linear range was increased by the
method suggested by Macura et al.50 The used mixing time was 150
ms for all compounds. Initially, diﬀerent mixing times were applied to
construct build-up curves to ensure the use of only cross-peaks that ﬁt
ISPA. The J-couplings from angles were calculated by the Karplus
equation51 as well as the HLA equation52 for the β-peptide protons.
Prime/MMGBSA Binding Energy Estimation. We estimated
binding free energies (dG_Bind) with Prime/MMGBSA (Prime
version 3.3, Schrödinger, LLC, New York, NY, 2013) calculations on
the Embrace-optimized complexes of HDAC3 and azumamide E
analogues generated with the “mutation” approach (see the
Supporting Information, Methods for details). The computational
protocol was tested with the following settings for receptor and ligand
ﬂexibility: (a) frozen Zn2+ and coordinating residues, ﬂexible
azumamide, and residues within 6 Å of azumamide, (b) ﬂexible Zn2+
and coordinating residues, ﬂexible azumamide, and residues within 6 Å
of azumamide, (c) frozen receptor and ﬂexible azumamide, (d) frozen
receptor and frozen ligand, and (e) repetition of the latter calculation
without water and K+. To ensure movement of the same residues
across all complexes in calculations with receptor ﬂexibility, the
residues used throughout were those detected within a 6 Å radius of
the substrate in the azumamide E:HDAC3 complex. Results from
Prime/MMGBSA calculations are given in Supporting Information,
Table S17.
DFT. The interaction between the β2-substituent in azumamide E
analogues and Phe200 in HDAC3B was further examined with density
functional theory (DFT) calculations. Because the size of HDAC3−
azumamide complexes precluded DFT calculations on the entire
systems, we carried out the calculations on two truncated model
systems referred to as “small” and “large” generated from each
Embrace optimized complex. The small system consisted of the
HDAC3B Phe200 side chain and the azumamide β2-carbon and its
substituents (hydrogen, methyl, or dimethyl). The large system
consisted of the HDAC3B Phe200 side chain and the entire
azumamide. For both types of systems, any bonds broken by the
excision from the Embrace complexes were saturated with hydrogen.
The interaction energy between the Phe200 side chain and azumamide
β2-substituent was calculated in Jaguar (version 8.1, Schrödinger, LLC,
New York, NY, 2013) at the B3LYP-D3/cc-pvtz level of theory using
the counterpoise (CP) correction for the basis set superposition error
(BSSE).53 To preserve Embrace geometries, no geometry optimization
was employed during the counterpoise calculations.
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Abstract: Investigation of the chemical profile of the industrially important black 
filamentous fungus Aspergillus aculeatus by UHPLC-DAD-HRMS and subsequent 
dereplication has led to the discovery of several novel compounds. Isolation and extensive 
1D and 2D NMR spectroscopic analyses allowed for structural elucidation of a 
dioxomorpholine, a unique okaramine, an aflavinine and three novel structures of mixed 
biosynthetic origin, which we have named aculenes A–C. Moreover, known analogues of 
calbistrins, okaramines and secalonic acids were detected. All novel compounds were 
tested for antifungal activity against Candida albicans, however all showed only weak or 
no activity. Aspergillus aculeatus IBT 21030 was additionally shown to be capable of 
producing sclerotia. Examination of the sclerotia revealed a highly regulated production of 
metabolites in these morphological structures.  
Keywords: Aspergillus aculeatus; Aspergilli; natural products; secondary metabolism; 
dereplication; sclerotia 
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1. Introduction 
Aspergillus aculeatus is a filamentous fungus belonging to Aspergillus section Nigri—the black 
aspergilli. At least 145 metabolites have been characterized from the black aspergilli [1], many of which 
are biologically active. Naphtho-γ-pyrones (NGPs) such as aurasperone A and rubrofusarin B from A. 
niger are known to be antifungal [2], while other NGPs are reported to have antitumor activities [3]. 
Mycotoxins produced by A. niger, such as ochratoxin A [4] or the fumonisins [5] are also known.  
The black aspergilli can be divided into different clades. A. aculeatus belongs to the uniseriate  
black aspergilli and is closely related to A. aculeatinus, A. uvarum, A. japonicus, A. fijiensis,  
A. trinidadensis, A. floridensis, A. brunneoviolaceus and A. violaceofuscus [6,7]. These fungi differ 
from the other black aspergilli in their morphology, physiological behavior and in the production of 
secondary metabolites. The fungi belonging to this group can produce secondary metabolites, which can 
be both polyketide (PK) and nonribosomal peptide (NRP) derived or of mixed biosynthetic origin [1]. 
Several metabolites, including aculeacins A–G [8,9], CJ-15,183 [10], secalonic acids D and F [11] and 
okaramines H and I [12], have been reported in fungi identified as A. aculeatus. Furthermore, 
asperaculin A [13], aspergillusol A [14] and aculeatusquinones A–D [15] have been reported in marine 
strains of A. aculeatus. Different biological activities are reported for these metabolites, including 
antifungal (aculeacins A-G and CJ-15,183), enzyme inhibitory (CJ-15,183 and aspergilluson A), 
antimicrobial activities (secalonic D and F) and cytotoxicity (aculeatusquinone B and D). 
While some black aspergilli are important in the biotechnological industry for production of 
enzymes and organic acids [16,17], some species can also be food and feed contaminants [18]. In fact, 
the black aspergilli are among the most common fungi connected to postharvest decay of fruit, beans 
and nuts, and A. aculeatus is no exception [18,19].  
A. aculeatus is used to produce important industrial enzymes such as cellulases [20],  
xylanases [21,22] and proteases [23], which are used commercially in the food and feed industries. 
Moreover a marine strain of A. aculeatus has tested active against Staphylococcus aureus [24]. Based 
on both the industrial applications of A. aculeatus as well as food and feed contamination hazards it is 
of great importance to know what metabolites are being produced by this fungus. The aim of the 
current work has been to investigate the chemical profile of A. aculeatus seeking to discover novel 
compounds and to test for the antifungal activity of its metabolites. 
2. Results and Discussion 
Initial analysis of the chemistry of A. aculeatus involved two strains (IBT 21030 and IBT 3244) 
which were investigated on a series of solid media (YES, CYA, MEA, OAT and CREA) [25]. The 
strains were cultivated at 25 and 30 °C in the dark for 7 days and were investigated with micro-scale 
extractions [26]. The secondary metabolite profiles were analyzed with UHPLC-DAD-HRMS, which 
demonstrated that the strains showed highly similar chemical profiles. However, more metabolites 
were produced by the A. aculeatus IBT 21030 strain, hence this strain was chosen for further work. 
The medium used in the cultivations had varying effect on metabolite production. While cultivation on 
MEA, OAT and CREA did not lead to diverse production, cultivation on both CYA and YES lead to 
production of several different metabolites. The YES medium was selected for further work, and it was 
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found that the optimal cultivation temperature was 25 °C. The A. aculeatus strain was inoculated on 
YES media and incubated at 25 °C and analyzed after 2, 4, 7, and 10 days to test the effect of 
incubation time on the metabolite production. These experiments showed that 7 days of incubation 
gave the optimum production of secondary metabolites. Based on these initial experiments,  
A. aculeatus was inoculated on 200 plates of YES and incubated at 25 °C for seven days in the dark. 
The results of the dereplication as well as isolation and elucidation of novel compounds are depicted  
in Figure 1. 
Figure 1. Base peak chromatogram illustrating the dereplication of some of the major 
compounds in the extract from A. aculeatus IBT 21030 as well as the results of purification 
and structural elucidation of novel compounds. Based on cultivation on YES media for  
7 days at 25 °C in the dark. * Novel compounds reported here for the first time.  
** Compounds reported from A. aculeatus for the first time. 
 
Dereplication was performed by UV- and HRMS-data to identify known compounds. An in-house 
library of microbial metabolites [27] as well as the AntiBase 2012 natural products database [28] were 
used for identification. Many of the major peaks could be dereplicated as compounds already known to 
be produced by A. aculeatus (Figures 1 and 2). This included secalonic acids D and F [11], as well as 
okaramines A and H [12]. One further okaramine was produced, which could not be unambiguously 
dereplicated, since the HRMS and UV data pointed towards either okaramine C, J or L. The compound 
was isolated and the structure was elucidated by 1D and 2D NMR and the structure was established to 
correspond to okaramine J, which has previously been described from Penicillium ochrochloron 
(formerly identified as Penicillium simplicissimum) [29,30]. 
Two calbistrin analogues could also be dereplicated from A. aculeatus. Calbistrins A–D, have been 
described from Penicillium restrictum by Jackson et al. [31] and the structures of the four compounds 
were later elucidated by the same group [32]. Calbistrin A is biologically active as an antifungal agent, 
a promoter of nerve growth factor production and a cholesterol lowering agent. Identification of the two 
calbistrins was not possible solely based on HRMS and DAD data, as calbistrins pairwise have the same 
molecular formula (A and B have the same molecular formula and likewise for calbistrins C and D). The 
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two compounds were therefore isolated and their structures elucidated by 1D and 2D NMR, and it was 
shown that the two compounds produced by A. aculeatus were calbistrin A and C, Figure 2. 
Figure 2. Known compounds dereplicated from A. aculeatus. Okaramines A and H as well 
as secalonic acids have previously been reported from the organism, whereas the 
calbistrins and okaramine J are reported from A. aculeatus for the first time. 
 
2.1. A Novel Class of Compounds, Named the aculenes, Has a Mixed Biosynthetic Origin 
The two major metabolites produced by A. aculeatus, aculenes A and B (Figure 1) have previously 
been detected by UHPLC-DAD-HRMS in the related black aspergillus A. saccharolyticus [33], but the 
structures have not been elucidated. The molecular formulae of the two compounds were determined 
by HRMS to be C19H25NO3 and C19H27NO3, respectively. The mass difference of 2 Da and the fact that 
the two compounds eluted very close to each other suggested that the compounds were related and 
only differed by a double bond. The UV-spectra differed greatly as depicted in Figure 3, indeed 
indicating aculene A to contain a more conjugated chromophore. 
The structures of the two compounds were elucidated by 1D- and 2D NMR spectroscopy and the 
structures of aculenes A and B are depicted in Figure 4. The conjugation in aculene A was in 
agreement with the recorded UV spectrum. The only difference with aculene B is the absent double 
bond between C-11 and C-12 and as seen, this structure was also in accordance with the obtained UV 
spectrum. The 1H-NMR spectra of both aculenes A and B revealed the presence of one Hα proton  
(H-5), which was found to be in a COSY spin system with three methylene groups (H-2, H-3 and H-4), 
which where elucidated as a proline ring. The remaining resonances in the 1H-NMR spectra belonged 
to a fused five and seven membered ring system. The linking between the COSY spin systems for this 
part and assignments of the quaternary carbons were accomplished through detailed analysis of the 
Molecules 2014, 19 10902 
 
 
HMBC experimental data. Some of the important HMBC correlations for the elucidation of aculene B 
are depicted in Figure 5. 
Figure 3. UV-spectra of selected A. aculeatus metabolites. The remaining UV spectra can 
be found in the Supporting Information. 
 
Figure 4. The structure of aculenes A–D. The structures of aculenes A–C have been 
verified by 1D and 2D NMR spectroscopy, whereas the structure of aculene D has been 
suggested based on UHPLC-DAD-HRMS data. The stereochemistry shown is relative. 
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Figure 5. A. Important HMBC correlations in the elucidation of aculene B.  
B. The NOEs used to solve the stereochemistry. Similar HMBCs and NOEs were observed 
for aculenes A and C, see Table 1 and Supplementary Table S2. 
 
Table 1. 1H-NMR spectroscopic data (500 and 800 MHz, DMSO-d6) and HMBCs for aculenes A–C. 
 Aculene A Aculene B Aculene C 
Position δH (J in Hz) HMBC δH (J in Hz) HMBC δH (J in Hz) HMBC 
1 - - - -   
2 3.15 (m) - 3.21 (m) 3,4,5   
2' 3.09 (m) - 3.14 (m) 3,4,5   
3 1.83 (m) - 1.84 (m) 2,4,5   
3' 1.67 (m) - 1.76 (m) 2,4,5   
4 1.94 (m) 2,6 2.05 (m) 2,3,5,6   
4' 1.46 (m) 2,6 1.55 (m) 2,6   
5 4.23 (t 7.7) 6 4.31 (t 7.8) 2,3,4,6   
6 - - - -   
7 5.33 (dd 4.4, 2.4) - 5.28 (dd 5.3, 2.3) 6,9,12,16 3.95 (t 3.5) 9,13,15 
8 2.82(br.d 20.8) - 2.67 (br. d 19.1) 16 2.52 (br. d 20.1)  
8' 2.55 (m) 9,10,16 2.37 (m) 7,9,10,16 2.31 (m) 7,9,10,16 
9 - - - - - - 
10 5.98 (d 7.4) 8,12,18 5.56 (m) 8,11,12,18 5.87 (d 7.3) 8,12,18 
11 6.24 (d 7.4) 9,13,16 2.12 (m) - 6.08 (d 7.4) 9,13,16 
11' - - 2.52 (m) 18 - - 
12 - - 3.31 (m) 10,11,14 - - 
13 - - - - - - 
14 6.03 (s) 
12,13,15,16,1
9 
5.81 (q 1.8) 12,13,15,16,19 5.93 (s) 
12,13,15,16,
19 
15 - - - - - - 
16 - - - - - - 
17 0.96 (s) 7,12,15,16 0.96 (s) 7,12,15,16 0.79 (s) 7,12,15,16 
18 1.85 (s) 8,9,10 1.68 (s) 8,9,10 1.82 (s) 8, 9,10 
19 2.55 (m) 13,20 2.39 (m) 13,14,20 2.48 (m) 12,13,14,20 
20 1.16 (t 7.4) 13,19 1.11 (t 7.3) 13,19 1.14 (t 7.4) 13,19 
-OH - - - - 4.43 (s) - 
The NMR data for aculene A were very comparable to those of aculene B (Tables 1 and 2), yet 
differences were observed corresponding to the additional double bond in aculene A. The chemical 
shift of H-10 and H-14 is seen to differ slightly and furthermore an additional resonance was present in 
the 1H-NMR spectrum in the aromatic/alkene area for compound A. This was located at a chemical 
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shift of δH = 6.24 ppm and assigned H-11. The only other location where the spectrum differed 
significantly was due to the extra diastereotopic CH2 groups in the 7-membered ring of aculene B. For 
this, and the diastereotopic CH2 group H8/H8' present in both compounds, rather large coupling 
constants were observed due to the geminal coupling. In compound A the H-8 doublet had a coupling 
constant of 20.8 Hz. Another notable chemical shift is the carbon chemical shift of C-13. This was at 
δC = 175.3 and 183.8 ppm, respectively for the two compounds, which is rather far downfield.  
Table 2. 13C-NMR spectroscopic data (125 and 200 MHz, DMSO-d6) for aculenes A–C. 
Position 
Aculene A Aculene B Aculene C 
δC δC δC 
1 - - - 
2 45.1 44.7 - 
3 22.3 22.3 - 
4 27.6 27.6 - 
5 58.4 58.3 - 
6 168.0 167.8 - 
7 72.9 73.5 67.6 
8 36.5 35.5 40.2 
9 141.7 130.7 142.5 
10 120.0 122.7 119.7 
11 118.5 24.9 117.8 
12 142.5 44.6 144.3 
13 175.3 183.8 174.3 
14 125.3 122.8 125.6 
15 205.8 208.2 208.2 
16 51.7 54.4 53.6 
17 17.9 17.1 18.3 
18 26.9 28.3 27.1 
19 20.1 23.1 19.8 
20 12.0 10.8 11.8 
A third and related compound (aculene C) was also characterized. The UV spectrum was similar to 
the UV spectrum observed for aculene A (Figure 3) and the molecular formula was determined by 
HRMS to be C14H18O2. The NMR data was comparable to that of aculene A (Tables 1 and 2), though 
with an absence of resonances originating from the proline part. Elucidation of the structure revealed 
that the compound was related to the aculenes, therefore it was named aculene C (Figure 4). Aculene C 
is a likely precursor to aculene A, having the same carbon skeleton, but missing the proline moiety. 
Analysis of the UHPLC-DAD-HRMS data showed a fourth compound, eluting close by aculene C, 
present in minute amounts, with a mass difference of 2 Da compared to aculene C, and with a UV 
spectrum very similar to aculene B (Figure 3). The HRMS data displayed the same adducts and 
fragmentation pattern as observed for aculene C. This compound, aculene D, is believed to have a 
similar structure as aculene C, but with the absence of the double bond between C-11 and C-12, as 
seen with the relation between aculenes A and B. This structure has not been verified by  
NMR experiments. 
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The stereochemistry of aculenes A-C was elucidated by NOEs, J-couplings and Marfey’s reaction [34], 
from which it was determined that aculenes A and B contained L-proline. The stereocenters (C-5, C-7 
and C-16) of aculenes A and B could not be connected, due to lack of NOEs from the proline to the 
bicyclic system and the free rotation of proline. The relative stereochemistry of stereocenters C-7 and 
C-16, as well as C-12 for aculene B, is depicted in Figure 4, suggested by NOEs and backcalculated  
3J-couplings of H-7 (see Supplementary Figure S37 and Supplementary Tables S1 and S2). Relevant 
NOEs are depicted for aculene B in Figure 5. 
We hypothesize the biosynthesis of the aculenes to originate from a terpene pathway. Aculene C 
and D consist of fourteen carbons, which could originate from a sesquiterpene with the loss of one 
carbon atom, possibly at C9. Aculene A and B furthermore contain the amino acid proline. 
The two compounds marked as acucalbistrin A and B in Figure 1 were also targeted. These 
compounds were intriguing because they could not be dereplicated, and because the HRMS data 
suggested that the size were somewhat larger than typical secondary metabolites. The molecular 
formulas for the two compounds were determined to be C50H63NO10 and C50H65NO10, the mass spectra 
are depicted in Figure 6. 
Figure 6. Mass spectra of acucalbistrin A (top) and acucalbistrin B (bottom). A fragment 
corresponding to m/z of the molecular ion [M+H]+ of aculene A (*) and aculene B (**) are 
observed for acucalbistrin A and B respectively. 
 
A feature noted in both mass spectra was a fragment corresponding to the mass of aculenes A and 
aculene B, respectively. Different chromatographic approaches were taken to purify both compounds, 
which however proved challenging as the compounds were unstable even under mild conditions. 
Apparently acucalbistrin A was degrading to aculene A and another compound X, while acucalbistrin 
B was degrading to aculene B and the same compound X. Analysis by UHPLC-DAD-HRMS of a 
small semipreparative proportion of this degradation product revealed to our surprise this compound to 
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be calbistrin A. This was verified by the UHPLC-DAD-HRMS data by comparison to the known 
compounds, see Supplementary Figure S39. 
The combined mass of aculene A and calbistrin A is higher than that of acucalbistrin A (and the 
same for the case of acucalbistrin B), where the difference corresponds to a single water molecule. We 
therefore hypothezise that the acucalbistrins undergo hydrolysis and with knowledge on the structures 
of aculenes A–B and calbistrin A, a possible structure could therefore be an amide bond between the 
nitrogen in the proline moiety in aculene to the carbonyl in the carboxylic acid part of calbistrin A (see 
Supplementary Figure S38). This would account for the observed masses. These acucalbistrin structures 
have not been verified by NMR spectroscopy. We note that the UV spectra of acucalbistrin A and B 
have UVmax values comparable to those observed for calbistrin A (Figure 3). The slight shift observed 
may be due to the aculene moiety being attached directly to the carboxylic acid, which is part of the 
conjugated system in calbistrin A. The proposed structures are given in Supplementary Figure S38. 
2.2. Discovery of Novel Indole Terpenoids 
Three other compounds were isolated and structure elucidated resulting in the novel compounds 
acu-dioxomorpholine, okaramine S and epi-10,23-dihydro-24,25-dehydroaflavinine with the structures 
shown in Figure 7. 
Figure 7. The structure of acu-dioxomorpholine, okaramine S and epi-10,23-dihydro-
24,25-dehydroaflavinine. 
 
NMR data for the compounds are presented in Table 3, Table 4, and Table 5, respectively. The 
structure of acu-dioxomorpholine reminds one of a diketopiperazine, but this structure differs in that it 
contains a lactone. The chemical shift of the proton adjacent to the lactone oxygen (H-3) clearly differs 
compared to the chemical shift of a proton in ordinary diketopiperazines, which is typically reported to 
be around δH = 3.50–4.50 ppm [35,36]. For acu-dioxomorpholine the proton chemical shift is  
δH = 5.32 ppm. The carbon chemical shift of C-3 is also shifted significantly downfield, with δC = 78.1 
ppm for the acu-dioxomorpholine, compared to around 60 ppm for diketopiperazines. Two compounds 
have been reported by Wang et al. with the same lactone feature [37], but differ by having leucine 
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incorporated instead of phenylalanine and by lacking the N-methylation. Otherwise the NMR data  
are comparable.  
NOESY experiments enabled determination of the relative stereochemistry of acu-dioxomorpholine. 
NOE connectivities were found between H-3 and H-16 placing these protons on the same side of the 
ring system. These had no NOE connectivities to H-6, which however displayed NOE connectivities to 
H-22 as well as several of the protons in the prenyl moiety (H-18, H-19, H-19' and H-20), strongly 
indicating the positioning of the prenyl group and H-6 on the other side of the ring system as compared 
to H-3 and H-16. 
Table 3. NMR spectroscopic data (500 and 800 MHz, DMSO-d6) for acu-dioxomorpholine. 
Position δH (J in Hz) δC  HMBC Noesy 
1 - 168.0 - - 
2 2.96 (3H, s) 32.7 6, 8 6,9 
3 5.32 (1H, dd, 8.8, 3.4) 78.1 4, 22, 23 16, 22, 22', 24/28 
4 - 163.5 - - 
5 - - - - 
6 5.43 (1H, s) 81.9 2, 4, 8, 13, 14, 15, 16, 17 12, 18, 19, 19', 20, 22 
7 - - - - 
8 - 150.8 - - 
9 6.44 (1H, d, 7.6) 105.6 11, 13 2, 10 
10 7.09 (1H, td, 7.6, 0.8) 128.5 8, 12 9, 11 
11 6.64 (1H, t, 7.3) 116.9 9, 12, 13 10, 12 
12 7.17 (1H, d, 7.3) 124.1 8, 10, 14 11, 15, 18, 20, 21 
13 - 128.8 - - 
14 - 59.6 - - 
15 2.43 (1H, dd, 12.7, 6.6) 36.6 1, 6, 13, 14, 16 12, 15', 16 
15' 2.21 ( 1H, dd, 12.7, 11.1) 36.6 1, 13, 14, 16 15, 16, 18, 20, 21 
16 4.17 (1H, dd, 11.1, 6.6) 56.7 1, 15 3, 15, 15' 
17 - 40.1 - - 
18 5.87 (1H, dd, 17.4, 11.0) 143.3 14, 17, 21 6, 12, 15', 19, 19', 20, 21 
19 5.02 (1H, dd, 17.4, 1.1) 113.7 14, 17, 18  6, 18, 19', 20, 21 
19' 5.06 (1H, dd, 11.0, 1.1) 113.6 14, 17, 18 6, 18, 19, 20, 21 
20 0.82 (3H, s) 22.4 14, 17, 18, 21 6, 12, 15', 18, 19, 19', 21 
21 0.97 (3H, s) 21.7 14, 17, 18, 20 12, 15', 18, 19, 19', 20 
22 2.98 (1H, dd, 14.8, 8.8) 34.9 3, 4, 23, 28 3, 6, 22', 24/28 
22' 3.33 (1H, m) 34.9 3, 4, 23, 28 3, 22, 24/28 
23 - 136.3 - - 
24 7.26 (1H, m) 129.2 22, 26, 28 3, 22, 22' 
25 7.28 (1H, m) 127.7 - 26 
26 7.22 (1H, tt, 7.2, 1.6) 126.2 28 25 
27 7.28 (1H, m) 127.7 23, 25 - 
28 7.26 (1H, m) 129.2 - 3, 22, 22' 
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Table 4. NMR spectroscopic data (500 and 800 MHz, DMSO-d6) for okaramine S. 
Position δH (J in Hz) δC  Hmbc Noesy 
1 7.64 (1H, s) 114.7 2, 4, 14, 15 - 
2 - 123.8 - - 
4 - 137.6 - - 
5 4.26 (1H, q, 6.5) 43.2 4, 14, 18 18 
6 - 51.2 - - 
7 5.87 (1H, s) - 5, 9, 13, 17 9 
8 - 144.5 - - 
9 6.90 (1H, d, 7.6) 118.8 11, 13 10 
10 6.99 (1H, t, 7.6) 127.4 8, 12 9 
11 6.65 (1H, t, 7.6) 116.8 9, 13 12 
12 7.74 (1H, d, 7.6) 128.3 8, 10, 14 1,11 
13 - 115.3 - - 
14 - 124.9 - - 
15 - 153.4 - - 
16 0.95 (3H, s) 27.1 5, 6, 17 17 
17 1.39 (3H, s) 29.3 5, 6, 16 16 
18 1.18 (3H, d, 7.2) 18.1 4, 5, 6 - 
19 7.76 (1H, s) 117.5 20, 25, 32, 33, 34 - 
20 - 125.2 - - 
22 5.90 (1H, d, 8.3) 123.6 23, 24 23 
23 6.15 (1H, d, 8.3) 140.2 22, 24, 35/36 22 
24 - 35.8 - - 
25 - 149.8 - - 
26 11.70 (1H, s) - 25, 32, 33 - 
27 - 134.2 - - 
28 7.44 (1H, m) 112.3 - 29/30 
29 7.17 (1H, m) 121.7 31 28, 31 
30 7.17 (1H, m) 121.7 31 28, 31 
31 7.63 (1H, m) 116.1 27, 29/30 12, 29/30 
32 - 105.3 - - 
33 - 129.5 - - 
34 - 157.6 - - 
35 1.69 (3H, s) 26.7 23, 24, 25, 35/36 - 
36 1.69 (3H, s) 26.7 23, 24, 25, 35/36 - 
For okaramine S the molecular formula was by HRMS predicted to be C32H30N4O2. The 
azocinoindole part of the novel okaramine (Figure 7) is identical to that observed in okaramines A and 
H (Scheme 1), also produced by A. aculeatus [12]. The remaining part is highly similar, also 
originating from tryptophan and an isoprene unit, but in okaramine S, the terpene is fused with the ring 
system of the tryptophan moiety resulting in an intriguing, additional seven-membered ring, not 
previously reported in any okaramine. Key HMBCs from this part of okaramine S are depicted  
in Figure 8. 
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Table 5. NMR spectroscopic data (500 MHz, DMSO-d6) for epi-10,23-dihydro-24,25-
dehydroaflavinine. 
Position δH (J in Hz) δC  HMBC H2BC NOESY 
1 10.66 (s) - 2, 3, 4, 9 2 2,8 
2 7.07 (d 2.0) 122.7 3, 4, 9 - 1, 23, 25, 27 
3 - 114.4 - -  
4 - 126.7 - -  
5 7.38 (d 7.8) 116.8 7, 9 6 10, 11, 18 
6 6.96 (t 7.2) 117.7 4, 8 5, 7  
7 7.02 (t 7.3) 120.0 5, 9 6, 8  
8 7.29 (d 8.0) 110.9 4, 6 7 1 
9 - 135.5 - -  
10 3.59 (dd 13.3, 5.0) 33.4 2, 3, 11, 12, 23, 24 11, 23 5, 11, 19, 25, 26 
11 2.47 (m) 37.6 10, 12, 23 10, 12 5, 10, 12, 13, 16, 19 
12 1.27 (m) 28.9 - 17 11 
13 1.53 (m) 28.1 29 - 11, 13', 16 
13' 0.81 (d 12.9) 28.1 - - 13 
14 1.46 (m) 27.4 - -  
14' 1.08 (d 13.7) 27.4 27 - 28 
15 - 38.2 - -  
16 2.04 (m) 30.4 - 17, 28 11, 13, 17', 28 
17 1.71 (m) 24.8 - 18  
17' 1.22 (m) 24.8 - -  
18 1.99 (d 11.3) 29.6 - - 5, 19 
18' 1.74 (m) 29.6 - - 19, 30 
19 4.64 (s) 65.6 - - 10, 11, 18, 18', 22, 26
20 - 42.9 - -  
21 2.07 (m) 23.5 - - 29, 30 
21' 1.65 (m) 23.5 19, 23 - 27 
22 1.85 (m) 26.6 20, 24 21, 23 19, 30 
22' 1.54 (m) 26.6 - -  
23 3.13 (m) 42.3 24, 25, 26 10, 22 2, 25, 27 
24 - 149.8 - -  
25 4.81 (d 1.8) 110.4 23, 26 26 2, 10, 23, 25' 
25' 4.58 (d 1.8) 110.4 23, 26 26 25, 26 
26 1.45 (s) 17.7 23, 24, 25 - 10, 19, 25' 
27 1.21 (s) 21.1 11, 12 12 2, 21', 23 
28 0.71 (d 6.7) 15.4 15, 16, 17 16 14', 16, 17' 
29 0.92 (s) 17.7 13, 15, 16, 20 - 17, 21, 30 
30 4.28 (d 4.3) - 19, 20 19 18', 21, 22, 29 
The molecular formula of the aflavinine analogue was predicted by HRMS to be C28H39NO  
and dereplication indicated it could be aflavinine or an analogue. Since no aflavinine or analogue was 
previously described in A. aculeatus, this compound was also a target for isolation and structural 
elucidation. The NMR data, see Table 5, suggested the structure of 10,23-dihydro-24,25-dehydroaflavinine. 
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Figure 8. Key HMBCs substantiating the seven-membered ring in okaramine S. 
 
10,23-Dihydro-24,25-dehydroaflavinine has earlier been reported from sclerotia from A. flavus,  
A. parasiticus and A. tubingensis [38]. The compound has not been reported from A. aculeatus, but it is 
known to be produced by the related black Aspergillus A. costaricaensis [39]. The stereochemistry of 
epi-10,23-dihydro-24,25-dehydroaflavinine was solved by the use of NOEs and J-couplings. The 
relative stereochemistry was found to be equal to that of 10,23-dihydro-24,25-dehydroaflavinine [38]. 
For investigation of the absolute configuration of the purified compound, optical rotation was measured. 
Two different values were obtained, [α] = 63.58° and [α] = 9.08° in MeOH and CHCl3 respectively. 
These values were compared to the value of [α]D = −1.20°, which has earlier been reported for  
10,23-dihydro-24,25-dehydroaflavinine in CHCl3 [38]. Due to those opposite signs, our result suggests that 
the compound from A. aculeatus is the enantiomer of 10,23-dihydro-24,25-dehydroaflavinine, 
wherefore we have named it epi-10,23-dihydro-24,25-dehydroaflavinine. The 3D structure (see 
Supplementary Figure S40) was suggested by the isolated spin pair approximation [40]. 
2.3. Biological Testing of the Novel A. aculeatus Metabolites 
Aculenes A–C, acu-dioxomorpholine, okaramine S and epi-10,23-dihydro-24,25-dehydroaflavinine 
were tested for antifungal activity against Candida albicans. Endpoint optical density from compound 
screens were normalized with the negative controls and susceptibility evaluated as percentage 
reduction in optical density. None of the compounds showed significant antifungal activity. 
2.4. Production of Sclerotia Reveals a Highly Regulated Metabolic Profile 
It has recently been demonstrated that sclerotium production can be prompted under specific 
conditions for a number of the black aspergilla [41]. This study showed that some metabolites are 
highly upregulated inside the sclerotia, compared to the metabolites in the mycelium. A. aculeatus is 
capable of producing sclerotia in vast amounts. Production was demonstrated on CYA and YES media, 
see Figure 9. 
Analysis of extracts of sclerotia from MM, CYA and YES showed large upregulations of 
okaramines, see Figure 10. Aculenes A–C were still produced, though in smaller amounts. 
Furthermore the analysis showed that production of secalonic acids abolished on MM and CYA. The 
calbistrins were still produced and the same were acucalbistrins A–B, though in trace amounts. Some 
okaramine analogues have shown activity against silkworms [42–44] and the substantial upregulation 
of okaramines can be connected to sclerotium production as a defense mechanism to protect  
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against insects. Sclerotia are survival structures and the production is often provoked by extreme  
conditions [41,45]. 
Figure 9. The figure shows production of sclerotia on YES (left) and CYA media (right) 
after growth for 7 days at 25 °C in the dark. The sclerotia are the white to cream-colored 
structures seen among the black conidial Aspergillus heads.  
 
Figure 10. Base peak chromatograms of extraction from sclerotia (top) and plug 
extractions of A. aculeatus IBT 21030 after cultivation on YES agar for 7 days at 25 °C in 
the dark (bottom) for reference. The chromatograms are to scale. Stars indicate okaramines 
produced in the sclerotium extract.  
 
3. Experimental Section  
3.1. Fungal Growth, Strains and Media 
For standard screening the fungal strain was inoculated as three point stabs on solid media and 
incubated for seven days at 25 °C. Media was prepared as described by Samson et al. [25] The strain 
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IBT 21030 was compared to the culture ex type IBT 3244 = CBS 172.66 = ATCC 16872 = IMI 
211388 = WB 5094, in order to authenticate the identity of the isolate.  
3.2. Large Scale Extraction 
For the large scale preparation, A. aculeatus (IBT 21030) was inoculated as three point stabs on 200 
plates of solid YES medium, and incubated in the dark for 7 days at 25 °C. The fungi were harvested 
and extracted. Ten Petri plates of fungi were transferred to separate stomacher bags. To each bag  
100 mL of ethyl acetate (EtOAc) containing 1% formic acid (FA) were added and the bags were 
subsequently crushed using a stomacher for 30–60 s. After one hour the liquid phase was filtered and 
concentrated in vacuo. The stomacher bags still containing the fungi were again filled with EtOAc 
containing 1% FA, and then left overnight. The following day the solution was filtered and then 
concentrated in vacuo. The combined extract was dissolved in 800 mL methanol (MeOH) and H2O 
purified and deionized by a Millipore system through a 0.22 μm membrane filter (MQ H2O) (9:1) and 
800 mL of heptane added, whereafter the phases were separated. To the MeOH/MQ H2O phase  
800 mL MQ H2O was added, and metabolites were then extracted with 4 × 400 mL dichloromethane 
(DCM). The phases were then concentrated separately in vacuo. 
3.3. Plug Extraction 
For standard screening three plugs were taken from one colony by use of a 6 mm plug drill; one 
from the center of the colony, one from the edge near the other colonies and one from the edge as far 
away from the other colonies. The plugs were transferred to 2 mL vials and 500 µL extraction solvent 
were added. A mixture of MeOH/DCM/EtOAc (1:2:3 v/v/v) containing 1% FA was used. To each 
sample 40 μL chloramphenicol in ethanol (500 μg/mL) was added as an internal standard. The vials 
were placed in an ultrasonic bath (Branson 2510 or 3520) for 60 min. The extract was then transferred 
to a clean vial and evaporated to dryness. This was either achieved by leaving the vials in a fume hood 
over night or by applying nitrogen airflow at 25–32 °C. After evaporation 500 µL MeOH was added 
and the sample was then ultrasonicated for 20 minutes. The extract was then filtered using a 0.45 μm 
PTFE filter. 
3.4. Sclerotium Extraction 
A. aculeatus IBT 21030 was three-point inoculated on YES, CYA and MM plates and incubated at 
30 °C for ten days and then at room temperature for eight days. Sclerotia were harvested by applying 
MQ H2O to the plate and carefully harvest with Drigalski spatula. The liquid including the sclerotia 
and spores was filtred through sterilised Miracloth and washed with MQ H2O, allowing for the spores to 
pass through, while sclerotia were staying in the filter. Sclerotia were transferred to true Eppendorf tubes 
and washed with water to remove remaining spores. After evaporation of excess MQ H2O, two big and two 
small steel balls was added to each tube and the tubes were shaken at 2000 rpm for 2 × 60 s. To each tube 
40 µL chloramphenicol (internal standard) and 1 mL MeOH/DCM/EtOAc (1:2:3 v/v/v) containing 1% 
FA was added and the extract was transferred to clean 2 mL vials. The samples were ultrasonicated for 
1 h and the extract was transferred to clean vials and solvent was evaporated by applying airflow at 
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25–32 °C. The samples were redissolved in 500 µL MeOH, ultrasonicated for 20 min and filtrated to 
fresh vials using 0.45 μm PTFE filters. 
3.5. UHPLC-DAD-HRMS Analysis 
Analysis was performed using ultra-high-performance liquid chromatography (UPHLC) UV/Vis 
diode array detector (DAD) high-resolution MS (TOFMS) on a maXis 3G orthogonal acceleration 
quadrupole time of flight mass spectrometer (Bruker Daltonics, Bremen, Germany) equipped with an 
electrospray ionization (ESI) source and connected to an Ultimate 3000 UHPLC system (Dionex, 
Sunnyvale, CA, USA). The column used was a reverse-phase Kinetex 2.6-μm C18, 100 × 2.1 mm 
(Phenomenex, Torrance, CA, USA), and the column temperature was maintained at 40 °C. A linear  
water-acetonitrile (ACN) (LCMS-grade) gradient was used (both solvents were buffered with 20 mM 
FA) starting from 10% (vol/vol) ACN and increased to 100% in 10 min, maintaining this rate for 3 min 
before returning to the starting conditions in 0.1 min and staying there for 2.4 min before the following 
run. A flow rate of 0.4 mL·min−1 was used. TOFMS was performed in ESI+ with a data acquisition 
range of 10 scans per second at m/z 100–1000. The TOFMS was calibrated using Bruker Daltonics 
high precision calibration algorithm (HPC) by means of the use of the internal standard sodium 
formate, which was automatically infused before each run. UV/VIS spectra were collected at 
wavelengths from 200 to 700 nm. Data processing was performed using DataAnalysis 4.0 software 
(Bruker Daltonics). 
3.6. NMR 
The 1D and 2D spectra were recorded on a Varian Unity Inova-500 MHz spectrometer located at 
DTU, or on a Bruker Avance 800 MHz spectrometer located at the Danish Instrument Centre for NMR 
Spectroscopy of Biological Macromolecules at Carlsberg Laboratory. Spectra were acquired using 
standard pulse sequences. The deuterated solvent was DMSO-d6 and signals were referenced by 
solvent signals for DMSO-d6 at δH = 2.49 ppm and δC = 39.5 ppm. The NMR data was processed in 
MestReNova V.6.0.1–5391 or Bruker Topspin. Chemical shifts are in ppm (δ) and scalar couplings are 
reported in hertz (Hz). The sizes of the J coupling constants reported in the tables are the 
experimentally measured values from the 1D 1H and DQF-COSY spectra. There are minor variations 
in the measurements which may be explained by the uncertainty of J and the spectral digital resolution. 
Distances for the epi-10,23-dihydro-24,25-dehydroaflavinine were obtained from 2D NOESY 
experiments using the isolated spin pair approximation (ISPA) [40]. The linear range was increased by 
the method suggested by Macura et al. [46,47]. The used mixing time was 150 ms. Different mixing 
times were used to construct a buildup curve to ensure that only crosspeaks which fitted the ISPA  
were used.  
The 3J-couplings from angles in the 3D structures of epi-10,23-dihydro-24,25-dehydroaflavinine 
and the aculenes were calculated by the Haasnoot-DeLeeuw-Altona (HLA) equation and by DFT 
computations of the final structure [48,49]. 
The simulations were conducted using the program Maestro (Version 9.3.515, MMshare  
Version 2.1.515) from the Schrödinger suite. Conformational searches in implicit solvents (DMSO) 
were run by MacroModel (version 9.9, Schrödinger, LLC, New York, NY, USA, 2012) using the force 
Molecules 2014, 19 10914 
 
 
fields OPLS2005 and MMFFs. Monte Carlo torsional sampling was used to generate the structures and 
the minimization method was PRCG. The number of steps were 20,000, and only conformations 
within 30 kJ/mol of the found minimum were considered. The solvent DMSO was treated as a constant 
dielectric constant of 47.0. Both force fields gave similar results.  
Selected structures were further optimized by HF/3-21G using Jaguar (Jaguar, version 7.9, 2012, 
Schrödinger, LLC, New York, NY, USA,) followed by DFT (for epi-10,23-dihydro-24,25-
dehydroaflavinine) [50]. DFT calculations were carried out by Gaussian09 [51] using cam-B3LYP/6-
311++G(d,p) for optimization and B3LYP/6-31G(d,p) u+1s for calculating J-coupling constants (only 
Fermi Contact contribution considered, see reference [49]). 
3.7. Marfey’s Reaction 
Aculenes A and B (100 µg) were hydrolyzed with 6 M HCl (200 µL) in 2 mL analytical vials with 
lids, and were left at 110 °C for 22 h. The solvent was removed at a speedvac. For reference, 50 µL  
(2.5 µmol) standard L- and D-proline were prepared. To all vials 50 µL H2O, 20 µL 1 M NaHCO3 and  
100 µL 1% 1-fluoro-2,4-dinitrophenyl-5-L-alanineamide (FDAA) in acetone were added. The vials 
were left for 40 °C for 1 h. 10 µL 2 M HCl was added followed by 820 µL MeOH and HPLC-DAD-
MS data were acquired. 
3.8. Purification of Metabolites 
The DCM phase from the large scale extraction consisting of 2.375 g was absorbed onto Sepra  
ZT C18 (Phenomenex) and dried before packing into a 50 g (~66 mL) SNAP column (Biotage, 
Uppsala, Sweden) with Septra ZT C18 material. The extract was then fractionated using an Isolera 
flash purification system (Biotage). The gradient started with 15:100 MeOH/H2O in the first three 
column volumes (CV), then went to 100% MeOH over 18 CVs and stayed here for 3 CVs using a flow 
rate of 40 mL/min. MeOH was of HPLC grade and H2O was purified and deionized by Millipore 
system through 0.22 μm membrane filter (MQ H2O) and both were added 50 ppm trifluoroacetic acid 
(TFA). Fractions were automatically collected 1 CV at a time. The fractions were subjected to further 
purification on a semi-preparative HPLC, which was either a Waters 600 Controller with a 996 
photodiode array detector (Waters, Milford, MA, USA) or a Gilson 322 Controller connected to a 215 
Liquid Handler, 819 Injection Module and a 172 DAD (Gilson, Middleton, WI, USA). This was 
achieved using a Luna II C18 column (250 × 10 mm, 5 μm, Phenomenex). 50 ppm TFA was added to 
ACN of HPLC grade and MQ H2O. For choice of system, flow rate, gradients and yields see 
descriptions for the specific compound.  
Aculenes A and B. The three first Isolera flash chromatography fractions, eluding with 10%–25% 
MeOH, were subjected to further purification on the waters semi-preparative HPLC. A linear  
water-ACN gradient was used starting with 15% ACN and increasing to 100% over twenty minutes 
using a flow rate of 4 mL/min. Two compounds eluting with 54% and 56% ACN respectively, were 
collected. This yielded two pure compounds, 3.0 mg of aculene A and 3.7 mg of aculene B. 
Aculene A: HRMS: m/z = 316.1910. [M+H]+, calculated for [C19H25NO3+H]+: m/z = 316.1907.  
[α]20 D  = +0.63° (MeOH). 1H- and 13C-NMR (see Tables 1 and 2). 
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Aculene B: HRMS: m/z = 318.2068. [M+H]+, calculated for [C19H27NO3+H]+: m/z = 318.2064.  
[α]20 D  = +6.96° (MeOH). 1H- and 13C-NMR (see Tables 1 and 2). 
Aculene C. One of the Isolera flash chromatography fractions, eluding with 50% MeOH, was 
subjected to further purification on the waters semi-preparative HPLC. An isocratic water-ACN 
gradient was used starting with 40% ACN over twenty minutes using a flow rate of 4 mL/min. A 
compound eluding with 40% ACN was collected. This yielded 2.0 mg of aculene C. 
HRMS: m/z = 319.1382 [M+H]+, calculated for [C14H18O2+H]+: m/z = 319.1379. [α]20 D  = 0.00° 
(MeOH). 1H- and 13C-NMR (see Tables 1 and 2). 
Calbistrin A and C. One of the Isolera flash chromatography fractions, eluding with 100% MeOH, 
was subjected to further purification on the waters semi-preparative HPLC. An isocratic water-ACN 
method was used with 52% ACN over eighteen minutes using a flow rate of 4 mL/min. Two 
compounds eluding at 52% ACN were collected. This yielded 5.2 mg of calbistrin A and 4.6 mg of 
calbistrin C. 
Calbistrin A: HRMS: m/z = 563.2622 [M+Na]+, calculated for [C31H40O8+Na]+: m/z = 563.2615.  
[α]20 D  = +46.1° (MeOH). 1H-NMR (499.87 MHz, DMSO-d6, 25 °C, 2.49 ppm): 0.77 (3H, d, J = 7.1 Hz), 
0.97 (3H, d, J = 7.1 Hz), 1.13 (3H, s), 1.22 (3H, s), 1.32 (1H, m), 1.69 (3H, s), 1.98 (3H, s), 2.02 (1H, m), 
2.30 (1H, dd, J = 13.8, 3.8 Hz), 2.37 (1H, m), 2.41 (1H, m), 2.69 (1H, dd, J = 13.8, 8.2 Hz), 2.80 (1H, 
m), 3.94 (1H, d, J = 9.4 Hz), 5.06 (1H, m, -OH), 5.10 (1H, m), 5.59 (1H, d, J = 9.6 Hz), 5.70 (1H, s), 
5.86 (1H, m), 5.88 (1H, d, J = 14.9 Hz), 5.97 (1H, d, J = 9.8 Hz), 6.05 (1H, d, J = 11.2 Hz), 6.30 (1H, 
d, J = 12.0 Hz), 6.38 (1H, d, J = 15.1 Hz), 6.68 (1H, dd, J = 15.1, 11.2 Hz), 7.51 (1H, dd, J = 14.9, 
12.0 Hz; 13C-NMR (125.70 MHz, DMSO-d6, 25 °C, 39.5 ppm): 10.9, 12.3, 13.0, 13.7, 20.6, 25.4, 26.0, 
34.7, 39.8, 43.6, 43.7, 56.2, 56.3, 68.3, 78.3, 121.2, 126.4, 127.0, 127.2, 130.8, 132.7, 133.8, 135.7, 
139.4, 140.9, 143.4, 173.9, 212.8. 
Calbistrin C: HRMS: m/z = 565.2776 [M+Na]+, calculated for [C31H42O8+Na]+: m/z = 565.2772.  
[α]20 D  = +8.67° (MeOH); 1H-NMR (499.87 MHz, DMSO-d6, 25 °C, 2.49 ppm): 0.77 (3H, d, J = 7.1 Hz), 
0.95 (3H, d, J = 7.1 Hz), 1.01 (3H, s), 1.21 (1H, m), 1.27 (3H, s), 1.71 (3H, s), 1.93 (1H, m), 1.98 (3H, 
s), 2.35 (1H, m), 2.38 (1H, qin, J = 8.4), 2.56 (1H, m), 2.92 (1H, dt, J = 17.5, 7.5 Hz), 2.99 (1H, m), 
3.56 (2H, m), 3.95 (1H, dd, J = 9.4, 3.1 Hz), 5.09 (1H, br.d, J = 3.5 Hz, -OH), 5.05 (1H, s, -OH), 5.20 
(1H, m), 5.37 (1H, d, J = 9.9 Hz), 5.59 (1H, m), 5.88 (1H, d, J = 14.9 Hz), 5.90 (1H, d, J = 9.9 Hz), 
6.07 (1H, d, J = 11.1 Hz), 6.31 (1H, d, J = 12.0 Hz), 6.39 (1H, d, J = 15.1 Hz), 6.69 (1H, dd, J = 15.1, 
11.1 Hz), 7.51 (1H, dd, J = 14.9, 12.0); 13C-NMR (125.70 MHz, DMSO-d6, 25 °C, 39.5 ppm): 10.9, 
12.3, 13.0, 13.7, 20.6, 25.4, 26.0, 34.7, 39.8, 43.6, 43.7, 56.2, 56.3, 68.3, 78.3, 121.2, 126.4, 127.0, 
127.2, 130.8, 132.7, 133.8, 135.7, 139.4, 140.9, 143.4, 173.9, 212.8. 
Acu-dioxomorpholine. One of the Isolera flash chromatography fractions, eluding with 95% ACN, 
was subjected to further purification on the waters semi-preparative HPLC). A linear water-ACN 
gradient was used starting with 60% ACN increasing to 100% over twenty minutes using a flow rate of 
4 mL/min. A compound eluding with 85% ACN was collected. This yielded 2.1 mg of  
acu-dioxomorpholine. HRMS: m/z = 417.2176 [M+H]+, calculated for [C26H29N2O3+H]+: m/z = 417.2173. 
[α]20 D  = −49.23° (MeOH). 1H- and 13C-NMR (see Table 3). 
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Epi-10,23-dihydro-24,25-dehydroaflavinine. One Isolera flash chromatography fraction eluding 
with 100% MeOH, was subjected to purification on the waters semi-preparative HPLC. A gradient of 
15%–100% ACN over twenty minutes was used and the flow rate was 4 mL/min. A compound eluding 
with 100% ACN was collected. This yielded 8.7 mg of epi-10,23-dihydro-24,25-dehydroaflavinine. 
HRMS: m/z = 406.3113 [M+H]+, calculated for [C28H39NO+H]+: m/z = 406.3104. [α]20 D  = +63.58° 
(MeOH); 1H- and 13C-NMR (see Table 5). 
Okaramine S. One Isolera flash chromatography fraction, eluding with 100% MeOH, was subjected 
to purification on the Gilson semi-preparative HPLC. This was done using a gradient of 70%–100% 
ACN over fifteen minutes using a flow rate was 5 mL/min. A compound eluding with 80% ACN was 
collected. This yielded 1.7 mg of the pure compound. HRMS: m/z = 503.2447 [M+H]+, calculated for 
[C32H30N4O2+H]+: m/z = 503.2441. [α]20 D  = −15.29° (MeOH); 1H- and 13C-NMR (see Table 4). 
Okaramine J. One Isolera flash chromatography fraction, eluding with 74% MeOH, was subjected 
to purification on the waters semi-preparative HPLC. This was done using a gradient of 50%–100% 
ACN over twenty minutes using a flow rate of 4 mL/min. A compound eluding with 82% ACN was 
collected. This yielded 2.5 mg of the pure compound. HRESIMS: m/z = 525.2865 [M+H]+, calculated 
for [C32H36N4O3+H]+: m/z = 525.2860. [α]20 D  = +15.38° (MeOH); 1H-NMR (499.87 MHz, DMSO-d6, 
25 °C, 2.49 ppm): 1.52 (6H, s, H-17, H-18), 1.68 (3H, s, H-34), 1.73 (3H, s, H-35), 1.86 (1H, m,  
H-20), 2.42 (1H, dd, 13.2, 6.8, H-20'), 2.99 (1H, dd, 15.2, 9.4, H-1), 3.14 (1H, dd, 16.3, 7.1, H-31), 
3.23 (1H, dd, 16.8, 7.5, H-31'), 3.59 (1H, dd, 15.2, 4.2, H-1'), 4.46 (1H, dd, 9.1, 4.4, H-2), 4.67 (1H, 
dd, 11.3, 6.4, H-19), 5.05 (1H, dd, 10.5, 1.1, H-4), 5.08 (1H, dd, 17.4, 1.1, H-4'), 5.26 (1H, t, 7.4,  
H-32), 5.33 (1H, d, 4.5, H-29), 6.01 (1H, s , H-36), 6.12 (1H, d, 4.4, H-28), 6.22 (1H, dd, 17.4, 10.5, 
H-5), 6.32 (1H, s, H-3), 6.67 (1H, t, 7.5, H-24), 6.88 (1H, d, 7.5, H-25), 6.96 (1H, t, 7.5, H-12), 6.96 
(H-26), 7.05 (2H, H-11, H-23), 7.35 (1H, s, H-10), 7.53 (1H, s, H-13), 10.67 (1H, s, H-8); 13C-NMR 
(125.70 MHz, DMSO-d6, 25 °C, 39.5 ppm): 17.5 (C-34), 24.7 (C-1), 25.2 (C-35), 27.6 (C-17,C-18), 
28.2 (C-31), 39.0 (C-6), 40.8 (C-20), 55.1 (C-2), 58.2 (C-19), 83.5 (C-29), 85.5 (C-21), 104.3 (C-15), 110.7 
(C-10), 110.9 (C-4), 117.6 (C-13), 118.4 (C-12, C-24), 118.9 (C-23), 120.0 (C-11), 121.5 (C-32), 122.7 
(C-22), 128.3 (C-14), 131.0 (C-26), 132.0 (C-33), 134.5 (C-9), 141.1 (C-7), 145.8 (C-27), 146.0 (C-5), 
167.5 (C-16), 169.7 (C-30). 
3.9. Antifungal Susceptibility Testing 
All compounds were screened for antifungal activity towards Candida albicans in accordance with 
the CLSI standards using RPMI-1640 medium adjusted to pH 7 with 0.165 M MOPS buffer [52]. The 
screening was performed as described by Holm et al. [53]. 
4. Conclusions  
Investigation of the chemical profile of Aspergillus aculeatus by UHPLC-DAD-HRMS has 
identified several novel compounds some of which have been selected, purified and their structure 
elucidated by 1D and 2D NMR spectroscopy. A novel class of related compounds – the aculenes – has 
been discovered. Aculenes A and B are hybrids containing the amino acid proline but also a fourteen 
carbon moeity we hypothesize to originate from a sesquiterpene with the loss of one carbon atom. 
Aculene C is believed to be a precursor to aculene A, missing the proline part of the molecule. 
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Moreover there is UHPLC-DAD-HRMS evidence suggesting a fourth structure, aculene D, a possible 
precursor to aculene B. Two other larger, however chemically unstable metabolites have been 
discovered. As they apparently were degrading to two known parts, aculene A and B respectively and 
calbistrin A, a tentative suggestion for their structures have been given. Two further novel compounds, 
acu-dioxomorpholine and okaramine S has also been discovered to be produced by A. aculeatus.  
Acu-dioxomorpholine has a remarkable structure, reminding of diketopiperazine, but with a lactone instead 
of the one lactame part and okaramine S displays a seven-membered ring, not previously seen in any 
reported okaramine. Furthermore the aflavinine analogue epi-10,23-dihydro-25,25-dehydroaflavinine 
was detected. Production of sclerotia was observed under specific conditions, and here an upregulation 
of okaramines was observed. Altogether the chemical profile of Aspergillus aculeatus has been 
examined and several novel compounds have been characterized. 
Supplementary Materials 
1H, DQF-COSY, HSQC, HMBC, NOESY and UV spectra for the novel compounds as well as 
suggestion for the structures of acucalbistrin A and B and elucidation of the stereochemistry of 
aculenes A–D and epi-10,23-dihydro-24,25-dehydroaflavinine are available in the supplementary. 
Supplementary materials can be accessed at: http://www.mdpi.com/1420-3049/19/8/10898/s1. 
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a b s t r a c t
A novel method, Spin-State-Selective (S3) HMBC, for accurate measurement of homonuclear coupling
constants is introduced. As characteristic for S3 techniques, S3 HMBC yields independent subspectra cor-
responding to particular passive spin states and thus allows determination of coupling constants between
detected spins and homonuclear coupling partners along with relative signs. In the presented S3 HMBC
experiment, spin-state selection occurs via large one-bond coupling constants ensuring high editing
accuracy and unequivocal sign determination of the homonuclear long-range relative to the associated
one-bond coupling constant. The sensitivity of the new experiment is comparable to that of regular edi-
ted HMBC and the accuracy of the J/RDC measurement is as usual for E.COSY and S3-type experiments
independent of the size of the homonuclear coupling constant of interest. The merits of the method
are demonstrated by an application to strychnine where thirteen JHH coupling constants not previously
reported could be measured.
 2015 Elsevier Inc. All rights reserved.
1. Introduction
J coupling constants have a long history of being among the
most important parameters in structural assignment of small and
large molecules by NMR spectroscopy. They provide angular infor-
mation that can be used to determine stereochemical relation-
ships. Particularly 1H–1H coupling constants over three bonds are
useful in this context due to the Karplus relation between 3JHH
and the dihedral angle between the protons [1,2].
Over the past couple of decades J coupling constants (Js) have
been supplemented by residual dipolar coupling constants (RDCs)
in structure elucidation. RDCs are observable in weakly oriented
solutions and are typically measured by the same methods as the
Js. Js and RDCs can be both positive and negative and, unless
the signs are known from other sources, it is crucial that they too
are determined by the methods used to measure the size of the
coupling constants.
Some of the techniques proposed for measurement of coupling
constants rely on use of selective pulses which can be useful in spe-
cial cases, but for general applications it is preferable to have tech-
niques employing only non-selective pulses and thus not requiring
prior detailed knowledge about spectral parameters for the mole-
cules under study.
E.COSY-type techniques exploit simplified multidimensional
multiplet patterns to extract even quite small coupling constants
from cross peaks between two (active) spins when a third (passive)
spin is coupled to both these spins, with a large coupling constant
to at least one of the active spins. This is for example the principle
behind the XLOC experiment measuring 1H–1H coupling constants
with one of the two protons being attached to a 13C spin, thus hav-
ing a large one-bond coupling constant [3].
In E.COSY jargon the large coupling constant spreads out multi-
plet components in one of the dimensions allowing measurement
of the small coupling constant of interest in an orthogonal dimen-
sion. Spin-State-Selective (S3) techniques take an E.COSY multiplet
simplification one step further by editing the spectrum into typi-
cally two independent subspectra corresponding to the two spin
states of the passive spin.
The HMBC experiment [4] correlates e.g. 1H and 13C spins via
the direct heteronuclear long-range coupling between the two
spins and when another (passive) 1H spin is attached to the 13C
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spin that attached 1H spin can be subjected to S3 editing via the
large one-bond heteronuclear coupling thus allowing the spectrum
of the active 1H to be split into two subspectra. That new experi-
ment we dub S3 HMBC and the necessary pulse sequences (out-
lined in Fig. 1) for its realization are derived below (vide infra).
2. The method
Spin-state selection can be done in a one-shot fashion where
only particular spin states are excited, or in a way where both sub-
spectra are generated from the same data set. The latter is usually
advantageous when it comes to overall sensitivity and typically
comprises addition and subtraction of data obtained with two dif-
ferent pulse sequences, possibly involving different phasing in the
subspectra.
S3 HMBC may be imagined as a simple version of two HMBC-
type experiments differing only in one of them employing an addi-
tional S3 pz(S) pulse affecting only e.g. the resonances associated
with a spin states of the attached proton(s). Then addition and
subtraction of the two resulting data sets will yield two subspectra
corresponding to the a and b spin states of the passive proton (I).
The S3 pz(S) propagators can be written as:
eipI
aSz ¼ ei p2 Sz eþi p2 2IzSz ð1aÞ
eipI
bSz ¼ ei p2 Sz ei p2 2IzSz ð1bÞ
The initial p/2 S-spin z rotation is of no great significance apart
from generating a p/2 phase shift demanding different t1 phase cor-
rections for odd and even numbers of protons attached to the S spin
(vide infra). However, these multiplicity-dependent F1 phases do call
for odd/evenmultiplicity editing to be incorporated into the S3 HMBC
experiment. One can say that each of the S-spin attached I spins adds
a p/2 phase shift on top of the evolution under the coupling term.
The key feature of the propagators in Eq. (1) is the p/2 rotation
under the heteronuclear (one-bond) coupling in a modified odd/
even-edited HMBC experiment, which may then be linearly com-
bined with a suitable standard odd/even-edited HMBC experiment.
These additive and subtractive linear combinations produce the
edited a and b subspectra, respectively, in both the odd and even
multiplicity subspectra.
The chosen standard odd/even-edited HMBC experiment is the
improved multiplicity-edited HMBC [5], as J cross talk between the
two subspectra in that experiment is a second-order effect in
the deviation from the J used in tuning the pertinent delays in
the experiment.
Also a suitable modified odd/even-edited HMBC pulse sequence
containing the additional p/2 rotation under the heteronuclear
(one-bond) coupling is available in the literature, namely in the form
of the HAT HMBC experiment [6]. That experiment was designed
with the additional p/2 coupling rotation in order to attenuate cross
peaks arising from heteronuclear couplings over more than two
bonds and in that way distinguish HMBC correlations over two
bonds from those over more bonds. HAT HMBC, where J cross talk
also is a second-order effect, is for general heteronuclear long-
range correlation an alternative to the H2BC experiment [7,8].
With the two building blocks in place the derivation of the S3
HMBC experiment amounts to combining data obtained with edi-
ted HMBC and HAT HMBC. For that to work a few amendments
to the HAT HMBC pulse sequences must be made. Firstly it is nec-
essary that the HAT HMBC sequences are extended, as to have the
same delay between the p/2(H) pulse, the p(H) pulse and the start
of acquisition as the edited HMBC sequences. This ensures equal
evolution under 1H-spin chemical shifts and 1H–1H homonuclear
couplings. Furthermore, a decoupling period is added to ensure
equal sample heating in all the sequences and the same evolution
under heteronuclear couplings. Other corrective delays are negligi-
ble on the time scales of the pertinent coupling constants.
Both edited HMBC and S3 HMBC are, for typical HMBC D delays,
about 5–10% longer than the corresponding regular HMBC pulse
sequence without these features. All of the individual pulse
sequences of S3 HMBC contain the same pulses as a regular HMBC.
S3 HMBC spectra are constructed by first performing the odd/
even or {CH/CH3}/{C/CH2} editing of the edited HMBC and HAT
HMBC time domain data separately. Thereafter, the two even parts
are added and subtracted from each other to produce the two S3
HMBC spectra for measuring JHH. Before performing the same pro-
cedure with the two odd parts of the standard HMBC and HAT
HMBC data, the term eip2Sz in Eq. (1) must be considered because
it effectively amounts to a p/2 phase shift for each attached proton
in the t1 dimension. Therefore, the odd HAT HMBC time domain
data must be phase shifted by p/2 prior to linear combinations.
This multiplication of the complex time domain data by eip2
amounts to swapping the real and imaginary data and changing
the sign of the new imaginary data. The choice of eip2 rather than
ei
p
2 is arbitrary, but it has the consequence of the center resonances
from methylene groups and quaternary carbons appearing in the
‘‘all add” subspectrum of the linear combinations indicated in Eq.
(2).
Disregarding the phase corrections, the S3 HMBC linear combi-
nations can with reference to the (a)–(e) pulse sequences in Fig. 1
be summarized as:
½a  1
2
½bþ c
 
 fd eg ð2Þ
The intra-brace operations are odd/even editing (HMBC and
HAT HMBC) and the inter-brace operations lead to the S3 editing.
Of these eight linear combinations in Eq. (2) the four with oppo-
site signs in the first and last term are not relevant as they would
combine odd and even data. The four final S3 HMBC time-domain
data sets are processed in the same way as regular HMBC data
and all the spectra are presented in absolute-value mode.
The best sensitivity is obtained when the factor 1/2 in Eq. (2) is
realized through adjustment of the number of scans for the (b) and
(c) pulse sequences to be only half of those of the other pulse
sequences. It can, of course, also be realized by numerical scaling
of the data when sensitivity is not an issue.
One final small correction rooted in the high editing accuracy of
the edited HMBC and HAT HMBC experiments can be taken into
account. Effectively, the magnetization components in the (b and
c) and (d and e) sequences that could give rise to out-of-phase error
terms are eliminated in the linear combinations [b + c] and [d ± e]
of the data. Thus, except for s perfectly matched to (2(1JCH))1,
the intensities in these linear combinations will be slightly lower
than those in the [a] spectrum. Therefore, to reduce the already
low level of J cross talk even further, it is an option to scale
[b + c] and [d ± e] by small factors k and
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
2k=ðkþ 1Þ
p
, respectively.
These factors are applicable for CH groups and correspond to
1/cos(2pJs) and 1/sin(pJs), respectively. This makes full elimina-
tion of J cross talk on an individual cross peak basis possible, which,
however, for the vast majority of applications is unnecessary. We
typically employ a small correction of k = 1.05.
To make the S3 HMBC experiment readily available we have
written a Bruker pulse program acquiring the data in an inter-
leaved pseudo-3D fashion and a Bruker AU program performing
all the necessary linear combinations and phase corrections. The
programs operate with four planes: plane #1 is the standard HMBC
sequence in Fig. 1a, plane #2 is the linear combination of the
sequences in Fig. 1b and c, and planes #3 and #4 are the HAT
HMBC sequences in Fig. 1d and e, respectively. This AU program
along with the pulse program is available from the website of
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Fig. 1. S3 HMBC pulse sequence comprising (a–c) the edited HMBC sequences and (d and e) the HAT HMBC sequences, all shown with a third-order low-pass J filter. Filled and
open bars refer to p/2 and p pulses, respectively, and the dashed open boxes represent 13C decoupling. s = (2 1JCH)1 or (1Jmax + 1Jmin)1, d is a gradient delay, e = 2 t1/2,min + t
(pH), e0 = e + t(pC), s1 =½[1Jmin + 0.07 (1Jmax  1Jmin)]1, s2 = (1Jmax + 1Jmin)1, s3 = ½[1Jmax  0.07 (1Jmax  1Jmin)]1. u1 = {x, x, x, x}, u2 = {x, x, 4(x), x, x}, u3 = {4(x), 4(y), 4(x),
4(y)}. D is the delay for evolution under heteronuclear long-range couplings.
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the NMR group at DTU Chemistry and from Bruker’s pulse program
site.
3. Applications and results
For demonstration of S3 HMBC two small molecules were cho-
sen; vinyl acetate and strychnine. Vinyl acetate is a simple organic
molecule with large 3JHH coupling constants and thus offers clear
visual inspection of the level of cross talk [9,10]. Strychnine is
one of the most widely used benchmark molecules for new small
molecule NMR experiments, and most of the coupling constants
have been measured and calculated [11–13], which makes it ideal
for showing the potential of the S3 HMBC experiment.
Four S3 HMBC cross peaks of vinyl acetate are shown in Fig. 2
along with 1D sections exhibiting excellent editing accuracy,
which translates into high accuracy measurement of the coupling
constants.
In general, measurement of the coupling constant between the
proton of a methine group with a 13C and a distant proton is
straightforward and analogous to earlier E.COSY and S3-type mea-
surements. This is not the case for methylene and methyl groups,
because the two S3 HMBC subspectra are not just displacements
of each other. Effectively, the two S3 HMBC subspectra for methine
and methylene carbons correspond to the multiplet components
with odd or even numbers of a spin states for 13C-attached pro-
tons, respectively.
The Js in the 13C4(H4a,H4b)-H3 multiplet of vinyl acetate could
not have been extracted from the unedited multiplet due to over-
lap of individual resonances, but in Fig. 2 it is possible, because the
individual multiplet components are well resolved. This is, how-
ever, in general not fulfilled. As we shall see below, strychnine con-
tains several methylene groups but most of them are not neighbor
to another methylene group. Hence the 3JHH that cannot easily be
determined from 13CH2–12CH moieties can be determined from
the complementary isotopomer, 12CH2–13CH.
Fig. 3 shows the structure of strychnine with atom numbering,
while representative cross peak excerpts and 1D sections from S3
HMBC subspectra are shown in Fig. 4.
34 JHH coupling constants in strychnine were determined by S3
HMBC and compared to coupling constants from the literature
[11–13] and DFT calculations [14]. The results are summarized in
Table 1 while the details of the DFT calculations may be found in
the Supplementary information.
Thirteen of the measured coupling constants had not previously
been determined experimentally and could therefore only be com-
pared to the results of the DFT calculation. The coupling constants
measured using S3 HMBC are in excellent agreement with both ref-
erence values and calculations (Table 1). H17ab is a second order
multiplet system in the 1H NMR spectrum; however a coupling
to H16 was measured. Since the chemical shifts of H17a and
3H4a
H
4b
O
H
2 CH3 1
O
Fig. 2. Structure of vinyl acetate with atom numbering in gray and excerpts of cross peaks along with F1 sections from S3 HMBC spectra of vinyl acetate (0.8 M in DMSO-d6,
500 ll, 400 MHz, 16 scans, 4096 data points, 128 increments, zero filled to 65,536  1024, Jmin = 130 Hz, Jmax = 190 Hz, s = 3.13 ms). The CH and CH2 subspectra corresponding
to multiplet components with an odd (even) number of a states for 13C-attached protons are plotted in blue (red). All subspectra and 1D sections were scaled to the same peak
intensity. The two 3JHH coupling constants across the double bond were measured in two different multiplets.
Fig. 3. Structure of strychnine with numbering and assignment of diastereotopic
protons.
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Fig. 4. S3 HMBC cross peaks for strychnine (300 mM in CDCl3, 500 ll, 400 MHz, 16 scans, 4096 data points, 256 increments, zero filled to 65,536  1024, standard HMBC
delays (Jmin = 124 Hz, Jmax = 169 Hz, s = 3.4 ms, delta = 65 ms). The coupling constants were measured by displacing 1D sections in analogy to the E.COSY method. The
excerpts and 1D sections were scaled individually to the same intensity.
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H17b could not be discriminated only one correlation was
observed. The measured coupling constant turned out to corre-
spond well with the combined values of calculated coupling con-
stants JH16–H17a and JH16–H17b.
To eliminate any human error or over-fitting of the data, a Mat-
lab script was used in order to extract the coupling constants
directly from the spectra. The overall correlation between manu-
ally and automatically extracted couplings is good with an RMSD
of 0.11 Hz. However some peaks are distorted due to strong cou-
pling and automatic fitting is somewhat hampered. A comparison
of couplings constants from manual versus automatic extraction
and more details on the script can be found in the Supplementary
information. Also a comparison of coupling constants from 400 and
800 MHz spectrometers is included.
Finally, it must be kept in mind that the current as well as prac-
tically all other similar techniques actually do not measure cou-
pling constants but peak separations, but since they are identical
in the weak coupling limit, and also for fair degrees of strong cou-
pling, it is customary jargon to refer to them as techniques for mea-
suring coupling constants. Thus slightly different values for the
same coupling constant can be measured in different cross peaks,
as there are a few examples of in Table 1. Based on measured peak
separations (and intensities) it would take a fitting program to
extract the actual coupling constants, something that is outside
the scope of this paper.
4. Conclusions
A novel and robust NMR experiment, S3 HMBC, has been intro-
duced for accurate measurement of homonuclear coupling con-
stants including their signs. For measurement of a n+1JHH coupling
constant, the critical parameter for the sensitivity is the heteronu-
clear long-range nJCH coupling constant on which all HMBC-type
experiments are based. However, the accuracy of the measurement
of n+1JHH is independent of the size of that coupling constant.
The MBOB or broadband HMBC approach [15,16] for obtaining
uniform excitation over a range of long-range JCH coupling con-
stants is straightforward to implement in the S3 HMBC experiment
by recording data for different D values.
S3 HMBC is expected to find widespread use for measurement of
homonuclear J and RDC coupling constants in small molecules, not
least for analysis of carbohydrates where e.g. the small interglyco-
sidic 4JHH coupling constants is expected to become visible via S3
HMBC when the corresponding 3JCH coupling constants do not van-
ish [17].
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Table 1
Experimental and theoretical JHH coupling constants of strychnine measured at 400 MHz (a 800 MHz) [11–13]. Coupling constants extracted by a Matlab script with a minimum
deviation of ±0.01 Hz. In some cases two values are reported, when J can be measured in the cross peaks of both protons. Calculations were performed using B3LYP/6-31G(d,p)u
+ 1s (fermi contact only, linearly scaled by a factor of 0.9117). b H17ab was seen as a broad singlet and the measured coupling constant was taken as the sum. c Carter et al. [13]
determined this coupling to 1.20 Hz, however this was suspected to be a mistake and therefore another reference was used for comparison [11]. d Top 30% of resonance used for
coupling constant determination instead of the otherwise used 95% due to slight differences in the base of the peak. See detailed discussion in SI. The RMSD between the
experimental and calculated coupling constants is 0.19–0.21 Hz based on the 400 MHz data, depending on the coupling constant used when two are measured (0.20 Hz if the
average is used).
#H1 #H2 Experimental S3 HMBC (Hz) Experimental 1H NMR (Hz) [13],⁄[11] Calculated (Hz)
1 2 7.68 7.41 7.61
1 3 1.50, 1.28 1.18 1.13
1 4 0.65, 0.66d 0.45 0.55
2 4 1.24, 1.07 1.12 0.97
2 3 7.55a 7.46 7.47
3 4 8.16 8.1 8.28
8 12 0.16, 0.01 – 0.10
8 13 10.58, 10.54d 10.47 9.96
8 16 0.32, 0.20 – 0.27
11a 12 8.54 8.44 8.43
11a 13 0.46 – 0.31
11b 12 3.35 3.28 3.75
12 13 3.23 3.12 3.58
12 14 0.32 – 0.20
12 15a 0.13 – 0.09
12 23a 0.10 – 0.09
12 23b 0.16 – 0.02
13 14 3.11 3.10 3.27
13 15a 0.27 0.49–0.59⁄ 0.38
13 15b 0.40 – 0.28
14 15a 4.95 4.58 4.60
14 15b 1.91 1.98 1.93
14 16 0.65 – 0.54
14 20b 0.49 – 0.50
14 22 2.91 2.82⁄ 3.03
15a 16 4.00 4.11 3.89
15b 16 2.15 1.82 2.02
16 17a – – 0.04
16 17b – – 0.18
16 17ab 0.20b – 0.14
16 18a 0.54 – 0.49
16 18b 0.08 – 0.06
16 20b 0.26 – 0.33
20a 22 1.36 1.47⁄ 1.82
20b 22 0.59 0.63c,⁄ 0.58
22 23a 6.98 6.88 6.86
22 23b 6.14 5.74 6.14
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Appendix A. Supplementary material
Supplementary data associated with this article can be found, in
the online version, at http://dx.doi.org/10.1016/j.jmr.2015.11.007.
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Specific Electrostatic Molecular Recognition in Water
Ming Li,[a] Casper Hoeck,[b] Sanne Schoffelen,[a] Charlotte H. Gotfredsen,[b] and
Morten Meldal*[a]
Abstract: The identification of pairs of small peptides that
recognize each other in water exclusively through electro-
static interactions is reported. The target peptide and a
structure-biased combinatorial ligand library consisting of
78125 compounds were synthesized on different sized
beads. Peptide–peptide interactions could conveniently be
observed by clustering of the small, fluorescently labeled
target beads on the surface of larger ligand-containing
beads. Sequences of isolated hits were determined by
MS/MS. The interactions of the complex showing the highest
affinity were investigated by a novel single-bead binding
assay and by 2D NMR spectroscopy. Molecular dynamics
(MD) studies revealed a putative mode of interaction for this
unusual electrostatic binding event. High binding specificity
occurred through a combination of topological matching
and electrostatic and hydrogen-bond complementarities.
From MD simulations binding also seemed to involve three
tightly bound water molecules in the interface between the
binding partners. Binding constants in the submicromolar
range, useful for biomolecular adhesion and in nano-
structure design, were measured.
Introduction
Molecular recognition plays a central role in biology and is
essential for life.[1] It is a crucial aspect of many biological
processes, such as protein folding,[2] the structural organization
of cells and organelles, signal transduction,[3] and the immune
response.[4] The phenomenon is defined as the specific interac-
tion between two or more molecules, mediated by non-cova-
lent forces, including hydrogen bonding, hydrophobic forces,
electrostatic and van der Waals interactions, aromatic stacking,
and metal coordination.[5] It is a complex and multifaceted pro-
cess, which depends not only on the structure and functional
groups of the molecules involved, but also on the environ-
ment. In particular, in water, parameters such as pH, salt
concentration, and temperature, have a large effect.[2]
In fact, the most prevailing means of cellular signaling and
event control in biology is constituted by the recognition be-
tween a peptide and a protein. Therefore, understanding this
process is a key element in the development of drugs[6] whose
mode of action is to interfere with such peptide–protein inter-
actions. Biomolecular binding events are characterized by
binding constants with values ranging from weak[7] to inter-
mediate[8, 9] and strong.[10] For tight binding of peptides to re-
ceptors, typically occurring in an aqueous environment, hydro-
phobic interactions are the principal thermodynamic driving
force. During the binding event, entropy is gained owing to
the release of organized water from the binding interface. This,
in turn, enables the establishment of a hydrogen-bonding
network, electrostatic interactions, and salt bridges, which to-
gether contribute to the enthalpy of binding.[11–13] In protein–
peptide interactions, the final hydrogen-bond network
frequently includes residual tightly bound water molecules.
Specific biomolecular interactions have been mimicked,
both by design[14] and combinatorial screening.[15] In material
sciences, supramolecular materials based on non-covalent
self-association have been developed involving, for example,
cucurbit[7]uril and biotin[6]uril.[16–18] In these examples, recog-
nition is of the lock-and-key type, which differs significantly
from the induced fit of designed synthetic peptide–receptor
pairs.[19–21] Artificial receptors developed through combinatorial
screening show binding constants in the range 10¢5–10¢3m,
and include examples such as tweezer- and tripodal
peptides,[22] bicyclic peptide receptors,[23] and peptidomimetic
receptors binding to a Ras-protein. Interestingly, Maeda et al.
reported the identification of pentapeptides binding to a
dopamine D2 receptor fragment with Kd values of 10
¢5m by
using a combinatorial bead–bead interaction assay.[24]
Elucidating the mechanism of molecular recognition is
challenging and may be best addressed through selection
processes and molecular evolution. In an effort to increase our
understanding of molecular recognition, we aim to systemati-
cally investigate each of the major types of interaction sepa-
rately, starting with electrostatic interactions. For this purpose,
we have developed a bead-based screening protocol that, in
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principle, allows for up to 1012 peptide–peptide interactions to
be evaluated simultaneously. In the present paper, we describe
this methodology as well as a model study performed to iden-
tify pairs of small linear polar peptides that specifically recog-
nize each other in an aqueous environment. The specific, com-
plex, and multifaceted interaction between one of the identi-
fied interacting peptide pairs, displaying a binding constant in
the submicromolar range, was investigated by 2D NMR
spectroscopy and molecular dynamics.
Results and Discussion
We have previously identified specific recognitions between
adhesion molecules and the lipid bilayer of cells through com-
binatorial screening.[25] Based on this study, we suggest that it
should be feasible to find pairs of peptides that specifically
bind to each other by using a similar approach. In contrast to
identification of receptor–ligand interactions by design, the
identification through combinatorial screening can accommo-
date, within the library design, all possible combinations of hy-
drogen bonding, electrostatic, and hydrophobic interactions,
as well as the conformational space of the potentially
interacting molecules.
As a model for this screen, the polar decapeptide
QTRTNTHRDG was selected and screened for binding to a com-
binatorial library of 78125 octapeptides. The target compound
was immobilized on 100 mm microbeads labeled with a
fluorescent dye, whereas the octapeptide ligand library was
synthesized on non-labeled 400 mm macrobeads. This provided
a convenient way of identifying positive hits by bead-to-bead
adherence, as depicted in Figure 1.
Design and synthesis of target peptide and ligand library
The target sequence and the ligand library were synthesized
on PEGA800 and PEGA1900 resins, respectively. Poly[acryloyl-bis
(aminopropyl)polyethylene glycol] (PEGA) resin was selected as
the solid support because of its low background fluorescence
and absence of unspecific interactions with reagents, peptides,
and proteins. Moreover, PEGA shows excellent swelling proper-
ties in polar solvents and is generally biocompatible.[23–25]
Prior to library assembly, the target was modelled in Molecu-
lar Operating Environment (MOEÏ) and virtually screened for
possible recognition elements. We analyzed substitution pat-
terns showing potential interactions with the selected target
peptide, using an octapeptide structure to generate ligands
with increased probability of strong and specific interactions.
The C-terminal position was maintained as glycine, as the ab-
sence of a side-chain in glycine allows for fast and quantitative
coupling and cleavage from the resin. For the other seven
positions, five different amino acids, both proteinogenic and
non-proteinogenic, were used, as presented in Table 1.
Solid-phase synthesis was performed by using a fluorenylme-
thyloxycarbonyl (Fmoc)-based protocol as shown in Scheme S1
(in the Supporting Information). The ligand library was synthe-
sized by using the base-labile linker 4-(hydroxymethyl)benza-
mide (HMBA). In this way, peptides could be deprotected on
the solid support and cleaved upon hit identification for
MS/MS analysis. The one-bead one-compound (OBOC) library
(78125 members) was prepared by the solid-phase split-and-
combine strategy on >100000 beads, thus providing the
majority of the theoretically possible sequences.
The small PEGA800 particles were labeled with ATOTA
(tris(dialkylamino)-trioxatriangulenium dye) by coupling a mix-
ture of ATOTA-OSu and Fmoc-Gly-OH (n/n=1:9). The ATOTA
fluorophore was selected based on its chemical stability under
both basic and acidic conditions.[26] The target peptide was
synthesized on the fluorescently labeled microbeads thus ob-
tained. No linker was added between the solid support and
peptide, such that the target molecule would stay attached to
the microbeads during cleavage of ligands from the macro-
bead.
Selection of positive hits
Combinatorial screening of ligands for proteins has conven-
tionally been performed by labeling the protein target with
biotin or fluorescent labels prior to incubation with the ligand
library.[15] Based on our success of adhering cells to beads, we
anticipated that bead–bead interaction as a measure of bind-
ing could have a range of advantages in the screening process.
Figure 1. Schematic representation of the bead-based screening protocol
employed in this study to identify peptide–peptide interactions. The target
peptide was synthesized on fluorescently labeled, 100 mm-sized microbeads.
The ligand library was synthesized by split/mix assembly on non-fluorescent
400 mm-sized macrobeads.
Table 1. The composition of the split/mix ligand library.
1[a] 2 3 4 5 6 7 8
D D GF
[b] E Dab D D G
E E K H Dap E E
L H O R O F F
F N R O R L L
N Q Y Q Q N N
[a] Numbers indicate the position in the octapeptide starting from the
N-terminus. [b] O, l-ornithine; GF, guanidino-l-phenylalanine; Dab, l-2,4-
diaminobutyric acid; Dap, l-2,3-diaminopropioic acid.
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The present screen directly relates to the property we were
looking for, thus reducing false positives. It also allows us to
distinguish strong and weak binders by shear force, and it fa-
cilitates binding competition studies with hydrogen-bond
donors and acceptors or electrostatic competitors. Key to its
success is the easy identification and isolation of macrobeads
that are covered with microbeads. Non-interacting microbeads
can be removed by sieving, after which, fluorescence sorting
can be employed to select positive hits.
When the macrobead library was mixed with the target-con-
taining microbeads, bead-to-bead adherence was observed
(Figure 2). The number of microbeads clustered to the individ-
ual macrobeads was found to vary, suggesting a variation in
the degree of adherence and thus varying affinities between
the ligands and target peptide. Several macrobeads were com-
pletely covered with microbeads, indicating maximum adhe-
sion. By combining bead-to-bead adherence with the fluores-
cent signal provided by the microbeads, it was possible
to track and isolate positive hits by using fluorescence
microscopy. At this stage, 33 initial hits were selected from the
78125-member ligand library.
As a pre-assessment for the degree of affinity, the isolated
bead clusters were incubated in the presence of salt by using
an aqueous solution of 50 mm phosphate buffered saline (PBS,
pH 7.4).Some of the hits were found to release the microbeads
under these conditions, implying weak interaction. In the end,
only 16 hits were obtained from 78125 possible entities (P=
0.02%<0.5%), indicating very specific recognition between
the target peptide and library-derived ligands.
Peptide sequence identification by MS/MS
The 16 isolated hits were subjected to sequence analysis. Tradi-
tionally, Edman degradation has been used in OBOC combina-
torial chemistry. However, rapid and straightforward HR-MS/MS
has recently been shown to facilitate high-throughput analysis
of the limited (nmol) quantities of compound available
from single library beads.[27,28] We found that matrix-assisted
laser desorption/ionization Fourier-transform ion cyclotron
resonance (MALDI-FT-ICR) mass spectrometry was extremely
sensitive and provided accurate sequence information of
pmol quantities of peptide by implementation of a variety of
fragmentation conditions.
Ligands were released from isolated beads by using a small
volume of triethylamine (TEA) in water. For hydrophilic sequen-
ces in particular, TEA/water was superior to the conventional
NaOH cleavage in providing sodium-free spectra for MS/MS.
The sequence data were analyzed with the software BioToolsÏ
(Bruker Daltonics) and the custom-made LibMSCalc. The latter
takes advantage of the knowledge of the library components,
thereby greatly improving fidelity, and is available from the
authors.
As a representative example, the MS/MS spectrum of
peptide 7 is shown in Figure 3. The sequences obtained from
the library-derived ligands 1–16 are presented in Table 2. In
addition, Table 2 contains compounds 17, 18, and 19. These
Figure 2. Microscopy image showing assembly of target-containing
microbeads clustered around a macrobead.
Figure 3. MS/MS sequence determined for compound 7. Peaks belonging to b, y and a ion series are assigned; b-18 is a b ion that has lost a water molecule.
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peptides were designed based on the level of activity of
ligands 1–16 and will be discussed in more detail below.
Binding studies under competitive conditions
The target sequence was deliberately designed to avoid un-
specific hydrophobic interactions. Therefore, the ligand–target
interaction was expected to be dominated by hydrogen-bond-
ing and charge–charge interactions. To confirm whether this
was the case, the hits were resynthesized and subjected to
more rigorous screening. The results of this qualitative study
are presented in Table 2.
Most of the molecules still presented high affinity in milli-Q
water. However, in an aqueous solution of 0.4m NaCl, binding
was completely abolished, probably as a result of reduced
charge–charge interactions in the presence of Na+ and Cl¢
ions. In contrast, when the beads were mixed in water prior to
addition of NaCl, adhesion between beads was surprisingly
maintained. This indicated that on the macroscopic level
charge–charge interactions were a required long-range interac-
tion (>1 mm) for the initial bead attraction, but that the actual
strong recognition was mediated by a variety of short-range
hydrogen-bonding, electrostatic, and polar van der Waals inter-
actions.
To investigate the significance of hydrogen bonds, the inter-
acting beads were incubated in 0.4m urea. Except for ligands
1 and 9, the microbeads were still capable of assembling onto
the macrobeads. However, the interaction was weakened, con-
firming that hydrogen bonding played a role. To mimic more
biologically relevant conditions, the beads were incubated in
10% fetal bovine serum (FBS), frequently used in the study of
biomolecular interactions. All of the ligand peptides presented
recognition of the target under these conditions. Peptide 7
(EDYEVEEG) was found to be superior to all other library-
derived ligands.
The results obtained from the screening indicated two re-
gions of electrostatic interaction in positions Aa1Aa2 and
Aa6Aa7 of the octapeptide. The present assay in which hits are
identified by bead–bead adherence may well be biased to-
wards weak charge–charge interactions, known to be active
over longer distances. Comparison of the intramolecular NOE’s
of the individual compounds and those of the complex indicat-
ed that the well-defined target structure, spatial preorganiza-
tion of the charges, and additional features for hydrogen
bonding secured strong binding. Although, the 16 identified
ligands were very similar, the degree of adherence varied
significantly. The unique motif and few hits identified both
indicate that the overall recognition is quite specific.
Determination of binding constants
It was decided to determine the binding constants of the four
most promising compounds from Table 2, that is, ligand 7, 17,
18, and 19. The binding constants were determined by using
a novel binding assay based on single beads fixed in a micro-
channel of a custom-made flow cell (see Figure S1 in the Sup-
porting Information). Binding is measured by fluorescence mi-
croscopy, visualizing the capture of fluorescently labeled bind-
ing partners to ligand molecules, immobilized by amino-func-
tionalized PEG tentacles in the bead. The binding assay takes
advantage of the stealth properties of the PEGA1900 resin. This
resin consists of a network of PEG chains and interaction with
proteins and peptides is negligible. The resin swells 15–20-fold
in buffer solutions, thereby providing extremely fast diffusion
of proteins up to 60 kDa.[29]
The binding assay is particularly useful for the measurement
of small-molecule interactions where surface plasmon reso-
nance (SPR) can be a challenge. Binding constants for bimolec-
ular interactions can in principle be determined by only two
background-corrected measurements of fluorescence intensi-
ties measured at saturation (IFmax) and at intermediate binding
concentration (IF at [T]0) of the target in solution by using the
equation Kd= [T]0Õ IFmax/IF¢[T]0 (see the Supporting Informa-
tion). Accurate determinations are obtained by fitting to a
complete binding curve.
The target was labeled with fluorescein and a dilution series
from 1 nm to 100 mm was prepared. The single bead was la-
beled with ligand and incubated with different concentrations
of target in solution. First, the fluorescence intensity at point
of saturation was determined with the second highest and
highest concentrations of target. Subsequently, the labeled
target was eluted from the bead to verify reversible binding.
Finally, the bead was incubated with the labeled target solu-
tion from low to high concentration, recording the fluores-
cence intensity of the bead in the same region of interest.
The binding curve for ligand 7 is presented in Figure 4 to-
gether with the background curve representing non-specific
binding (acetamide-modified PEGA bead). The binding data
Table 2. Library-derived ligands and their affinity for targeting
QTRTNTHRDG under various conditions.
Cmpd Sequence [M+H]+ Milli-Q[a] Urea FBS
1 ENYQRFFG 1060.4864 + – +
2 EDGFQDapFDG 952.3985 – + + + +
3 DEGFEVDDG 982.3744 + + + + +
4 EDYEREDG 1012.3840 + + + + +
5 EQYEDabDDG 955.3636 + + + + +
6 DDGFHDapDDG 963.3190 + + + + + +
7 EDYEVEEG 969.3687 + + + + + + + + + +
8 DQYERDDG 997.3845 + + + + + +
9 DEYRVEEG 996.4266 + + + – +
10 EDGFEOEEG 1025.4171 + + + + + +
11 EDYQVEEG 968.3835 + + + + + +
12 EHOHOFLG 967.5116 + + + +
13 EDGFEDabEDG 997.3846 + + + + + + +
14 DDYEODDG 942.3310 + + + + + + + +
15 EDREVDEG 948.3904 + + + + + + + +
16 EDGFEVDDG 982.3755 + + + + + + + +
17 EDDWDDG 851.7515 + + + + + + + + + +
18 EDYEVDDG 941.8740 + + + + + + + +
19 EDYEWEEG 1057.0169 + + + + + + + + + +
[a] The strength of binding of target-containing microbeads to ligands on
macrobeads in water, 0.4m urea, and 10% fetal bovine serum (FBS) as
indicated in a qualitative manner. O, l-ornithine; GF, guanidino-l-phenyl-
alanine; Dab, l-2,4-diaminobutyric acid; Dap, l-2,3-diaminopropioic acid.
Chem. Eur. J. 2016, 22, 7206 – 7214 www.chemeurj.org Ó 2016 Wiley-VCH Verlag GmbH&Co. KGaA, Weinheim7209
Full Paper
were fitted [Eq. (8) in the Supporting Information] providing
the Kd values presented in Table 3. The binding curves for
ligand 17, 18, and 19 are presented in Figure SI2 (in the Sup-
porting Information).
Ligand 7 (EDYEVEEG) had the highest affinity with a Kd of
0.658(0.029) mm. Ligand 18 (EDYEVDDG), which was generat-
ed from the consensus of the library screening, only showed
weak affinity during the subsequent binding study. This indi-
cates that the unique interactions required for specificity are
best identified by direct selection from a library. The extent of
the preorganized, three-dimensional structure could play a role
in the recognition and the structures were further studied by
NMR spectroscopy.
Characterization of the ligand–target interaction by NMR
spectroscopy
Further investigation of the interaction of ligand 7 (EDYEVEEG)
and target 20 (QTRTNTHRDG, Figure 5) was performed by 1D
and 2D NMR spectroscopy as detailed in the Supporting Infor-
mation.
Nuclear Overhauser effect (NOE) spectroscopy was the initial
focus owing to the through-space correlations and the possi-
bility to obtain distances between nuclei. Although several
intra-molecular NOEs were identified and subsequently quanti-
fied, no inter-molecular NOEs were observed to support the in-
teraction of the two peptides in the mixture. This may in part
be attributed to a crowdedness of the sidechain region of the
spectra, and most likely the absence of inter-peptide backbone
contacts.
However, other clear NMR indications of complex formation
were observed. There was a large shift in the rotational correla-
tion time. This change was visible in the NOESY spectra, as the
ratio of cross-peak to diagonal-peak intensity was significantly
higher for the mix of the peptides compared with the single
peptides. An increase in the size of the peptide, which should
correlate to a longer correlation time, would lead to an in-
crease in the NOE intensities (Tables SI1 and SI2 in the Support-
ing Information). Moreover, a number of variations in specific
inter-proton distances from NOEs of the target (largest for
residue R3) resulting from induced conformational changes
Figure 4. Net fluorescence intensity versus concentration of ligand 7 in solu-
tion. Squares: background, open circles: intensity obtained with compound
7 upon subtraction of the background.
Table 3. Binding constants, Kd, for binding of target 20 to the four
superior ligands identified.
Ligand Structure Kd [mm]
7 EDYEVEEG 0.6580.029
17 EDDWDDG 3.370.25
18 EDYEVDDG 6.951.49
19 EDYEWEEG 0.6610.059
Figure 5. The superior recognition pair consisting of target 20 and ligand 7. Screening was performed at pH 7.0, hence, R carried a positive charge while E
and D were negative. Arrows indicate the important charge–charge interactions.
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suggested significant interaction of ligand and target in the
mixture.
To further evaluate the binding interactions, we investigated
the change of backbone chemical shift (Figure 6). The overall
change in chemical shifts was insignificant in the target and
small in the ligand, indicating that binding occurred essentially
without major conformational changes. From the change in
backbone chemical shifts for ligand residues 3, 4, 5, 6, and 7, it
can be concluded that the ligand undergoes small adaptations
to the target structure during the binding event, possibly as
the two ends interact with the arginine residues of the target,
which induce a conformational change in the central part of
the ligand and an additional interaction with the target. Titra-
tion studies (see Figures SI3–SI5 in the Supporting Information)
confirmed that the changes in chemical shift are gradual when
titrating target 20 into the ligand 7. The amino-terminal alfa
protons in both ligand 7 and target 20 were particularly sensi-
tive to peptide interaction (Figure SI5). Dilution of the mixture
returned the chemical shift values back to the chemical shift
values of the free ligand. However, the chemical shifts for the
free ligand were not reached at concentrations suitable for
NMR (>10¢5m, compare Figure SI6 with SI4 in the
Supporting Information).
Restrained molecular dynamics (MD)
No direct NOEs could be observed between target 20 and
ligand 7. To provide structure information on distances, NOEs
and MD calculations of the complex were combined. The NOE
distances derived from the complex of ligand 7 and target 20,
were larger than those of the free compounds owing to an
increase in cross relaxation rate, leading to a better signal-to-
noise ratio. Therefore, these NOE determinations were first
implemented in annealing MD calculations for each individual
compound.
Structures that fulfilled all the observed distances were read-
ily obtained (see the Supporting Information). Assuming that
charge–charge interactions of both R3 and R8 are involved
and minimal structural changes occur during binding, only
four orientations of the ligand and target were feasible. Two of
those were most probable due to the NOEs of Arg-NH to Arg
side chain protons. The NOE restraints were maintained while
MD calculations of the complex in these two orientations were
performed, including several rounds of annealing from 700 K.
The complex presented in Figure 7 was by far the best fit and
in addition provided the highest calculated binding energy.
The free ligand conformation was determined from those of
the complex by implementing the NOE restraints determined
for the individual compounds in MD calculations with anneal-
ing (see Figure SI8c and e in the Supporting Information).
The complex provided turns both in the ligand and the
target sequence. The ligand had a turn at residue E5 and the
target at residues T6-H7, in strong agreement with the ob-
Figure 6. Changes in the chemical shifts in the amide region upon
complexation (a) of ligand 7 (b) and target 20 (c).
Figure 7. Model of the 7–20 complex derived through restrained (88 distan-
ces) MD computer simulations, showing the ball-and-stick representation
and Connolly molecular surface from two different angles.
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served NOEs. The His side chain folded into the turn and
showed a significant number of NOEs to neighboring residues.
The backbone NOE distances suggested a high degree of b-
strand structure from short NHn to CaH
n¢1 distances, which
were in agreement with the optimized structures, as illustrated
in separate images of the structures in the Supporting Informa-
tion. In the complex, there is tight interaction between target
residue R3 and ligand residues E1 and D2, whereas target
residue R8 is suspended between the carboxylates of ligand
residues E6 and E7.
The complex presents rim contact with a closed cavity con-
taining four water molecules (Figure 7), three of which are in
tight hydrogen-bonding contact with both ligand residue D2
and target residues Q1, T2, R3, H7, and R8 (see Figure SI9 in
the Supporting Information). We assume that this could be
one reason for the fact that no NOEs are observed between
the ligand and target in spite of the strong binding. The inter-
molecular distances in the structure derived for the complex
did not give rise to expected intermolecular NOEs. Most impor-
tantly, the ligand and target presented surface complementari-
ty in the topology of the complex, and the conformations of
the free compounds are quite similar to those observed in the
complex in full agreement with the NMR data. Although the
structure was an optimized fit to the observed NMR-data, we
acknowledge that this is a putative structure in the absence of
crystal data and direct intermolecular NOEs for this novel type
of binding.
Conclusions
In the present work, highly specific recognition based exclu-
sively on electrostatic interactions between linear peptides in
water was achieved through combinatorial screening. As dem-
onstrated, interaction between two peptides does not have to
involve lipophilic domains, but can be based entirely on the
optimal spatial arrangement of functional groups involved in
charge–charge and hydrogen-bond interactions. This seems to
be dependent on the native topology of the binding partners
and their topological matching of complementary electrostat-
ics. An important observation was the fact that specific molec-
ular interaction does not always provide NOEs resulting from
short proton–proton distances, although tumbling and other
spectral parameters clearly show the formation of a binary
complex. Particularly interesting was the contribution of
bound water for the complex formation suggested by restrain-
ed MD calculations. Such pairs of target peptides and match-
ing ligands may find many applications for selective recogni-
tion events in protein purification and in cell biology. We pre-
sented a peptide–target-based assay for finding the optimal
recognition pair by using a library biased towards the target
sequence. Other targets would have called for different bias
and would probably result in different modes of recognition.
Such studies are in progress.
Experimental Section
Materials
Beaded poly-ethylene glycol-poly-dimethyl acrylamide copolymer
PEGA800 resin was synthesized by radical inverse suspension poly-
merization of bis-acrylamido isopropyl polyethylene glycol (900)
and dimethyl acrylamide (5% by weight), as previously de-
scribed.[29] PEGA1900 was prepared accordingly by using bis-acryla-
mido isopropyl polyethylene glycol (2000) and acrylamide (5% by
weight). Fmoc amino acids were obtained from Bachem AG or
from Chemimpex. Solvents were high-purity grade from Sigma–
Aldrich and were used without further purification. Milli-Q water
(Millipore) was used throughout the work.
Synthesis of target on resin without HMBA linker
Dry PEGA800 resin (1.0 g, 0.33–0.35 mmol) was swelled in CH2Cl2
and washed with DMF (3 vol). The resin was coupled for 2 h with
a mixture of Fmoc-Gly-OH (272.9 mg, 0.918 mmol) and ATOTA-OSu
(59.5 mg, 0.102 mmol) pre-activated with 1H-benzotriazolyl tetra-
methyluronium tetrafluoroborate (TBTU, 314.4 mg, 0.98 mmol) and
4-ethylmorpholine (NEM, 173 mL, 1.36 mmol) in DMF (10 mL). Prior
to the coupling, the fluorescence of the resin was confirmed by
fluorescence microscopy and the resin presented strong fluores-
cence at 520 nm. Removal of the Fmoc-group with 20% piperidine
in DMF was confirmed by the Kaiser test, which showed intensely
colored blue beads. The subsequent Fmoc amino acids were
coupled to the resin by following the general solid-phase peptide
synthesis (SPPS) procedure (see the Supporting Information).
Library synthesis
A peptide library was synthesized on dried PEGA1900 resin (1.0 g,
bead diameter 400–500 mm, 0.2 mmolg¢1, 1.1Õ105 beads).
Before transfer into a 20-well multiple column peptide synthesizer
(MCPS), the HMBA-modified PEGA1900 resin was coupled with
Fmoc-Gly-OH in a sinter-fitted syringe.[30] The resin was transferred
to the MCPS instrument. To equally divide the beads into the col-
umns, the MPCS was filled with DMF (45 mL), sealed, turned over,
and shaken for 10 min. Then, the MCPS was turned upright and an
even distribution of the resin was visually confirmed. The Fmoc
group was removed by 20% piperidine in DMF including 2%
HOBt. After washing with DMF (6 vol), Fmoc-Asn(trt)-OH, Fmoc-
Phe-OH, Fmoc-Glu(tBu)-OH, Fmoc-Leu-OH, and Fmoc-Asp(OtBu)-
OH, pre-activated with TBTU and NEM, were sequentially coupled
to the resin for 1 h. Couplings were repeated to drive the reaction
to completion. The above-described mixing, splitting, and coupling
steps were repeated until the peptides consisted of eight residues.
Details about the amino acids used are shown in Table 1. Finally,
after removing the N-terminal Fmoc group, side chain deprotec-
tion was performed by treatment with aqueous trifluoroacetic acid
(TFA/H2O/triisopropysilane, 95:3:2). The library was washed with
95% aqueous acetic acid solution (3 vol), methanol (3 vol), CH2Cl2
(3 vol), and water (30 vol).
Library screening
The library was screened in two separate stages. First, the library
resin and the microbeads with target peptide were incubated in
separate containers with gentle agitation in water for 2 h. Then,
the library resin and target resin were mixed in water and the mix-
ture was incubated for 12 h with gentle stirring (150 rmin¢1),
avoiding grinding of the beads. Hits visualized by fluorescence mi-
croscopy were manually picked, transferred to a column, and
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washed with PBS buffer (50 mm, pH 7.4). In the second stage, the
hits were incubated in PBS buffer for 12 h. Hits that remained cov-
ered with microbeads were isolated, providing pairs displaying
strong recognition.
Peptide release from single beads and MS analysis
The small PEGA800 beads containing the target peptide were re-
moved from the positive library beads with a syringe needle, by
using a microscope for visualization. The library beads were trans-
ferred to separate wells of a 96-well plate. Release of the peptides
was achieved by addition of aqueous TEA solution (10 mL, 5%). The
cleavage mixture was allowed to react for 2 h at room tempera-
ture. The solutions were transferred to Eppendorf tubes. All beads
were washed twice with aqueous acetonitrile solution (20 mL, 70%)
for 10 min. Wash fractions were combined with the respective
cleavage solutions. The samples were lyophilized twice. Water was
added prior to the second lyophilization step to remove the major-
ity of TEA. Samples were analyzed by MALDI-MS as described in
the Supporting Information.
Resynthesis of hit sequences and verification of binding
Following the general SPPS procedure, the positive hits from the li-
brary and three consensus sequences were synthesized on 0.1 g
PEGA1900 resin. Following deprotection, the resin was incubated in
water for two hours. During this incubation, the water was ex-
changed three times. Small amounts of the ligand-containing
beads were transferred to a 96-well plate. Binding under the condi-
tions of water, urea solution, high salt, and FBS was investigated
both for assembly of microbeads on macrobeads and for dissocia-
tion of pre-assembled clusters. The beads were incubated for 0.5 h
in water, 0.4m NaCl aqueous solution, 0.4m urea solution, and
10% FBS aqueous solution. The density of small, target-containing
beads on the larger library beads was used as a qualitative mea-
sure of the binding affinity. The recognition was shown to be spe-
cific, as unrelated peptides did not show any binding in these
assays.
Synthesis of the fluorescein-labeled target
The amino fluorescein-labeled target was synthesized as follows.
HMBA-modified PEGA800 resin (0.5 g) was esterified with Fmoc-Gly-
OH by using 1-(2-mesitylenesulfonyl)-3-nitro-1H-1,2,4-triazole
(MSNT) and N-methylimidazole. For subsequent couplings, the
Fmoc group was removed with 20% piperidine in DMF and the
amino acid derivatives were activated as described above with
TBTU and NEM. Coupling reaction times were 2 h. The second
amino acid was tert-butoxycarbonyl (Boc)-protected Dap for at-
tachment of the fluorophore. After coupling of Fmoc-Dap(Boc)-OH
(204.6 mg, 0.48 mmol) by using TBTU (148 mg, 0.46 mmol) and
NEM (112 mL, 0.64 mmol), the Boc group was removed by 95% TFA
(1.5 h) and washed with CH2Cl2 (6 vol), methanol (6 vol), and CH2Cl2
(1 vol). The NH2 group was protected with an allyloxycarbonyl
(Aloc) group by following the procedure of Cilibrizzi.[31] The resin
was washed with cold CH2Cl2 and allyl chloroformate (Aloc-Cl,
20 mL, 0.2 mmol, 2.0 equiv) in cold CH2Cl2 was added and reacted
for 3 h. Then, the resin was washed with CH2Cl2 (3 vol), methanol
(3 vol), and DMF (3 vol). The other amino acids were coupled by
following the general SPPS procedure. Upon completion of the
peptide synthesis, the Aloc group was removed according to the
procedure by Thieriet.[32] The beads were washed with CH2Cl2, and
PhSiH3 (24 equiv, in CH2Cl2) was added under N2. The suspension
was bubbled with N2. Pd(PPh3)4 (0.1 equiv, in CH2Cl2) was added
and the reaction was allowed to take place for 15 min under N2
bubbling. The resin was washed and the process was repeated.
The reaction was monitored by using the Kaiser test. Following
washing with CH2Cl2 (3 vol), methanol (3 vol), and DMF (3 vol), a so-
lution of amino-fluorescein succinate (134.3 mg, 0.3 mmol,
3.0 equiv) was added and reacted for 2 h. After washing with DMF
(3 vol), methanol (3 vol), and CH2Cl2 (3 vol), the peptide was depro-
tected by using 20% piperidine and 95% TFA following the gener-
al SPPS procedure. The fluorescent-labeled peptide was purified by
preparative HPLC and analyzed by HRMS-ESI (m/z [M+2H+]: calcd
879.36676, found 879.36649).
Determination of Kd values
The fluorescently labeled target molecule (20.82 mg, 0.0118 mmol)
was dissolved as a 10 mm stock solution. This solution was diluted
in Milli-Q purified water to concentrations ranging from 0.001 mm
to 100 mm. A single bead was isolated and immobilized in the mi-
crochannel of a custom-made flow device (see the Supporting In-
formation). The fluorescence intensity was monitored by using an
Olympus IC73 fluorescence microscope. First, the bead labeled
with ligand 7 was incubated with the second highest (50 mm) and
highest (100 mm) concentrations of target solution. At these two
concentrations, the fluorescence intensity of the bead was shown
to be constant, hence, it was defined as the fluorescence intensity
at the point of saturation (IFmax). Unbound ligand was removed,
providing an IFmax of 5300. The target was completely eluted from
the bead in less than 1 min by using aqueous 0.1% TFA. The bead
was washed with Milli-Q water and the background intensity in the
absence of the fluorophore was determined. The bead was incu-
bated with a flow of 1 nm target solution until the fluorescence in-
tensity was constant. This was followed by flow of increasing
target concentrations (0.002, 0.004, 0.008, 0.016, 0.032, 0.064, 0.1,
0.2, 0.4, 0.6, 0.7, 0.8, 1, 2, 3, 5, 10, 15, 20 mm) until constant intensi-
ty. Each measurement was performed in triplicate and averaged.
The binding constants of ligands 17, 18, and 19 were determined
by using this same method.
Recognition measurements by 2D NMR spectroscopy
Solution-state NMR spectroscopy, in particular NOESY spectra, was
utilized to investigate the interactions between the two peptides.
All NMR spectra were acquired by using standard pulse sequences
on a Bruker Avance 800 spectrometer at 298 8C. Both pre-satura-
tion and watergate pulses were used for water suppression and
the resulting spectra were compared to ensure that the suppres-
sion did not affect the cross-peaks of, for example, the NOESY
spectra. The individual spectra were fully assigned from phase-sen-
sitive DQF-COSY, NOESY, and HSQC experiments. Spectra were ac-
quired for the individual peptides and for a mix of the two. The
pure target 20 (6.97 mg, 5.88 mmol) was dissolved in 0.5 mL D2O/
H2O (1:9). The pure ligand 7 (5.43 mg, 5.61 mmol) was dissolved in
0.5 mL D2O/H2O (1:9) and the pH was adjusted to 5.5, 6.0, or 6.5 by
using 1m NaOH solution. The pH of the target solution was adjust-
ed to 5.5, 6.0, or 6.5 by using NaOH solution. Oxygen was removed
by bubbling N2 through the solutions for 15 min. Following acquis-
ition of the individual NMR spectra of the ligand and target pep-
tides, the solutions were mixed. Oxygen was again removed by N2
bubbling. The mixture (0.5 mL) was transferred to an NMR tube
and subsequently NOESY and ROESY (rotating frame NOE spectros-
copy) spectra were acquired. Acquisition parameters and condi-
tions, as well as tables with observed distances, correlation times,
chemical shift differences, and experimental procedures of the
NMR titrations are presented in the Supporting Information.
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Abstract 
Six novel secondary metabolites, homomorphosins A-F, were isolated from the filamentous fungus 
Aspergillus homomorphus. The metabolites share structural features and the majority of compounds 
were discovered based on a proposed shared biosynthesis origin and the dereplication of proposed 
precursors. The structures of the compounds were elucidated using UHPLC-DAD-MS and 
especially NMR spectroscopy. Their respective stereochemistry was elucidated based on 
NOESY/ROESY data, back calculation of distances and chemical analysis using Marfey’s reagent.  
Introduction 
Aspergilus homomorphus is a lesser studied Aspergillus species residing in section Nigri (the black 
Aspergilli), which includes fungi such as A. niger and A. carbonarius.[1] Black aspergilli are of 
industrial use and known to cause food spoilage.[2] An example of the latter is A. niger which is 
used in large scale production of citric acid, but may also produce ochratoxin A and fumonisin 
B2.[3,4] A. homomorphus was first identified by R. Steiman et al. from soil near the Dead Sea in 
Israel, and belongs in the same clade as A. aculeatus. [1,5] 
Through the years a wide variety of secondary metabolites (SMs) have been reported from black 
Aspergilli.[6] The continued search for new chemical entities (NCEs) in the section is thus spurred 
by the ability of related species to produce quite different SMs.[7,8] A. homomorphus have 
previously been reported to produce secalonic acid D and F as well as dehydrocarolic acid.[1] Here 
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the SM chemistry of A. homomorphus is explored using UHPLC-DAD-MS and NMR spectroscopy 
in the continued search for both NCEs and the elucidation of their biosynthetic origin.  
Most of the reported structures share features and were identified through a proposed shared 
biosynthetic relationship, which was used to guide the identification and isolation of novel 
precursor compounds. This was proposed without any knowledge from genetics, as the genome of 
A. homomorphus has not yet been explored. 
Results and discussions 
The structures of the metabolites isolated and characterized from A. homomorphus are shown in 
Figure 1. Most of these are presumably altered non-ribosomal peptides (NRPs) with attached 
isoprene units. They are thereby related to other natural compounds such as okaramines, which are 
produced by other black aspergilli, e.g. A. aculeatus and A. indologenus, as well as Penicillium 
simplicissimum.[9–14] All relevant MS, UV and NMR data are found in the Supporting Information.  
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Figure 1. Novel compounds from A. homomorphus (1-6), compounds previously reported as 
“unnatural” (8,9)[15,16] and rediscovered compounds (7,10)[17,18]. Compound 7 is included due to 
its likely biosynthetic relationship with 1, 4, 5 and 6. Data of 8-10 may be found in the Structural 
data section. Also secalonic acid D and F were reconfirmed to be produced via UHPLC-DAD-
MS in accordance with previous publications.1  
Novel metabolites 
The common name of the novel compounds, homomorphosin, was chosen due to their fungal 
origin. The NMR data for the homomorphosins are given in Table 1. 
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Table 1. 1H NMR (500 or 800 MHz) and 13C NMR data (125 or 200 MHz) for 1-6 (in DMSO-d6. δ in ppm and J in Hz) 
# 1 2 3 4 5 6 
 δH (mult, J) δC δH (mult, J) δC δH (mult, J) δC δH (mult, J) δC δH (mult, J) δC δH (mult, J) δC 
1 6.72 (s)  6.69 (1,s)  6.66 (s)  10.59 (s)  10.51 (s)    
2  90.8  90.7  90.3  141.2  140.9 5.31 (s) 88.0 
5  139.3  139.3  139.3  132.7 7.42 (d,7.8) 117.8 7.17 (d,7.2) 122.3 
6 6.47 (d,7.6) 119.3 6.47 (d,7.4) 119.5 6.47 (d,7.4) 119.6 6.69 (d,7.1) 119.2 6.92 (t,7.1) 118.2 6.72 (t,7.4) 118.5 
7 6.99 (t,7.7) 129.4 6.99 (t,7.7) 129.3 6.99 (t,7.7) 129.5 6.92 (t,7.6) 120.4 7.00 (t,7.1) 120.3 7.11 (t,7.5) 129.7 
8 6.56 (d,7.8) 107.8 6.57 (d,7.6) 108.1 6.57 (d,7.4) 108.2 7.21 (d,7.9) 108.9 7.30 (d,8.0) 110.6 6.45 (d,7.9) 108.7 
10       6.84 (s)  7.49 (1,d,3.0)    
11 3.66 (dd,11.5,7.3) 57.0 3.68 (dd,11.5,7.3) 57.3 3.72 (dd,11.5,7.5) 57.4 4.03 (d,10.4) 55.9 3.99 (m) 55.4 4.57 (dd,11.6,6.3) 59.2 
12a 2.54 (m)  2.53 (m)  2.53 (m)  3.13 (dd,14.8,10.7)  2.99 (dd,14.5,9.2)  1.78 (m)  
12b 2.62 (dd,13.0,7.4)  2.62 (m)  2.63 (dd,11.5,7.4)  3.57a (m)  3.41 (dd,14.5,4.3)  2.40b (m)  
14 7.95 (s)  8.05 (s)  8.10 (s)  8.12 (s)  8.18 (d,2.7)  7.98 (s)  
15 3.77 (d,1.9) 60.4 3.84 (t,4.5) 56.1 3.89 (q,6.8) 51.3 3.57b (m) 59.2 3.48 (m) 59.6 4.02 (m) 60.4 
17a 2.32 (septd,7.1,2.0)  1.68 (m)  1.16 (m)  2.13 (m)  1.98 (dd,12.4,6.8)  2.40a (m)  
17b   1.71 (m)          
18 0.86 (d,6.8) 15.8 0.85 (t,7.3) 8.7   0.91 (d,6.7) 17.4 0.89 (d,6.8) 17.4 0.87 (d,6.8) 16.5 
19 0.98 (d,7.2) 18.1     0.99 (d,7.0) 18.5 0.96 (d,6.9) 18.4 1.02 (d,7.2) 18.5 
20a           3.93 (m)  
20b           4.00 (m)  
21 6.27 (dd,17.6,10.8) 145.2 6.27 (dd,17.6,10.9) 145.4 6.26 (dd,17.6,10.8) 145.6 6.16 (dd,17.5,10.5) 146.7 6.15 (dd,17.5,10.5) 146.3 5.08 (t,5.8) 119.9 
22a 4.85 (m)  4.84 (d,11.1)  4.85 (dd,12.8,1.7)  5.03 (d,11.0)  5.00 (m)    
22b 4.85 (m)  4.87 (d,17.6)  4.88 (dd,17.9,1.7)  5.04 (d,17.5)  5.03 (m)    
23 1.17 (s) 24.2 1.17 (s) 24.2 1.17 (s) 24.2 1.49 (s) 27.3 1.47 (s) 27.5 1.60 (s) 26.0 
24 1.20 (s) 24.5 1.20 (s) 24.6 1.19 (s) 24.6 1.52 (s) 27.8 1.48 (s) 27.5 1.67 (s) 18.4 
25a 3.33 (m)  3.34 (m)  3.34 (m)  3.67 (m)      
25b 3.47 (dd,15.6,7.3)  3.46 (dd,15.7,6.9)  3.47 (dd,15.7,7.5)  3.75 (m)      
26 5.22 (t,6.9) 123.0 5.23 (1,td,6.7,1.4) 123.1 5.23 (t,6.9) 123.2 5.21 (t,6.7) 123.9     
28 1.70 (s) 17.7 1.70 (s) 25.2 1.71 (s) 25.3 1.68a (s) 17.7     
29 1.70 (s) 25.2 1.69 (s) 17.6 1.70 (s) 17.6 1.68b (s) 25.5     
30 5.70 (s)  5.69 (s)  5.69 (s)        
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Homomorphosin A (1) was isolated as a white solid. The [M+H]+ of 1, m/z 438.2754, corresponds 
to a constituent formula of C26H36N3O3 (theoretical m/z 438.2751). The 35 protons found in the 1D 
1H spectrum were divided among six methyl groups at δH 0.86 (3H, d, J=6.8, H-18), 0.98 (3H, d, 
J=7.2, H3-19), 1.17 (3H, s, H3-23), 1.20 (3H, s, H3-24) and 1.70 (6H, s, H3-28/29), three aromatic 
protons at δH 6.47 (1H, d, J=7.6, H-6), 6.56 (1H, d, J=7.8, H-8) and 6.99 (1H, t, J=7.7, H-7), four 
olefinic protons at δH 4.85 (2H, m, H2-22), 5.22 (1H, t, J=6.9, H-26) and 6.27 (1H, dd, J=17.6, 10.8, 
H-21), two methines with neighboring heteroatoms at δH 3.66 (1H, dd, J=11.5, 7.3, H-11) and 3.77 
(1H, d, J=1.9, H-15), two diastereotopic methylenes at δH 2.54 (1H, m, H-12a), 2.62 (1H, dd, 
J=13.0, 7.4, H-12b), 3.33 (1H, m, H-25a) and 3.47 (1H, dd, J=15.6,7.3, H-25b), a methine at  δH 
2.32 (1H, septd, J=7.1, 2.0, H-17) along with exchangeable protons at δH 5.70 (1H, s, H-30), 6.72 
(1H, s, H-1) and 7.95 (1H, s, H-14). All protons could be coupled to their respective carbon 
resonances (as in Table 2) through gHSQC correlations. The diastereotopic protons and the 
resonance at 1.70 ppm could thus be elucidated. Five spin systems were established from the DQF-
COSY experiment; an aromatic, an olefinic and three aliphatic, and the spin systems and quaternary 
carbons were joined through gHMBC correlations as illustrated in Figure 2a. 
The relative stereochemistry of 1 is suggested from a network of NOEs obtained from NOESY and 
ROESY experiments with the key NOE being H-11/H-15, which established that the amino acids 
share handedness. NOE correlations between H-11/H-12b, H-12a/H-30, H-12a/H3-23/24 and H-
21/H-30 were all used to solve the remaining relative stereochemistry. The coupling constants of H-
11 and H-12a/b fit to the proposed stereochemistry of the methylene group with a smaller 3J-
coupling originating from H-11/H-12b in comparison to H-11/H-12a, which shows a large 3J-
coupling constant. Figure 2b includes the important NOEs, while 2c shows the 3D structure with 
the best fit to the correlating distances obtained by the isolated spin pair approximations (ISPA) and 
the observed coupling constants. The absolute configuration was solved by hydrolyses and reaction 
with Marfey’s reagent which suggested an L-configuration of valine.[19] The 3J-coupling constant 
between  H-15 and H-17 is 2.0 Hz which suggests a restriction in the rotation of the isopropyl group 
attached to C-1.  
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Figure 2. a: COSY spin systems (▬) and chosen HMBC correlations (→) of 1. b: Chosen NOEs  
(→) of 1. c: The 3D structure of 1 which fit the NOESY data the best. 
Biosynthesis of the homomorphosins 
The isolation of 1 led to a hypothetical biosynthesis as proposed in Figure 3, which in turn led to the 
discovery of more NRPs. This methodology of discovering new metabolites was used, as 1 was by 
far the main metabolite produced on the media used. The biosynthesis was proposed utilizing 
known reactions from organic and biochemical synthesis, starting from L-valine and L-tryptophan 
(not shown in figure). The mechanisms needed to obtain the compounds are two C-prenylations, an 
epoxidation and subsequent an intramolecular ring-closure. Both mechanisms have been described 
previously or suggested in the biosynthesis of other natural products. [20–29] 
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Figure 3. The suggested biosynthesis of 1. Compound 7 is proposed to be made by the 
cyclization of L-valine and L-tryptophan (not shown). [1] C-prenylation, [2] epoxidation/ring 
closure. 
A dereplication, utilizing UHPLC-DAD-MS (chromatograms in Figure 4), was then conducted in 
order to identify the proposed stable intermediates, which were all isolated and structure elucidated. 
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Figure 4. Base peak chromatogram (BPC) of extract of A. homomorphus (top) and extracted ion 
chromatograms (EICs) of the m/z values for the suggested intermediates with a mass tolerance of 
±0.005 Da in the biosynthesis of 1. Chromatograms are scaled.  
The novel diketopiperazines homomorphosins D (4) and E (5) as well as L-valyl-L-tryptophan 
anhydride (7) were isolated as white solids. The NMR data resembles that of 1 where structural 
features are shared, and the data of the rediscovered compound 7 corresponds to  literature data.[17] 
The NMR data and UVmax suggested that these compounds contain an indole ring which 
differentiates them from 1.[30] It is speculated that the compounds 4, 5 and 7 share a biosynthetic 
pathway though the genome sequence has yet to be explored. 
Due to the successful identification of precursors for 1, a new round of dereplication to identify 
structural analogues of 1 was conducted, with tryptophan coupled to other amino acids, which 
revealed compounds 2 and 3.  
Homomorphosins B (2) and C (3) were both white solids. The NMR data corresponds to that of 1, 
except that valine is exchanged with alanine (3) or the “unnatural” amino acid 2-aminobutyrate (2). 
The latter amino acid is not commonly found in natural diketopiperazines, although some have been 
published, which were functionalized at the α-position.[31] The 3J-coupling of H-15 and H-17 
increases as the size of the substituent attached to C-15 decreases, which may support the suggested 
rotational restriction for 1. 
Homomorphosin F (6) was isolated as a white solid (data found in supporting info). The compound 
differs from the other homomophosins, and compounds isolated from A. homomorphus in general, 
as it is N-prenylated. As for 1, 2 and 3 the UVmax of 6 showed a reduction of the indole ring. The 
alcohol 1H resonance did not appear in the NMR spectra, probably due to a high water content of 
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the sample. The proposed structure was mainly elucidated based on the constituent formula 
obtained from HRMS, the chemical shift of C-3 and the UV spectrum. The respective UV-spectra 
are compared in Supporting Information. 
The absolute stereochemistry of 2-6 is believed to be the same as that of 1 due to a similar relative 
stereochemistry in between the compounds, and the possible involvement of 4 and 5 in the 
biosynthesis of 1. The absolute stereochemistry of 7 was established by Marfey’s chemical analysis 
to be that of 1. No NOE between H-11 and H-15 was found in the NOESY/ROESY spectra of 3, 
which might suggest another relative configuration of the amino acids. This could also be due to the 
sparse amount of compound, as the sign of the optical rotation is of the same sign as that of the 
remaining homomorphosins. A DP4 analysis, as suggested by  Smith and Goodman,[32] of 
experimental and calculated shifts from optimized structures also points towards the L,L compound 
with a probability of 97.7 %. Coupled to the sign of the optical rotation the stereochemistry is 
deemed equal to that of 1. 
Conclusion 
A large scale cultivation of A. homomorphus led to the discovery of six novel NRP based 
metabolites with a diketopiperazines skeleton. They were all characterized using UHPLC-DAD-MS 
and NMR spectroscopy. Based on NOESY and ROESY NMR data, J-coupling constants and 
structural simulations the relative stereochemistry and a possible 3D structure for the compounds 
have been proposed. For compound 1 the absolute stereochemistry  was obtained using Marfey’s 
chemical analysis. It is speculated that all the new compounds have a shared biosynthetic origin. 
The proposed biosynthetic pathway was used to identify new metabolites and have gained 
credibility by the identification of the proposed structures by isolation of these and elucidation of 
their structures.   
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Experimental 
Fungal growth, extraction and the isolation of compounds. 
A. homomorphus (IBT 21893) was inoculated on different media to determine the preferred growth 
media and time in order to get as diverse a chemical profile as possible. The used media were yeast 
sucrose agar (YES), Czapek yeast extract agar (CYA), malt extract agar (MEA), oatmeal agar 
(OAT) and creatine sucrose agar (CREA) for 2, 5, 7 and 9 days.[33] The major metabolites from 
most growth media were homomorphosin A (1) and 3-methyl-4-methoxy-6-(4-phenyl-1,3-
butadienyl)-2H-pyran-2-one (9) which could originate from polyketide and Shikimi pathways.[34] 
The chosen media and time were YES for 7 days. 
A. homomorphus was inoculated as three-point stabs on agar plates and incubated in the dark at 30 
°C for 7 days. The used media were YES for the NRPs (200 plates) and MEA for the other isolated 
metabolites (50 plates). The fungi were harvested and extracted twice with EtOAc (1 % FA) (once 
overnight), m(YES) = 7.8 g, m(MEA) = 217.1 mg. The combined extract was dissolved in 9:1 
MeOH:H2O and washed with heptane. Water was added to give 1:1 MeOH/H2O and compounds 
were extracted with DCM followed by concentration in vacuo, m(YES) = 4.90 g, m(MEA) = 36.3 
mg. The DCM phase (YES) was absorbed onto reverse phase column material and fractioned by an 
Isolera One flash chromatography system by Biotage with auto-fractionation and a 120 g Biotage 
Snap KP-C18-HS column. The column volume used 132 mL and fractions of 115 mL (max) were 
collected. The gradient ranged from 30 to 100 % MeCN/H2O with a flow rate of 40 mL/min over 65 
min.   
The fractions (see table below) which showed possible targets after UHPLC-DAD-MS analysis 
were further purified on a semi-preparative HPLC; the Waters 600 Controller coupled to a Waters 
996 Photodiode Array Detector with a flow rate of 5 mL/min. The columns used were Luna II C18, 
5 μm, 250 × 10 mm by Phenomenex and Gemini C6-Phenyl, 5 μm, 250 × 10 mm by Phenomenex. 
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Table 2. Purification of compounds. 
 
Isolera fraction 
#/%MeCN:H2O 
m [mg] 
Waters run  
%MeCN:H2O/Time [min] 
Waters 
Time [min]/ %MeCN:H2O 
m [mg] 
1 15/70-74 180.7 - - 180.7 
2 13/64-68 72.0 Iso 65/15 7.3/65 2.7 
3 11/56-60 14.6 Grad 40-70/20 14.5/63 0.9 
4 13/64-68 72.0 Iso 65/15 7.7/65 3.6 
5 8/45-49 36.9 Iso 45/15 7.5/45 1.7 
6 4/30-34 72.6 Grad 30-40/15 5.3/34 8.1 
7 10/52-56 27.0 Iso 40/20 15.5/40 1.9 
8 - 36.3 Iso 55/20 13.4/55 1.7 
9 - 36.3 Iso 55/20 15.8/55 2.5 
10 8/45-49 36.9 Iso 45/15 6.35/45 3.5 
 
NMR 
All NMR spectra were acquired using standard pulse sequences on a Unity Inova 500 by Varian or 
on a Bruker Avance 800 spectrometer of the Danish Instrument Center for NMR Spectroscopy of 
Biological Macromolecules at 298 °C.[35–40] The deuterated solvent used for all compounds was 
DMSO-d6 which was used as internal standard (δH = 2.49 ppm, δC = 39.5 ppm). Typical acquisition 
conditions were as follows (exemplified by the conditions for homomorphosin A at 500 MHz). 1D 
1H: Spectrometer frequency (sf) = 499.87 MHz, spectral width (sw) = 5000.0 Hz, Fourier transform 
size (si) = 20480, acquisition time (aq) = 2.05 s, 90 ° pulse width (pw) = 7.0 µs, relaxation delay 
(rd) = 2 s, number of scans (ns) = 32, number of dummy scans (ds) = 8. gHSQC: sf = 499.87 MHz, 
sw(1H) = 5000.0 Hz, sw(13C) = 30007.7 Hz, si = 2048, ni = 512, aq = 0.20 s, pw = 6.9 µs, rd = 1.5 
s, ns = 8, ds = 64. DQF-COSY: sf = 499.87 MHz, sw = 5000.0 Hz, si = 2048, ni = 1024, aq = 0.20 
s, pw = 6.9 µs, rd = 1.5 s, ns = 8, ds = 16. gHMBC: sf = 499.87 MHz, sw(1H) = 5000.0 Hz, sw(13C) 
= 34999.7 Hz, si = 2048, ni = 512, aq = 0.20 s, pw = 6.9 µs, rd = 1.5 s, ns = 8, ds = 64. 
NOESY/ROESY: sf = 499.87 MHz, sw = 5000.0 Hz, si = 2048, ni = 512, aq = 0.20 s, pw = 7 µs, rd 
= 2 s, ns = 8, ds = 16. All spectra were processed as given, phase corrected and baseline corrected 
by a 5 degree polynomial function. 1D: Number of points (np) = 65k, windows function (wdw) = 
exponential, line broadening (lb) = 0.3. 2D: np(F1) = 1k, np(F2) = 4k, wdw(F1,F2) = sine squared, 
sine bell shift (sbs) (F1,F2) = 2. Reported J-coupling constants are reported as extracted from the 
spectra and may differ due to uncertainties.  
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Structural parameters from NMR 
To check the stereochemical assignment of homomorphosin A the isolated spin-pair approximation 
(ISPA) method, with increased linear range as suggested by Macura et al., was applied.[41] The 
applied mixing time was 150 ms which was found to be within the linear range (50, 100, 150, 200 
ms was used for buildup curve). The volumes from the peaks in the ROESY spectra were extracted 
by integration in Topspin3.1. For the calculation of J-couplings from dihedral angles the Karplus 
equation for amino acids was used.[42,43] Experimental couplings constants were measured in 1D 1H 
or DQF-COSY spectra and averaged if necessary. Structures were generated using Macromodel in 
the Maestro (Schrödinger Release 2013-2: Maestro, version 9.5, Schrödinger, LLC, New York, NY, 
2013). A conformational search was conducted in implicit DMSO, treated as a constant dielectric 
constant of 46. The mixed mode option was used with 10,000 steps and PRCG as minimization 
method using the force field MMFFs. Structures within 25 kJ of the found minimum was 
considered. From the conformational search 364 conformations was found. The structure which 
fitted the data the best was found by comparing back-calculated distances and J-couplings with the 
found values.  
Averaging of NMR parameters was done iteratively over 10,000 steps were each step included the 
structure which would give the best average fit to the data. NOE to J-couplings were weighted 10:1. 
Distances was averaged according to 𝑟𝑟𝑎𝑎𝑎𝑎𝑎𝑎 = 〈𝑟𝑟𝑖𝑖−6〉1/6. The script was written in-house in Matlab 
(R2013b, 8.2.0.701, The MathWorks, Inc., Natick, MA). 
UHPLC-DAD-MS 
UHPLC-DAD-MS data was acquired by a Maxis 3G UHR-QTOF-MS by Bruker Daltonics 
(Bremen, Germany) with an electrospray ionization (ESI) source combined with an UltiMate 3000 
Rapid Separation LC by system Thermo Scientific Dionex (Sunnyvale, CA, USA). The column 
used was a Kinetex C18, 100x2.1 mm, 2.6 μm, by Phenomenex (Torrance, CA, USA) maintained at 
40 °C. Solvents were acetonitrile (ACN) and H2O (buffered with 20 mM FA) and a linear gradient 
from 10 to 100 % (v/v) ACN over 10 min with a flow rate was 0.4 mL/min was used. MS was run 
in positive mode (ESI+) with a mass range of m/z 100–1000. Sodium formate was used as internal 
standard for mass calibration. UV/VIS spectra from the DAD were collected at wavelengths from 
200-700 nm. 
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Marfey’s reagent 
Stereoisometry of the amino acid valine was elucidated using Marfey’s method.[19] 100 μg of 1 and 
7 was hydrolyzed with 200 μL of 6 M HCl at 110 °C for 20 h. To the hydrolysis product and vials 
with 2.5 μmol of standard D- and L-amino acids were added 50 μL of water, 20 μL of 1 M NaHCO3 
solution, and 100 μL of 1 % 1-fluoro-2-4-dinitrophenyl-5-L-alanine amide (FDAA) in acetone and 
left at 40 °C for 1 h to react. The reaction mixtures were removed from the heat and neutralized 
with 10 μL of 2 M HCl, and the solutions were diluted with 820 μL of MeOH. See supporting 
information for more details. 
Structural data 
Homomorphosin A (1): HRMS:  m/z = 438.2754. [M+H]+, calculated for [C26H35N3O3+H]+: m/z = 
438.2751. Adducts: 460 [M+Na]+. [𝛼𝛼]589.320 𝐶𝐶  = -1.37° 
Homomorphosin B (2): HRMS:  m/z = 422.2803. [M+H]+, calculated for [C26H35N3O2+H]+: m/z = 
422.2802. Adducts: 444 [M+Na]+. [𝛼𝛼]589.320 𝐶𝐶  = -0.14° 
Homomorphosin C (3): HRMS:  m/z = 354.2181. [M+H]+, calculated for [C21H27N3O2+H]+: m/z = 
354.2176. Adducts: 376 [M+Na]+, 707 [2M+H]+, 729 [2M+Na]+. [𝛼𝛼]589.320 𝐶𝐶  = -0.15° 
Homomorphosin D (4): HRMS:  m/z = 424.2599. [M+H]+, calculated for [C25H33N3O3+H]+: m/z = 
424.2595. Adducts: 446 [M+Na]+, 869 [2M+Na]+. [𝛼𝛼]589.320 𝐶𝐶  = -0.55° 
Homomorphosin E (5): HRMS:  m/z = 410.2446. [M+H]+, calculated for [C24H31N3O3+H]+: m/z = 
410.2438. Adducts: 432 [M+Na]+, 841 [2M+Na]+. [𝛼𝛼]589.320 𝐶𝐶  = -0.66° 
Homomorphosin F (6): HRMS:  m/z = 370.2128. [M+H]+, calculated for [C20H19N3O2+H]+: m/z = 
370.2125. Adducts: none. [𝛼𝛼]589.320 𝐶𝐶  = -0.01° 
L-valyl-L-tryptophan anhydride (7)[17]: HRMS:  m/z = 286.1548. [M+H]+, calculated for 
[C16H19N3O2+H]+: m/z = 286.1550. Adducts: 308 [M+Na]+, 571 [2M+H]+, 593 [2M+Na]+.  [𝛼𝛼]589.320 𝐶𝐶  
= -0.14° 
1H NMR (499.9 MHz, DMSO-d6, 25 °C, 2.49 ppm):  δ 10.82 (s, 1H, H-1), 7.95 (s, 1H, H-14), 7.85 
(s, 1H, H-10), 7.58 (d, J = 7.8 Hz, 1H, H-5), 7.27 (d, J = 8.1 Hz, 1H, H-8), 7.06 (d, J = 2.1 Hz, 1H, 
H-3), 7.00 (t, J = 7.5 Hz, 1H, H-7), 6.92 (t, J = 7.4 Hz, 1H, H-6), 4.12 (t, J = 4.4 Hz, 1H, H-11), 
3.47 (dd, J = 3.6, 2.1, 1.6 Hz, 1H, H-15), 3.19 (dd, J = 14.4, 5.0 Hz, 1H, H-12b), 3.06 (dd, J = 14.4, 
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4.5 Hz, 1H, H-12a), 1.63 (sept-d, J = 6.9, 4.0 Hz, 1H, H-17), 0.59 (d, J = 7.0 Hz, 1H, H-18), 0.17 
(d, J = 6.8 Hz, 1H, H-19) 
13C NMR (125.7 MHz, DMSO-d6, 25 °C, 39.5 ppm): δ 166.8 (C-13), 166.2 (C-16), 135.5 (C-9), 
127.8 (C-4), 124.2 (C-2), 120.4 (C-7), 118.6 (C-5), 118.0 (C-6), 110.8 (C-8), 108.5 (C-3), 59.0 (C-
15), 54.9 (C-11), 30.7 (C-17), 28.4 (C-12), 18.0 (C-18), 15.8 (C-19) 
4-Methoxy-6-(4-phenyl-1,3-butadienyl)-2H-pyran-2-one (8)[15]: HRMS:  m/z = 255.1018. 
[M+H]+, calculated for [C16H14O3+H]+: m/z = 255.1016. Adducts: 277 [M+Na]+, 531 [2M+Na]+.  
1H NMR (499.9 MHz, DMSO-d6, 25 °C, 2.49 ppm):  δ 7.55 (d, J = 7.4 Hz, 2H, H-12), 7.38 (t, J = 
7.5 Hz, 2H, H-13), 7.30 (t, J = 7.3 Hz, 1H, H-14), 7.15 (mult, 1H, H-8), 7.10 (mult, 1H, H-9), 7.01 
(d, J = 14.8 Hz, 1H, H-10), 6.44 (d, J = 14.6 Hz, 1H, H-7), 6.31 (d, J = 2.1 Hz, 1H, H-5), 5.63 (d, J 
= 2.1 Hz, 1H, H-3), 3.83 (s, 3H, H-15) 
13C NMR (125.7 MHz, DMSO-d6, 25 °C, 39.5 ppm): 170.7 (C-4), 162.3 (C-2), 157.7 (C-6), 137.4 
(C-10), 136.1 (C-11), 134.0 (C-8), 128.5 (C-13), 128.3 (C-14), 127.2 (C-9), 126.6 (C-13), 122.5 (C-
7), 100.8 (C-5), 88.3 (C-3), 56.1 (C-15) 
3-Methyl-4-Methoxy-6-(4-phenyl-1,3-butadienyl)-2H-pyran-2-one (9)[16]: HRMS:  m/z = 
269.1171. [M+H]+, calculated for [C17H16O3+H]+: m/z = 269.1172. Adducts: 291 [M+Na]+, 559 
[2M+Na]+ 
1H NMR (499.9 MHz, DMSO-d6, 25 °C, 2.49 ppm):  δ 7.56 (d, J = 7.4 Hz, 2H, H-12), 7.38 (t, J = 
7.6 Hz, 2H, H-13), 7.30 (t, J = 7.3 Hz, 1H, H-14), 7.16 (mult, 1H, H-8), 7.16 (mult, 1H, H-9), 7.00 
(d, J = 14.6 Hz, 1H, H-10), 6.72 (s, 1H, H-5), 6.46 (d, J = 14.5 Hz, 1H, H-7), 3.92 (s, 3H, H-15), 
1.82 (s, 3H, H-16) 
13C NMR (125.7 MHz, DMSO-d6, 25 °C, 39.5 ppm): 165.9 (C-4), 163.3 (C-2), 156.7 (C-6), 137.4 
(C-10), 136.4 (C-11), 134.5 (C-8), 128.8 (C-13), 128.5 (C-14), 127.4 (C-9), 126.9 (C-12), 123.0 (C-
7), 100.8 (C-3), 96.9 (C-5), 56.6 (C-15), 8.8 (C-16) 
Q-20547-E (10)[18]: HRMS:  m/z = 645.2821. [M+H]+, calculated for [C37H36N6O5+H]+: m/z = 
645.2820. Adducts: 667 [M+Na]+.  [𝛼𝛼]589.320 𝐶𝐶  = -0.86°.  
1H NMR (499.9 MHz, DMSO-d6, 25 °C, 2.49 ppm):  8.91 (1H, s, formic acid), 8.05 (1H, s, H-14),  
7.96 (1H, s, H-14’), 7.73 (1H, m, H-8), 7.54 (1H, m, H-5), 7.27 (1H, m, H-5’), 7.24 (2H, m, H-7, H-
19’), 7.21 (1H, m, H-20’), 7.18 (1H, m, H-19’), 7.15 (2H, m, H-20’, H-21’), 7.07 (1H, m, H-6), 
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6.93 (1H, m, H-7’), 6.70 (1H, s, H-1’), 6.50 (1H, m, H-6’), 6.47 (1H, m, H-8’), 5.97 (1H,  s, H-2), 
5.09 (1H, s, H-2’), 4.35 (1H, t,  4.6, H-15’), 3.94 (1H,  s, H-15), 3.80 (1H, m, H-11), 3.78 (1H, m, 
H-11’), 3.08 (1H, m, H-17b’), 2.97 (1H, m, H-17a’), 2.73 (1H, m, H-12b), 2.67 (1H, m, H-12b’), 
2.32 (1H, m, H-12a), 2.25 (1H, m, H-17), 2.03 (1H,  t,  12.0, H-12a’), 0.92 (3H, d,  6.0, H-19), 0.73 
(3H, d,  6.4, H-18). 
13C NMR (125.7 MHz, DMSO-d6, 25 °C, 39.5 ppm): 167.8 (2C, C-16, C-13’), 165.8 (C-13), 164.7 
(C-16’), 161.9 (formic acid), 150.6 (C-9’), 141.0 (C-9), 137.0 (C-18’), 131.2 (C-4), 130.4 (C-20’), 
129.3 (C-21’), 129.1 (C-7), 129.0 (C-7’), 128.0 (C-19’), 126.6 (C-4’), 126.3 (2C, C-19’, C-20’), 
124.7 (C-5), 124.5 (C-6), 123.9 (C-5’), 117.6 (C-6’), 115.6 (C-8), 108.7 (C-8’), 76.7 (C-2), 76.6 (C-
2’), 59.3 (C-15), 58.5 (C-3’), 57.7 (C-3), 57.4 (C-11’), 57.2 (C-11), 55.1 (C-15’), 36.3 (C-12), 35.9 
(C-12’), 35.0 (C-17’), 28.7 (C-17), 18.0 (C-19), 16.3 (C-18) 
NOTE: Q-20547-E was isolated with as an amide of the secondary amine at position 5 and formic 
acid, which was used in the “large scale” extraction procedure (not plugs). By dereplication it was 
found that this artificial m/z peak only appears after extraction and was coupled to the 
disappearance of the m/z of unreacted Q-20547-E. 
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Spectra of homomorphosin A
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DQF-COSY
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ROESY (150 ms)
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Marfey’s reagents 
  
Figure S1. The retention times of the FDAA derivatives compared with retention times of the 
standard amino acid derivatives. 
 
UV-data 
The UV data shows that 1, 2, 3 and 6 probably share a similar chromophore. This is different than 
the chromophore of 4, 5 and 6 which corresponds to the absorption of an indole ring.  
        
Figure S2. UV data of the homomorphosins. 
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Stereochemistry of homomorphosin A 
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Figure S3. Numbering of homomorphosin A 
Table S1. Distances of homomorphosin A from ISPA in Å. a: used as reference. 
Nucleus 
1 
Nucleus 
2 Exp Dist 
Lower 
bound Violation 
Upper 
bound Violation 
1 8 2.66 2.39  2.92  1 21 2.88 4.18 1.30 5.11  1 23/24 2.44 2.10  2.56  6 25a 2.78 2.70  3.30  6 26 2.92 2.71  3.31  6 29 3.67 3.32  4.05  7 8 2.48a 2.23  2.73  11 15 2.46 2.20  2.69  14 15 2.72 2.46  3.00  14 17 2.94 3.33 0.39 4.07  15 18 3.05 3.17 0.12 3.88  15 19 2.58 2.25  2.75  15 17 2.53 2.27  2.77  17 18 2.30 2.08  2.54  17 19 2.30 2.07  2.53  21 23/24 2.47 2.26  2.77  21 12a 2.87 2.44  2.98  21 30 2.80 2.96 0.16 3.62  22b 23/24 2.28 2.07  2.53  22b 18 4.30 3.69  4.51  25b 29 2.59 2.46  3.00  25b 12b 2.26 1.88  2.30  26 28 2.39 2.15  2.63  30 23/24 2.41 2.38  2.91  30 12a 2.84 1.92  2.35 0.49 30 25b 2.95 2.89  3.53  
Table S2. Coupling J-constants in Hz for homomorphosin A. 
H1 H2 J exp. J calc Diff 
11 12b 7.3 8.0 0.7 
15 17 2.0 2.3 0.3 
11 12a 11.5 10.3 1.2 
 
When averaging over the 364 structures from a conformational search, and only taking the 
structures into account which leads to increased fit iteratively over 10,000 steps, the errors are all 
but eliminated as seen below. This serves to show that the errors seen for a single structure may be 
partially due to flexibility and subsequent conformational averaging. 
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 Figure S4. Superposition of the cyclic heavy atoms of ten structures which give the lowest 
averaged error. 
Table S3. Average distances for homomorphosin A from ISPA in Å. a: used as reference. 
Nucleus 
1 
Nucleus 
2 
Experimental 
distance 
Averaged 
distance Diff (Å) Diff (%) 
1 8 2.61 2.66 0.05 1.9 
1 21 2.88 2.96 0.08 2.7 
1 23/24 3.34 3.37 0.03 0.9 
6 25a 2.78 2.76 0.03 0.9 
6 26 2.79 2.80 0.01 0.3 
6 29 4.41 4.42 0.01 0.1 
7 8 2.48a 2.48 0.00 0.0 
11 15 2.53 2.44 0.09 3.7 
14 15 2.72 2.73 0.00 0.1 
14 17 2.94 2.93 0.01 0.5 
15 18 3.42 3.50 0.08 2.3 
15 17 2.25 2.52 0.27 12.1 
15 19 2.76 3.01 0.25 9.1 
17 18 2.81 2.62 0.20 7.0 
17 19 2.75 2.61 0.14 5.0 
21 12a 2.87 2.96 0.09 3.1 
21 23/24 3.10 3.28 0.18 5.8 
21 30 2.77 2.89 0.12 4.2 
22b 18 4.71 4.67 0.04 0.8 
22b 23/24 3.05 3.16 0.11 3.6 
25b 12b 2.18 2.27 0.09 4.1 
25b 29 3.11 3.07 0.04 1.3 
26 28 2.96 2.82 0.14 4.6 
30 12a 2.84 2.75 0.09 3.1 
30 23/24 3.09 3.35 0.26 8.5 
30 25b 2.81 2.92 0.11 4.0 
Table S4. Average J-coupling constants in Hz for homomorphosin A calculated by the HLA, or 
Altona, equation. 
H1 H2 J HLA J meas. Diff 
11 12b 6.5 7.3 0.8 
11 12a 10.2 11.5 1.3 
15 17 2.0 2.0 0.0 
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DP4 investigation of homomorphosin C 
A DP4 statistical investigation was conducted as suggested by Smith and Goodman as no NOE was 
observed between H11 and H15 for homomorphosin C, possibly due to very low amounts of 
compound isolated.[32] Homomorphosin C was truncated at C-20 and C-25 to simplify due to 
flexibility in the chains. Methyl groups were used as replacements. The shielding of C-2 and C-5 
was not used in the DP4 calculation, nor was any protons attached to heteroatoms. This resulted in 
eight proton chemical shifts and twelve carbons. The four diastereomers were optimized to 
B3LYP/6-31G(d) level and shielding tensors were calculated using mPW1PW91/6-311+G(2d,p) 
and GAIO in Gaussian09, revision C.01 (Gaussian, Inc., Wallingford CT, 2013). The IEFPCM 
solvent model was used for DMSO. Tables with calculated and experimental chemical shifts and 
the result of the DP4 analysis are included below. 
Table S5. Experimental vs. calculated 1H shifts in ppm. The stereochemistry of 1 and 14 is given 
as 1,14.  
H Exp. L,L Δ D,L Δ 
6 6.57 6.50 0.07 6.59 0.02 
7 6.99 7.03 0.04 7.10 0.11 
8 6.47 6.35 0.12 6.41 0.06 
11 3.72 3.85 0.13 3.81 0.09 
15 3.89 3.95 0.06 3.80 0.09 
17 1.16 1.08 0.08 1.24 0.08 
12a 2.63 2.98 0.35 2.82 0.19 
12b 2.53 2.38 0.15 2.03 0.50 
Table S5. Experimental vs. calculated 13C shifts in ppm. The stereochemistry of 1 and 14 is 
given as 1,14.  
C Exp. L,L Δ D,L Δ 
3 89.0 87.8 1.2 87.0 2.0 
4 127.2 126.9 0.3 126.7 0.5 
6 119.6 120.1 0.5 120.2 0.6 
7 129.5 131.0 1.5 131.2 1.7 
8 108.2 106.7 1.5 106.3 1.9 
9 149.4 151.1 1.7 151.8 2.4 
11 57.4 58.9 1.5 55.8 1.6 
12 34.6 33.6 1.0 36.9 2.3 
13 169.7 169.8 0.1 171.8 2.1 
15 51.3 53.3 2.0 55.3 4.0 
16 172.8 170.6 2.2 170.9 1.9 
17 14.9 13.6 1.3 13.3 1.6 
Table S5. The result of the DP4. The stereochemistry of 1 and 14 is given as 1,14. 
DP4 L,L D,L 
 97.7 2.3 
 
24 
 
S3 HMBC hetero: Spin-State-Selective HMBC for accurate measurement of long-range heteronuclear 
coupling constants. 
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Abstract 
  
A novel method, Spin-State-Selective (S3) HMBC hetero, for accurate measurement of heteronuclear 
coupling constants is introduced. The method extends the S3 HMBC technique for measurement of 
homonuclear coupling constants by appending a pulse sequence element that interchanges the polarization in 
e.g. 13C-1H pairs. This amounts to converting the spin-state selectivity from 1H spin states to 13C spin states 
in the spectra of long-range coupled 1H spins, allowing convenient measurement of heteronuclear coupling 
constants similarly to other S3 or E.COSY-type methods. As usual in this type of techniques, the accuracy of 
coupling constant measurement is independent of the size of the coupling constant of interest. The merits of 
the new method are demonstrated by application to vinyl acetate, the alkaloid strychnine, and the 
carbohydrate methyl β-maltoside. 
 
Keywords 
S3 HMBC; HMBC; RDC; J coupling constants; heteronuclear; small molecules 
 
Introduction 
Ever since the first discoveries of correlations between J coupling constants (Js) and molecular structure, 
methods for determining Js has been of keen interest .1,2 Both the magnitude and the sign of Js are necessary 
for correlation with structure, thus favoring techniques where both the value and sign of the coupling 
1 
 
constant is determined, unless the sign is known in advance. More recently, residual dipolar coupling 
constants (RDCs) have become a valuable addition to J coupling constants in structural work, and as RDCs 
depend on a time averaged molecular orientation in a suitable alignment medium, their signs are  crucial in 
obtaining structural information.3,4 For small organic molecules the most abundant RDCs determined are 
1DCH in weak alignment media where 1DCH <1JCH, and the sign is always known. This is not necessarily the 
case for long range coupling constants and thus the sign of nJ and nD is of utmost importance. 
The probably most prominent example of correlation between J and structure is represented by 3JHH coupling 
constants and dihedral angles,5–7 but further information is available from long range heteronuclear Js and 
RDCs, in particular in small organic molecules, which is the subject of this Communication. 
It extends the recently published technique S3 HMBC (Spin-State-Selective HMBC) designed for accurate 
measurement of homonuclear coupling constants based on editing of an HMBC-type spectrum into two 
subspectra corresponding to the α and β spin states of the 1H spin in a 13C-1H methine group, which is long-
range coupled to another proton. The extension results in the conversion of the 1H spin-state selectivity to a 
13C spin-state selectivity by application of a zero-quantum (ZQ) π rotation within the 13C-1H methine group. 
A similar approach was used in connection with the original S3 work.8We dub the new experiment S3 HMBC 
hetero and note that it is only applicable to 13C methine groups long-range coupled to protons of any kind. 
 
Method 
The approach to the new experiment is simplistic in that it includes the same five pulse sequences as S3 
HMBC, with the ZQ π rotation inserted right before acquisition sequences. The resulting data may thus be 
processed identically for both S3 HMBC experiments. Therefore it suffices to briefly review the principles of 
S3 HMBC. 
The five pulse sequences which constitute the experiment include three from multiplicity-edited HMBC13 
and two from the HAT HMBC experiment that also includes multiplicity editing.9,10 In the latter two 
experiments there are an additional S3 πz(S) rotation that creates an antiphase relationship between the 
resonances associated with the α and β spin states of the passive 1H spin attached to 13C nuclei, which is the 
basis of the original S3 HMBC. All five pulse sequences of S3 HMBC hetero are outlined in Fig. 1. 
The two subspectra for extraction of the coupling constants using S3 HMBC hetero are generated by the 
following two linear combinations of time-domain data: 
�[𝑎𝑎] − 1
2
[𝑏𝑏 + 𝑐𝑐]� ±  {𝑑𝑑 + 𝑒𝑒}           (1) 
where a to e refer to the individual pulse sequences in Fig. 1. The two resulting data sets are processed as 
ordinary HMBC data in magnitude mode and the subspectra contain methine as well as methyl group 13C 
cross peaks. Subspectra containing quaternary and methylene 13C cross peaks may be generated by other 
linear combinations, but they are not relevant in the present context. 
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The high editing accuracy of the S3 HMBC experiments is caused by elimination of error terms in the [b+c] 
and {d+e} linear combination which, except for perfect matching of τ = (21J)-1, results in slightly reduced 
signal intensity. This loss can for the sake of cross talk reduction be recovered by scaling [b+c] and {d+e} by 
small factors k and (2k/[k+1])½, respectively. These factors correspond to –1/cos(2πJτ) and 1/sin(πJτ), 
respectively, for methine groups. It is an option to apply the correction to individual cross peaks, but 
typically k = 1.05 is employed throughout the entire spectral data set. 
To illustrate the relationship between S3 HMBC and S3 HMBC hetero, spectra of vinyl acetate from the two 
experiments are shown in Fig. 2. In S3 HMBC the displacement of the multiplets in the two subspectra 
correspond to 3J(H3,H4a) and 3J(H3,H4b), respectively, whilst in S3 HMBC hetero the displacement of the 
multiplets in the two subspectra correspond to 2J(C3,H4a) and 2J(C3,H4b), respectively. The difference in 
multiplet patterns in the subspectra reflects the interchange of passive 1H3 and 13C3 spin states between S3 
HMBC and S3 HMBC hetero. Literature values for the two 2J(C3-H4a/b) coupling constants are +7.6 Hz and 
-7.9 Hz, respectively, which fit well to the extracted values.11 
A little cross talk is visible in the C3-H4b cross peak. It can be eliminated by the procedure outlined 
elsewhere,12 shown in the lower panel of Fig. 2. The resulting change in the measured coupling constant is 
only a minor, below 0.1 Hz .  
 
 
Figure 1. Excerpts of cross peaks of vinyl acetate from S3 HMBC and S3 HMBC hetero spectra using identical setup (0.22 M 
in DMSO-d6, 500 µl, 400 MHz, 16 scans, 4096 data points, 256 increments, zero filled to 32k × 1k, Jmin = 130 Hz, Jmax = 190 
Hz, Δ = 62.5 ms). All subspectra were scaled to the same peak intensity. The spectra in the upper part are shown without 
further correction whilst the cross peak of C3-H4b in the lower part was corrected subtracting 16 % of the β subspectrum 
from the α subspectrum and vice versa to fully eliminate cross talk.12 
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The additional ZQ π rotation in S3 HMBC hetero is expected to cause only a minor reduction in sensitivity 
compared to S3 HMBC, which was confirmed by our experiments. Nevertheless, it is clear that the 
interchange of 1H and 13C spin-state selectivity critically depends on absence of large off-resonance effect on 
13C. The MBOB or broadband HMBC approach to cover a broad range of heteronuclear long-range coupling 
constants can be readily employed by repeating the experiment using different Δ delays in the pulse 
sequences and co-adding the resulting edited subspectra.13,14 
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Figure 2. S3 HMBC hetero pulse sequence based on a-c) the sequences for edited HMBC, and d,e) the sequences for HAT 
HMBC, all shown with a 2nd order low-pass J filter. Filled and open bars refer to π/2 and π pulses, the dashed open boxes 
represent 13C decoupling. τ = (2 1JCH)-1 or (1Jmax + 1Jmin)-1, δ is a gradient delay, ε = 2 t1/2,min+t(πH), ε’ = ε + t(πC), τ1 = ½[1Jmin + 
0.146 (1Jmax - 1Jmin)]-1, τ3 = ½[1Jmax - 0.146 (1Jmax - 1Jmin)]-1. Δ is the delay for evolution under heteronuclear long-range 
coupling constants. The gradient pair encasing the new pulses was set to ±4/√1.5G ~ ±3.27G .  φ1 = {x, x 4(-x), x, x}, φ2 = {4(x), 
8(-x), 4(x)}, φ3 = {8(x), 8(y), 8(-x), 8(-y)}, φ4 = {y, -y, -y, y}, φ5 = {x, -x, -x, x}.  
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Application 
To demonstrate the S3 HMBC hetero pulse sequence,  nJCH coupling constants of the alkaloid strychnine were 
determined. Strychnine is the benchmark molecule for heteronuclear small-molecule NMR experiments, and 
a large number of nJCH coupling constants have been previously published for comparison, see Table 1.15–19 
As for S3 HMBC, the sizes and signs of the coupling constants are easily extracted by measuring the 
multiplet displacements in the two subspectra, leading to the determination of 23 nJCH coupling constants. Of 
these, 20 were included in the chosen comparison publications and are in excellent agreement. Most of the 
comparative experiments do not yield the sign of the coupling constants, but in all those that do there is full 
agreement with the signs determined with S3 HMBC hetero. All signs determined also agree with theoretical 
coupling constants from DFT calculations. The calculated theoretical coupling constants may be scaled, as 
previously shown for other coupling constant calculations, to obtain a better correlation to the data.19,20 
Excerpts of representative cross peaks are found in Figure 3.  
Coupling constants were calculated in Gaussian09 using MPW1PW91/6-311G+(d,p) from the lowest energy 
structures optimized to the same level of theory which was found to give a good correlation in between 
experimental and theoretical data. The theoretical coupling constants are in line with previously reported 
calculated coupling constants of strychnine.19,21  
 
Figure 3. Examples S3 HMBC hetero cross peaks for strychnine (0.18 M in CDCl3, 500 µl, 400 MHz, 16 scans, 4096 data 
points, 256 increments, zero filled to 32k × 1k, Jmin = 124 Hz, Jmax = 167 Hz, δ = 62.5 ms). The coupling constants were 
measured by displacing 1D sections in analogy to the E.COSY method. The excerpts were scaled individually to the same 
intensity.  
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Table 1. Experimental and theoretical nJCH coupling constants of strychnine measured at 400 MHz, compared to 
experimental data from different experiments, see references [15–18]. Both optimization and J coupling constant calculations 
were performed at a MPW1PW91/6-311+G(d,P) level of theory. Calculated coupling constants are given without scaling and 
linearly scaled to the experimental data as Jscaled = (Jcalc-b)/a, with a = 0.92, b = -0.14. The figure on the right depicts S3 HMBC 
hetero data versus the scaled theoretical data, RMSD = 0.23 Hz.  
H C Experimental (Hz) Theoretical (Hz) 
# # S3 HMBC hetero [
15] [16] [17] [18] Calc. Scaled 
1 3 7.4 7.5,7.2 
   
6.7 7.4 
2 4 7.9 
    
7.0 7.8 
3 1 8.9 8.9,9.3 
   
8.1 8.9 
4 2 7.7 
 
7.5,7.4 7.9 
 
7.1 7.8 
8 12 6.4 5.8,5.6 5.5,5.6 5.3 
 
5.6 6.2 
8 13 -1.7 
 
 
  
-1.7 -1.6 
11b 12 -7.1 6.9,-6.9 7,6.9 6.8 
 
-6.9 -7.3 
13 8 -6.3  6.3,6.4,6.3 6.2  -6.0 -6.3 
13 14 -4.9 5.5,-4.5 4.6,4.7 4.5 4.7 -4.7 -5.0 
15a 13 7.7 
 
8,8.1 8 7.9 7.0 7.7 
15a 14 -2.9 1.2,-2.9 1.8,2.8,2.8 2 3.2 -2.5 -2.6 
15a 16 -4.6 
 
4.5,4.3 4 
 
-4.3 -4.5 
15b 14 -3.2 2.3,-2.6 3.2,3.6 2.8 4.8 -3.1 -3.2 
15b 16 -1.9 
 
2.7,3 1.4 
 
-2.1 -2.2 
16 14 6.2 6.7,6.4  
 
6.4 5.8 6.4 
20a 22 1.4     1.3 1.6 
20a 22 5.6 4.7,5 6.1,5.8 5.1 
 
4.6 5.1 
20b 14 5.5 5.7,5.4 5.4,5.3 5.1 5.5 4.7 5.2 
20b 16 7.8 
 
6.9,6.9 6.7 
 
6.3 6.9 
20b 22 4.6 5.1,5.5 4.5,4.6 4.2 
 
4.6 5.1 
22 14 8.5 8.5,8.6 7.9,8.5,8.6 8.8 8.9 8.0 8.8 
23a 22 -3.8 4.2,-3.8 3.8,4 
  
-3.8 -3.9 
23b 22 -3.4 3.6,-3.4 4,3.9 
  
-3.0 -3.1 
 
 
An immediate application of the new pulse sequence is in conformational studies of polysaccharides, where 
the heteronuclear coupling constants across the glycosidic linkage have proven valuable.22–25 To test the 
applicability of the S3 HMBC hetero in the extraction of such coupling constants, spectra of the disaccharide 
methyl β-maltoside were acquired, and a coupling constant across the glycosidic linkage is shown in Figure 
4. The 3JCOCH-coupling constant may be compared to a previously reported value of 4.0 Hz.25 The 3JCH-
coupling constant of the C1’-H4 pair was not determined, due to spectral overlap in between H4 and H2’ and 
strong coupling interference from the strongly coupled H4-H5 proton pair. 
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Figure 4. A S3 HMBC hetero cross peak across the glycosidic linkage of methyl β-maltoside, shown to the right. (56 mM in 
D2O, 500 µl, 800 MHz, 16 scans, 4096 data points, 256 increments, zero filled to 16k × 1k, Jmin = 140 Hz, Jmax = 171 Hz, δ = 
125 ms). The coupling constants were measured by displacing 1D sections in analogy to the E.COSY method.  
Conclusions 
The S3 HMBC experiment for measurement of homonuclear coupling constants has been extended to cover 
heteronuclear coupling constants involving methine groups and dubbed S3 HMBC hetero. The extension 
consists of insertion of a ZQ π rotation in the pulse sequence prior to acquisition in S3 HMBC. The method 
was successfully tested on the alkaloid strychnine with accurate measurement of 23 long-range JCH. The 
experiment is expected not least to find widespread application to carbohydrates where methine groups are 
abundant and the valuable conformational information contained in the inter-glycosidic 3JCH coupling 
constants, which was exemplified by the disaccharide methyl β-maltoside.22,25,26 
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Atom # 
1H chemical shift [ppm] 
multiplicity, J [Hz] 
13C chemical shift [ppm] 
1 7.12, 1H, d, 7.6 122.3 
2 7.05, 1H, t, 7.6, 124.3 
3 7.21, 1H, t, 7.8 128.6 
4 8.05, 1H, d, 8.0 116.2 
5 - 142.3 
6 - 132.9 
7 - 51.9 
8 3.82, 1H, d, 10.4 60.1 
9-N - - 
10 - 169.4 
11a 3.09, 1H, m 42.4 
11b 2.63, 1H, dd, 17.5, 3.4 42.4 
12 4.25, 1H, dt, 8.2, 3.4 77.5 
13 1.23, 1H, dt, 10.5, 3.2 48.1 
14 3.10, 1H, m 31.5 
15a 2.31, 1H, dt, 14.4, 4.3 26.7 
15b 1.41, 1H, br. d, 14.5 26.7 
16 3.90, 1H,  br. S 60.1 
17a/b 1.84, 2H, m 42.8 
18a 3.15, 1H, m 50.2 
18b 2.83, 1H, m 50.2 
19-N - - 
20a 3.66, 1H, d, 14.9 52.6 
20b 2.69, 1H, d, 14.6 52.6 
21 - 140.6 
22 5.86, 1H, m 127.3 
23a 4.10, 1H, dd, 13.7, 7.1 64.6 
23b 4.02, 1H, dd, 13.7, 5.9 64.6 
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Atom  # 
1H chemical shift [ppm] 
multiplicity, J [Hz] 
13C chemical shift [ppm] 
1 4.33, 1H, d, 8.0 102.9 
2 3.23, 1H, dd, 9.4, 8.1 72.9 
3 3.71, 1H, m 76.1 
4 3.55, 1H, m 76.7 
5 3.54, 1H, m 74.4 
6a 3.72, 1H, m 60.6 
6b 3.88, 1H, dd, 12.2, 1.8 60.6 
1’ 5.35, 1H, d, 4.1 99.4 
2’ 3.51, 1H, m 71.8 
3’ 3.62, 1H, m 72.6 
4’ 3.33, 1H, t, 9.5 69.2 
5’ 3.64, 1H, m 72.8 
6’a 3.69, 1H, m 60.3 
6’b 3.79, 1H, dd, 12.2, 2.1 60.3 
OMe 3.50, 3H, s 57.0 
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Fig. S1. Comparison of the J cross talk in standard and edited spectra of the C3-H4a crosspeak of vinyl acetate. Edited as αS 
= α - kS·β and βS = β - kS·α. The difference in the extracted JCH-coupling constant is below 0.1 Hz. 
 
Akin to the original S3 HMBC work, a script written in Matlab was used to extract the coupling constants 
from the subspectra. A comparison between this automated extraction, and the coupling constants 
determined manually is seen in Fig. S2 
 
Fig. S2. Manual versus automatic extraction of J coupling constants 
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Fig. S3. S3 HMBC hetero spectrum of strychnine. (-) spectrum (red) offset vertically to better visualize displacements. 
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